
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-15001-15300*
  '(".225+2T" ".2545+591C" ".2625+367A" ".9118-2A " ".9118-2G " ".9402delT"
    "A-box" "A-box-mutated" "A-negative" "A-positive" "A-type" "A1846G" "A20-m"
    "A227T" "A251T" "A549-H" "A549-L" "A767T" "A85V" "A939572-treated" "AA-861"
    "AA-MLC" "AC61" "ACA45" "ACCCGC" "ACS" "ACTRN12609001036202" "AD-like"
    "AD169" "AECs" "AF35" "AGEs-RAGE" "AGEs-RAGE-induced" "AGEs-induced"
    "AGEs-mediated" "AGEs-treated" "AGEs–endothelium" "AGGTCA" "AGN2a"
    "AID2-expressing" "AIDS-like" "AIP1–SNAP647" "AJCC-UICC" "AK015428"
    "AK098037" "AKT-mTOR-p70S6K" "AKT-related" "AKT1-E17K-expressing"
    "ALIX-dependent" "AM-630" "AM1" "AM1-BCC" "AMBER" "AMPK-Ulk"
    "AMPK-defective" "AMPKa" "AMPKα2" "ANOS1" "ANZCTR" "AP-MS" "AP5" "APACHE"
    "APACHE-II" "APAK" "APOE*e4" "APPswe" "AQAAA" "AR-wt" "AR458323" "ARCaPE"
    "ARCaPM" "ARE-like" "ARMCX1" "ARMCX3" "ARMS-qPCR" "ARS" "ARSSRNEYMRS" "ARV"
    "ARVs" "ARintoS" "ASCO" "ASPM" "ATCC" "ATGG" "ATM-Rad3-related" "ATMi"
    "ATP-actin" "ATP-bound" "ATTG" "ATXN2" "AVN" "AVN-944" "AW" "AZD9150"
    "Abcam" "Abdel-Fatah’s" "Abnormally-amplified" "Absorptiometry" "Achilles"
    "Actinidia" "Ad" "Ad-GFP" "Ad-GFP-infected" "Ad-PP2A" "Ad-PP2A-infected"
    "Ad-PTEN" "Ad-derived" "Ad-dn-Akt" "Ad-dn-PP2A" "Ad-induced" "Ad-mTOR-T"
    "Ad-mTOR-T-infected" "Ad-mediated" "Ad35" "Ad5" "Ad5F35" "AdCC" "AdCCs"
    "AdF35-MK" "AdF35-Sur" "Adda" "Adenoid" "Advanced" "Affymetrix" "Africa"
    "African" "African-American" "Africans" "Afro-Caribbean" "Agami"
    "Age-at-onset" "Ago-binding" "Ahrens" "Aichi" "Akavia"
    "Akt-inhibition-induced" "AktVIII" "Alexa" "All-L" "Allen" "Alpha-Lipoic"
    "Alpha-lipoic" "Alphaherpesvirinae" "Alphaviridae" "Alzheimer"
    "Alzheimer's" "Alzheimer’s" "Amadori" "Amaxa" "America" "American" "Amish"
    "AmpliSeq" "Amplicon" "Amsterdam" "Analyser" "Andrei" "AngII" "Angelis"
    "Angulo" "Ankara" "Anti" "Anura" "Apaf-1" "ApoEˉ" "Arab" "Arabia" "Araki"
    "Arg+Arg" "Arg194Trp" "Arg399Gln" "Ariad" "Arriola" "Artemisia" "Asamura"
    "Asan" "Asaoka" "Ashkenazi" "Asian" "Asians" "Asp-Glu-Val-Asp-Gly"
    "Asp1023-Asp1024" "AspGTC" "AstraZeneca" "Atoh" "Atoh1-CreER" "Attaleb"
    "Aurora" "Auspep" "Australia" "Austria" "Autosomal-dominant" "Aves" "Avi"
    "AxxA" "AzdC" "Aβ" "A–E" "A’Eurasian-type" "A→G" "B-DNA" "B-LCL" "B-LCLs"
    "B-cyclin" "B-lineage" "B-lymphoblastoid" "B-lymphoid" "B-lymphomas"
    "B-mediated" "B1" "B1–DNA" "B2GALNT1" "B80-T8" "B95.8" "BABE" "BADGE"
    "BAFT" "BALB" "BAPTA-AM" "BAY1170-82" "BC" "BCAR4" "BCR-ABL1" "BCR-antigen"
    "BCR-triggering-induced" "BCRA1" "BCRs" "BCSS" "BD" "BE-2C"
    "BEAS-AKT1-E17K" "BEAS-AKT1-E17K-shp27" "BEAS-AKT1-WT" "BEAS-C"
    "BEAS-PI3K-E545K" "BEAS-PIK3CA" "BEAS-p27-4A" "BEAS-shPTEN" "BEX-1" "BGJ"
    "BGJ398" "BH3-only" "BHK21" "BICR" "BJ" "BL1" "BLBC" "BLOC-1" "BMFS"
    "BMH-21" "BMI" "BMS" "BMS-225975" "BMS-893204" "BOLERO-2" "BOLEROII" "BRA"
    "BRCA-mutated" "BRCA1-miR-143-miR-145" "BRCA1-mutated" "BRCA1a" "BRD3"
    "BRDT" "BRDs" "BSW" "BWA" "BZLF1" "Ba" "Background" "Baechler" "Baird"
    "Bak-dependent" "Bak-independent" "Bak-induced" "Bak-mediated" "Baltimore"
    "Barlow" "Barrett" "Barrett’s" "Bartek" "Basak" "Battafarano" "Bax"
    "Bax-deficient" "Bck" "Bck-xL" "Bcl-2-inhibitable" "Bdz" "BeadChip"
    "BeadChips" "Beckman" "Beckman-Coulter" "Becton" "Begg" "Begg’s" "Behcet"
    "Bel-7402" "Belgium" "Benson" "Bethesda" "Beyotime" "Bhaskara" "Bick"
    "Bicêtre" "Bigas" "Bindea" "Bio" "Bio-informational" "BioBank" "BioGRID"
    "BioNeer" "BioNet" "Biomedica" "Biorad" "Biosystems" "Bista" "Blanchet"
    "Blaschko" "Blaschko’s" "BoM" "Boccardi" "Bock" "BodyMap" "Bonferroni"
    "Boston" "Boyden" "BrM" "Bradford" "Braf" "Brca1" "Brd" "BrdU-ChIP"
    "BrdUrd" "Brehm" "Brieher" "British" "Brouwer" "Browser" "Brucea" "Brucein"
    "Bruton" "Bryophyta" "Bub1-Venus" "Bub1ΔCD1-Venus" "Bub1–Mad1" "Bucur"
    "Bueno" "Bueno’s" "Burkitt" "Burkitt’s" "Burris" "Burstein" "Bz" "Bz-only"
    "Bzd" "B–C" "B–G" "C-labeled" "C-labeling" "C-lobe" "C-mediated" "C-β"
    "C-θ" "C1" "C1-C4" "C1501X" "C18" "C1orf" "C1orf43" "C1orf97" "C2" "C2–10"
    "C3" "C3-C4" "C30C31" "C33A-SOX9-1" "C3H10T1" "C4" "C5" "C57BL6" "C57Bl6"
    "C797S-mutant" "CA058187" "CA19-9" "CAAG" "CACCC" "CALGB" "CAP" "CAP10"
    "CAP10-like" "CARHSP1" "CARLo-5" "CB17" "CCAAT" "CCAT" "CCAT1" "CCAT8"
    "CCFF" "CCGGAA" "CCGGAG" "CCL221" "CCL4L1" "CCND1-HA" "CCND1p" "CCNE" "CCR"
    "CCSG" "CCSP-rtTA" "CD" "CD042" "CD133-negtive" "CD133-positive" "CD34-PAS"
    "CD44v10" "CD44v5" "CD44v6" "CD44v8–10" "CD8α" "CDC25s" "CDC6_w0.5_MCM7"
    "CDC6_w0.5_MCM7_w0.5" "CDC6_w0.5_MCM7_w0.5_sGRWD1"
    "CDC6_w0.5_MCM7_w0.5_sGRWD1_w0.5_SNS" "CDK2-DN" "CDK2-V5" "CDKN1A-S"
    "CE-TOF" "CE-TOFMS" "CEF" "CEN8" "CEP17" "CEP7" "CFCF" "CFFC" "CFPAC" "CGI"
    "CGI3" "CGIs" "CGTACG" "CH157-MN" "CHARMM" "CHEC" "CHK1i" "CHLA" "CHLA-171"
    "CHLA-79" "CHMs" "CHP-212" "CHP-901" "CI-1.03–3.27" "CI=1.30–2.75"
    "CI=1.31–2.77" "CID" "CIMP" "CIMS" "CK2a" "CK6" "CLB-Ga" "CLBGa" "CLCGP"
    "CLCGP-NGM" "CLIP-seq" "CLL-like" "CM-DCFH" "CM-DCFH2-DA" "CMIR" "CN-LM1a"
    "CNS1" "CNS2" "CNSs" "CNV" "CNVs" "CO23" "COAD" "COBRA" "COPI-vesicle"
    "COSM164493" "CPA3" "CPPED1"
    "CR011-maleimidocaproyl-valinecitruline-monomethyl" "CR011-vcMMAE" "CRE-2"
    "CRIF" "CRISPR" "CRL-1593.2" "CRLM" "CRM197" "CSC2" "CSDA" "CT1-10" "CTAR1"
    "CTAR2" "CTAR3" "CTC" "CTDSP" "CTDSP-like" "CTDSPL2" "CTG" "CTGFsi" "CTTG"
    "CU" "CU-box" "CU-boxes" "CUL4" "CV2" "CW" "CWWG" "CX-5461"
    "CX-5461-induced" "CX-5461dose" "Cagliari" "Calbiochem"
    "Calcium-stress-induced" "Callahan" "Callahan’s" "Cambridge" "Camidge"
    "Campisi" "Canada" "Canadians" "Cancer" "Cantu" "Caprioli" "Caribbean"
    "Carlsbad" "Caro" "Carrassa" "CasPro" "Casali" "CaspPro" "Caspase-9"
    "Castleman" "Caucasians" "Cav-1" "Cd" "Cd-activated" "Cd-elevated"
    "Cd-elicited" "Cd-exposed" "Cd-inactivation" "Cd-increased" "Cd-induced"
    "Cd-poisoning" "Cd-triggered" "Cdk1" "Cdt" "Cdt6" "CePa" "CeRNA"
    "Cedarlane" "Cedex" "CellTiterGlo" "Celldex" "CenpE" "Center-Institute"
    "Cergy" "Cergy-Pontoise" "Ceriops" "ChIP" "ChIP-deep" "ChIP-microarray"
    "ChIP-qPCR" "Chae" "Chandarlapaty" "Chandra" "Chaoshan" "Chaperone-like"
    "Charcot-Marie-Tooth" "Charles" "Chatterjee" "Cheng" "Cheong" "Chi-Squared"
    "Chi-square" "Chiang" "Chiba" "Chicago" "Chicas" "Chicken" "Chinnaiyan"
    "Chiu" "Chk1" "Chk1-CA" "Chordata" "Chou" "Chou-Talalay" "Chr8"
    "Chromatin-immunoprecipitation" "Chu" "Chugai" "Chw" "Cip" "Cip1" "Cl"
    "Clara" "Clear-cell" "Click-iT" "Clin" "ClinicalTrials" "Close-range"
    "ClusPro" "Cluster1" "Cmini" "Cntl" "CoC" "Cof1+AIP1" "Cohen" "Cohen’s"
    "Collado" "Colo" "Colo357-Scr" "Colo357-sh" "Colombo" "Colorado" "Comité"
    "Commisso" "CompE" "Compagno" "CompareACE" "Complex" "Con-miR"
    "Con-miR-transfected" "ConSite" "Condel" "Connell" "Conroy" "Coomasie"
    "Coomassie" "Cor1B" "Cor1B–Cof1–AIP1" "Cor1B–SNAP649" "Corcoran" "Cornils"
    "Costa" "Costanzo" "Cowell" "Cox-2" "Cox-model" "Cp-value" "CpG15" "Cpg"
    "Cre" "CreER" "Crispr" "Crohn" "Crohn's" "Cruz" "Cs" "CucI" "Cut-off"
    "Cutsem" "Cybulski" "Cyclosome" "Cyclus3D" "Cylcin" "Czech" "Cα" "C‐4"
    "C→T" "D&E" "D-PBS" "D-cyclin" "D-type" "D538G" "D770_N771insGL" "D946N"
    "DASL" "DAVID" "DBD-truncated-Elk-1" "DBD-truncated-MZF-1" "DCFH" "DCq"
    "DE-luciferase" "DEFA1" "DEVD" "DEVDG" "DF1" "DG" "DHPLC" "DHT-liganded"
    "DIANA" "DIANA-Lab" "DIV" "DKK1-4" "DL23" "DLCBL" "DLD1" "DLD1-derived"
    "DMAP" "DMEM" "DMR" "DMR1" "DMRs" "DN-AA-MLC" "DNA-binding-deficient"
    "DNA-copy-number" "DNA-damaging" "DNA-methyltransferase" "DNA-protein"
    "DNase‐mediated" "DO-1" "DOTAP" "DOX-induced" "DOX-insensitive"
    "DOX-treated" "DP2-BSW" "DPSCs" "DQ-BSA" "DRA001271" "DSBs" "DSPs" "DSSP"
    "DTIC" "DU-145R" "DXA" "DY647-labelled" "DZNep" "DaeJeon" "Danish" "Darby"
    "Darmstadt" "Darwin" "Datto" "Davis" "DeNicola" "Deep-sequencing-based"
    "Deiry" "Delphi" "Delphi-style" "Deng" "Deng1" "Deng2" "Dermatopathology"
    "Dharmacon" "Dia1" "Diabetes-induced" "Dian" "Dian-sheng" "Dick" "Dickson"
    "Diego" "DilC" "Do-calculus" "Dobashi" "Dolff" "Dominguez" "Dong" "Doppler"
    "Dorr" "Double-label" "Down-expression" "Dox" "Doxo" "Drygin" "Du"
    "Dually-targeting" "Dudognon" "Dutch" "Dyn2K44A" "E-Cadherin-CT" "E-box"
    "E-cadherin" "E-type" "E1B" "E1B-19" "E1B-55" "E1b" "E299Stop" "E2A"
    "E394X" "E4" "E746-A750" "E746_A750del" "EACs" "EAIS" "EAR" "EBPα"
    "EBPα-NF" "EBPγ" "EBUS" "EC-1" "EC-4" "EC-SMV" "EC-borne" "EC-vSMC" "ECOG"
    "EC–mural" "EE" "EFGR" "EFM" "EFM-19" "EGB" "EGF-like" "EGFR-DEL"
    "EGFR-E746-A750" "EGFR-EYFP" "EGFR-Fc" "EGFR-GS" "EGFR-RTK"
    "EGFR-WT-expressing" "EGFR-containing" "EGFR-family" "EGFR-mutated"
    "EGFR-partner" "EGFR-therapy" "EGFR-to-chromosome" "EGFR-vIII" "EGFR-ΔAP2"
    "EGFRvIII-PEDF-Notch-Sox2" "EGFRvIII-mutation-bearing" "EGFR–RTKs" "EGRF"
    "EHEB" "ELISAs" "ELK4-AA" "ELREA" "EMT-activator" "ENSG00000017427"
    "ENSG00000019991" "ENSG00000023445" "ENSG00000077150" "ENSG00000090339"
    "ENSG00000100906" "ENSG00000104856" "ENSG00000107968" "ENSG0000010882"
    "ENSG00000109320" "ENSG00000119630" "ENSG00000119655" "ENSG00000120738"
    "ENSG00000138675" "ENSG00000140443" "ENSG0000014480" "ENSG00000167244"
    "ENSG00000168610" "ENSG00000169429" "ENSG00000172602" "ENSG00000184371"
    "ENSG00000197081" "ENSG119655" "EOL-1R" "ER-15" "ER-Golgi" "ER-neg"
    "ER-pos" "ER-resident" "ER-status" "ER-stress" "ER-ve" "ER-α36"
    "ER-α66-mut" "ERBB-receptor" "ERE–luciferase" "ERG-fusion" "ERGIC"
    "ERK-dependent" "ERK–MMPs–Ln5γ2" "ERK–MMPs–laminin5γ2" "ERP44" "ERPR"
    "ERPR+ " "ERα + " "ER + " "ESCRT" "ESCRT-0" "ESCRT-I" "ESCRTs" "ESE"
    "ESURF" "ET-743" "ETS-195" "ETS-200" "ETS-294" "EU" "EVS" "EWS1R"
    "EWS1R-DDIT3" "EYFP-fused" "EZH" "EZH2-axis" "EZH2i" "Early"
    "Echinodermata" "Egger" "Egger’s" "Egr" "Eighty-eight" "Eisinger"
    "Eisinger's" "Eizai" "Ekalaksananan" "El-Deiry" "El24" "Elk-1ΔDBD"
    "Endocrinology" "English" "Ensembl" "Ensembl’s" "Entellan" "Eosin" "EpiQ"
    "EpiSC" "EpiSCs" "EpiTYPER" "Epithelial-Mesenchymal"
    "Epithelial-mesenchymal" "Epithelial–mesenchymal" "Epstein" "Epstein-Bar"
    "ErbB" "ErbB-3-partner" "ErbB2-downstream" "ErbB2-expressing"
    "ErbB2-induced" "ErbB2-moderate" "ErbB2-negative" "ErbB2-overexpressing"
    "ErbB2-positive" "ErbB2–ErbB3" "Erlotinib-partially" "Espin" "Estevés"
    "Estrogen–ERα" "Eto" "Ets-like" "EuHMTase1" "Eugene" "Eurasian-type"
    "Eurogentec" "Europe" "European" "Europeans" "Ever-smokers" "Ex-vivo"
    "Ex19" "Ex4" "ExomeCNV" "Exon10" "F-H9S3" "F-H9S3-2" "F-H9S3–14" "F-OS3"
    "F-OS3-10" "F-OS3–10" "F-actin" "F1L" "F3-FLT3-ITD" "F80-T1" "FABPpm" "FAD"
    "FADD-like" "FAIRE-Seq" "FAIRE-qPCR" "FAIRE-quantitative" "FBS-containing"
    "FCCF" "FCFC" "FDMs" "FEL" "FF144SC" "FFCC" "FGF" "FGF-BP1"
    "FGF2-dependency" "FGFR2b" "FIGO" "FIG–ROS-driven" "FK1" "FL3"
    "FLAG-MZF-1∆DBD" "FLAG-NT" "FLAG-immuno-purified" "FLAG-mTOR-T"
    "FLAG-purifications" "FLICE-Like" "FLICE-like" "FLT3-ITD"
    "FLT3-ITD-dependent" "FLT3-ITD-driven" "FLT3-ITD-induced" "FMNL2-CT"
    "FMNL2-GFP–expressing" "FMNL2-NT" "FMNL2ΔDAD" "FMNL2ΔDAD-GFP" "FMS-like"
    "FOLFIRI" "FOLFIRINOX" "FOLFOX" "FOMA4" "FOPflash" "FRA17B" "FRAX1036"
    "FUBP1" "FUGUE" "FUrd" "Fagagna" "Fas" "Fas-Death" "Fas-agonists"
    "Fas-death" "Fas-receptor" "FasL-induced" "Fazekas" "Fc-fusion" "Fdu" "Feb"
    "Feng-Sheng" "Fernandez" "Fernandez-Valdivia" "Fiber-modified" "Fifty-one"
    "Fifty-three" "Fifty-two" "Fig. S1A" "Fig. S1B" "Fig. S4A" "Fig. S5A"
    "Fig. S6A" "Fig. S6B–E" "Fig. S6F" "Fig. S6G" "File-2" "File-6" "File-7"
    "First-line" "Flag-p40Met" "Florida" "Floris" "Flp-In" "Flt3" "Fluidigm"
    "Follow-up" "Forty-eight" "Forty-four" "Forty-nine" "Forty-one" "Fourier"
    "France" "Fraumeni" "Fre-71s-1" "French" "Fu" "Fuchs" "Fuqua" "Furlan"
    "Fyn-mediated" "G-C" "G-CIMP" "G-T" "G-actin" "G-agarose" "G-alpha"
    "G-quadruplex" "G0" "G0-G1" "G1" "G1-to-S" "G12C" "G12D" "G13" "G1M2"
    "G1M4" "G1M6" "G1‐S" "G2" "G2M1" "G2M2" "G2M4-G2M8" "G2M6" "G3M2" "G3M3"
    "G3M5-G3M7" "G3M6" "G6" "G719A" "GA+AA" "GAS5-B" "GAS5-D" "GAS5-DEL"
    "GAS5-E" "GAS5-FL" "GBC" "GC24" "GCB" "GCV" "GEMMs" "GENECODIS"
    "GFP-LSD1-positive" "GFP-S-NDR1" "GFPsi" "GG+GA" "GGAAG"
    "GGATACTTTTTAAGGTCA" "GGGCGG" "GGGGCGGGGC" "GGGTG" "GGTIs" "GGTase-I"
    "GGTase-l" "GIFSKLAGKKIKNLLISGLKG" "GL8TD1" "GMDR" "GNP-like" "GNPs"
    "GO-203" "GO-term" "GOLOBOCON" "GPMNB" "GPNMB-positive" "GPNMB-si1"
    "GPNMB-si2" "GRCh37" "GRE" "GRKP" "GRP78-infection" "GRWD1_w0.5" "GSAP-FL"
    "GSC-CM" "GSE16454" "GSE29397" "GSE30611" "GSE61272" "GSE64527" "GSE6891"
    "GSE7866" "GSK-1120212" "GSM" "GST-FMNL2-GBD" "GST-GRWD1-His" "GST-SP"
    "GST-fusion" "GST-pulldown" "GST-sHB-EGF-specific" "GST-sHB-EGF-treated"
    "GS " "GT-Pase" "GT-box" "GTAGTT" "GWASs" "GYNGYN" "GYNGYNs" "Gabriel"
    "Gafni" "Gain-of-function" "GalO" "Galectin" "Gallen" "Gallios" "Galon"
    "Galwey" "Gankyin" "García-Segarra" "Gastrocnemius" "Gavilán" "Gdansk"
    "GeNorm" "Genbank" "Gene-Environment" "Gene-Gene" "Gene-environment"
    "Gene-pair-by-gene-pair" "GeneBank" "GeneChip" "GeneEraser" "GeneScan"
    "Genentech" "Genetica" "Gene–gene" "Geng" "Genome-Wide" "Genome-wide"
    "George" "Gerdes" "Gerlinger" "German" "Germany" "Gerrit" "Gibco" "Gin4p"
    "Glaxo" "Glaysher" "Glc-6-P" "Gleason" "Gli1" "Gln775Ter" "Glu791–Asp792"
    "Gluck" "Glutamax" "Gly538–Asp531" "GlyTCC" "GoNL" "Goeman" "Goeman's"
    "Gollard" "Gonal" "Gonal-F" "Gonzalez-Angulo" "Google" "Graczyk"
    "Gram-negative" "GraphPad" "Graz" "Groot" "Group4" "Guarente" "Gui" "Gupta"
    "Gurevich" "Gurtner" "Gustave" "Gvritishvili" "Gy" "Gö-6983" "Gö6976" "Gαi"
    "G " "G→A" "H&E" "H-bond" "H-bonded" "H-bonds" "H-score" "H-scores" "H1"
    "H1299-LKB1shRNA" "H1975" "H1993" "H1N1" "H2AK15ub" "H2K27Ac" "H3" "H3-H4"
    "H3-pSer10" "H358-TetO-EGFR" "H358KRASG12C-TetOEGFR-L808R"
    "H358KRASG12C-TetOEGFR-L858R" "H3Ac" "H3K27" "H3K27Ace" "H3K56" "H3K9"
    "H3K9Ace" "H3KMe1" "H3KMe3" "H3R8" "H4" "H460-LV-NC"
    "H460-LV-miR-29b-inhibitor" "H4Ac" "H4K12ac" "H4K16" "H4K16ac" "H4K20"
    "H4K20m2" "H4K5" "H4K91" "H4K91ac" "H4K91ub1" "H4R3" "H5LO" "H5N1"
    "H773_V774insNPH" "H9" "HA-GRWD1-overexpressed" "HA-LSD1res"
    "HA-TAp73-expressing" "HAART" "HADOCK" "HAECs" "HAN" "HATAp73" "HB-EG"
    "HBA1c" "HCC1806-TEAD4sh#3" "HCDR3s" "HCT" "HCT116-p53-null" "HCT116-p53wt"
    "HD-MB3" "HDAC3-1" "HDAC3-2" "HDMB3" "HDMVECs" "HER2-HER3" "HER2-amplified"
    "HER2-enriched" "HER2-mediated" "HER2-negative" "HER2-overexpressing"
    "HER2-positive" "HER2-rich" "HER2-targeted" "HER2 + " "HERK-293" "HF-fed"
    "HG-FIN" "HGF-treatment" "HGNECs" "HGSC" "HIF-lα" "HIL" "HIMP-2"
    "HITS-CLIP" "HIV-1-Tat" "HK" "HMD2" "HMGIC8" "HMIP-1" "HMIP-2" "HMIP-2A"
    "HMIP-2B" "HMVEC" "HMVEC-L" "HNF-3α" "HNF-4α" "HO-1-dependent" "HOIL-1L"
    "HOpic" "HPNE" "HPVE6" "HR-HPV" "HR=1.481" "HR=1.809" "HRAS-GTP" "HRs"
    "HSC-CMs" "HSV-1" "HT1080" "HTC116" "HUGO" "HUH-28" "HWE" "Haarberg"
    "Haemophilus" "Hakka" "Half-life" "HaloPlex" "Hamilton" "HapMap"
    "HapMap550" "HaploRegv2" "Hardy-Weinberg" "Hardy–Weinberg" "Hasei"
    "Hashimoto" "Hatay" "HbS" "HbSS" "Hdac1,2" "Hdac1-null" "HeCOG" "HeG2"
    "HeLa-shSOX9" "HeLa-shSOX9-1" "Heat-induced" "Heat-shock" "Heiden"
    "Heijboer" "Hekem" "Helsinki" "Henan" "HepG2-TRα1-LCN2-KD"
    "HepG2-TRα1-LCN2-KD-T" "HepG2-TRα1-Luc" "HepG2-TRα1-control" "Her-2" "Her2"
    "Her2-negative" "Her2-positive" "Hercules" "Herishanu" "Hermans" "Heubner"
    "Hidden" "High-Concentration" "High-affinity" "High-concentration"
    "High-grade" "High-invasion" "High-yield" "Hiller" "Hillsberg" "Hino"
    "Hippo-LATS" "Hippo-YAP" "Hirosue" "His-p73α" "His-p73β" "His-ubiquitin"
    "Hodgkin" "Hodgkin’s" "Hoechst" "Hoechst33342" "Hollestelle" "Homburg"
    "Hopkins" "Hornby" "Hou" "HpsB6" "Hsieh" "Hsl1p" "Huang" "Huh" "Huh7-L#1"
    "Huh7-V#1" "Human" "HumanMethylation450" "Huntington" "Huntington's"
    "Huperzia" "Hutchinson" "Huynen" "Huzarski" "Hydroxydeoxyguanine" "Hylidae"
    "I-specific" "I-to-II" "I-to-III" "IARC" "IASLC" "IBCR" "IBCRs" "IC50"
    "IC50-value" "IC50-values" "ICI" "ICU" "ICUs" "ID10" "ID20" "ID25" "ID29"
    "ID30" "IE72" "IECs" "IFNγ-treatment" "IGF-1–independent" "IGF-IIR"
    "IGF-axis" "IGROV" "IGROV1-R10" "IGVH" "IGX1" "II+ID" "II-III" "II-IV"
    "II-to-III" "III-ESC" "III-IV" "III-IVA" "III-Mediated" "III-to-ESC" "IIIA"
    "IIIA–IIID" "IIIB" "IIID" "IIIor" "IIR" "IIS" "IIa" "IKKs" "IL-3+TNFα"
    "IL-3+TNFα-activated" "IL21R" "IL2Rγ" "IL3+TNFα" "IL5-family" "ILD-like"
    "ILV" "IMR32-LV-h-p53" "IMR5-TR-shNMYC" "INCA-Brazil" "INF1" "INR" "INRG"
    "IOP" "IOPs" "IP-like" "IQR" "IRAK1-NF-κB" "IRES" "IRF-R1" "IRGB" "ISH"
    "ISI" "ISIS" "ISIS-STAT3Rx" "ISO" "ITC" "ITCHC830A" "ITD-SmoM2" "IU" "IUIS"
    "IVS" "IVS2" "IXI" "I_⊿CpG_2" "Iacopino" "Ib" "Identifier" "IgA" "IgG-F"
    "Igor" "Igs" "Ilic" "Illumina" "Illumina-Truseq" "Illumina’s" "ImageJ"
    "Imai" "Imamura" "Immuno-positivity" "ImmunoScore" "Immunoprecipitation"
    "In-silico" "In-solution" "InDel" "InDels" "Inc" "Indian" "Indianapolis"
    "Infinium" "Inoue" "Insilico" "Institut" "Int4" "Intensity-modulated"
    "Inteplex" "Inter-cellular" "Inter99" "Invitrogen" "Ion-Torrent" "Iowa"
    "Ishibe" "Israeli" "Istituto" "Iwaschima" "IκBε-mutated" "I–IIIa" "J166"
    "J7" "J7-KD#1" "J7-LCN2-KD" "J7-Luc" "J7-TRα1" "J7-control" "JAK-STAT1α"
    "JC70A" "JNJ" "JNJ-38877605" "JNK1-3" "JQ1" "JR" "JUNB" "JW" "James"
    "Jameson" "Jang" "Jansen" "Japanese" "Jaulin" "Jcam" "Jeselsohn" "Jews"
    "Jia-Qing" "Jiang" "Jin" "Jo2" "Johansen" "Johnson" "Jose" "Juhasz"
    "Jurkats" "K-48-linked" "K-63-linked" "K-RasG12V" "K-fiber" "K-fibers"
    "K-means" "K38R" "K6" "K63-chains" "K63-pUb-linked" "K8.1A" "K821R" "K8α"
    "K9" "KATO" "KCKO" "KCM" "KD#2" "KDACs" "KG" "KITL1" "KITL2"
    "KLF8-depndent" "KLF8-miR141-EGFR" "KM000795" "KM000796" "KMN" "KOPN"
    "KOPN-8" "KO→WT" "KRAS-mutated" "KU" "KU-812" "Kaifeng" "Kallmann" "Kamino"
    "Kaplan" "Kaplan-Meier" "Kaplan-Meir" "Kaplan–Meier" "Kaplon" "Kaposi"
    "Kaposi’s" "Karnofsky" "Kasumi-3" "Kawamura" "Kaz" "Kcal" "Kcc4p" "Keam"
    "Kelch-like" "Kellgren" "Kellgren–Lawrence" "Kerlikowske" "KeyMolnet"
    "Khenchouche" "Ki-67" "Ki-67-positive" "Kif11" "Kim" "Kinoshita" "Kip"
    "Kirsten" "Klonowska" "Knock-down" "Knudson" "Kohler" "Kokhan" "Konopka"
    "Korea" "Korean" "Koreans" "Kouri" "KrasLA2" "Krebs" "Krebs–Ringer"
    "Kriege" "Krishnan" "Kruppel" "Kruppel-like" "Kruskal–Wallis"
    "Krüppel-like" "Kubo" "Kuefer" "Kueh" "Kuilman" "Kumazawa" "Kumler"
    "Kurrey" "Kwak" "Kyoto" "Kyushu" "L#1" "L#2" "L1" "L2" "L2-mediated" "L3"
    "L3C-BLK" "L3P-BLK" "L3P-BLK-overexpressing" "L858R" "LAN-6" "LBD" "LC-3I"
    "LC1.0" "LC2.0" "LC3-I" "LC3A-II" "LC3B-I" "LC3BI" "LC3I" "LCL" "LCLs"
    "LDL-cholesterol" "LFS-like" "LGPIN" "LKB1-competent" "LMAC2" "LNA-PCR"
    "LO" "LOC442075" "LOC550643" "LOC728724" "LOD" "LOV2-Rac1" "LOWER-GRADE"
    "LR" "LUNA" "LV-1" "LV-2" "LV-miR-29b" "LVEF" "LY29004" "Lac"
    "LacZ-infected" "Laemmli" "Lagger" "Lamiaceae" "Lancaster" "Landry"
    "Lansdorp" "Large-scale" "Lats1" "Le" "Leguminosae" "Lehmann" "Leiden"
    "Lennard" "Lennard-Jones" "Lenti-shRNA" "Lenti-shRNA1" "Lepleux" "Lewontin"
    "Li" "Li-Fraumeni" "Lid-backbone" "LifeAct-GFP"
    "LifeAct-mCherry–expressing" "LifeTechnologies"
    "Lifeact-mCherry–expressing" "Ligand" "LightCycler" "Lipofectamine" "Lite"
    "Liu" "Live-cell" "Lockwood" "Loeb" "Log-Rank" "Log-rank" "Log2"
    "Long-lasting" "Lonza" "Lopez" "Lopez-Bigas" "Lopez-Martin" "Lopez-Otin"
    "Loss-of-function" "Low-dose" "Lower-grade" "Lu" "Lu-1566" "Lu-1875"
    "Lu-1995" "Lu-243" "Lu-246" "Lu-5" "Lucsh" "Lukacs" "Luminal" "Luminal-A"
    "Luo" "LvBr4" "LvBr5-Luc" "LxKxxT" "Lyon" "Lys25Pro" "Lys39His" "Lys7"
    "Lys7Glu" "Lys8" "Lys8Glu" "LysTTT" "M-CLL" "M1-3" "M1-linked-pUb" "M1-pUb"
    "M1-pUb-linked" "M1-pUb-specific" "M5" "MA32" "MACS2" "MAGE-A"
    "MAGE-A-dependent" "MAGE-A-interacting" "MAGE-A-silencing" "MAGE-D1"
    "MAGE-I" "MAGE-II" "MAH" "MAH-3100A" "MAIT" "MALT" "MAPK15-pCMV6-Myc-DDK"
    "MAPKAP" "MARQUEE" "MBC " "MCC-3" "MCC-5" "MCF-10" "MCF-7-sh53BP1" "MCF10"
    "MCF10AT1" "MCF10CA" "MCIC" "MCM2–7" "MCM7_w0.5" "MCMD" "MCMs" "MD30"
    "MDA-LM2" "MDA-MB-451" "MDA-MB-648" "MDA-MB0231" "MDA-MD-157" "MDA-MD-231"
    "MDAMB" "MDAMB231-BoM" "MDAMD175V11a" "MDM2ΔRING" "MDM4BD" "MDM4BD+RF"
    "MDM4C437G" "MDM4ΔBD" "MDR1and" "MDS-AML" "MEF-to-ThyI" "MEM" "MEM-199"
    "MES-MM98" "MET-ORF" "MET-dependent" "MET-full" "MFS" "MGC" "MGH" "MGH176"
    "MGH700" "MGH706" "MGH748" "MGMT-defective" "MI-77301" "MIA-PaCa2" "MIO-M1"
    "MIR1" "MIR148A" "MIR3" "MIR34A" "MIR675" "MI_N" "MI_S" "MK-8876" "MK775"
    "MKL-1" "ML324" "MLL-AF9-driven" "MMPs–Ln5γ2" "MMTV-ErbB2" "MMTV-PyMT"
    "MNK-45" "MOI" "MPACT" "MPAK" "MPN-like" "MPS" "MRL" "MRLPS" "MS" "MS-PCR"
    "MSC-like" "MSCVpuro" "MSI-H" "MSKCC" "MSTO" "MSTO-H211" "MTS" "MUC-C"
    "MUC1-hi" "MUC1-null" "MULTIPLATFORM" "MUM-2C" "MV4" "MVR" "MVRs" "MYBPB1A"
    "MYC-function" "MYCL-4" "MYCL-4∼6" "MYCL-5" "MYCL-5∼6" "MYCLo" "MYCLo-1"
    "MYCLo-1∼3" "MYCLo-3" "MYCLo-4" "MYCLo-4∼6" "MYCLo-5" "MYCLo-6" "MYCLos"
    "MYCN-157" "MYCN-normal" "MYLR" "MYPT" "MZF-1ΔDBD" "Maathuis" "Mad1–Mad2"
    "Madin" "Madin-Darby" "Mage-D1" "Magnaghi" "Magnaghi-Jaulin" "MammaPrint"
    "Mammary-targeted" "Manassas" "Mancera" "Manchester" "Maniotis " "Manley"
    "Mansouri" "Markov" "Marshall" "Martijn" "Mascot-score" "MassArray"
    "Material" "MaxEntScan" "Mayo" "Mazurek" "Mbp" "McLaughlin" "McNeeley"
    "Mdm2-null" "Meda" "Mediterranean" "Medline" "Meg-01" "Meier" "Meijers"
    "Meijers-Heijboer" "Meir" "Melbourne" "Melin" "Melville" "Meningococci"
    "Merck" "Merkel" "Mesenchymal-to-epithelial" "Mester" "Met-CTF" "Met-FAK"
    "Met-NTF" "Met-NTFs" "Met-receptor-targeting" "MetLung" "Metallo"
    "Metastatic" "Methods" "MethyLight" "Methyleguanine" "Meylan" "Mi1" "Mi3"
    "MiR-124" "MiR-144" "MiR-182" "MiR-451" "MiR-95-3p" "MiR200" "Michelsen"
    "Michigan" "MicroRNA-155" "Middle" "Middlesex" "MigRI" "Millipore"
    "Minneapolis" "Minuti" "Mir-155" "Miseq" "Mn" "ModFit" "Modena" "Molm"
    "Molm-14" "Molt" "Monnien" "Mono-ovulation" "Mono-treatment" "Moore"
    "More-over" "Morpholino" "Morrice" "Mosammaparast" "Mountzios" "Mst1" "Mu"
    "Muc1-null" "Muc1KO" "Muller" "Mundulea" "Munoz" "Munoz-Espin" "Musacchio"
    "MutationTaster" "Mutp53" "MxRxxT" "Myc-tag" "Myc-ΔChe-1" "Myxoid"
    "Männedorf" "Müller" "Müllerian" "MβCD" "N-AI" "N-acety" "N-acetyl"
    "N-acyltransferase" "N-arachidonoylethanolamide" "N-cadherin" "N-lobe"
    "N-methyl-N" "N-nitroso" "N-nitrosobutyl" "N-trimethylated" "N0" "N1"
    "N1-marker" "NB110" "NCBI" "NCI" "NCI-60" "NCIC" "NCT01004224"
    "NDR1-binder" "NEK" "NF-kbp65" "NF-κB1" "NFKB" "NFKB1-94ins" "NFKB19-4"
    "NFKB19–4" "NFKB1ins" "NFKBIA3" "NFTs" "NFY" "NFκB-activity" "NGP-LV-h-p53"
    "NGRC" "NGRC-PD" "NH" "NH2-termnial" "NHK" "NHSC" "NHSM" "NHSM-naive"
    "NIMBUS" "NLF" "NMIBC" "NM_001220777" "NM_001220778" "NM_006058.4"
    "NOD-SCID" "NOD-SCIDγ" "NOTCH2-ICD" "NP-GFP-expressing"
    "NP-GFP-transfected" "NPE" "NP–pHLZ" "NRF2-dependent" "NRF2-pathway" "NTAM"
    "Nagel" "Nair" "Naive-State" "Nakachi" "Nakayama" "NanoDrop" "Narayan"
    "Narayanaswamy" "Narita" "Necidin" "Nek6" "NetPhos" "Netherlands" "Neu"
    "Nevanlinna" "Next-Generation" "Next-generation" "Nextera" "Ni" "Nichols"
    "Nieborowska" "Nieborowska-Skorska" "Niemann" "Niemann-Pick" "Niho" "Nikon"
    "Nikulenkov" "Ninety-three" "Nino" "Nitrosourea" "Nitta" "Ni–NTA" "NoRNA"
    "Nordt" "NormFinder" "North-American" "Notch" "Notch-Sox2" "Nov" "Novartis"
    "Noxa-antagonist" "Nqo1-ARE-Luc" "Nrf" "NuMA-LGN" "NuRD" "Nurieva"
    "Nussinov" "Nutlin3a-MDM2" "Nδ" "NκFB" "O-group" "OATP-1" "OBP-702" "OCP"
    "OHdG" "OKM" "OMIM" "ONCOSEQ" "OR=1.18" "OR=1.24" "OR=1.27" "OR=1.32"
    "OR=1.34" "OR=1.35" "OR=1.36" "OR=1.39" "OR=1.43" "OR=1.48" "OR=1.65"
    "OR=1.71" "OR=1.88" "OR=1.89" "OR=1.91" "OR=2.46" "ORCA" "ORs" "OSC3"
    "OSC4" "OSK" "OXPHOS" "Oci" "Oci-LY1" "Okamoto" "Oligo" "Olympus" "Omni"
    "OncoSign" "Oncology" "Oncomine" "Oncotype" "Oregon" "Oregon-green"
    "Origene" "Orrenius" "Orsay" "Orthoreovirus" "Otin" "OvidSP" "Ovitrelle"
    "Ozyme" "Oε" "P*Pak" "P*S1466" "P*T288" "P0" "P1" "P2" "P30CA046934" "P39C"
    "P39L" "P61A6" "P7" "P=0.01" "P=0.02" "P=0.021" "P=0.024" "P=0.028"
    "P=0.03" "PA-Rac1–induced" "PADIs" "PAGE" "PAK1-DNA" "PAK2-autoinhibitory"
    "PAK4-6" "PAK4-null" "PAK6-null" "PAM50" "PANTHER" "PARADIGM-SHIFT" "PC-3R"
    "PC-3prostate" "PC-algorithm" "PC14PE6-LvBr4" "PC14PE6-LvBr5-Luc" "PC4PE6"
    "PC9-TetO-KRAS" "PCAT" "PCNA-immunopositive" "PCO" "PCR-HRM" "PCR-RFLP"
    "PCR-Sanger" "PCS+IAV" "PCaradio" "PD185" "PD98059" "PDAs" "PDBID" "PDFRA"
    "PDGF-β" "PDP2–PDH" "PDRM1" "PDX118" "PE14PE6" "PERK-eIF2α-CHOP"
    "PF-04217903" "PF21A" "PFK" "PFSs" "PHA" "PHKs" "PI-naïve" "PI3K-like"
    "PI3KCA" "PID-genes" "PIK3A" "PIKKs" "PINXI" "PITSTOPII" "PKC-β"
    "PKC-β-dependent" "PKC-β–mediated" "PKCδ-CA" "PKCδ-DN" "PKCθ" "PLCξ"
    "PLINK" "PLMIV" "PMA" "PMID" "PMSS1" "PMUT" "PNAs" "POAG" "PP2Acα" "PP2Acβ"
    "PP2C-family" "PQQAT" "PRGFRA" "PRMTs" "PROPKA" "PSC-1" "PSC-2" "PSDH10"
    "PaSMC" "PaSMCs" "Paget" "Pak" "Pak1" "Pak2#1" "Pak4-6" "Pakistani" "Paks"
    "Papanicolaou" "Paraná" "Parkinson" "Pase" "PatchDoc" "PatchDock" "Pearson"
    "Pearson's" "Pede" "Peifer" "Pelophylax" "Pelosi" "Peng" "Per-family"
    "Perez" "Perez-Mancera" "Ph" "Pharma" "Phe19-Trp23-Leu26" "Phi29"
    "Phi29-mRNA" "Philadelphia" "PhosSTOP" "Phosphorylated-HSP27" "Physico"
    "Pietras" "Pinophyta" "Pip2-MDM2" "Pip2-lid" "Piperidin" "Piperidin-1-yl"
    "Pirker" "Plos" "Pn-status" "Poisson" "PolIII" "Poland" "Pollack"
    "Polo-box" "PolyPhen" "PolyPhen-2" "Polyphen2" "Ponasterone" "Pontoise"
    "Poole" "Porath" "Post-EMT" "Post-hoc" "Post-rociletinib"
    "Post-translational" "Poulain" "Prism5" "Pro-MMP-2" "Pro-inflammatory"
    "Profiler" "Promega" "Propidium" "Provean" "Prudkin" "Pteridophyta"
    "Puerto" "PxxP" "Pérez" "Q563X" "QKG" "QKGRKPRD" "QKI-5" "QKI-6" "QKI-7"
    "QQ" "QQAT" "QT" "QT-PCR" "QTL" "QTLs" "QTc" "QVD" "Qiagen" "QqQMS"
    "Quantile–quantile" "Qubit" "Quebec" "Queensland" "Quentin" "Quijano" "R&D"
    "R-OS3" "R-OS3-10" "R-Taxol" "R-Vinblastine" "R-Vinblastne" "R-loop"
    "R-looping" "R-miR-335" "R-miR335" "R-taxol" "R0" "R1" "R10" "R1751X"
    "R1LM" "R2" "R257X" "R3" "R3128X" "RAE" "RAEB" "RAEs" "RAGE-AGEs"
    "RAGE–PKC-β" "RARG" "RAS-MAPK-mediated" "RB12" "RB14" "RB15" "RB17" "RB20"
    "RB21" "RB23" "RB24" "RB24-RB33" "RB25" "RB30" "RB32" "RB33" "RB4" "RB8"
    "RB9" "RCUD" "REMARK" "REMBRANDT" "RFLP" "RGQ" "RH-41" "RIP-ChIP" "RIP-seq"
    "RIPA" "RISC-transcript" "RLU " "RMSDs" "RMSF" "RNA" "RNA-CHIP" "RNAPII"
    "RNAPIII" "RNF168-dependent" "RNF168-mediated" "RNF43-Flag-HA-expressing"
    "RNF43-HA-expressing" "RNF43–pYESTrp2" "ROSI" "ROS‐dependent"
    "ROS‐mediated" "RPKS6KA3" "RPMI-1640" "RPN" "RPPH1" "RRSE" "RRSEs"
    "RS-cell" "RS-like" "RSV" "RTK-like" "RUNX" "RacL61" "Rac∙GTP" "Rad3"
    "Rad3-related" "Radiation-induced" "Ral-effector" "Rancho" "Ranidae"
    "Raouf" "RasLSL" "Ratajska" "Rb" "Rb-proficiency" "Rb-proficient" "RbTKO"
    "Re-AKT" "Re-ASPP2" "Re-Bcl-2" "Re-ChIP" "Re-Chip" "Re-analyses"
    "Re-expression" "Rebeiz" "Receptor" "Reduction–oxidation" "Reed-Sternberg"
    "RefSeq" "Replication-competent" "Restin" "Results" "Reynolds" "Rho-GTP"
    "Rho-family" "RhoA-GTP" "RhoA-GTPase" "RhoA-T19N" "RhoA-p27" "RhoGTP"
    "RhoGTPases" "Ricerca" "Rico" "Right-sided" "Ro-318220" "Robinson" "Roche"
    "Rockford" "Rockville" "Rodel" "Rodier" "Roeb" "Roehrborn" "Rogers"
    "Roizman" "Román-Pérez" "Rosa26" "Rosell" "Rosell’s" "Rotln" "Roussy"
    "Rrbm2b" "Rudin" "Rui" "Rui-li" "Rx" "Ryan" "S-A" "S-IC" "S-based"
    "S-induced" "S-labelled" "S-producing" "S-transferase-fused" "S-α" "S-β"
    "S1" "S1-S3" "S1133-infection" "S1A–E" "S1C" "S1D" "S1F" "S1F–H" "S1I"
    "S2A" "S2A-C" "S2B" "S2C" "S2C-D" "S2C–F" "S2D" "S2E" "S2a–c" "S2–S6" "S3"
    "S33Y-mutated" "S345A" "S359" "S370" "S379" "S387A" "S3A–C" "S3B-D" "S3C"
    "S3D" "S3D–G" "S3H" "S3I" "S4" "S463P" "S4A" "S4B" "S4C" "S4D" "S5A" "S5C"
    "S5D" "S5E" "S6" "S6K" "S7" "S727-STAT3" "S7A" "S7A–C" "S7B" "S7C" "S7D"
    "S7E" "S7F" "S7G" "S8" "S8A" "S8B" "S8D" "S8a" "S8c" "S8d" "S8e" "S8f" "S9"
    "SAMtools" "SAP-1a" "SAR405383" "SATB" "SATURN" "SB20358" "SC37007" "SCACP"
    "SCUBYC" "SDT" "SET1C-coupled" "SET1C-specific" "SF-pretreated" "SH-shCON"
    "SH-shCON-derived" "SH-shYB-1" "SH-shYB-1-derived" "SHAPEIT" "SHARIPN"
    "SIAH" "SIAHs" "SIE" "SIFT" "SINE-associated-Pol" "SIRT" "SIRT1-7" "SISH"
    "SK-HEP1-L#1" "SK-HEP1-V#1" "SK-N-DZ" "SK-N-F1" "SK-N-FI" "SKM-1cells"
    "SKUT" "SKUT-1-B" "SLEDAI" "SLUG2" "SM83" "SMAC-mimetics" "SMP14" "SMV"
    "SMYD" "SMYD3-EEL" "SMYD3putative" "SMs" "SN387" "SNAP649" "SNHG1"
    "SNHG1-sno-miR-28" "SNORA" "SNORA80-B" "SNORD" "SNORD-28" "SNORD114-1"
    "SNORD25" "SNORD28" "SNORD29" "SNORD66" "SNORDs" "SNP" "SNP-level" "SNPas"
    "SNPhad" "SNPs" "SNPthan" "SNPwas" "SNV" "SNVs" "SOCS-JAK-STAT-SRC" "SOFA"
    "SOS1-promoted" "SOX" "SPRYs" "SPSS" "SQCCs" "SQQHpTPVLSSQPLR" "SQSTM"
    "SRFs" "SRN" "SSEA4" "SSP-25" "SSP-25-Control" "SSP-25-KD1" "ST-23"
    "ST-HSC" "STAT-1α" "STAT-pathway" "STAT1α" "STAT3-dependent" "STAT3α"
    "STAT3β" "STATA" "STD-NMR" "SUPPLEMENTAY" "SUV39" "SUV420" "SXS" "SYBR"
    "Saegusa" "Saharan" "Salama" "Salvesen" "Samsung" "Sanchez" "Sanchez-Nino"
    "Sanger" "Sanli" "Sardinia" "Satoh" "Saudi" "Scheffé" "Schiff" "Schmidt"
    "Schmidtea" "Schneider" "Schutzman" "Schwann" "Seeger" "Segarra"
    "Self-renewal" "Semliki" "Sequencing-strategy" "Sequenom" "Ser-33" "Ser-34"
    "Ser-380" "Ser-726" "Ser-99" "Ser1981" "Ser432" "Ser436"
    "Ser5-phospho-RNAPII" "Ser9" "SerAGA" "Serine-5-phosphorylated" "Serono"
    "Serrano" "Seventy-five" "Seventy-nine" "Seventy-two" "Sex-determining"
    "Sgk" "Shantou" "Shen" "Shih" "Shimada" "Shishodia" "Short-term"
    "Showalter" "SiBcl-2" "SiHa-SOX9-1" "Sigma-Aldrich" "SignalChem" "Silber"
    "Sinai" "Singh" "Sirtuins" "Sixty-five" "Sixty-one" "Sixty-two" "Skorska"
    "Skp1–Cullin1–F-box" "Smad2" "Smad2-4" "Smad3-null" "Smad3-regulated"
    "Smads" "Small-cell" "Small-molecules" "Smyth" "Snailin" "Snailproteins"
    "Solvang" "Sourbier" "Sox2" "Sp" "SpW" "Spain" "Spanish" "Spearman"
    "Spearman's" "Spearmann" "Spearman’s" "Sproutys" "Src" "Srinivasan"
    "Stagakis" "Stage" "Stage_Site_tumour" "Ste20-like" "Stennicke" "Sternberg"
    "Stransky" "Strep" "Strep-Tactin" "Strep-tag" "Stress-induced"
    "Stress-internalized" "Strongylocentrotus" "Stupp" "Sub-G1" "Sub-Saharan"
    "SubAB" "Sugimura" "Sup" "Super-enhancers" "Sur" "Sur-induced"
    "Sur-infected" "SureSelect" "Suv3h1" "Swedish" "Swiss" "Switzerland" "S‐G2"
    "T-P-X-K" "T-PXR" "T-TBS" "T-TBS-milk" "T-acute" "T-allele" "T-stage"
    "T0052α" "T1" "T1-T2" "T10" "T157" "T194A" "T198" "T2" "T2-3" "T202" "T2D"
    "T2DM" "T3" "T3-T4" "T378" "T382" "T4" "T7" "T7-Cdt1" "T790M" "T852A" "T9"
    "TAM67" "TAP-tag" "TAPI" "TAPI-2" "TATA" "TAZ-dependent" "TAZsi" "TAp63α"
    "TAp63αR279Q" "TAp73α" "TAp73αV156A" "TB40E" "TBS" "TC10a" "TCF-responsive"
    "TCF-site" "TCFs" "TCM" "TCONS" "TCONS_00014956" "TCRα" "TCRδ" "TCT" "TCoB"
    "TC‐induced" "TC‐mediated" "TD" "TEAD1–4" "TEADs" "TES2" "TES2-mediated"
    "TFCP2L1" "TFSEARCH" "TF‐induced" "TGF-βRI" "TGF-βpathway" "TGGGAA" "THRB"
    "THS1" "THS2" "TIAGR" "TIGRA" "TKI-R" "TL-H9" "TL-H9S3" "TL-H9S3-2"
    "TL-H9S3–14" "TL-OS3" "TL-OS3–10" "TL2i-H9" "TL2i-H9S3" "TL2i-H9S3-2"
    "TL2i-H9S3–14" "TL2i-OS3" "TL2i-OS3–10" "TN1-16" "TN1-4" "TNBCs"
    "TNF-receptor" "TNFsf" "TNIP" "TNIP1shRNA" "TNIPs" "TOCA" "TOFMS"
    "TOPFlash-Luc" "TPA" "TPXR" "TRA-1–60" "TRA-1–81" "TRA160" "TRANSFAC"
    "TRAP-eze" "TRE-BCBL-1-RTA" "TRE-BCBL1-RTA" "TRIRC" "TRIRC-WGA" "TRITC-WGA"
    "TRK-Met" "TRS8" "TRα" "TSC3" "TTAAGGG" "TTAGGG" "TTT" "TU"
    "TUC2-erlotinib" "TUJ1" "TUNEL-positivity" "TUNNEL" "TUSC"
    "TUSC2-Erlotinib" "TUSC2-defective" "TUSC2-erlotinb" "TUSC2-erlotinib"
    "TUSC2-nanovesicles" "TW" "TYK" "Tactin" "Taipei" "Taiwan" "Taiwanese"
    "Tajkhorshid" "Takahashi" "Takashima" "Talalay" "Talluri" "Tanzania"
    "TaqMan" "Targeting" "Tat-activated" "Tat-induced" "Tau-AxxA7" "Tau-RD"
    "Tau-noRD" "Tavolaro" "Tbc1Ds" "Tbet" "Tecan" "Telomerase-mediated"
    "Templeton" "Teng" "Tert" "Testis" "Tet-On" "TetO-oncogenes" "Tff"
    "Tff1-KO" "Tfsitescan" "Tg2576" "Tgf-β" "Th1-like" "Th17" "Th17-polarizing"
    "Th17-type" "Therascreen" "Thermo" "Thierry" "Thirty-eight" "Thirty-five"
    "Thirty-six" "Thirty-three" "Thirty-two" "Thornton" "Thr-382" "Thr-41"
    "Thr-713" "Thr14" "Thr16" "Thr202" "Three-dimensional" "Thyroxine"
    "Tiam1-His" "Tiam1-Pak-Rac" "Tiam1-Rac-Pak" "Time-course" "Time-lapse"
    "Titus" "Tokyo" "Toll-like" "Tom" "Tomas" "Toxoid" "Tra" "Transducers"
    "Trastuzamab" "Traube" "Travis" "Treatment-naïve" "TreeView" "Trentino"
    "Treut" "Triple-negative" "Triple-positive" "Tris-HCl" "Trometamol"
    "Trp+Trp" "Truseq" "Tudzarova" "Tukey" "Tung" "Tunisia" "Turkish" "Tutt"
    "Twenty-five" "Twenty-four" "Twenty-nine" "Twenty-one" "Twenty-six"
    "Twenty-three" "Twenty-two" "Two-thirds" "Two-way" "Tyr-704" "Tyr-705s"
    "Tyr15" "Tyr204" "Tzeng" "T‐cell" "U-CLL" "U1" "U138MG" "U219" "U251" "UA"
    "UC2288" "UCSC" "UCSF" "UICC" "UMD" "UMD-BRCA1" "UMIN000004561" "UNC0642"
    "UNC53-like" "USA" "UTRs" "UV-irradiated" "UVC" "UVC-pre-treated"
    "Ub-His-expressing" "Ub4KR" "Ubwt" "Uhlman" "Uhrinova" "Ulk" "Umemura"
    "UniProt" "Univariate" "Universidade" "Unni" "Uygur" "V#1" "V#2" "V-ets"
    "V218delV" "V5" "VAD" "VDRAs" "VDW" "VE-cad" "VE-cad-Src"
    "VE-cad–β-catenin" "VE822" "VER" "VER-155008" "VI" "VIC" "VK" "VKH" "VLDL"
    "VO1" "VO1-7" "VO2" "VOP" "VOP3" "VOP4" "VUSs" "Val14" "Valdivia" "Vallat"
    "Vanaja" "Vander" "Varum" "Vassena" "Vehicle-treated" "Ventana" "Versteeg"
    "Villejuif" "Villepinte" "Vinblastne" "Vogelstein" "Vogt–Koyanagi–Harada"
    "Vousden" "Vriend" "Västerås" "Vα24" "Vα24-Jα18" "Vα7.2" "Vα7.2-Jα33"
    "Vβ11" "Vγ9Vδ2" "Vδ1" "W-Quad" "W731X" "WASP" "WD-7" "WD-8" "WD40-repeat"
    "WDLPS" "WDSCC" "WEE1i" "WHI" "WIF" "WIP1-mediated" "WIP1-modulated"
    "WM45.1" "WMH" "WST" "WST-1" "WT-PAK1" "WTp53" "WT→KO" "WT→WT"
    "WW-domain-containing" "WZ" "Wachowiak" "Wald" "Wallis" "Warburg" "Warfel"
    "Warsaw" "Wasserkort" "Weakly-activating" "Webby" "Weber-Nordt" "Weger"
    "Weinberg" "Weisberg" "Weischer" "Well-differentiated" "Wemmert" "Weng"
    "Wentzensen" "Western" "Western-blot" "Whalley" "Whitney" "Whole-Genome"
    "Whole-genome" "Wierenga" "Wilcoxon" "Wildey" "Wiley" "Wilson" "Wingeyer"
    "Wnt-5a" "Wnt10" "Wnt4" "Wnt5b" "Wong" "Wraight" "Wu" "Wyeth" "X-31"
    "X-PAK5" "X-Tile" "X-ray" "X-score" "X-scores" "X-tile" "X01-PEDF-KD" "X03"
    "X04" "X06" "X08" "X09" "X100" "XAV" "XAV-939" "XBBBX" "XBBX" "XBX" "XELOX"
    "XIAO" "XJ" "XLA-07" "XRCC" "XRCC1-Arg280His" "XRCC1-Arg399Gln" "XTT" "XY"
    "Xa" "Xba1" "Xe1" "Xe2" "Xi" "Xp22" "Xq" "Xq22.1" "Xq22.2" "X²" "Y-box"
    "Y1234" "Y1235" "Y204" "Y394F" "Y505F" "Y537N" "Y537S" "YB-1-reactive"
    "YBX1-RNA" "YBX1-antagonistic" "YBX1-dependence" "YBX1-tRF" "YES" "YES-2"
    "YES-5" "YES-6" "YRI" "Yale" "Yamanaka" "Yat" "Yat-sen" "Ye" "Yes"
    "Yeudall" "Yin-Yang" "Yoruba" "Youden" "Yu" "Yvelines" "Z-DEVD" "Z-stack"
    "Z-stacks" "ZBD" "ZDOCK1" "ZEB" "ZHONG" "ZVAD" "Zammarchi" "Zealand" "Zeng"
    "Zeo" "Zhang" "Zheng" "Zhou" "Zn" "Zn-superoxide" "Zuckermann" "a1" "a4b1"
    "aCGH" "aCGH-244K" "aCGH-400K" "aIgG" "aPTT" "aa106–360" "ab117139"
    "above-median" "absentia" "absorbance" "acH4" "acety" "acetyl-mimic"
    "acetyl-mimicking" "acetylome" "acneiform" "across-the-board"
    "actin-depolymerization" "activator-proteins-1" "activators" "acute-phase"
    "acyl" "ad-hoc" "adFOXO3a" "adGFP" "adduct" "adducts" "adeno"
    "adenoma-cancer" "adenoma-carcinoma" "adenylate" "adenylyl"
    "adenylyl-imidotriphosphate" "adipogenic-lineage" "adryamicin"
    "advanced-stage" "affinity-purification" "agar" "age-at-onset"
    "age-distribution" "age-gender" "age-induced" "age-modifying"
    "age-of-onset" "aggregate-induced" "aggregometer" "agomir" "agtgATTGTgatgg"
    "akinesia" "alanine-substitution" "albicans" "alggen" "aligner" "aligners"
    "alikes" "alkyl" "all-D" "all-D-enantiomer" "all-L" "alle"
    "allelic-specific" "allo" "allograft" "alpha-amino" "alpha-helical"
    "alpha-induced" "alpha-lipoic" "alpha-minimum" "alterations"
    "aluminum-induced" "alveolar–capillary" "alveoli" "ambient-air"
    "ameloblast-like" "amino-acid" "amino-acids" "amino-terminal"
    "amino-terminus" "amplicons" "anaeig" "analyte" "anastazole"
    "ancestry-informative" "and-independent" "andA" "andLipo246" "andSirt1"
    "andTau" "andVLA4" "andcell" "andcyclin" "androgen-deprivation" "andγ-TT"
    "aneuploidy" "angiogenesis-associated" "anlage" "anosmia" "antagomir"
    "anterograde" "antibody-chemotherapy" "anticodon" "antigen-like"
    "antiparallel" "antitumour" "anti‐cancer" "aphidocoline"
    "apoptosis-evasion" "apoptotic-inducing" "apoptotic-like" "approachs"
    "apraxia" "arisen" "arrest-deficient" "as-yet-undetermined" "aspartates"
    "astral-MT" "at-risk" "ataxiatelangiectasia" "ation" "atomic-level"
    "aureus" "auristatin" "authophagy" "auto-antibody" "auto-inhibition"
    "auto-inhibitory" "auto-reactivity" "auto-regulation" "auto-regulatory"
    "autocleavage" "autopahgy" "autopsy-proven" "autoradiography" "axon"
    "azadeoxycitidine" "b-TRAF6" "b-d" "b-defensin-1" "b-k" "b-lineage"
    "back-fuse" "back-fusion" "bacteriaemia" "bandpass" "bar-code" "basal-like"
    "base-base" "basepair" "bead-bound" "begun" "benefit–risk" "benzo"
    "benzodiazepinedione" "benzyl" "better-targeted" "between-study"
    "betweencyclin" "betweenness" "bi" "bi-allelic" "bi-functional"
    "bi-transgenic" "bilayer" "biliverdin" "biomass" "biomolecules"
    "biopsy-proven" "biotin" "biquitin" "bis-ANS" "bis-ANS-binding"
    "bisphosphate" "bivariate" "blastocyst" "blastocysts" "blocker" "blockers"
    "blood-brain" "blood-retinal" "blood–brain" "blue-green" "bona" "bona-fide"
    "bonda" "bone-marrow" "bortezomid" "bpv" "brainstem" "breakpoint"
    "breakpoints" "breast-cancer-specific" "breast-like" "breast-ovarian"
    "bridge-forming" "brighter" "brightfield" "broad-acting" "broad-spectrum"
    "broader" "buffy" "build-up" "bursa" "butanone" "butwas" "butwhen"
    "by-product" "c-Met3" "c-Myc-Elk-1∆DBD" "c-Myc-vector-transfected" "cGFP"
    "cIL" "cIL-10" "cIL-10-neutralizing" "cMD" "cT" "calcium-ionophore-induced"
    "calcium-stress-induced" "callosum" "calorie-rich" "calphostin"
    "cancer-adjacent" "cancer-cell-killing" "cancer-relevant"
    "cancer-susceptibility" "cancer-therapy" "caner" "cannabinoid"
    "cannabinoids" "capillary-like" "capillary-network" "carbamoyl-Asp"
    "carbamoyl-phosphate" "carbonyl" "carbonyls" "carboplatin-paclitaxel"
    "carboxyl" "carboxyl-terminal" "carcinogenically-relevant" "carriers"
    "case-control" "casepase-8" "case–control" "casitas" "caspase‐dependent"
    "catalyse" "catch-up" "cation-aromatic" "cation-π" "causalities"
    "cell-cycle-related" "cell-dense" "cell-extrinsic" "cell-intrinsic"
    "cell-permeable" "cell-substratum" "cell-to-cell" "cell-type-specific"
    "cellTiterGlo" "cells" "cementoblasts" "centromere" "centuximab"
    "cerebellum" "cerebrum" "cerevisiae" "cervices" "cfDNA" "cfand" "cg"
    "cg00601836" "cg04063345" "cg15626350" "ch-TOG" "ch-TOG–TACC3"
    "chaperone-like" "charcoal-filtered" "cheaper" "checkpoint-abrogated"
    "chemio" "chemo" "chemo-radioresistance" "chemo-radiotherapy"
    "chemo-sensitivity" "chemo-therapies" "chemo-therapy" "chemoattractant"
    "chemoradiotherapies" "chemoradiotherapy" "chemoresistance"
    "chemoresistant" "chemotherapy-resistance" "chi-square" "childlessness"
    "chimerism" "chloro" "chloro-phenyl" "chlorobenzyloxy" "chloroethyl"
    "chloroindole" "chlorophenyl" "chol-TUSC2" "cholecystitis"
    "chondrocyte-lineage" "chondrodysplasia" "chosen" "chr16" "chr6" "chr9"
    "chromatid" "chromatids" "chromatin-immunoprecipitation"
    "chromatin-remodeling" "chromoprotein" "chromosome-positive"
    "chromosome-to-gene" "chromosomes–breakpoint-enriched" "circuitry"
    "cis-eQTL" "cisplatin-dependent" "cisplatin-navelbine"
    "cisplatin-stimulated" "cisplatin-triggered" "clade" "clade-dependant"
    "clades" "clear-cut" "clearer" "cleavage-ligation"
    "cleaved-caspase-3-positive" "clerocidin" "clinic-pathological"
    "clinical-pathological" "clinical-trial" "clinically-advanced" "clinicians"
    "clinico" "clinico-pathologic" "clinico-pathological" "close-range"
    "cluster-variable" "clustered-type" "coagulant" "coauthors"
    "cobblestone-forming" "cobblestone-like" "codon" "codonArg399Gln" "codons"
    "coefficien" "coevolve" "cofillin" "coiled-coil" "cold-shock"
    "cold-treated" "coli" "colitis-associated" "colitis-driven" "collagens"
    "collegues" "colonies" "colonoscopy" "colony-enhancing" "colony-forming"
    "combination-treated" "common-law" "commonest" "comodule" "comparingcyclin"
    "competition-based" "complex-1" "concentration-dependently" "confounder"
    "confounders" "consumables" "contexture" "control-cDNA"
    "convergence-extension" "copy-number" "copy-number-stable" "coregulate"
    "corneum" "cost-effective" "cost-effectiveness" "cost-efficient"
    "counter-intutive" "covar" "covariance" "covariate" "covariates"
    "coworkers" "coxsackie" "creatinin" "cremaster" "cribriform" "criterea"
    "cross-contamination" "cross-immunoprecipitate" "cross-phosphorylation"
    "cross-react" "cross-reactivity" "cross-resistance" "cross-sectional"
    "cross-species" "cross-talking" "cross-validation" "cryo-EM"
    "cryo-EM-based" "cryo-electron" "cryo-immuno" "cryo-immunoEM" "cryoEM"
    "csATM" "ctDNA" "cumulus-oocyte-complexes" "cut-off" "cut-offs" "cut-point"
    "cut-points" "cycle-threshold" "cyclin-G" "cyclin-dependant"
    "cyclin-dependent" "cyclin-like" "cyclohexamide" "cycloheximide-chase"
    "cysteine-ubiquitin" "cysteinylglycine" "cytochromes" "cytology"
    "cytometer" "cytopenia" "cytospins" "d-e" "d-k" "dI" "dL" "dMMR" "daf-16"
    "data" "data-independent" "dataset" "datasets" "day-treatment" "dbGaP"
    "dbSNP" "dbSNP132" "ddPCR" "de-convolute" "de-induction" "de-novo"
    "de-regulation" "de-repressed" "de-repression" "de-ubiquitylases"
    "deacetalyse" "deactylases" "decamer" "decamers" "decreasses" "decrements"
    "deep-sequence" "deep-sequence-based" "deeper" "deficientmice"
    "deficit-enabling" "degraders" "deiminases" "del19" "del5395"
    "delE746-A750" "delE746_A750" "deleter" "deletions" "delta-like"
    "densitometer" "dentin" "dentin-pulp-like" "deoxcytidine"
    "deoxynucleotidyl" "deoxyuridine" "dependnt" "depression-like" "derivate"
    "desaturase-1" "desmoplasia" "destabilise" "detergent-insoluble"
    "di-methylation" "diabetes-induced" "diaminibenzidine" "dicarbonyl"
    "dichlorofluorescein" "dichlorophenyl" "diet-induced" "diethylstilbesterol"
    "differentia" "diffuse-type" "difluorophenacetyl" "dihydroxy"
    "dihydroxyvitamin" "dihyroxyacetone" "diindolylmethane"
    "dimethylaminopurine" "dimethylbenz" "dimethylsulfoxide" "dinucleotides"
    "diphenylene" "diphosphate" "diploid" "direct-space" "disc-like"
    "discharger" "discoidin" "discrepant" "discriminant" "disease-relevant"
    "dismutase-2" "disomy" "disorder-to-order" "displasia" "diterpenoids"
    "dithiocarbamate" "does-dependently" "doi" "dolabrane" "dolabrane‐type"
    "dolittle" "domain-defective" "dominant-negative" "dormancy"
    "dosage-sensitivity" "dose-and" "dose-dense" "dose-dependently"
    "dose-limiting" "dose-response" "dose‐dependent" "dose–response" "dot-plot"
    "double-blind" "double-immunofluorescence" "double-membrane"
    "double-minute" "double-mutants" "double-strand" "doublecort"
    "double‐strand" "doublings" "down-modulates" "down-modulation"
    "down-stream" "downmodulate" "doxo" "doxo-ABT-888" "doxorubicin‐induced"
    "doxorubicin‐mediated" "doxrobicin" "doxycline" "doxycyline" "drawn"
    "droplet" "drug-combination" "drug-like" "drug-removal" "drug-sensitivity"
    "drug-washout" "dsDNA" "dual-ISH" "dul" "dulH773" "duplet" "duplets"
    "duplexes" "dye-exclusion" "dysfunction-induced" "dyslipidemia"
    "dysmorphia" "dysplasia" "d–f" "e-g" "eGWAS" "eIF4-mimetic" "eLife" "eRNAs"
    "early-onset" "early-phase" "early-stage" "echocardiography" "ectoderm"
    "ectodomain" "edema" "efficacy-prediction" "eigenvectors" "eight-cell"
    "eight-stranded" "eighty-five" "eighty-six" "eithercyclin" "el"
    "electron-transfer" "electrophoresis-time" "electrospray" "element-binding"
    "embryoïd" "enantiomer" "enantiomers" "end-directed" "end-replication"
    "end-stage" "end-to-end" "endoderm" "endogenously-synthesized"
    "endometrioid" "endometrium" "endoplasmic-reticulum" "endosome-to-Golgi"
    "endpoint" "endpoints" "ends-directed" "energy-conserving"
    "enhanced-strength" "enhancer" "enhancer-binding" "enhancer-like"
    "enrollees" "ensemble-view" "enthalpy" "entropies" "entropy"
    "entropy-enthalpy" "eosinophil" "eosinophils" "epidermoid" "epigenome"
    "epirubocin" "episome" "epithelia" "epithelial-derived" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "epithelium" "eribulin" "erlotinb"
    "erythema" "erythroid-cell-derived" "esculenta" "esculentin-1a"
    "esophagectomy" "estrogen-only" "estrogen-signaling" "et" "ethynylphenyl"
    "etoposide-treatment" "et " "euthyroid" "events" "ever-smokers" "ex"
    "ex-smokers" "ex-vivo" "exclusiveness" "exhibitedsignificant" "exome"
    "exon-only" "exon18" "exon2" "exons" "exovinyl" "explicit-solvent"
    "expressionwhile" "expressors" "extended-lid" "extra-chromosomal"
    "extra-telomeric" "extra-terminal" "extracellular-signal-regulated"
    "extrathyroid" "eye-visible" "eze" "factor-1" "factor-2α" "factor-кB"
    "fallen" "families" "far-red" "farnesyl" "fat-fed" "feed-back"
    "feedforward" "female-specific" "fetal-hemoglobin" "fiber-knob"
    "fibroblast-like" "fibroblast-to-I" "fibroblastoid" "fibronectine" "fide"
    "fine-tune" "fine-tuned" "fine-tuning" "finger-type" "firmoss"
    "first-generation" "first-in-class" "first-in-man" "first-line"
    "fission–fusion" "fit-in" "five-year" "flatworm" "flavonoid" "flora"
    "florescence-activated" "flow-chart" "flow-cytometric" "flow-in"
    "flowchart" "flp-in" "fluid-flow" "fluorescently-labeled"
    "fluorodeoxyglucose" "fluoromethyl" "fluorouridine" "flurouracil"
    "focusses" "folinate" "folium" "follicle" "follicles" "follow-up"
    "followed-up" "forand" "forebrain" "formazan" "former-smokers" "foud"
    "four-color" "four-stranded" "frame-shift" "frameshift" "frameshifts"
    "free-energy" "free-survival" "frequent-occurred" "fresh-frozen"
    "frog-skin" "fromSirt1" "fromTau" "fromin" "frozen" "full-serum"
    "full-texts" "full-thickness" "functionally-relevant" "furthet" "fusiform"
    "fusions-driven" "g-anaeig" "g-covar" "gD" "gD-positive" "gJ" "gNf1"
    "gPtch1.1" "gPtch1.3" "gPten" "gTrp53" "gain-of-function" "gallbladder"
    "gamma-herpesvirus" "gastric-esophageal" "gastro" "gastro-oesophageal"
    "gatekeeper" "gavage" "gedatolisib" "gefitinib-senstive" "gel-shift"
    "gender-specific" "gene-association" "gene-by-gene" "gene-dosage"
    "gene-environment" "gene-gene" "gene-to-chromosome" "gene-to-gene"
    "genetically-homogeneous" "genetically-modified" "genetics-based"
    "gene–gene" "genito" "genito-urinary" "genitors" "genome"
    "genome-stability" "genome-wide" "genome-wide-association" "genomes"
    "genomewide" "geranylgeranyl" "germ-layer" "germ-line" "germline" "glia"
    "glioams" "globally-prevalent" "glomerulonephritis" "glucose-deprivation"
    "glucuronidase-β" "glutamate-rich" "glutathion-S-transferase"
    "glutathione-agarose" "glutatione" "glycerophosphate" "glycinamide"
    "glycolaldehyde" "gonad" "gonads" "gowth" "gp350" "graft-versus-host"
    "gram-negative" "granulosa" "grape-like" "greater" "greatest" "gromacs"
    "ground-state" "growth-suppressive" "gse10613" "gse13733" "gtagtt" "gttgtt"
    "guanine-cytosine" "guide-RNA" "g " "hAK015428" "hAoSMC" "hAoSMCs" "hCLP"
    "hCLP46-full" "hDPSCs" "hEGFRp" "hESC" "hESC-like" "hESCs" "hMSCs" "hONS"
    "hTAF" "hTERT-HPNE" "hTERT-INS1b" "hTREX" "hUCB" "hYAP" "hYAP1" "hYAP2"
    "half-ERE" "half-ERE-containing" "half-life" "half-maximal" "half-site"
    "half-sites" "hands-on" "haplo" "haplo-insufficient" "haplotype"
    "haplotype2" "haplotypes" "harpin" "harsher" "hbA1C" "head-neck"
    "head-to-head" "head-to-tail" "headgroup" "healing-modulatory"
    "health-care" "heat-shock" "heat-shock-induced" "heatmap" "heatmaps"
    "heavy-atom" "heavy-chain" "helices" "helix" "helix-loop-helix"
    "hematologists" "hemi" "hemizygousFlt3" "hepatectomy" "heptapeptide"
    "hereon" "herterodimer" "hetero" "hetero-trimers" "heterooligomers"
    "heterotetramer" "heterotrimer" "heterotrimers" "heterozygote"
    "hexokinases" "hg19" "hiPSC" "hiPSCs" "high-HbF" "high-Met" "high-affinity"
    "high-altitude" "high-concentration" "high-concentrations"
    "high-confidence" "high-copy" "high-coverage" "high-density" "high-dose"
    "high-expression" "high-glucose-induced" "high-grade" "high-incidence"
    "high-level" "high-metastatic" "high-mobility" "high-penetrance"
    "high-performance" "high-potential" "high-quality" "high-rate"
    "high-resolution" "high-risk" "high-salt" "high-serum" "high-stage"
    "high-tension" "higher-grade" "higher-order" "highly-expressed" "hindlimbs"
    "histione" "histo" "histo-pathological" "histogram-plot" "histologies"
    "histology" "histone-2B-GFP" "histone-DNA" "histone-like"
    "histopathologically-confirmed" "histopathology" "histoscore" "histotype"
    "histotypes" "hit-or-miss" "hoc" "holo" "holo-apoptosome" "holocrine"
    "homeodomain" "homo-oligomeric" "homogenates" "homolog" "homologs"
    "homooligomers" "homotrimer" "homotrimers" "homozygote" "homozygotes"
    "homozygousFlt3" "honoraria" "hormone-receptor" "host–microbe" "hot-spot"
    "hotspot" "hotspots" "hourscyclin" "hr" "hsRNA" "hsa-miR-140"
    "hsa-miR-140-5p" "hsa-miR-144" "hsa-miR-20b" "hsa-miR-92a" "hsa-miR-99b"
    "http" "huperzine" "hydrogen-bonds" "hydrophobicity-value" "hydroxyacetyl"
    "hydroxybutyl" "hydroxycamptothecin" "hydroxydeoxyguanosine" "hydroxyl"
    "hyper" "hyper-aggregation" "hyper-fragmentation" "hypercholanemia"
    "hyperinsulinemia" "hyperoxia" "hyperploid" "hyperploidy" "hyperthyroid"
    "hyperthyroxinemia" "hypo-activity" "hypo-phosphorylation" "hypotrophy"
    "hypoxemia" "i3T3" "iCOGS" "iMEFs" "iNKT" "iOvCa" "iOvCa147-E2" "iPLEX"
    "iTRAQ" "ibidi" "icro" "idth" "ie" "ii" "iii" "ikd" "imidazole"
    "imidotriphosphate" "immediate-early" "immmune" "immune-compromized"
    "immune-deficient" "immune-depletion" "immune-mediated" "immune-modulator"
    "immune-purified" "immune-reactive" "immune-regulatory"
    "immuno-fluorescence" "immuno-histochemical" "immunoEM" "immunoblasts"
    "immunocomplex" "immunocytes" "immunocytochemistry" "immunoglobulin"
    "immunoglobulin-like" "immunohischemistry" "immunohistochemistry"
    "immunophenotypes" "immunostainings" "immunotherapy" "implys" "imporant"
    "importin-α3" "in-depth" "in-frame" "in-house" "in-utero" "in-vitro"
    "in-vivo" "inSirt1" "inTau" "incdk4" "incidences" "increased-AGEs"
    "incyclin" "indcate" "indels" "individuate" "inefficacy"
    "infection-induced" "inflammation-associated" "inflammatory-mediated"
    "inflammatory-related" "inframe" "ingle" "inhbitors" "inline" "innate-like"
    "ins+ins" "insertions" "insightful" "insulin-like" "insulin-responsive"
    "ins→del" "int" "integrators" "integrin-α2β1" "inter-MT" "inter-cellular"
    "inter-domain" "inter-individual" "inter-laboratory" "inter-nucleosomal"
    "inter-observer" "inter-relatedness" "interaction=0.021" "interactome"
    "interdomain" "interfers" "intermediate-grade" "intermembrane"
    "interobserver" "interquartile" "interstrand" "interventio" "intima"
    "intoTau" "intocyclin" "intra" "intra-chromosomal" "intra-follicular"
    "intra-tumor" "intracardiac" "intraclass" "intramembrane" "intraobserver"
    "intrastrand" "intrasynaptic–extrasynaptic" "intratumour" "intron-exon"
    "inturn" "invariant" "iodide-exclusion" "iodophenyl" "ion-torrent" "ionic"
    "ip53" "ischemia-reperfusion" "isoenzyme" "isomers" "isoprenylcysteine"
    "isotopologue" "isotopomer" "isotype" "isotypes" "isozymes" "itro" "iv"
    "izTRAIL" "javanica" "junction-induced" "kDa-defective"
    "kappa-light-chain-enhancer" "karyotype" "kbp" "kcal" "kd-1463" "kd-3650"
    "kd-4351" "kd-LacZ" "keto" "kg" "kianses" "kidney-293" "kilobases" "kinas"
    "kinase-death" "kinase-defective" "kinase1" "kinasereceptors" "knock-down"
    "knock-in" "knocked-down" "knocked-in" "knocking-down" "knockingdown"
    "kown" "kyte" "kyte-dolittle" "labor-intensive" "lactatemia" "lactone"
    "laevis" "laminin5γ2" "large-mutation" "large-scale" "largely-negative"
    "laser-capture" "laser-induced" "laser-microdissection" "late-failure"
    "late-onset" "late-pregnant" "late-recurrences" "late-stage"
    "latency-associated" "latency-induced" "lavage" "leave-one-out" "leds"
    "left-side" "left-sided" "left-tailed" "leftover" "lentivectors"
    "lentiviral-mediated" "lessonae" "let-7a" "let-7b" "let-7c" "let-7d"
    "let-7e" "let-7f" "let-7g" "letrazole" "leukoencephalopathy" "levels"
    "levle" "lid-core" "lid-including" "lid-interacting" "lid-interactions"
    "lid-lid" "lid-ligand" "lifecycle" "lifecycles" "lifespan" "ligand-lid"
    "ligand-receptor" "light-chain" "limulus" "lineLNCaP" "lineage-specific"
    "lipoplex" "lipopolysaccharide" "lipopolysaccharides" "lipoproteins"
    "littermates" "live-cell" "live-imaging" "lnc-KIF13B-1"
    "load-versus-capacity" "localization " "locations" "locked-nucleic"
    "loco-regional" "locus-specific" "log-fold" "log-phase" "log2" "log2ratio"
    "logrank" "long-course" "long-distance" "long-lasting" "long-lived"
    "long-living" "long-range" "long-standing" "longer-term" "look-alikes"
    "loop-sheet-helix" "loss-and" "loss-of-function" "loss-of-heterozygosity"
    "low-HbF" "low-affinity" "low-burden" "low-concentration" "low-coverage"
    "low-cytotoxicity" "low-dimensionality" "low-dose" "low-estrogen"
    "low-frequency" "low-grade" "low-invasion" "low-level" "low-metastatic"
    "low-mobility" "low-molecular-weight" "low-nutrient" "low-pass"
    "low-penetrance" "low-resolution" "low-risk" "low-serum" "low-symptomatic"
    "low-throughput" "lower-grade" "lower-left" "loxP" "lpr" "luminal-A"
    "luminal-B" "lumpectomy" "lurker" "lympho" "lympho-blastic"
    "lymphoblastoid" "lymphoma-2" "lymphopenia" "lysine-aspartate"
    "lysine-less" "lysis" "lyso" "lyso-bisphosphatidic" "mAoSMCs" "mDIVI-1"
    "mESCs" "mIS-variable" "mIU" "mIκBα" "mKLF8" "mPKCθ" "mTOR-T" "mTOR-driven"
    "mTOR-related" "mTesr1" "macro-vascular" "macroglobin" "macroglobulin"
    "macule" "macules" "make-up" "maligancy" "malignacy" "malignance"
    "malignances" "mammary-targeted" "mammography" "mammoplasty" "mammosphere"
    "mammospheres" "man-made" "marker-candidates" "masking-oligonucleotides"
    "mass-spectroscopy" "mastectomy" "mastopathy" "maternal-fetal"
    "matrix-remodeling" "mean±SD" "mean ± SD" "mediated-apoptosis"
    "mediterranea" "megabases" "melanin" "melanogaster" "mellitus"
    "member-knockout" "membrance" "membrane-impermeable" "membrane-proximal"
    "meninges" "meningiomas-WHO" "mesangium" "mesencephalon"
    "mesenchymal-derived" "mesenchymal-epithelial" "mesenchymal-like"
    "mesenchymal–epithelial" "mesenchyme" "mesoderm" "meta-regression"
    "metabolome" "metalloproteinase-9" "metastasis-suppressive" "methanone"
    "methoxyethoxy" "methoxyphenyl" "methyl-beta-cyclodextran" "methyl-group"
    "methyladenine" "methylcytosine" "methylene"
    "methylenedioxymethamphetamine" "methylnitrosamino" "methyltransferse"
    "mevalonate" "mg•m" "miPSCs" "miR-106" "miR-106a-363" "miR-106a-92"
    "miR-106b" "miR-106b-25" "miR-106b-transfection-only" "miR-1204" "miR-124"
    "miR-124-mediated" "miR-124-transfected" "miR-124-treated" "miR-132"
    "miR-132~212" "miR-133b" "miR-135b" "miR-138" "miR-138-5p" "miR-141"
    "miR-143" "miR-143-miR-145" "miR-144" "miR-144-3p" "miR-144-5p"
    "miR-144-based" "miR-144-dependent" "miR-144-depleted" "miR-144-induced"
    "miR-144-mediated" "miR-144inhibited" "miR-144’s" "miR-145" "miR-146"
    "miR-146a" "miR-146b" "miR-146b-5p" "miR-148a-mut" "miR-149" "miR-15"
    "miR-150" "miR-153" "miR-154" "miR-155" "miR-155-encoding"
    "miR-155-transduced" "miR-155a" "miR-15a" "miR-16-1" "miR-1699" "miR-17"
    "miR-17-92" "miR-181d" "miR-182" "miR-182-TIAM1" "miR-182-mediated"
    "miR-190b" "miR-191" "miR-1915" "miR-192" "miR-195" "miR-195-5p" "miR-199a"
    "miR-19a-5p" "miR-200" "miR-200b" "miR-20a" "miR-211" "miR-212" "miR-214"
    "miR-218" "miR-22" "miR-222" "miR-23b" "miR-25" "miR-26a" "miR-27a"
    "miR-29a" "miR-29b-p53-PTEN" "miR-31" "miR-326" "miR-335"
    "miR-335-SAIH2-HDAC3" "miR-335-SIAH2-HDAC3" "miR-335-mediated" "miR-337-3p"
    "miR-34" "miR-362-3p" "miR-379" "miR-421" "miR-429" "miR-449" "miR-451"
    "miR-451a" "miR-451expression" "miR-4728" "miR-4728-3p" "miR-486" "miR-494"
    "miR-497" "miR-509" "miR-517a" "miR-545" "miR-584" "miR-603" "miR-605"
    "miR-648" "miR-767-3p" "miR-9" "miR-92a-1-5p" "miR-936" "miR-95"
    "miR-95-3b" "miR-95-3p" "miR-95-3p-transfected" "miR-96" "miR141-EGFR"
    "miR141-EGFR-ERK" "miR146a" "miR17" "miR200c" "miR212" "miRDB" "miRNA-106b"
    "miRNA-29b" "miRNA-gene" "miRNA-gene-network" "miRNA-like" "miRNP"
    "miRanda" "miRome" "mice" "miceand" "micro-deletions" "micro-dissection"
    "micro-environment" "micro-invasive" "micro-irradiation-induced"
    "micro-metastases" "microRNA-128" "microRNA-148a" "microRNA-200"
    "microRNA-20a" "microRNA-21" "microRNA-29c" "microRNA-329" "microRNA-451"
    "microRNA-675" "microRNA-gene" "microRNA141" "microRNAome" "microdomains"
    "micrographs" "microirradiation-induced" "micromass" "micropenis"
    "microplate" "microrchidia" "microribonucleoprotein" "microsatellite"
    "microsatellite-unstable" "microseconds" "microtubule+TIP" "microvessel"
    "microvessels" "mid-gestation" "mid-life" "mid-long" "mid-prophase"
    "midbrain" "midium" "midline" "mild-to-moderate" "mini-CMV"
    "mini-chromosome" "minichromosome" "minigene" "minigenes" "minus-end" "mir"
    "mir-141" "mir-200" "mir-200b" "mir-200s" "mir-429" "mir-4728"
    "mir-4728-3p" "mir-4728-mediated" "mir-4728-overexpressing" "mirVana"
    "miroRNAs" "mis-segregation" "mislocalizes" "missense" "mitogen-activated"
    "mitomycin" "mixed-population" "mmu-miR-291-3p" "mock-depleted"
    "mock-transduced" "mock-transfected" "mock-transfections" "mock-treated"
    "mode-of-action" "moderate-high" "moderately-expressed" "moiety-containing"
    "molecular-marker" "molecular-target" "molecularly-targeted" "molecule-1"
    "mono-agents" "mono-allelic" "mono-form" "mono-phosphate" "mono-targeting"
    "mono-treatment" "mono-treatments" "mono-unsaturated" "mono-unsaturation"
    "monocyte-derived" "monocyte-like" "monolayer" "mononucleosomes" "monosomy"
    "monotherapies" "monotherapy" "more-than-additive" "morpholinos"
    "morpholinyl" "mortem" "morulae" "mountant" "mt" "mtp53" "mtp53's"
    "mtp53’s" "mucosa" "mucosal-associated" "multi-cancer" "multi-drug"
    "multi-exon" "multi-factorial" "multi-functional" "multi-kinase"
    "multi-modal" "multi-modality" "multi-omics" "multi-organ" "multi-platform"
    "multi-polar" "multi-step" "multi-wavelength" "multicenter" "multicyst"
    "multidomain" "multigene" "multiparameter" "multiple-drug"
    "multiple-predictor" "multiple-source" "multiple-ubiquitinated"
    "multiprotein" "multisubunit" "multivariable-adjusted" "multivariate"
    "muscle-invasive" "muscularis" "mutant-erlotinib" "mutant-inhibitor"
    "mutant-partner" "mutants" "mutations" "mutp53" "myc-CT" "mylabris"
    "myocardium" "myofibroblast-like" "myosin-light-chain" "myrAkt1"
    "myrPI3KCA" "myrPIK3CA" "myristoylation-tag" "myxoid" "n=104" "n=3" "n=6"
    "nATM" "nCounter" "nLDL" "nUPLC-MS" "nab-paclitaxel" "naive-like"
    "naive-specific" "naive-state" "nano" "nano-molar" "nanofibre"
    "nanoseconds" "nanovesicle" "ncATM" "ncomms8095" "ncomms8162" "ncomms8202"
    "ncomms8247" "ncomms8324" "ncomms8391" "ncomms8437" "near-complete"
    "near-endogenous" "nearest" "nearest-neighbour" "necropsy"
    "necroptotic-inducing" "necrotic-like" "negatively-charged" "neo-adjuvant"
    "neoadjuvant" "neoantigens" "neoplasias" "nephrectomy" "nephron"
    "nephropathy" "nested-in-cohort" "neurite" "neuro" "neuro-inflammation"
    "neuro-inflammatory" "neurobiology" "neuroendocrine" "neurokinin-1"
    "neuropathology" "neurosphere" "neurospheres" "neurosurgery" "neutropenia"
    "neutrophil-borne" "never-smokers" "never-smoking" "newer"
    "newly-constructed" "newly-formed" "next-generation" "nick-end" "nigra"
    "nitroso" "nitrosobutyl" "no-familial-mutation" "no-mutation"
    "node-positive" "nomal" "nomograms" "nonbulky" "nondrinkers" "nonfat"
    "nonhistone" "nonhuman" "nonpeptidyl" "nonredundant" "nonsense-mediated"
    "nonsignificant" "nonsmall" "nonsmall-cell" "normal-like" "normal-tension"
    "normals" "normal–adenoma–carcinoma–metastasis" "ns-long" "nsNSCLC"
    "nsp1-4" "nt" "nucle" "nucleases" "nucleate" "nucleators" "nucleo"
    "nucleophosmin1" "nucleotide-excision" "nucleotide-shortage"
    "nucleus-to-cytoplasm" "ob" "occupancies" "octamers" "odonto"
    "odontoblast-like" "oedema" "oestrogen" "ofSirt1" "ofTau" "ofconfers"
    "ofcould" "ofcyclin" "off-target" "off-targets" "offs" "ofwas" "ofwith"
    "ol" "oligoguanine" "oligos" "omain" "omentum" "omics" "on-and-off"
    "on-going" "on-site" "onco" "oncogenically-relevant" "oncologists"
    "one-fourth" "one-quarter" "one-side" "one-third" "one-to-one" "one-way"
    "online-only" "oocyte-specific" "oocytes" "oolemma" "oophorectomy"
    "open-angle" "open-label" "opioids" "option-oq" "oq" "orTau" "orcyclin"
    "organelle" "organelles" "organism-wide" "organoids" "origin-distal"
    "origin–distal" "ortholog" "orthologue" "orthologues" "osteoactivin"
    "osteoblastoids" "osteoblasts" "osteocyte-like" "out-of-frame" "outs"
    "ovary-specific" "over-activation" "over-decoration" "over-diagnosis"
    "over-proliferative" "over-representation" "over-simplification"
    "over-treatment" "overdominant" "overgrew" "overnutrition-induced" "ovo"
    "oxidases" "oxygenase-1" "oxygens" "oylalanide" "p-Tyr" "p13suc1" "p21-L"
    "p21-Rb-E2F" "p21-luc" "p21CDKN1A" "p21L" "p21Waf1" "p23-EYFP" "p2–5"
    "p38-mediated" "p38K" "p38MAPK" "p38β" "p47phox-null" "p53-6M"
    "p53-dependency" "p53-dn" "p53-function" "p53-independent" "p53-like"
    "p53-mediated" "p53-mutated" "p53-mutational" "p53-null" "p53-pathway"
    "p53-proficient" "p53-transcriptional" "p53A" "p53B" "p53DBD" "p53R175H"
    "p53R273H" "p53RE" "p53REs" "p53Se46" "p53WT" "p53wt" "p73-null"
    "p73-shRNAs" "p73dependent" "p73mediated" "p73sh-RNA" "p73specific" "p73α"
    "p73β" "p85S6K" "p85α" "p=0.0069" "p=0.007" "p=0.010" "p=0.043" "p=1.1×10"
    "p=1.4×10" "p=3.0×10" "p=3.9×10" "p=4.9×10" "p=5.0×10" "pA3TK-luc" "pAKT1"
    "pBabe" "pCAGGS-NAMPT" "pCAGGS-NAMPT-H247E" "pCAGGS-vector" "pCCNE1"
    "pCDC2" "pCDK" "pCDK1" "pCDK2" "pCDNA-c-Met" "pCDNA-c-Met-induced"
    "pCDNA3-HA-GSK-3β-S9A" "pCDNA3.1" "pCDNA3.1-Myc-NP"
    "pCDNA3.1-RNF43-Flag-HA" "pCHK1" "pCHK2" "pCMV" "pCMV6" "pCMV6-empty" "pCR"
    "pEGFP-C1" "pEGFP-C1-ERα" "pEGFPN1" "pEGFP–hTERT" "pEGFR" "pEGFR-EYFP"
    "pFLAG" "pFLAG-CMV" "pG5E1bLuc" "pGER" "pGL-3" "pGL2-Basic" "pGL3-Basic"
    "pGL3-basic-IGFBP3-box" "pGL3N2PR-110" "pGL3N2PR-2327" "pGL3basic" "pGSK3α"
    "pGalA" "pGalO" "pH2A" "pHDAD5" "pHH3" "pHLZ" "pHSP27" "pHsp70" "pHybLexA"
    "pH " "pI3-AKT" "pIRES-INS1b" "pIRES-hTERT-INS1b" "pIS0" "pInducer" "pIκB"
    "pIκBα" "pLSD1" "pM" "pMB1" "pMMR" "pMSCVpuro" "pMSCVpuro-ICN2" "pMT2TMyc"
    "pMigRI" "pMigRI-ICN2" "pN" "pN0" "pNF-κB-luc" "pS131" "pS137" "pS473"
    "pSMAD" "pSMAD-luc" "pSTAT3" "pSTAT5" "pSV-Renilla" "pSer-675" "pSmad1,5,8"
    "pStage" "pSuper" "pSyk" "pT" "pT3" "pT308" "pT444" "pTNM" "pTopFlash"
    "pX330" "pY397-FAK" "pY416-Src" "pYAP" "pYESTrp2" "pack-years" "paired-end"
    "pairwise" "pan-MAGE-A" "pan-cancer" "pan-cytokeratin-negative"
    "pan-cytokeratin-positive" "pan-inhibitor" "pancreatitis" "papillae"
    "papilliferum" "papules" "para-carcinoma" "paracrine" "paradigme" "paralog"
    "paralogues" "parenchyma" "parity-identified" "parkinsonism" "parotid"
    "partially-independent" "particulate" "partite" "passage-0" "patho"
    "patho-biology" "pathobiology" "pathogen-associated" "pathophysiology"
    "patient-and" "pcDNA3" "pcDNA3.0-pooled" "pds" "pectoris" "penetrance"
    "penetrant" "penile" "pepscan" "peptide-like" "peptidyl" "peptidylarginine"
    "per-allele" "perhaps" "peri-cancer" "peri-nuclear" "pericardium"
    "perichondrium" "periosteum" "peritoneum" "peroxide-treated" "persistant"
    "person-time" "personalise" "personnes" "phTERTpromoterLuc" "phalanges"
    "pharmacophore" "pharmacotherapies" "pharmacotherapy" "phase-2"
    "phase-translucent" "pheneotypes" "phenyl" "phenylarsine" "phosphatase-2"
    "phosphatase-activity-dependent" "phosphoflow" "phosphogluconate"
    "phosphoinositol" "phosphoinositol-3" "phosphopentose" "phosphopeptide"
    "phosphorin" "phosphorylated-HSP27" "phosphorylation-defective"
    "phosphorylation-dependnt" "phosphosite" "phs000196" "physical-functional"
    "picoseconds" "pifithrin-α" "piperazinone" "piperidinone-2" "piv" "pixel"
    "placebo-controlled" "plasmacytoid" "pletelets" "pleura" "plex" "ploïdy"
    "pluripotency-specific" "pluripotent-cell" "plus-end-directed" "plus-ends"
    "pmirGLO" "pmirGLO-miR-143" "pmirGLO-miR-145" "pneumophila" "podosome-like"
    "polarisome" "polivinilidene" "poly-and" "polyA" "polychemotherapy"
    "polycomb-repressive" "polyethylenimine" "polymerase-1" "polymophisms"
    "polymorphism" "polymorphisms" "polyphenol" "polypoid" "polysomy"
    "polyubiquitination-defective" "polyubiqutin" "poor-prognosis"
    "poor-prognostic" "poorer" "poorly-defined" "positive-association"
    "positive-regulatory" "positron" "post-ARV" "post-HRT" "post-adFOXO3a"
    "post-delivery" "post-disease" "post-doxycycline" "post-endocytic"
    "post-failure" "post-hoc" "post-implantation" "post-infection"
    "post-injection" "post-inoculation" "post-internalization"
    "post-menopausal" "post-menopausally" "post-mortem" "post-natal"
    "post-operative" "post-protocol" "post-receptor" "post-resistance"
    "post-rociletinib" "post-stimulation" "post-surgery" "post-surgical"
    "post-transcription" "post-transcriptional" "post-transcriptionally"
    "post-transduction" "post-transfection" "post-translation"
    "post-translational" "post-translationally" "post-translationtional"
    "post-transplant" "post-treatment" "post-vaccination" "postangioplasty"
    "potential–driven" "pp" "prebound" "pregranulosa" "premolars" "prepregnant"
    "pretRNA" "pri-miR-124-1" "pri-miR-132" "pri-miR-143" "pri-miR-145"
    "pri-miR-451" "pri-miR-95" "primed-state" "primer-specific" "priori"
    "pro-angiogenic" "pro-atherogenic" "pro-autophagic" "pro-caspase-3"
    "pro-coagulant" "pro-death" "pro-drug" "pro-drugs" "pro-enzyme"
    "pro-inflammatory" "pro-invasive" "pro-life" "pro-metastatic"
    "pro-migratory" "pro-neoplastic" "pro-proliferative" "pro-survival"
    "pro-tumorigenic" "pro-tumoural" "proband" "probands" "procaspase-3"
    "processosome" "prodomain" "profilers" "progenies" "progenitor-associated"
    "progenitor-initiated" "progenitors" "progeny" "progestin"
    "proinflammatory-inducible" "proliferator-activated"
    "proliferator–activated" "proline-to-alanine" "prolonged-duration"
    "promoter-distal" "promoter-proximal" "promoter-region"
    "promoter-regulatory" "promoterless" "proof-of-concept"
    "proof-of-principle" "propositus" "propria" "prosencephalon"
    "prostaglandins" "prostatectomies" "prostatectomy" "protease-like"
    "protectiveness" "protein-RNA" "protein-gene" "proteins" "protein–DNA"
    "proteome" "proteome-wide" "proteomes" "proteosome" "proto" "protooncogene"
    "prototrophy" "proven" "proximity-mediated" "pseudo-substrate"
    "pseudo-substrates" "pseudogene" "pseudopeptide" "pseudosubstrate"
    "pseudosubstrates" "pseudovirus" "psiCHECK-2-Mut1-3-PTEN-3" "psiCHECK2"
    "psoriasiform" "psoriasis-like" "pts" "public-Versteeg"
    "publically-available" "pull-down" "pulldown" "pulldowns" "pulposus"
    "pulsatile" "pulse-chase" "punch-in-a-punch" "punctae" "punctata"
    "punctiform" "purpuratus" "pyerene" "pyrazole" "pyridyl" "p " "qChIP" "qRT"
    "qRT-PCR" "qRT-qPCR" "quadruplex" "quadrupole" "quantitative-trait"
    "quinazolin" "quinazolin-4-amine" "quinazolinamine" "quinazolone"
    "quinolinyl" "quintuple" "r=0.231" "rAd-ASPP2" "rAd-Vector" "rHGF" "rKSHV"
    "rKSHV-EA" "rNTP" "rNTPs" "rPAPPA" "rRANKL" "rTNIP1" "r_rmsf"
    "radiation-induced" "radiation-treated" "radio-resistance"
    "radio-sensitivity" "radio-sensitize" "radioimmunotherapy"
    "radioresistance" "radioresistant" "random-effect" "random-effects"
    "rank-sum" "rapalog" "rapalogs" "rapamcyin" "rarer" "re-accumulating"
    "re-addition" "re-adjusting" "re-analysis" "re-analyzed" "re-analyzing"
    "re-attached" "re-biopsied" "re-characterize" "re-chromatin" "re-confirmed"
    "re-considered" "re-enter" "re-epithelialisation" "re-epithelialized"
    "re-establish" "re-established" "re-evaluate" "re-evaluated"
    "re-examination" "re-expressed" "re-expressing" "re-expression"
    "re-implantation" "re-initiation" "re-instatement" "re-internalization"
    "re-introduced" "re-introduction" "re-localization" "re-orientated"
    "re-phosphorylation" "re-sensitize" "re-sensitized" "re-sequenced"
    "re-stimulated" "re-vaccination" "re-wired" "reactants"
    "reaction–restriction" "read-depth" "read-in" "read-score" "readout"
    "readouts" "reattach" "rebiopsy" "receptor-ligand" "receptor-like"
    "receptor-tyrosine-kinase-activated" "receptor-α" "receptor-γ"
    "recirculate" "redirect" "redox-homeostasis" "redox-stress"
    "refractoriness" "regrew" "regrow" "regrown" "regulomes" "regulon"
    "relatedness" "remarkably-strong" "remodeler" "remodelers" "renal-cell"
    "reoccurs" "repeat-containing" "replication-competent"
    "replication-incompetent" "replication-induced" "replication-mediated"
    "replicon" "replicons" "reprogramme" "reprogrammes" "rescuecyclin"
    "reseveratrol" "resp" "responder" "responders" "restriction–induced"
    "reticulum" "retromer" "retroperitoneum" "reveratrol" "reverse-phase"
    "reverse-transcription" "rewritten" "rhGRP78" "rhHGF" "ribonucleases"
    "ribose" "ribose-5-phophate" "ribose-5-phosphate" "ribosomal-RNA"
    "ridibundus" "right-sided" "rightmost" "ring-in-between-ring" "risen"
    "risk-associated" "risk-factors" "roscovotine" "rotamers" "rpHSP27"
    "rs10036748" "rs10069690" "rs10183914" "rs10404382" "rs10423702"
    "rs1043994" "rs1043997" "rs1049334" "rs1049337" "rs1052990" "rs10893872"
    "rs10930781" "rs10979327" "rs11178748" "rs11200014" "rs1128334" "rs1152591"
    "rs12901499A" "rs13035806" "rs13376333" "rs13393791" "rs1376090"
    "rs140492671" "rs150221955" "rs1590A" "rs17032957" "rs17588172" "rs1768190"
    "rs1768208" "rs1799782" "rs1800469C" "rs1806649" "rs1903974" "rs1920116"
    "rs1928482" "rs1962142" "rs1962223G" "rs200047376" "rs2001350" "rs2040862"
    "rs20417" "rs2106261" "rs2200733" "rs2242652" "rs2269736" "rs2284902"
    "rs2364725" "rs2410" "rs242557" "rs25487" "rs25489" "rs2625955" "rs2706110"
    "rs2736098" "rs2736098-rs2736109" "rs2736100" "rs2736109" "rs2802288"
    "rs2802288*A" "rs2802290" "rs2802292" "rs2802292*G" "rs28362491"
    "rs2853676" "rs2853677" "rs2981579" "rs34154613" "rs345299" "rs35652124"
    "rs35786788" "rs3599686" "rs35996865" "rs36000704" "rs3803662" "rs3807989"
    "rs3815188" "rs393152" "rs4236601" "rs4243387" "rs45464800" "rs4895441"
    "rs4975605" "rs4977756" "rs498872" "rs5275" "rs531564" "rs55705857"
    "rs6010620" "rs610604" "rs631312" "rs643472" "rs6494629T" "rs6597584"
    "rs6661074" "rs66650371" "rs6706649" "rs6721961" "rs6726395" "rs672961"
    "rs689466" "rs696" "rs715572G" "rs715572GA" "rs715572GG" "rs7193343"
    "rs7341233" "rs7557529" "rs7571971" "rs7725218" "rs7726159" "rs78378222"
    "rs78501403" "rs857989" "rs9376090" "rs9376090-C" "rs9389269" "rs9399137"
    "rs9402686" "rs9483788" "rs9494145" "rs963731" "rs963950" "rs969" "run-on"
    "s00432-015-1989-z" "s12881-015-0155-4" "s12885-015-1335-5"
    "s12885-015-1360-4" "s12885-015-1363-1" "s12885-015-1388-5"
    "s12885-015-1392-9" "s12885-015-1393-8" "s12885-015-1460-1"
    "s12885-015-1474-8" "s12885-015-1477-5" "s12885-015-1482-8"
    "s12891-015-0606-2" "s12918-015-0167-x" "s12920-015-0092-2"
    "s12943-015-0364-7" "s12943-015-0370-9" "s12943-015-0385-2"
    "s12957-015-0596-4" "s12957-015-0601-y" "s13000-015-0289-x"
    "s13023-015-0287-9" "s13046-015-0169-y" "s13048-015-0159-x"
    "s13058-015-0575-2" "s13062-015-0059-4" "s13075-015-0639-9"
    "s13075-015-0660-z" "s13104-015-1214-9" "s1981" "sALS" "sGRP78" "sGRWD1"
    "sHB-EGF-driven" "sHB-EGF-induced" "sHB-EGF-stimulated" "sHB-EGF-treated"
    "sHSP" "sHSPs" "sRAGE" "sVCAM-1" "salt-bridge" "scape" "scatterplot"
    "scissile" "score≥4" "scr" "scramble-control-infected" "sdRNAs" "sebaceus"
    "secnarios" "second-degree" "second-line" "second-order" "second-site"
    "secretome" "self-assembly" "self-association" "self-destruction"
    "self-digestive" "self-distraction" "self-evidently" "self-niche"
    "self-renew" "self-renewal" "self-tolerance" "semi" "semi-quantitative"
    "semi-quantitatively" "semi-solid" "sen" "senesces" "sequelae"
    "sequence-altering" "sequence-specific" "sericea" "serotype" "serrata"
    "serum-CM" "sessile" "sgRNA" "sh-1250-1278" "sh-331-359" "sh-non-targeting"
    "sh-scramble" "sh1α" "sh1β" "shATM" "shATR" "shATRs" "shCav" "shCav-1"
    "shCav-1-A" "shCav-1-B" "shCtrl" "shFLIP" "shFLIP-RNA" "shFMNL2" "shGFP"
    "shLSD1–1" "shLuc" "shMet" "shMet1" "shMet4" "shNC" "shNT" "shPEDF"
    "shPKCδ" "shPKCδ-Ishikawa" "shPTEN" "shPTPRT" "shRAC" "shRAC2"
    "shRAC2-transduced" "shRNA-1" "shRNA-CT" "shRNA1" "shRRM2" "shSAM"
    "shSAM50-transduced" "shSCR" "shT1" "shcontrol" "sheng" "shock–induced"
    "short-course" "short-hairpin" "short-range" "short-sized" "short-term"
    "short-time" "shorter-term" "shot-gun" "shp53" "shut-down" "shwon"
    "si-Akt2#2" "si-c-Met" "si-c-Met-induced" "si3" "siATM" "siBRCA1" "siBim"
    "siCRTL " "siCT" "siChe-1" "siCntrl" "siControl" "siCtrl" "siEGFRvIII"
    "siERK2" "siErk" "siFOXO3a" "siHDAC" "siHDAC5-treated" "siHIPK2" "siMAPK15"
    "siMAPK15#2" "siMDM4" "siMYBBP1A" "siNF" "siNF-κB" "siNon" "siPAK1"
    "siPARP-1" "siRNA-1" "siRNA-2" "siRNA-cntl" "siROR1" "siTIF" "siTIF-IA"
    "sialoglycoprotein" "side-by-side" "side-chain" "sideroblasts" "signifcant"
    "significantly-strong" "signiﬁcance" "silico" "simpler" "simplest"
    "simplex" "simutantp53" "single-base" "single-cell" "single-center"
    "single-copy" "single-dose" "single-institution" "single-molecule"
    "single-nucleotide" "single-parameter" "single-particle" "single-vector"
    "singleplex" "singulets" "sinusoids" "sirtuin" "size-exclusion"
    "skin-derived" "slighty" "slow-cycling" "slow-growing" "slower-migrating"
    "smRNA" "small-RNA" "small-RNAs" "small-cell" "small-molecule"
    "small-molecules" "small-size" "small-vessel" "smokers" "smooth-muscle"
    "sno-miR-25" "sno-miR-28" "sno-miR-28-TAF9B-p53" "sno-miRNA-28" "socio"
    "socio-economically" "sodium-independent" "sodium-taurocholate" "solute"
    "solvent-inaccessible" "sonography" "sorafenib-everolimus" "sorafenib-like"
    "sorted-cell" "sought-after" "spacer" "spatially-restricted" "spatio"
    "spatio-temporal" "spectrometery" "sphere-forming" "spheroid-induced"
    "spike-like" "spilus" "spindle-associated" "spindle-like" "spindle–cortex"
    "spitz" "spitzoid" "spliced-in" "spliceform" "sqm" "srep09755" "srep09887"
    "srep09893" "srep10027" "srep10154" "srep10159" "srep10424" "srep10449"
    "srep10854" "srep10856" "srep10867" "srep11086" "ssDNA"
    "stability-targeted" "stably-transfected" "stage-specificity" "standalone"
    "standard-dose" "start-up" "state-of-the-art" "steady-state" "stellate"
    "stem-cell" "stem-cell-like" "stem-like" "stem-loop" "stemness"
    "step-by-step" "step-wise" "stepwise" "stereotypy" "steroid-induced"
    "steroid-inducible" "stimulators" "stiochiochemistry" "straight-forward"
    "streptavidin-beads" "stress-activated" "stress-associated"
    "stress-enhanced" "stress-induced" "stress-internalized" "stress-mediated"
    "stress-response" "stress-responses" "stress-stimulated" "stressful"
    "stressors" "stress–induced" "stroma-to-tumor" "stromally-derived"
    "strongly-associated" "structurally-defined" "structure-based"
    "structure-function" "struma" "sub-G1" "sub-analysis" "sub-cellular"
    "sub-classify" "sub-clinical" "sub-clonal" "sub-clone" "sub-clones"
    "sub-diploid" "sub-families" "sub-family" "sub-group" "sub-groups"
    "sub-lethal" "sub-loci" "sub-locus" "sub-nuclear" "sub-optimal"
    "sub-population" "sub-sampling" "sub-set" "sub-type" "sub-types" "subG"
    "subG1" "subG1-phase" "subcategories" "suber" "suber-oylalanide"
    "subfeatures" "subgraphs" "subhaplotype" "sublines" "submucosa"
    "subnetwork" "subphylum" "subsequences" "subsite" "substituents"
    "substrate-enzyme" "substrate-receptor" "substudy" "subtype" "succinate"
    "sulfhydryl" "sulphur-zinc" "sunitinib-like" "super-enhancer"
    "super-enhancers" "super-family" "supernatant" "supernatants"
    "superstructure-forming" "suppressive-like" "supra-micrometric"
    "suspension-induced" "switched-off" "symporters" "synapse"
    "syndromes-myeloproliferative" "synergism" "syntotrophoblasts"
    "systemic-onset" "t-MDS" "tATM" "tHSP27" "tMUC1" "tRF-specific"
    "tRNA-fragments" "tRNA-halves" "tSNP" "tSNPs" "tagal" "tagalsin"
    "tagalsins" "tagalsins‐induced" "tagalsin‐induced" "tagalsin‐mediated"
    "taregets" "targetome" "targetscan" "tau-dependent" "taxane-based"
    "telomerase-immortalized" "telomerase-independent" "telomerase-mediated"
    "telomerase-negative" "telomerase-positive" "temperature-induced"
    "temporins" "tertile" "tertiles" "testes" "tet-on" "tetrahydrochloride"
    "tetrodotoxin" "thaliana" "thanTau" "thePAK" "thePAK4-LIMK1" "theSTAT"
    "theSTAT3-ER" "theca" "thecyclin" "thedata" "therapeutic-agents"
    "therapy-mediated" "therapy-resistant" "thiazole" "thiazole-ring"
    "thiazolide" "thiazolides" "thiazolinone" "thiol-disulfide"
    "third-generation" "third-leading" "third-line" "thirty-seven" "thiswas"
    "thread-like" "three-colour" "three-component" "three-dimensional"
    "three-part" "three-partite" "three-year" "threonine-specific" "tiRNA"
    "tiRNAs" "time-course" "time-efficient" "time-frame" "time-intervals"
    "time-lapse" "time-period" "time-point" "time-scale"
    "time-to-first-treatment" "time-to-progression" "time-to-recurrence"
    "timeframe" "timeline" "timepoints" "tion" "titer" "titers" "toin"
    "toll-like" "toolbox" "topology" "toxicities" "to~740" "trait-associated"
    "trait-association" "trans-locates" "trans-proteolysis" "trans-regulators"
    "transaminases" "transcatheter" "transcription-PCR"
    "transcription-competent" "transcription-quantitative"
    "transcription-start-site" "transcriptionally-altered" "transcriptome"
    "transcriptomes" "transducer" "transducts" "transfectant" "transfectedTau"
    "transitionwhether" "transmigraton" "transmittance" "transporter-2"
    "transposon" "transwell" "trasmembrane" "trastuzumab-emtansine"
    "trauma-induced" "treatment-naïve" "treatments" "tri-transgenic"
    "tri-transgenics" "trifluoromethoxyphenylhydrazone" "trihydroxystilbene"
    "trimester" "trioxide" "tripeptid" "triphosphate" "triple-mutants"
    "triple-negative" "triple-positive" "trisomy" "trisphosphate" "triton-X100"
    "trophoblasts" "tropomyosine" "tubal" "tubercle" "tubular-reticular"
    "tubule" "tubules" "tumor-adjacent" "tumor-aggressive"
    "tumor-nodes-metastasis" "tumor-suppressive" "tumorgraft" "tumorsand"
    "tumour-associated" "tumour-derived" "tumour-microenvironment"
    "tumour-promoting" "tumour-suppressive" "tumour-suppressor" "tumour-tissue"
    "twenty-four" "two-cell" "two-colour" "two-field" "two-hybrid" "two-locus"
    "two-sided" "two-stage" "two-step" "two-tailed" "two-thirds" "two-way"
    "twofolds" "type-2" "type-I-cadherin" "tyro-sine"
    "tyrosine-kinasereceptors" "tyrosine-to-phenylalanine" "uCCNE1"
    "ubiquitina" "ubiquitine" "ubiquitinproteasome" "ubiquitylation-defective"
    "ubiqutin" "ubule" "ucleotide" "ultra-deep" "ultrasonography"
    "ultrastructure" "ultrathin" "un" "under-expressed" "under-expression"
    "under-grading" "undergoes" "undergone" "underpinnings" "undertaken"
    "unilineage" "unmet" "unresponsiveness" "untransfectedTau" "up-grading"
    "up-staging" "upmodulate" "upper-left" "upregulaton" "urea" "ureter"
    "urologists" "ursane" "usingcyclin" "utero" "uvea" "uveal" "v-Ki-ras2"
    "v567es" "vFEP" "vRNA" "vSMC" "vacuoles" "values" "variants" "variates"
    "vedotin" "vehicle-treated" "vehiclecyclin" "vera" "very-conserved"
    "vessel-like" "villi" "villus" "vinca" "viral-mediated" "viscera" "vitro"
    "vivo" "viz" "vs.TT" "vscyclin" "weakest" "weakly-activating"
    "well-acknowledged" "well-annotated" "well-characterised" "well-defined"
    "well-designed" "well-differentiated" "well-documented" "well-formed"
    "well-identified" "well-know" "well-maintained" "well-matched"
    "well-orchestrated" "well-recognized" "well-resolved" "well-suited"
    "werecdk4" "white-matter" "whole-body" "whole-cell" "whole-exome"
    "whole-genome" "whole-genome-sequence" "whole-transcriptome" "wide-array"
    "wide-scope" "widely-used" "wildtype" "window-o-opportunity" "with18.9%"
    "withY267F" "withcyclin" "withdrawn" "withthan" "wk" "work-up" "workers"
    "workflow" "workflows" "world-wide" "wound-closure" "wre" "written"
    "wtMGMT" "wtp53" "www" "x-axis" "x-ray" "x10" "xL" "xenograt" "y-axis"
    "y-genes" "year-old" "years" "yet-to-be-described" "yl" "yr" "z-DEVD-fmk"
    "z-VAD" "z-axis" "z-scores" "z-sections" "z-stacks" "zVAD‐fmk"
    "zipper-interacting" "zipper-like" "zymogen" "zymography" "×
10"
    "×10" "×5.0" "× 10" "× 10" "ƘB" "ʹUTR" "Β-catenin" "Δ1,000" "Δ142–337"
    "Δ1–146" "Δ222–303" "Δ265–788" "Δ266–311" "Δ276–284" "Δ3" "Δ314" "Δ437–521"
    "Δ523" "Δ698" "ΔAP-1" "ΔAP-1-ΔCRE" "ΔBD" "ΔC" "ΔCD1" "ΔCRE" "ΔCol" "ΔCp"
    "ΔCp-value" "ΔCp-values" "ΔCt" "ΔDAD" "ΔDBD" "ΔF" "ΔG" "ΔHECT" "ΔN" "ΔNTE"
    "ΔNp63αR279Q" "ΔNp73" "ΔRING" "ΔS" "ΔS-α" "ΔS-β" "Δct" "α-3" "α-KG" "α-LA"
    "α-LA-induced" "α-crystallin" "α-crystallins" "α-galactosylceramide"
    "α-helical" "α-helices" "α-helix" "α-induced" "α-subunit" "α2-helix" "α3β1"
    "αB-crystallin" "αIgM" "β-3" "β-4" "β-5" "β-6" "β-IκB" "β-barrel"
    "β-blades" "β-catenin-TCF-dependent" "β-chains" "β-deletion"
    "β-glycerophosphate" "β-mutants" "β-propeller" "β-propellers" "β-sandwich"
    "β-sheet" "β-sheets" "β-strand" "β-strands" "β-synthase" "β-turn" "β1"
    "β1-subunit" "β2-β6" "β6-strand" "γ-2" "γ-H2A" "γ-TT" "γ-irradiated"
    "γ-irradiation" "γ-lyase" "γ-tocotrienol" "δ-chain–expressing" "δ1" "δ2"
    "ε-amino" "κB" "μM-mM" "μg" "μg " "μg " "μmol" "ρ-AKT" "ρ-ERK" "ρ-PI3K"
    "χ2" "кB" "‘CCGGAA’" "”analyte" "€75" "∆Cp" "∆Cp-value" "∆DBD" "∆EEL"
    "∆EEL-PC3" "∆NHSC" "∙GTP" "≧1.5-FC" "⊿CpG"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-15001-15300*
  '("SKM-1 cells" "LSCM" "Hoechst33342" "anti-malarial" "Artemisia"
    "differentia" "non-methylated" "remodelers" "Webby" "PADIs" "deiminases"
    "peptidylarginine" "H4R3" "H3R8" "a symmetrical sulfonated urea" "xenograt"
    "PRMTs" "1.0× 10" "non-histones" "10.1038/ncomms8437" "TCoB"
    "the Pak siRNA oligos compared with a non-target control ( xref )" "Pak2#1"
    "centrosomal P*T288" "*T288" "P*Pak" "centrosomal P*Pak" "*Pak"
    "their other mitotic roles xref  xref  xref Paks" "co-precipitating" "dox"
    "punctae" "P*S1466" "*S1466" "S/T-P-X-K" "*Ser/Thr-Pro" "Pak4-6" "Paks"
    "Pak" "the mitotic kinases cyclin-dependant kinase 1" "Whalley" "Pak1/2"
    "4 h" "de-regulation" "non-target" "re-expressing" "10.1038/ncomms8247"
    "neurite" "normals" "phosphatase-2" "TCONS_00014956" "and 2p22" "=7.91"
    "TCONS" "_00014956" "mirVana" "/rs963731" "/rs1768208" "/rs8070723"
    "SNP/transcript" "technical covariates" "DASL" "eGWAS" "OR=1.89" "OR=1.91"
    "=457" "2p22" "HaploRegv2" "the most significant SNPs" "SHAPEIT" "NGRC"
    "dbGaP" "2q22" "an intronic SNP" "lnc-KIF13B-1" "rs643472" "rs393152"
    "subhaplotype" "covariate" "QQ" "PLINK" "nearest" "Mayo Clinic Florida"
    "Florida" "BeadChips" "and 3p22" "=152" "|CBD" "apraxia" "akinesia"
    "Rebeiz" "GWASs" "and 3p12 ( MOBP )" "Kouri" "3p22" "rs963731" "rs1768208"
    "rs242557"
    "top progressive supranuclear palsy (PSP) GWAS single-nucleotide polymorphisms"
    "=19" "=22" "=1.02" "=1.39" "=0.36" "=0.40" "=1.31" "N =3" "n =3" "=2"
    "=1.42" "Celldex" "vedotin" "auristatin"
    "insulin-like growth factor receptor1" "MBC/Stage" "cholecystitis"
    "mastopathy" "western blot 48 h" "Eizai" "eribulin" "Middlesex" "Glaxo"
    "Chugai" "GPMNB" "HER2-rich" "osteoactivin" "HIL" "Tra" "P  =   0.021"
    "= 50" "P  = 0.021" "Cantu" "ARE-like" "T-allele" "the associated SNPs"
    "the 10 associated SNPs" "1.17–3.18" "rs4243387" "≥5" "ICU" "≥80"
    "hyperoxia" "erythroid 2-like" "severe hypoxemia" "hypoxemia"
    "protein-rich alveolar edema" "ICUs" "rs6706649" "10.1038/srep11086"
    "an attractive and viable Aβ" "12/15LO" "3xTg" "3xTg/H5LO" "procaspase-3"
    "12–15LO" "LO" "APPswe" "neurobiology" "AD-like" "anti-Aβ" "5LO" "WT/" "/H"
    "BAY1170-82" "isozymes" "homodimer/heterodimer" "C/EBPγ" "p38β"
    "pseudopeptide" "IKKs" "Supernatants" "pseudovirus" "persistant" "MCMD"
    "HAART" "8 h" "ΔCT" "30 min" "ERK3/4" "p85α" "p38MAPK" "± 6" "48 h" "72 h"
    "24 h" "1 h" "p38 MAPK" "reactants" "protectiveness" "Turkish" "Hashimoto"
    "Czech" "substudy" "Boccardi" "herterodimer" "NFKBIA 3" "kown"
    "polymophisms" "ATGG" "NFKBIA3" "rs 696" "NFKB1-94ins/del"
    "NFKB1-94 ins/del" "rs28362491" "rs696" "pectoris (SAP)" "pectoris" "A/G"
    "Uygur" "P = 0.010" "P = 0.007" "-297" "NF- κ B1" "κ B" "co-silencing"
    "CEP17" "LR" "PDX118" "Anti-HER2" "re-implantation" "HER2-amplified" "vIII"
    "publicly available datasets" "suppression/activation" "Schutzman" "hemi-"
    "hemi" "prostatic intraepithelial neoplasias"
    "the Varambally Gene Expression Omnibus dataset" "Vanaja"
    "immunopositive prostatic epithelia" "littermates" "LGPIN"
    "public gene expression datasets" "Sproutys" "Roehrborn" "$204,136,795"
    "SPRYs" "deficientmice" "Jameson" "Ulk" "Leguminosae" "sericea" "Mundulea"
    "p44/42" "p53: DNA" "7.2–7.4" "100-times" "CCFF" "FFCC" "CFFC" "CFCF"
    "FCFC" "FCCF" "PDBID" "SAR405383" "G3M6" "G2M6" "approximately 3–5"
    "G3M5-G3M7" "G1M4" "G3M5- G3M7" "G3M3" "G3M2" "regressed tumors regrew"
    "the sublines obtained from prolonged treatment of SAR405838 in vivo"
    "G2M4—G2M8" "G1M6" "G1M2" "G2M2" "G2M1" "regrow" "regrew" "CMIR" "3–5"
    "regrown" "non-bonded" "re-sensitized" "tubal" "George"
    "the secretory epithelium" "the ovarian surface epithelium"
    "non-proliferating" "iOvCa" "reattach" "2/6" "spheroid-induced dormancy"
    "Prism 5" "non-proliferative" "PAK1/2" "interfers" "orthologues"
    "Rac1 siRNA-treated cells re-orientated" "re-orientated" "4h" "ß-COP"
    "TOCA" "polarisome" "3X" "often Pseudomonas -super-infected"
    "-super-infected" "ibidi" "punch-in-a-punch" "immunocytes" "serum/plasma"
    "the longer peptide esculentin-1a" "Ranidae" "Hylidae" "Anura" "erbB" "β1"
    "temporins" "the Esc(1-21)-stimulated re-epithelialisation"
    "Esc(1-21)-stimulated re-epithelialisation" "μm/h" "NHK" "isomers"
    "enantiomer" "enantiomers" "all-D-enantiomer" "glycinamide" "esculenta"
    "Pelophylax" "GIFSKLAGKKIKNLLISGLKG" "the natural microbial flora"
    "holocrine" "a stratified squamous epithelium" "genito" "neutral pH"
    "re-epithelialisation" "esculentin-1a" "non-stressed" "12h" "1x 10"
    "gastro" "oedema" "10/10" "rs715572GA" "=0.007" "rs1962223G/C"
    "rs12901499A/G" "rs1590A/G" "rs1800469C/T"
    "a pleiotropic cytokine/growth factor" "rs6494629T/C" "Kellgren"
    "rs715572G/A" "TGF-βRI" "mean±SD" "-881" "-826" "P=0.03" "=0.05" "del/del"
    "only NFKBIA -826CT and -881AG polymorphisms" "ins/del" "A→G" "9-4" "CGAS"
    "P=0.02" "P=0.01" "=0.02" "ins→del" "ATTG" "mean ±SD" "±6" "NF-κB1"
    "Material/Methods" "unfavorable DMFS" "DMFS" "AVN-944" "AVN" "231:BoM"
    "231:BrM" "BoM" "MDAMB" "mtp53's" "rNTPs" "rNTP" "GGAAG"
    "approximately 1.5 kilobases" "kilobases"
    "our previously reported mtp53 ChIP-Seq dataset" "deoxcytidine"
    "mevalonate" "mtp53’s" "Mtp53" "NMG" "mtp53" "log2" "Nu/Nu" "WTp53" "p21L"
    "Darwin" "III/" "ab117139" "Graczyk" "signal/background" "ImageJ" "79%±1%"
    "data/comments" "HCT116 p53-/-" "NM_001220778" "NM_001220777" "eRNAs"
    "rewritten" "PolIII" "genebank" "Agami" "RNAPIII" "Allen" "twofolds"
    "RPPH1" "pSUPER" "deleted or mutated A-box" "A-box" "MIR3" "_001220778"
    "_001220777" "R-looping" "53−/−" "HCT116 p53+/+" "HCT116 p53−/−" "pretRNA"
    "TFIIIB/DNA" "anti-Mouse" "R-loop" "10.1038/ncomms8391"
    "the respective indels" "nucleases" "translational oncology" "frameshifts"
    "gPten" "cerebrum" "gTrp53" "at most three indels" "gPtch1 / Cas9" "Group4"
    "CreER" "Atoh" "Pairwise" "fl/fl" "postnatal murine GNPs" "gPtch1 /Cas9"
    "gPtch1 /" "transposon" "pX330" "gPtch1.1" "folium"
    "the neonatal cerebellum" "CRISPR/Cas" "prosencephalon" "f/f" "f/+"
    "forebrain" "GNPs" "polyethylenimine (PEI)" "polyethylenimine" "GEMMs"
    "Zuckermann" "WGS" "_1" "n =6" "8/10" "1 /" "Hermans" "Wingeyer" "Segarra"
    "non-surviving" "30-day" "aPTT" "lactatemia" "/FIO" "SOFA" "APACHE" "INR"
    "creatinin" "5G/5G" "4G/5G" "Spanish" "4G/4G" "= 1.24" "= 0.03" "6-month"
    "10.1038/ncomms8324" "ESCRTs/ALIX" "non-degradative" "re-internalization"
    "stress-induced EGFR TK activation/signalling" "activation/signalling"
    "-ΔAP2" "ΔAP2" "ESCRT-" "lyso" "ILVs" "ILV" "Hrs" "co-segregated" "ESCRTs"
    "co-stain" "BLOC-1" "retromer" "fibrillar PMEL co-segregate" "immunoEM"
    "non-fibrillar" "melanin"
    "stress-activated EGFR showed very limited co-staining"
    "negligible co-localization" "PITSTOPII" "ESCRT" "WASP" "Tomas"
    "Stress-internalized EGFR co-segregates" "UVC" "≥4 " "co-segregates"
    "Hapmap" "rs1049337" "very low-penetrance SNPs" "nondrinkers" "= 1.31–2.11"
    "0–1" "GG genotype" "tSNPS" "rs35996865" "rs1049334" "ccRCC" "OR = 1.35"
    "OR = 1.34" "= 0.006" "= 1.37" "= 1.39" "OR = 1.32" "= 1.31" "PKCβ/θ" "Cl"
    "1346±60" "mPKCθ" "Rotln" "1594±44" "diphenylene" "RLU " "Egr"
    "postangioplasty" "mAoSMCs" "calphostin" "PKCθ" "hAoSMC" "hAoSMCs" "nLDL"
    "co-incubation" "extracellular signal-regulated kinase 1/2"
    "Extracellular signal-regulated kinase 1/2" "10.1038/srep10867"
    "Cav-1/caveolae" "pH2A" "a significantly larger clinical dataset"
    "pancreatitis" "shCav-1" "0/5" "5/5" "1/5" "CB17" "shCav-1-A" "shCav"
    "MβCD" "methyl-beta-cyclodextran" "histopathology" "= 0.04"
    "the major allele homozygous genotype (CC)" "_000963.2:c"
    "this nonsynonymous polymorphism" "T/C" "_009135.4:p" "GG genotypes"
    "_001033.3:c" "the major allele homozygous (CC) genotype" "_000416.2:c"
    "the major allele homozygous genotype (AA)" "File-2"
    "colorectal cancer several polymorphisms" "-rs5275"
    "102 previously reported common
genetic polymorphisms"
    "PolyPhen-2" "±3" "decreasses" "obstructive nephropathy"
    "progressive glomerulonephritis" "glomerulonephritis"
    "cell survival/proliferation" "experimental diabetic nephropathy" "TAPI-2"
    "AngII" "RAAS" "dihydroxy" "VDRAs" "μ mol/L" "substrate/inhibitor"
    "sulfhydryl" "serrata" "Huperzia" "firmoss" "Huperzine"
    "a yellow crystalline flavonoid" "Pteridophyta" "Bryophyta" "Pinophyta"
    "flavonoid" "Lamiaceae" "huperzine" "X-scores" "fluoromethyl" "DEVD"
    "carbonyls" "sALS" "mesencephalon" "NFTs" "nigra"
    "excitatory amino-acid transporter-2" "brainstem" "Salvesen" "Stennicke"
    "scissile" "DEVDG" "prodomain" "allograft" "Nonpeptidyl" "X-score"
    "peptidyl" "nonpeptidyl" "Huntington's" "and 3D" "5I" "2H" "H-bonds"
    "newer" "rpHSP27" "rRANKL" "proteomes" "tHSP27"
    "communication/signal transduction"
    "Dual Energy X-ray Absorptiometry (DXA)" "Absorptiometry (DXA)" "DXA"
    "Absorptiometry" "osteoblasts" "iTRAQ" "plex" "= 0.015" "= 0.0001" "≥1"
    "× 10 " "/IGF/IGFBP" "p73sh-RNA" "an Alzheimer's" "CTTG" "CAAG" "decamer"
    "CWWG" "decamers" "p53wt" "HCT" "TAp63α" "C/T" "5–10" "TAp73α" "SGA"
    "pGL-3" "_m1" "U/ml" "p53 REs" "= 0.15" "p53REs" "anti-oncogenic" "CNS1"
    "CD127dim/" "COBRA" "acH4" "+DHT" "non-Treg" "ChIP/qRT-PCR" "±1.9" "yr"
    "CNS2" "three important intronic enhancers 1–3" "CNSs" "= 2" "Δ Ct" "± 0.8"
    "± 0.4" "± 0.2" "CD8 +" "siCRTL " "3–4" "dichlorofluorescein" "derivate"
    "CM-DCFH2-DA" "form Applied Biosystems" "LifeTechnologies" "Orsay" "TBS"
    "Yvelines" "Quentin" "Ozyme" "Calbiochem" "pH " "singulets" "bandpass"
    "cytometer" "Gallios" "Villepinte" "Beckman" "Meylan" "Analyser" "Cedex"
    "Lepleux" "siCTRL" "siBim" "Belgium" "Eurogentec" "Trometamol" "Homburg"
    "Pharma" "Meda" "Glutamax" "Pontoise" "Cergy" "Poulain" "R10" "Villejuif"
    "Roussy" "Gustave" "Institut" "succinate" "Alpha-Lipoic" "DCFH" "IGROV"
    "Anti-apoptotic" "anti-tumoral" "Written" "taregets" "MiRanda" "MAH"
    "miRNA-29b" "** P  " "* P  " "active pSTAT5"
    "acquired segmental uniparental disomy" "anti-leukemic" "pSTAT5" "Molm"
    "AFA" "chimerism" "KSL" "non-hematopoietic" "int" "I:C" "genital tubercle"
    "tubercle" "SmoM2" "Log2" "=0.045" "=0.049" "=0.034" "P =0.024" "2 +"
    "=0.046" "FMS-like" "Estevés" "Cowell" "Benson" "Kerlikowske" "Västerås"
    "IBCRs" "IBCR" "= 0.40" "= 0.03" "hDPSCs" "alpha-minimum" "cementoblasts"
    "DSPs" "pp" "phosphorin" "glycerophosphate" "25OHD" "Progenitor/stem cells"
    "in 1α" "nM 1α" "trioxide" "regenerate dentin-pulp-like" "COLI"
    "progenitor/stem cells" "osteoblastoids" "DPSCs" "dentin"
    "dihydroxyvitamin" "p21/Rb/E2F" "Rb/E2F" "ob/ob" "-triphosphate"
    "triphosphate" "mono-unsaturation" "lymphopenia" "mono-unsaturated"
    "reticulum" "cyclin-dependent kinase inhibitor 1A" "proto-" "headgroup"
    "acyl" "-1000s" "sequelae" "Confounders" "rs78378222" "rs55705857"
    "Kaplan–" "7p" "neuropathology" "CDKN2A/B" "OncoSign" "multiplatform"
    "co-deletion" "FUBP1" "a predominant CoC" "CoC" "MULTIPLATFORM" "SUBTYPES"
    "intraobserver" "19q" "1p/19q" "genomewide" "9p" "1p" "CX-5461dose" "vinca"
    "pCHK2" "pCHK1" "pCDC2" "B-lymphoma" "B-lymphomas" "KOPN" "nano" "Drygin"
    "NCI-60" "G1‐S" "‐M" "‐S" "‐divinyl" "‐18" "‐enol" "‐enol (TC)" "vi"
    "exovinyl" "hydroxyacetyl" "T10" "Clerocidin" "DNase‐mediated"
    "double‐strand" "tagalsin‐induced" "tagalsin‐mediated" "caspase‐dependent"
    "g " "anti‐cancer" "‐cancer" "doxorubicin‐induced" "‐Cyclin A" "S‐G2"
    "ROS‐mediated" "tagalsins‐induced" "TC‐induced" "TF‐induced" "CGTACG"
    "tagalsin" "ataxiatelangiectasia" "‐strand" "clerocidin" "‐induced" "‐fmk"
    "5–20" "‐2" "‐stimulation" "PHA" "‐dependent" "‐8266" "‐H2" "‐T1"
    "the human acute T cell leukemia Molt‐4" "‐4" "TW" "TD" "‐regulated" "‐G2"
    "dolabrane‐type" "‐60" "tagal" "‐cell" "dolabrane"
    "potentially cytotoxic diterpenoids" "diterpenoids" "Tagalsins" "‐mediated"
    "‐type" "Ceriops" "tagalsins" "= 1.35" "IC 50  " "= 0.017" "Rad3" "μg "
    "ACA45" "bonda" "SNORD29" "exogenous sno-miR-28" "SNORD-28" "SNORD25-"
    "SNORD28-" "SNORD25" "SNORD28" "sdRNAs" "miRNA-like" "SNORD" "C/D" "SNORDs"
    "Nikulenkov" "sno-miR-28" "SNHG1" "mmol/L" "30 mins" "co-transcriptional"
    "non-protein" "siHDAC" "at least 48 hrs" "at least 24 hrs" "pneumophila"
    "non-activated" "20 ng/ml" "transaminases" "co-infected" "Hasei" "14-3-3σ"
    "infectious Ad progenies" "Ad5F35/MK" "LC3A/B" "xL" "Bck" "hyperploid"
    "hyperploidy" "YES-2" "combinatory anti-tumor"
    "subsequently augment anti-tumor" "the viral progenies" "Ad35" "coxsackie"
    "replication-competent AdF35" "replication-competent AdF35 progenies"
    "the replication-competent AdF35" "Replication-competent AdF35" "AdF35"
    "viral progenies" "progenies" "serotype" "E1B" "1/2 " "1 × 10" "nu/nu"
    "exon 2/3/4" "2/3/4" "2/9" "non-hypoxic" "promoterless" "shT1" "GalO"
    "pG5E1bLuc" "pGalO" "pGalA" "DNA/protein" "co-activators" "Inoue" "Wildey"
    "Datto" "DMEM" "hCLP" "CAP10" "Valdivia" "Chu" "Teng" "μmol/L"
    "10.1038/srep10449" "centromeres" "/K" "pT444"
    "constitutive active NDR1 EAIS" "o" "ingle" "idth" "auto-antibody" "EAIS"
    "Cornils" "Kohler" "Chiba" "ubule (MT)" "ubule" "icro" "dysmorphia" "-20 "
    "30 min" "and 3E" "MALT" "miR-26a" "miR-195-5p" "antitumour" "miR-29a"
    "133a" "GENECODIS" "tumour-suppressive miR-144-5p" "XTT" "miR-451a"
    "miR-144-3p" "MIBC" "NMIBC" "miR-144-5p" "log 2 ratio" "=50" "70–80"
    "=0.025" "=0.04" "38.5±10.5%" "=0.03" "MFS"
    "an importin/CRM1 (chromosomal region maintenance 1)-mediated nuclear/cytoplasmic"
    "cells/HPF" "±19" "nuclear/cytoplasmic" "5382insC" "viral progeny"
    "the viral lifecycle" "Crispr/Cas" "rKSHV" "K8α" "TRE-BCBL1-RTA"
    "late lytic glycoprotein K8.1A" "the late envelope glycoprotein K8.1A"
    "K8.1A" "hTREX" "viral genomes" "lifecycles" "ssDNA"
    "an extrachromosomal episome" "episome" "a biphasic lifecycle" "lifecycle"
    "multicentric Castleman’s" "multicentric Castleman" "Castleman" "Kaposi’s"
    "CHK1 is" "HUH-28" "TOPFlash" "Wnt5b" "Wnt4/5" "SSP-25-KD1/2" "shRNA1/2"
    "confounder" "signiﬁcance" "the previously reported c" "risen" "log 2"
    "CA 19-9" "Wnt/ β-catenin" "shRNA1" "72h" "0–5" "Stagakis" "Connell" "MRL/"
    "lpr" "Huang" "Nurieva" "Caprioli" "Baechler" "CD4+CD45RO+" "Dolff" "CucI"
    "SLEDAI" "CXCR" "STAT3/5" "re-wired" "CD45RO+" "CD8+"
    "invasive capacity/migration" "maligancy"
    "the normal proliferating epithelium" "transmigraton"
    "the previously detected trend became signifcant" "signifcant" "shLuc"
    "harpin" "the glandular epithelium" "endometrium (NPE)" "NPE" "malignacy"
    "normal proliferating endometrium" "SKUT" "Cs"
    "type I endometrial cancer biopsies" "CHEC" "endometrial epithelia"
    "12-O-tetradecanoyl-phorbol-13-acetate" "-20 " "#5" "Davis" "pCDK1/2"
    "Carrassa" "McNeeley" "Haarberg" "Mono-targeting" "pHH3" "pCDK1" "Tukey"
    "Mono-treatment" "DTIC" "mono-treatment" "CellTiterGlo"
    "spheroids given mono-treatments" "Co-treatment" "Talalay" "Chou" "WM45.1"
    "mono-targeting" "Chk1/2" "S3C" "co-targeting" "30 min" "3 × 10 " "24 h "
    "anti-tumour" "a well-documented cancer risk-associated polymorphism"
    "non-randomly" "Minigene" "rs7726159" "Ex4/Int4" "morpholino" "Morpholino"
    "late (pd 190) timepoints" "overgrew" "the first approximately 80 pds"
    "approximately every 20 pds" "pds" "doublings" "HT1080" "pIRES" "Minigenes"
    "rs7725218" "rs2242652" "minigene" "minigenes" "1.15–1.40" "COGS"
    "Multiple cancer-associated single nucleotide polymorphisms"
    "a cancer risk-associated SNP" "INS1b" "rs10069690"
    "Numerous cancer-associated single-nucleotide polymorphisms"
    "the bidirectional JNK transducts" "transducts" "mylabris" "autophagy/p21"
    "GGGGCGGGGC" "GGGCGG" "inhbitors" "Spearman's" "PP2Acα" "PP2Acβ"
    "protein phosphatase 2A" "Protein phosphatase 2A" "–1000" "30 min" "G0/G1"
    "17q" "11q23" "11qter" "INRG" "-JQ1" "CLBGa" "Swiss" "30min"
    "chromoprotein" "LAN-6" "intragenic deletions/duplications" "CHLA" "DHPLC"
    "Ga" "CLB" "11q22-q23" "11q" "C1orf" "non-amplified" "mislocalizes"
    "promigratory/invasive" "T157/T198" "MCF-10" "immunostainings"
    "nuclear/low" "pAKT1" "p27-4A" "shPTEN" "pGSK3α/β" "μm/min" "GSK3α/β"
    "BEAS-AKT1-E17K" "BEAS-AKT1-WT" "BEAS" "0.6–2" "fide" "bona"
    "approximately 0.6–2" "4-6" "± 3" "pS473" "colonoscopy" "= 0.41–0.88"
    "person-time" "approximately 1%–3" "Hakka" "Amsterdam" "= 1.72" "= 1.36"
    "= 1.64" "= 0.38" "= 0.68" "= 0.40" "lipoplex" "Templeton" "TUNNEL" "DOTAP"
    "-7-methoxy-6-" "quinazolin" "quinazolinamine" "methoxyethoxy"
    "ethynylphenyl" "nanovesicle" "erlotinb" "TUSC"
    "intravenous TUSC2 nanovesicles" "nanovesicles" "non-responders" "3p21"
    "3p" "non-receptor tyrosine kinase" "S2b" "STAT3/pSTAT3" "PDSCC" "WDSCC"
    "cervical biopsies" "17q23.2" "proteins/activity" "Shishodia" "−20 " "1X"
    "Let-7a" "male and female CHH/KS" "CHH/KS" "paradigme" "propositus"
    "the almost complete penetrance" "testicular hypotrophy" "correct penile"
    "hypotrophy" "penile" "punctata" "chondrodysplasia" "megabases" "Bick"
    "sonography" "R257X" "micropenis" "X-linked Kallmann’s" "Endocrinology"
    "Ovitrelle" "Lyon" "Serono" "Gonal" "IU" "mIU/L" "pmol/L" "pulsatile"
    "respectively 2.7 IU/L" "IU/L" "premolars" "anosmia" "proband" "France"
    "personnes" "Comité" "Bicêtre" "midline" "ANOS1" "HUGO" "CHH" "Kallmann"
    "/day" "2–3.5" "1.53–3.48" "QNBC" "quintuple" "BLBC"
    "the most aggressive subtype" "Minuti" "0.91–1.59" "Darby" "Madin"
    "1.11–1.79" "1.48–2.80" "trasmembrane" "the Begg’s"
    "lymph node negative and different molecular subtypes" "= 0 %" "= 0.001"
    "P  = 0.043" "= 50 " "P- value " "95 % CIs" "normal-like"
    "H358KRASG12C-TetOEGFR-L808R" "Commisso" "Feb" ":358-67" "Corcoran" "Ryan"
    "Charles" "stress-associated protein kinases"
    "large phase-translucent vacuoles" "pInducer" "co-production" "Clara"
    "SKCM" "COAD" "co-existing" "non-silent" "co-occur" "co-existence"
    "co-incidence" "∼15%" "co-incidences" "Lockwood" "Unni" "co-occurrence"
    "LUAD" "wt/" "Thr202/Tyr204" "co-occurred" "2X" "criterea" "utero" "hidden"
    "non-carrier" "childlessness" "non-mutated" "Eisinger's" "Manchester"
    "Eisinger" "UMD" "genitors" "cfand" "non-carriers" "≥70" "BRCA-mutated"
    "- 10" "Axon" "anti-malignant" "anti-metabolite" "radioresistant" "pT3/4"
    "pT1/2" "Rodel" "personalise" "three-year" "Non-significant" "Val14/Thr16"
    "-chlorobenzyloxy" "chlorobenzyloxy" "chloroindole" "Bista" "-chlorophenyl"
    "chlorophenyl" "enthalpy" "piperazinone" "kcal" "microseconds" "pairwise"
    "Lennard" "conformational entropies" "entropies" "-chloro" "Bdz" "NH"
    "phenyl" "chloro" "DSSP" "9–10" "Uhrinova" "ITC" "conformational entropy"
    "precise and accurate conformational entropy" "RMSDs"
    "more unfavorable binding entropy" "entropy"
    "a sharp bend around residues 17–20" "17–20" "Bzd" "Nutlin-3a/MDM2" "CV2"
    "cMD" "vFEP" "piperidinone-2" "Michelsen" "1,4-benzodiazepine-2,5-diones"
    "Showalter" "Ground" "focusses" "Metallo" "benzodiazepinedione" "AM1"
    "= 41" "enrollees" "ILD-like" "Kwak" "E746_A750del" "Tzeng" "MPACT"
    "FOLFIRINOX" "Conroy" "Moore" "Burris" "•m" "ECOG" "CA19-9" "buffy" "W731X"
    "≤ 5" "P = 0.043" "BEX-1" "cerebellum" "paralog" "BEX" "tyrosine kinase-3"
    "Anti-phosphotyrosine" "corneum" "Callahan’s" "Callahan" "TU" "midium"
    "erythema" "Johansen" "tissue/cell types" "_006058.4" "TNIP1 shRNA"
    "Beyotime" "CK6" "rTNIP1" "Gurevich" "psoriatic biopsies" "TNIP" "TNIPs"
    "psoriasis-like" "psoriasiform" "IMQ"
    "extracellular signal-regulated kinase1/2" "PHKs" "8–10"
    "Co-Immunoprecipitation" "spectrometery" "mono-phosphate (AMP)"
    "mono-phosphate (IMP)" "dihyroxyacetone" "discriminant" "shScr" "FSC"
    "Colo" "biomass" "2×10" "myocardium" "transmittance" "pg/ml/platelet"
    "non-responding" "non-DM" "pletelets" "HSPB" "coagulant" "aggregometer"
    "toll-like" "= 0.043" "= 27" "p = 0.010" "± 2" "αB-crystallin" "S6K/S6"
    "rapamycin/PD98059" "parkinsonism" "edema" "Cd-exposed" "Cd-increased"
    "Cd-triggered" "Cd-elicited" "rapamcyin" "with/without" "caspases 3/7"
    "a macrocyclic lactone" "lactone" "cortical displasia" "displasia"
    "ribosomal p70 S6 kinase 1" "Cd-induced" "Cd" "caspase3/7" "JNK1/2/3"
    "10.1038/srep10854" "Kumazawa" "recognises" "S8f" "S8e" "S5d" "S8d" "S8b"
    "S8a" "siMYBBP1A" "siTIF" "subG1" "S2e" "S2d" "S2c" "recognise" "Gαi"
    "currently no pharmacotherapies" "pharmacotherapies" "synapse" "Opioids"
    "adaptation/plasticity" "neuronal adaptation/plasticity"
    "kappa-light-chain-enhancer" "opioids" "toolbox" "3/4" "SATURN"
    "developed ILD" "ILD" "Oncology (ASCO)" "ASCO" "monotherapies"
    "UMIN000004561" "UMIN" "acneiform" "= 4" "g/dL" "10/130" "53/73" "18/57"
    "38/57" "32/73" "mg/day" "Smyth" "97/262" "Rb1+" "LGSC" "HGSC" "H-Score"
    "≤5 %" "~ 80 %" "inactive thiazolides" "active thiazolides" "proteosome"
    "zVAD" "substituents" "thiazole" "anti-infectious" "-cysteinylglycine"
    "cysteinylglycine" "tripeptid" "Thiazolides" "thiazolide" "thiazolides"
    "class P1" "1.8 × 10" "hematologists" "Paget" "NFKB" "a dramatic co-opting"
    "SQSTM1-" "SQSTM" "ERGIC" "anti-myeloma" "co-opting" "HCQ" "authophagy"
    "1 × 10" "rs2853677"
    "other nearby biologically potential functional polymorphisms" "Melin"
    "Begg’s" "non-significant" "iPLEX" "Africans"
    "important cancer-related polymorphisms" "TTAGGG"
    "palate transmembrane 1-like" "5p15.33" "ISI" "1×10" "= 0.82" "= 0.92"
    "= 1.02" "rs2853676" "kinasereceptors" "+2/+3" "thiswas" "Camidge" "Intra"
    "endpoints" "MetLung" "MARQUEE" "non-squamous" "nsNSCLC" "non-smoking"
    "Anti-human" "MET /CEP7" "kianses" "p38K" "Scr" "autopahgy" "LC3BI/II"
    "spherical vacuoles" "superfluous organelles" "biliverdin" "Gurtner"
    "regulomes" "heatmaps" "only one dataset" "E2F1/NFY" "IGX1"
    "a publicly available microarray expression dataset" "NFY"
    "10.1038/srep10856" "MxRxxT" "LxKxxT" "Morrice" "auto-inhibition"
    "α-3/S345A" "α-4/S345A" "T378/T382" "α-3" "β-6" "β-4" "β-3" "β-2" "α-4"
    "FUGUE" "de-repression" "2-6" "= 19" "auto-inhibitory" "ductal histotype"
    "Gallen" "Keam" "a more indolent subtype" "AR+" "sen" "Yat" "Angulo"
    "17/45" "24/45" "6/45" "4/45" "3/45" "11/45" "21/45" "pts" "collegues"
    "Gerdes" "EC-1" "EC-4" "EFM" "Xq" "Burstein"
    "a mesenchymal stem-like (MSL)"
    "at least 6 different tumor molecular subtypes" "Lehmann"
    "an aggressive subset" "≥ 10%" "= 0.013" "1+" "16q22.1" "only 2 SNPs"
    "Begg" "GA+AA" "PU" "Fuchs" "VKH" "BD" "Behcet" "rs10893872" "rs1128334"
    "OvidSP" "ets" "= 0.010" "S1I" "S1F" "= 0.003" "= 0.001" "lurker" "E2A"
    "Lite" "KeyMolnet" "Nrf" "7-day" "/mouse" "Pase" "Imamura" "Thierry"
    "1.32–6.61" "1.00–3.17" "1.13–2.55" "0.83–2.62" "1.05–2.27" "hepatectomy"
    "G12C" "mt" "the Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "CRLM" "one-quarter" "= 256" "12C" "WIF"
    "bacterial lipopolysaccharides" "lipopolysaccharides" "Sheng" "SANFH"
    "Wnt/β-catenin" "μg/kg" "MPS" "8p12" "± 2" "mean ± SD" "Wnt/" "Baird"
    "Ishibe" "at least ±2" "ET-743" "Promega"
    "the highly FGFR specific compound BGJ398" "BGJ398" "GraphPad" "NormFinder"
    "GeNorm" "the last 24 codons" "alikes" "EWS1R" "PLPS" "MRLPS" "myxoid"
    "Myxoid" "– 10" "≥ 7" "AW" "JW" "VK" "honoraria" "D&E"
    "oxidation/transport" "readouts" "small intestinal villi" "Rosi" "siPAK1"
    "small intestinal organoids (SIO)" "villus" "IECs" "IEC"
    "p-21 activated kinase-1" "Crohn's" "Crohn" "BADGE"
    "PAK1-KO small intestinal organoids" "intestinal villi" "villi"
    "Small intestinal organoids" "organoids" "*p " "1 h" "2–3 s" "–5 "
    "Co-culture" "Saegusa" "agtgATTGTgatgg" "= 0.5655" "qChIP" "TRANSFAC"
    "shcontrol" "transitionwhether" "Vallat" "Tavolaro" "Pede" "Herishanu"
    "EHEB" "decrements" "CLL-like" "deacetalyse" "miRome" "patho" "HCDR3s"
    "time-to-first-treatment" "miR-132~212" "CD19 +" "non-histonic" "= 0.0017"
    "Toll-like" "= 0.41" "cyclohexamide"
    "c-Jun amino (N)-terminal kinases 1/2/3" "1/2/3" "MAPK15-pCMV6-Myc-DDK"
    "approximately 7∼8%" "siCtrl" "siMAPK15#2" "siMAPK15" "DaeJeon" "BioNeer"
    "301-1" "G 1 /S phase" "-to-S" "Five-year" "downmodulate" "upmodulate"
    "PNAs" "pseudosubstrates" "pseudosubstrate" "chloroethyl" "bis"
    "available anti-cancer" "non-quantitative" "221/222" "chemio-" "chemio"
    "antagomiR" "paralogues" "miR-767-3p" "miR-181d" "d" "MCB" "Stupp"
    "oylalanide" "suber" "-1α" "c/EBP" "the cytogenetic location 10q26.3"
    "10q26.3" "nitrosourea" "alkyl" "Cox-2/PGE 2" "with18.9%" "PTGS2/Ptgs2"
    "CRE-2" "TATA" "Ptgs2/PTGS2" "Muc1KO" "KCKO" "KCM" "protooncogene" "CFPAC"
    "tMUC1" "desmoplasia" "pancreatic intraepithelial neoplasias" "neoplasias"
    "PDA" "PDAs" "C/EBP" "anti–rabbit" "L/well" "mDIVI-1" "Dermatopathology"
    "Sinai" "∼10%" "Attaleb" "Narayan" "Dong" "Khenchouche" "Ekalaksananan"
    "Nichols" "Wentzensen" "4/15" "5/15" "co-infection" "8/15"
    "normal cervical epithelia" "stepwise" "5/18" "Viral co-infection"
    "cervices" "11/18" "13/17" "1 X" "10.1038/ncomms8162" "Musacchio" "loxP"
    "iMEFs" "Coomasie" "Tactin" "Strep" "co-purified" "R1LM" "Δ265–788"
    "catalyse" "ΔCD1" "Δ437–521" "Δ266–311" "amino acids 1,000–1" "ZBD"
    "Δ1,000" "1,834–2" "oligo" "Venus" "centromere" "Mad1/2" "KMN"
    "Complex/Cyclosome" "the mitotic co-activator" "RZZ" "Z-stacks" "∼35%"
    "∼40%" "co-transfecting" "∼20%" "nsp1-4" "replicons" "caspase-3/-7"
    "the major sentinel/sensor" "gD" "Roizman" "HSV-1-" "Bmf-/-"
    "real time/quantitative reverse transcriptase PCR" "the respective 3T9"
    "Puma-/-" "3T9" "3T9-immortalized" "Jurkats" "ZVAD" "FDMs"
    "high viral titers" "HSV-1 viral titers" "gD-positive" "Bax/Bak-/-"
    "activation/processing" "Bak-/-" "condensation/fragmentation" "QVD" "mIκBα"
    "moi" "adeno-" "adeno" "F1L" "Ankara" "prebound" "Alphaviridae" "type-2"
    "gJ" "Alphaherpesvirinae" "simplex" "HSV-1" "herpes simplex virus-1" "SFV"
    "Semliki" "1 x" "non-phosphorylatable" "co-evolutionary" "Yeudall" "Clin"
    "PMID:24068928" "Vousden" "Muller" "PMID" "Singh" "Plos" "Costa"
    "a strong dataset" "Manley" "James" "shNC" "inline" "siATM" "siNon"
    "co-depletion" "Et" "eLife" "DOI" "#4" "∼90%" "co-regulated" "∼ 60%"
    "generally applicable multiparameter" "multiparameter" "deletion—one"
    "Zhong" "cT" "and 3p13" "= 0.001" "6q15" "5q21" "3p13" "SOX"
    "a particularly aggressive subset" "= 0.73" "non-informative"
    "thiazolinone" "quinolinyl" "co-administration" "HDMB3" "subG"
    "NGP-LV-h-p53" "IMR32-LV-h-p53" "protein phosphatase 1α" "RH-41" "SK-N-FI"
    "NHDF" "NLF" "re-analyzed" "Brd" "amplification/mutation" "CO23" "Achilles"
    "onco" "pro-proliferative TRα" "Thyroxine" "co-localisation" "THRB" "si3"
    "WST-1" "scr" "possible confounders" "3/12" "11/38" "19/86" "50/86" "17/38"
    "20/38" "T0052α" "vaginal epithelium" "struma"
    "regarding histologic subtype" "pN0" "histo" "= 0.021" "= 0.034" "12/29"
    "—7" "non-mesothelin" "expressors" "pericardium" "unmet" "= 0.045"
    "Non-small" "siERK2" "siERK" "parental HME" "SM83/CPT" "VAD" "D13/+"
    "the parental HME" "HME" "hydroxycamptothecin" "izTRAIL" "SM83" "SMs" "SM"
    "unresponsiveness" "pg/ml" "BRCA1a/1b" "CID" "TPA" "TCFs" "SAP-1A"
    "T194A/S387A" "renilla" "SAP-1a" "TPXR" "autoradiography" "NetPhos" "MCMs"
    "SIE" "Xba1" "S/T" "Cip/Kip" "HAN" "li" "Rui" "XIAO" "ZHONG" "sheng" "Dian"
    "rapalog" "and 2H" "H1299-LKB1shRNA" "PLKO" "nmol/L" "Kubo" "cerevisiae"
    "p73dependent" "ModFit" "p73mediated" "approximately 6 hr"
    "approximately 4 hr" "pcDNA3" "approximately 3 hr" "approximately 1 hr"
    "ΔHECT" "FK1" "ubiquitination/IP" "mono-form" "p73β" "p73α" "Ub4KR" "Ubwt"
    "MDM2ΔRING" "ubiquitinproteasome" "A β" "SMP14" "IP/Western" "miR200c"
    "6–7" "231-K8iKD" "231-K8ikd" "WST-" "WST" "MiR141" "GGGTG" "CACCC"
    "hEGFRp" "ikd" "co-overexpressed" "microRNA141" "Krüppel-like" "miR141"
    "co-overexpression" "4 - 6" "non-tumorigenic" "AR458323" "p53-mutated"
    "Synergism" "standalone" "CHK1i" "WEE1i" "ATMi" "flurouracil" "2 × 10"
    "Gö6976" "immunoglobulins" "SubA" "CD138+" "subcategories" "levels/cell"
    "cytospins" "S2E" "slightly higher Ki67+" "Ki67+" "de-induction"
    "azadeoxycitidine" "SubAB" "Bz" "~30 %" "Anti-Rabbit" "Anti-Mouse" "pYap"
    "nanofibre" "Ahrens" "mesenchyme" "phalanges" "non-transduced"
    "Constitutively active hYAP" "hYAP2" "the constitutively active hYAP1"
    "hYAP1" "constitutively active hYAP1" "hMSCs" "-Smad 1,5" "Lats1/2"
    "Mesenchymal stromal/stem cells" "periosteum" "stromal/stem cells" "OA"
    "anlage" "perichondrium" "DNA binding/differentiation" "hYAP" "C3H10T1/2"
    "hindlimbs" "pSmad" "bone morphogenetic protein-2" "micromass"
    "mesenchymal stromal/stem cells" "Mst1/2" "dormant primordial follicles"
    "piv" "Tsc/mTORC1" "dormancy" "secondary/preantral"
    "primordial activated follicles" "the activated primordial follicles"
    "McLaughlin" "the primordial follicles" "HOpic"
    "viable activated primordial follicles" "fc" "bpV" "vs . G2" "LOD" "bpv"
    "activated primordial follicles" "both the fresh and cryopreserved IVA"
    "viable primordial follicles" "human dormant primordial follicles" "IVA"
    "Kawamura" "primordial oocytes" "all primordial follicles" "commonest"
    "gonads" "available primordial follicles" "quiescent primordial follicles"
    "FP" "fertilizable oocytes" "primordial dormant follicles" "the Egger’s"
    "AZD9150" "Rx" "ISIS" "P = 0.024" "1.104–4.024" "= 2.108" "1.364–2.632"
    "1.028–2.133" "HR = 1.481" "1.442–2.270" "Deng" "flowchart" "Monnien"
    "inclusion/exclusion" "=0.024" "95 % CIs" "nonhistone" "intergenic spacer"
    "fluorouridine" "ol" "nucle" "FUrd" "110/T852A" "B-mediated" "re-enter"
    "the intergenic spacer" "-IGS" "IGS" "spacer" "dimethylaminopurine" "DMAP"
    "imidotriphosphate" "adenylyl" "bead-bound p13suc1" "hTAF"
    "SQQHpTPVLSSQPLR" "heptapeptide" "nucleate" "H4K16Ac" "co-staining"
    "G 1 /S" "homologs" "TGACC" "mammospheres" "pEGFP-C1-ERα-" "pEGFP-C1-ERα"
    "mammosphere" "BALB/C" "≥10%" "G-agarose" "E-box" "stem cell-like" "−1000"
    "SPSS" "a composite histoscore" "histoscore" "mountant"
    "tetrahydrochloride (DAB)" "tetrahydrochloride" "diaminibenzidine" "Henan"
    "Kaifeng" "Chaoshan" "Shantou" "damage/repair" "the esophageal epithelium"
    "Meir" "Wu" "2/18" "IIIa" "Patients underwent transthoracic esophagectomy"
    "esophagectomy" "CW" "microrchidia" "fatal subtype" "PESCC" "T1/T2"
    "= 0.026" "EGFR -mutated" "positron" "fluorodeoxyglucose"
    "homozygous mutp53" "mutp53" "kinase 1 (ROCK)" "Mutp53" "TC10a"
    "survival/proliferation" "Glc-6-P" "Lac" "isotopologue" "isotopomer" "EFGR"
    "non-ATP" "gedatolisib" "H1975" "symporters" "solute" "hexokinases"
    "C-labeled" "Cocultures" "SMV" "PaSMC" "cGFP" "GFP/HUVECs" "RFP/HUVECs"
    "AktVIII" "PaSMCs" "IRES" "myrAkt1" "HDMVECs" "Coculture" "phosphoflow"
    "cocultures" "capillary-like" "Rosell’s" "the optimal ∆Cp"
    "amounts/quality" "This theoretical ∆Cp threshold chosen" "consumables"
    "ID29" "ID30" "∆Cp-value" "EBUS" "ID10" "LightCycler" "ΔCp-values"
    "D770_N771insGL" "_D770insASV" "∆Cp" "Subsequent Sanger" "ΔCp-value" "ΔCp"
    "PCR/sequencing" "methylene" "Rosell" "Spain" "the mutated exons"
    "cytology" "ELREA" "RGQ" "Therascreen" "H773_V774insNPH" "Hamilton"
    "costs approximately €50-€75" "€75" "employed SNPs" "normal/equivocal"
    "monosomy" "ERPR" "the only 2 informative SNPs" "non-contiguous" "2x" "1x"
    "3x" "ERPR+ " "ERPR+" "TN1-4" "2–5" "11 informative SNP’s" "interquartile"
    "VIC/FAM" "scatterplot" "heterozygous SNPs" "Polymorphisms (SNP)"
    "Polymorphisms" "Trastuzamab" "13/15" "Polymorphism" "= 1" "HER2 + "
    "ER-ve" "17β-ED " "17β-ED" "sterol regulatory element binding protein 1c"
    "desaturase-1" "± 0.5 " "ERα + " "- 5" "2 × 10" "ER + " "CALGB"
    "HER2-negative" "lobular and mixed histology" "histological grade I/II"
    "Cohen’s" "Cohen" "the Hellenic Cooperative Oncology Group (HeCOG) 10/00"
    "10/00"
    "Australian New Zealand Clinical Trials Registry ACTRN12609001036202"
    "ACTRN12609001036202" "Zealand" "clinico" "HeCOG" "= 5" "= 0.023" "= 1.60"
    "= 0.045" "= 0.002" "= 0.017" "= 0.003" "= 1" "HER2-positive" "= 0.028"
    "miR-155 as" "RasLSL" "alle" "DeNicola" "Mir" "miroRNAs" "antagomir"
    "agomir" "HPNE" "hTERT" "siNF" "siErk" "hrs" "doxycline" "doxycyline"
    "48 hs" "thaliana" "causalities" "IkB-" "IkB" "rPAPPA" "Compagno" "IIR"
    "Niemann" "non-empty" "the largest regulated subnetwork" "BioNet"
    "subnetwork" "BioGRID" "lipopolysaccharide" "Maathuis"
    "around tumor sinusoids" "sinusoids" "only observational transcriptome"
    "n = 104" "= 19" "non-cancerous" "overdominant" "homozygotes"
    "the heterozygous rs4975605" "intrastrand" "interstrand" "TFSEARCH"
    "heterozygous rs4975605" "rs2736100" "the wild-type homozygous genotypes"
    "severe neutropenia" "neutropenia" "rs2736098" "Gabriel"
    "the wild-type homozygous genotype" "= 0.023" "C/C" "rs4975605" "C/A"
    "IIIor" "the heterozygous genotype" "rs2736109" "G/A" "= 1" "= 0.046"
    "=0.002" "Ventana" "CCSG" "Gdansk" "Colorado" "FGF/FGFR1" "SqCC" "Origene"
    "FGF/FGFR" "German" "FGFR1 /CEN8" "FGFR1/CEN8" "CEN8" "FGFR1/" "SISH" "ISH"
    "H-scores" "H-score" "Cambridge" "Ariad" "AstraZeneca" "Novartis" "BGJ"
    "Ligand/Receptor" "n = 6" "Chiu" "Konopka" "19/96" "sessile" "= 0.025"
    "pulposus" "the EBV-infected B-cell non-Hodgkin's"
    "-tetradecanoyl-phorbol-1-acetate" "GCV" "slighty"
    "DNase-treated culture supernatants" "supernatant" "late viral lytic gp350"
    "gp350" "lytic viral BZLF1" "DBZ" "CompE" "pGL3N2PR-110" "pCGN-HA-S33Y-"
    "XAV-939" "XAV" "pGL3N2PR-2327/-99" "dimethylsulfoxide" "-99"
    "pGL3N2PR-2327" "pEGFP" "pMSCVpuro" "pMigRI" "phTERTpromoterLuc" "MSCVpuro"
    "MigRI" "4134/Early" "4134/BABE" "4134/TERT+" "latent/lytic" "BZLF1"
    "P- value" "1 h" "Δ C" "non-Hodgkin" "ΔCRE" "ΔAP-1" "TAM67"
    "the antiapoptotic caspase 2S" "co-activation" "re-evaluated" "Skorska"
    "Nieborowska" "shSAM" "Avi" "shRAC2" "DilC" "pheneotypes" "shRAC" "shSCR"
    "BCR-ABL-transformed co-cultures" "reoccurs" "20 ng/mL" "Co-cultures"
    "20ng/mL" "sHB-EGF-stimulated" "predominant co-localization" "bilayer"
    "dependnt" "butwhen" "sHB-EGF-" "phenylarsine" "glutatione"
    "sHB-EGF- induced" "pEGFR" "co-translocation" "EYFP" "EGF-like"
    "Co-localization" "1h" "non-stimulated" "SNPas"
    "the marginal association ofcould" "ofcould" "Koreans" "butwas" "p=3.0×10"
    "more evident withthan" "ofwith" "withthan" "IOPs"
    "the HTG risk-associated allele ofconfers" "thedata" "ofconfers" "forand"
    "=−0.11" "ofwas" "SNPthan" "toin" "fromin" "The HTG risk-associated SNPwas"
    "SNPwas" "=0.043" "=0.010" "=0.0069" "the SNP’s" "SNPhad" "=1" "Caribbean"
    "Iowa" "an intergenic single nucleotide polymorphism (SNP)"
    "polymorphism (SNP)" "NTG" "POAG" "rs17588172" "rs4236601" "eQTL"
    "rs1052990" "HTG" "IOP" "Pakistani" "−10" "≥0.8" "Qubit" "NanoDrop"
    "T790M/control" "L858R/control" "Poisson" "Papanicolaou" "Ex19" "Kyushu"
    "T/A" "−80" "1.0 × 10" "~60%" "membraneous ER-α36" "endometrium" "shPKCδ"
    "isotypes" "membrane-associated ER-α36" "ER-α66" "ER-α36" "non-genomic"
    "progestin" "endometrioid" "** P" "* P" "1 h" "approximately 1h" "Gankyin"
    "kinases (JNK)" "microRNA-29c" "c" "necropsy" "LV-1" "Lenti" "non–small"
    "cytochrome c/Apaf-1" "Nussinov" "Groot" "Thornton" "Barlow" "UCSF"
    "CHARMM" "only three acidic duplets" "Chordata" "HADOCK"
    "possible rotamers" "Delphi" "rotamers" "PROPKA" "Google"
    "bridges/hydrogen" "cryoEM" "insightful" "eukaryotic cytochromes"
    "cytochrome c / Apaf-1" "multisubunit" "processosome" "duplets"
    "Gvritishvili" "around 15–20" "15–20" "cytochrome c /" "duplet" "PDB:3CXH"
    "anti-cooperativity" "Cα" "anti-cooperative" "Aves"
    "planarian flatworm Schmidtea mediterranea and sea urchin Strongylocentrotus purpuratus"
    "Echinodermata" "purpuratus" "Strongylocentrotus" "mediterranea"
    "Schmidtea" "flatworm" "PatchDoc" "approximately 0.1 kcal/mol" "ionic" "ΔG"
    "Lys7/Lys8" "partite" "PDB:3J2T" "ZDOCK" "PatchDock" "ClusPro" "~9.5 "
    "co-evolution" "Tajkhorshid" "Wraight" "Kokhan" "cytochromes"
    "variants/mutants" "holo" "omain (NBD)" "omain" "ucleotide" "WD-7"
    "antiparallel" "eukaryotic genomes" "intermembrane" "Huynen" "Martijn"
    "Vriend" "Gerrit" "Igor" "Srinivasan" "Narayanaswamy" "Andrei" "kcal/mol"
    "~10-fold" "Stransky" "spitzoid" "n=6" "tyrosine 1234/5" "breakpoint"
    "Kamino" "7q22.3" "leftover" "Spitz" "6-week-old" "200a" "miR-200c/141"
    "MCF-7-sh53BP1" "miR-23b" "miR-200b/429 mediated 53BP1 ’s" "MCF-7-sh 53BP1"
    "miRDB" "Miranda" "miR-200b/429" "miR-199a" "mesenchymal-like" "–5-"
    "miR-200b" "Yes" "q/11" "kinases (SFK)" "cells/hpf" "electrospray"
    "KrasLA2" "expression/activity" "keto" "11ßHSD1" "11ßHSD2" "epidermoid"
    "11βHSD2" "*P" "R&D" "5 x 10" "non-functional" "30 ns" "nitroso"
    "Methyleguanine" "scape" "anaeig" "covar" "Both the Ev’s"
    "Principal Component (PC) eigenvectors" "ED" "GROMACS" "covariance" "Ev"
    "eigenvectors" "Cluster 1" "stiochiochemistry" "ID:1T39" "dolittle" "kyte"
    "y-" "x-" "oq" "_rmsf" "RMSF" "inturn" "wtMGMT"
    "which uses different algorithm" "151AGC" "Amplicons" "FEL" "gromacs" "Mu"
    "Wildtype" "Insilico" "viz" "Nitrosourea (NMU)" "Nitrosourea" "GOLOBOCON"
    "Kcal/mol" "A:T" "cell proliferation/migration/invasion" "GRKP" "QKG"
    "QKGRKPRD" "SRN" "ARS" "ARSSRNEYMRS" "XBBBX" "XBBX" "XBX" "aspartates"
    "grape-like" "Bio" "Elk-1ΔDBD" "MZF-1ΔDBD" "ΔDBD" "isoenzyme" "pFLAG"
    "Re-ChIP" "TTT" "Elk-1∆DBD" "MZF-1∆DBD" "Kruppel" "SRFs" "Ets-like" "∆DBD"
    "zinc finger-1" "migration/invasion" "pcDNA 3.1"
    "the disease-associated NFE2L2 SNPs" "all significant AAO-delaying SNPs"
    "VO2" "TCT" "haplotypes (VO)" "VOP" "larger haplotypes"
    "AAO-modifying SNPs" "years/allele" "QTc" "rs13035806" "rs6721961"
    "rs2706110" "rs1806649" "rs6726395" "rs35652124" "rs10183914" "rs7557529"
    "Bonferroni" "PolyPhen" "PMUT" "rs34154613" "the Queensland Parkinson’s"
    "Queensland" "Swedish" "Taiwanese" "oxygenase-1" "midbrain" "mortem"
    "neurosphere" "rs2364725" "the olfactory mucosa" "hONS" "re-examination"
    "pack-years" "= 0.6" "P -value" "non-exposed" "= 0.014" "HER2-enriched"
    "omics" "exhibitedsignificant" "Frameshift" "Ampliseq" "Samsung" "LABC"
    "polychemotherapy" "refractoriness" "pCR" "Neoadjuvant" "P-values"
    "P -values" "PAM50" "Fifty-one" "HER2−" "Cheong" "Tudzarova" "Colombo"
    "coregulate" "KG" "Hino" "epigenome" "Chandra" "Orrenius" "Heiden" "Vander"
    "Warburg" "Reynolds" "Blanchet" "Hsieh" "Mazurek" "OXPHOS (OCR)" "Bigas"
    "PFK" "K-means" "Kyoto" "ECAR" "diphosphate" "electrophoresis-time" "TOFMS"
    "CE" "quadrupole" "Metabolome" "Chicas" "-deoxyuridine" "deoxyuridine"
    "the proton gradient discharger" "-trifluoromethoxyphenylhydrazone (FCCP)"
    "discharger" "-trifluoromethoxyphenylhydrazone"
    "trifluoromethoxyphenylhydrazone" "Hirosue" "Takahashi" "Kaplon" "Dorr"
    "Quijano" "Varum" "Zhou" "normal cells mainly use OXPHOS" "Dick" "Talluri"
    "Jaulin" "Magnaghi" "Brehm" "Narita" "Porath" "Collado" "Salama" "Mancera"
    "Perez" "Serrano" "Espin" "Munoz" "Otin" "Rodier" "Kuilman" "Fagagna"
    "Adda" "Campisi" "metabolome" "OXPHOS" "2 h" "–10 "
    "all preantral follicles" "preovulatory follicles" "all antral follicles"
    "human preantral follicles" "pregranulosa" "preantral and antral follicle"
    "PCOS antral follicles" "PCOS preantral follicles" "the secondary follicle"
    "PCOS patients more consistently exhibited strong oolemma"
    "a secondary follicle" "no secondary follicles" "non-PCOS"
    "the antral follicles" "Antral follicles"
    "primordial and primary follicles" "oolemma" "VIC" "Melbourne" "Auspep"
    "KITL2" "the pre-ovulatory follicles" "primordial and preantral follicles"
    "preantral/ early antral follicles" "CGC" "MGC"
    "several healthy preantral follicles" "GNNK+" "KITL1" "PCO"
    "antral follicles" "preantral follicles" "intra-follicular paracrine"
    "ovarian follicles" "theca" "granulosa" "Oocytes" "atretic follicles"
    "large antral follicles" "primordial follicles" "GNNK-" "GNNK"
    "the preovulatory follicles" "40X" "−80 " "Whitney" "microplate" "CV"
    "Minneapolis" "nonfat" "v/v" "polivinilidene" "Hercules" "Biorad"
    "Bradford" "Indianapolis" "Roche" "Cmini" "BSW" "Tokyo" "Olympus" "Germany"
    "Darmstadt" "Millipore" "Merck" "Entellan" "monocytes/well" "Gö" "Krebs"
    "MEM-199" "formazan" "monocytes/mL" "Manassas" "ATCC" "Melville" "Nikon"
    "U/mL" "Gibco" "MEM" "Rockford" "Coomassie" "Switzerland" "Männedorf"
    "Tecan" "Absorbance" "Dominguez" "Rancho" "Iwaschima" "Aldrich" "Paraná"
    "Universidade" "pg/mL" "Lukacs" "glycolaldehyde" "sRAGE" "sVCAM-1" "EU/mL"
    "limulus" "diabetic nephropathy" "mesangium" "nephropathy"
    "-carboxymethyl-lysine" "dicarbonyl" "Amadori" "Schiff" "non-enzymatic"
    "CKD" "anti-mouse" "anti-rabbit" "RhoA/ROCK" "Deiry" "Warfel"
    "Annexin V/flow" "Carlsbad" "Invitrogen" "Lipofectamine" "Chicago"
    "Dharmacon" "Thermo" "Eugene" "Hornby" "Cedarlane" "Jose" "Dickson"
    "Becton" "monolayers" "Rockville" "Baltimore" "Hopkins" "Vogelstein"
    "UC2288" "PhosSTOP" "~40%" "Yu" "exponentially growing HCT116p21−/−"
    "BrdUrd" "non-apoptogenic" "~95%" "Exponentially growing HCT116p21−/−"
    "HCT116p21−/−" "PI3K-like" "NCI" "these γH2AX foci around each DSB"
    "kinases" "progeny" "DO-1" "~10%" "shMET" "rHGF" "Y1234/Y1235" "andLipo246"
    "shMet4" "shMet1" "shNT" "shMet" "rhHGF" "Met:HGF" "ELISAs" "Peng"
    "histologies" "retroperitoneum" "Approximately 15–20" "WDLPS"
    "subcutaneous DDLPS" "kinas" "anti-DDLPS" "DDLPS" "& D" "pCDK"
    "human-specific pluripotent splicing variant pCCNE1" "OSK" "Yamanaka"
    "co-regulation" "co-targeted" "RPN" "cells display around 65%–80" "uCCNE1"
    "ESC/iPSC-" "ground" "ESC/iPSC" "ESC/iPSCs" "OKM" "RARG" "hESC-like"
    "around 4%–6" "ASE" "CCNE" "pCCNE1" "fully reprogrammed miPSCs"
    "reprogrammed miPSCs" "miPSCs" "hiPSC" "TRA160" "OSKM" "S4C" "–80"
    "fibroblast-like" "SUPPLEMENTAY" "MYCLo-4∼6" "MYCLo" "MYCLo-1" "MYCLo-4/6"
    "nonfunctional MYCLo-4 siRNA-1" "siRNA-1" "siRNA-2" "nCounter" "MYCLo-5/6"
    "Taqman" "MYCLo-5" "MYCLo-6" "AK098037" "PCAT" "CCAT1" "CCAT" "Alzheimer's"
    "Parkinson" "Huntington" "MYCLo-4" "MYCLos" "clinicians" "TP53 -mutated"
    "ploïdy" "Gerlinger" "Frozen" "available biopsy" "13/36" "15/180" "Uhlman"
    "-1000" "–4" "- mutated" "PLMIV" "approximately 6.5 h to 2.5 h" "4–6"
    "pepscan" "S-labelled" "6C1" "stimulators" "nucleo" "Cancer/Testis"
    "bortezomid" "non-silencing" "Non-silencing" "co-repressor" "4/5" "in 1/5"
    "the Burkitt’s" "upregulaton" "A20-m" "H/RS-like" "desorption/ionization"
    "Classical Hodgkin’s" "Classical Hodgkin" "antigen-like"
    "classical Hodgkin’s" "classical Hodgkin" "H/RS" "Hodgkin’s" "mean ± SD"
    "2.0×10" "3+" "the eIF4-mimetic 4EG-1" "eIF" "rapalogs"
    "publically available gene expression and mutation datasets"
    "Annexin V+/DAPI+" "eIF4G protein" "10uM" "CD19+" "subfeatures" "heatmap"
    "the downstream mRNA translational machinery proteins eukaryotic translation factor 4G"
    "factor 4G" "the Bruton's" "Bruton" "IGVH" "Annexin V+" "non-supervised"
    "localization/recruitment" "simplest" "Mosammaparast" "HA-LSD1res"
    "shLSD1–1" "Hekem" "KBD" "S4D" "CK2a" "pLSD1" "phosphopeptide"
    "/phosphatase" "2+" "Mn" "SDT" "FAD" "deacetylase 1/2" "histione" "S2D"
    "S1981" "HDAC1/2" "furthet" "miR-146a" "re-initiation" "expressionwhile"
    "SIAH" "gowth" "R-miR335" "R-Taxol" "tion" "ubiquitina-" "ubiquitina"
    "Vinblastne" "absentia" "SIAHs" "R-taxol" "ERbB" "miR-146b-5p" "Nakayama"
    "pcDNA3.1" "ΔC" "–28" "miR-27a" "AdCCs" "n=104" "=104"
    "the tubular subtype" "the two-tailed Pearson's" "the two-tailed Pearson"
    "cribriform" "TreeView" "AdCC" "Adenoid" "Hypoxia-inducible factor-1α"
    "hypoxia-inducible factor-1α" "an Alzheimer’s"
    "the mitochondrial circular genome" "CRIF" "non-receptor" "Jcam" "lympho"
    "plasma membrane-associated signal transducers" "−20" "EBV+" "MIR1"
    "Kaposi" "non-lysine" "Sternberg" "subsequent timepoints" "sgRNA" "shGFP"
    "the germinal center lymphoma subtype" "Laemmli" "SDS/PAGE" "Immuno" "cIAP"
    "homotrimer" "cIAP1/2" "hetero" "CC" "AQAAA" "TES2" "TES" "AP/MS"
    "biquitin" "pulldowns" "significant co-purification" "SHARIPN"
    "both conditional 293 cells and GM12878 LCLs" "protein A20" "HOIL-1L"
    "computational algorithm" "Interactome"
    "thirty publically-available 293 cell FLAG AP/MS control datasets" "UBAN"
    "family member 4-1BB" "homotrimers" "heterotrimers" "immunoblasts" "PQQAT"
    "QQAT" "Hodgkin" "ubiqutin" "TES1/CTAR1"
    "lysine 63 (K63)-linked polyubiqutin" "heterotrimer" "polyubiqutin" "LUBAC"
    "immuno" "B-lymphoblastoid" "Non-canonical" "AP-MS" "co-incubated"
    "CRISPR/Cas9" "non-canonical" "tropomyosine" "TAPI" "p40Met"
    "intramembrane" "Furlan" "20 ng/ml" "transfectants"
    "pCDNA3.1-RNF43-Flag-HA" "transfectant" "Ni" "~98%" "vRNA" "pCDNA3.1"
    "Bethesda" "MOI" "pEGFPN1" "prototrophy" "pYESTrp2" "pHLZ" "pHybLexA/Zeo"
    "vitro" "~8-fold" "haplo" "Che-1/p53/Brca1" "Traube" "ΔChe-1" "Brca1/Che-1"
    "p53/Che-1" "anti-Che-1" "Dox" "Che-1/p53" "growth-arrest-" "X100" "MACS2"
    "8 h" "10.1038/ncomms8202" "cryo" "Kueh"
    "stochastic and coupled severing/capping" "SNAP647" "SNAP649" "benzyl"
    "Oregon" "TIRF" "Brieher" "Srv2/CAP" "Jansen" "Cor1B" "+25 " "−20 " "2 h"
    "=50 " "−80 " "–20 s" "2–3 " "−4" "–20 " "10.1038/srep10424" "Klonowska"
    "#53" "Ratajska" "PANTHER" "1972C " "*12" "ESE" "1977A " "assay/probes"
    "_e07" "previously reported SNPs" "co-occurs" "BRCA1 / BRCA2"
    "co-segregate" "~5%" "secnarios" "ESURF" "RRSE" "RAE" "RRSEs" "RAEs" "PFSs"
    "shwon" "_P753" "EGB" "VDW" "RMSD" "nanoseconds" "picoseconds"
    "delE746_A750" "delL747_P753insS" "responder" "_A750" "dul" "_A755insSKG"
    "AMBER" "2ITZ" "and 2ITZ" "their essential pharmacophore" "1M17" "2ITY"
    "-helices" "helices" "-helix" "_P753insS" "_T790M" "∼ 30%" "non-small"
    "high/low" "Wallis" "= 0.29" "glioams" "lymphoma-2" "CH157" "≥4" "3-μm"
    "Zheng" "6/6" "Shimada" "shYB-1" "namely CCND1p #1 and CCND1p #2" "shCON"
    "NGP" "Wachowiak" "5/6" "X 100" "–10"
    "further next-generation sequencing-based exome" "easier" "T2D" "Nair"
    "T2DM" "Danish" "9/10" "GMDR" "rs2802288*A" "*A" "rs2802292*G" "tertiles"
    "tertile" "HbA 1c" "rs2802290" "*G" "rs2802292" "rs2802288" "non-FH"
    "rs7341233" "tSNPs" "MI_N" "MI_S" "tSNP" "_N" "_S" "*e4" "class O3" "IIS"
    "EASD" "LLI" "non-GSCs" "meninges" "DG" "REMBRANDT" "callosum" "83NS"
    "1123NS" "MD30" "528NS" "X09" "X08" "X03" "X06" "X04" "TGGGAA"
    "difluorophenacetyl" "ʹUTR" "shPEDF" "SVZ" "Vivo" "Ex" "serum-CM" "GSC-CM"
    "siEGFRvIII" "CSC2" "Stemness" "neural stem/progenitors" "parenchyma"
    "stemness" "* p" "2 h" "stem/progenitors" "stem-cell-like" "2h" "ACS" "ISO"
    "MNK-45" "anti-human" "RPKS6KA3" "CSDA" "Greater" "subsequences"
    "mature miRNA duplexes" "duplexes" "targetome" "–20" "Anti-Human" "Wyeth"
    "OATP-1" "oocytes" "laevis" "g" "this heterozygous polymorphism"
    "+2508/2607" "co-isolation" "non-Amish" "+2556" "Genotype"
    "the EPHX1 intron 1 region around +2556" "+3460" "-1797" "+2462/+2641"
    "+2557" "-10" "-20" "topology" "-4" "-28" "-80" "+25" "-784" "Lancaster"
    "HNF-4α" "capacity/function" "hypercholanemia" "polymerase-1" "Amish"
    "2 bp" "multicyst" "Angelis" "punctiform" "ameloblast-like" "metastasise"
    "ORCA" "S8B" "GRWD1_w0.5" "CDC6_w0.5_MCM7_w0.5_sGRWD1_w0.5_SNS"
    "investigated quantitative FAIRE" "_SNS" "_sGRWD1" "sGRWD1"
    "CDC6_w0.5_MCM7_w0.5" "∼27%" "CDC6_w0.5_MCM7" "co-localize" "_w0.5" "_MCM7"
    "approximately ∼27%" "co-localizes" "mononucleosomes" "coli" "octamers"
    "S3H" "S3D" "Cdt1-" "Cdt" "chromatin/nuclear" "A-positive" "A-negative"
    "replicon" "FAIRE-quantitative" "-seq" "FAIRE"
    "significant genome-wide co-localization" "Seq" "S7E" "S7A" "S5D" "S5C"
    "3 × 10" "S2C" "S1D" "SXS" "IKKα/β" "S7G" "S7D"
    "dominant-negative p53 R175H" "S5E" "feedforward" "RbTKO" "DLD1" "DL23"
    "rightmost" "DLD1-derived DL23" "RNAPII" "CTDSP" "orthologue" "O-group"
    "S5A" "S2B" "S1C" "Ilic" "Arriola" "Floris" "Lopez" "Casali" "Araki"
    "Nitta" "Jiang" "Pirker" "Mountzios" "Schneider" "Pelosi" "Kumler" "Asaoka"
    "exclusiveness" "strongly positive non-EGFR–RTKs" "non-EGFR–RTKs" "Niho"
    "Treut" "Le" "Kinoshita" "Travis" "pStage" "IASLC" "Umemura" "NGM" "CLCGP"
    "Rudin" "Peifer" "Dobashi" "Nakachi" "Gollard" "Fernandez" "Asamura"
    "Gupta" "Battafarano" "fusiform" "z" "SQCC" "HGNEC" "SQCCs" "HGNECs"
    "non-resectable" "the classical subtype" "extrathyroid"
    "the more common classical papillary subtype" "phosphoinositol"
    "the second most common histological subtype" "Arabia" "Saudi" "Doppler"
    "the follicular variant subset" "grounds" "αIgM" "SNORA" "DAVID" "co-IP"
    "and 3/170" "3/66" "7/136" "-mutated" "clinically aggressive CLL subsets"
    "TTFT" "different poor-prognostic stereotyped subsets"
    "poor-prognostic stereotyped subset #2" "poor-prognostic subset #1" "8/568"
    "4/495" "hotspot" "#6" "especially subset #1"
    "certain poor-prognostic stereotyped CLL subsets" "stereotypy" "43/692"
    "GeneScan" "poor-prognostic subsets" "poor-prognostic stereotyped subsets"
    "Igs" "IGHV" "BcRs" "24/124" "reads/base" "pathobiology" "Mansouri" "∼5%"
    "10/18" "peritoneum" "pseudogene" "10q23" "y" "Taipei" "ΔCt"
    "chemoattractant" "TCM/CCM" "TCM" "anti-tumoural" "PF-04217903" "JNJ"
    "intratumour" "PyMT" "KO→WT" "WT→WT" "deleter" "non-adherent" "4G10"
    "anti-phosphotyrosine" "3×10" "20 ng/ml" "± 0.3" "Mayo" "Hillsberg"
    "10.1038/srep09755" "Jang" "senesces" "Hutchinson" "Inc"
    "the adjacent non-involving bronchial epithelium" "_V774insNPH" "343AA"
    "2-3" "Fluidigm" "Lu-5" "Lu" "employed whole transcriptome" "Diego"
    "MassArray" "America" "and 2/64" "co-ordination" "Ensembl’s" "Ensembl"
    "GYNGYNs" "Hiller" "predictive algorithms" "Tyr-705s"
    "more biological replicates" "replicates" "RIVA" "spliceform"
    "using Illumina’s" "GYNGYN" "GTAGTT" "BodyMap" "17±6%" "11±3%" "GBC"
    "IL3+TNFα-treated eosinophils" "IL3+TNFα" "Oci" "α/β" "GCB" "B cell-like"
    "Eosinophils" "UniProt" "here called ΔS/S" "Zammarchi" "redirect"
    "morpholinos" "STAT3 α" "JAK1/2" "Illumina’s" "STAT3β" "ΔS-β" "ΔS-α"
    "DLCBL" "ΔS/S" "ΔS" "STAT3α" "= 0.06" "the biological underpinnings"
    "underpinnings" "a PTPRT -methylated HNSCC heterotopic tumorgraft" "gavage"
    "BICR" "tumorgraft" "shPTPRT" "PTPRs" "PTPR" "pSTAT3" "LOF" "HNSCC"
    "non-targeted" "co-cultured" "tubular/reticular" "PSC-2" "zymography"
    "supernatants" "non-invadopodial" "timepoints" "podosome-like" "Dyn2 K44A"
    "GTPase defective Dyn2K44A" "4HT" "DKO"
    "fluorescent gelatin-coated coverslips" "coverslips" "stellate"
    "Non-targeting" "non-permeabilized" "κB" "non-apoptotic" "kd" "p53DBD"
    "Re-Bcl-2" "Re-ASPP2" "CO-IP" "El" "Apoptosis-stimulating protein of p53-2"
    "co-culture" "coculture" "PMSS1" "J166" "JR" "BJ" "Marshall"
    "the gastric epithelium" "microbial flora" "Tff1-" "Tff" "-KO" "KO"
    "pTopFlash" "methyltransferse" "microvessel" "deeper" "SMYD3putative"
    "SMYD3-" "SMYD" "ovo" "ex" "the repressive H4K20" "H4K20" "NHSC" "proto"
    "mg/mL" "co-workers" "hsRNA" "siControl" "siROR1" "4/37" "2/8" "4/29" "MFI"
    "immunoglobulin-like" "ROR1/2" "~90%" "12 h" "anti-migratory"
    "pharmacophore" "ursane" "UA" "CHMs" "Actinidia" "mg/ mL" "Anti-cancer"
    "anti-migration" "mg/kg/day" "PDFRA" "EGRF" "non-treated" "collagens"
    "discoidin" "PRGFRA" "pyrazole" "8H" "Non-Small Cell Lung Carcinoma"
    "non-small cell lung carcinoma" "English" "Chiang" "RFLP" "nonhuman" "kbp"
    "rs689466" "rs20417" "rs5275" "+837" "P = 0.021" "glutathione peroxidase-1"
    "≈2-fold" "S-producing" "carbonyl" "Zn" "Cu" "Gastrocnemius" "CLI"
    "G-quadruplex" "quadruplex" "2.9/2.4" "5.0/4.6" "approximately 10.5bp"
    "41bp" "10.5bp" "Fourier" "‘CCGGAA’" "Weisberg" "P-value" "itro" "CCGGAG"
    "CCGGAA" "A/T" "finite lifespan" "heterotetramer" "P=0.028" "Kurrey"
    "P=0.021" "r=0.231" "Imai" "=−0.225" "=0.028" "=0.021" "=0.231"
    "ovarian cancer cell line TYK"
    "the undifferentiated human ovarian cancer cell line TYK"
    "the human mucinous ovarian cancer cell line 3AO" "3AO" "lα" "and 3AO"
    "TYK" "≤5%" "thePAK" "follicle" "co-association" "immunocomplex"
    "using Pearson’s" "cofillin" "co-localization " "interventio" "Jin" "GNEF"
    "vera" "anti-metastatic" "Monolayer" "Cruz" "Ad/β-gal-" "Ad/β-gal"
    "Ad/GRP78" "sGRP78" "levle" "mir-200c/141" "+120" "mir-200b/a/429"
    "mir-200b/a" "mir-200b" "MDA-MB-451" "undergone" "spindle-like"
    "cobblestone-like" "ƘB" "Necidin" "mir-200a/b" "ZEB1/2" "Co-IP"
    "Analyses using publicly available algorithms" "Smad2/3" "MIR148A"
    "ConSite" "MIR" "dithiocarbamate" "U138MG" "miRNP"
    "three publicly available algorithms" "miRanda" "TargetScan" "MiR-148a"
    "microRNA-20a" "6q26-27" "microribonucleoprotein" "pSMAD" "miR-148a"
    "microRNA-148a" "anti-HA" "TGF-β pathway" "javanica" "Brucea" "Brucein"
    "radioresistance" "DIANA" "the bronchial epithelia" "miR- 95-3p"
    "cyclin D1-targeting miR-95-3p" "the MSKCC public dataset" "MSKCC" "BMFS"
    "MiR-95- 3p" "miR- 95- 3p" "pmirGLO" "Pri-miR-95" "Pri- miR-95"
    "pri- miR- 95" "parental and metastatic sublines" "sublines" "Biosystems"
    "Identifier" "PE14PE6/LvBr4" "Du" "neurosurgery" "miR-95- 3p" "pri-miR-95"
    "miR-95-3p" "MiR-95-3p" "PC14PE6/LvBr4" "intracardiac" "pYAP" "Lucsh"
    "pBabe" "Alexa" "Co-immunoprecipitation" "184A1" "FGF-BP1" "Smads" "TEADs"
    "YAP/TAZ" "5 g/L" "4.5 g/L" "accumulative evidence implys" "implys" "Kim"
    "Ser1981" "s1981" "oxidases" "indcate" "N-acety" "acety" "p-ERK1/2"
    "immunoscore" "gallbladder" "«necrotic"
    "the tumour-associated immune contexture" "Caro" "CD3+" "L colonic mucosa"
    "Kaz" "follicles" "flora" "Bindea" "Immunoscore" "Galon" "contexture"
    "_tumour" "_Site" "Wilcoxon" "Normal Colonic Mucosa" "Mucosa" "Spearmann"
    "≥65" "endpoint" "3-year" "1.02–2.97" "offs" "pMMR" "1.14–3.43" "1.05–2.71"
    "Wald" "UICC" "AJCC" "immmune" "profiler" "ImmunoScore" "multigene"
    "profilers" "DCq" "XELOX" "FOLFOX" "neoantigens"
    "adjacent normal colonic mucosa" "ANZCTR" "CD3Z/CD8" "qRT" "1/3" "Exome"
    "imporant" "Glaysher" "radioimmunotherapy" "CNV" "TNBCs" "21p" "in 1q"
    "substitution/indels"
    "the clinically relevant chemotherapy 5:1 docetaxel/doxorubicin" "ATXN2"
    "homolog" "BALB/c" "andcell" "Provean" "Nextera" "Omni" "MCF10CA" "20ng/ml"
    "docetaxel/doxorubicin" "MTS" "5x10" "wildtype" "-GS" "MCF10AT1" "~11%"
    "rarer" "TNBC/basal-like" "exon 18" "~ 10%" "Basal-like"
    "10.1038/ncomms8095" "reprogrammes" "NHSM-naive hESCs" "XCI" "Gafni"
    "the recently reported naive hESCs" "EpiSC" "theSTAT" "blastocyst" "and 2i"
    "5i" "Vassena" "morulae" "bi" "Xa" "Xi" "DE-luciferase" "RRBS" "5hmC" "5mC"
    "5-hydroxy-mC" "methylcytosine" "TL2i-H9S3" "BRA" "TFCP2L1" "TL-H9S3" "PCA"
    "U219" "Affymetrix" "Transcriptome" "TL2i-H9S3-2" "TUJ1" "TL2i" "TL-H9S3-2"
    "JUNB" "XY" "SSEA4" "endoderm" "mesoderm" "ectoderm" "embryoïd"
    "TL-H9S3–14" "TL" "withdrawn" "F-H9S3" "+LIF/4" "F-H9S3-2" "-OHT" "OHT"
    "Sgk" "Takashima" "5i/A/L" "FGF2-independent naive hESC" "KOSR" "NHSM"
    "hiPSCs" "hESC" "EpiSCs" "hESCs" "blastocysts" "2i/LIF" "mESCs"
    "naive-like" "reprogramme" "non-random" "1–3" "μg " "∼30%" "Juhasz"
    "Iacopino" "Kuefer" "Rogers" "ectodomain" "T-stage" "Pn" "bivariate" "GS "
    "≥ 7" "GS" "fallen" "Nomograms" "≥7" "Galectin" "Profiler" "Proteome"
    "prostatectomy (RPE)" "&D" "chemoradiotherapy" "7/139" "139/376" "≥ 4"
    "≥ 50" "reversible dissociation/association" "P39C" "melanogaster"
    "ortholog" "subphylum" "sHsps" "Non-linear" "chaperone-like"
    "Chaperone-like" "urea" "priori" "MAPKAP" "mg/ml" "absorbance" "physico"
    "P39L" "sHsp" "ANS" "heterooligomers" "homooligomers" "Physico" "8 h"
    "NuRD" "RIPA" "lysis" "EE" "E/D" "histone chaperone ASF1A" "Kegg" "MCM2–7"
    "AAA+" "SILAC" "minichromosome" "LC-MS/MS" "Aβ-" "Fdu" "microdomains"
    "methylenedioxymethamphetamine" "thanTau" "AP5" "Tg2576" "AxxA7" "AxxA"
    "PxxP" "0N4R" "andTau" "tetrodotoxin" "noRD" "transfectedTau" "intoTau"
    "untransfectedTau" "DIV" "fromTau" "ofTau" "GSM" "axons" "axon" "hAPP/Aβ"
    "orTau" "inTau" "anterograde" "Aβ" "Alzheimer’s" "Alzheimer" "≥3" "IC 50"
    "2–3" "spatio" "FMNL2ΔDAD" "multiprotein" "-CT" "active FMNL2ΔDAD-GFP"
    "FMNL2ΔDAD-GFP" "nucleation/polymerization" "active FMNL2ΔDAD"
    "co-transduced" "an active FMNL2ΔDAD" "ΔDAD" "LifeAct" "wk" "monolayer"
    "active RhoGTPases" "GBD" "RhoGTP" "RhoGTPases" "multidomain" "nucleators"
    "1/" "membrance" "Cylcin" "nomal" "Chae" "approachs" "Youden" "139/150"
    "neuroendocrine" "5q12" "≥ 3" "5-year" "10.1038/srep09893" "Bucur"
    "possible CasPro" "CasPro" "oxygens" "dysregulation/deregulation" "CaspPro"
    "auto-" "autocleavage" "interdomain" "zymogen" "co-treatments" "# 10"
    "the renal proximal tubules" "undertaken" "Nino" "Sanchez" "Landry"
    "the proximal tubules" "autophagy/mitophagy" "renal proximal tubules"
    "densitometer" "micrographs" "the renal proximal tubules 24 h"
    "proximal tubules" "the renal cortical tubules 24 h"
    "the renal cortical tubules" "tubules" "sHSPs" "sHSP" "nephron"
    "Ischemia/reperfusion" "deoxynucleotidyl" "h" "ischemia/reperfusion"
    "tubule" "AKI" "24h" "-5" "ML324" "UNC0642" "nonsignificant" "EpiQ"
    "Markov" "Hidden" "browser" "H3K9" "KZNF" "APAK" "homeodomain" "inefficacy"
    "importin-α3" "Immunohistochemistry" "Gy" "pSuper" "WCE" "nUPLC-MS"
    "dismutase-2" "proteome" "MDM4C437G" "MDM4ΔBD" "ΔBD" "MDM4BD+RF" "siHIPK2"
    "ΔRING" "region/s" "adryamicin" "siMDM4" "Co-expression"
    "CaM kinase-like-1" "doublecort" "miR-144 inhibited" "c-Met3"
    "available algorithms" "uvea" "Uveal" "inMUM-2B cells" "uveal" "safest"
    "synchronous MPBC" "our cohort lobular histology" "lobular histology"
    "a synchronous MPBC" "a bilateral mastectomy" "bilateral mastectomy"
    "unilateral mastectomy" "a unilateral mastectomy" "lumpectomy"
    "the fifth soft agar" "OCP" "compared histologic BC tumor subtypes" "WHI"
    "non-variant" "HRT" "MPBC" "S4B" "= 0.003" "= 1.42" "= 0.024" "PPI"
    "greatest" "GL8TD1" "resp" "Goeman's" "Goeman" "CePa" "miR-362-3p" "ASPM"
    "pri-miR-145" "pri-miR-143" "miR-143-miR-145" "subgraphs" "algorithm"
    "betweenness" "CCR" "10q11-q27" "17q21" "BRCA1-miR-143-miR-145" "comodule"
    "Pérez" "Akavia" "Solvang" "Pollack" "basal-like" "aCGH"
    "well-defined molecular subtypes" "let-7e" "μ g" "-diindolylmethane"
    "diindolylmethane" "3-Methoxycarbonylmethyl-1H-indol-2-yl" "Bel-7402/5FU"
    "MIAM" "p21 Waf1/Cip1" "G 0 /G 1" "72 h" "μ g/mL" "G 0 /G 1 phase"
    "-1H-indol-3-yl" "10.1038/srep10159" "Liu" "Okamoto" "#1/#2/#3"
    "DNA/RNA binding protein" "GRE" "biomolecules" "μg" "1-3" "let-7a" "Y-box"
    "10.1038/srep10154" "Weng" "I_⊿CpG_2" "_⊿CpG_2" "element/region" "DMR1"
    "the methylated ICR/DMD" "ICR/DMD" "Loeb" "CGI3" "sequenom" "DMRs"
    "inframe" "⊿CpG" "dinucleotides" "_2" "DMR" "EpiTYPER" "Sequenom" "~30%"
    "GRCh37/hg19" "–7 " "~60KDa" "* as" "*as"
    "a specialized invasive organelle" "organelle" "pY397-FAK" "pY416-Src"
    "pulldown" "rhGRP78" "biotin" "Transwell" "-macroglobulin" "macroglobulin"
    "ɑ" "TRIRC" "macroglobin" "48 h" "drawn" "Huzarski" "BCSS" "non- CHEK2"
    "Tutt" "Gluck" "0.71–1.49" "0.63–1.30" "viscera" "Schmidt" "Kriege" "Nagel"
    "Bock" "Hollestelle" "IVS" "Tung" "Roeb" "Bartek" "Nevanlinna" "Weischer"
    "Heijboer" "Meijers" "Cybulski" "MBC " "PFS" "1100delC" "MBC" "hereon"
    "≥50" "= 6" "non-homologous" "95 % CI" "oligoguanine" "non-metastatic"
    "CeRNA" "CN-LM1a" "tRF-specific" "anti-correlated" "CompareACE" "CIMS"
    "named CU-box" "CU-box" "CU" "the bound tRF" "tRFs" "-tiRNA" "tRF" "SerAGA"
    "LysTTT" "AspGTC" "GlyTCC" "smRNA" "regulon" "-UTRs" "seq" "tiRNA"
    "co-precipitation" "nt" "SCUBYC" "pH" "anticodon" "ribonucleases" "tiRNAs"
    "MCF10" "non-transformed" "Schwann" "co-clustering" "re-localization"
    "Rac∙GTP" "oligos" "∙GTP" "co-precipitate" "co-precipitates" "gonad"
    "epithelia" "the latency-induced secretome" "Nordt" "the viral genome"
    "LUNA" "IE72" "Kasumi-3" "Lonza" "Amaxa" "Abcam" "SYBR" "Qiagen" "IE"
    "secretome" "microRNAome" "cIL" "PLCξ" "geranylgeranyl" "farnesyl"
    "isoprenylcysteine" "FRAX1036" "FTI/GGTI" "Genentech" "BMS-225975" "BMS"
    "P61A6" "GGTIs" "1 x 10" "-7 " "x 10" "Biomedica (IRGB)" "Cagliari" "IRGB"
    "Biomedica" "Genetica" "Ricerca" "Istituto" "singleplex" "cases/controls"
    "Trentino" "Modena" "Europeans" "rs2981579" "rs3803662" "x10" "iCOGS"
    "1.16x10" "1x10" "10q26.13" "16q12.1" "the predominant molecular subtype"
    "-mutation-negative" "Mediterranean" "relatedness" "non-familial" "GWA"
    "Only SNP rs345299" "rs345299" "HapMap" "GeneChip" "Sardinia" "−7" "PR+"
    "ER+" "chemo-" "amplification/overexpression" "Pietras" "Heubner" "HER2-"
    "SATB1/HER2" "HR+" "SATB1/" "SATB1+/HER2+" "SATB1-" "SATB" "SATB1+" "HER2+"
    "Kato" "proven" "χ 2  " "= 0.003" "vascular cellular adhesion molecule-1"
    "molecule-1" "andVLA4" "a4b1" "fibronectine" "exhaustion/senescence" "hUCB"
    "EZH2i" "DZNep" "EOL-1R" "MPAK" "Ph" "Philadelphia" "7q36.1" "# 12" "-7"
    "= 6" "CD34 +" "Luo" "re-expressed" "pCMV" "pCMV6/RPRM" "5/20" "15/20"
    "NTAM" "Spearman’s" "KATO" "non-tumor" "= 0.012" "g/mL" "-6" "non-invasive"
    "co-precipitated" "-trisphosphate" "trisphosphate" "leds" "CCRCC" "BioBank"
    "7q31" "1q24" "14q23" "9q22" "5q31" "15q24" "10q22" "1q21" "16q22" "=1.24"
    "silico" "=1.43" "OR=1.34" "=2.20×10" "OR=1.36" "=1.36" "gender/age"
    "echocardiography" "LVEF" "=1.35" "=1.34" "Genotypes" "Only SNP rs3807989"
    "Weinberg" "only 1 genotype" "rs2040862" "rs1152591" "rs13376333" "4q25"
    "mellitus (DM)" "GeneBank" "Japanese" "rs3807989" "GWAS" "=5" "95% CIs"
    "−5" "=4" "EGFR-FISH positive or high polysomy" "trisomy" "disomy"
    "polysomy" "propria" "muscularis" "submucosa" "EACs" "χ2" "–7" "–5" "= 0 %"
    "≥ 50" "five-year" "= 0.046" "intraclass" "Fazekas" "sporadic SVD" "IIID"
    "IIIA" "IIA" "WMH" "SVD" "rs1043997" "rs10423702" "rs1043994" "rs10404382"
    "Galwey" "leukoencephalopathy" "non-complex" "HPSC" "3–6"
    "the most frequently mutated codons" "AML/MDS" "UKMRC"
    "sideroblasts (RARS)" "dysplasia (RCUD)" "RAEB" "sideroblasts" "RCUD"
    "dysplasia" "unilineage" "cytopenia" "Wong" "Missense" "MDS/AML"
    "/acute myeloid leukemia" "C:G " "C:G" "= 4" "= 5" "a strong synergism"
    "the histologic subtype" "histotypes" "microvessels" "vs" "EV" "MES-MM98"
    "IC50" "the biological readout" "readout" "MSTO" "transducers" "histotype"
    "each major histological subtype" "10 sarcomatous histology" "epithelioid"
    "pleura" "immunophenotypes" "Transducers" "–6" "Sourbier" "−6" "Cheng"
    "Sugimura" "let-7d" "Chemoresistance" "Targetscan" "let- 7b" "nephrectomy"
    "let-7c" "let-7b" "χ  2" "48 h" "H & E" "el" "Dudognon" "shCtrl" "*p"
    "chosen" "TNFsf" "FLICE-Like" "IPF" "approximately 25 mg/sqm" "mg/sqm"
    "1980s–1990s" "hTERT+" "shFLIP" "alveolar epithelium" "C57BL/6" "P-loop"
    "spilus" "spitz" "Shen" "-OH" "OH" "SNV" "104x" "columnar epithelium"
    "papillae" "papules" "Helsinki" "Yale" "Blaschko’s" "Blaschko"
    "sebaceus (NS)" "sebaceus" "OMIM" "papilliferum (SCACP)"
    "papilliferum (SCAP)" "SCACP" "papilliferum" "year-old" "v567es" "Δ142–337"
    "Titus" "wt" "and 2–3" "withY267F" "Gui" "Lagger" "CHX"
    "non-acetyl-mimicking" "°C" "acetylome" "48 h" "12 h" "non-histone"
    "Pearson's" "Pearson" "p-ERK 1/2" "KEGG" "targetscan" "algorithms"
    "timeframe" "Boyden" "miR-4728-3p" "mir" "Caspase 3/7" "μ g/ml" "=6" "24 h"
    "FOLFIRI" "Cutsem" "= 0.017" "χ 2" "ORR" "Kirsten" "v" "folinate (CF)"
    "folinate" "Fu" "27/87" "= 5" "TAp73/ BNIP3" "p53-like" "Hou" "TAp73/ΔNp73"
    "p53RE" "WB" "48h" "g/ml" "ΔNp73" "TAp73" "72 h" "5 g/L"
    "syntotrophoblasts" "maternal BMI" "RSV-" "RSV" "ROSI" "Trophoblasts"
    "Prepregnant" "trimester" "VLDL" "prepregnant maternal BMI" "prepregnant"
    "trophoblasts" "FABPpm" "HF-fed" "$20" "VUSs"
    "intronic, and small in-frame insertion/deletions" "insertion/deletions"
    ".9118-2A " "prophylactic mastectomy" "oophorectomy" "mastectomy"
    "ultrasonography" "mammography" "Warsaw" ".9118-2G "
    "a pathogenic BRCA1/2 mutation massive amplicon" "amplicon" "Condel" "VUS"
    "≥Q20" "Mbp" ".9402delT" "_3704del5" "_67delAG" "non-synonymous" "cheaper"
    "Poland" "Jews" "Ashkenazi" "Q563X" "indels" "AmpliSeq" "BRCA1 / 2"
    "co-localized" "coauthors" "Wasserkort" "centuximab" "immunotherapy"
    "MethyLight" "Inteplex" "amplicons" "analyte" "= 0.0108" "27/85" "70/85"
    "69±14" "discrepant" "plasma/tissue" "Weger" "Chatterjee" "Raouf" "Basak"
    "Perhaps" "Browser" "UCSC" "AGGTCA" "lenti" "i3T3" "ICI" "andA"
    "mammoplasty" "72 h" "24 h" "non-malignant" "begun" "RhoA/ROCK1"
    "Methyladenine" "GTP-bound RhoA" "+197" "Hoechst" "DF1" "CEF" "kinase 1"
    "kinase1" "bursa" "Orthoreovirus" "ARVs" "ARV" "10.1038/srep09887" "doi"
    "Krishnan" "CNS" "MEK-1/2" "Tat-activated Müller glia" "Clade" "un" "pIκB"
    "destabilise" "pIκBα" "6-Iodo-2-methyl-1-" "AM-630" "-5-" "methanone"
    "methoxyphenyl" "morpholinyl" "dichlorophenyl" "iodophenyl" "yl"
    "Piperidin" "MKP-1/2" "blocker" "Anti-inflammatory"
    "Tat-induced Müller glia" "STAT1α" "STAT-1α" "CB1/2" "anti-inflammatory"
    "B/C" "blockers" "Cannabinoid" "cannabinoid" "BBB" "cannabinoids"
    "retinal Müller glia" "human retinal primary Müller glia" "BRB" "neuro"
    "Human immunodeficiency virus-1" "socio" "harsher" "glia" "Müller"
    "cells/well" "4.5 g/ L" "Co-incubation" "Si" "wre" "Stem-like" "ARCaPE"
    "ARCaPM" "кB" "PCaradio" "stem-like" "si" "Oligo" "ARS/P" "Snailin"
    "Snailproteins" "lineLNCaP" "tumorsand" "stem/progenitor" "CRPC" "andγ-TT"
    "S/P" "or/and" "Non-specific" "Sirtuin" "Johnson" "Bhaskara" "EZH2-" "EZH"
    "H4K91ac" "H4K91" "DTX" "remodeler" "H4K16ac" "DSBs" "DSB"
    "mature non-dividing" "Hdac1,2" "chromatids" "Sirtuins" "IIa" "KDACs"
    "non-redundant" "MKL-1" "Austria" "Graz" "MCC-3" "co-occupancies"
    "co-occupancy" "BRD3" "Enhancers" "BRDT" "BRDs" "enhancers" "Merkel"
    "non-targeting" "mg/kg" "#10" "#12" "H3K27" "JQ1" "IL21R" "TAE" "Th17"
    "PMA/ionomycin" "Tbet" "∼50%" "δ1-" "TCRδ" "δ1" "δ2" "TCRα" "Vβ11"
    "nonredundant" "These different δ-chain–expressing subsets" "∼70%" "aureus"
    "albicans" "iNKT" "invariant" "MAIT" "Wilson" "± 0.5" "10.1038/srep10027"
    "Gavilán" "pRb/Rb" "autophagic vacuoles" "ultrathin" "vacuoles"
    "pCDNA3-HA-GSK-3β-S9A" "pCDNA" "G1/S" "organelles" "co-treatment"
    "methyladenine" "G1/S phase" "anti-cancer" "/S" "TGF-βpathway"
    "public Oncomine microarray datasets" "Oncomine" "coefficien" "Spearman"
    "V#1" "L#1" "J7-LCN2-KD" "~80%" "HepG2-TRα1-LCN2-KD" "Luc" "euthyroid"
    "hyperthyroid" "H&E" "eosin" "L#2" "V#2" "Huh" "GGATACTTTTTAAGGTCA" "p2–5"
    "luc" "invasion/metastasis" "prostaglandins" "lipoproteins"
    "hyperthyroxinemia" "Met/FAK" "TRα" "5-triiodo-L-thyronine" "&E" "9q34"
    "clearer" "vivo" "Nov" "knockingdown" "CTGFsi" "TAZsi" "NOD/SCID" "GFPsi"
    "soft agar" "agar" "SK-N-F1" "SK-N-DZ" "Seeger" "Versteeg" "PDGF-β" "Rb"
    "chemo" "non-cancer" "re-introduction" "ErbB" "miR17/20" "usingcyclin"
    "rescuecyclin" "QT" "intocyclin" "anti-sense" "ponasterone" "logrank"
    "rtTA/CCND1" "rtTA/" "Dataset" "transgenes" "rtTA" "Ponasterone"
    "vs.cyclin D1" "incdk4/6" "vehiclecyclin" "vscyclin" "betweencyclin"
    "hourscyclin" "Aneuploidy" "comparingcyclin" "withcyclin" "andcyclin" "ChW"
    "SpW" "Chw" "−/−KE" "−/−D1" "Thecyclin" "thecyclin" "multi" "aphidocoline"
    "Incyclin" "incyclin" "SUV39" "orcyclin" "eithercyclin" "aneuploidy"
    "ofcyclin" "= 4" "= 0.002" "CenpE" "pHsp70" "K-fibers" "NEBD" "VER-155008"
    "VER" "Nek6-" "Nek" "KESTREL" "NEK" "Grp78/BiP" "K-fiber" "Non–cancer"
    "72 h" "MMP-2/14" "USA" "Boston" "MMPs" "HDAC3-2" "HDAC3-1" "HDAC3+++"
    "HDAC3++" "+++" "++" "Karnofsky" "chemoradiotherapies" "vessel-like"
    "Maniotis " "laminin5γ2" "VM" "=  0.024" "24 h" "12 h" "× 10" "synergism"
    "Eto" "Δ3" "anti-tumor" "ubiquitine" "lentivectors" "non-specific"
    "co-transfection" "doi:10.1186" "a possible clinical workflow" "workflow"
    "interobserver" "prostatectomies" "urologists" "nomograms" "Wiley" "55/612"
    "57/612" "prostatectomy" "Gleason" "non-overlapping"
    "performed serial ddPCR" "ddPCR" "quinazolone" "rebiopsy" "T790M+"
    "droplet" "cfDNA" "del 19" "individuate" "arisen" "H3Ac"
    "inhibition/depletion" "doxo/ABT-888" "promoter/enhancer" "Doxo/ABT-888"
    "SIRE" "siCT" "Doxo" "chemoresistant" "doxo" "monotherapy" "hyper-" "hyper"
    "chemoresistance" "ation" "Non-Targeting" "representative polymorphisms"
    "Arg194Trp" "carboxyl" "194Trp" "194trp" "Arg/Trp + Trp/Trp"
    "Arg/Arg + Arg/Gln" "TTAAGGG" "et" "adduct" "ng/mg" "Arg/Arg+Arg/Gln"
    "Haplotype" "Lewontin" "1.06–2.36" "non-smokers" "399 Gln/Gln" "G→A"
    "ELISA" "8-oxo-7,8-hydro-2" "hydroxyl" "hydroxydeoxyguanosine" "butanone"
    "pyridyl" "methylnitrosamino" "1.6:1" "Taiwan" "the urothelial epithelium"
    "ureter" "malignances" "UC" "OHdG" "Hydroxydeoxyguanine" "95%CIs" "= 0.01"
    "rs25487" "rs25489" "399 Gln" "C-labeling" "mutation/deletion"
    "shATM/shRRM2" "phenocopies" "shp53" "pHSP27" "metabolizes" "shRRM2/shATM"
    "phosphogluconate" "VE822" "shATRs" "shATR" "shATM" "shRRM2" "diploid"
    "24 h" "#1" "DNA binding/activity"
    "metabolically stressful events/locations" "events/locations" "Sanli"
    "miR-451expression" "co-activator" "iv" "iii" "ii" "weakest" "neurospheres"
    "SignalChem" "AMPKa" "AMPK β1/2" "miR-451 expression" "re-introduced"
    "~4-fold" "~2-fold" "Tfsitescan" "1.0g/L" "4.5g/L" "pri-miR-451" "16–18h"
    "circuitry" "5g/L" "1/2" "MammaPrint" "Oncotype" "simpler" "ncATM" "intra-"
    "intra" "Bueno’s" "Bueno" "paracrine"
    "stromal tissues around normal breast epithelium" "fluorescent IHC"
    "workflows" "brightfield" "broader" "T3/T4" "subsets"
    "the stromal compartment around normal breast epithelium"
    "automated quantitative fluorescence IHC" "LVI" "TNBC" "REMARK"
    "fluorescent immunohistochemistry (IHC)" "BRCA1/2" "PIKKs"
    "the most aggressive breast cancer subtype" "oncologists" "Western Europe"
    "Europe" "csATM" "nATM" "tATM" "Tom" "EBC" "HNBC" "HPBC" "≥25" "S2A"
    "= 0.014" "= 0.002" "co-treated" "non-inhibitor" "Poole"
    "anti-proliferative" "adGFP-" "caspase 3/7" "adGFP" "adFOXO3a" "siCntrl"
    "siFOXO3a" "pM" "adequate BMI" "pharmacotherapy" "CTG" "MCIC" "BOLEROII"
    "HRs" "the categorical covariates" "covariates" "univariate"
    "non-metformin" "Scheffé" "hoc" "BMI" "subtypes" "CTC" "NCIC"
    "epidermal growth factor receptor-2" "mellitus"
    "the consequent hyperinsulinemia" "hyperinsulinemia" "British" "Meier"
    "Kaplan" "Asan" "95 % CI" "positive/negative" "pre-" "responders" "MGH"
    "11a" "#2" "#3" "T790M/activating"
    "the thoracentesis cell-block revealed del19" "del19" "re-biopsied" "11b"
    "ctDNA" "gatekeeper" "phosphorylation/activation" "stressors" "NAFLD" "HK"
    "Renilla" "omentum" "I/II" "XJ" "FIGO" "MiR-106b" "miR-106b" "106b" "EOC"
    "anti-apoptotic" "= 3" "cells/mL" "CSE/PCSE" "increased viral titers"
    "PCSE/CSE" "viral titers" "the viral titer" "titer" "EAR" "eosinophils"
    "5/group" "non-smoked" "alveoli" "TUNEL" "& E" "mg/m" "particulate"
    "lavage" "co-localization" "homogenates" "Eosin" "eosinophil" "AEC" "PCSE"
    "AECs" "IAV" "=0.014" "=0.003" "_1132insT" "+6T" "ACCCGC" "_1255delCTTACG"
    "WBC" "Korean" "karyotype" "casitas" "DFS" "ITD" "IDH1/2"
    "mucinous histology" "Cpg" "CIMP" "codons"
    "a frequently encountered histologic subtype" "subsite" "Univariate" "pN"
    "pT" "poorer" "repetitive microsatellite" "mucinous subtype"
    "microsatellite" "dMMR" "histology" "pTNM" "immunohistochemistry (IHC)"
    "IHC" "95% CI " "the metastatic pattern/" "factor-2α" "Shih"
    "adjacent bronchial epithelium" "Prudkin" "Multivariate"
    "histological subtype" "Ye" "fibroblastoid" "multivariate" "subtype"
    "phenocopy" "immunohischemistry" "Silber" "Barrett’s" "Barrett"
    "interdisciplinary oncology" "oncology" "pcDNA" "foud" "epithelium"
    "transducer" "re-expression" "Co-transfection" "6-week" "μg/mL" "TIGRA"
    "doxrobicin-" "doxrobicin" "MRN" "dsDNA" "undergoes" "PIKK" "Costanzo"
    "Ribose" "TIAGR" "epirubocin" "roscovotine" "Zhang" "μg/ml" "bisphosphate"
    "caner" "mitomycin" "transcatheter" "et " "phosphopentose" "ribose" "×
10"
    "heterozygotes" "11-kb" "a globally-prevalent HbF QTL" "6q24.3" "rs9402686"
    "rs9389269" "rs4895441" "clades" "rs9376090" "genotypes" "rs9483788" "QTL"
    "Yoruba" "rs9494145" "rs66650371" "and -2B" "enhancer" "QTLs" "HbS/β"
    "Tanzania" "Saharan" "Genomes" "indel" "clade" "haplotype" "haplotypes"
    "HMIP-2B" "HMIP-2A" "YRI" "HMIP-2" "HbSS"
    "HBS1L-MYB intergenic polymorphism" "Satoh" "48-hour" "ultrastructure"
    "imidazole" "N-nitrosobutyl" "dimethylbenz" "hydroxybutyl" "nitrosobutyl"
    "pyerene" "benzo" "toxicities" "nuclear factor (erythroid-derived 2)-like"
    "pathophysiology" "Wemmert" "PINXI" "breakpoints" "immunohistochemistry"
    "parotid" "Chandarlapaty" "interactome" "hotspots" "coevolve"
    "the evolutionary timeline" "timeline" "Chinnaiyan" "Robinson"
    "diethylstilbesterol" "apostructure" "helix" "protein A1B1" "S463P/D538G"
    "Israeli" "a subsequent biopsy" "Jeselsohn" "BOLERO-2" "5/44" "6/183"
    "naïve" "ClinicalTrials" "neoadjuvant"
    "80 triple-negative breast carcinoma transcriptomes" "transcriptomes"
    "Genome" "transcriptome" "Oncology" "Michigan" "ONCOSEQ" "coworkers"
    "Fuqua" "Mester" "letrazole" "anastazole" "degraders" "LBD" "ERE"
    "nonsmall" "a unilateral patient RB30" "UTRs" "200X" "Sureselect"
    "_1963del" "both pathogenic germline" "RB30" "MutationTaster" "HGMD" "RB12"
    "RB8" "RB32" "RB21" "Exons" "detected five heterozygous germline CNVs"
    "the Knudson’s" "Knudson" "RB9" "RB15" "RB14" "RB17" "RB4" "MaxEntScan"
    "RB24" "Miseq" "SureSelect" "Amplicon" "Truseq" "QMPCR" "frameshift"
    "13q14.2" "CNVs" "ExomeCNV" "insertions/deletions" "SNVs" "CD38−" "CD"
    "sialoglycoprotein" "LOC728724" "RITS" "PTGS" "immunocytochemistry" "RUNX"
    "3D1" "S4A" "S/G2/M" "FACS" "cells/ml" "AzdC" "THS2" "and 3D1" "32E3"
    "32H8" "22B11" "GeneEraser" "pGER" "polyA" "hAK015428" "THS1" "AK015428"
    "Genbank" "8q24" "Burkitt’s" "Burkitt" "MYLR" "KU" "pediatric AML genomes"
    "approximately 20 bp" "non-KD" "TGS" "promoter-associated CGIs" "genomes"
    "G0/G1 phase" "hypothesise" "Yang" "biopsy" "BeadChip" "Infinium" "IQR"
    "cg" "dataset" "MVR" "FFPE" "frozen" "replicate" "p " "Pre" "x" "pre" "IGM"
    "CGI" "the promoter region-associated CGIs" "CGIs" "emphasise"
    "heterogeneous tumour biopsies" "Illumina"
    "155 invasive ductal carcinoma biopsies" "neg" "pos" "TCGA" "biopsies"
    "oestrogen" "MVRs" "non-coding" "× 10" "= 6" "= 0.01" "= 3" "WZ"
    "cremaster" "phosphorylation/inhibition" "RhoA" "dyslipidemia" "FOPflash"
    "TOPflash" "inactivation/phosphorylation" "glycogen synthase kinase-3β"
    "MYPT" "ie" "HAECs" "platelet-endothelial cell adhesion molecule-1"
    "the arterial subendothelial intima" "intima" "adenylate" "× 10"
    "miR-34a/c" "-UTR" "matrigel-treated transwell" "transwell" "RefSeq" "NCBI"
    "UTR" "malignance" "p" "b" "co-transfected" "http://www"
    "other more important polymorphisms" "Arg280His" "280His" "399Glu/Glu"
    "Zeng" "Asians" "Africa" "Geng" "95% CI" "Arg399Gln" "datasets" "genome"
    "greater" "&b" "HA" "GA" "95%CI" "GG" "genotype" "written" "African"
    "Asian" "HWE" "XRCC1-Arg399Gln" "XRCC" "399Gln" "AP" "Codon"
    "The nonsynonymous Arg280His polymorphism" "adducts" "chromatid" "nonbulky"
    "UV" "Australia" "XRCC1-Arg280His polymorphism"
    "the XRCC1-Arg399Gln polymorphism" "homozygote" "STATA" "Egger’s" "Egger"
    "Medline" "3/7" "utilise" "a premature stop codon" "738-3539A" "polyA:T"
    "Leiden" ".225+2T" "rs140492671" "226-1086delTTGTCTGAAT" "2838-122G" "VI"
    "heterozygote" "rs45464800" "SAMtools" ".2625+367A" "rs200047376"
    "rs6597584" "rs2284902" "SNP" "rs36000704" "hypomelanotic macules"
    "macules" ".2545+591C" "chr16" "chr9" "and 3/5" "hypomelanotic macule"
    "macule" "InDels" "2 and 40 heterozygous SNPs" "InDel" "dbSNP132"
    "0 and 74 heterozygous SNPs" "SNPs" "basepair" "aligners" "Brouwer"
    "aligner" "NIMBUS" "BWA" "HaloPlex" "introns" "16p13.3" "Penetrance"
    "multicenter" "confounders" "5-aza-2" "1.13–2.61" "=0.01" "=2.49" "=0.06"
    "=1.90" "=5.47" "=8.55" "mucosa" "Tunisia" "Korea" "=2.55" "ORs"
    "reseveratrol" "C57 BL/6J" "Guarente" "sirtuin" "stressful" "eze"
    "11-weeks" "miceand" "11-week" "27-week" "μg protein" "C57BL/6J" "±0.8"
    "brighter" "±0.4" "=3" "Tert" "1.9±0.1" "1.6±0.1" "TaqMan"
    "at least one intron" "intron" "SIRT" "pCAGGS-NAMPT-H247E" "pCAGGS" "hr"
    "noRNA" "1.5±0.1" "1.5±0.3" "cntl" "NoRNA" "±0.5" "±0.3" "±0.2" "±0.1"
    "reveratrol" "Pixel" "Cntl" "pixel" "bp" "semi" "HMVEC" "lifespan"
    "deactylases" "Lansdorp" "-trihydroxystilbene" "trihydroxystilbene"
    "anti-aging" "polyphenol" "subset" "allo" "toxoid" "outs" "isotype"
    "peptide/Class II" "co-stimulatory" "co-cultures" "Toxoid"
    "anti-IgM/anti-IgG" "titers" "LCL" "lymphoblastoid" "Epstein" "pSyk" "Fc"
    "SIFT" "GoNL" "Dutch" "_001715.2" "IUIS" "bacteriaemia" "/L" "×10"
    "intravenous immunoglobulin" "immunoglobulin" "Meningococci" "Haemophilus"
    "Netherlands" "IgA" "plasmacytoid" "BCRs" "recirculate" "Caucasians" "LCLs"
    "L3P" "antigen" "exome" "Southeastern Brazil" "Brazil" "Gln775Ter"
    "PALB2:p" "BRCA1/BRCA2" "BRCA1/" "European" "codon" "polymorphism" "EVS"
    "dbSNP" "polymorphisms" "perhaps" "IARC" "missense" "breast/ovarian"
    "penetrant" "American" "LFL" "penetrance" "HBC/HBOC" "HBOC"
    "cases/families" "Targeted bidirectional Sanger" "Bidirectional Sanger"
    "probands" "exons" "Sanger" "Fraumeni" "Li" "Germline" "Canada" "Quebec"
    "Canadians" "French" "germline"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-15001-15300*
  '(("subcelluar β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("β-catenin/E-cadherin" . SPARSER::COLLECTION)
    ("LEF-1/TCF-4" . SPARSER::COLLECTION)
    ("the other currently available drugs" . SPARSER::DRUG)
    ("Azacitidine and Decitabine" . SPARSER::COLLECTION)
    ("Decitabine" . SPARSER::DRUG) ("Azacitidine" . SPARSER::DRUG)
    ("b-d" . SPARSER::PROTEIN-PAIR)
    ("C-myc and cyclinD1" . SPARSER::COLLECTION)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("c-myc and cyclinD1" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin, c-myc and cyclinD1" . SPARSER::COLLECTION)
    ("Demethylase" . SPARSER::PROTEIN)
    ("the possible involved pathway genes" . SPARSER::GENE)
    ("ART" . SPARSER::PROTEIN) ("Artesunate" . SPARSER::DRUG)
    ("TCF-4" . SPARSER::PROTEIN) ("T-cell factor-4" . SPARSER::PROTEIN)
    ("γ-catenin" . SPARSER::PROTEIN) ("SKM-1" . SPARSER::PROTEIN)
    ("BRG1 and hBRM" . SPARSER::COLLECTION) ("hSWI/SNF" . SPARSER::COLLECTION)
    ("hBRM" . SPARSER::PROTEIN) ("siRNA or inhibitor" . SPARSER::COLLECTION)
    ("FGFR3 or eIF4E" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("eIF4G, and ATP-dependent" . SPARSER::COLLECTION)
    ("PRMT3 and PRMT6" . SPARSER::COLLECTION)
    ("therapeutic reagents" . SPARSER::MOLECULE)
    ("Jumonji domain-containing protein (JMJD6) and peptidylarginine deiminases (PADIs)"
     . SPARSER::COLLECTION)
    ("AKT, ERK and mTOR" . SPARSER::COLLECTION)
    ("methyl-histone" . SPARSER::PROTEIN)
    ("alkaline phosphatase, creatinine, and creatine kinase"
     . SPARSER::COLLECTION)
    ("si-NC" . SPARSER::COLLECTION) ("PRMT7 and PRMT1" . SPARSER::COLLECTION)
    ("si-PRMT5" . SPARSER::COLLECTION)
    ("PRMT5 as well as type I enzymes" . SPARSER::COLLECTION)
    ("NATs" . SPARSER::PROTEIN) ("FHC" . SPARSER::PROTEIN)
    ("symmetric dimethylarginine" . SPARSER::DRUG)
    ("dimethylarginine (ADMA)" . SPARSER::DRUG) ("ADMA" . SPARSER::MOLECULE)
    ("dimethylarginine" . SPARSER::DRUG) ("AdoMet" . SPARSER::MOLECULE)
    ("eIF4E and FGFR3" . SPARSER::COLLECTION)
    ("FGFR3 and eIF4E" . SPARSER::COLLECTION)
    ("Arginine" . SPARSER::AMINO-ACID) ("CX-1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E binding protein 1"
     . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("7-methylguanosine" . SPARSER::MOLECULE)
    ("PRMT6" . SPARSER::PROTEIN) ("PRMT3" . SPARSER::PROTEIN)
    ("JMJD6" . SPARSER::PROTEIN) ("Jumonji domain" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("PRMT7" . SPARSER::PROTEIN)
    ("AIM-1" . SPARSER::PROTEIN) ("PRMT4" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S -adenosylmethionine" . SPARSER::DRUG) ("H4R" . SPARSER::PROTEIN)
    ("AMI-1" . SPARSER::PROTEIN) ("PRMT5" . SPARSER::PROTEIN)
    ("Ras/Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("Tiam1 or Pak1/2, or de-regulation" . SPARSER::COLLECTION)
    ("MCAK" . SPARSER::PROTEIN)
    ("the centrosomal signalling complex" . SPARSER::BIO-COMPLEX)
    ("GIT1-PIX" . SPARSER::COLLECTION) ("PIX" . SPARSER::PROTEIN)
    ("Tiam1-Rac" . SPARSER::COLLECTION)
    ("Pak1, Pak2 or Tiam1" . SPARSER::COLLECTION)
    ("α-tubulin-RFP" . SPARSER::COLLECTION)
    ("non-targeting (NT) or Pak1/2 siRNAs ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Tiam1 or Pak2" . SPARSER::COLLECTION)
    ("Pak1 ( xref ) and Pak2 ( xref )" . SPARSER::COLLECTION)
    ("–CFP" . SPARSER::COLLECTION) ("Pak2-CFP" . SPARSER::COLLECTION)
    ("CFP" . SPARSER::PROTEIN)
    ("either Pak1 ( xref ) or Pak2 ( xref )" . SPARSER::COLLECTION)
    ("both Pak2 ( xref ) and Pak1 ( xref )" . SPARSER::COLLECTION)
    ("re-expressing RNAi-resistant phospho-mutant Tiam1 or WT Tiam1 (see xref )"
     . SPARSER::COLLECTION)
    ("the centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("Tiam1 and P*Pak" . SPARSER::COLLECTION) ("sucrose" . SPARSER::MOLECULE)
    ("Pak1 or Pak2" . SPARSER::COLLECTION)
    ("Tiam1 and Rac" . SPARSER::COLLECTION)
    ("exogenous Tiam1" . SPARSER::PROTEIN)
    ("The phospho-mimetic Tiam1" . SPARSER::PROTEIN)
    ("a signal around mitotic asters" . SPARSER::BIO-COMPLEX)
    ("asters" . SPARSER::BIO-COMPLEX) ("only total Tiam1" . SPARSER::PROTEIN)
    ("a monopolar state" . SPARSER::BIO-STATE)
    ("cyclin B1 ( xref ) and cyclin" . SPARSER::COLLECTION)
    ("GFP-trap" . SPARSER::COLLECTION) ("Tiam1 (WT)" . SPARSER::PROTEIN)
    ("Tiam1-HA" . SPARSER::COLLECTION) ("Cdk1–cyclin" . SPARSER::COLLECTION)
    ("Cdk1–cyclin B1" . SPARSER::COLLECTION) ("Cdk/MAPK" . SPARSER::COLLECTION)
    ("Tiam1-GFP" . SPARSER::COLLECTION)
    ("the chief mitotic kinase Cdk1" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("Pak1-3" . SPARSER::COLLECTION)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("Cdk1 and Plk1" . SPARSER::COLLECTION) ("S-S/T-P" . SPARSER::COLLECTION)
    ("Cdk1-cyclin" . SPARSER::COLLECTION)
    ("mitotic centrosomes" . SPARSER::PROTEIN)
    ("the guanine-nucleotide exchange factor (GEF) Tiam1 and its substrate Rac"
     . SPARSER::COLLECTION)
    ("HSET" . SPARSER::PROTEIN) ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the plus-end-directed kinesin Eg5" . SPARSER::PROTEIN)
    ("Pak1 and Pak2" . SPARSER::COLLECTION) ("Paks" . SPARSER::PROTEIN-FAMILY)
    ("Tiam1 and its substrate Rac" . SPARSER::COLLECTION)
    ("SP8" . SPARSER::PROTEIN) ("FC 1" . SPARSER::PROTEIN)
    ("P-Thr" . SPARSER::PROTEIN) ("IB 1" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN) ("GIT1" . SPARSER::PROTEIN)
    ("NSC 23766" . SPARSER::DRUG) ("DH-PH" . SPARSER::PROTEIN)
    ("S/T" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("T-P" . SPARSER::PROTEIN) ("S-S" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("Nek2" . SPARSER::PROTEIN) ("Pak2" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("Kinesin-5" . SPARSER::PROTEIN)
    ("MAPT and MOBP" . SPARSER::COLLECTION)
    ("PP-2A and PP-1" . SPARSER::COLLECTION)
    ("tyrosine and threonine-directed dephosphorylation xref"
     . SPARSER::COLLECTION)
    ("SNARE" . SPARSER::PROTEIN)
    ("end-directed microtubule motor protein" . SPARSER::PROTEIN)
    ("RNA or lincRNA" . SPARSER::COLLECTION) ("genes—" . SPARSER::GENE)
    ("PSP and CBD" . SPARSER::COLLECTION)
    ("the largest possible cohort" . SPARSER::MOLECULE)
    ("Paris" . SPARSER::PROTEIN) ("RIN-RIN" . SPARSER::COLLECTION)
    ("disease-associated functional variants" . SPARSER::VARIANT)
    ("Genotypes" . SPARSER::PROTEIN) ("RNA, or lincRNA" . SPARSER::COLLECTION)
    ("KIF13B and DUSP4" . SPARSER::COLLECTION) ("lincRNA" . SPARSER::RNA)
    ("MOBP , EIF2AK3 , and STX6" . SPARSER::COLLECTION)
    ("the first principal component" . SPARSER::COMPONENT)
    ("Quad" . SPARSER::DRUG)
    ("STX6 , EIF2AK3 , and MOBP" . SPARSER::COLLECTION)
    ("CBD or PSP" . SPARSER::COLLECTION) ("levodopa" . SPARSER::DRUG)
    ("CBD and PSP" . SPARSER::COLLECTION)
    ("MAPT , and rs1768208/" . SPARSER::COLLECTION) ("MOBP" . SPARSER::PROTEIN)
    ("PSP" . SPARSER::PROTEIN) ("p22" . SPARSER::PROTEIN)
    ("CBD" . SPARSER::DRUG) ("cdc25" . SPARSER::PROTEIN)
    ("son of sevenless" . SPARSER::PROTEIN) ("PP-1" . SPARSER::PROTEIN)
    ("PP-2A" . SPARSER::PROTEIN)
    ("dual-specificity protein phosphatase" . SPARSER::PROTEIN)
    ("kinesin family member 13B" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("EIF2AK3" . SPARSER::PROTEIN) ("STX6" . SPARSER::PROTEIN)
    ("myelin-associated oligodendrocyte basic protein" . SPARSER::PROTEIN)
    ("KIF13B" . SPARSER::PROTEIN) ("glembatumumab" . SPARSER::DRUG)
    ("HER1/HER2" . SPARSER::COLLECTION) ("pertuzumab" . SPARSER::DRUG)
    ("IRF" . SPARSER::PROTEIN) ("ER and growth factors" . SPARSER::COLLECTION)
    ("endocrine or anti-HER2" . SPARSER::COLLECTION)
    ("GPNMB and GPNMB" . SPARSER::COLLECTION)
    ("the epithelial type and the stromal type" . SPARSER::COLLECTION)
    ("Luminal or DCIS" . SPARSER::COLLECTION)
    ("GPNMB (GPNMB-si1) and control-si" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("HER2 and/or EGFR (Fig. xref A)" . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("GPNMB and certain growth factors" . SPARSER::COLLECTION)
    ("GPNMB and growth factor" . SPARSER::COLLECTION)
    ("epirubicin and cyclophosphamide" . SPARSER::COLLECTION)
    ("DTX and Tra" . SPARSER::COLLECTION) ("DTX" . SPARSER::PROTEIN-FAMILY)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sera" . SPARSER::PROTEIN)
    ("apparent soluble GPNMB" . SPARSER::PROTEIN)
    ("ERα, HER2, and EGFR" . SPARSER::COLLECTION)
    ("disintegrin and metallopeptidase" . SPARSER::COLLECTION)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("dendritic cell-associated heparin sulfate proteoglycan-dependent integrin ligand"
     . SPARSER::MOLECULE)
    ("HG" . SPARSER::MOLECULE) ("proteoglycan" . SPARSER::PROTEIN)
    ("sulfate" . SPARSER::MOLECULE) ("ECD" . SPARSER::PROTEIN)
    ("GPNMB and HER2" . SPARSER::COLLECTION) ("GPNMB" . SPARSER::PROTEIN)
    ("Glycoprotein" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("phosphatase and TENsin homolog" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("1–4 " . SPARSER::PROTEIN) ("MK-2206" . SPARSER::MOLECULE)
    ("ER α" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("hematopoietic growth factor" . SPARSER::PROTEIN)
    ("a modest fraction" . SPARSER::COMPONENT)
    ("prooxidant" . SPARSER::MOLECULE)
    ("environmental oxidants" . SPARSER::MOLECULE)
    ("allele " . SPARSER::ALLELE) ("Genotype" . SPARSER::PROTEIN)
    ("Collar basic leucine zipper transcription factor family"
     . SPARSER::PROTEIN-FAMILY)
    ("NRF2 or NFE2L2" . SPARSER::COLLECTION)
    ("oxidant–antioxidant" . SPARSER::COLLECTION) ("Mach2" . SPARSER::DRUG)
    ("erythroid 2" . SPARSER::PROTEIN)
    ("Lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classic γ-secretase inhibitors" . SPARSER::INHIBITOR)
    ("GSAP and 5LO, caspase-3 and 5LO, and caspase-3 and GSAP"
     . SPARSER::COLLECTION)
    ("caspase-3 and GSAP" . SPARSER::COLLECTION)
    ("GSAP 16 kDa, active caspase-3 levels and activity, and Aβ levels"
     . SPARSER::COLLECTION)
    ("caspase-3 and GSAP 16 " . SPARSER::COLLECTION)
    ("cell permeable caspase-3 inhibitor" . SPARSER::INHIBITOR)
    ("GSAP and 5LO" . SPARSER::COLLECTION)
    ("GSAP and 12–15LO" . SPARSER::COLLECTION) ("zileuton" . SPARSER::DRUG)
    ("HETE" . SPARSER::MOLECULE)
    ("two other γ-secretase modulatory proteins" . SPARSER::PROTEIN)
    ("TMP21 and CD147" . SPARSER::COLLECTION)
    ("an attractive and viable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a larger precursor protein" . SPARSER::PROTEIN)
    ("the γ-secretase complex and its activator" . SPARSER::COLLECTION)
    ("activating protein (GSAP)" . SPARSER::PROTEIN)
    ("GSAP" . SPARSER::PROTEIN)
    ("gamma-secretase activating protein" . SPARSER::PROTEIN)
    ("GSAP16 " . SPARSER::PROTEIN-FAMILY) ("CD147" . SPARSER::PROTEIN)
    ("TMP21" . SPARSER::PROTEIN) ("GSAP-16 " . SPARSER::PROTEIN-FAMILY)
    ("GSAP 16 " . SPARSER::PROTEIN-FAMILY) ("amyloid-β" . SPARSER::MOLECULE)
    ("5-Lipoxygenase" . SPARSER::PROTEIN)
    ("possible therapeutic inhibitors" . SPARSER::INHIBITOR)
    ("PI3K-PKCζ" . SPARSER::COLLECTION)
    ("only p65 homodimers" . SPARSER::HOMODIMER)
    ("other HIV-1 proteins namely HIV-1 gp120" . SPARSER::DRUG)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("AP-1 and C/EBP" . SPARSER::COLLECTION)
    ("AP-1 and C/EBPα" . SPARSER::COLLECTION)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION)
    ("SB203580 or siRNA" . SPARSER::COLLECTION)
    ("NF-κB, p53, C/EBPβ, C/EBPα, C/EBPγ and AP-1" . SPARSER::COLLECTION)
    ("PI3K-PKCζ-NF-κB" . SPARSER::COLLECTION)
    ("LY294002 and PKCζ" . SPARSER::COLLECTION)
    ("PI3K and NF-κB" . SPARSER::COLLECTION) ("Ia" . SPARSER::MOLECULE)
    ("p65/p50 heterodimers or p50 homodimers" . SPARSER::COLLECTION)
    ("p65/p65" . SPARSER::COLLECTION)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("IKK and IκBα" . SPARSER::COLLECTION)
    ("human fetal astrocytes" . SPARSER::PROTEIN)
    ("the primary human fetal astrocytes" . SPARSER::PROTEIN)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("the Jun family or a heterodimer" . SPARSER::COLLECTION)
    ("a functional transcription factor" . SPARSER::PROTEIN)
    ("Fos and Jun" . SPARSER::COLLECTION)
    ("c-Fos and c-jun" . SPARSER::COLLECTION) ("AP-1 " . SPARSER::PROTEIN)
    ("C/EBPα, C/EBPγ and AP-1" . SPARSER::COLLECTION)
    ("p38α, p38β, p38γ and p38δ" . SPARSER::COLLECTION)
    ("mRNA (6 h post-transfection) and protein (48 h post-transfection)"
     . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("experiments LY294002 or the pseudopeptide" . SPARSER::COLLECTION)
    ("PKCδ, PKCθ and PKCζ" . SPARSER::COLLECTION)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("PI3K-PKC" . SPARSER::COLLECTION) ("IKK and NF-κB" . SPARSER::COLLECTION)
    ("IKK1 and IKK2" . SPARSER::COLLECTION) ("p-IKK" . SPARSER::COLLECTION)
    ("p-IκBα" . SPARSER::COLLECTION) ("IκBα and IKK1/2" . SPARSER::COLLECTION)
    ("IκBα and/or IKK" . SPARSER::COLLECTION)
    ("IKK2 (IKKβ) and IKKγ" . SPARSER::COLLECTION)
    ("three subunits IKK1 (IKKα), IKK2 (IKKβ) and IKKγ" . SPARSER::COLLECTION)
    ("IκBα and IKK" . SPARSER::COLLECTION)
    ("appropriate secondary antibodies" . SPARSER::ANTIBODY)
    ("IL-6/IL-8" . SPARSER::COLLECTION)
    ("human fetal astrocytes (HFA)" . SPARSER::PROTEIN)
    ("primary human fetal astrocytes (HFA)" . SPARSER::PROTEIN)
    ("HFA" . SPARSER::MOLECULE) ("IL-6 and/or IL-8" . SPARSER::COLLECTION)
    ("PI3K-Akt/PKC" . SPARSER::COLLECTION)
    ("its viral proteins" . SPARSER::PROTEIN) ("CA1" . SPARSER::PROTEIN)
    ("IL-8/CXCL8" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("a 26-kDa proinflammatory cytokine" . SPARSER::PROTEIN)
    ("CCL2, IL-6, TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("a multifunctional viral accessory protein" . SPARSER::PROTEIN)
    ("a recent study human fetal astrocytes" . SPARSER::PROTEIN)
    ("Astrocytes" . SPARSER::PROTEIN)
    ("arachidonic acid metabolites" . SPARSER::MOLECULE)
    ("toxic mediators" . SPARSER::PROTEIN)
    ("These viral proteins" . SPARSER::PROTEIN)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN) ("PI3K/PKC" . SPARSER::COLLECTION)
    ("PI3K/Akt/PKC" . SPARSER::COLLECTION)
    ("HIV-1 Nef-transfected SVGA astrocytes and HIV-1 Nef-treated primary fetal astrocytes"
     . SPARSER::PROTEIN)
    ("IL-6 and IL-8" . SPARSER::COLLECTION) ("CSF" . SPARSER::PROTEIN)
    ("HIV-1 viral proteins" . SPARSER::PROTEIN) ("Variety" . SPARSER::VARIETY)
    ("HD2" . SPARSER::PROTEIN) ("p38 α" . SPARSER::PROTEIN)
    ("Hypoxanthine-guanine phosphoribosyl-transferase" . SPARSER::PROTEIN)
    ("Bay11-7082" . SPARSER::DRUG) ("IKK 2" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("IP-10" . SPARSER::PROTEIN)
    ("p38δ" . SPARSER::PROTEIN) ("p38γ" . SPARSER::PROTEIN)
    ("BAY11-7082" . SPARSER::DRUG) ("BAY11–7082" . SPARSER::DRUG)
    ("SC-514" . SPARSER::PROTEIN) ("IKK-2" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("genotype and ins/del" . SPARSER::COLLECTION)
    ("IL-6, IL-10, and IL-12" . SPARSER::COLLECTION)
    ("IL-10 and IL-12" . SPARSER::COLLECTION) ("tocilizumab" . SPARSER::DRUG)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("a pleiotropic glycoprotein cytokine" . SPARSER::PROTEIN)
    ("ins/ins/GG combined genotype" . SPARSER::PROTEIN)
    ("P65/p50" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF and IL-1β" . SPARSER::COLLECTION)
    ("TNF and IL-12" . SPARSER::COLLECTION)
    ("glucose, TG, TC, HDL, and LDL" . SPARSER::COLLECTION)
    ("ins/del genotype and ins/ins genotype (3.51 ± 0.91 pg/ml vs. 3.24 ± 0.78 pg/ml, P = 0.021, 3.51 ± 0.91 pg/ml vs. 3.02 ± 0.81 pg/ml, P < 0.001, respectively)"
     . SPARSER::COLLECTION)
    ("genotypes and IL-6" . SPARSER::COLLECTION)
    ("SAP and ACS" . SPARSER::COLLECTION)
    ("Allele and genotype frequencies" . SPARSER::COLLECTION)
    ("had lower HDL and higher BMI" . SPARSER::COLLECTION)
    ("glucose, and P" . SPARSER::COLLECTION) ("HDL" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("three differential genotypes" . SPARSER::PROTEIN)
    ("p50/p50" . SPARSER::COLLECTION) ("p50 and p105" . SPARSER::COLLECTION)
    ("p50/p105" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("acute phase proteins" . SPARSER::PROTEIN)
    ("genotypes ( P = 0.001) and alleles ( P = 0.001)" . SPARSER::COLLECTION)
    ("SAP" . SPARSER::PROTEIN) ("IL-6 receptor" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("High density lipoprotein" . SPARSER::PROTEIN)
    ("Low density lipoprotein" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG) ("Interleukin-6" . SPARSER::PROTEIN)
    ("I κ Bα" . SPARSER::PROTEIN) ("I κ B" . SPARSER::PROTEIN)
    ("NF- κ B2" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN)
    ("STARD3, GRB7, PSMD3 and PERLD1" . SPARSER::COLLECTION)
    ("trastuzumab, T-DM1 and lapatinib" . SPARSER::COLLECTION)
    ("a prototypic biomarker" . SPARSER::MOLECULE)
    ("Lapatinib" . SPARSER::DRUG)
    ("trastuzumab and T-DM1" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("PDXs" . SPARSER::PROTEIN)
    ("-Colchicine" . SPARSER::DRUG)
    ("amplified Myc [ xref ] or dihydrofolate reductase [ xref ]"
     . SPARSER::COLLECTION)
    ("vIII" . SPARSER::PROTEIN) ("EGFR-vIII" . SPARSER::COLLECTION)
    ("emtansine" . SPARSER::DRUG)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PERLD1" . SPARSER::PROTEIN) ("PSMD3" . SPARSER::PROTEIN)
    ("GRB7" . SPARSER::PROTEIN) ("STARD3" . SPARSER::PROTEIN)
    ("T-DM1" . SPARSER::PROTEIN) ("Sprouty and Spreds" . SPARSER::COLLECTION)
    ("the Sprouty and Sprouty-related negative regulators"
     . SPARSER::COLLECTION)
    ("a classic example" . SPARSER::EXAMPLE)
    ("sprouty" . SPARSER::PROTEIN-FAMILY)
    ("Spry1 or Spry2" . SPARSER::COLLECTION)
    ("both Spry1  −/− (14%; P < 0.0001) and Spry1  −/− (25%; P < 0.0001)"
     . SPARSER::COLLECTION)
    ("normal acini" . SPARSER::PROTEIN)
    ("Spry1 and Spry2" . SPARSER::COLLECTION)
    ("Spry 1 or Spry 2" . SPARSER::COLLECTION)
    ("SPRY1 and SPRY2" . SPARSER::COLLECTION) ("cRaf" . SPARSER::PROTEIN)
    ("Spred" . SPARSER::PROTEIN-FAMILY) ("Spreds" . SPARSER::PROTEIN-FAMILY)
    ("Each Spry protein" . SPARSER::PROTEIN)
    ("Spry1 and Spry4" . SPARSER::COLLECTION)
    ("MAPK/ERK1/2" . SPARSER::COLLECTION) ("SPREDs" . SPARSER::PROTEIN-FAMILY)
    ("Spry1- or Spry2-" . SPARSER::COLLECTION) ("Spry2-" . SPARSER::PROTEIN)
    ("Spry1-" . SPARSER::PROTEIN) ("SPRY and SPRED" . SPARSER::COLLECTION)
    ("Sprouty (SPRY) and Sprouty-related (SPRED) antagonists"
     . SPARSER::COLLECTION)
    ("SPRED" . SPARSER::PROTEIN-FAMILY) ("SPRY" . SPARSER::PROTEIN)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY) ("SPRY 2" . SPARSER::PROTEIN)
    ("NF κ B" . SPARSER::PROTEIN) ("SPRED2" . SPARSER::PROTEIN)
    ("Spry 2" . SPARSER::PROTEIN) ("Spry 1" . SPARSER::PROTEIN)
    ("SPRY1" . SPARSER::PROTEIN) ("SPRED1" . SPARSER::PROTEIN)
    ("SPRY2" . SPARSER::PROTEIN) ("Spry4" . SPARSER::PROTEIN)
    ("Spry2" . SPARSER::PROTEIN) ("Spry1" . SPARSER::PROTEIN)
    ("cetuximab and erlotinib" . SPARSER::COLLECTION)
    ("The client protein" . SPARSER::PROTEIN)
    ("Akt, EGFR, and IGF1R" . SPARSER::COLLECTION)
    ("Ras-MEK-ERK" . SPARSER::COLLECTION)
    ("CDK4/Survivin" . SPARSER::COLLECTION) ("Survivin" . SPARSER::PROTEIN)
    ("IGF1-Akt" . SPARSER::COLLECTION)
    ("ERK inhibitor U0126 and PI-3 kinase/Akt inhibitor LY294002"
     . SPARSER::COLLECTION)
    ("PI-3 kinase/Akt" . SPARSER::COLLECTION) ("p-IGF1R" . SPARSER::COLLECTION)
    ("IGF1R-ERK" . SPARSER::COLLECTION) ("p-EGFR" . SPARSER::COLLECTION)
    ("total EGFR, p-Akt, and p-ERK in SCC-4 cells" . SPARSER::COLLECTION)
    ("SCC-4 and HSC-4" . SPARSER::COLLECTION) ("SCC-4" . SPARSER::PROTEIN)
    ("kinase-Ulk1" . SPARSER::COLLECTION) ("ceramide" . SPARSER::MOLECULE)
    ("protein (HSP)" . SPARSER::PROTEIN)
    ("survivin and cyclin-dependent kinase 4" . SPARSER::COLLECTION)
    ("IGF1R-Akt" . SPARSER::COLLECTION) ("EGFR-Akt" . SPARSER::COLLECTION)
    ("a ubiquitously expressed transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("IGF1R, Akt, and extracellular signal-regulated kinase1/2"
     . SPARSER::COLLECTION)
    ("deguelin" . SPARSER::DRUG) ("rotenoid" . SPARSER::MOLECULE)
    ("Deguelin" . SPARSER::DRUG) ("HSP 90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-3 kinase" . SPARSER::PROTEIN) ("HSC-4" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Ulk1" . SPARSER::PROTEIN) ("IGF-1-" . SPARSER::PROTEIN)
    ("drug and p53" . SPARSER::COLLECTION)
    ("2 mutated p53 and 2 wild-type p53 molecules" . SPARSER::MOLECULE)
    ("the vehicle-treated subline" . SPARSER::PROTEIN)
    ("highly efficacious MDM2 inhibitor" . SPARSER::INHIBITOR)
    ("wild-type p53 and an amplified MDM2 gene" . SPARSER::COLLECTION)
    ("a dimer and two C176F p53 mutant monomers form another dimer"
     . SPARSER::COLLECTION)
    ("a wild-type p53 monomer molecule and a C176F p53 mutant monomer form"
     . SPARSER::COLLECTION)
    ("respective monomers" . SPARSER::MONOMER)
    ("p53, MDM2 and p21 proteins" . SPARSER::COLLECTION)
    ("p53, p21 and MDM2" . SPARSER::COLLECTION)
    ("the vehicle-treated 7.2 subline" . SPARSER::PROTEIN)
    ("p21, MDM2 and p53" . SPARSER::COLLECTION)
    ("approximately 100 mm 3" . SPARSER::PROTEIN)
    ("MDM2, p21 and p53" . SPARSER::COLLECTION)
    ("acute leukemia RS4" . SPARSER::PROTEIN) ("MV" . SPARSER::PROTEIN)
    ("an effective cellular antagonist" . SPARSER::MOLECULE)
    ("DNAs" . SPARSER::DNA) ("mRNA and MDM2 protein" . SPARSER::COLLECTION)
    ("sulphur" . SPARSER::MOLECULE) ("cation" . SPARSER::MOLECULE)
    ("p53 or p53" . SPARSER::COLLECTION) ("MIR2" . SPARSER::PROTEIN)
    ("SAR405838" . SPARSER::DRUG)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("a putative tumour-associated antigen" . SPARSER::PROTEIN)
    ("at least 12 other downstream proteins" . SPARSER::PROTEIN)
    ("at least one STK11 allele" . SPARSER::ALLELE)
    ("Stk11" . SPARSER::PROTEIN) ("STK11 or PRKAA1" . SPARSER::COLLECTION)
    ("PRKAA1 or STK11" . SPARSER::COLLECTION)
    ("STK11 and PRKAA1" . SPARSER::COLLECTION)
    ("PRKAA1 (AMPKα1) and STK11 (LKB1)" . SPARSER::COLLECTION)
    ("AICAR-" . SPARSER::PROTEIN) ("Hey" . SPARSER::PROTEIN-FAMILY)
    ("AICAR and A-769662" . SPARSER::COLLECTION)
    ("AMP mimetic AICAR" . SPARSER::PROTEIN) ("p-AMPK α" . SPARSER::COLLECTION)
    ("p-LKB1" . SPARSER::COLLECTION) ("p-AMPKα" . SPARSER::COLLECTION)
    ("STK11 (LKB1) and PRKAA1 (AMPKα1)" . SPARSER::COLLECTION)
    ("LKB1 and AMPKα" . SPARSER::COLLECTION)
    ("LKB1 and AMPK" . SPARSER::COLLECTION) ("ATP:ADP" . SPARSER::BIO-COMPLEX)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("the AMP mimetic AICAR or allosteric AMPK activator A-769662"
     . SPARSER::COLLECTION)
    ("the AMP mimetic AICAR" . SPARSER::PROTEIN)
    ("AMPK and its upstream kinase LKB1" . SPARSER::COLLECTION)
    ("-AMP-activated" . SPARSER::COLLECTION) ("NaB 4" . SPARSER::PROTEIN)
    ("Hema-3" . SPARSER::PROTEIN) ("SIK3" . SPARSER::PROTEIN)
    ("SIK2" . SPARSER::PROTEIN) ("salt inducible kinase 2" . SPARSER::PROTEIN)
    ("PRKAA2" . SPARSER::PROTEIN) ("AMPK α" . SPARSER::PROTEIN-FAMILY)
    ("PRKAA1" . SPARSER::PROTEIN) ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("A-769662" . SPARSER::DRUG) ("fish" . SPARSER::PROTEIN)
    ("PAK4 instead of PAK1/2" . SPARSER::COLLECTION)
    ("the Cdc42 target Par6 and atypical PKCζ [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("atypical PKCζ" . SPARSER::PROTEIN) ("acto-myosin" . SPARSER::COLLECTION)
    ("other junctional effectors" . SPARSER::EFFECTOR)
    ("N-WASP and Par6" . SPARSER::COLLECTION)
    ("Cdc42 and MRCK" . SPARSER::COLLECTION)
    ("APC and Dlg1" . SPARSER::COLLECTION) ("Dlg1" . SPARSER::PROTEIN)
    ("Dlg" . SPARSER::PROTEIN) ("Par6/PKCζ" . SPARSER::COLLECTION)
    ("Gab1 and DGCR6L" . SPARSER::COLLECTION) ("Par6b" . SPARSER::PROTEIN)
    ("Par3/Par6/aPKC" . SPARSER::COLLECTION) ("aPKC" . SPARSER::PROTEIN)
    ("zonula" . SPARSER::PROTEIN) ("RhoGEFs" . SPARSER::PROTEIN)
    ("junctional proteins" . SPARSER::PROTEIN)
    ("Akt and PKA" . SPARSER::COLLECTION)
    ("IQGAP1 and N-WASP" . SPARSER::COLLECTION)
    ("Par3/Par6/PKCζ" . SPARSER::COLLECTION)
    ("a role alongside other established Cdc42 polarity effectors"
     . SPARSER::EFFECTOR)
    ("Par6 and MRCK" . SPARSER::COLLECTION)
    ("PAK5 and PAK6" . SPARSER::COLLECTION)
    ("neither PAK4 siRNA nor PF-3758309" . SPARSER::COLLECTION)
    ("MRCK" . SPARSER::PROTEIN) ("Par6-PKCζ" . SPARSER::COLLECTION)
    ("Par3, Par6 and PKCζ" . SPARSER::COLLECTION) ("Par3" . SPARSER::PROTEIN)
    ("CRIB and auto-inhibitory domains [ xref ]" . SPARSER::COLLECTION)
    ("both the N-terminal fragments PAK4(1–270) and PAK4(1–64)"
     . SPARSER::COLLECTION)
    ("RFP-centrin" . SPARSER::COLLECTION) ("centrin" . SPARSER::PROTEIN)
    ("EGTA" . SPARSER::MOLECULE) ("F-actin or myosin" . SPARSER::COLLECTION)
    ("Cdc42 or Rac1" . SPARSER::COLLECTION) ("GFP-PAK4" . SPARSER::COLLECTION)
    ("PAK4 or Cdc42" . SPARSER::COLLECTION)
    ("Cdc42 or PAK4" . SPARSER::COLLECTION)
    ("PAK4 and Par6" . SPARSER::COLLECTION)
    ("the group I and group II PAKs" . SPARSER::COLLECTION)
    ("LIMK1, Bad and stathmin" . SPARSER::COLLECTION)
    ("stathmin" . SPARSER::PROTEIN) ("whose effectors" . SPARSER::EFFECTOR)
    ("N-WASP, CIP4, IRSp53, TOCA, PAK1 and PAK4" . SPARSER::COLLECTION)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("CRIB" . SPARSER::DRUG)
    ("PAK5-" . SPARSER::PROTEIN)
    ("a ubiquitously expressed essential kinase" . SPARSER::KINASE)
    ("The group II PAKs" . SPARSER::PROTEIN-FAMILY)
    ("the group II PAKs" . SPARSER::PROTEIN-FAMILY)
    ("PAK1-3" . SPARSER::COLLECTION)
    ("a conserved cell-cell junctional polarity Cdc42 complex"
     . SPARSER::BIO-COMPLEX)
    ("DGCR6L" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("IQGAP1" . SPARSER::PROTEIN)
    ("GF109203X" . SPARSER::DRUG) ("4-1" . SPARSER::PROTEIN)
    ("GM-130" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRSp53" . SPARSER::PROTEIN) ("CIP4" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("PAK6" . SPARSER::PROTEIN)
    ("PAK5" . SPARSER::PROTEIN) ("PF-3758309" . SPARSER::DRUG)
    ("this short-sized AMP" . SPARSER::AMP)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("significantly less cytotoxic" . SPARSER::PROTEIN)
    ("cathelicidins" . SPARSER::PROTEIN-FAMILY)
    ("classical mammalian AMPs" . SPARSER::AMP)
    ("bivalent cations" . SPARSER::MOLECULE)
    ("immunomodulators" . SPARSER::DRUG)
    ("hBD-2 and LL-37" . SPARSER::COLLECTION) ("cations" . SPARSER::MOLECULE)
    ("frog skin-derived AMPs" . SPARSER::AMP) ("erbB4" . SPARSER::PROTEIN)
    ("other frog skin-derived peptides" . SPARSER::PEPTIDE)
    ("the prototypic human skin AMP" . SPARSER::AMP)
    ("amphibian skin AMPs" . SPARSER::AMP)
    ("AMP and cell" . SPARSER::COLLECTION) ("rhodamine" . SPARSER::PROTEIN)
    ("approximately a 20" . SPARSER::PROTEIN)
    ("the epidermal growth factor receptor (EGFR) and STAT3 protein"
     . SPARSER::COLLECTION)
    ("the anionic phospholipids" . SPARSER::PHOSPHOLIPID)
    ("cationic peptides" . SPARSER::PEPTIDE) ("Rana" . SPARSER::PROTEIN)
    ("neuropeptides and AMPs" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("frog skin-derived peptides" . SPARSER::PEPTIDE)
    ("hBD2 and hBD3" . SPARSER::COLLECTION) ("defensins" . SPARSER::PROTEIN)
    ("Gene-encoded antimicrobial peptides" . SPARSER::PEPTIDE)
    ("fungi" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor and STAT3" . SPARSER::COLLECTION)
    ("cathelicidin" . SPARSER::PROTEIN-FAMILY)
    ("Antimicrobial peptides" . SPARSER::PEPTIDE) ("AMPs" . SPARSER::AMP)
    ("hBD-2" . SPARSER::PROTEIN) ("FPRL-1" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("STAT-3" . SPARSER::PROTEIN) ("hBD3" . SPARSER::PROTEIN)
    ("hBD2" . SPARSER::PROTEIN) ("LL-37" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("TGF-β1 and TGF-βRI" . SPARSER::COLLECTION)
    ("genotypes and alleles" . SPARSER::COLLECTION)
    ("Smad3 (rs12901499A/G and rs6494629T/C) and TIMP3 (rs1962223G/C) polymorphisms"
     . SPARSER::COLLECTION)
    ("genotype or allele" . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("TGF-β, TGF-βRI, Smad3 and TIMP3 allele and genotype frequencies"
     . SPARSER::COLLECTION)
    ("TGF-β, TGF-βRI, Smad3 and TIMP3" . SPARSER::COLLECTION)
    ("TGF-β/Smad3" . SPARSER::COLLECTION)
    ("TGF-β1, TGF-βRI, Smad3 and TIMP3" . SPARSER::COLLECTION)
    ("ASPN and GDF5" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN) ("asporin" . SPARSER::PROTEIN)
    ("ASPN" . SPARSER::PROTEIN)
    ("Smad3 and tissue inhibitor" . SPARSER::COLLECTION)
    ("RI" . SPARSER::MOLECULE)
    ("Transforming growth factor/Smad" . SPARSER::COLLECTION)
    ("K-L" . SPARSER::PROTEIN) ("K–L" . SPARSER::PROTEIN)
    ("ADAMTS-4" . SPARSER::PROTEIN)
    ("a disintegrin and metalloproteinase with thrombospondin motifs 4"
     . SPARSER::PROTEIN)
    ("growth differentiation factor 5" . SPARSER::PROTEIN)
    ("GDF5" . SPARSER::PROTEIN) ("metalloproteinases 3" . SPARSER::PROTEIN)
    ("family member 3" . SPARSER::PROTEIN)
    ("all other combinative genotypes" . SPARSER::PROTEIN)
    ("these 2 combinative genotypes" . SPARSER::PROTEIN)
    ("all combinative genotypes" . SPARSER::PROTEIN)
    ("many inflammatory-related cytokines" . SPARSER::PROTEIN)
    ("The p50 (NF-κB1) and IκBα proteins" . SPARSER::COLLECTION)
    ("NFKB19-4 ATTG ins/del + NFKBIA mutant combinative genotypes"
     . SPARSER::PROTEIN)
    ("ins/ins" . SPARSER::COLLECTION)
    ("genotype and del/del" . SPARSER::COLLECTION)
    ("genotype" . SPARSER::PROTEIN)
    ("many pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TGF-β, TNF-α, IL-6, and IL-8" . SPARSER::COLLECTION)
    ("inducible nitric oxide synthase (iNOS) and cyclooxygenase-2"
     . SPARSER::COLLECTION)
    ("p50 (NF-κB1) and its critical inhibitor" . SPARSER::COLLECTION)
    ("the polymorphic genotypes" . SPARSER::PROTEIN)
    ("NFKB1 and NFKBIA" . SPARSER::COLLECTION) ("genotypes" . SPARSER::PROTEIN)
    ("exogenous nucleotides" . SPARSER::NUCLEOTIDE)
    ("nucleotide metabolism genes, proliferation and invasion"
     . SPARSER::COLLECTION)
    ("EGFR, CCNA, CDK1, CDC25C, MYC, and PCNA" . SPARSER::COLLECTION)
    ("CCNA" . SPARSER::PROTEIN) ("disable p73" . SPARSER::PROTEIN)
    ("RRM2, p53R2 and TYMS" . SPARSER::COLLECTION)
    ("GMPS and dCK" . SPARSER::COLLECTION)
    ("GMP biosynthetic enzymes" . SPARSER::ENZYME)
    ("RFS and DMFS" . SPARSER::COLLECTION)
    ("RRM2 and GMPS" . SPARSER::COLLECTION)
    ("a significantly poorer RFS and unfavorable DMFS" . SPARSER::COLLECTION)
    ("a significantly poorer RFS" . SPARSER::PROTEIN)
    ("exogenous nucleosides" . SPARSER::MOLECULE)
    ("nucleosides" . SPARSER::MOLECULE) ("CDP" . SPARSER::PROTEIN)
    ("dCDP" . SPARSER::DCDP)
    ("DHFR, TYMS, DTYMK and TK1" . SPARSER::COLLECTION)
    ("proper dNTP" . SPARSER::MOLECULE)
    ("lymphoid and erythroid" . SPARSER::COLLECTION)
    ("p53 or ETS2" . SPARSER::COLLECTION) ("dCK or p53" . SPARSER::COLLECTION)
    ("cisplatin and doxorubicin" . SPARSER::COLLECTION)
    ("MDAMD" . SPARSER::DRUG) ("prodrug" . SPARSER::DRUG)
    ("GMPS and AVN-944" . SPARSER::COLLECTION)
    ("IMPDH1 and IMPDH2" . SPARSER::COLLECTION)
    ("Exogenous guanosine" . SPARSER::MOLECULE)
    ("RRM1 and RRM2" . SPARSER::COLLECTION)
    ("DTYMK and GMPS" . SPARSER::COLLECTION) ("DTYMK" . SPARSER::PROTEIN)
    ("its highly metastatic derivatives MDAMB231-BrM (231:BrM) and MDAMB231-BoM (231-BoM) xref"
     . SPARSER::COLLECTION)
    ("BrM" . SPARSER::PROTEIN)
    ("GTPases, Rac1 and cdc42" . SPARSER::COLLECTION)
    ("Rho, Rac and cdc42" . SPARSER::COLLECTION)
    ("active (GTP bound) and inactive (GDP bound)" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION)
    ("dATP and dTTP levels" . SPARSER::COLLECTION) ("dCTP" . SPARSER::MOLECULE)
    ("dGTP" . SPARSER::DGTP) ("dCK, TK1, and DHFR" . SPARSER::COLLECTION)
    ("RRM2 and TYMS" . SPARSER::COLLECTION) ("TYMS" . SPARSER::PROTEIN)
    ("DHFR" . SPARSER::PROTEIN) ("dTTP" . SPARSER::MOLECULE)
    ("purine and pyrimidine" . SPARSER::COLLECTION) ("purine" . SPARSER::DRUG)
    ("p53 and ETS2" . SPARSER::COLLECTION)
    ("p53, ETS1 or ETS2" . SPARSER::COLLECTION) ("RRM2b" . SPARSER::PROTEIN)
    ("GMPS" . SPARSER::PROTEIN) ("GMPR" . SPARSER::PROTEIN)
    ("both oncogenes (e.g. myc) and tumor suppressor genes (e.g. pRb) xref"
     . SPARSER::COLLECTION)
    ("dCK" . SPARSER::PROTEIN) ("nucleoside" . SPARSER::MOLECULE)
    ("exogenous guanosine or GTP" . SPARSER::COLLECTION)
    ("guanosine or GTP" . SPARSER::COLLECTION) ("NMG" . SPARSER::GENE)
    ("genes (NMG)" . SPARSER::GENE)
    ("nucleoside diphosphate kinase" . SPARSER::PROTEIN)
    ("myc protein" . SPARSER::PROTEIN) ("MMP13" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("γ−H2AX" . SPARSER::PROTEIN)
    ("IMPDH2" . SPARSER::PROTEIN) ("IMPDH1" . SPARSER::PROTEIN)
    ("TK1" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("guanosine monophosphate reductase" . SPARSER::PROTEIN)
    ("deoxycytidine kinase" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("P/CAF, or KAT2B" . SPARSER::COLLECTION)
    ("Pol III promoter" . SPARSER::PROMOTER) ("MAF1/Pol" . SPARSER::COLLECTION)
    ("CDKN1A , GDF15 and TAF5" . SPARSER::COLLECTION)
    ("MAF1 (#1, the original one) and POLR3A (#1, the original one)"
     . SPARSER::COLLECTION)
    ("MAF1 and POLR3A" . SPARSER::COLLECTION)
    ("TBP and RBP5" . SPARSER::COLLECTION)
    ("active promoters" . SPARSER::PROMOTER)
    ("p53 instead of MAF1" . SPARSER::COLLECTION)
    ("bringing p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exactly MAF1 and POLIII" . SPARSER::COLLECTION)
    ("MAF1 and POLIII" . SPARSER::COLLECTION) ("POLIII" . SPARSER::PROTEIN)
    ("CDKN1A and Chromatin" . SPARSER::COLLECTION)
    ("CDKN1A (and for GDF15 , where the up-regulation is larger) and perhaps"
     . SPARSER::COLLECTION)
    ("immuno" . SPARSER::PROTEIN) ("protein and RNA" . SPARSER::COLLECTION)
    ("Pol III-mediated promoter" . SPARSER::PROMOTER)
    ("‘promoters’" . SPARSER::PROMOTER)
    ("an isogenic system -/+ p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inducible neuronal genes" . SPARSER::GENE)
    ("TFIIB and TFIIIB" . SPARSER::COLLECTION)
    ("TBP/TFIIB" . SPARSER::COLLECTION)
    ("this active promoter" . SPARSER::PROMOTER)
    ("TFIIIB and TFIIB" . SPARSER::COLLECTION)
    ("GTF2B, and Pol" . SPARSER::COLLECTION)
    ("a Pol II promoter" . SPARSER::PROMOTER)
    ("The core Pol III transcription factor TFIIIC" . SPARSER::PROTEIN)
    ("TFIIIC" . SPARSER::PROTEIN) ("TFIIS" . SPARSER::PROTEIN)
    ("active Pol III-transcribed genes" . SPARSER::GENE)
    ("Active Pol III-transcribed genes" . SPARSER::GENE)
    ("general Pol II genes" . SPARSER::GENE) ("neuronal genes" . SPARSER::GENE)
    ("TBP and POLR2E" . SPARSER::COLLECTION)
    ("some Pol II genes" . SPARSER::GENE)
    ("type II Pol III promoters" . SPARSER::PROMOTER)
    ("the type II internal Pol III promoter" . SPARSER::PROMOTER)
    ("CDKN1A and GDF15" . SPARSER::COLLECTION)
    ("CDKN1A , GDF15 , and TAF5" . SPARSER::COLLECTION)
    ("the Pol II gene" . SPARSER::GENE) ("MAF1- and Pol" . SPARSER::COLLECTION)
    ("MAF1-" . SPARSER::PROTEIN) ("other Pol II genes" . SPARSER::GENE)
    ("MAF1 and TBP" . SPARSER::COLLECTION)
    ("p300 and PCAF" . SPARSER::COLLECTION)
    ("CFP1 (SET1C-specific subunit) and p300" . SPARSER::COLLECTION)
    ("SET1/MLL" . SPARSER::COLLECTION)
    ("the Pol III-transcribed RPPH1 promoter" . SPARSER::PROMOTER)
    ("anti-Pol III antibody" . SPARSER::PROTEIN)
    ("the Pol III antibody" . SPARSER::PROTEIN)
    ("IgG or no antibody ( xref )" . SPARSER::COLLECTION)
    ("anti-Pol II antibody" . SPARSER::PROTEIN)
    ("the Pol III promoter" . SPARSER::PROMOTER)
    ("MAF1 and BRF1" . SPARSER::COLLECTION)
    ("Pol III polymerases" . SPARSER::PROTEIN)
    ("MAF1 or Pol" . SPARSER::COLLECTION)
    ("Arg and pretRNA" . SPARSER::COLLECTION)
    ("ACTB and TAF5" . SPARSER::COLLECTION)
    ("two Pol III genes" . SPARSER::GENE)
    ("GAPDH , ACTB , and TAF5" . SPARSER::COLLECTION)
    ("Tyr and pretRNA" . SPARSER::COLLECTION)
    ("124 Pol II-transcribed genes" . SPARSER::GENE)
    ("Pol II-transcribed genes" . SPARSER::GENE)
    ("both promoter looping and activation of CDKN1A transcription"
     . SPARSER::COLLECTION)
    ("TBP, p300, CFP1, and PCAF" . SPARSER::COLLECTION)
    ("the Cip and Kip family" . SPARSER::COLLECTION)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("Pol II genes" . SPARSER::GENE) ("Pol III genes" . SPARSER::GENE)
    ("Pol III-transcribed genes" . SPARSER::GENE)
    ("Pol III promoters" . SPARSER::PROMOTER)
    ("possibly other genes" . SPARSER::GENE)
    ("BRF1 and several other proteins" . SPARSER::COLLECTION)
    ("one RNA polymerase—called Pol III—makes RNA" . SPARSER::RNA)
    ("MAF1 and Pol" . SPARSER::COLLECTION)
    ("TATA binding protein (TBP) and POLR2E" . SPARSER::COLLECTION)
    ("protein (TBP)" . SPARSER::PROTEIN)
    ("CFP1, p300, and PCAF" . SPARSER::COLLECTION)
    ("TFIIIB and Pol" . SPARSER::COLLECTION) ("KAT2B" . SPARSER::PROTEIN)
    ("P/CAF" . SPARSER::PROTEIN)
    ("lysine acetyltransferase 2B" . SPARSER::PROTEIN)
    ("Ex1" . SPARSER::PROTEIN) ("RBP5" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("NAHCO 3" . SPARSER::DRUG)
    ("Protein +" . SPARSER::PROTEIN) ("POLR3A" . SPARSER::PROTEIN)
    ("negative regulator of transcription" . SPARSER::PROTEIN)
    ("GTF2B" . SPARSER::PROTEIN) ("BRF2" . SPARSER::PROTEIN)
    ("Histone H3K" . SPARSER::PROTEIN) ("B-box" . SPARSER::PROTEIN)
    ("RPB5" . SPARSER::PROTEIN) ("CXXC1" . SPARSER::PROTEIN)
    ("SET1" . SPARSER::PROTEIN) ("TAF5" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("POLR2E" . SPARSER::PROTEIN)
    ("CFP1" . SPARSER::PROTEIN) ("BRF1" . SPARSER::PROTEIN)
    ("MAF1" . SPARSER::PROTEIN) ("using viral gene" . SPARSER::GENE)
    ("intracerebral somatic gene" . SPARSER::GENE)
    ("the respective genes" . SPARSER::GENE)
    ("Pten and Nf1" . SPARSER::COLLECTION) ("multiplex gene" . SPARSER::GENE)
    ("again only found Ptch1" . SPARSER::PROTEIN) ("Boc" . SPARSER::PROTEIN)
    ("Hhip" . SPARSER::PROTEIN) ("Ctnnb1" . SPARSER::PROTEIN)
    ("Mycn" . SPARSER::PROTEIN)
    ("a Shh pathway target and signature gene" . SPARSER::COLLECTION)
    ("Sfrp1, a Shh pathway target and signature gene" . SPARSER::COLLECTION)
    ("NeuN" . SPARSER::PROTEIN)
    ("the prototypic histopathological variant" . SPARSER::VARIANT)
    ("Atoh1" . SPARSER::PROTEIN)
    ("the postmitotic marker p27 Kip1" . SPARSER::PROTEIN)
    ("Agarose" . SPARSER::MOLECULE) ("transposase" . SPARSER::PROTEIN)
    ("the upper rhombic lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("postnatal somatic gene" . SPARSER::GENE) ("gNT" . SPARSER::PROTEIN)
    ("pX" . SPARSER::PROTEIN) ("gRNAs" . SPARSER::RNA)
    ("hGFAP-Cre" . SPARSER::COLLECTION) ("hGFAP" . SPARSER::PROTEIN)
    ("P53, PTEN and NF1" . SPARSER::COLLECTION)
    ("both the Cas9 nuclease and a gRNA" . SPARSER::COLLECTION)
    ("an essential negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("PEI" . SPARSER::MOLECULE) ("gRNA" . SPARSER::RNA)
    ("Nf1" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("Sfrp1" . SPARSER::PROTEIN) ("Mib1" . SPARSER::PROTEIN)
    ("Pax6" . SPARSER::PROTEIN) ("Pax2" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN)
    ("the tissue-type plasminogen activator (t-PA) and the urokinase-type plasminogen activator (u-PA)"
     . SPARSER::COLLECTION)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bilirubin" . SPARSER::MOLECULE) ("PaO" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRF" . SPARSER::PROTEIN) ("fibrin" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("LBPA and ALIX" . SPARSER::COLLECTION)
    ("tyrosine phosphatases or the TK Src" . SPARSER::COLLECTION)
    ("P38-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("−ΔAP2" . SPARSER::COLLECTION)
    ("ΔAP2" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("some stress-internalized EGFR" . SPARSER::PROTEIN)
    ("EGFR-ΔAP2" . SPARSER::PROTEIN-PAIR) ("dynasore" . SPARSER::MOLECULE)
    ("Anisomycin" . SPARSER::DRUG) ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tsg101/ALIX" . SPARSER::COLLECTION) ("ALIX-" . SPARSER::PROTEIN)
    ("ALIX or Tsg101" . SPARSER::COLLECTION) ("Tsg101" . SPARSER::PROTEIN)
    ("Tsg" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-activated EGFR" . SPARSER::PROTEIN)
    ("EGF and UVC" . SPARSER::COLLECTION) ("EGFR-15KR" . SPARSER::PROTEIN)
    ("EGFR-wt" . SPARSER::COLLECTION) ("PAE" . SPARSER::PROTEIN-FAMILY)
    ("lysotracker" . SPARSER::DRUG)
    ("stress-induced lysosomal" . SPARSER::PROTEIN)
    ("MEFs, EGFR and EGF" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("flox" . SPARSER::PROTEIN)
    ("OA1 and fibrillar PMEL co-segregate" . SPARSER::COLLECTION)
    ("stress-stimulated EGFR" . SPARSER::PROTEIN)
    ("non-fbrillar PMEL and C-terminal PMEL" . SPARSER::COLLECTION)
    ("OA1 and fibrillar PMEL" . SPARSER::COLLECTION)
    ("ligand-" . SPARSER::LIGAND) ("peroxidase (HRP)" . SPARSER::PROTEIN)
    ("fluorescent EGF" . SPARSER::PROTEIN)
    ("cryo-immuno" . SPARSER::PROTEIN-PAIR) ("Lamp1" . SPARSER::PROTEIN)
    ("TfR" . SPARSER::PROTEIN) ("perinuclear EGFR" . SPARSER::PROTEIN)
    ("stress-induced EGFR" . SPARSER::PROTEIN)
    ("traffic ligand-stimulated EGFR" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug" . SPARSER::DRUG)
    ("an archetypal receptor tyrosine kinase (TK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-internalized EGFR" . SPARSER::PROTEIN)
    ("Stress-internalized EGFR" . SPARSER::PROTEIN) ("ILVs" . SPARSER::PROTEIN)
    ("ALIX" . SPARSER::PROTEIN)
    ("exogenously expressed pre-melanosomal markers OA1 and fibrillar PMEL"
     . SPARSER::COLLECTION)
    ("fibrillar PMEL" . SPARSER::PROTEIN) ("PMEL" . SPARSER::PROTEIN)
    ("LBPA" . SPARSER::MOLECULE)
    ("the cancer therapeutic cisplatin" . SPARSER::DRUG)
    ("ultraviolet light" . SPARSER::PROTEIN) ("IRE2" . SPARSER::PROTEIN)
    ("HMB45" . SPARSER::DRUG) ("ZD1839" . SPARSER::DRUG)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AP2α" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN)
    ("G-protein–coupled receptor" . SPARSER::PROTEIN)
    ("premelanosome protein" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("Transferrin Receptor" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN)
    ("ALG-2-interacting Protein X" . SPARSER::PROTEIN)
    ("OA1" . SPARSER::PROTEIN) ("Cav-1 and RhoA/ROCK1" . SPARSER::COLLECTION)
    ("hereditary background and genetic variants" . SPARSER::VARIANT)
    ("A allele of rs1049334 and G allele of rs35996865" . SPARSER::COLLECTION)
    ("Caveolin-1 and Rho" . SPARSER::COLLECTION) ("-GTPases" . SPARSER::GTPASE)
    ("Rho/Rho" . SPARSER::COLLECTION) ("src" . SPARSER::PROTEIN)
    ("triphosphatases" . SPARSER::PROTEIN) ("AA or AG" . SPARSER::COLLECTION)
    ("Cav-1 and ROCK1" . SPARSER::COLLECTION) ("Alleles" . SPARSER::ALLELE)
    ("Cav-1 and rs35996865" . SPARSER::COLLECTION)
    ("Cav-1 and ccRCC" . SPARSER::COLLECTION)
    ("ROCK1/RhoA" . SPARSER::COLLECTION)
    ("ROCK , CITRON , and PRK1" . SPARSER::COLLECTION)
    ("CITRON" . SPARSER::PROTEIN) ("RhoA" . SPARSER::PROTEIN)
    ("HBP and high BMI" . SPARSER::COLLECTION) ("HBP" . SPARSER::PROTEIN)
    ("src kinase" . SPARSER::PROTEIN) ("cav-1" . SPARSER::PROTEIN)
    ("PRK1" . SPARSER::PROTEIN) ("MAPK and PKCβ/θ" . SPARSER::COLLECTION)
    ("Erk1/2 and PKCβ/θ" . SPARSER::COLLECTION)
    ("MAPK and PKCβ" . SPARSER::COLLECTION) ("polyproline" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE) ("stimulants" . SPARSER::DRUG)
    ("Nox2" . SPARSER::PROTEIN)
    ("nLDL-dependent superoxide ( xref middle, # vs nLDL, 96±12.3 vs 151±9.7%) as well as cell proliferation ( xref lower, # vs nLDL, 92±11.3 vs 131±5.1%)"
     . SPARSER::COLLECTION)
    ("DIDS" . SPARSER::MOLECULE)
    ("apocynin (# vs nLDL, 1.00±0.04 vs 1.36±0.05) and DPI (# vs nLDL, 0.97±0.11 vs 1.36±0.05)"
     . SPARSER::COLLECTION)
    ("p22phox and p47phox" . SPARSER::COLLECTION)
    ("PD98059 and calphostin C" . SPARSER::COLLECTION)
    ("MAPK and PKC" . SPARSER::COLLECTION)
    ("MAPK, phospho-PKCθ and phospho-PKCβ" . SPARSER::COLLECTION)
    ("MAPK, PKCθ and PKCβ" . SPARSER::COLLECTION)
    ("the nLDL-treated membrane fraction" . SPARSER::COMPONENT)
    ("iodonium and NADPH oxidase" . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE)
    ("N G -monomethyl- L -arginine or mitochondrial electron transport chain inhibitor"
     . SPARSER::COLLECTION)
    ("indomethacin" . SPARSER::DRUG) ("allopurinol" . SPARSER::DRUG)
    ("lucigenin" . SPARSER::DRUG) ("DHE" . SPARSER::DRUG)
    ("Erk1/2 and PKCβ and PKCθ" . SPARSER::COLLECTION)
    ("PKCβ and PKCθ" . SPARSER::COLLECTION)
    ("Erk1/2 and PKC" . SPARSER::COLLECTION) ("Nox1" . SPARSER::PROTEIN)
    ("Isolated aortic SMCs" . SPARSER::PROTEIN)
    ("dihydroethidine" . SPARSER::DRUG)
    ("mitogen-activated protein kinase, PKCθ and PKCβ" . SPARSER::COLLECTION)
    ("p47phox and p22phox" . SPARSER::COLLECTION)
    ("MEK and PKC" . SPARSER::COLLECTION) ("Superoxide" . SPARSER::MOLECULE)
    ("Lucigenin" . SPARSER::DRUG) ("PKC β" . SPARSER::PROTEIN)
    ("chloride channel 3" . SPARSER::PROTEIN)
    ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L -arginine" . SPARSER::MOLECULE) ("H-5" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("Thiobarbituric acid" . SPARSER::MOLECULE)
    ("NoxO1" . SPARSER::PROTEIN) ("Nox4" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE)
    ("Nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("early growth response" . SPARSER::PROTEIN) ("p22phox" . SPARSER::PROTEIN)
    ("p47phox" . SPARSER::PROTEIN) ("PKCβ" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Multi" . SPARSER::PROTEIN)
    ("a prognostic and predictive biomarker" . SPARSER::MOLECULE)
    ("Cav-1 and both JAK/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and JNK" . SPARSER::COLLECTION)
    ("well-characterized caveolae-associated proteins" . SPARSER::PROTEIN)
    ("Src and Src" . SPARSER::COLLECTION)
    ("SOCS2, PIAS3, and DUSP5" . SPARSER::COLLECTION)
    ("Radiation-induced Cav-1" . SPARSER::PROTEIN)
    ("radiation-induced DNA" . SPARSER::DNA)
    ("multiple distinct siRNAs" . SPARSER::PROTEIN)
    ("fatty-acid synthase (FAS) and Cav-1" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("p38 and p42/44" . SPARSER::COLLECTION) ("JNK/SAPK" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MIA" . SPARSER::PROTEIN)
    ("STAT3, Src, and JNK" . SPARSER::COLLECTION)
    ("a completely distinct shRNA" . SPARSER::PROTEIN)
    ("BRCA1 and DNA-PK" . SPARSER::COLLECTION)
    ("gemcitabine and 5-fluorouracil" . SPARSER::COLLECTION)
    ("siRNA and gemcitabine" . SPARSER::COLLECTION)
    ("gemcitabine and 5-FU" . SPARSER::COLLECTION)
    ("Gemcitabine and 5-fluorouracil" . SPARSER::COLLECTION)
    ("two distinct siRNA" . SPARSER::PROTEIN) ("chelator" . SPARSER::MOLECULE)
    ("a single mutated KRAS allele" . SPARSER::ALLELE)
    ("one mutated KRAS allele" . SPARSER::ALLELE)
    ("Pdx1-cre" . SPARSER::COLLECTION) ("KPC" . SPARSER::PROTEIN)
    ("tissue type and histopathology" . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("reliable biomarkers" . SPARSER::MOLECULE)
    ("gemcitabine, 5-fluorouracil, oxaliplatin, nab-paclitaxel, and irinotecan"
     . SPARSER::COLLECTION)
    ("an appreciable barrier" . SPARSER::PROTEIN)
    ("JNK, and Src" . SPARSER::COLLECTION) ("2–4 " . SPARSER::PROTEIN)
    ("a 37 " . SPARSER::PROTEIN) ("fatty-acid synthase" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("DUSP5" . SPARSER::PROTEIN)
    ("protein inhibitor of activated STAT3" . SPARSER::PROTEIN)
    ("PIAS3" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("the AG and GG genotypes" . SPARSER::COLLECTION)
    ("their polymorphic alleles" . SPARSER::ALLELE)
    ("the biological modifiers" . SPARSER::MOLECULE)
    ("our colorectal
cancer patient cohort"
     . SPARSER::MOLECULE)
    ("a colorectal cancer patient cohort" . SPARSER::MOLECULE)
    ("heat-shock protein" . SPARSER::PROTEIN) ("GEMIN3" . SPARSER::PROTEIN)
    ("interferon gamma receptor 1" . SPARSER::PROTEIN)
    ("HS2ST1" . SPARSER::PROTEIN) ("DDX20" . SPARSER::PROTEIN)
    ("RRM1" . SPARSER::PROTEIN)
    ("that vitamin D or VDRAs increase cell proliferation via EGFR in different cell types"
     . SPARSER::COLLECTION)
    ("vitamin D and EGFR" . SPARSER::COLLECTION)
    ("the MAPK ERK kinase and the STAT-1 transcription factor ( xref )"
     . SPARSER::COLLECTION)
    ("PI3-kinase/Akt/mTOR/p70S6 K1" . SPARSER::COLLECTION)
    ("TGF- α and HB-EGF" . SPARSER::COLLECTION)
    ("TGF- α , HB-EGF, and amphiregulin" . SPARSER::COLLECTION)
    ("TGF- α , HB-EGF, amphiregulin, and connective tissue growth factor"
     . SPARSER::COLLECTION)
    ("amphiregulin" . SPARSER::PROTEIN) ("EGFR/ADAM17" . SPARSER::COLLECTION)
    ("eplerenone" . SPARSER::DRUG)
    ("tubular epithelial cells Aldo" . SPARSER::PROTEIN)
    ("Paricalcitol" . SPARSER::DRUG) ("CCL-2 and CCL-5" . SPARSER::COLLECTION)
    ("an anti-TGF- α" . SPARSER::ANTIBODY)
    ("ADAM-17/EGFR" . SPARSER::COLLECTION)
    ("a nontoxic mutant" . SPARSER::MUTANT)
    ("HB-EGF and TGF- α" . SPARSER::COLLECTION) ("/EGFR" . SPARSER::COLLECTION)
    ("ADAM17/TGF- α" . SPARSER::COLLECTION)
    ("ADAM17/EGFR" . SPARSER::COLLECTION) ("TWEAK" . SPARSER::PROTEIN)
    ("ADAM-17/TGF- α" . SPARSER::COLLECTION)
    ("Aldo/EGFR" . SPARSER::COLLECTION)
    ("disintegrin and metalloproteases" . SPARSER::COLLECTION)
    ("ADAMs" . SPARSER::PROTEIN) ("The hormonal form" . SPARSER::FORM)
    ("angiotensin II (AngII) and aldosterone (Aldo)" . SPARSER::COLLECTION)
    ("the most relevant RAAS components" . SPARSER::COMPONENT)
    ("Aldo" . SPARSER::PROTEIN)
    ("1,25–dihydroxy vitamin D(3) or calcitriol" . SPARSER::COLLECTION)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("VDR" . SPARSER::PROTEIN)
    ("calcitriol" . SPARSER::MOLECULE) ("proteinuria" . SPARSER::PROTEIN)
    ("/ADAM-17" . SPARSER::COLLECTION) ("paricalcitol" . SPARSER::DRUG)
    ("VDRA" . SPARSER::PROTEIN) ("ERK and STAT-1" . SPARSER::COLLECTION)
    ("/ADAM17/EGFR" . SPARSER::COLLECTION) ("/ADAM17" . SPARSER::COLLECTION)
    ("Aldosterone" . SPARSER::PROTEIN)
    ("/epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("renin-angiotensin-aldosterone" . SPARSER::COLLECTION)
    ("aldosterone" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("phosphatase-1" . SPARSER::PROTEIN) ("p70S6 K1" . SPARSER::PROTEIN)
    ("aldosterone synthase" . SPARSER::PROTEIN)
    ("diphtheria toxin" . SPARSER::PROTEIN) ("CCL-5" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("heparin binding EGF-like growth factor" . SPARSER::PROTEIN)
    ("parathyroid hormone" . SPARSER::PROTEIN) ("ADAM-17" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN)
    ("an almost similar and stable tetrahedral transition state"
     . SPARSER::BIO-STATE)
    ("the tetrahedral transition state" . SPARSER::BIO-STATE)
    ("a naturally occurring sesquiterpene alkaloid" . SPARSER::MOLECULE)
    ("occurring sesquiterpene alkaloid" . SPARSER::MOLECULE)
    ("alkaloid" . SPARSER::MOLECULE) ("sesquiterpene" . SPARSER::MOLECULE)
    ("Luteolin" . SPARSER::DRUG)
    ("APP, HTT, PSEN2, PARK2, and SOD1" . SPARSER::COLLECTION)
    ("tetrapeptide and caspase-3" . SPARSER::COLLECTION)
    ("luteolin" . SPARSER::DRUG) ("GOLD and X-score" . SPARSER::COLLECTION)
    ("GOLD" . SPARSER::MOLECULE)
    ("the crystallographic complex" . SPARSER::BIO-COMPLEX)
    ("CASP3 and other input proteins" . SPARSER::COLLECTION)
    ("The X-linked inhibitor of apoptosis and the neuronal inhibitor"
     . SPARSER::COLLECTION)
    ("the neuronal inhibitor" . SPARSER::INHIBITOR)
    ("Ac-DEVD-CMK" . SPARSER::COLLECTION) ("aldehyde" . SPARSER::MOLECULE)
    ("tetrapeptide" . SPARSER::MOLECULE) ("ketone" . SPARSER::MOLECULE)
    ("Peptide" . SPARSER::PEPTIDE)
    ("activated caspase-3 and its resultant β -actin cleavage fragments"
     . SPARSER::COLLECTION)
    ("its resultant β -actin cleavage fragments" . SPARSER::FRAGMENT)
    ("normal and mutated huntingtin (HTT)" . SPARSER::PROTEIN)
    ("caspase-1 and caspase-3" . SPARSER::COLLECTION)
    ("PARK2, SNCA, and MAPT" . SPARSER::COLLECTION) ("SNCA" . SPARSER::PROTEIN)
    ("PSEN-2" . SPARSER::COLLECTION)
    ("caspase-3 and calpain" . SPARSER::COLLECTION)
    ("huntingtin" . SPARSER::PROTEIN) ("HTT" . SPARSER::PROTEIN)
    ("the nucleophilic thiol" . SPARSER::MOLECULE)
    ("caspase-2, caspase-8, caspase-9, and caspase-10" . SPARSER::COLLECTION)
    ("caspase-3, caspase-6, and caspase-7" . SPARSER::COLLECTION)
    ("inflammatory and apoptotic caspases" . SPARSER::PROTEIN)
    ("a unique class" . CLASS) ("Caspases" . SPARSER::PROTEIN)
    ("the previously identified peptidyl inhibitors" . SPARSER::INHIBITOR)
    ("Rosmarinic acid and curcumin" . SPARSER::COLLECTION)
    ("Gold" . SPARSER::MOLECULE) ("ALS" . SPARSER::PROTEIN)
    ("B chain" . SPARSER::PROTEIN) ("A chain" . SPARSER::PROTEIN)
    ("PSEN2" . SPARSER::PROTEIN) ("rosmarinic acid" . SPARSER::MOLECULE)
    ("PARK 2" . SPARSER::PROTEIN) ("PSEN 1" . SPARSER::PROTEIN)
    ("CASP 3" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis" . SPARSER::PROTEIN)
    ("AC-DEVD-CHO" . SPARSER::DRUG) ("mSOD1" . SPARSER::PROTEIN)
    ("caspase-1" . SPARSER::PROTEIN) ("PARK2" . SPARSER::PROTEIN)
    ("presenilin-2" . SPARSER::PROTEIN) ("PSEN-1" . SPARSER::PROTEIN)
    ("presenilin-1" . SPARSER::PROTEIN) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("EAAT2" . SPARSER::PROTEIN)
    ("caspase-6" . SPARSER::PROTEIN) ("caspase-10" . SPARSER::PROTEIN)
    ("caspase-2" . SPARSER::PROTEIN) ("Rosmarinic acid" . SPARSER::MOLECULE)
    ("interleukin-1, interleukin-6, and tumor necrosis factor-alpha"
     . SPARSER::COLLECTION)
    ("a secreted protein and its exogenous form" . SPARSER::COLLECTION)
    ("its exogenous form" . SPARSER::FORM)
    ("a multifunctional moonlighting protein" . SPARSER::PROTEIN)
    ("differentially expressed proteins" . SPARSER::PROTEIN)
    ("confidence interval (CI) = 1.001–1.002" . SPARSER::PROTEIN)
    ("group and P" . SPARSER::COLLECTION)
    ("HSPB1, CCT4, RPS12, and RPS28" . SPARSER::COLLECTION)
    ("RAC1, RHOT2, ANXA1, ANXA2, ANXA6, CARHSP1, and EEF1D"
     . SPARSER::COLLECTION)
    ("VIM, CAPG, TUBB6, and FMNL1" . SPARSER::COLLECTION)
    ("SAMHD1, HLA-DR, DEFA1, and ARMCX3" . SPARSER::COLLECTION)
    ("LYZ, PRMT1, and SULT1A1" . SPARSER::COLLECTION)
    ("HIST1H4I, HIST1H1B, HIST1H2BB, HNRNPC, HNRNPD, HNRNPU, HNRNPUL2, RNASE2, SET, XRCC5, MNDA, KHDRBS1, and DCLRE1A"
     . SPARSER::COLLECTION)
    ("SLC2A3, VPS37A, ABCB6, and KDELR1" . SPARSER::COLLECTION)
    ("PYCARD" . SPARSER::PROTEIN) ("MNDA" . SPARSER::PROTEIN)
    ("SET" . SPARSER::PROTEIN) ("HNRNPU" . SPARSER::PROTEIN)
    ("HNRNPD" . SPARSER::PROTEIN) ("HNRNPC" . SPARSER::PROTEIN)
    ("LYZ" . SPARSER::PROTEIN) ("CAPG" . SPARSER::PROTEIN)
    ("VIM" . SPARSER::PROTEIN)
    ("peptides and gene ontology information" . SPARSER::COLLECTION)
    ("revealed 30,608 peptides and 1801 proteins (including CD14) which were common to both replicate experiments"
     . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("RANKL" . SPARSER::PROTEIN)
    ("differentially expressed monocyte proteins" . SPARSER::PROTEIN)
    ("Peripheral monocytes" . SPARSER::PROTEIN)
    ("osteoclasts" . SPARSER::PROTEIN) ("interleukin-1" . SPARSER::PROTEIN)
    ("YIF1B" . SPARSER::PROTEIN) ("TMED3" . SPARSER::PROTEIN)
    ("SPRYD4" . SPARSER::PROTEIN) ("KDELR1" . SPARSER::PROTEIN)
    ("ABCB6" . SPARSER::PROTEIN) ("VPS37A" . SPARSER::PROTEIN)
    ("SLC2A3" . SPARSER::PROTEIN) ("DCLRE1A" . SPARSER::PROTEIN)
    ("KHDRBS1" . SPARSER::PROTEIN) ("XRCC5" . SPARSER::PROTEIN)
    ("RNASE2" . SPARSER::PROTEIN) ("HNRNPUL2" . SPARSER::PROTEIN)
    ("HIST1H2BB" . SPARSER::PROTEIN) ("HIST1H1B" . SPARSER::PROTEIN)
    ("HIST1H4I" . SPARSER::PROTEIN) ("SULT1A1" . SPARSER::PROTEIN)
    ("SAMHD1" . SPARSER::PROTEIN) ("TUBB6" . SPARSER::PROTEIN)
    ("EEF1D" . SPARSER::PROTEIN) ("ANXA6" . SPARSER::PROTEIN)
    ("ANXA2" . SPARSER::PROTEIN) ("ANXA1" . SPARSER::PROTEIN)
    ("RHOT2" . SPARSER::PROTEIN) ("RPS28" . SPARSER::PROTEIN)
    ("RPS12" . SPARSER::PROTEIN) ("CCT4" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN)
    ("no predictive biomarker" . SPARSER::MOLECULE)
    ("IGFBP3 and TAp73α" . SPARSER::COLLECTION)
    ("p73 and p63" . SPARSER::COLLECTION) ("CTAG" . SPARSER::PROTEIN)
    ("CATG" . SPARSER::PROTEIN) ("GH/IGFs/IGFBP3" . SPARSER::COLLECTION)
    ("PTPN11 , RAS , and RAF1" . SPARSER::COLLECTION)
    ("SHOX" . SPARSER::PROTEIN) ("mRNAs and IGFBP3" . SPARSER::COLLECTION)
    ("IGFBP3 and p73" . SPARSER::COLLECTION)
    ("p73-shRNA" . SPARSER::COLLECTION) ("pRS" . SPARSER::PROTEIN)
    ("RNA and RNA" . SPARSER::COLLECTION)
    ("p53 and TAp73α" . SPARSER::COLLECTION) ("Flp" . SPARSER::PROTEIN)
    ("a TAp73α transcriptional target as well as a p53 target"
     . SPARSER::COLLECTION)
    ("p53, TAp73α, and TAp63α" . SPARSER::COLLECTION)
    ("functional p53, p63, and TAp73α" . SPARSER::COLLECTION)
    ("p53, p63, and TAp73α" . SPARSER::COLLECTION)
    ("p53, TAp73α, TAp63α, and ΔNp63α" . SPARSER::COLLECTION)
    ("TAp73 and IGFBP3" . SPARSER::COLLECTION) ("AGA" . SPARSER::PROTEIN)
    ("IGFs and IGF-1" . SPARSER::COLLECTION) ("GH/IGF" . SPARSER::COLLECTION)
    ("GH/IGF1" . SPARSER::COLLECTION)
    ("growth hormone/insulin-like growth factor" . SPARSER::COLLECTION)
    ("a good biomarker" . SPARSER::MOLECULE)
    ("p73 and IGFBP3" . SPARSER::COLLECTION) ("IGFBP-3" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("IGF-1–" . SPARSER::PROTEIN)
    ("short stature homeobox" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("ΔNp63α" . SPARSER::PROTEIN)
    ("Insulin-like growth factor–binding protein 3" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN)
    ("insulin-like growth factor–binding protein 3" . SPARSER::PROTEIN)
    ("low-androgen" . SPARSER::PROTEIN) ("liganded" . SPARSER::MOLECULE)
    ("corepressors" . SPARSER::PROTEIN)
    ("active euchromatin" . SPARSER::BIO-COMPLEX)
    ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("SMAD3, REL, Fos, Jun, FOXO, and Ets-1" . SPARSER::COLLECTION)
    ("a genome-wide in vivo mapping" . SPARSER::PROTEIN)
    ("promoter and fragment" . SPARSER::COLLECTION)
    ("the promoter and fragments I and II" . SPARSER::COLLECTION)
    ("androgens, estrogens, and progesterone" . SPARSER::COLLECTION)
    ("the repressive histone modification H3K27me3" . SPARSER::PROTEIN)
    ("acH" . SPARSER::PROTEIN) ("AR and regions C–G" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("–DHT" . SPARSER::COLLECTION)
    ("promoter or fragment" . SPARSER::COLLECTION)
    ("flutamide" . SPARSER::DRUG) ("HEK" . SPARSER::PROTEIN)
    ("the Foxp3 promoter and/or two fragments" . SPARSER::COLLECTION)
    ("-2b" . SPARSER::COLLECTION) ("Foxp3 and AR" . SPARSER::COLLECTION)
    ("AR and Foxp3" . SPARSER::COLLECTION) ("dim" . SPARSER::PROTEIN-FAMILY)
    ("Nr4a2" . SPARSER::PROTEIN) ("promoter and CNS" . SPARSER::COLLECTION)
    ("Smad3 and NFAT" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("The Foxp3 promoter and three important intronic enhancers 1–3"
     . SPARSER::COLLECTION)
    ("peripheral naive CD4 + CD25" . SPARSER::PROTEIN)
    ("TGF-β and IL-2" . SPARSER::COLLECTION) ("Androgens" . SPARSER::DRUG)
    ("DNA-Polymerase" . SPARSER::PROTEIN) ("histone 4" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("Foxp 3" . SPARSER::PROTEIN)
    ("H–K" . SPARSER::PROTEIN) ("E–G" . SPARSER::PROTEIN)
    ("C–G" . SPARSER::PROTEIN) ("and -1" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("Stat5" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CSN2" . SPARSER::PROTEIN)
    ("forkhead box P3" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN)
    ("the pro-apoptotic BH3-only protein Bim" . SPARSER::PROTEIN)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("a pro-apoptotic transcription factor" . SPARSER::PROTEIN)
    ("Bim and CHOP" . SPARSER::COLLECTION)
    ("CHOP and Bim" . SPARSER::COLLECTION) ("bim" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION)
    ("MMPs-2 and MMP-9" . SPARSER::COLLECTION) ("MMPs-2" . SPARSER::PROTEIN)
    ("lipoic acid (LA) molecule" . SPARSER::MOLECULE)
    ("α-LA-induced ROS" . SPARSER::PROTEIN)
    ("DCF 3 h and 6 h" . SPARSER::COLLECTION)
    ("BimEL and BimS" . SPARSER::COLLECTION) ("BimS" . SPARSER::PROTEIN)
    ("BimEL" . SPARSER::PROTEIN) ("- 1 " . SPARSER::PROTEIN)
    ("condensations" . SPARSER::PROTEIN-FAMILY)
    ("h or 24 h" . SPARSER::COLLECTION) ("Bim and Mcl-1" . SPARSER::COLLECTION)
    ("Mcl-1 mRNA (assay ID#HS 001 720 36_m1) and endogenous control gene GAPDH mRNA [ xref ]"
     . SPARSER::COLLECTION)
    ("TRIzol" . SPARSER::DRUG)
    ("anti-rabbit or anti-mouse secondary antibodies" . SPARSER::ANTIBODY)
    ("thiourea" . SPARSER::MOLECULE) ("chloroform" . SPARSER::MOLECULE)
    ("polylysine" . SPARSER::MOLECULE) ("phenylindole" . SPARSER::MOLECULE)
    ("Iodide (PI)" . SPARSER::PROTEIN) ("Prep" . SPARSER::PROTEIN)
    ("-uaacagucguaagauaacctt-3" . SPARSER::COLLECTION)
    ("trypsinization" . SPARSER::PROTEIN)
    ("the BH3 only protein Bim" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("pro-apoptotic effectors" . SPARSER::EFFECTOR)
    ("can also inactive" . SPARSER::INACTIVE)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN)
    ("an essential co-factor" . SPARSER::MOLECULE) ("SDH" . SPARSER::PROTEIN)
    ("proteins, Mcl-1 and Bcl-x" . SPARSER::COLLECTION)
    ("-DA" . SPARSER::MOLECULE) ("LA" . SPARSER::PROTEIN)
    ("inhibitor of apoptosis protein 1" . SPARSER::PROTEIN)
    ("Mcl-1 protein" . SPARSER::PROTEIN) ("L −1" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("Alpha-" . SPARSER::PROTEIN) ("CDC42 and p85α" . SPARSER::COLLECTION)
    ("indolent lymphocytic leukemia" . SPARSER::PROTEIN)
    ("miR-29b mimic group and the blank" . SPARSER::COLLECTION)
    ("mutant-type1 or mutant-type2" . SPARSER::COLLECTION)
    ("PTEN-luc" . SPARSER::COLLECTION)
    ("psiCHECK-2-Mut-MMP2-3" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("psiCHECK-2-Wt-MMP2-3" . SPARSER::COLLECTION)
    ("the NC group and Blank groups (Fig.  xref , * P  < 0.05)"
     . SPARSER::COLLECTION)
    ("probable down stream tumor metastasis-related genes" . SPARSER::GENE)
    ("miR-29b, tumor stage and lymphatic metastasis in NSCLC tissues"
     . SPARSER::COLLECTION)
    ("t  " . SPARSER::PROTEIN) ("PTEN and MMP2" . SPARSER::COLLECTION)
    ("PTEN , ETV4 , COL4A2 , and MMP2" . SPARSER::COLLECTION)
    ("PAHS" . SPARSER::MOLECULE)
    ("CD133-positive/negative" . SPARSER::PROTEIN-PAIR)
    ("the metastasis-related miRNAs and target genes" . SPARSER::COLLECTION)
    ("PTEN, ETV4, COL4A2 and MMP2" . SPARSER::COLLECTION)
    ("miR-125b [ xref ] and miR-10b [ xref ]" . SPARSER::COLLECTION)
    ("oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("MMP2 and PTEN" . SPARSER::COLLECTION) ("CDC42" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("type3" . SPARSER::PROTEIN)
    ("type2" . SPARSER::PROTEIN) ("type1" . SPARSER::PROTEIN)
    ("MiR-29b" . SPARSER::MOLECULE) ("COL4A2" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("miR-29b" . SPARSER::MOLECULE)
    ("GLI1 and SMO" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("normal HSPCs" . SPARSER::PROTEIN) ("SHh" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK" . SPARSER::COLLECTION)
    ("next generation FLT3 and Hh pathway inhibitors" . SPARSER::COLLECTION)
    ("quizartinib" . SPARSER::DRUG) ("PTCH1 or SMO" . SPARSER::COLLECTION)
    ("PTCH1 and SMO" . SPARSER::COLLECTION)
    ("IPI-926 and sorafenib" . SPARSER::COLLECTION)
    ("STAT5 and active" . SPARSER::COLLECTION)
    ("the naturally occurring Smo antagonist cyclopamine" . SPARSER::DRUG)
    ("occurring Smo antagonist cyclopamine" . SPARSER::DRUG)
    ("Gli1 , Gli2, and Ptch1" . SPARSER::COLLECTION)
    ("Ptch1" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("cyclopamine" . SPARSER::DRUG)
    ("sorafenib and/or IPI-926" . SPARSER::COLLECTION)
    ("Sorafenib and IPI-926" . SPARSER::COLLECTION)
    ("FLT3/ITD" . SPARSER::COLLECTION) ("pAKT or pERK" . SPARSER::COLLECTION)
    ("FLT3 and SMO" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("sorafenib or IPI-926" . SPARSER::COLLECTION)
    ("sorafenib and IPI-926" . SPARSER::COLLECTION)
    ("LDE225, and siRNA" . SPARSER::COLLECTION)
    ("GLI1 and GLI2" . SPARSER::COLLECTION)
    ("both expressed Hh signaling pathway components as well as Indian Hh ligand"
     . SPARSER::COLLECTION)
    ("Indian Hh ligand" . SPARSER::MOLECULE) ("ITD/ITD" . SPARSER::COLLECTION)
    ("Anti" . SPARSER::PROTEIN) ("Flt3-ITD" . SPARSER::COLLECTION)
    ("MEPs" . SPARSER::PROTEIN) ("GMPs" . SPARSER::GMP)
    ("HSPC" . SPARSER::PROTEIN) ("MEP" . SPARSER::PROTEIN)
    ("CMP" . SPARSER::CMP) ("GMP" . SPARSER::GMP) ("MPP" . SPARSER::PROTEIN)
    ("lineage negative (Lin − ) multipotent bone marrow cKit + Sca1 + (KSL) HSPCs"
     . SPARSER::PROTEIN)
    ("cKit" . SPARSER::PROTEIN) ("Myeloid" . SPARSER::PROTEIN)
    ("Flt3/ITD-SmoM2" . SPARSER::COLLECTION) ("SmoM2" . SPARSER::PROTEIN)
    ("ligand (SHH)" . SPARSER::MOLECULE) ("SHH" . SPARSER::PROTEIN)
    ("Sonic" . SPARSER::PROTEIN) ("Gli1 and Gli2" . SPARSER::COLLECTION)
    ("-cre" . SPARSER::COLLECTION) ("cre" . SPARSER::PROTEIN)
    ("ITD-SmoM2" . SPARSER::PROTEIN-PAIR) ("Flt3/ITD" . SPARSER::COLLECTION)
    ("Gli2" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("-Cre" . SPARSER::COLLECTION) ("YFP" . SPARSER::PROTEIN)
    ("GLI2 and its target gene BCL2" . SPARSER::COLLECTION)
    ("FLT3 and Hh pathway inhibitors" . SPARSER::COLLECTION)
    ("Smo" . SPARSER::PROTEIN) ("aBCC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vismodegib" . SPARSER::DRUG) ("CyclinD1 and N-Myc" . SPARSER::COLLECTION)
    ("GLI" . SPARSER::PROTEIN) ("SMO" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an indolent myeloproliferative state" . SPARSER::BIO-STATE)
    ("-ITD" . SPARSER::COLLECTION) ("IL7R" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("Interleukin-3" . SPARSER::PROTEIN) ("LDE225" . SPARSER::DRUG)
    ("IPI-926" . SPARSER::DRUG) ("Flk2" . SPARSER::PROTEIN)
    ("CD48" . SPARSER::PROTEIN) ("CD150" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("the invasive component" . SPARSER::COMPONENT)
    ("an invasive foci" . SPARSER::PROTEIN)
    ("presumable prone" . SPARSER::PROTEIN-FAMILY)
    ("a long-term prognostic biomarker" . SPARSER::MOLECULE)
    ("a co-existing invasive component" . SPARSER::COMPONENT)
    ("ER- and PR" . SPARSER::COLLECTION) ("endocrine-" . SPARSER::PROTEIN)
    ("odontoblastic differentiation-associated genes and mineralization"
     . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("osteo/odontogenic" . SPARSER::COLLECTION)
    ("DSP-PP" . SPARSER::COLLECTION) ("DSPP and DSPs" . SPARSER::COLLECTION)
    ("DSP and phosphorin" . SPARSER::COLLECTION)
    ("DSPP (DSP) and DMP1" . SPARSER::COLLECTION)
    ("dexamethasone and β-glycerophosphate" . SPARSER::COLLECTION)
    ("odontoblastic differentiation-associated genes" . SPARSER::GENE)
    ("DSPP, ALP, and DMP1" . SPARSER::COLLECTION)
    ("DSPP and DMP-1" . SPARSER::COLLECTION) ("Alizarin" . SPARSER::DRUG)
    ("DSPP (DSP) and DMP1 protein" . SPARSER::COLLECTION)
    ("DSP" . SPARSER::PROTEIN)
    ("osteoblastic differentiation marker genes" . SPARSER::GENE)
    ("hydroxycholecalciferol" . SPARSER::MOLECULE)
    ("alkaline phosphatase (ALP)" . SPARSER::PROTEIN-FAMILY)
    ("collagen (COLI)" . SPARSER::PROTEIN) ("OCN" . SPARSER::PROTEIN)
    ("osteocalcin" . SPARSER::PROTEIN) ("DSPP and DMP1" . SPARSER::COLLECTION)
    ("ALP" . SPARSER::PROTEIN)
    ("dentin sialophosphoprotein (DSPP) and dentin matrix protein1 (DMP1)"
     . SPARSER::COLLECTION)
    ("DSPP" . SPARSER::PROTEIN) ("HDPCs" . SPARSER::DRUG)
    ("odontogenic" . SPARSER::PROTEIN) ("Cbfa1" . SPARSER::PROTEIN)
    ("DMP-1" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("magnesium dichloride" . SPARSER::MOLECULE)
    ("extracellular signal regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vitamin D" . SPARSER::MOLECULE) ("matrix protein 1" . SPARSER::PROTEIN)
    ("DMP1" . SPARSER::PROTEIN) ("matrix protein1" . SPARSER::PROTEIN)
    ("dentin sialophosphoprotein" . SPARSER::PROTEIN)
    ("vitamin D 3" . SPARSER::MOLECULE) ("vitamin D" . SPARSER::MOLECULE)
    ("SREBP1 and/or SCD" . SPARSER::COLLECTION)
    ("PIP 2 and PIP 3" . SPARSER::COLLECTION)
    ("SREBP1c and its downstream target SCD" . SPARSER::COLLECTION)
    ("p53-AKT" . SPARSER::COLLECTION) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("transcriptional activator, and gene" . SPARSER::COLLECTION)
    ("normal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oleic acid or PI" . SPARSER::COLLECTION)
    ("phosphatidylinositol-" . SPARSER::PROTEIN)
    ("SREBP1/SCD" . SPARSER::COLLECTION) ("p53 and AKT" . SPARSER::COLLECTION)
    ("the prosurvival pathway AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SREBP1 and SREBP2" . SPARSER::COLLECTION)
    ("SREBP1c or SCD" . SPARSER::COLLECTION)
    ("SREBP1c and SCD" . SPARSER::COLLECTION)
    ("fatty acyl elongation" . SPARSER::PROTEIN)
    ("FASN (fatty acid synthase) and ELOVL5 (ELOVL fatty acid elongase 5)"
     . SPARSER::COLLECTION)
    ("this lipogenic transcription factor" . SPARSER::PROTEIN)
    ("SREBP1c and its target SCD" . SPARSER::COLLECTION)
    ("Srebp1c" . SPARSER::PROTEIN)
    ("the master lipogenic regulator SREBP1c" . SPARSER::PROTEIN)
    ("phosphatidylinositol (PI)" . SPARSER::MOLECULE)
    ("p53 and its targets p21 and MDM2" . SPARSER::COLLECTION)
    ("p21 and MDM2" . SPARSER::COLLECTION)
    ("lipogenic enzymes" . SPARSER::ENZYME)
    ("Phospholipids" . SPARSER::PHOSPHOLIPID)
    ("the BCL2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Oleic acid" . SPARSER::MOLECULE)
    ("nutlin-3 as" . SPARSER::DRUG) ("PIP 2" . SPARSER::PIP2)
    ("PIP 3" . SPARSER::PIP3) ("SREBF1" . SPARSER::PROTEIN)
    ("SREBP2" . SPARSER::PROTEIN)
    ("ELOVL fatty acid elongase 5" . SPARSER::PROTEIN)
    ("ELOVL5" . SPARSER::PROTEIN)
    ("fatty acid desaturase 2" . SPARSER::PROTEIN) ("FADS2" . SPARSER::PROTEIN)
    ("ELOVL fatty acid elongase 6" . SPARSER::PROTEIN)
    ("ELOVL6" . SPARSER::PROTEIN) ("SREBP1" . SPARSER::PROTEIN)
    ("Srebp1" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("oligodendroglial components" . SPARSER::COMPONENT)
    ("histologic type and grade" . SPARSER::COLLECTION)
    ("type and grade" . SPARSER::COLLECTION)
    ("histologic type, and grade" . SPARSER::COLLECTION)
    ("type, and grade" . SPARSER::COLLECTION)
    ("MYC and specific SNPs (such as rs55705857)" . SPARSER::COLLECTION)
    ("TERT or TERC" . SPARSER::COLLECTION)
    ("TERT or ATRX" . SPARSER::COLLECTION)
    ("an oligodendroglial component" . SPARSER::COMPONENT)
    ("This group and the group" . SPARSER::COLLECTION)
    ("PIK3CA or PIK3R1" . SPARSER::COLLECTION)
    ("CCDC26 and TERT" . SPARSER::COLLECTION)
    ("CDKN2A or CDKN2B" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("the frontal lobe" . SPARSER::PROTEIN)
    ("specific histologic types" . TYPE)
    ("all histologic types and grades" . SPARSER::COLLECTION)
    ("types and grades" . SPARSER::COLLECTION)
    ("the oligodendroglial histologic type" . TYPE)
    ("TERT and IDH" . SPARSER::COLLECTION) ("POT1" . SPARSER::PROTEIN)
    ("RTEL1" . SPARSER::PROTEIN) ("PHLDB1" . SPARSER::PROTEIN)
    ("ATRX , CIC , and FUBP1" . SPARSER::COLLECTION)
    ("a biologic or genetic signature" . SPARSER::COLLECTION)
    ("IDH and 1p/19q" . SPARSER::COLLECTION)
    ("three cohesive tumor classes" . CLASS)
    ("IDH, 1p/19q, and TP53" . SPARSER::COLLECTION)
    ("three robust tumor classes" . CLASS) ("frontal lobes" . SPARSER::PROTEIN)
    ("TERT , NOTCH1 , CIC , and FUBP1" . SPARSER::COLLECTION)
    ("variants, and fusions" . SPARSER::COLLECTION)
    ("EGFR , PDGFRA , MET , and FGFR" . SPARSER::COLLECTION)
    ("NF1 and BRAF" . SPARSER::COLLECTION)
    ("p53 and RB1" . SPARSER::COLLECTION)
    ("MDM2 , MDM4 , MDM1 , CDKN2A and CDKN2B" . SPARSER::COLLECTION)
    ("SYK, E-cadherin, and annexin 1" . SPARSER::COLLECTION)
    ("PROTEIN" . SPARSER::PROTEIN) ("PDGFRA and MET" . SPARSER::COLLECTION)
    ("EGFR and FGFR3" . SPARSER::COLLECTION)
    ("EGFR , FGFR3 , NOTCH1 , ATRX , and CDK4" . SPARSER::COLLECTION)
    ("extra-chromosomal DNA" . SPARSER::DNA)
    ("EGFR , MDM4 , and CDK4" . SPARSER::COLLECTION)
    ("CDKN2A and RB1" . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("CIC , FUBP1 , and NOTCH1" . SPARSER::COLLECTION)
    ("OSC" . SPARSER::PROTEIN) ("CDK4 and PDGFRA" . SPARSER::COLLECTION)
    ("SNF" . SPARSER::PROTEIN-FAMILY) ("SWI" . SPARSER::PROTEIN)
    ("CIC and FUBP1" . SPARSER::COLLECTION)
    ("ATRX and TERT" . SPARSER::COLLECTION)
    ("ZBTB20 (9%) and ARID1A (6%)" . SPARSER::COLLECTION)
    ("this predominant mapping" . SPARSER::PROTEIN)
    ("a specific histologic class" . CLASS)
    ("histologic class and CoC" . SPARSER::COLLECTION)
    ("class and CoC" . SPARSER::COLLECTION) ("M2 and M3" . SPARSER::COLLECTION)
    ("other histologic classes and grades" . SPARSER::COLLECTION)
    ("classes and grades" . SPARSER::COLLECTION)
    ("the oligodendroglioma histologic class" . CLASS)
    ("HISTOLOGIC AND MOLECULAR SUBTYPES" . SPARSER::PROTEIN)
    ("SUBTYPES" . SPARSER::PROTEIN) ("IDH1 and IDH2" . SPARSER::COLLECTION)
    ("IDH1 or IDH2" . SPARSER::COLLECTION)
    ("TP53 and ATRX" . SPARSER::COLLECTION) ("CIC" . SPARSER::PROTEIN)
    ("IDH , 1p/19q, and TP53" . SPARSER::COLLECTION)
    ("IDH , TP53 , and ATRX" . SPARSER::COLLECTION)
    ("histologic class" . CLASS) ("CDKN2C" . SPARSER::PROTEIN)
    ("MDM1" . SPARSER::PROTEIN) ("annexin 1" . SPARSER::PROTEIN)
    ("PLCG1" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("EIF1" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("ZBTB20" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("IDH –1" . SPARSER::PROTEIN) ("mitotic inhibitors" . SPARSER::INHIBITOR)
    ("alkaloids" . SPARSER::MOLECULE)
    ("these nucleolar components" . SPARSER::COMPONENT)
    ("Nucleolar components" . SPARSER::COMPONENT)
    ("Many chemotherapeutic drugs" . SPARSER::DRUG)
    ("actinomycin D, doxorubicin, camptothecin and 5-fluorouracil"
     . SPARSER::COLLECTION)
    ("VE-822 and CX-5461 showed minimal induction of apoptosis"
     . SPARSER::COLLECTION)
    ("100 nM VE-822 and 250 nM KU-60019" . SPARSER::COLLECTION)
    ("VE-822 and KU-60019" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia-mutated (ATM) and ATM-Rad3-related (ATR)"
     . SPARSER::COLLECTION)
    ("nocodazole or both (Fig. xref )" . SPARSER::COLLECTION)
    ("one p53 mutant (SEM) and one p53 wild type (NALM-6) cell lines"
     . SPARSER::COLLECTION)
    ("mutant (SEM)" . SPARSER::MUTANT) ("pifithrin" . SPARSER::DRUG)
    ("p53 or p21" . SPARSER::COLLECTION) ("MLL-AF4" . SPARSER::COLLECTION)
    ("their respective DMSO" . SPARSER::MOLECULE)
    ("SL1 and rDNA" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("AML1-ETO" . SPARSER::COLLECTION)
    ("ribosomal DNA" . SPARSER::DNA)
    ("5-FU, Actinomycin D and DRB" . SPARSER::COLLECTION)
    ("DRB" . SPARSER::PROTEIN)
    ("Recently two novel rRNA synthesis inhibitors" . SPARSER::INHIBITOR)
    ("BMH" . SPARSER::PROTEIN) ("CX" . SPARSER::PROTEIN-FAMILY)
    ("Cyclin-B" . SPARSER::PROTEIN-FAMILY) ("β-TUBULIN" . SPARSER::PROTEIN)
    ("TIF-1A" . SPARSER::PROTEIN) ("factor 1A" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("VE-822" . SPARSER::DRUG)
    ("CDC2" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("AF4" . SPARSER::PROTEIN) ("RS4" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("‐Chk1/Chk2" . SPARSER::COLLECTION)
    ("enol" . SPARSER::MOLECULE) ("guanines" . SPARSER::NUCLEOBASE)
    ("Camptothecin" . SPARSER::DRUG)
    ("GSH and generation of H 2 O 2" . SPARSER::COLLECTION)
    ("Salvicine" . SPARSER::DRUG)
    ("artemisinin and artesunate" . SPARSER::COLLECTION)
    ("Glutathione" . SPARSER::DRUG) ("Artemisinin" . SPARSER::DRUG)
    ("artesunate" . SPARSER::DRUG) ("artemisinin" . SPARSER::DRUG)
    ("Cdc25A and Cdc25B" . SPARSER::COLLECTION)
    ("ATM and ataxia" . SPARSER::COLLECTION) ("DCFDA" . SPARSER::DRUG)
    ("diterpenoid" . SPARSER::MOLECULE)
    ("currently used anticancer drugs" . SPARSER::DRUG)
    ("salvicine" . SPARSER::DRUG) ("fmk" . SPARSER::PROTEIN)
    ("caspases and PARP" . SPARSER::COLLECTION)
    ("the human acute T cell leukemia cell line Jurkat" . SPARSER::PROTEIN)
    ("terpenoids" . SPARSER::MOLECULE) ("MeOH" . SPARSER::MOLECULE)
    ("triterpenoids" . SPARSER::MOLECULE)
    ("ATM/ATR—Chk1/Chk2" . SPARSER::COLLECTION)
    ("diterpenes" . SPARSER::MOLECULE) ("etc ." . SPARSER::PROTEIN)
    ("Rag2" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("Cdc25B" . SPARSER::PROTEIN) ("p53 and a miRNA" . SPARSER::COLLECTION)
    ("p53 and MDM4" . SPARSER::COLLECTION) ("p53-MDM2" . SPARSER::COLLECTION)
    ("CCNE2 and CDK4" . SPARSER::COLLECTION)
    ("CCND1 and CDK6" . SPARSER::COLLECTION)
    ("p53, SNHG1 and TAF9B" . SPARSER::COLLECTION)
    ("stabilizer" . SPARSER::MOLECULE)
    ("tRNAs and rRNAs" . SPARSER::COLLECTION)
    ("Drosha or Dicer" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("84 intronic miRNAs" . SPARSER::PROTEIN)
    ("25-nt-long RNAs" . SPARSER::RNA) ("polycistronic snoRNAs" . SPARSER::RNA)
    ("which targets TAF9B" . SPARSER::PROTEIN)
    ("protein and CDK1A" . SPARSER::COLLECTION)
    ("CDKN1A, HDM2, FAS, BAX and GADD45A" . SPARSER::COLLECTION)
    ("RRM2B, CCNG1, FAS and HDM2" . SPARSER::COLLECTION)
    ("TFIID (transcription initiation factor II D) and TFTC (TATA-binding Protein-free TAF-containing)"
     . SPARSER::COLLECTION)
    ("TFTC" . SPARSER::PROTEIN) ("a canonical miRNA" . SPARSER::PROTEIN)
    ("BHLHE41 (class E basic helix-loop-helix protein 41) and TGFBR2 (transforming growth factor beta receptor II)"
     . SPARSER::COLLECTION)
    ("TAF9B (transcription initiation factor TFIID subunit 9B), BHLHE41 (class E basic helix-loop-helix protein 41) and TGFBR2 (transforming growth factor beta receptor II)"
     . SPARSER::COLLECTION)
    ("other moderately-expressed well characterized miRNAs" . SPARSER::PROTEIN)
    ("Associated small RNAs" . SPARSER::RNA)
    ("sno-miRNAs or snoRNA-derived small RNAs (sdRNAs)" . SPARSER::COLLECTION)
    ("Argonaute (AGO)" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal RNA" . SPARSER::RNA)
    ("the same polycistronic gene" . SPARSER::GENE)
    ("a polycistronic miRNA host gene" . SPARSER::GENE)
    ("PonA" . SPARSER::PROTEIN)
    ("CCNB1 [ xref ] and MIRH1 (miR-17-92 host gene)" . SPARSER::COLLECTION)
    ("E2F1 [ xref ], CCNE2 [ xref ], POLD1 [ xref ], CDCA8 [ xref ], FBXO5 [ xref ], PLK4 [ xref ], BRCA1 [ xref ], CCNB1 [ xref ] and MIRH1 (miR-17-92 host gene)"
     . SPARSER::COLLECTION)
    ("BAX, CCNG1, TLR3 and MIR34A" . SPARSER::COLLECTION)
    ("GAPDH, PSMB4 and C1orf43" . SPARSER::COLLECTION)
    ("p53R2" . SPARSER::PROTEIN) ("ACTB" . SPARSER::PROTEIN)
    ("mRNAs, miRNAs and snoRNAs" . SPARSER::COLLECTION)
    ("p53 and various non-coding RNAs" . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA) ("an operative miRNA" . SPARSER::PROTEIN)
    ("polycistronic C/D box snoRNAs" . SPARSER::RNA) ("snoRNAs" . SPARSER::RNA)
    ("tRNA and rRNAs" . SPARSER::COLLECTION) ("rRNAs" . SPARSER::RNA)
    ("various indirect effectors or non-protein" . SPARSER::COLLECTION)
    ("effectors or non-protein" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("p53, SNHG1, sno-miR-28 and TAF9B" . SPARSER::COLLECTION)
    ("polycistronic miRNA-like non-coding RNAs" . SPARSER::RNA)
    ("U44" . SPARSER::PROTEIN) ("HSV-TK" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("110 kD)" . SPARSER::PROTEIN)
    ("P 32" . SPARSER::PROTEIN) ("CDC2L6" . SPARSER::PROTEIN)
    ("LIN28" . SPARSER::PROTEIN) ("CDK1A" . SPARSER::PROTEIN)
    ("transforming growth factor beta receptor II" . SPARSER::PROTEIN)
    ("TGFBR2" . SPARSER::PROTEIN) ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("BHLHE41" . SPARSER::PROTEIN) ("subunit 9" . SPARSER::PROTEIN)
    ("MIRH1" . SPARSER::PROTEIN) ("PLK4" . SPARSER::PROTEIN)
    ("FBXO5" . SPARSER::PROTEIN) ("CDCA8" . SPARSER::PROTEIN)
    ("POLD1" . SPARSER::PROTEIN) ("PSMB4" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("CCNG1" . SPARSER::PROTEIN)
    ("TAF9B" . SPARSER::PROTEIN) ("small nucleolar RNAs" . SPARSER::RNA)
    ("TLR4 or TLR9" . SPARSER::COLLECTION)
    ("classical anti-inflammatory cytokine" . SPARSER::PROTEIN)
    ("TNF and MCP-1" . SPARSER::COLLECTION)
    ("pro-inflammatory TNFα and MCP-1" . SPARSER::COLLECTION)
    ("preadipocytes" . SPARSER::PROTEIN)
    ("TGFβ, IL-6 or MCP-1" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC4" . SPARSER::COLLECTION)
    ("LPS and CpG" . SPARSER::COLLECTION)
    ("TLR4 and TLR9" . SPARSER::COLLECTION)
    ("only IFNγ or CpG oligonucleotides" . SPARSER::MOLECULE)
    ("IFNγ or CpG" . SPARSER::COLLECTION) ("TLR4 or CpG" . SPARSER::COLLECTION)
    ("pro-inflammatory LPS or IFNγ" . SPARSER::COLLECTION)
    ("LPS or IFNγ" . SPARSER::COLLECTION)
    ("pro-inflammatory TNFα" . SPARSER::PROTEIN)
    ("CD80 or CD86" . SPARSER::COLLECTION)
    ("TNFα and MCP-1" . SPARSER::COLLECTION)
    ("IL-10 and IL-6" . SPARSER::COLLECTION)
    ("HDAC5 mRNA (Fig. xref ) and protein (Fig. xref )" . SPARSER::COLLECTION)
    ("the costimulatory molecules" . SPARSER::MOLECULE)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("a strong promoter" . SPARSER::PROMOTER)
    ("MCP-1 or IL-4 " . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine IFNγ" . SPARSER::PROTEIN)
    ("receptor-" . SPARSER::RECEPTOR)
    ("The HDAC5-specific Western blot" . SPARSER::PROTEIN)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("TNFα, IL-1α, IL-1β and IFNγ" . SPARSER::COLLECTION)
    ("pro-inflammatory macrophages" . SPARSER::PROTEIN)
    ("MCP" . SPARSER::PROTEIN) ("Macrophages" . SPARSER::PROTEIN)
    ("STAT3 or p65" . SPARSER::COLLECTION)
    ("lysine and histone deacetylases (HDAC)" . SPARSER::COLLECTION)
    ("DNA-associated histones" . SPARSER::PROTEIN)
    ("HDAC5-mRNA" . SPARSER::COLLECTION)
    ("the monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("Interferon-γ" . SPARSER::PROTEIN)
    ("deacetylases (HDAC)" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("Cox2" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("IL-4 " . SPARSER::PROTEIN)
    ("130 kD" . SPARSER::PROTEIN) ("pGL4" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("ACC5" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN)
    ("mitotic arrest-deficient 2 molecules" . SPARSER::MOLECULE)
    ("kDa and E4-ORF3" . SPARSER::COLLECTION)
    ("co-infected replication-competent AdF35" . SPARSER::PROTEIN)
    ("Ad-induced p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ad-derived E1B-19 kDa molecules" . SPARSER::MOLECULE)
    ("OBP" . SPARSER::PROTEIN)
    ("infection-induced down-regulated p21 and Mdm-2" . SPARSER::COLLECTION)
    ("p21 and Mdm-2" . SPARSER::COLLECTION)
    ("Sur [ xref ] or TERT promoter [ xref , xref ]" . SPARSER::COLLECTION)
    ("wild-type Ad5 [ xref ] or replication-competent Ad5"
     . SPARSER::COLLECTION)
    ("replication-incompetent Ad5/p53" . SPARSER::COLLECTION)
    ("the MK and the Sur" . SPARSER::COLLECTION)
    ("MK or Sur" . SPARSER::COLLECTION)
    ("simultaneous dual gene" . SPARSER::GENE)
    ("Fiber-modified AdF35" . SPARSER::PROTEIN)
    ("Bax, Fas, p21 and 14-3-3σ" . SPARSER::COLLECTION)
    ("Bax and 14-3-3σ" . SPARSER::COLLECTION)
    ("replication-competent AdF35 and Ad5/p53" . SPARSER::COLLECTION)
    ("Fa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("replication-competent AdF35" . SPARSER::PROTEIN)
    ("Atg5, Beclin-1, and LC3A/B" . SPARSER::COLLECTION)
    ("Atg5" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("Bcl-2 and Bck-xL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("FADD and DR5" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("the late viral protein" . SPARSER::PROTEIN)
    ("the early viral proteins, and hexon" . SPARSER::COLLECTION)
    ("proteins, and hexon" . SPARSER::COLLECTION) ("hexon" . SPARSER::PROTEIN)
    ("hyperploidy fractions and AdF35/LacZ infection" . SPARSER::COLLECTION)
    ("MK-" . SPARSER::PROTEIN) ("Ad5/LacZ" . SPARSER::COLLECTION)
    ("AdF35/LacZ" . SPARSER::COLLECTION) ("AdF35/Sur" . SPARSER::COLLECTION)
    ("Ad5/Sur" . SPARSER::COLLECTION) ("AdF35/MK" . SPARSER::COLLECTION)
    ("Ad5/MK" . SPARSER::COLLECTION)
    ("replication-competent AdF35 and Ad5" . SPARSER::COLLECTION)
    ("AdF35 and Ad5" . SPARSER::COLLECTION) ("AdF35/GFP" . SPARSER::COLLECTION)
    ("Ad5/GFP" . SPARSER::COLLECTION) ("Ad5 and AdF35" . SPARSER::COLLECTION)
    ("AdF35" . SPARSER::PROTEIN)
    ("MK (AdF35-MK) or Sur (AdF35-Sur)" . SPARSER::COLLECTION)
    ("AdF35-Sur" . SPARSER::PROTEIN-PAIR) ("AdF35-MK" . SPARSER::PROTEIN-PAIR)
    ("the midkine ( MK ) or the survivin ( Sur ) gene" . SPARSER::COLLECTION)
    ("an exogenous gene" . SPARSER::GENE) ("midkine ( MK )" . SPARSER::PROTEIN)
    ("Sur" . SPARSER::PROTEIN)
    ("simultaneously transferring dual genes" . SPARSER::GENE)
    ("an exogenous therapeutic gene" . SPARSER::GENE)
    ("the corresponding replication-competent Ad5" . SPARSER::PROTEIN)
    ("Ad5/p53" . SPARSER::COLLECTION) ("AdF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the midkine or the survivin gene" . SPARSER::COLLECTION)
    ("replication-competent Ad5" . SPARSER::PROTEIN)
    ("midkine" . SPARSER::PROTEIN) ("E4-ORF3" . SPARSER::PROTEIN)
    ("Mdm-2" . SPARSER::PROTEIN) ("mm 3" . SPARSER::PROTEIN)
    ("t-Bid" . SPARSER::PROTEIN) ("death receptor 5" . SPARSER::PROTEIN)
    ("CD46" . SPARSER::PROTEIN) ("Type 5" . SPARSER::PROTEIN)
    ("Ad5" . SPARSER::PROTEIN) ("type 5" . SPARSER::PROTEIN)
    ("RAS and EGFR" . SPARSER::COLLECTION)
    ("antibody-EGFR" . SPARSER::COLLECTION)
    ("cetuximab or control antibody rituximab" . SPARSER::COLLECTION)
    ("cetuximab, panitumumab and erlotinib" . SPARSER::COLLECTION)
    ("rituximab or erlotinib" . SPARSER::COLLECTION)
    ("wt or mutant" . SPARSER::COLLECTION)
    ("mutant and ii" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("Fc" . SPARSER::PROTEIN)
    ("the previously published EGFR S492R mutant" . SPARSER::MUTANT)
    ("EGFR-Fc" . SPARSER::COLLECTION)
    ("panitumumab and FOLFOX" . SPARSER::COLLECTION)
    ("EGFR and RAS" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("EGFR antibody-naïve" . SPARSER::COLLECTION)
    ("the chimeric EGFR antibody cetuximab and the fully human antibody panitumumab"
     . SPARSER::COLLECTION)
    ("the fully human antibody panitumumab" . SPARSER::DRUG)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("aa1" . SPARSER::PROTEIN) ("KRAS 2" . SPARSER::PROTEIN)
    ("TAZ and HIF-1" . SPARSER::COLLECTION)
    ("JMJD2C and PKM2" . SPARSER::COLLECTION)
    ("TAZ-HIF-1α" . SPARSER::COLLECTION)
    ("the specific target genes and mechanisms of transcriptional activation and co-activation that mediate this effect"
     . SPARSER::COLLECTION)
    ("those encoding plasminogen activator inhibitor 1 and the anti-apoptotic factor survivin [ xref ]"
     . SPARSER::COLLECTION)
    ("HIF-1 and TAZ" . SPARSER::COLLECTION)
    ("TAZ and the SIAH1 gene" . SPARSER::COLLECTION)
    ("HIF-1α (Figure xref ) and HIF-1β (Figure xref )" . SPARSER::COLLECTION)
    ("BNIP3 (Figure xref ) and P4HA2 (Figure xref )" . SPARSER::COLLECTION)
    ("the HIF-1 target genes PDK1 (Figure xref ), LDHA (Figure xref ), BNIP3 (Figure xref ) and P4HA2 (Figure xref )"
     . SPARSER::COLLECTION)
    ("the CTGF proximal promoter" . SPARSER::PROMOTER)
    ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("NTC or shT1" . SPARSER::COLLECTION)
    ("HIF-1α or TAZ" . SPARSER::COLLECTION)
    ("HIF-1α or HIF-1β" . SPARSER::COLLECTION)
    ("HIF-1α, HIF-1β, or TAZ" . SPARSER::COLLECTION)
    ("pGL2-CTGF" . SPARSER::COLLECTION) ("-RCGTG-3" . SPARSER::COLLECTION)
    ("-GGAATG-3" . SPARSER::COLLECTION)
    ("shRNA or shRNA" . SPARSER::COLLECTION)
    ("TAZ (Figure xref ) and anti-TAZ antibody" . SPARSER::COLLECTION)
    ("glutathione- S -transferase (GST) and a recombinant GST-HIF-1α (531-826) fusion protein"
     . SPARSER::COLLECTION)
    ("anti-TAZ and anti-GST" . SPARSER::COLLECTION)
    ("GST-HIF-1α" . SPARSER::COLLECTION) ("Renilla" . SPARSER::PROTEIN)
    ("HIF-1–dependent reporter plasmid p2.1" . SPARSER::PROTEIN)
    ("pSV-Renilla" . SPARSER::COLLECTION) ("pSV" . SPARSER::PROTEIN)
    ("shT" . SPARSER::PROTEIN) ("NTC" . SPARSER::PROTEIN)
    ("TAZ and HIF-1α" . SPARSER::COLLECTION) ("TAZ/TEAD" . SPARSER::COLLECTION)
    ("Pontin [ xref ] and XBP1s [ xref ]" . SPARSER::COLLECTION)
    ("Pontin" . SPARSER::PROTEIN)
    ("SLC2A1 , LDHA , and PDK1" . SPARSER::COLLECTION)
    ("lactate dehydrogenase A, and pyruvate dehydrogenase kinase 1"
     . SPARSER::COLLECTION)
    ("Pyruvate" . SPARSER::PROTEIN)
    ("prolyl and asparaginyl" . SPARSER::COLLECTION)
    ("Elongin" . SPARSER::PROTEIN) ("PHD1-3" . SPARSER::COLLECTION)
    ("asparaginyl" . SPARSER::PROTEIN)
    ("subunits, HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("Intratumoral hypoxia" . SPARSER::PROTEIN)
    ("PDK1, LDHA, BNIP3 and P4HA2" . SPARSER::COLLECTION)
    ("HIF-1α and TAZ" . SPARSER::COLLECTION)
    ("TAZ and TAZ" . SPARSER::COLLECTION)
    ("intratumoral hypoxia" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("pGL2" . SPARSER::PROTEIN)
    ("glutathione- S -transferase" . SPARSER::PROTEIN)
    ("pG5" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("HIF-2" . SPARSER::PROTEIN)
    ("XBP1s" . SPARSER::PROTEIN) ("JMJD2C" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 1" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("Cullin 2" . SPARSER::PROTEIN)
    ("von Hippel-Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("asparagine residue" . SPARSER::MOLECULE) ("FIH-1" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN) ("P4HA2" . SPARSER::PROTEIN)
    ("Xin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Yang" . SPARSER::PROTEIN)
    ("NICD and Smad3" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION) ("TRex" . SPARSER::PROTEIN-FAMILY)
    ("hCLP46 1–120 aa (no CAP10 domain) or hCLP46 121–392 aa (with CAP10 domain)"
     . SPARSER::COLLECTION)
    ("other global regulators" . SPARSER::REGULATOR)
    ("Rumi" . SPARSER::PROTEIN) ("hCLP46" . SPARSER::PROTEIN)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("Yan" . SPARSER::PROTEIN) ("NuMA-LGN" . SPARSER::PROTEIN-PAIR)
    ("mitotic kinases" . SPARSER::KINASE)
    ("PLK1 and TTK" . SPARSER::COLLECTION) ("TTK" . SPARSER::PROTEIN)
    ("NDR1-Mob2" . SPARSER::COLLECTION) ("TIP" . SPARSER::PROTEIN)
    ("EB1" . SPARSER::PROTEIN) ("the astral microtubules" . SPARSER::PROTEIN)
    ("astral microtubules and cortical proteins" . SPARSER::COLLECTION)
    ("cortical proteins" . SPARSER::PROTEIN)
    ("either LGN (~44% for GFP-NDR1 3A and ~39% for GFP-NDR1 EAIS ) or NuMA (~30% for GFP-NDR1 3A and ~28% for GFP-NDR1 EAIS )"
     . SPARSER::COLLECTION)
    ("LGN/NuMA" . SPARSER::COLLECTION)
    ("Dynein-dynactin" . SPARSER::COLLECTION)
    ("dynein-dynactin" . SPARSER::COLLECTION)
    ("dynactin" . SPARSER::PROTEIN-FAMILY)
    ("Mob2 and Mob1" . SPARSER::COLLECTION) ("GFP-Mob1A" . SPARSER::COLLECTION)
    ("mCherry-Mob2" . SPARSER::COLLECTION) ("GST-Mob1" . SPARSER::COLLECTION)
    ("phosphomimetic mutant NDR1 3E" . SPARSER::PROTEIN)
    ("PLK1-NDR1" . SPARSER::COLLECTION)
    ("NDR1 and its substrates" . SPARSER::COLLECTION)
    ("phospho-mimetic mutant" . SPARSER::MUTANT)
    ("Flag-NDR1" . SPARSER::COLLECTION) ("MBP-NDR1" . SPARSER::COLLECTION)
    ("GST-PLK1" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("FLAG-NDR1" . SPARSER::COLLECTION) ("GFP-PLK1" . SPARSER::COLLECTION)
    ("PLK1 and NDR1" . SPARSER::COLLECTION) ("PW" . SPARSER::MOLECULE)
    ("ACA" . SPARSER::PROTEIN) ("GFP-NDR1" . SPARSER::COLLECTION)
    ("mitotic NDR1" . SPARSER::PROTEIN)
    ("a primordial kinase" . SPARSER::KINASE)
    ("mitotic kinase PLK1" . SPARSER::PROTEIN)
    ("astral microtubules" . SPARSER::PROTEIN)
    ("ends-directed motor complex" . SPARSER::BIO-COMPLEX)
    ("Dynein-Dynactin" . SPARSER::COLLECTION)
    ("other cortical polarity proteins" . SPARSER::PROTEIN)
    ("LGN-NuMA" . SPARSER::COLLECTION)
    ("LGN-NuMA-Dynein-Dynactin" . SPARSER::COLLECTION)
    ("Dynactin" . SPARSER::PROTEIN-FAMILY) ("Dynein" . SPARSER::PROTEIN)
    ("NuMA" . SPARSER::PROTEIN) ("LGN" . SPARSER::PROTEIN)
    ("P-1" . SPARSER::PROTEIN) ("Sgo1" . SPARSER::PROTEIN)
    ("Mob1A" . SPARSER::PROTEIN) ("GPS 2" . SPARSER::PROTEIN)
    ("Mob2" . SPARSER::PROTEIN) ("NDR1" . SPARSER::PROTEIN)
    ("critically important targets" . SPARSER::TARGET-PROTEIN)
    ("CCNE1 , CCNE2 , and CDC25A" . SPARSER::COLLECTION)
    ("target genes and pathways" . SPARSER::COLLECTION)
    ("CCNE2 , CDC25A , and PKMYT1" . SPARSER::COLLECTION)
    ("‘peroxisome'" . SPARSER::PROTEIN)
    ("CCNE2 , PKMYT1 , CDC25A , and CCNE1" . SPARSER::COLLECTION)
    ("mock or miR-control transfectants" . SPARSER::PROTEIN)
    ("- 1" . SPARSER::PROTEIN) ("tumour-suppressive miRNAs" . SPARSER::PROTEIN)
    ("CCNE1 and CCNE2" . SPARSER::COLLECTION)
    ("CCNE1 or CCNE2" . SPARSER::COLLECTION)
    ("CCNE1 , CCNE2 , CDC25A , and PKMYT1" . SPARSER::COLLECTION)
    ("BIRC5" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("miR-133a" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("cell division cycle 25A" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("non-muscle" . SPARSER::PROTEIN)
    ("PKMYT1" . SPARSER::PROTEIN) ("CCNE2" . SPARSER::PROTEIN)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("cytosolic BRCA1 and distant MFS" . SPARSER::COLLECTION)
    ("dysfunctional BRCA1" . SPARSER::PROTEIN)
    ("caveolin and osteopontin" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("BRCA1 or mutant" . SPARSER::COLLECTION)
    ("p53 and BARD1" . SPARSER::COLLECTION)
    ("importin/CRM1" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN)
    ("BRCA1-associated RING domain protein 1" . SPARSER::PROTEIN)
    ("newly synthesised viral DNA" . SPARSER::DNA)
    ("Rad51 and Rad52" . SPARSER::COLLECTION)
    ("RNF8 and RNF168" . SPARSER::COLLECTION)
    ("these viral proteins" . SPARSER::PROTEIN)
    ("RTA and K8α" . SPARSER::COLLECTION)
    ("NBS1 and RPA32" . SPARSER::COLLECTION)
    ("ATM and downstream substrates" . SPARSER::COLLECTION)
    ("RPA32 and H2AX" . SPARSER::COLLECTION)
    ("LANA and ORF57" . SPARSER::COLLECTION)
    ("ORF6 and K8α" . SPARSER::COLLECTION) ("discrete foci" . SPARSER::PROTEIN)
    ("doxycycline and DMSO" . SPARSER::COLLECTION)
    ("DMSO or the higher concentrations of DDR kinase inhibitors 1 h"
     . SPARSER::COLLECTION)
    ("DNA-PK and ATM" . SPARSER::COLLECTION)
    ("ATM, NBS1 and CHK2" . SPARSER::COLLECTION)
    ("PKi" . SPARSER::PROTEIN-FAMILY)
    ("ATR, ATM and DNA-PK inhibitors or an equivalent concentration of DMSO 1 h"
     . SPARSER::COLLECTION)
    ("ATR, ATM and DNA-PK" . SPARSER::COLLECTION)
    ("viral DNA or expression of late lytic proteins" . SPARSER::COLLECTION)
    ("late lytic proteins" . SPARSER::PROTEIN)
    ("H2AX and RPA32" . SPARSER::COLLECTION)
    ("the immediate-early lytic proteins RTA and ORF57" . SPARSER::COLLECTION)
    ("ganciclovir and doxycycline" . SPARSER::COLLECTION)
    ("RTA and ORF57" . SPARSER::COLLECTION)
    ("doxycycline and ganciclovir or ganciclovir" . SPARSER::COLLECTION)
    ("ganciclovir or ganciclovir" . SPARSER::COLLECTION)
    ("hy" . SPARSER::MOLECULE) ("Ganciclovir" . SPARSER::DRUG)
    ("the antiviral compound ganciclovir" . SPARSER::DRUG)
    ("SMC1 and CHK1" . SPARSER::COLLECTION)
    ("ATM, DNA-PKcs, CHK2, KAP1, NBS1, RPA32 and H2AX" . SPARSER::COLLECTION)
    ("immediate-early lytic proteins" . SPARSER::PROTEIN)
    ("ORF50/RTA" . SPARSER::COLLECTION)
    ("immediate-early lytic protein ORF57" . SPARSER::PROTEIN)
    ("ATR-interacting protein (ATRIP)" . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("ATRIP" . SPARSER::PROTEIN)
    ("Ku70/Ku80" . SPARSER::COLLECTION)
    ("H2AX, CHK2, KAP1, SMC1 and NBS1" . SPARSER::COLLECTION)
    ("ATM- and Rad3-related" . SPARSER::COLLECTION)
    ("Lytic viral genes" . SPARSER::GENE)
    ("The viral replication and transcription activator (RTA)"
     . SPARSER::PROTEIN)
    ("RTA" . SPARSER::PROTEIN) ("viral DNA" . SPARSER::DNA)
    ("the latency-associated nuclear antigen (LANA)" . SPARSER::PROTEIN)
    ("antigen (LANA)" . SPARSER::PROTEIN) ("viral genes" . SPARSER::GENE)
    ("LANA" . SPARSER::PROTEIN) ("MCD" . SPARSER::PROTEIN)
    ("RPA32 and MRE11" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION) ("Rad52" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("v-cyclin" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ORF59" . SPARSER::PROTEIN) ("ORF6" . SPARSER::PROTEIN)
    ("NU7441" . SPARSER::MOLECULE) ("ORF57" . SPARSER::PROTEIN)
    ("TOPBP1" . SPARSER::PROTEIN) ("DNA topoisomerase 2" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN)
    ("DNA-PK catalytic subunit" . SPARSER::PROTEIN) ("Ku80" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("ORF50" . SPARSER::PROTEIN)
    ("replication and transcription activator" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Par1A" . SPARSER::PROTEIN) ("Wnt5a" . SPARSER::PROTEIN)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("Wnt2b, Wnt5, Wnt10 and several receptors" . SPARSER::COLLECTION)
    ("arginine and proline" . SPARSER::COLLECTION)
    ("VEGF, CD24 , and NEDD9" . SPARSER::COLLECTION)
    ("the cancer stem cell-associated membrane protein CD24"
     . SPARSER::PROTEIN)
    ("a cytoskeletal protein" . SPARSER::PROTEIN)
    ("LKB1 and nuclear β-catenin (Figure xref , R = −0.147, P < 0.05)"
     . SPARSER::COLLECTION)
    ("LKB1 and β-catenin" . SPARSER::COLLECTION)
    ("TOPFlash" . SPARSER::PROTEIN) ("TOPFlash-Luc" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("Wnt-5B" . SPARSER::PROTEIN)
    ("Wnt2b" . SPARSER::PROTEIN) ("arginine/proline" . SPARSER::COLLECTION)
    ("Genes and Genomes (KEGG)" . SPARSER::COLLECTION)
    ("LKB1, HIF-1α, CA9, CD24, VCL, TLN1, Wnt4, and Wnt5"
     . SPARSER::COLLECTION)
    ("Vinculin (VCL)" . SPARSER::PROTEIN) ("VCL" . SPARSER::PROTEIN)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION) ("shorter TTR" . SPARSER::PROTEIN)
    ("TTR" . SPARSER::PROTEIN) ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("APC and E-Cad" . SPARSER::COLLECTION)
    ("uncovered potential target genes and critical signaling pathways such as Wnt/β-catenin"
     . SPARSER::COLLECTION)
    ("P53 or PTEN" . SPARSER::COLLECTION) ("ERRFI" . SPARSER::PROTEIN)
    ("IL-6/STAT" . SPARSER::COLLECTION) ("K-RAS/MAPK" . SPARSER::COLLECTION)
    ("EGFR, N-RAS, PI3K , and APC" . SPARSER::COLLECTION)
    ("LKB1 and nuclear β-catenin" . SPARSER::COLLECTION)
    ("Vinculin" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("S6k" . SPARSER::PROTEIN) ("Talin 1" . SPARSER::PROTEIN)
    ("Par1" . SPARSER::PROTEIN) ("Gsk3β" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("NEDD9" . SPARSER::PROTEIN) ("N-Cad" . SPARSER::PROTEIN)
    ("Wnt-5" . SPARSER::PROTEIN) ("FZD2" . SPARSER::PROTEIN)
    ("C-MYC" . SPARSER::PROTEIN) ("CYCD1" . SPARSER::PROTEIN)
    ("FZD1" . SPARSER::PROTEIN) ("Wnt2" . SPARSER::PROTEIN)
    ("Wnt4" . SPARSER::PROTEIN) ("TLN1" . SPARSER::PROTEIN)
    ("E-Cad" . SPARSER::PROTEIN) ("Liver kinase B1" . SPARSER::PROTEIN)
    ("N-RAS" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("Talin1" . SPARSER::PROTEIN) ("active and inactive" . SPARSER::COLLECTION)
    ("MRL" . SPARSER::PROTEIN-FAMILY) ("IFNα and IL-6" . SPARSER::COLLECTION)
    ("immunoregulatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and transforming growth factor" . SPARSER::COLLECTION)
    ("eGFP" . SPARSER::PROTEIN) ("IL-21 and STAT3" . SPARSER::COLLECTION)
    ("RM" . SPARSER::MOLECULE)
    ("regulators of gene expression and function" . SPARSER::COLLECTION)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY) ("Naïve" . SPARSER::PROTEIN)
    ("STAT3 and the main signaling molecule" . SPARSER::COLLECTION)
    ("STAT1 and STAT5" . SPARSER::COLLECTION)
    ("autoantibodies and IgG" . SPARSER::COLLECTION)
    ("autoantibodies" . SPARSER::PROTEIN)
    ("programmed death (PD)-1 and CXC chemokine receptor (CXCR)"
     . SPARSER::COLLECTION)
    ("chemokine receptor (CXCR)" . SPARSER::PROTEIN)
    ("autoreactive antibodies" . SPARSER::ANTIBODY)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("STAT3 and IL-21" . SPARSER::COLLECTION)
    ("a key cytokine" . SPARSER::PROTEIN) ("autoantibody" . SPARSER::PROTEIN)
    ("Interleukin" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("IL-21 receptor" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("cucurbitacin I" . SPARSER::DRUG) ("RPS11" . SPARSER::PROTEIN)
    ("3A3" . SPARSER::PROTEIN) ("UCHL1" . SPARSER::PROTEIN)
    ("Brefeldin A" . SPARSER::MOLECULE)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("shCav-1" . SPARSER::COLLECTION) ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("esters" . SPARSER::MOLECULE)
    ("caveolin-1, -2 and -3" . SPARSER::COLLECTION)
    ("caveolin" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("caveolin-2" . SPARSER::PROTEIN) ("caveolin-3" . SPARSER::PROTEIN)
    ("phorbol-13-acetate" . SPARSER::MOLECULE)
    ("Wee1 and/or Chk1" . SPARSER::COLLECTION)
    ("Wee1 as well as Chk1" . SPARSER::COLLECTION)
    ("DNA-damage and anti-tumour" . SPARSER::COLLECTION)
    ("Chk1 and Wee1" . SPARSER::COLLECTION) ("tyr" . SPARSER::AMINO-ACID)
    ("novel Chk1 (MK-8876/SCH 900776) and Chk1/2 (LY2606368) inhibitors"
     . SPARSER::COLLECTION)
    ("Chk1 and Chk1/2" . SPARSER::COLLECTION)
    ("Wee1 (MK1775) and Chk1 inhibitors PF-00477736 (or allegedly AZD7762)"
     . SPARSER::COLLECTION)
    ("Chk1 or Wee1" . SPARSER::COLLECTION)
    ("Wee1 (MK1775) and Chk1 (MK8776)" . SPARSER::COLLECTION)
    ("Chk1-" . SPARSER::PROTEIN) ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("commercial inhibitors" . SPARSER::INHIBITOR)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("DNA-replication" . SPARSER::DNA) ("phospho-Histone" . SPARSER::PROTEIN)
    ("the respective drugs" . SPARSER::DRUG)
    ("DNA-damage and apoptosis in melanoma cell lines" . SPARSER::COLLECTION)
    ("Caspase 3 and PARP" . SPARSER::COLLECTION)
    ("Wee1 and Chk1" . SPARSER::COLLECTION)
    ("DNA-damage and apoptosis" . SPARSER::COLLECTION)
    ("SD " . SPARSER::PROTEIN) ("b and d" . SPARSER::COLLECTION)
    ("200nM MK1775 and/or 100nM AZD7762" . SPARSER::COLLECTION)
    ("MK1775 and AZD7762" . SPARSER::COLLECTION)
    ("Wee1 or Chk1" . SPARSER::COLLECTION) ("MK" . SPARSER::PROTEIN)
    ("MK1775 or 100nM" . SPARSER::COLLECTION)
    ("the other cell lines neither MK1775 nor AZD7762" . SPARSER::COLLECTION)
    ("the commercially available inhibitors MK1775 (Wee1) and AZD7762 (Chk1/2)"
     . SPARSER::COLLECTION)
    ("the commercially available inhibitors MK1775" . SPARSER::DRUG)
    ("Wee1 inhibitor MK1775 and Chk1/2 inhibitor AZD7762"
     . SPARSER::COLLECTION)
    ("Chk1 and ATM" . SPARSER::COLLECTION)
    ("ATR-Chk1-CDC25" . SPARSER::COLLECTION)
    ("ATM-Chk2-p53-p21" . SPARSER::COLLECTION)
    ("increased DNA-damage" . SPARSER::DNA)
    ("DNA-damage or replication" . SPARSER::COLLECTION)
    ("CDK2 and CDK1" . SPARSER::COLLECTION)
    ("unrepaired DNA-damage" . SPARSER::DNA) ("DNA-repair" . SPARSER::DNA)
    ("Ipilimumab, Vemurafenib, Trametinib and Dabrafenib"
     . SPARSER::COLLECTION)
    ("Dabrafenib" . SPARSER::DRUG) ("Ipilimumab" . SPARSER::DRUG)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Wee1 and Chk1/2" . SPARSER::COLLECTION)
    ("types and makes" . SPARSER::COLLECTION) ("LY2606368" . SPARSER::DRUG)
    ("SCH 900776" . SPARSER::DRUG) ("MK8776" . SPARSER::DRUG)
    ("PLX4720" . SPARSER::DRUG) ("foxn1" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("MK1775" . SPARSER::DRUG)
    ("a catalytically inactive telomerase enzyme complex"
     . SPARSER::BIO-COMPLEX)
    ("INS1b and FL-hTERT" . SPARSER::COLLECTION)
    ("the risk-associated minor (A) allele" . SPARSER::ALLELE)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("protein and INS1b" . SPARSER::COLLECTION)
    ("pIRES-neo" . SPARSER::COLLECTION)
    ("an inactive enzyme complex" . SPARSER::BIO-COMPLEX)
    ("full-length and INS1b" . SPARSER::COLLECTION)
    ("pIRES-hTERT" . SPARSER::COLLECTION)
    ("metaphase telomere dysfunction-induced foci" . SPARSER::PROTEIN)
    ("TIFs" . SPARSER::PROTEIN) ("fragment (TRF)" . SPARSER::FRAGMENT)
    ("TRF" . SPARSER::PROTEIN) ("pIRES-hTERT-INS1b" . SPARSER::COLLECTION)
    ("pIRES" . SPARSER::PROTEIN) ("pIRES-INS1b" . SPARSER::COLLECTION)
    ("INS1b" . SPARSER::PROTEIN) ("hTERT-INS1b" . SPARSER::PROTEIN-PAIR)
    ("INS1 and INS1b" . SPARSER::COLLECTION) ("Intron" . SPARSER::PROTEIN)
    ("the telomerase-positive breast cancer cell line MCF7" . SPARSER::PROTEIN)
    ("cancer-risk associated (A) allele" . SPARSER::ALLELE)
    ("p53 and pRB" . SPARSER::COLLECTION)
    ("the risk-associated minor allele" . SPARSER::ALLELE)
    ("hTR" . SPARSER::RNA) ("-hTERT" . SPARSER::COLLECTION)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("Int4" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("INS1" . SPARSER::PROTEIN) ("Yin and Yang" . SPARSER::COLLECTION)
    ("Yin-Yang" . SPARSER::PROTEIN-PAIR) ("Yin" . SPARSER::PROTEIN)
    ("long-living cellular proteins and organelles" . SPARSER::COLLECTION)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("c-Myc, Ah, Arnt, ER, AR, GATAs, p53, MEF2C, Smad2-4, Msx1, Rb, NF-κB, NF-YA, VHL, MyoD, E2F, NFAT-1, and YY1"
     . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN) ("GATAs" . SPARSER::PROTEIN)
    ("Ah" . SPARSER::MOLECULE) ("JNK/CDK1" . SPARSER::COLLECTION)
    ("that cantharidin and OA share extremely similar effects on expression on target genes"
     . SPARSER::COLLECTION)
    ("a classic autophagy inhibitor" . SPARSER::INHIBITOR)
    ("DsRed-LC3" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("cantharidin and OA repressed p21 expression through a PP2A independent manner"
     . SPARSER::COLLECTION)
    ("a transcriptional activator or a repressor" . SPARSER::COLLECTION)
    ("PP2A/JNK/Sp1" . SPARSER::COLLECTION)
    ("PP2A/JNK/CDK1" . SPARSER::COLLECTION)
    ("the unique G2/M cell cycle regulator" . SPARSER::REGULATOR)
    ("siRNAs or PP2A" . SPARSER::COLLECTION) ("CKIs" . SPARSER::PROTEIN)
    ("colchicine" . SPARSER::DRUG) ("Colchicine" . SPARSER::DRUG)
    ("mithramycin" . SPARSER::DRUG)
    ("the classic JNK inhibitor" . SPARSER::INHIBITOR)
    ("p38, Akt, and PKC" . SPARSER::COLLECTION)
    ("a multimeric serine/threonine phosphatase" . SPARSER::PHOSPHATASE)
    ("PP2A/JNK/Sp1/CDK1" . SPARSER::COLLECTION)
    ("Cantharidin and OA also up-regulated the expression of p21"
     . SPARSER::COLLECTION)
    ("PP2A/JNK" . SPARSER::COLLECTION) ("Cantharidin" . SPARSER::MOLECULE)
    ("JNK/Sp1" . SPARSER::COLLECTION)
    ("cantharidin and okadaic acid (OA)" . SPARSER::COLLECTION)
    ("cantharidin" . SPARSER::MOLECULE) ("GAG-3" . SPARSER::PROTEIN)
    ("PP2 Ac" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("YY1" . SPARSER::PROTEIN)
    ("NFAT-1" . SPARSER::PROTEIN) ("NF-YA" . SPARSER::PROTEIN)
    ("Msx1" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("Protein phosphatase 2" . SPARSER::PROTEIN)
    ("ATM or TP53" . SPARSER::COLLECTION)
    ("sporadic colon cancer" . SPARSER::PROTEIN)
    ("CADM1 or IGSF4" . SPARSER::COLLECTION)
    ("SDHD and H2AX" . SPARSER::COLLECTION) ("SDHD" . SPARSER::PROTEIN)
    ("sporadic NB" . SPARSER::PROTEIN)
    ("a large distal part" . SPARSER::COMPONENT) ("SRO" . SPARSER::PROTEIN)
    ("NB and 11q" . SPARSER::COLLECTION) ("kd" . SPARSER::PROTEIN)
    ("kd-LacZ" . SPARSER::COLLECTION) ("BCHE" . SPARSER::PROTEIN)
    ("MYC/MYCN" . SPARSER::COLLECTION) ("DNER or TEX15" . SPARSER::COLLECTION)
    ("DNER (downregulated 6.38-fold in SK-N-SH kd-3650 cells vs SK-N-SH LacZ cells; thus consistent with negative regulation by MYCN [ xref ]) and TEX15 (upregulated 2.39-fold in SK-N-SH kd-3650 cells vs SK-N-SH LacZ cells; thus consistent with positive regulation by MYCN [ xref ])"
     . SPARSER::COLLECTION)
    ("only two genes" . SPARSER::GENE) ("DNER" . SPARSER::PROTEIN)
    ("RHOC" . SPARSER::PROTEIN) ("LacZ or CLBGa" . SPARSER::COLLECTION)
    ("CLU" . SPARSER::PROTEIN) ("PTMA" . SPARSER::PROTEIN)
    ("MTAP" . SPARSER::PROTEIN) ("CRTAP" . SPARSER::PROTEIN)
    ("ALK and PHOX2B" . SPARSER::COLLECTION)
    ("MYCN , ALK , and PHOX2B" . SPARSER::COLLECTION)
    ("almost undetectable protein" . SPARSER::PROTEIN)
    ("strong ATM" . SPARSER::PROTEIN) ("external mutagens" . SPARSER::MOLECULE)
    ("ATM/p53" . SPARSER::COLLECTION) ("Ga" . SPARSER::PROTEIN)
    ("CLB-Ga" . SPARSER::COLLECTION) ("several neuronal genes" . SPARSER::GENE)
    ("SYP" . SPARSER::PROTEIN) ("NEFH" . SPARSER::PROTEIN)
    ("NEFM" . SPARSER::PROTEIN) ("NEFL" . SPARSER::PROTEIN)
    ("MAPT" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("p21/WAF1" . SPARSER::COLLECTION) ("enediyne" . SPARSER::MOLECULE)
    ("one of the ATM phosphorylation substrates and transcriptional effectors [ xref ]"
     . SPARSER::COLLECTION)
    ("almost undetectable ATM protein" . SPARSER::PROTEIN)
    ("LacZ" . SPARSER::PROTEIN)
    ("functional ATM and p53" . SPARSER::COLLECTION) ("CHP" . SPARSER::PROTEIN)
    ("EFS" . SPARSER::PROTEIN)
    ("a homonymous Ser/Thr protein kinase" . SPARSER::KINASE)
    ("adrenergic" . SPARSER::PROTEIN)
    ("a potential haploinsufficient neuroblastoma tumor suppressor"
     . SPARSER::SUPPRESSOR)
    ("CLB" . SPARSER::PROTEIN)
    ("a cell cycle checkpoint kinase and tumor suppressor"
     . SPARSER::COLLECTION)
    ("ATM , a cell cycle checkpoint kinase and tumor suppressor"
     . SPARSER::COLLECTION)
    ("nutlin-3" . SPARSER::DRUG) ("IGSF4" . SPARSER::PROTEIN)
    ("CADM1" . SPARSER::PROTEIN) ("TSLC1" . SPARSER::PROTEIN)
    ("IMPA2" . SPARSER::PROTEIN) ("MAGEC2" . SPARSER::PROTEIN)
    ("ZNF208" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("CDO1" . SPARSER::PROTEIN) ("GALNT1" . SPARSER::PROTEIN)
    ("ACOT2" . SPARSER::PROTEIN) ("ACOT1" . SPARSER::PROTEIN)
    ("TSTD1" . SPARSER::PROTEIN) ("TEX15" . SPARSER::PROTEIN)
    ("SYT4" . SPARSER::PROTEIN) ("SUSD5" . SPARSER::PROTEIN)
    ("PDE5A" . SPARSER::PROTEIN) ("UBE2H" . SPARSER::PROTEIN)
    ("SYNPO2" . SPARSER::PROTEIN) ("SKA3" . SPARSER::PROTEIN)
    ("SESTD1" . SPARSER::PROTEIN) ("RAD54L" . SPARSER::PROTEIN)
    ("RAD51AP1" . SPARSER::PROTEIN) ("MBNL2" . SPARSER::PROTEIN)
    ("CNTN1" . SPARSER::PROTEIN) ("PRMT1" . SPARSER::PROTEIN)
    ("DKC1" . SPARSER::PROTEIN) ("ATAD2" . SPARSER::PROTEIN)
    ("PHOX2B" . SPARSER::PROTEIN) ("NTRK2" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("GAP43" . SPARSER::PROTEIN)
    ("LIN28B" . SPARSER::PROTEIN) ("N-myc" . SPARSER::PROTEIN)
    ("cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("AKT1 not only mislocalizes p27" . SPARSER::PROTEIN)
    ("RhoA-p27" . SPARSER::PROTEIN-PAIR)
    ("the mechanism whereby mutant AKT1" . SPARSER::PROTEIN)
    ("p27-4A" . SPARSER::PROTEIN) ("cyclin/cdks" . SPARSER::COLLECTION)
    ("RAS [ xref , xref ] and mutant p53 [ xref ]" . SPARSER::COLLECTION)
    ("KRAS, PIK3CA or AKT1" . SPARSER::COLLECTION)
    ("AKT1 or PIK3CA" . SPARSER::COLLECTION)
    ("pAKT and p27" . SPARSER::COLLECTION)
    ("AKT1, PIK3CA and KRAS, polysomy or gene" . SPARSER::COLLECTION)
    ("KRAS, polysomy or gene" . SPARSER::COLLECTION)
    ("AKT1 and PIK3CA" . SPARSER::COLLECTION)
    ("BEAS-p274A" . SPARSER::COLLECTION) ("BEAS-p27-4A" . SPARSER::COLLECTION)
    ("BEAS" . SPARSER::PROTEIN) ("BEAS-PIK3CA" . SPARSER::PROTEIN-PAIR)
    ("pAKT (S473) and pGSK3α/β (9/21)" . SPARSER::COLLECTION)
    ("the exogenous AKT1-WT or AKT1-E17K proteins" . SPARSER::PROTEIN)
    ("RAS, p53 or ERBB2" . SPARSER::COLLECTION)
    ("relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("p110 α-catalytic subunit of PI3K" . SPARSER::COLLECTION)
    ("Type VII" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN)
    ("cyclin dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("p110 α" . SPARSER::PROTEIN) ("MLH1 or MSH2" . SPARSER::COLLECTION)
    ("MSH6 , PMS2 and EPCAM" . SPARSER::COLLECTION)
    ("more potential hazardous chemicals" . SPARSER::MOLECULE)
    ("only blood group" . SPARSER::MOLECULE) ("EPCAM" . SPARSER::PROTEIN)
    ("MLH1 , MSH2 , and MSH6" . SPARSER::COLLECTION)
    ("genes, and patients" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION) ("D5S346" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("transgene and gene" . SPARSER::COLLECTION)
    ("the cationic lipids" . SPARSER::LIPID)
    ("neutral lipids" . SPARSER::LIPID) ("Cationic lipids" . SPARSER::LIPID)
    ("nanovesicles" . SPARSER::PROTEIN)
    ("FGFR2 and EGFR" . SPARSER::COLLECTION) ("TUC" . SPARSER::PROTEIN)
    ("AZD4547, or siRNA" . SPARSER::COLLECTION)
    ("EGFR and FGFR" . SPARSER::COLLECTION)
    ("five receptor and four non-receptor molecules" . SPARSER::COLLECTION)
    ("two receptor and one non-receptor molecules" . SPARSER::COLLECTION)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("TUSC2 and gefitinib" . SPARSER::COLLECTION)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("rapamycin and erlotinib" . SPARSER::COLLECTION)
    ("TIE1, ROS1, MATK, EPHA5, ROR2, FGFR3, JAK3, FES, and PTK2B"
     . SPARSER::COLLECTION)
    ("PTK2, FLT3, and FGFR2" . SPARSER::COLLECTION) ("MATK" . SPARSER::PROTEIN)
    ("-2 and +2" . SPARSER::COLLECTION)
    ("TUSC2 and erlotinib" . SPARSER::COLLECTION)
    ("TUSC2-nanovesicles" . SPARSER::PROTEIN-PAIR)
    ("TUSC2 or erlotinib" . SPARSER::COLLECTION) ("mm3" . SPARSER::PROTEIN)
    ("Tarceva" . SPARSER::DRUG)
    ("undruggable mutated tumor suppressor genes" . SPARSER::GENE)
    ("transcriptionally active tumor suppressor genes" . SPARSER::GENE)
    ("FGFR2 and mTOR" . SPARSER::COLLECTION)
    ("receptor and non-receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("MK2206" . SPARSER::DRUG) ("PTK2" . SPARSER::PROTEIN)
    ("PTK2B" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("EPHA5" . SPARSER::PROTEIN) ("TIE1" . SPARSER::PROTEIN)
    ("A beta" . SPARSER::PROTEIN) ("FUS1" . SPARSER::PROTEIN)
    ("AZD4547" . SPARSER::DRUG) ("TUSC2" . SPARSER::PROTEIN)
    ("transcriptionally-active phospho (Y705) form" . SPARSER::FORM)
    ("stable biologically active" . SPARSER::ACTIVE)
    ("cellular miR-21" . SPARSER::PROTEIN)
    ("curcumin or Stattic" . SPARSER::COLLECTION) ("curcumin" . SPARSER::DRUG)
    ("PTEN and TIMP-3" . SPARSER::COLLECTION)
    ("PTEN, and TIMP-3" . SPARSER::COLLECTION)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("STAT3-miR" . SPARSER::COLLECTION)
    ("STAT3 or pSTAT3" . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("internal control U6" . SPARSER::PROTEIN)
    ("miR-21, let-7a, STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("STAT3 (MMP-2 and MMP-9) and miR-21 (TIMP-3 and PTEN)"
     . SPARSER::COLLECTION)
    ("TIMP-3 and PTEN" . SPARSER::COLLECTION)
    ("STAT3 and active" . SPARSER::COLLECTION) ("TIMPs" . SPARSER::PROTEIN)
    ("miR-21, let-7a or STAT3" . SPARSER::COLLECTION)
    ("carcinogenically-relevant cytokine" . SPARSER::PROTEIN)
    ("oncogenically-relevant miRNAs" . SPARSER::PROTEIN)
    ("clinically relevant integral components" . SPARSER::COMPONENT)
    ("PTEN and negative regulator" . SPARSER::COLLECTION)
    ("miR-21 and let-7a" . SPARSER::COLLECTION)
    ("Beta-globin" . SPARSER::PROTEIN) ("TIMP-3" . SPARSER::PROTEIN)
    ("IHH" . SPARSER::PROTEIN) ("oligogenic forms" . SPARSER::FORM)
    ("KAL1 and FGFR1" . SPARSER::COLLECTION)
    ("KAL1 or FGFR1" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE)
    ("FGFR1 or KAL1" . SPARSER::COLLECTION)
    ("no clinically inapparent malformations" . SPARSER::PROTEIN)
    ("DHEAS" . SPARSER::MOLECULE)
    ("steroid sulfatase ( STS ) and chondrodysplasia punctata ( CDPX1 ) genes"
     . SPARSER::COLLECTION)
    ("the KAL1 , steroid sulfatase ( STS ) and chondrodysplasia punctata ( CDPX1 ) genes"
     . SPARSER::COLLECTION)
    ("recombinant human pituitary gonadotrophins" . SPARSER::PROTEIN)
    ("gonadotrophins" . SPARSER::PROTEIN) ("testosterone" . SPARSER::MOLECULE)
    ("gonadotropins" . SPARSER::PROTEIN) ("−3SD" . SPARSER::COLLECTION)
    ("-3SD" . SPARSER::COLLECTION) ("hCG" . SPARSER::PROTEIN)
    ("autosomal KS" . SPARSER::PROTEIN)
    ("showed partial bilateral deafness" . SPARSER::PROTEIN)
    ("Pituitary MRI" . SPARSER::PROTEIN)
    ("peak cortisol (25 μg/dL; N > 18) and peak GH (45 mIU/L; N > 20)"
     . SPARSER::COLLECTION)
    ("prolactin" . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("cortisol" . SPARSER::DRUG) ("Ovarian MRI" . SPARSER::PROTEIN)
    ("inhibin" . SPARSER::PROTEIN) ("clomiphene" . SPARSER::DRUG)
    ("des" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("this latter form" . SPARSER::FORM)
    ("neurogenic deafness" . SPARSER::PROTEIN) ("deafness" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("Digenic and oligogenic forms" . SPARSER::FORM)
    ("Monogenic forms" . SPARSER::FORM)
    ("X-linked, autosomal dominant and autosomal recessive"
     . SPARSER::COLLECTION)
    ("GnRH" . SPARSER::PROTEIN) ("FGFR1 and KAL1" . SPARSER::COLLECTION)
    ("KS" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("family 2" . SPARSER::PROTEIN) ("CDPX1" . SPARSER::PROTEIN)
    ("steroid sulfatase" . SPARSER::PROTEIN) ("Family 2" . SPARSER::PROTEIN)
    ("Family 1" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor Receptor 1" . SPARSER::PROTEIN)
    ("KAL1" . SPARSER::PROTEIN) ("ER- and HER2-positive" . SPARSER::COLLECTION)
    ("C-Met and the Ron receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("Ron" . SPARSER::PROTEIN) ("ER, PR, HER-2 and Ki67" . SPARSER::COLLECTION)
    ("the Western patient group" . SPARSER::MOLECULE)
    ("Iressa" . SPARSER::DRUG)
    ("herceptin and gefitinib" . SPARSER::COLLECTION)
    ("a statistically significant poor RFS" . SPARSER::PROTEIN)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neu and epidermal growth factor receptor (EGFR)" . SPARSER::COLLECTION)
    ("neu and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("herceptin and endocrine" . SPARSER::COLLECTION)
    ("herceptin" . SPARSER::DRUG)
    ("a dual tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("ALK and c-Met" . SPARSER::COLLECTION)
    ("MET and hepatocyte growth factor receptor" . SPARSER::COLLECTION)
    ("HGFR" . SPARSER::PROTEIN)
    ("tamoxifen and trastuzumab" . SPARSER::COLLECTION)
    ("poor RFS" . SPARSER::PROTEIN)
    ("siRNAs and small molecule inhibitors" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION) ("MAPK/JNK" . SPARSER::COLLECTION)
    ("MET or ERBB2" . SPARSER::COLLECTION) ("Parts" . SPARSER::COMPONENT)
    ("quinine" . SPARSER::DRUG) ("vacquinol-1" . SPARSER::COLLECTION)
    ("a stress-activated kinase" . SPARSER::KINASE)
    ("phospho-ERK (p44/42) and phospho-p38" . SPARSER::COLLECTION)
    ("EGFR-RAS-MAPK" . SPARSER::COLLECTION) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("144 unique genes" . SPARSER::GENE) ("TetO-GFP" . SPARSER::COLLECTION)
    ("TetO-KRAS" . SPARSER::COLLECTION)
    ("fluorescent 70 kDa dextran" . SPARSER::DEXTRAN)
    ("macromolecule" . SPARSER::MOLECULE) ("dextran" . SPARSER::DEXTRAN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("a process whereby intracellular proteins and whole organelles"
     . SPARSER::COLLECTION)
    ("a process whereby intracellular proteins" . SPARSER::PROTEIN)
    ("Annexin V and 7-AAD" . SPARSER::COLLECTION) ("AAD" . SPARSER::MOLECULE)
    ("KRAS and mutant" . SPARSER::COLLECTION) ("Ubc" . SPARSER::PROTEIN)
    ("KRAS or GFP" . SPARSER::COLLECTION) ("EGFR or GFP" . SPARSER::COLLECTION)
    ("KRAS or mutant" . SPARSER::COLLECTION)
    ("EGFR and mutant" . SPARSER::COLLECTION)
    ("Kras or EGFR" . SPARSER::COLLECTION)
    ("EGFR and p-ERK" . SPARSER::COLLECTION)
    ("transgene, Kras or EGFR" . SPARSER::COLLECTION)
    ("only EGFR transgenic RNA" . SPARSER::RNA)
    ("tri-transgenic mice almost always contained RNA" . SPARSER::RNA)
    ("EGFR or Kras" . SPARSER::COLLECTION) ("TetO-Cre" . SPARSER::COLLECTION)
    ("rtTA" . SPARSER::PROTEIN) ("TetO-Myc" . SPARSER::COLLECTION)
    ("only one oncogenic transgene" . SPARSER::PROTEIN)
    ("Kras and mutant" . SPARSER::COLLECTION)
    ("proteins and rtTA" . SPARSER::COLLECTION)
    (":EGFR" . SPARSER::BIO-COMPLEX) ("TetO-EGFR" . SPARSER::COLLECTION)
    ("TetO-Kras" . SPARSER::COLLECTION) ("CCSP-rtTA" . SPARSER::COLLECTION)
    ("a Clara Cell Secretory Protein promoter ( CCSP )" . SPARSER::PROMOTER)
    ("promoter ( CCSP )" . SPARSER::PROMOTER) ("CCSP" . SPARSER::PROTEIN)
    ("transgenes" . SPARSER::PROTEIN) ("TetO" . SPARSER::PROTEIN)
    ("Kras and EGFR transgenes" . SPARSER::PROTEIN)
    ("Kras and EGFR" . SPARSER::COLLECTION)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("EGFR-RAS-RAF" . SPARSER::COLLECTION)
    ("a few genes—such as STK11 (also known as LKB1 ) and ATM"
     . SPARSER::COLLECTION)
    ("the largest genes" . SPARSER::GENE) ("TTN" . SPARSER::PROTEIN)
    ("KRAS—non-synonymous" . SPARSER::PROTEIN-PAIR)
    ("each gene and the proto-oncogene" . SPARSER::COLLECTION)
    ("both the specified proto-oncogene and every other gene"
     . SPARSER::COLLECTION)
    ("KRAS or EGFR" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("EGFR and codon" . SPARSER::COLLECTION)
    ("genes or signaling pathways" . SPARSER::COLLECTION)
    ("receptor-RAS-PIK3CA" . SPARSER::COLLECTION)
    ("genes and proto-oncogenes" . SPARSER::COLLECTION)
    ("mutated forms" . SPARSER::FORM)
    ("ERK, p38 and JNK" . SPARSER::COLLECTION)
    ("only one oncogene" . SPARSER::ONCOGENE) ("p38 alpha" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::DRUG) ("MKK4" . SPARSER::PROTEIN)
    ("Erbb3" . SPARSER::PROTEIN) ("new light" . SPARSER::PROTEIN)
    ("congenital malformations" . SPARSER::PROTEIN)
    ("more recent cohorts" . SPARSER::MOLECULE)
    ("BRCA and non-BRCA" . SPARSER::COLLECTION)
    ("at least 8 families" . SPARSER::PROTEIN-FAMILY)
    ("TP53 or pRb" . SPARSER::COLLECTION)
    ("hereditary breast/ovarian cancer (HBOC) families"
     . SPARSER::PROTEIN-FAMILY)
    ("Volasertib" . SPARSER::DRUG)
    ("a potentially useful prognostic biomarker" . SPARSER::MOLECULE)
    ("antigen (CEA)" . SPARSER::PROTEIN)
    ("Carcinoembryonic" . SPARSER::PROTEIN)
    ("better predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("fluoropyrimidine" . SPARSER::DRUG) ("Bora" . SPARSER::PROTEIN)
    ("rectal tumour PLK1" . SPARSER::PROTEIN)
    ("NAT and NCT" . SPARSER::COLLECTION)
    ("PLK1 and Ki67" . SPARSER::COLLECTION) ("TRG" . SPARSER::PROTEIN)
    ("NAT" . SPARSER::PROTEIN) ("TP and TC" . SPARSER::COLLECTION)
    ("TC and TP" . SPARSER::COLLECTION)
    ("capecitabine or FOLFOX (5-FU and oxaliplatin)" . SPARSER::COLLECTION)
    ("infusional 5-FU" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("a promising predictive and prognostic biomarker" . SPARSER::MOLECULE)
    ("a mitotic serine/threonine kinase cell cycle regulator"
     . SPARSER::REGULATOR)
    ("a novel predictive biomarker" . SPARSER::MOLECULE)
    ("BI2536" . SPARSER::DRUG) ("TRG3" . SPARSER::PROTEIN)
    ("TRG 3" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("structure-based drug" . SPARSER::DRUG)
    ("Nutlin-3a or Bzd ligands that show similar affinity for short or long MDM2 lid constructs hinder formation"
     . SPARSER::COLLECTION)
    ("shorter MDM2" . SPARSER::PROTEIN)
    ("some crystallographic complexes" . SPARSER::BIO-COMPLEX)
    ("induced-fit" . SPARSER::PROTEIN-FAMILY)
    ("a well-defined open and closed lid state" . SPARSER::BIO-STATE)
    ("MDM2-p53" . SPARSER::COLLECTION)
    ("an α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("imidazoline" . SPARSER::MOLECULE) ("Apo" . SPARSER::PROTEIN)
    ("lidless MDM2" . SPARSER::PROTEIN)
    ("the previously observed states" . SPARSER::BIO-STATE)
    ("apo and Nutlin3a-MDM2" . SPARSER::COLLECTION)
    ("apo-MDM2" . SPARSER::COLLECTION) ("bin" . SPARSER::PROTEIN)
    ("spin" . SPARSER::PROTEIN) ("FES" . SPARSER::PROTEIN)
    ("explicit solvent" . SPARSER::MOLECULE) ("Pip2" . SPARSER::PIP2)
    ("Pip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligands and small-molecules" . SPARSER::COLLECTION)
    ("piperidinones" . SPARSER::MOLECULE) ("benzodiazepine" . SPARSER::DRUG)
    ("Nutlins" . SPARSER::DRUG)
    ("GPCR-(ant)agonists or transition state analogue enzyme inhibitors"
     . SPARSER::COLLECTION)
    ("GPCR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ant" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("different conformational states" . SPARSER::BIO-STATE)
    ("the flexible MDM2" . SPARSER::PROTEIN)
    ("biological molecules" . SPARSER::MOLECULE)
    ("Nutlin or benzodiazepinedione inhibitors" . SPARSER::COLLECTION)
    ("Nutlin" . SPARSER::DRUG) ("apo" . SPARSER::PROTEIN)
    ("piperidinone" . SPARSER::MOLECULE)
    ("distinct conformational states" . SPARSER::BIO-STATE)
    ("rational drug" . SPARSER::DRUG) ("i -1" . SPARSER::PROTEIN)
    ("RG7112" . SPARSER::DRUG) ("Nutlin3a" . SPARSER::DRUG)
    ("leucovorin, fluorouracil, irinotecan, and oxaliplatin"
     . SPARSER::COLLECTION)
    ("gemcitabine and nab-paclitaxel" . SPARSER::COLLECTION)
    ("fluorouracil, leucovorin, irinotecan, and oxaliplatin"
     . SPARSER::COLLECTION)
    ("Gemcitabine and EGFR" . SPARSER::COLLECTION)
    ("the pivotal PA" . SPARSER::PROTEIN)
    ("erlotinib and capecitabine" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG) ("aminotransferase" . SPARSER::PROTEIN)
    ("gemcitabine and erlotinib" . SPARSER::COLLECTION)
    ("both exon 2 and exon 3" . SPARSER::COLLECTION)
    ("erlotinib arm and the gemcitabine" . SPARSER::COLLECTION)
    ("erlotinib and gemcitabine" . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR) ("Gemcitabine" . SPARSER::DRUG)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("gemcitabine or gemcitabine" . SPARSER::COLLECTION)
    ("naïve" . SPARSER::PROTEIN) ("5–2" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("FLT-ITD" . SPARSER::COLLECTION)
    ("FLT" . SPARSER::PROTEIN) ("ERK1/2 and STAT5" . SPARSER::COLLECTION)
    ("sorafenib and azacytidine" . SPARSER::COLLECTION)
    ("KRAS and RAF" . SPARSER::COLLECTION)
    ("MPO, IL8, APOC1, CECR1 and CCL4L1" . SPARSER::COLLECTION)
    ("NPW" . SPARSER::PROTEIN) ("unique genes" . SPARSER::GENE)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("temporal lobe" . SPARSER::PROTEIN)
    ("BEX1 and BEX2" . SPARSER::COLLECTION)
    ("BEX1 or BEX2" . SPARSER::COLLECTION) ("BEX3/NADE" . SPARSER::COLLECTION)
    ("NADE" . SPARSER::PROTEIN) ("BEX" . SPARSER::PROTEIN)
    ("Wild-type FLT3 and its oncogenic mutants" . SPARSER::COLLECTION)
    ("PI3K-AKT and MAPK" . SPARSER::COLLECTION)
    ("t(15:17) and trisomy" . SPARSER::COLLECTION) ("FMS" . SPARSER::PROTEIN)
    ("ERK1/2 or STAT5" . SPARSER::COLLECTION)
    ("pro-B and myeloid cells" . SPARSER::COLLECTION)
    ("ITD" . SPARSER::PROTEIN) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("Flt3" . SPARSER::PROTEIN) ("CCL4L" . SPARSER::PROTEIN)
    ("CECR1" . SPARSER::PROTEIN) ("APOC1" . SPARSER::PROTEIN)
    ("PRG2" . SPARSER::PROTEIN) ("SLC22A16" . SPARSER::PROTEIN)
    ("protocadherin 10" . SPARSER::PROTEIN) ("BEX3" . SPARSER::PROTEIN)
    ("BEX2" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("BEX1" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("TLR7 and TLR8" . SPARSER::COLLECTION)
    ("IL-23/IL-17" . SPARSER::COLLECTION)
    ("transiently decrease C/EBPβ" . SPARSER::PROTEIN)
    ("C/EBPβ, and TNIP1" . SPARSER::COLLECTION) ("LIP" . SPARSER::PROTEIN)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("psoriatic keratinocytes" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("TNIP1 and CK6" . SPARSER::COLLECTION)
    ("Erk1/2 or CK6" . SPARSER::COLLECTION) ("t-Erk1/2" . SPARSER::COLLECTION)
    ("Erk1/2 and C/EBPβ" . SPARSER::COLLECTION)
    ("The same unspecific shRNA" . SPARSER::PROTEIN) ("CK" . SPARSER::PROTEIN)
    ("/TNIP1" . SPARSER::COLLECTION) ("IMQ" . SPARSER::DRUG)
    ("different inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("Keratinocytes" . SPARSER::PROTEIN)
    ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("proteins, TNIP1, TNIP2 and TNIP3" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("TNIP1 and TNFAIP3" . SPARSER::COLLECTION)
    ("the tumor necrosis factor α-induced protein 3 ( TNFAIP3) gene"
     . SPARSER::GENE)
    ("imiquimod" . SPARSER::DRUG) ("TNF-" . SPARSER::PROTEIN)
    ("TLR8" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-17R" . SPARSER::PROTEIN) ("IL-1b" . SPARSER::PROTEIN)
    ("IL-1a" . SPARSER::PROTEIN) ("AE3" . SPARSER::PROTEIN)
    ("TNIP3" . SPARSER::PROTEIN) ("TNIP2" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNIP1" . SPARSER::PROTEIN) ("NADPH and ROS" . SPARSER::COLLECTION)
    ("DCA" . SPARSER::PROTEIN) ("dichloroacetate" . SPARSER::MOLECULE)
    ("PEP" . SPARSER::DRUG) ("glucose and nucleotide" . SPARSER::COLLECTION)
    ("c-MYC and mTORC1" . SPARSER::COLLECTION)
    ("hyaluronan" . SPARSER::PROTEIN)
    ("key glycolytic genes and glycolytic activity of the pancreatic cancer cells"
     . SPARSER::COLLECTION)
    ("MUC16/CA-125" . SPARSER::COLLECTION) ("Oncogenes" . SPARSER::ONCOGENE)
    ("IMP and AMP" . SPARSER::COLLECTION) ("IMP" . SPARSER::PROTEIN)
    ("inosine" . SPARSER::MOLECULE) ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("DA" . SPARSER::MOLECULE)
    ("MUC16 , Capan1-shScr and Capan1-sh" . SPARSER::COLLECTION)
    ("MUC16-" . SPARSER::PROTEIN) ("MUC16 and c-MYC" . SPARSER::COLLECTION)
    ("Akt and mTORC1" . SPARSER::COLLECTION)
    ("p70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTORC1" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("GLUT1, HKII and LDHA" . SPARSER::COLLECTION)
    ("GLUT1 and HKII" . SPARSER::COLLECTION)
    ("GLUT1, HKII , and LDHA" . SPARSER::COLLECTION)
    ("LDHA" . SPARSER::PROTEIN) ("HKII" . SPARSER::PROTEIN)
    ("MUC16 and Capan1-sh" . SPARSER::COLLECTION)
    ("NADPH and ATP" . SPARSER::COLLECTION)
    ("MUC1 and MUC4" . SPARSER::COLLECTION)
    ("MUC1, MUC4, and MUC5AC" . SPARSER::COLLECTION)
    ("Mucin" . SPARSER::PROTEIN) ("Mucins" . SPARSER::PROTEIN)
    ("the most aggressive type" . TYPE)
    ("a transmembrane mucin" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Beta-actin" . SPARSER::PROTEIN)
    ("c MYC" . SPARSER::PROTEIN) ("HK II" . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::PROTEIN) ("c - MYC" . SPARSER::PROTEIN)
    ("Proto-oncogene" . SPARSER::PROTEIN) ("MUC 16" . SPARSER::PROTEIN)
    ("MUC5AC" . SPARSER::PROTEIN) ("MUC4" . SPARSER::PROTEIN)
    ("MUC16" . SPARSER::PROTEIN)
    ("a subendothelial collagen" . SPARSER::PROTEIN)
    ("global ischemia" . SPARSER::PROTEIN)
    ("-2 and TLR4" . SPARSER::COLLECTION) ("thrombin" . SPARSER::PROTEIN)
    ("the pathological state" . SPARSER::BIO-STATE)
    ("p38 MAP kinase and p44/p42 MAP kinase" . SPARSER::COLLECTION)
    ("MAP kinase and p38" . SPARSER::COLLECTION)
    ("The exogenous recombinant phosphorylated-HSP27" . SPARSER::PROTEIN)
    ("exogenous recombinant phosphorylated-HSP27" . SPARSER::PROTEIN)
    ("dimer or monomer" . SPARSER::COLLECTION)
    ("actin and microtubules" . SPARSER::COLLECTION)
    ("HSP27 (HSPB1) and αB-crystallin (HSPB5)" . SPARSER::COLLECTION)
    ("kinase and p38" . SPARSER::COLLECTION) ("p44/p42" . SPARSER::COLLECTION)
    ("GPVI" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::PROTEIN)
    ("subendothelial collagen" . SPARSER::PROTEIN)
    ("those pathological states" . SPARSER::BIO-STATE)
    ("Exogenous recombinant phosphorylated- HSP27" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("HSPB5" . SPARSER::PROTEIN)
    ("P2Y12" . SPARSER::PROTEIN)
    ("platelet-derived growth factor-AB" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("PDGF-AB" . SPARSER::PROTEIN)
    ("NOX2 and its regulatory proteins" . SPARSER::COLLECTION)
    ("enzyme NADPH oxidase 2 (NOX2) and its regulatory proteins (p22 phox , p67 phox , p40 phox , p47 phox , and Rac1)"
     . SPARSER::COLLECTION)
    ("p22 phox , p67 phox , p40 phox , p47 phox , and Rac1"
     . SPARSER::COLLECTION)
    ("cellular PTEN and PP2A" . SPARSER::COLLECTION)
    ("PTEN and PP2A" . SPARSER::COLLECTION)
    ("mTOR and Erk1/2" . SPARSER::COLLECTION)
    ("ester (PMA)" . SPARSER::MOLECULE)
    ("U0126 and rapamycin" . SPARSER::COLLECTION) ("Phorbol" . SPARSER::DRUG)
    ("raptor" . SPARSER::PROTEIN) ("MEK/Erk1/2" . SPARSER::COLLECTION)
    ("PTEN, Akt and Erk1/2" . SPARSER::COLLECTION)
    ("-PP2A" . SPARSER::COLLECTION)
    ("demethylated-PP2Ac and phospho-PP2Ac" . SPARSER::COLLECTION)
    ("Erk1/2 and caspase-3" . SPARSER::COLLECTION)
    ("a lipophilic macrolide antibiotic" . SPARSER::DRUG)
    ("macrolide" . SPARSER::MOLECULE)
    ("PP2A/PTEN/Akt/Erk" . SPARSER::COLLECTION)
    ("PTEN, phospho-Akt, and phospho-Erk1/2" . SPARSER::COLLECTION)
    ("PTEN, phospho-Akt, phospho-Erk1/2 and cleaved-caspase-3"
     . SPARSER::COLLECTION)
    ("Akt or Erk1/2" . SPARSER::COLLECTION)
    ("rapamycin and PD98059" . SPARSER::COLLECTION)
    ("rapamycin or Akt" . SPARSER::COLLECTION)
    ("rapamycin and Akt" . SPARSER::COLLECTION)
    ("Akt/Erk1/2" . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION)
    ("wild-type human PTEN (Ad-PTEN) or Ad-GFP (as control)"
     . SPARSER::COLLECTION)
    ("PP2A-wt" . SPARSER::COLLECTION)
    ("demethylated-PP2Ac, phospho-PP2Ac and phospho-Erk1/2"
     . SPARSER::COLLECTION)
    ("h or 24 h" . SPARSER::COLLECTION)
    ("demethylated-PP2A and phospho-PP2A" . SPARSER::COLLECTION)
    ("rapamycin or PD98059" . SPARSER::COLLECTION)
    ("phospho-Erk1/2 and cleaved-caspase-3" . SPARSER::COLLECTION)
    ("p-Erk1/2" . SPARSER::COLLECTION) ("mTOR/MAPK" . SPARSER::COLLECTION)
    ("PP2A and PTEN" . SPARSER::COLLECTION)
    ("PP2A, and rapamycin" . SPARSER::COLLECTION)
    ("Erk1/2 and JNK" . SPARSER::COLLECTION)
    ("JNK and/or p38 MAPK" . SPARSER::COLLECTION)
    ("Erk1/2, JNK and/or p38 MAPK" . SPARSER::COLLECTION)
    ("Akt/mTOR" . SPARSER::COLLECTION)
    ("various pathologic states" . SPARSER::BIO-STATE)
    ("a dual specificity protein and lipid phosphatase" . SPARSER::PHOSPHATASE)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN) ("poisoning" . SPARSER::MOLECULE)
    ("mTOR-PP2A/PTEN" . SPARSER::COLLECTION)
    ("wild-type PTEN or dominant negative Akt" . SPARSER::COLLECTION)
    ("PTEN/Akt" . SPARSER::COLLECTION) ("p47 phox" . SPARSER::PROTEIN)
    ("p40 phox" . SPARSER::PROTEIN) ("p67 phox" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN) ("NADPH oxidase 2" . SPARSER::PROTEIN)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("PP2Ac" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("p38 MAPKs" . SPARSER::PROTEIN)
    ("ERK3" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("S6K1" . SPARSER::PROTEIN) ("p70 S6" . SPARSER::PROTEIN)
    ("Cd-" . SPARSER::PROTEIN) ("BAX , NOXA and PUMA" . SPARSER::COLLECTION)
    ("b and S8a" . SPARSER::COLLECTION)
    ("MYBBP1A and p53" . SPARSER::COLLECTION) ("nucleolar RNA" . SPARSER::RNA)
    ("p300 and p53" . SPARSER::COLLECTION)
    ("The nucleolar protein MYBBP1A" . SPARSER::PROTEIN)
    ("transcription factor, or PES1" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("RPL11 or MYBBP1A" . SPARSER::COLLECTION)
    ("PES1, WDR3 and Las1L" . SPARSER::COLLECTION) ("Las1L" . SPARSER::PROTEIN)
    ("p53, p21 and BAX" . SPARSER::COLLECTION)
    ("Pre-rRNA" . SPARSER::COLLECTION)
    ("MYBBP1A and RPL11" . SPARSER::COLLECTION)
    ("the nucleolar protein MYBBP1A" . SPARSER::PROTEIN)
    ("p53 and p300" . SPARSER::COLLECTION)
    ("p53 and histone" . SPARSER::COLLECTION)
    ("a nucleolar stress response molecule" . SPARSER::MOLECULE)
    ("nucleolar protein Myb-binding protein 1A" . SPARSER::PROTEIN)
    ("RPL11 and RPL5" . SPARSER::COLLECTION) ("RNP" . SPARSER::PROTEIN)
    ("nucleophosmin, nucleolin, nucleostemin, RPL11, RPL5, RPL23 and RPS7"
     . SPARSER::COLLECTION)
    ("p14/p19 Arf" . SPARSER::COLLECTION) ("nucleostemin" . SPARSER::PROTEIN)
    ("nucleolin" . SPARSER::PROTEIN)
    ("many ribosomal proteins" . SPARSER::PROTEIN)
    ("a distinct subnuclear component" . SPARSER::COMPONENT)
    ("p21 and BAX" . SPARSER::COLLECTION)
    ("the nucleolar protein Myb-binding protein 1 A" . SPARSER::PROTEIN)
    ("several nucleolar proteins" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("UTP6" . SPARSER::PROTEIN)
    ("NOL1" . SPARSER::PROTEIN) ("C-1" . SPARSER::PROTEIN)
    ("S6d" . SPARSER::PROTEIN) ("WDR3" . SPARSER::PROTEIN)
    ("PES1" . SPARSER::PROTEIN)
    ("transcription initiation factor IA" . SPARSER::PROTEIN)
    ("POLR1A" . SPARSER::PROTEIN)
    ("upstream binding factor" . SPARSER::PROTEIN)
    ("POLR1B" . SPARSER::PROTEIN) ("Myb-binding protein 1A" . SPARSER::PROTEIN)
    ("RPS7" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("p19 Arf" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("TP53I3" . SPARSER::PROTEIN) ("P53AIP1" . SPARSER::PROTEIN)
    ("PMAIP1" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("MYBBP1A" . SPARSER::PROTEIN)
    ("Myb-binding protein 1 A" . SPARSER::PROTEIN)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotrophins" . SPARSER::PROTEIN) ("NMDA" . SPARSER::MOLECULE)
    ("AMPA" . SPARSER::MOLECULE) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("dopamine" . SPARSER::DRUG) ("morphine" . SPARSER::MOLECULE)
    ("striatum" . SPARSER::PROTEIN) ("oncologic medicine" . SPARSER::DRUG)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("TLR6, CXCL5, CXCL3, CRHR1 and CCL21" . SPARSER::COLLECTION)
    ("NFkB" . SPARSER::PROTEIN)
    ("RAC1, FOS, ERK, Creb, PI3K, BDNF and Pka" . SPARSER::COLLECTION)
    ("Pka" . SPARSER::PROTEIN) ("Creb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFSF11 and TNFSF15" . SPARSER::COLLECTION)
    ("DEFB4A/DEFB4B" . SPARSER::COLLECTION)
    ("DEFB103A/DEFB103B" . SPARSER::COLLECTION) ("LTF" . SPARSER::PROTEIN)
    ("lactoferrin" . SPARSER::PROTEIN) ("ELANE" . SPARSER::PROTEIN)
    ("chemokine ligand 5 (CXCL5) and toll-like receptor 6 (TLR6)"
     . SPARSER::COLLECTION)
    ("opioid and nicotine" . SPARSER::COLLECTION)
    ("opioid and alcohol" . SPARSER::COLLECTION)
    ("NF-κB, RELA, and ERK1/2" . SPARSER::COLLECTION)
    ("TNF, ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("TNF, NF-κB, and ERK1/2" . SPARSER::COLLECTION)
    ("DRD2 and CRHR1" . SPARSER::COLLECTION)
    ("BDNF and CNR1" . SPARSER::COLLECTION)
    ("nicotine and opioid" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("Dopamine" . SPARSER::DRUG)
    ("Nicotinic acetylcholine receptor genes" . SPARSER::GENE)
    ("alcohol and nicotine" . SPARSER::COLLECTION)
    ("alcohol and opioid" . SPARSER::COLLECTION)
    ("drugs and dosage" . SPARSER::COLLECTION)
    ("drug and alcohol" . SPARSER::COLLECTION) ("analgesics" . SPARSER::DRUG)
    ("candidate genes and biological pathways underlying addiction phenotypes"
     . SPARSER::COLLECTION)
    ("GABA" . SPARSER::MOLECULE)
    ("alcohol, smoking and opioid" . SPARSER::COLLECTION)
    ("alcohol, smoking, and opioid" . SPARSER::COLLECTION)
    ("opioid" . SPARSER::PROTEIN) ("alcohol and tobacco" . SPARSER::COLLECTION)
    ("opioid receptor" . SPARSER::PROTEIN) ("DRD1" . SPARSER::PROTEIN)
    ("E-12" . SPARSER::PROTEIN) ("TNFSF15" . SPARSER::PROTEIN)
    ("TNFSF11" . SPARSER::PROTEIN)
    ("tumor necrosis factor ligand superfamily member 11" . SPARSER::PROTEIN)
    ("interleukin 1 receptor type 1" . SPARSER::PROTEIN)
    ("CXCL2" . SPARSER::PROTEIN) ("CCL22" . SPARSER::PROTEIN)
    ("TSC22D3" . SPARSER::PROTEIN)
    ("TSC22 domain family protein 3" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("toll-like receptor 1" . SPARSER::PROTEIN)
    ("F2RL1" . SPARSER::PROTEIN) ("DEFB4B" . SPARSER::PROTEIN)
    ("DEFB4A" . SPARSER::PROTEIN) ("beta-defensin 2" . SPARSER::PROTEIN)
    ("DEFB103B" . SPARSER::PROTEIN) ("DEFB103A" . SPARSER::PROTEIN)
    ("beta-defensin 103" . SPARSER::PROTEIN) ("TLR6" . SPARSER::PROTEIN)
    ("toll-like receptor 6" . SPARSER::PROTEIN) ("CXCL5" . SPARSER::PROTEIN)
    ("CXCL3" . SPARSER::PROTEIN) ("CCL21" . SPARSER::PROTEIN)
    ("corticotropin-releasing hormone receptor" . SPARSER::PROTEIN)
    ("CNR1" . SPARSER::PROTEIN) ("OPRM1" . SPARSER::PROTEIN)
    ("CRHR1" . SPARSER::PROTEIN) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("Opioid receptor" . SPARSER::PROTEIN) ("DRD2" . SPARSER::PROTEIN)
    ("a large-scale erlotinib-treated Japanese cohort" . SPARSER::MOLECULE)
    ("p  " . SPARSER::PROTEIN) ("vinorelbine" . SPARSER::DRUG)
    ("daily oral erlotinib" . SPARSER::DRUG) ("DELTA" . SPARSER::PROTEIN)
    ("-wt" . SPARSER::COLLECTION) ("3–2" . SPARSER::PROTEIN)
    ("intact tumor suppressor protein" . SPARSER::PROTEIN)
    ("P16 and ER" . SPARSER::COLLECTION)
    ("antiestrogens and aromatase" . SPARSER::COLLECTION)
    ("antiestrogens" . SPARSER::DRUG) ("Antiestrogens" . SPARSER::DRUG)
    ("HR " . SPARSER::PROTEIN) ("antiestrogen" . SPARSER::DRUG)
    ("CDKN2A , RB , CCNE1 , and CCND1" . SPARSER::COLLECTION)
    ("CDK4/6–cyclin D" . SPARSER::PROTEIN-PAIR)
    ("anthracyclines, taxanes, topotecan and gemcitabine"
     . SPARSER::COLLECTION)
    ("topotecan" . SPARSER::DRUG) ("more frequent P16" . SPARSER::PROTEIN)
    ("more frequent Rb1" . SPARSER::PROTEIN)
    ("Rb1 and P16" . SPARSER::COLLECTION)
    ("Rb1, P16 and ER" . SPARSER::COLLECTION)
    ("letrozole and CDK4/6" . SPARSER::COLLECTION)
    ("cyclin D/P16" . SPARSER::COLLECTION) ("CDK 4/6" . SPARSER::PROTEIN)
    ("PD-0332991" . SPARSER::DRUG)
    ("potent pro-apoptotic drugs" . SPARSER::DRUG)
    ("TRAIL and cisplatin" . SPARSER::COLLECTION)
    ("such chemotherapeutic drugs" . SPARSER::DRUG)
    ("NAC and NAC-induced increased levels of GSH" . SPARSER::COLLECTION)
    ("NAC and RM4819" . SPARSER::COLLECTION)
    ("Bim or Puma" . SPARSER::COLLECTION) ("p38 and JNK" . SPARSER::COLLECTION)
    ("cisplatin- or compound 2-treated cells" . SPARSER::COLLECTION)
    ("cisplatin-" . SPARSER::DRUG)
    ("RM4819 and cisplatin" . SPARSER::COLLECTION)
    ("Puma and Bim" . SPARSER::COLLECTION)
    ("shRNA- or Puma" . SPARSER::COLLECTION) ("shRNA-" . SPARSER::PROTEIN)
    ("Bim nor Puma" . SPARSER::COLLECTION) ("EL" . SPARSER::PROTEIN)
    ("JNK or p38" . SPARSER::COLLECTION)
    ("around 2 h and p38 activation 4 h" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug cisplatin" . SPARSER::MOLECULE)
    ("substance" . SPARSER::SUBSTANCE) ("JNK-" . SPARSER::PROTEIN)
    ("particular JNK" . SPARSER::PROTEIN) ("kinase (JNK)" . SPARSER::KINASE)
    ("GSTs, and GSTP1-1" . SPARSER::COLLECTION) ("bromo" . SPARSER::MOLECULE)
    ("cisplatin, doxorubicin, and etoposide" . SPARSER::COLLECTION)
    ("substances and carcinogens" . SPARSER::COLLECTION)
    ("electrophilic substances" . SPARSER::SUBSTANCE) ("GSH" . SPARSER::DRUG)
    ("GSTs" . SPARSER::PROTEIN)
    ("the pro-apoptotic Bcl-2 homologs Bim and Puma" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-x" . SPARSER::COLLECTION)
    ("p38 and Jun" . SPARSER::COLLECTION) ("CAT-3" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("α -Tubulin" . SPARSER::PROTEIN)
    ("s21" . SPARSER::PROTEIN) ("1-2 " . SPARSER::PROTEIN)
    ("H2DCFDA" . SPARSER::DRUG)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("N -acetyl- L -cysteine" . SPARSER::MOLECULE)
    ("anti-microbial" . SPARSER::DRUG) ("RM4819" . SPARSER::DRUG)
    ("TLK199" . SPARSER::DRUG)
    ("Glutathione- S -transferases" . SPARSER::PROTEIN)
    ("GSTP1-1" . SPARSER::PROTEIN) ("class P" . SPARSER::PROTEIN)
    ("autophagic receptors" . SPARSER::PROTEIN)
    ("KEAP1-NFE2L2" . SPARSER::COLLECTION)
    ("leupeptin or SQSTM1" . SPARSER::COLLECTION)
    ("HCQ and ATG7" . SPARSER::COLLECTION) ("HCQ" . SPARSER::DRUG)
    ("total and spliced XBP1" . SPARSER::PROTEIN)
    ("HSPA5/BiP" . SPARSER::COLLECTION) ("P4HB/PDI" . SPARSER::COLLECTION)
    ("PDI" . SPARSER::PROTEIN) ("LMAN1/ERGIC53" . SPARSER::COLLECTION)
    ("at least 2 peptides" . SPARSER::PEPTIDE)
    ("ATP or viability" . SPARSER::COLLECTION)
    ("normal PCs" . SPARSER::PROTEIN)
    ("a major autophagic substrate" . SPARSER::SUBSTRATE)
    ("the distal autophagy inhibitor bafilomycin A 1" . SPARSER::DRUG)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("detergent-insoluble fractions" . SPARSER::COMPONENT)
    ("the autophagic receptors NBR1" . SPARSER::PROTEIN)
    ("OPTN/optineurin" . SPARSER::COLLECTION) ("optineurin" . SPARSER::PROTEIN)
    ("OPTN" . SPARSER::PROTEIN) ("KEAP1, PRKCI, and Ub" . SPARSER::COLLECTION)
    ("PRKCI" . SPARSER::PROTEIN) ("an autophagic receptor" . SPARSER::RECEPTOR)
    ("opts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lentiviral ATG7" . SPARSER::PROTEIN)
    ("Ub-proteins" . SPARSER::COLLECTION)
    ("bortezomib and the distal authophagy inhibitor leupeptin"
     . SPARSER::COLLECTION)
    ("insoluble SQSTM1" . SPARSER::PROTEIN)
    ("the distal authophagy inhibitor leupeptin" . SPARSER::DRUG)
    ("leupeptin" . SPARSER::DRUG)
    ("detergent-insoluble cellular fractions" . SPARSER::COMPONENT)
    ("detergent" . SPARSER::MOLECULE)
    ("the prototypical autophagic receptor" . SPARSER::RECEPTOR)
    ("heterogeneous ubiquitinated proteins" . SPARSER::PROTEIN)
    ("MAP1LC3A/LC3A" . SPARSER::COLLECTION)
    ("Ub-protein" . SPARSER::COLLECTION)
    ("a conserved self-digestive lysosomal" . SPARSER::PROTEIN)
    ("PI-naïve" . SPARSER::PROTEIN-PAIR) ("hydroxychloroquine" . SPARSER::DRUG)
    ("the autophagic cargo receptor and adapter protein" . SPARSER::COLLECTION)
    ("the autophagic cargo receptor" . SPARSER::RECEPTOR)
    ("SQSTM1/p62" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("XBP1 s" . SPARSER::PROTEIN) ("peptidase activity" . SPARSER::PROTEIN)
    ("PRDX4" . SPARSER::PROTEIN) ("TUBA4A" . SPARSER::PROTEIN)
    ("MAP1LC3" . SPARSER::PROTEIN-FAMILY) ("ANXA5" . SPARSER::PROTEIN)
    ("SDC1" . SPARSER::PROTEIN) ("HSPA5" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("RAB7A" . SPARSER::PROTEIN)
    ("ERGIC53" . SPARSER::PROTEIN) ("LMAN1" . SPARSER::PROTEIN)
    ("NBR1" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("LC3A" . SPARSER::PROTEIN) ("MAP1LC3A" . SPARSER::PROTEIN)
    ("bafilomycin A 1" . SPARSER::DRUG) ("carboxy-" . SPARSER::MOLECULE)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("repetitive DNA" . SPARSER::DNA)
    ("cleft lip and palate transmembrane 1-like ( CLPTM1L ) and telomerase reverse transcriptase ( TERT )"
     . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type, ethnicity and source" . SPARSER::COLLECTION)
    ("CLPTM1L" . SPARSER::PROTEIN) ("Onartuzumab" . SPARSER::DRUG)
    ("Tivantinib" . SPARSER::DRUG)
    ("the correct predictive biomarker" . SPARSER::MOLECULE)
    ("ROS or ALK" . SPARSER::COLLECTION)
    ("predominant cytoplasmic MET" . SPARSER::PROTEIN)
    ("Kappa" . SPARSER::PROTEIN-FAMILY) ("MetMab" . SPARSER::DRUG)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("a heterodimeric transmembrane receptor" . SPARSER::RECEPTOR)
    ("the epidermal growth factor receptor ( EGFR ) [ xref ] or anaplastic lymphoma kinase ( ALK )"
     . SPARSER::COLLECTION)
    ("Metmab" . SPARSER::DRUG)
    ("the numerous receptor tyrosine kinases (such as EGFR, PDGFR and EGFR) and the focal adhesion kinase (FAK)"
     . SPARSER::COLLECTION)
    ("EGFR, PDGFR and EGFR" . SPARSER::COLLECTION) ("PDGFR" . SPARSER::PROTEIN)
    ("c-Src cellular tyrosine kinase" . SPARSER::PROTEIN)
    ("Dasatinib" . SPARSER::DRUG) ("STAT3 and AP-1" . SPARSER::COLLECTION)
    ("downstream signaling molecules or signal transduction events"
     . SPARSER::COLLECTION)
    ("Beclin-1 and LC3I/II" . SPARSER::COLLECTION)
    ("Src, STAT3 or HO-1" . SPARSER::COLLECTION)
    ("Src/STAT3/HO-1" . SPARSER::COLLECTION)
    ("Src and STAT3" . SPARSER::COLLECTION)
    ("HO-1, Beclin-1 and LC-3I/II" . SPARSER::COLLECTION)
    ("I/II" . SPARSER::PROTEIN)
    ("HO-1, Beclin-1 and LC3BI/II" . SPARSER::COLLECTION)
    ("Src siRNA or control siRNA" . SPARSER::COLLECTION)
    ("JAK2 and Src" . SPARSER::COLLECTION)
    ("Src and JAK2" . SPARSER::COLLECTION)
    ("Beclin-1 and LC3BI/II" . SPARSER::COLLECTION)
    ("Nrf2, NF-κB, Egr-1, AP-1 and STAT3" . SPARSER::COLLECTION)
    ("proteins, Beclin-1 and LC3BI/II" . SPARSER::COLLECTION)
    ("BI" . SPARSER::PROTEIN) ("chloroquine" . SPARSER::PROTEIN)
    ("LC3B-I/II and Beclin-1" . SPARSER::COLLECTION)
    ("LC3B-I/II" . SPARSER::PROTEIN-PAIR) ("Cyto-ID" . SPARSER::COLLECTION)
    ("Reagent" . SPARSER::MOLECULE) ("Doxorubicin" . SPARSER::PROTEIN)
    ("STAT3 or Src kinase" . SPARSER::COLLECTION)
    ("Src-STAT3" . SPARSER::COLLECTION) ("ferrous ion" . SPARSER::MOLECULE)
    ("oxygenase (HO)" . SPARSER::PROTEIN) ("Heme" . SPARSER::PROTEIN)
    ("anthracyclines and taxanes" . SPARSER::COLLECTION)
    ("Src/STAT3" . SPARSER::COLLECTION) ("LC-3" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("NFYB/E2F" . SPARSER::COLLECTION)
    ("both a topoisomerase inhibitor (irinotecan) and an HDAC inhibitor (panobinostat)"
     . SPARSER::COLLECTION)
    ("NFYB and E2F1" . SPARSER::COLLECTION)
    ("NF-Y and E2F1" . SPARSER::COLLECTION)
    ("E2F1 and different subunits" . SPARSER::COLLECTION)
    ("CDC25C as well as the other two subunits" . SPARSER::COLLECTION)
    ("multiple mitotic genes" . SPARSER::GENE)
    ("NFYA and NFYC" . SPARSER::COLLECTION)
    ("NF-Y and E2F" . SPARSER::COLLECTION)
    ("E2F1 and NF-Y" . SPARSER::COLLECTION) ("panobinostat" . SPARSER::DRUG)
    ("E2F1/NFYB" . SPARSER::COLLECTION) ("E2F and NFY" . SPARSER::COLLECTION)
    ("E2F1-NFYB" . SPARSER::COLLECTION)
    ("the apoptotic arm" . SPARSER::PROTEIN)
    ("SFRP1 and FOLH1" . SPARSER::COLLECTION)
    ("SFRP1 ( xref ) and FOLH1 ( xref )" . SPARSER::COLLECTION)
    ("PRKCZ" . SPARSER::PROTEIN)
    ("SIVA1 ( xref ) as well as API5 ( xref )" . SPARSER::COLLECTION)
    ("E2F1 directly targets NFYB" . SPARSER::PROTEIN)
    ("siRNAs or siRNAs" . SPARSER::COLLECTION)
    ("APAF1, Cyclin E, and E2F1" . SPARSER::COLLECTION) ("OHT" . SPARSER::DRUG)
    ("ER-E2F1" . SPARSER::COLLECTION)
    ("cyclin B2, CDC25A, CDC25C, and CDK1" . SPARSER::COLLECTION)
    ("NFYB and NFYC" . SPARSER::COLLECTION)
    ("NFYA, NFYB, and NFYC" . SPARSER::COLLECTION) ("NFYC" . SPARSER::PROTEIN)
    ("NFYA" . SPARSER::PROTEIN) ("CCAAT" . SPARSER::PROTEIN)
    ("trimer" . SPARSER::TRIMER) ("E2F1-E2F3" . SPARSER::COLLECTION)
    ("NFYB/E2F1" . SPARSER::COLLECTION) ("E2F1 and NFYB" . SPARSER::COLLECTION)
    ("NFYB" . SPARSER::PROTEIN) ("a considerable variety" . SPARSER::VARIETY)
    ("SIVA1" . SPARSER::PROTEIN) ("MALT1" . SPARSER::PROTEIN)
    ("API5" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("FOLH1" . SPARSER::PROTEIN) ("SFRP1" . SPARSER::PROTEIN)
    ("B12)" . SPARSER::PROTEIN) ("2F1" . SPARSER::PROTEIN)
    ("4-Hydroxytamoxifen" . SPARSER::DRUG)
    ("nuclear transcription factor Y" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("NF-YB" . SPARSER::PROTEIN)
    ("-mutants" . SPARSER::MUTANT) ("threonines" . SPARSER::AMINO-ACID)
    ("CDC25 and Wee1" . SPARSER::COLLECTION)
    ("the mitotic CDK1/B-cyclin complex" . SPARSER::BIO-COMPLEX)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("acute DNA" . SPARSER::DNA)
    ("essential charged and hydrophobic amino acids" . SPARSER::AMINO-ACID)
    ("SOS3 and PP2C-family" . SPARSER::COLLECTION)
    ("α-4/S345A" . SPARSER::PROTEIN)
    ("Chk1 α-3/S345A and Chk1 α-4/S345A" . SPARSER::PROTEIN)
    ("3T cell lines expressing WT Chk1 and the various KA1 mutants"
     . SPARSER::COLLECTION)
    ("α-4" . SPARSER::PROTEIN) ("exogenous substrates" . SPARSER::SUBSTRATE)
    ("Kinase" . SPARSER::KINASE) ("GST-CDC25C" . SPARSER::COLLECTION)
    ("β-2" . SPARSER::PROTEIN) ("Chk1 (WT)" . SPARSER::PROTEIN)
    ("TET" . SPARSER::PROTEIN) ("Chk1 β-2" . SPARSER::PROTEIN)
    ("Chk1 α-3 and Chk1 α-4" . SPARSER::PROTEIN)
    ("SOS2 and Chk1" . SPARSER::COLLECTION)
    ("Gin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOS2, AMPK and MARK3" . SPARSER::COLLECTION)
    ("serine-glutamine" . SPARSER::COLLECTION) ("Wee1" . SPARSER::PROTEIN)
    ("SOS3" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("pH3" . SPARSER::MOLECULE)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Hsl1" . SPARSER::PROTEIN) ("MARK3" . SPARSER::PROTEIN)
    ("SOS2" . SPARSER::PROTEIN) ("KA1" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("E-cadherin and Ki-67" . SPARSER::COLLECTION)
    ("docetaxel and doxorubicin" . SPARSER::COLLECTION)
    ("Enzalutamide" . SPARSER::DRUG) ("PgR-" . SPARSER::PROTEIN)
    ("mTNBC—AR" . SPARSER::COLLECTION) ("antiandrogen" . SPARSER::DRUG)
    ("anthracycline and taxanes" . SPARSER::COLLECTION)
    ("The main histological type" . TYPE)
    ("androgen receptor, E-cadherin and Ki-67" . SPARSER::COLLECTION)
    ("either ductal type or histological grade 3" . SPARSER::COLLECTION)
    ("either ductal type" . TYPE)
    ("AR, E-Cadherin and Ki 67" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("EC-2" . SPARSER::COLLECTION) ("subdomains" . SPARSER::PROTEIN)
    ("AR, ER and PgR" . SPARSER::COLLECTION) ("Mibolerone" . SPARSER::DRUG)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("proteins and forms" . SPARSER::COLLECTION)
    ("E-Cadherin and Ki-67" . SPARSER::COLLECTION)
    ("4 clinically- relevant subtypes" . SPARSER::PROTEIN)
    ("LAR" . SPARSER::PROTEIN) ("claudin" . SPARSER::PROTEIN)
    ("The predominant histological type" . TYPE)
    ("AR and E-cadherin" . SPARSER::COLLECTION)
    ("AR and Ki-67" . SPARSER::COLLECTION)
    ("AR, CDH1 and Ki-67" . SPARSER::COLLECTION)
    ("AR, E-cadherin and Ki-67" . SPARSER::COLLECTION)
    ("e-cadherin" . SPARSER::PROTEIN) ("ad 5" . SPARSER::PROTEIN)
    ("Ki 67" . SPARSER::PROTEIN) ("E-cadherins" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("ADs" . SPARSER::PROTEIN) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OR 1" . SPARSER::PROTEIN) ("ETS-1" . SPARSER::PROTEIN)
    ("siRNA or Juglone" . SPARSER::COLLECTION)
    ("Androgen Receptor, PTEN, or mutant" . SPARSER::COLLECTION)
    ("p53 and the Androgen Receptor" . SPARSER::COLLECTION)
    ("p21CIP1, and KLF" . SPARSER::COLLECTION)
    ("CCND1, CYP1A1 and CCNB1" . SPARSER::COLLECTION)
    ("GRB2, HEATR1, IFT57 and SGMS2" . SPARSER::COLLECTION)
    ("KLK3, HMGA1, FGFR2, PPM1A, HPGD, TM4SF1 and SH3GLB1"
     . SPARSER::COLLECTION)
    ("HPGD" . SPARSER::PROTEIN)
    ("MRF, TR, CPEB, KLF and HIF" . SPARSER::COLLECTION)
    ("p53 and the androgen receptor" . SPARSER::COLLECTION)
    ("the Ets-domain family, DBP, Nrf, p53 and the androgen receptor"
     . SPARSER::COLLECTION)
    ("KLF and HIF" . SPARSER::COLLECTION)
    ("FXR and the Androgen Receptor" . SPARSER::COLLECTION)
    ("Myc, FXR and the Androgen Receptor" . SPARSER::COLLECTION)
    ("DBP" . SPARSER::PROTEIN) ("KLF" . SPARSER::PROTEIN)
    ("CPEB" . SPARSER::PROTEIN) ("MRF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EBF" . SPARSER::PROTEIN)
    ("a tumor-associated antigen" . SPARSER::PROTEIN)
    ("revealed approximately 25 genes" . SPARSER::GENE)
    ("GRB2, HEATR1, IFT57, and SGMS2" . SPARSER::COLLECTION)
    ("FC" . SPARSER::PROTEIN)
    ("the two Pin1 siRNAs or control siRNA" . SPARSER::COLLECTION)
    ("LNCap and DU145" . SPARSER::COLLECTION) ("LNCap" . SPARSER::PROTEIN)
    ("pure secondary metabolites" . SPARSER::PROTEIN)
    ("parvulin" . SPARSER::PROTEIN) ("PPIase" . SPARSER::PROTEIN)
    ("two prostate cancer cell line types, LNCaP which has an androgen dependent growth property, and DU145 which shows androgen independent growth"
     . SPARSER::COLLECTION)
    ("tumor suppressors or growth inhibitors [ xref ]" . SPARSER::COLLECTION)
    ("numerous oncogenes or growth enhancers" . SPARSER::COLLECTION)
    ("immediately preceding proline" . SPARSER::AMINO-ACID)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("Peptidyl-prolyl" . SPARSER::COLLECTION)
    ("siRNA and Juglone" . SPARSER::COLLECTION)
    ("LNCaP and DU145" . SPARSER::COLLECTION)
    ("Pin1 siRNA or the Pin1 inhibitor Juglone" . SPARSER::COLLECTION)
    ("LNCaP (androgen-dependent) and DU145 (androgen-independent)"
     . SPARSER::COLLECTION)
    ("a commercially available Pin1 inhibitor" . SPARSER::INHIBITOR)
    ("Juglone" . SPARSER::DRUG) ("cis/trans" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("isomerases" . SPARSER::ISOMERASE)
    ("Growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYP1A1" . SPARSER::PROTEIN) ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EDN1" . SPARSER::PROTEIN) ("TACSTD2" . SPARSER::PROTEIN)
    ("SH3GLB1" . SPARSER::PROTEIN) ("PPM1A" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("HIP1" . SPARSER::PROTEIN)
    ("TM4SF1" . SPARSER::PROTEIN) ("KLK3" . SPARSER::PROTEIN)
    ("SGMS2" . SPARSER::PROTEIN) ("IFT57" . SPARSER::PROTEIN)
    ("HEATR1" . SPARSER::PROTEIN) ("trans isomerase" . SPARSER::PROTEIN)
    ("wt-" . SPARSER::PROTEIN) ("carcinoembryonic" . SPARSER::PROTEIN)
    ("the most commonly available biomarkers" . SPARSER::MOLECULE)
    ("N 1–2" . SPARSER::PROTEIN) ("RAS family" . SPARSER::PROTEIN)
    ("Dickkopf (DKK)" . SPARSER::PROTEIN-FAMILY) ("DKK" . SPARSER::PROTEIN)
    ("Dickkopf" . SPARSER::PROTEIN)
    ("Bcl-2, c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("/lymphoid" . SPARSER::COLLECTION)
    ("Fzd family proteins and the low-density lipoprotein receptor-related protein (LRP5/6)"
     . SPARSER::COLLECTION)
    ("Fzd" . SPARSER::PROTEIN-FAMILY) ("sFRP" . SPARSER::PROTEIN)
    ("Fas/FasL" . SPARSER::COLLECTION) ("methylprednisolone" . SPARSER::DRUG)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("caspase-3 and Bax" . SPARSER::COLLECTION)
    ("β-catenin and c-Myc" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION) ("TdT" . SPARSER::PROTEIN)
    ("model group (group B) and sFRP1 group (group C)" . SPARSER::COLLECTION)
    ("DKK1" . SPARSER::PROTEIN) ("LRP5/6" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("group C" . SPARSER::PROTEIN)
    ("sFRP1" . SPARSER::PROTEIN) ("group B" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("FGF5 and FGF18" . SPARSER::COLLECTION)
    ("the rather broad-spectrum tyrosine kinase inhibitor TKI258"
     . SPARSER::DRUG)
    ("FGFR1 and FGFR3" . SPARSER::COLLECTION)
    ("premature adipocytes" . SPARSER::PROTEIN)
    ("FGF5 , FGF11 and FGF18" . SPARSER::COLLECTION)
    ("FGFR2 , FGFR4 and FGF18" . SPARSER::COLLECTION)
    ("differentially expressed candidate genes" . SPARSER::GENE)
    ("B2M and IPO8" . SPARSER::COLLECTION)
    ("nearly 8,000 genes" . SPARSER::GENE)
    ("PD173074 and BGJ398 displayed a greater impact on the migration of myxoid liposarcoma cells"
     . SPARSER::COLLECTION)
    ("PD173074 and BGJ398 showed much stronger effects" . SPARSER::COLLECTION)
    ("ApoTox-Glo" . SPARSER::COLLECTION) ("Glo" . SPARSER::PROTEIN)
    ("the two clinically applicable FGFR inhibitors dovitinib" . SPARSER::DRUG)
    ("MLS 1765 cells even single receptor" . SPARSER::RECEPTOR)
    ("FGFR1 and/or FGFR3" . SPARSER::COLLECTION)
    ("FGFR1 or FGFR3" . SPARSER::COLLECTION)
    ("using REST (Relative Expression Software Tool) and graphically visualized using GraphPad Prism (Figure xref )"
     . SPARSER::COLLECTION)
    ("Prism" . SPARSER::PROTEIN) ("REST" . SPARSER::PROTEIN)
    ("IPO8 and B2M" . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION) ("the exact type" . TYPE)
    ("FUS or EWS1R" . SPARSER::COLLECTION) ("RIN" . SPARSER::PROTEIN)
    ("siRNAs and tyrosine kinase" . SPARSER::COLLECTION)
    ("the new chemotherapeutic compound trabectedin" . SPARSER::DRUG)
    ("either FUS (>90%) or EWS1R [ xref - xref ]" . SPARSER::COLLECTION)
    ("MDM2 and CDK4" . SPARSER::COLLECTION) ("trabectedin" . SPARSER::DRUG)
    ("TKI258 (dovitinib) and BGJ398 as well as specific siRNAs reduced cell proliferation"
     . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG)
    ("diagnostic or prognostic biomarkers" . SPARSER::MOLECULE)
    ("FUS-DDIT3" . SPARSER::COLLECTION) ("FUS" . SPARSER::PROTEIN)
    ("HPRT 1" . SPARSER::PROTEIN) ("FGFR 1" . SPARSER::PROTEIN)
    ("FGF11" . SPARSER::PROTEIN) ("FGF18" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("IPO8" . SPARSER::PROTEIN) ("PGK1" . SPARSER::PROTEIN)
    ("MLS 1" . SPARSER::PROTEIN) ("FRS2" . SPARSER::PROTEIN)
    ("TKI258" . SPARSER::DRUG) ("EWS1" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("MP" . SPARSER::PROTEIN)
    ("PPARγ/NF-κB" . SPARSER::COLLECTION) ("PPARs" . SPARSER::PROTEIN)
    ("NIK" . SPARSER::PROTEIN) ("JNK or ERK" . SPARSER::COLLECTION)
    ("PAK1/PPARγ" . SPARSER::COLLECTION)
    ("PAK1 and NF-κB" . SPARSER::COLLECTION) ("IKKα/IkB" . SPARSER::COLLECTION)
    ("p65, and NF-κB" . SPARSER::COLLECTION)
    ("IL-1β and IFNγ" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("PPARγ and CD36" . SPARSER::COLLECTION)
    ("PPARγ mRNA and its downstream target CD36 ( xref D)"
     . SPARSER::COLLECTION)
    ("PAK1 and PPARγ" . SPARSER::COLLECTION)
    ("TNFα-PAK1-PPARγ" . SPARSER::COLLECTION)
    ("both Rosiglitazone (Rosi; a PPARγ agonist) and 5-ASA"
     . SPARSER::COLLECTION)
    ("Rosiglitazone" . SPARSER::DRUG) ("PPAR" . SPARSER::PROTEIN)
    ("PPARγ/p65" . SPARSER::COLLECTION)
    ("that PAK1's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK1 inhibitors IPA-3 as well as 5-ASA" . SPARSER::COLLECTION)
    ("IKKα/β or IκB" . SPARSER::COLLECTION) ("IKKα/β" . SPARSER::PROTEIN)
    ("IKKα/β-IκB" . SPARSER::PROTEIN-PAIR) ("SIO" . SPARSER::MOLECULE)
    ("PAK1 and p65" . SPARSER::COLLECTION) ("p-PAK1–p65" . SPARSER::COLLECTION)
    ("p65 and PAK1" . SPARSER::COLLECTION) ("KD-PAK1" . SPARSER::COLLECTION)
    ("both a PAK1 and p-PAK1 antibody" . SPARSER::COLLECTION)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα or IL-1β" . SPARSER::COLLECTION)
    ("IBD and CAC" . SPARSER::COLLECTION) ("CAC" . SPARSER::PROTEIN)
    ("ASA" . SPARSER::PROTEIN) ("Mesalamine" . SPARSER::DRUG)
    ("IBD" . SPARSER::PROTEIN)
    ("PPARγ and mesalamine recovered PPARγ" . SPARSER::PROTEIN)
    ("PPARγ and mesalamine" . SPARSER::COLLECTION)
    ("mesalamine" . SPARSER::DRUG) ("PAK1–p65" . SPARSER::COLLECTION)
    ("p65 and NF-κB" . SPARSER::COLLECTION)
    ("IFNγ, IL-1β, and TNFα" . SPARSER::COLLECTION)
    ("NF-κB and PPARγ" . SPARSER::COLLECTION) ("PAK1-KO" . SPARSER::COLLECTION)
    ("P65" . SPARSER::PROTEIN) ("p-21 activated kinase" . SPARSER::PROTEIN)
    ("the only cell cycle protein" . SPARSER::PROTEIN)
    ("p14, p53, p21, CDK4, and cyclin D1" . SPARSER::COLLECTION)
    ("-agtgATTGTgatgg-3" . SPARSER::COLLECTION)
    ("SiHa-SOX9 and HeLa-shGFP" . SPARSER::COLLECTION)
    ("SiHa-GFP and HeLa-shSOX9" . SPARSER::COLLECTION)
    ("SOX9 and p21" . SPARSER::COLLECTION)
    ("a possible positively regulated target" . SPARSER::TARGET-PROTEIN)
    ("SiHa-SOX9 and SiHa-GFP" . SPARSER::COLLECTION)
    ("exogenous SOX9" . SPARSER::PROTEIN)
    ("SiHa-SOX9, SiHa-GFP, HeLa-shSOX9 and HeLa-shGFP" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("oncogene and tumor" . SPARSER::COLLECTION) ("P2R" . SPARSER::PROTEIN)
    ("CX31" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("SYK, BTK and PI3Kδ" . SPARSER::COLLECTION)
    ("Eu-TCL1" . SPARSER::COLLECTION) ("lys" . SPARSER::PROTEIN)
    ("TP53, Ku70, and FOXO" . SPARSER::COLLECTION)
    ("soluble or immobilized anti-IgM" . SPARSER::PROTEIN)
    ("miR132 and miR212" . SPARSER::COLLECTION) ("miR132" . SPARSER::PROTEIN)
    ("miR-" . SPARSER::PROTEIN)
    ("ZAP-70, CD38 and CD49d" . SPARSER::COLLECTION)
    ("FISH, CD38, CD49d and ZAP-70" . SPARSER::COLLECTION)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSEA and DIANA-Lab" . SPARSER::COLLECTION) ("GEP" . SPARSER::PROTEIN)
    ("soluble and immobilized anti-IgM" . SPARSER::PROTEIN)
    ("soluble anti-IgM" . SPARSER::PROTEIN)
    ("SYK, BTK, and PI3Kδ" . SPARSER::COLLECTION)
    ("/SIRT1/TP53" . SPARSER::COLLECTION) ("global microRNA" . SPARSER::RNA)
    ("receptor (BCR)" . SPARSER::RECEPTOR)
    ("actinomycin-D" . SPARSER::MOLECULE) ("CD16" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("TCL1" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ZAP-70" . SPARSER::PROTEIN) ("CD49d" . SPARSER::PROTEIN)
    ("MYC (8q24.21) and MAPK15 (8q24.3)" . SPARSER::COLLECTION)
    ("MAPK15 and MYC" . SPARSER::COLLECTION)
    ("JNK/SAPKs" . SPARSER::COLLECTION) ("SAPKs" . SPARSER::PROTEIN)
    ("intestinal type" . TYPE) ("JNK, MEK1/2, and p38" . SPARSER::COLLECTION)
    ("JNK, p38, or ERK" . SPARSER::COLLECTION)
    ("ras and fos" . SPARSER::COLLECTION)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DDK" . SPARSER::BIO-COMPLEX)
    ("c-Jun and phosphorylated-c-Jun" . SPARSER::COLLECTION)
    ("MAPK15 (siMAPK15) or nonspecific siRNA (siCtrl)" . SPARSER::COLLECTION)
    ("nonspecific siRNA" . SPARSER::PROTEIN) ("SNU-16" . SPARSER::PROTEIN)
    ("CNAs and mRNA" . SPARSER::COLLECTION) ("RET/PTC3" . SPARSER::COLLECTION)
    ("typical MAPKs" . SPARSER::PROTEIN)
    ("an atypical MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2, JNK, p38s, and ERK5" . SPARSER::COLLECTION)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SCRIB, PUF60 , and PARP10" . SPARSER::COLLECTION)
    ("SCRIB" . SPARSER::DRUG) ("new biomarkers" . SPARSER::MOLECULE)
    ("loco" . SPARSER::PROTEIN) ("D-H" . SPARSER::PROTEIN)
    ("RPLP0" . SPARSER::PROTEIN) ("Y chromosome" . SPARSER::PROTEIN)
    ("P200" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-jun" . SPARSER::PROTEIN) ("PTC3" . SPARSER::PROTEIN)
    ("ERK5" . SPARSER::PROTEIN) ("p38s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK7" . SPARSER::PROTEIN) ("PARP10" . SPARSER::PROTEIN)
    ("PUF60" . SPARSER::PROTEIN) ("RECQL 4" . SPARSER::PROTEIN)
    ("SLC39A4" . SPARSER::PROTEIN) ("BOP1" . SPARSER::PROTEIN)
    ("GPAA1" . SPARSER::PROTEIN) ("PLEC1" . SPARSER::PROTEIN)
    ("MAPK15" . SPARSER::PROTEIN)
    ("both innovative chemical inhibitors" . SPARSER::INHIBITOR)
    ("molecules and analogues" . SPARSER::COLLECTION)
    ("temozolomide or MGMT" . SPARSER::COLLECTION)
    ("-BG" . SPARSER::COLLECTION) ("BG" . SPARSER::PROTEIN)
    ("hydrochloride (ACNU)" . SPARSER::MOLECULE)
    ("Different alternative small organic molecules" . SPARSER::MOLECULE)
    ("-1-nitrosourea" . SPARSER::PROTEIN-PAIR) ("nimustine" . SPARSER::DRUG)
    ("ACNU" . SPARSER::DRUG) ("hydrochloride" . SPARSER::MOLECULE)
    ("carmustine" . SPARSER::DRUG) ("BCNU" . SPARSER::DRUG)
    ("Temozolomide" . SPARSER::DRUG) ("bevacizumab" . SPARSER::DRUG)
    ("clinical predictive biomarker" . SPARSER::MOLECULE)
    ("a relevant predictive biomarker" . SPARSER::MOLECULE)
    ("the previously reported miRs" . SPARSER::PROTEIN)
    ("the potentially relevant miRs" . SPARSER::PROTEIN)
    ("a genome-wide miR" . SPARSER::PROTEIN)
    ("temozolomide and MGMT" . SPARSER::COLLECTION)
    ("miRs and the target" . SPARSER::COLLECTION) ("miRs" . SPARSER::PROTEIN)
    ("the MGMT proxymal promoter" . SPARSER::PROMOTER)
    ("chromatin and active" . SPARSER::COLLECTION)
    ("Sp1, AP-1, CEBP, NF-κB and HIF-1α" . SPARSER::COLLECTION)
    ("enhanceosome" . SPARSER::PROTEIN)
    ("steroid-inducible N-myc downstream regulated gene 1 (NDRG1) protein"
     . SPARSER::PROTEIN)
    ("MGMT/HIF-1α" . SPARSER::COLLECTION)
    ("AP-2, NF-IL6, and ER-α" . SPARSER::COLLECTION)
    ("Sp1, AP-1 and c/EBP" . SPARSER::COLLECTION)
    ("CEBP ( xref ) and AP-1 ( xref , xref )" . SPARSER::COLLECTION)
    ("Sp1 ( xref ), NF-κB ( xref ), CEBP ( xref ) and AP-1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("CEBP" . SPARSER::PROTEIN)
    ("So far 142 single nucleotide variants" . SPARSER::VARIANT)
    ("MLH1, MSH2, MSH6 and PMS2" . SPARSER::COLLECTION)
    ("mutagens" . SPARSER::MOLECULE) ("O 6 -benzylguanine" . SPARSER::DRUG)
    ("miR-221" . SPARSER::PROTEIN) ("MeCP2" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock protein 90" . SPARSER::PROTEIN) ("LBH589" . SPARSER::DRUG)
    ("NDRG1" . SPARSER::PROTEIN)
    ("N-myc downstream regulated gene 1" . SPARSER::PROTEIN)
    ("BMP2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN)
    ("cellular tumor antigen p53" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("MUC" . SPARSER::PROTEIN) ("Cox-2 or MUC1" . SPARSER::COLLECTION)
    ("CD44, MMP-2, and EP4" . SPARSER::COLLECTION)
    ("COX-2/Cox-2" . SPARSER::COLLECTION)
    ("MAPK, and PI3K" . SPARSER::COLLECTION)
    ("the proinflammatory-inducible enzyme" . SPARSER::ENZYME)
    ("Celecoxib" . SPARSER::DRUG) ("Ptgs2" . SPARSER::PROTEIN)
    ("MUC1-CT and NF-κB" . SPARSER::COLLECTION)
    ("MUC1 and NF-κB" . SPARSER::COLLECTION)
    ("Neo and KCKO" . SPARSER::COLLECTION)
    ("MUC1 and KCM" . SPARSER::COLLECTION) ("PGEM" . SPARSER::MOLECULE)
    ("MUC1 and Cox-2" . SPARSER::COLLECTION)
    ("celecoxib, and gemcitabine" . SPARSER::COLLECTION)
    ("gemcitabine and celecoxib" . SPARSER::COLLECTION)
    ("Cox-2 and PGE 2" . SPARSER::COLLECTION)
    ("a heavily glycosylated membrane tethered glycoprotein"
     . SPARSER::PROTEIN)
    ("Cyclooxygenase 2 and PGE 2" . SPARSER::COLLECTION)
    ("the major functional metabolite" . SPARSER::MOLECULE)
    ("COX-2 and MUC1" . SPARSER::COLLECTION)
    ("reverse transcriptase–polymerase" . SPARSER::COLLECTION)
    ("EP4" . SPARSER::PROTEIN) ("galectin 3" . SPARSER::PROTEIN)
    ("NF-IL6" . SPARSER::PROTEIN) ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("PTGS2" . SPARSER::PROTEIN) ("anti–MUC1" . SPARSER::DRUG)
    ("lamin A/C" . SPARSER::PROTEIN) ("CT2" . SPARSER::PROTEIN)
    ("anti-MUC1" . SPARSER::DRUG) ("Muc1" . SPARSER::PROTEIN)
    ("Mucin 1" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("MUC1-CT" . SPARSER::PROTEIN) ("cyclooxygenase 2" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("mucin 1" . SPARSER::PROTEIN)
    ("potentially other proteins" . SPARSER::PROTEIN)
    ("mDIVI-1" . SPARSER::COLLECTION)
    ("BRAF V600E or MEK" . SPARSER::COLLECTION)
    ("BRAF V600E or MEK (with PLX-4032 or GSK-1120212, respectively)"
     . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN)
    ("an additional larger cohort" . SPARSER::MOLECULE)
    ("no primary antibody and rabbit IgG" . SPARSER::COLLECTION)
    ("Wt" . SPARSER::PROTEIN) ("Drp1" . SPARSER::PROTEIN)
    ("PLX-4032" . SPARSER::DRUG) ("DRP1" . SPARSER::PROTEIN)
    ("possible biomarkers and cofactors" . SPARSER::COLLECTION)
    ("biomarkers and cofactors" . SPARSER::COLLECTION)
    ("HPV genes or even host genes" . SPARSER::COLLECTION)
    ("even host genes" . SPARSER::GENE) ("INCA-Brazil" . SPARSER::PROTEIN-PAIR)
    ("INCA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RB1 and CDH1" . SPARSER::COLLECTION)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("BubR1–Bub1" . SPARSER::COLLECTION)
    ("KNL1 and target" . SPARSER::COLLECTION)
    ("mitotic exit Bub1" . SPARSER::PROTEIN)
    ("BubR1 and the R1LM" . SPARSER::COLLECTION)
    ("GST–Bub1" . SPARSER::COLLECTION) ("Bub1 and Bub1" . SPARSER::COLLECTION)
    ("reversine-" . SPARSER::DRUG) ("Bub1–BubR1" . SPARSER::COLLECTION)
    ("reversine" . SPARSER::DRUG) ("BubR1 and Bub1" . SPARSER::COLLECTION)
    ("western blot and indeed Bub1 co-purified BubR1" . SPARSER::COLLECTION)
    ("indeed Bub1 co-purified BubR1" . SPARSER::PROTEIN)
    ("BubR1 and Bub3" . SPARSER::COLLECTION)
    ("exogenous Venus-tagged Bub1" . SPARSER::PROTEIN)
    ("LM" . SPARSER::MOLECULE) ("exogenous Bub1" . SPARSER::PROTEIN)
    ("Venus" . SPARSER::PROTEIN) ("ZW10 or Zwilch" . SPARSER::COLLECTION)
    ("Indeed Bub1 missing CD1" . SPARSER::PROTEIN)
    ("missing CD1" . SPARSER::PROTEIN)
    ("ZW10 and Zwilch" . SPARSER::COLLECTION)
    ("expressed exogenous Bub1" . SPARSER::PROTEIN)
    ("exogenous and endogenous Bub1" . SPARSER::PROTEIN)
    ("Bub1-Venus" . SPARSER::COLLECTION) ("mut and KNL1" . SPARSER::COLLECTION)
    ("Bub1 and Zwint" . SPARSER::COLLECTION) ("thymidine" . SPARSER::PROTEIN)
    ("dynein" . SPARSER::PROTEIN) ("Mad1/2" . SPARSER::PROTEIN)
    ("Bub1–Mad1/2" . SPARSER::COLLECTION) ("Mad3–Bub3" . SPARSER::COLLECTION)
    ("Bub1–Bub3" . SPARSER::COLLECTION) ("MELT" . SPARSER::DRUG)
    ("KNL1-Mis12-Ndc80" . SPARSER::COLLECTION)
    ("Bub1 and Mad1" . SPARSER::COLLECTION)
    ("the mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("Mad2 and BubR1" . SPARSER::COLLECTION) ("a soluble form" . SPARSER::FORM)
    ("Bub1 and BubR1" . SPARSER::COLLECTION)
    ("Mad2 and the Mps1" . SPARSER::COLLECTION)
    ("Cyclosome" . SPARSER::PROTEIN) ("Zwint" . SPARSER::PROTEIN)
    ("Rod–Zwilch–ZW10" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Zwilch" . SPARSER::PROTEIN)
    ("Rod" . SPARSER::PROTEIN) ("Mad" . SPARSER::PROTEIN)
    ("SAC" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("L-15" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("N-term" . SPARSER::PROTEIN) ("Spc7" . SPARSER::PROTEIN)
    ("Ndc80" . SPARSER::PROTEIN) ("Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KNL1" . SPARSER::PROTEIN) ("Mps1" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("Mad3" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN) ("Bub1" . SPARSER::PROTEIN)
    ("ZW10" . SPARSER::PROTEIN) ("viral component" . SPARSER::COMPONENT)
    ("MEFs and FDMs" . SPARSER::COLLECTION)
    ("dsRNA or any of the non-structural proteins nsp1-4"
     . SPARSER::COLLECTION)
    ("a viral component" . SPARSER::COMPONENT)
    ("growth factor/cytokine" . SPARSER::COLLECTION)
    ("IKK1/IKK2/Nemo" . SPARSER::COLLECTION) ("Nemo" . SPARSER::PROTEIN)
    ("healthy MEFs" . SPARSER::PROTEIN)
    ("both SV40 TAg-transformed and 3T9-immortalized MEFs" . SPARSER::PROTEIN)
    ("MOMP and caspase-3/-7" . SPARSER::COLLECTION)
    ("p53 or p73" . SPARSER::COLLECTION) ("CHOP/CBP" . SPARSER::COLLECTION)
    ("the viral component" . SPARSER::COMPONENT) ("sentinel" . SPARSER::DRUG)
    ("the RIP1 inhibitor necrostatin-1 and shRNA-mediated downregulation of RIP3"
     . SPARSER::COLLECTION)
    ("used neutralizing antibodies or recombinant Fc proteins"
     . SPARSER::COLLECTION)
    ("TRAIL nor their receptors" . SPARSER::COLLECTION)
    ("FasL/Fas" . SPARSER::COLLECTION) ("soluble Fas" . SPARSER::PROTEIN)
    ("Fas or FasL" . SPARSER::COLLECTION)
    ("The only other BH3-only protein" . SPARSER::PROTEIN)
    ("the major BH3-only protein" . SPARSER::PROTEIN)
    ("the major transcriptional inducers" . SPARSER::MOLECULE)
    ("p53, p73 and p65" . SPARSER::COLLECTION)
    ("Puma or Bax and Bak" . SPARSER::COLLECTION)
    ("Bim, Bik, Bad and Noxa" . SPARSER::COLLECTION)
    ("MEFs or p73 or p65" . SPARSER::COLLECTION)
    ("p73 or p65" . SPARSER::COLLECTION)
    ("the classical Puma transcription factors p53, p73 or p65 NFκB"
     . SPARSER::PROTEIN)
    ("MOMP and neither p53" . SPARSER::COLLECTION)
    ("p73 nor p65 NFκB" . SPARSER::COLLECTION)
    ("respective scrambled shRNA" . SPARSER::PROTEIN)
    ("Bid, Bad or Bik or 3T9" . SPARSER::COLLECTION)
    ("Bik or 3T9" . SPARSER::COLLECTION) ("Bim or Noxa" . SPARSER::COLLECTION)
    ("Bik" . SPARSER::PROTEIN) ("SV40 TAg-transformed MEFs" . SPARSER::PROTEIN)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("the respective ligands" . SPARSER::LIGAND)
    ("antibodies or recombinant Fc proteins" . SPARSER::COLLECTION)
    ("FasL, TNFα or TRAIL" . SPARSER::COLLECTION)
    ("FasL, Fas, TRAIL, TRAIL-R1 or TNF-R1" . SPARSER::COLLECTION)
    ("RIP1 and RIP3" . SPARSER::COLLECTION) ("RIP1-" . SPARSER::PROTEIN)
    ("FB" . SPARSER::PROTEIN) ("Bax and Bak" . SPARSER::COLLECTION)
    ("MEFs or Bcl-2" . SPARSER::COLLECTION)
    ("active caspase-3 antibodies and nuclear condensation/fragmentation"
     . SPARSER::COLLECTION)
    ("Bax and/or Bak" . SPARSER::COLLECTION)
    ("respective shRNAs" . SPARSER::RNA) ("annexin-V/PI" . SPARSER::COLLECTION)
    ("gD/HVEM" . SPARSER::COLLECTION) ("HVEM" . SPARSER::PROTEIN)
    ("the viral proteins ICP4" . SPARSER::PROTEIN)
    ("mitochondrial MAVS" . SPARSER::PROTEIN)
    ("whose product tBid" . SPARSER::PROTEIN)
    ("a cytosolic monomeric enzyme" . SPARSER::ENZYME)
    ("Fas, TNF-R1 or TRAIL" . SPARSER::COLLECTION) ("crmA" . SPARSER::PROTEIN)
    ("Puma or Noxa" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("HBx" . SPARSER::PROTEIN) ("apoptotic sentinels" . SPARSER::DRUG)
    ("Bid" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("Bmf" . SPARSER::PROTEIN) ("sentinels" . SPARSER::DRUG)
    ("tBid, Bim or Puma" . SPARSER::COLLECTION) ("tBid" . SPARSER::PROTEIN)
    ("caspase-3 and -7" . SPARSER::COLLECTION)
    ("caspase-8/caspase-3" . SPARSER::COLLECTION) ("MAVS" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA)
    ("FLIP, c-IAP2 and survivin" . SPARSER::COLLECTION)
    ("ICP27 [ xref ] and ICP22 [ xref ]" . SPARSER::COLLECTION)
    ("the late viral glycoproteins" . SPARSER::PROTEIN)
    ("the late protein kinase" . SPARSER::KINASE)
    ("the immediate-early proteins ICP4" . SPARSER::PROTEIN)
    ("LAT" . SPARSER::PROTEIN)
    ("both viral and cellular genes" . SPARSER::GENE)
    ("an ancestral form" . SPARSER::FORM)
    ("p53, p73 or p65" . SPARSER::COLLECTION) ("Bax/Bak" . SPARSER::COLLECTION)
    ("MOMP" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("ZVAD-fmk" . SPARSER::DRUG) ("Q-VD-OPH" . SPARSER::DRUG)
    ("actinomycin D" . SPARSER::MOLECULE) ("32 kD" . SPARSER::PROTEIN)
    ("nsp1" . SPARSER::PROTEIN) ("IKK2" . SPARSER::PROTEIN)
    ("IKK1" . SPARSER::PROTEIN) ("Foxo3A" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN) ("necrostatin-1" . SPARSER::MOLECULE)
    ("RIP3" . SPARSER::PROTEIN) ("env protein" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("TNF-R1" . SPARSER::PROTEIN)
    ("v-FLIP" . SPARSER::PROTEIN) ("E1B-55K" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN) ("Bcl-2-like" . SPARSER::PROTEIN)
    ("HSV-2" . SPARSER::PROTEIN) ("c-IAP2" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN) ("ICP22" . SPARSER::PROTEIN)
    ("ICP27" . SPARSER::PROTEIN) ("ICP4" . SPARSER::PROTEIN)
    ("Bcl-x" . SPARSER::PROTEIN) ("NF-κB or NEMO" . SPARSER::COLLECTION)
    ("IL-8 and IL-8" . SPARSER::COLLECTION)
    ("siRNA or shRNA" . SPARSER::COLLECTION) ("Exp" . SPARSER::PROTEIN)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("a model whereby mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a viral protein" . SPARSER::PROTEIN) ("Given ATM" . SPARSER::PROTEIN)
    ("NEMO-RIPK1" . SPARSER::COLLECTION) ("p53 or p65" . SPARSER::COLLECTION)
    ("p53, and p65" . SPARSER::COLLECTION)
    ("the apical kinase" . SPARSER::KINASE)
    ("Several pro-metastatic genes" . SPARSER::GENE)
    ("CXCL11, CCL2 , MMP1 and SAA2" . SPARSER::COLLECTION)
    ("p53 or p38" . SPARSER::COLLECTION) ("MLL-AF9" . SPARSER::COLLECTION)
    ("several pro-metastatic genes" . SPARSER::GENE)
    ("NF-κB and NEMO" . SPARSER::COLLECTION)
    ("several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("SASP" . SPARSER::PROTEIN) ("pro-metastatic genes" . SPARSER::GENE)
    ("ATM and IL-8" . SPARSER::COLLECTION) ("defective ATM" . SPARSER::PROTEIN)
    ("Ataxia" . SPARSER::PROTEIN) ("ATM- and mutant" . SPARSER::COLLECTION)
    ("ATM-" . SPARSER::PROTEIN) ("p53 and ATM" . SPARSER::COLLECTION)
    ("ATM or mutant" . SPARSER::COLLECTION) ("only ∼40 genes" . SPARSER::GENE)
    ("oxidative stress and mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("CHK2, MRE11 or NBS1" . SPARSER::COLLECTION)
    ("ATM and p53" . SPARSER::COLLECTION) ("exogenous DNA" . SPARSER::DNA)
    ("phosphorylated H2AX, p53 and KAP1 confirmed DNA" . SPARSER::DNA)
    ("H2AX, p53 and KAP1" . SPARSER::COLLECTION)
    ("topoisomerase II poisons etoposide (Et) and doxorubicin (Dox)"
     . SPARSER::COLLECTION)
    ("topoisomerase II poisons etoposide" . SPARSER::DRUG)
    ("poisons" . SPARSER::MOLECULE) ("ATM and mutant" . SPARSER::COLLECTION)
    ("NF-κB and ATM" . SPARSER::COLLECTION)
    ("anti and pro-tumorigenic" . SPARSER::COLLECTION)
    ("DDRs" . SPARSER::PROTEIN) ("a defective DDR" . SPARSER::PROTEIN)
    ("ATM and/or p53" . SPARSER::COLLECTION)
    ("an important pro-inflammatory molecule" . SPARSER::MOLECULE)
    ("harmful chemicals" . SPARSER::MOLECULE) ("RIPK1" . SPARSER::PROTEIN)
    ("Non-targeting" . SPARSER::PROTEIN) ("KU-55933" . SPARSER::DRUG)
    ("SAA2" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("CXCL11" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG)
    ("possibly many more genes" . SPARSER::GENE)
    ("ß-catenin/WNT" . SPARSER::COLLECTION)
    ("ERG and SOX9" . SPARSER::COLLECTION)
    ("SOX9 and PTEN" . SPARSER::COLLECTION)
    ("PTEN and SOX9" . SPARSER::COLLECTION)
    ("SOX9 and ERG" . SPARSER::COLLECTION)
    ("PTEN, 3p13, 6q15 and 5q21" . SPARSER::COLLECTION)
    ("hormone-refractory disease state [ xref ] or poor patient prognosis [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("PIN" . SPARSER::PROTEIN) ("prostatic" . SPARSER::PROTEIN)
    ("SRY" . SPARSER::PROTEIN)
    ("preoperative prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("PTEN , 3p13, 5q21 and 6q15" . SPARSER::COLLECTION)
    ("androgen-receptor" . SPARSER::PROTEIN) ("chi 2" . SPARSER::PROTEIN)
    ("MAP3K7" . SPARSER::PROTEIN) ("CHD1" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN)
    ("p53 as well as caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("cdk1 and polo-like kinase 1" . SPARSER::COLLECTION)
    ("p53 or a dominant negative form" . SPARSER::COLLECTION)
    ("unspecific inhibitors" . SPARSER::INHIBITOR)
    ("p21, BAX and MDM2" . SPARSER::COLLECTION)
    ("sequence-specific siRNAs (Figure xref ) or the quinolinyl thiazolinone derivative"
     . SPARSER::COLLECTION)
    ("normal MYCN" . SPARSER::PROTEIN) ("cdk4 and cdk6" . SPARSER::COLLECTION)
    ("cdk4 and CCND1" . SPARSER::COLLECTION)
    ("CCND1 [ xref ] and cdk4 [ xref ]" . SPARSER::COLLECTION)
    ("cdk4/cdk6" . SPARSER::COLLECTION) ("palbociclib" . SPARSER::DRUG)
    ("those investigational drugs" . SPARSER::DRUG)
    ("flavopiridol and roscovitine" . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG)
    ("cyclin dependent kinases (cdks) and their corresponding cyclins"
     . SPARSER::COLLECTION)
    ("cyclins and cdks" . SPARSER::COLLECTION)
    ("RO-3306 and Q-VD-OPh" . SPARSER::COLLECTION)
    ("caspase 8 and caspase 9" . SPARSER::COLLECTION)
    ("BAX and MDM2" . SPARSER::COLLECTION) ("p53-wt" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM) ("HD" . SPARSER::PROTEIN)
    ("RO-3306 and JNJ-7706621" . SPARSER::COLLECTION)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a previously described cdk1 inhibitor" . SPARSER::INHIBITOR)
    ("sequence-specific siRNAs" . SPARSER::PROTEIN)
    ("CCNB1 or cdk1" . SPARSER::COLLECTION)
    ("CCNB1 and cdk1" . SPARSER::COLLECTION) ("MYCN-ER" . SPARSER::COLLECTION)
    ("Cdk1/CCNB1" . SPARSER::COLLECTION)
    ("cdk1 and CCNB1" . SPARSER::COLLECTION)
    ("Cyclin/cdk" . SPARSER::COLLECTION)
    ("cdk4 ( p = 0.003) or cdk6 ( p = 0.045, xref )" . SPARSER::COLLECTION)
    ("cdk2 ( p = 0.006), cdk4 ( p = 0.003) or cdk6 ( p = 0.045, xref )"
     . SPARSER::COLLECTION)
    ("cdk1 or CCNB1" . SPARSER::COLLECTION)
    ("Cdk1 and CCNB1" . SPARSER::COLLECTION)
    ("MYCN and p53" . SPARSER::COLLECTION) ("CCNB1/cdk1" . SPARSER::COLLECTION)
    ("the cell cycle regulators Cyclin B1 (CCNB1) and the cell cycle dependent kinase 1 (cdk1)"
     . SPARSER::COLLECTION)
    ("the most aggressive forms" . SPARSER::FORM) ("Rb1" . SPARSER::PROTEIN)
    ("either dominant-negative p53 or a short hairpin RNA"
     . SPARSER::COLLECTION)
    ("either dominant-negative p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdk1/CCNB1" . SPARSER::COLLECTION)
    ("both cdk1 and its corresponding cyclin" . SPARSER::COLLECTION)
    ("NB" . SPARSER::PROTEIN) ("cdks" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNJ-7706621" . SPARSER::DRUG) ("cdk6" . SPARSER::PROTEIN)
    ("cdk2" . SPARSER::PROTEIN) ("Q-VD-OPh" . SPARSER::DRUG)
    ("pPP1" . SPARSER::PROTEIN-FAMILY) ("PP1α" . SPARSER::PROTEIN)
    ("cdk-1" . SPARSER::PROTEIN) ("MB3" . SPARSER::DRUG)
    ("RO-3306" . SPARSER::DRUG) ("Brd4" . SPARSER::PROTEIN)
    ("cdk1" . SPARSER::PROTEIN) ("GC1 or GC24" . SPARSER::COLLECTION)
    ("TRα1 and Ubiquitin" . SPARSER::COLLECTION)
    ("just expressing TRβ" . SPARSER::PROTEIN)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogen and ERs" . SPARSER::COLLECTION)
    ("triiodothyronine" . SPARSER::DRUG) ("TRAKs" . SPARSER::PROTEIN-FAMILY)
    ("TRα1 and ubiquitin" . SPARSER::COLLECTION)
    ("functional BRCA1" . SPARSER::PROTEIN) ("THRA" . SPARSER::PROTEIN)
    ("BRCA1 competent MCF7" . SPARSER::PROTEIN) ("pN1-3" . SPARSER::COLLECTION)
    ("these twelve (9/12, 75.0%) triple negative BRCA1" . SPARSER::PROTEIN)
    ("pT1 (p = 0.008) and pN0 (p = 0.040)" . SPARSER::COLLECTION)
    ("Cohort" . SPARSER::MOLECULE)
    ("classical steroid hormone receptors" . SPARSER::RECEPTOR)
    ("either classical hormone receptors" . SPARSER::RECEPTOR)
    ("triple negative BRCA1" . SPARSER::PROTEIN)
    ("classical hormone receptors" . SPARSER::RECEPTOR)
    ("estrogen or progesterone" . SPARSER::COLLECTION)
    ("GC1" . SPARSER::PROTEIN) ("beta catenin" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("pN1" . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("—3" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE)
    ("the most commonly mutated oncogene in NSCLC and one"
     . SPARSER::COLLECTION)
    ("mutant KRAS and wild-type EGFR" . SPARSER::COLLECTION)
    ("BRAF, AKT1, PIK3CA or HER2" . SPARSER::COLLECTION)
    ("expressed at least some mesothelin" . SPARSER::PROTEIN)
    ("SS1P and other mesothelin-targeted therapies" . SPARSER::COLLECTION)
    ("immunotoxin" . SPARSER::DRUG) ("immunotoxins" . SPARSER::DRUG)
    ("EGFR and ALK" . SPARSER::COLLECTION)
    ("mutant KRAS ( P < 0.0001) and wild-type EGFR ( P = 0.002)"
     . SPARSER::COLLECTION)
    ("EGFR, KRAS, BRAF, AKT1, PIK3CA and HER2" . SPARSER::COLLECTION)
    ("potentially actionable genes" . SPARSER::GENE)
    ("mesothelin" . SPARSER::PROTEIN) ("Mesothelin" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("TEF-1" . SPARSER::PROTEIN)
    ("SS1P" . SPARSER::DRUG) ("EGFR/MAPK" . SPARSER::COLLECTION)
    ("some pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("MEK1/2, AKT and PI3K" . SPARSER::COLLECTION)
    ("pro-apoptotic mediators" . SPARSER::PROTEIN)
    ("CPT and/or SM83" . SPARSER::COLLECTION)
    ("Noxa and Mcl1" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("PD98059 and UO126" . SPARSER::COLLECTION)
    ("Triciribine or PI3K" . SPARSER::COLLECTION)
    ("Triciribine" . SPARSER::MOLECULE)
    ("MAPK, AKT and PI3K" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("CPT and SM83" . SPARSER::COLLECTION)
    ("PARP, caspase-8 and -3" . SPARSER::COLLECTION)
    ("the TNF-specific blockers Infliximab (Figure xref middle panel) and Enbrel (Figure xref right panel)"
     . SPARSER::COLLECTION)
    ("Infliximab" . SPARSER::DRUG) ("Pre" . SPARSER::PROTEIN)
    ("the topoisomerase II inhibitor etoposide (ETO)" . SPARSER::DRUG)
    ("etoposide (ETO)" . SPARSER::DRUG) ("NCS" . SPARSER::PROTEIN)
    ("neocarzinostatin" . SPARSER::PROTEIN) ("ETO" . SPARSER::PROTEIN)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("the pro-apoptotic protein Noxa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligand (TRAIL)" . SPARSER::LIGAND)
    ("a natural antagonist" . SPARSER::MOLECULE)
    ("cIAP1, cIAP2 and XIAP" . SPARSER::COLLECTION)
    ("Cellular IAP1 (cIAP1) and cIAP2" . SPARSER::COLLECTION)
    ("Cellular IAP1" . SPARSER::PROTEIN)
    ("essentially apoptosis negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("BIR" . SPARSER::PROTEIN) ("MEK and BCL-XL" . SPARSER::COLLECTION)
    ("5-FU and oxaliplatin" . SPARSER::COLLECTION)
    ("5-FU and the camptothecin (CPT) analogue irinotecan [ xref ]"
     . SPARSER::COLLECTION)
    ("CPT" . SPARSER::PROTEIN) ("camptothecin" . SPARSER::DRUG)
    ("RAF/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("HRAS, KRAS, and NRAS" . SPARSER::COLLECTION)
    ("GDP and display low activity" . SPARSER::COLLECTION)
    ("RAF1" . SPARSER::PROTEIN) ("RAS-GTP" . SPARSER::PROTEIN)
    ("Ras-GTP" . SPARSER::PROTEIN) ("GDC-0941" . SPARSER::DRUG)
    ("UO126" . SPARSER::DRUG) ("Mcl-1" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("X-linked IAP" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1" . SPARSER::PROTEIN) ("IL-6 and IL-1" . SPARSER::COLLECTION)
    ("CDK3 and CDK4" . SPARSER::COLLECTION)
    ("ATF1 and c-Jun" . SPARSER::COLLECTION)
    ("ERKs and JNKs" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("the NID (net inhibitory domain) and the CID (C-terminal binding protein interaction domain)"
     . SPARSER::COLLECTION)
    ("ELK1 and ELK4" . SPARSER::COLLECTION) ("NID" . SPARSER::PROTEIN)
    ("ELK1, ELK4 and ELK3" . SPARSER::COLLECTION)
    ("S/T-PXR" . SPARSER::PROTEIN-PAIR) ("PXR" . SPARSER::PROTEIN)
    ("the ELK4 T194A/S387A mutant in vitro and ex vivo ( xref )"
     . SPARSER::COLLECTION)
    ("ELK4 ( xref ) and ELK4" . SPARSER::COLLECTION)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("ELK4 (SAP-1A) and NET (SAP-2)" . SPARSER::COLLECTION)
    ("ELK1, ELK4 (SAP-1A) and NET (SAP-2)" . SPARSER::COLLECTION)
    ("NET" . SPARSER::PROTEIN) ("Ras/MEK" . SPARSER::COLLECTION)
    ("T194A/S387A" . SPARSER::PROTEIN) ("JNK1 and CDK2" . SPARSER::COLLECTION)
    ("JNK1 and GST-ELK4" . SPARSER::COLLECTION)
    ("CDK2 or JNK1" . SPARSER::COLLECTION) ("GST-ELK4" . SPARSER::COLLECTION)
    ("ELK4-HisG" . SPARSER::COLLECTION) ("HisG" . SPARSER::PROTEIN-FAMILY)
    ("ELK4 and CDK2" . SPARSER::COLLECTION)
    ("a dispensable molecular target" . SPARSER::TARGET-PROTEIN)
    ("p27Kip1 and p21Cip1" . SPARSER::COLLECTION)
    ("p27Kip1 and p21/Cip1" . SPARSER::COLLECTION)
    ("siRNA or antisense" . SPARSER::COLLECTION)
    ("p21Cip1 and p27Kip1" . SPARSER::COLLECTION)
    ("CDK2/cyclin" . SPARSER::COLLECTION)
    ("CDK2 or CDK1" . SPARSER::COLLECTION)
    ("CDK2/cyclin E" . SPARSER::COLLECTION)
    ("CDK4 and/or CDK6" . SPARSER::COLLECTION)
    ("RAS/ERKs" . SPARSER::COLLECTION) ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the SRF (serum response factor) and TCF (ternary complex factor)"
     . SPARSER::COLLECTION)
    ("the transcription factor ternary complex" . SPARSER::BIO-COMPLEX)
    ("the serum response element (SRE) and the cAMP response element (CRE) ( xref – xref )"
     . SPARSER::COLLECTION)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("sis" . SPARSER::PROTEIN) ("ELK4 or CDK2" . SPARSER::COLLECTION)
    ("PMD2" . SPARSER::MOLECULE) ("p-S" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("ATF1" . SPARSER::PROTEIN)
    ("CDK3" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("ELK3" . SPARSER::PROTEIN) ("SAP-2" . SPARSER::PROTEIN)
    ("ELK1" . SPARSER::PROTEIN) ("P-S" . SPARSER::PROTEIN)
    ("SAP-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p27kip1" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("ELK4" . SPARSER::PROTEIN)
    ("Cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("WANG" . SPARSER::PROTEIN) ("EGFR, HER2, and HER3" . SPARSER::COLLECTION)
    ("mTOR/PI3K dual inhibitors" . SPARSER::INHIBITOR)
    ("mTOR/PI3K" . SPARSER::COLLECTION)
    ("IGF-IR/IRS-1/PI3K" . SPARSER::COLLECTION)
    ("PI3K/AKT/PTEN" . SPARSER::COLLECTION)
    ("RAD001 and LY294002" . SPARSER::COLLECTION)
    ("rapamycin and RAD001" . SPARSER::COLLECTION)
    ("a lentiviral short hairpin RNA" . SPARSER::RNA)
    ("SRB" . SPARSER::PROTEIN-FAMILY) ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("RAD001 (everolimus) and CCI-779 (temsirolimus)" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("Rapamycin" . SPARSER::DRUG)
    ("the downstream substrates eukaryotic initiating factor 4E Binding Protein 1"
     . SPARSER::PROTEIN)
    ("LKB1/AMPK" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the causative gene" . SPARSER::GENE)
    ("rapamycin or RAD001" . SPARSER::COLLECTION)
    ("4EBP1 and S6K" . SPARSER::COLLECTION)
    ("rapamycin or everolimus" . SPARSER::COLLECTION)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("CCI-779" . SPARSER::DRUG)
    ("p70S6K1" . SPARSER::PROTEIN)
    ("factor 4E Binding Protein 1" . SPARSER::PROTEIN)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("RAD001" . SPARSER::DRUG)
    ("Mdm2 and Itch" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("p73-MDM2" . SPARSER::COLLECTION)
    ("lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p73α, or p73β" . SPARSER::COLLECTION) ("-luc" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("WAF" . SPARSER::PROTEIN)
    ("MDM2 and ITCH" . SPARSER::COLLECTION) ("p21-luc" . SPARSER::PROTEIN-PAIR)
    ("Mdm2 or Itch and p73β" . SPARSER::COLLECTION)
    ("Itch and p73β" . SPARSER::COLLECTION)
    ("Mdm2 or Itch" . SPARSER::COLLECTION)
    ("ubiquitinated p73 (Figure xref , upper image) and a p73-specific antibody (ER-15)"
     . SPARSER::COLLECTION)
    ("HA-Ub" . SPARSER::COLLECTION) ("ITCH-siRNA" . SPARSER::COLLECTION)
    ("wild type MEFs and Mdm2 null MEFs" . SPARSER::PROTEIN)
    ("MEFs and Mdm2" . SPARSER::COLLECTION)
    ("Itch-siRNA" . SPARSER::COLLECTION)
    ("Itch or both Itch and Mdm2" . SPARSER::COLLECTION)
    ("Itch and Mdm2" . SPARSER::COLLECTION)
    ("a p73-specific antibody (H-79) and a Myc-specific antibody"
     . SPARSER::COLLECTION)
    ("Mdm2 −/− p53 −/− double null MEFs" . SPARSER::PROTEIN)
    ("FK" . SPARSER::MOLECULE)
    ("the structural and functional homologue" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("mixtures" . SPARSER::MOLECULE)
    ("MDM2 and p73" . SPARSER::COLLECTION) ("wt-Ub" . SPARSER::COLLECTION)
    ("E1, E2, and Ub" . SPARSER::COLLECTION) ("GST-MDM2" . SPARSER::COLLECTION)
    ("the anti-p73" . SPARSER::ANTIBODY) ("the anti-MDM2" . SPARSER::ANTIBODY)
    ("p73 and MDM2" . SPARSER::COLLECTION)
    ("wild type MEFs or Mdm2 null MEFs" . SPARSER::PROTEIN)
    ("Mdm2 null MEFs" . SPARSER::PROTEIN)
    ("MEFs or Mdm2" . SPARSER::COLLECTION) ("MDM2-siRNA" . SPARSER::COLLECTION)
    ("p73 and ITCH" . SPARSER::COLLECTION)
    ("ubiquitin and p73α or p73β" . SPARSER::COLLECTION)
    ("MDM2 or ITCH" . SPARSER::COLLECTION)
    ("HA-tagged ubiquitin or various HA-tagged ubiquitin mutants"
     . SPARSER::COLLECTION)
    ("weak E3 ligase activity" . SPARSER::PROTEIN)
    ("ITCH/AIP4" . SPARSER::COLLECTION) ("Flag-p73" . SPARSER::COLLECTION)
    ("MDM2 and wild-type ubiquitin (Ubwt)" . SPARSER::COLLECTION)
    ("ubiquitinated p73 (Figure xref , upper image) or a p73-specific antibody (ER-15)"
     . SPARSER::COLLECTION)
    ("Myc-tagged wild-type ubiquitin (Ubwt) or Myc-tagged Ub4KR"
     . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("HECT" . SPARSER::PROTEIN)
    ("ITCH" . SPARSER::PROTEIN) ("MDM2 or Hdm2" . SPARSER::COLLECTION)
    ("a spontaneously transformed derivative" . SPARSER::DERIVATIVE)
    ("p73 and p53" . SPARSER::COLLECTION)
    ("ligase activity and p73" . SPARSER::COLLECTION)
    ("UbcH5b" . SPARSER::PROTEIN) ("B-2" . SPARSER::PROTEIN)
    ("Tag1" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("FK-1" . SPARSER::PROTEIN) ("AIP4" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("K29" . SPARSER::PROTEIN)
    ("K11" . SPARSER::PROTEIN) ("KLF8, miR141 and EGFR" . SPARSER::COLLECTION)
    ("miR141 and miR200c" . SPARSER::COLLECTION)
    ("the miR-200 family and this family" . SPARSER::COLLECTION)
    ("the strong EMT inducers" . SPARSER::MOLECULE)
    ("miR141 and EGFR" . SPARSER::COLLECTION)
    ("KLF8-miR141-EGFR" . SPARSER::COLLECTION) ("miR141" . SPARSER::PROTEIN)
    ("miR141-EGFR" . SPARSER::PROTEIN-PAIR) ("BLI" . SPARSER::PROTEIN)
    ("KLF8 or miR141" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("EGFR-ERK" . SPARSER::COLLECTION)
    ("MMP2, MMP9, and MMP14" . SPARSER::COLLECTION)
    ("a repression domain-defective mutant" . SPARSER::MUTANT)
    ("ZEB1 and SIP1" . SPARSER::COLLECTION)
    ("miR7 and miR141" . SPARSER::COLLECTION) ("miR7" . SPARSER::PROTEIN)
    ("PITA" . SPARSER::PROTEIN) ("BOP" . SPARSER::PROTEIN)
    ("the activation domain-defective mutant" . SPARSER::MUTANT)
    ("lapatinib" . SPARSER::DRUG)
    ("a dual transcription factor" . SPARSER::PROTEIN)
    ("KLF8 and EGFR" . SPARSER::COLLECTION) ("KLF8-EGFR" . SPARSER::COLLECTION)
    ("PGL3" . SPARSER::PROTEIN) ("C-16" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iK8" . SPARSER::PROTEIN) ("KLF8" . SPARSER::PROTEIN)
    ("ATM or DNA-PK" . SPARSER::COLLECTION)
    ("WEE1 and CDC25s" . SPARSER::COLLECTION)
    ("G 2 /M and sub-G 1" . SPARSER::COLLECTION) ("– 1" . SPARSER::PROTEIN)
    ("ATRi and ATMi" . SPARSER::COLLECTION)
    ("ATR-CHK1/CHK2-WEE1" . SPARSER::COLLECTION) ("ATRi" . SPARSER::MOLECULE)
    ("CHK1 (IC 50 : 5 nM) and CHK2 (IC 50 : < 10 nM)" . SPARSER::COLLECTION)
    ("ATR, CHK1, and WEE1" . SPARSER::COLLECTION)
    ("ATM and CHK2" . SPARSER::COLLECTION)
    ("CHK1 and ATR" . SPARSER::COLLECTION)
    ("chemosensitizers or radiosensitizers" . SPARSER::COLLECTION)
    ("chemosensitizers" . SPARSER::DRUG)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("ATR-CHK1-WEE1" . SPARSER::COLLECTION) ("ATR-CHK1" . SPARSER::COLLECTION)
    ("ATM-CHK2" . SPARSER::COLLECTION) ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("ATR/ATM" . SPARSER::COLLECTION) ("TQ" . SPARSER::DRUG)
    ("ATM and the related ATR" . SPARSER::COLLECTION)
    ("CHK1 and WEE1" . SPARSER::COLLECTION)
    ("CHK1 (AZD7762) or WEE1 (MK-1775)" . SPARSER::COLLECTION)
    ("radiosensitizer" . SPARSER::DRUG) ("CHK1/CHK2" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MK-8776" . SPARSER::DRUG)
    ("PF-00477736" . SPARSER::DRUG) ("PARP1" . SPARSER::PROTEIN)
    ("KU-60019" . SPARSER::DRUG) ("VE-821" . SPARSER::DRUG)
    ("CDC25" . SPARSER::PROTEIN) ("MK-1775" . SPARSER::DRUG)
    ("AZD7762" . SPARSER::DRUG) ("WEE1" . SPARSER::PROTEIN)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("an amenable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("p21 CIP1 , Ki67 and P-Rb" . SPARSER::COLLECTION)
    ("p15 INK4B , p16 INK4A and p21 CIP1" . SPARSER::COLLECTION)
    ("the tumor suppressors p15 INK4B [ xref ] and p16 INK4A"
     . SPARSER::COLLECTION)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a bacterial AB 5 toxin" . SPARSER::MOLECULE) ("CDKi" . SPARSER::DRUG)
    ("p15 INK4B , p16 INK4A and p21 cip1" . SPARSER::COLLECTION)
    ("AZA " . SPARSER::DRUG) ("Ki67 and P-Rb" . SPARSER::COLLECTION)
    ("DMSO and Aza " . SPARSER::COLLECTION) ("DMSO " . SPARSER::MOLECULE)
    ("p21 CIP1 , Ki67, p15 INK4B and p16 INK4A" . SPARSER::COLLECTION)
    ("p16 INK4A and apoptosis inducers" . SPARSER::COLLECTION)
    ("cytidine" . SPARSER::MOLECULE)
    ("caspase-3 and the quiescence marker p21 CIP1" . SPARSER::COLLECTION)
    ("RPMI8226" . SPARSER::PROTEIN)
    ("cyclin-D3 and CDK4" . SPARSER::COLLECTION)
    ("significantly more p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Western blot and IF" . SPARSER::COLLECTION)
    ("blot and IF" . SPARSER::COLLECTION)
    ("the cyclin-dependent kinase inhibitor p21 CIP1 mRNA and nuclear protein [Fig.  xref ]"
     . SPARSER::COLLECTION)
    ("RPMI-Tet-H2B-GFP" . SPARSER::COLLECTION) ("RPMI 8226" . SPARSER::PROTEIN)
    ("GADD34/PP1C" . SPARSER::COLLECTION) ("BiP/GRP78" . SPARSER::COLLECTION)
    ("Aza " . SPARSER::DRUG) ("/P-Rb" . SPARSER::COLLECTION)
    ("/CDK6" . SPARSER::COLLECTION) ("/p21" . SPARSER::COLLECTION)
    ("Grp78" . SPARSER::PROTEIN)
    ("a specific SubAB bacterial toxin" . SPARSER::MOLECULE)
    ("Aza" . SPARSER::DRUG) ("CDK6, Ki67 and P-Rb" . SPARSER::COLLECTION)
    ("GRP78/BiP" . SPARSER::COLLECTION) ("Azacytidine" . SPARSER::DRUG)
    ("H2B-GFP" . SPARSER::COLLECTION) ("bortezomib" . SPARSER::DRUG)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4A" . SPARSER::PROTEIN) ("p15 INK4B" . SPARSER::PROTEIN)
    ("cyclin-D3" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("PP1C" . SPARSER::PROTEIN) ("GADD34" . SPARSER::PROTEIN)
    ("P-Rb" . SPARSER::PROTEIN) ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YAP1 and YAP2" . SPARSER::COLLECTION)
    ("Id1 and Id2" . SPARSER::COLLECTION)
    ("R-Smads and inhibitory Smads" . SPARSER::COLLECTION)
    ("TGF-β/BMP" . SPARSER::COLLECTION) ("PLGA-nanofibre" . SPARSER::DRUG)
    ("PLGA" . SPARSER::DRUG) ("BMP-2 or TGF-β1" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("myogenic" . SPARSER::PROTEIN)
    ("promoter or enhancer" . SPARSER::COLLECTION) ("Seq" . SPARSER::PROTEIN)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nine currently known transcript variants" . SPARSER::VARIANT)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("Id1, Id2 and Id3" . SPARSER::COLLECTION)
    ("BMP and TGF-β" . SPARSER::COLLECTION)
    ("Sox9, Col2a1 and Col10a1" . SPARSER::COLLECTION)
    ("Col10a1" . SPARSER::PROTEIN) ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("hSM-MSCs" . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("CTGF and CYR61" . SPARSER::COLLECTION) ("hSM" . SPARSER::PROTEIN)
    ("high cell density mimicking embryonic mesenchymal condensation"
     . SPARSER::PROTEIN-FAMILY)
    ("both R-Smads and inhibitory Smads [ xref , xref ]" . SPARSER::COLLECTION)
    ("BMP/TGF-β" . SPARSER::COLLECTION)
    ("heteromeric receptors" . SPARSER::PROTEIN)
    ("the bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("BMPs" . SPARSER::PROTEIN) ("mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a key transcriptional co-factor" . SPARSER::MOLECULE)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN) ("Id2 and Id3" . SPARSER::COLLECTION)
    ("MSC" . SPARSER::PROTEIN) ("paralogue" . SPARSER::PROTEIN)
    ("the transcriptional co-factor Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("YAP2" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("MT-MMP" . SPARSER::PROTEIN)
    ("Id1" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("mId1" . SPARSER::PROTEIN) ("Col2a1" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad 6" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("R-Smad" . SPARSER::PROTEIN-FAMILY) ("Smad 1" . SPARSER::PROTEIN)
    ("Lats1" . SPARSER::PROTEIN) ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Id3" . SPARSER::PROTEIN) ("Id2" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("BMP-2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("PTEN-PI3K-Akt" . SPARSER::COLLECTION) ("PTEN/PI3K" . SPARSER::COLLECTION)
    ("PTEN and Akt" . SPARSER::COLLECTION)
    ("PTEN , PI3K and FOXO3" . SPARSER::COLLECTION)
    ("Delta" . SPARSER::PROTEIN)
    ("the PTEN (fc = -1.21, p = 0.03) and PI3K (fc = -2.43) genes"
     . SPARSER::COLLECTION)
    ("AKT (fc = 7.65, p = 0.015) and FOXO3 (fc = 6.78, p = 0.01)"
     . SPARSER::COLLECTION)
    ("AMH and Estradiol" . SPARSER::COLLECTION)
    ("Estradiol" . SPARSER::PROTEIN) ("AMH" . SPARSER::PROTEIN)
    ("pic" . SPARSER::BIO-COMPLEX)
    ("PI3K-Protein kinase B" . SPARSER::COLLECTION)
    ("the main ovarian reserve component" . SPARSER::COMPONENT)
    ("PTEN-Akt" . SPARSER::COLLECTION) ("FoxO3" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("forkhead box O3" . SPARSER::PROTEIN)
    ("Protein kinase B" . SPARSER::PROTEIN)
    ("Phosphatase and TENsin homolog" . SPARSER::PROTEIN)
    ("varieties" . SPARSER::VARIETY)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("VEGF, EGFR and HER-2" . SPARSER::COLLECTION)
    ("the carcinogenetic inflammatory cytokine IL-6" . SPARSER::PROTEIN)
    ("p-STATs" . SPARSER::COLLECTION)
    ("signal transducer and activator of transcription3" . SPARSER::PROTEIN)
    ("the euchromatic histone" . SPARSER::PROTEIN)
    ("condensin" . SPARSER::PROTEIN-FAMILY) ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("SIRT1 and UBF" . SPARSER::COLLECTION)
    ("the mitotic histone" . SPARSER::PROTEIN) ("pSer" . SPARSER::PROTEIN)
    ("UBF and Pol" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("SIRT1 and SIRT7" . SPARSER::COLLECTION)
    ("ar" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIRT6 or SIRT7" . SPARSER::COLLECTION) ("TFIIB" . SPARSER::PROTEIN)
    ("FU" . SPARSER::PROTEIN) ("mitotic NORs" . SPARSER::PROTEIN)
    ("SL1 and Pol" . SPARSER::COLLECTION) ("Flag-TAF" . SPARSER::COLLECTION)
    ("TBP-TAF" . SPARSER::COLLECTION) ("mitotic SL1" . SPARSER::PROTEIN)
    ("UBF and histone" . SPARSER::COLLECTION)
    ("intergenic spacer sequences separating individual rDNA"
     . SPARSER::PROTEIN)
    ("asynchronous cells hCdc14B" . SPARSER::PROTEIN)
    ("nucleolar chromatin" . SPARSER::PROTEIN)
    ("many nucleolar proteins" . SPARSER::PROTEIN)
    ("calf intestine alkaline phosphatase (CIAP) or Cdc14B"
     . SPARSER::COLLECTION)
    ("alkaline phosphatase (CIAP)" . SPARSER::PROTEIN-FAMILY)
    ("CIAP" . SPARSER::PROTEIN)
    ("serine, threonine and tyrosine" . SPARSER::COLLECTION)
    ("two tryptic peptides" . SPARSER::PEPTIDE)
    ("Cdk1 and SIRT1" . SPARSER::COLLECTION)
    ("SL1 and UBF" . SPARSER::COLLECTION)
    ("TATA-box binding protein (TBP)" . SPARSER::PROTEIN)
    ("most nucleolar proteins" . SPARSER::PROTEIN)
    ("UBF and TTF-I" . SPARSER::COLLECTION) ("NORs" . SPARSER::PROTEIN)
    ("TFIIIB" . SPARSER::PROTEIN)
    ("TFIIH [ xref , xref ] and the heptapeptide" . SPARSER::COLLECTION)
    ("carboxy" . SPARSER::MOLECULE) ("TFIIH" . SPARSER::PROTEIN)
    ("TFIID" . SPARSER::PROTEIN) ("UBF" . SPARSER::PROTEIN)
    ("metazoans" . SPARSER::PROTEIN-FAMILY) ("pre-rRNA" . SPARSER::COLLECTION)
    ("Cdc14B" . SPARSER::PROTEIN) ("Cdk1/cyclin" . SPARSER::COLLECTION)
    ("TBP" . SPARSER::PROTEIN) ("TAF" . SPARSER::PROTEIN)
    ("SL1" . SPARSER::PROTEIN) ("TIF-IA" . SPARSER::PROTEIN)
    ("BR 3" . SPARSER::PROTEIN) ("RPA194" . SPARSER::PROTEIN)
    ("TAF1B" . SPARSER::PROTEIN) ("AMP-PNP" . SPARSER::MOLECULE)
    ("TAF1C" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN)
    ("TTF-I" . SPARSER::PROTEIN) ("cdk7" . SPARSER::PROTEIN)
    ("hCdc14B" . SPARSER::PROTEIN) ("Cdc14" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk1" . SPARSER::PROTEIN) ("RNA polymerase I" . SPARSER::PROTEIN)
    ("developing new biomarkers" . SPARSER::MOLECULE)
    ("Bmi1 and its down-stream genes" . SPARSER::COLLECTION)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN)
    ("Slug [ xref , xref ] and NF-κB [ xref ]" . SPARSER::COLLECTION)
    ("a BMI1 promoter-driven reporter gene" . SPARSER::GENE)
    ("Snail, Slug and Zeb1" . SPARSER::COLLECTION)
    ("Twist1 and FoxC2" . SPARSER::COLLECTION)
    ("ERα-Bmi1-E-cadherin" . SPARSER::COLLECTION)
    ("ERα or E-cadherin" . SPARSER::COLLECTION)
    ("Bmi1, ERα and E-cadherin" . SPARSER::COLLECTION)
    ("ERα and E-cadherin" . SPARSER::COLLECTION)
    ("promoter and Renilla" . SPARSER::COLLECTION)
    ("IgG, or anti-Twist1" . SPARSER::COLLECTION)
    ("unlabeled oligonucleotides or non-specific competition"
     . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE)
    ("classical ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Bmi1 and E-cadherin" . SPARSER::COLLECTION)
    ("post-EMT" . SPARSER::PROTEIN) ("EMT and stemness" . SPARSER::COLLECTION)
    ("ERα and Bmi1" . SPARSER::COLLECTION)
    ("EMT and cell stemness" . SPARSER::COLLECTION)
    ("/CD24" . SPARSER::COLLECTION)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("FoxC2" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("DPX" . SPARSER::PROTEIN)
    ("PAK1 or γH2AX" . SPARSER::COLLECTION) ("DAB" . SPARSER::MOLECULE)
    ("rabbit polyclonal anti-p21 activated kinase 1 antibody (Cell signaling Technology, Boston, MA, USA) or γH2AX (Ser139, Cell Signaling Technology, Boston, MA, USA)"
     . SPARSER::COLLECTION)
    ("EDTA" . SPARSER::MOLECULE)
    ("synaptophysin (Syn) and chromogranin" . SPARSER::COLLECTION)
    ("CgA" . SPARSER::PROTEIN) ("chromogranin" . SPARSER::PROTEIN)
    ("Syn" . SPARSER::PROTEIN) ("synaptophysin" . SPARSER::PROTEIN)
    ("NSE" . SPARSER::PROTEIN) ("PAK1 and ERCC1" . SPARSER::COLLECTION)
    ("an elegant biomarker" . SPARSER::MOLECULE)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("PAK1 and DNA" . SPARSER::COLLECTION)
    ("EAC, and PAK1" . SPARSER::COLLECTION) ("EAC" . SPARSER::PROTEIN)
    ("Lv" . SPARSER::MOLECULE)
    ("targets and anti-cancer" . SPARSER::COLLECTION) ("IIIb" . SPARSER::DRUG)
    ("Ib" . SPARSER::DRUG) ("PAK1 and γH2AX" . SPARSER::COLLECTION)
    ("PAK1 and DDR" . SPARSER::COLLECTION) ("a far more common type" . TYPE)
    ("a ubiquitous serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("p21 activated kinase 1" . SPARSER::PROTEIN)
    ("neuron-specific enolase" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN) ("MORC2" . SPARSER::PROTEIN)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("P21-activated kinase 1" . SPARSER::PROTEIN)
    ("PI3K/AKT/mTOR-GLUT" . SPARSER::COLLECTION)
    ("RHOA/ROCK" . SPARSER::COLLECTION) ("PC-9, and p" . SPARSER::COLLECTION)
    ("activated RAS homolog gene family member A (RHOA) and the downstream effector"
     . SPARSER::COLLECTION)
    ("member A (RHOA)" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("tumor-associated mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AS160 (Akt substrate of 160 kDa) and Tbc1Ds" . SPARSER::COLLECTION)
    ("Tbc" . SPARSER::BIO-COMPLEX) ("TC10" . SPARSER::PROTEIN)
    ("TKIs and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("siNC" . SPARSER::DRUG) ("DMSO or BEZ235" . SPARSER::COLLECTION)
    ("erlotinib and BEZ235" . SPARSER::COLLECTION)
    ("EGFR and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("transporter and hexokinase" . SPARSER::COLLECTION)
    ("hexokinase" . SPARSER::PROTEIN)
    ("AZD9291 and HCC827" . SPARSER::COLLECTION)
    ("pyrimidines" . SPARSER::DRUG) ("carbamoyl" . SPARSER::MOLECULE)
    ("PC-9 and H1975" . SPARSER::COLLECTION) ("CE-TOF" . SPARSER::PROTEIN-PAIR)
    ("TOF" . SPARSER::PROTEIN) ("methanol" . SPARSER::MOLECULE)
    ("AZD9291 and PKI-587" . SPARSER::COLLECTION)
    ("DMSO, AZD9291, and PKI-587" . SPARSER::COLLECTION)
    ("Glc" . SPARSER::MOLECULE) ("Pentose" . SPARSER::MOLECULE)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("RAS/MEK/MAPK" . SPARSER::COLLECTION)
    ("BEZ235 and PKI-587" . SPARSER::COLLECTION)
    ("EGFR, AKT, and ERK" . SPARSER::COLLECTION)
    ("erlotinib, AZD6244, BEZ235, AZD9291, and PKI-587" . SPARSER::COLLECTION)
    ("NVP-BEZ235 (dactolisib) and PKI-587 (gedatolisib)" . SPARSER::COLLECTION)
    ("dual pan PI3K and mTOR inhibitors" . SPARSER::INHIBITOR)
    ("a non-ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION) ("dactolisib" . SPARSER::DRUG)
    ("selumetinib" . SPARSER::DRUG)
    ("Dual PI3K/mTOR Inhibitors" . SPARSER::INHIBITOR)
    ("symporter" . SPARSER::PROTEIN) ("hexose" . SPARSER::MOLECULE)
    ("GLUT" . SPARSER::PROTEIN)
    ("transporters, GLUTs and sodium-glucose" . SPARSER::COLLECTION)
    ("sodium-glucose" . SPARSER::PROTEIN) ("GLUTs" . SPARSER::PROTEIN)
    ("GLUT1, or solute" . SPARSER::COLLECTION)
    ("adequate oxygen" . SPARSER::MOLECULE)
    ("dehydrogenase ( IDH )" . SPARSER::PROTEIN) ("IDH" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("facilitative glucose transporter" . SPARSER::PROTEIN)
    ("transporters or hexokinases" . SPARSER::COLLECTION)
    ("PI3K/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("RAS/MEK/ERK" . SPARSER::COLLECTION) ("LAD" . SPARSER::PROTEIN)
    ("GLUT3" . SPARSER::PROTEIN)
    ("thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("member A" . SPARSER::PROTEIN)
    ("RAS homolog gene family" . SPARSER::PROTEIN) ("AS160" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("PKI-587" . SPARSER::DRUG) ("BEZ235" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("SGLT1" . SPARSER::PROTEIN)
    ("SLC2A" . SPARSER::PROTEIN-FAMILY) ("SLC2A1" . SPARSER::PROTEIN)
    ("fumarate hydratase" . SPARSER::PROTEIN)
    ("PI3K and MAP kinase" . SPARSER::COLLECTION)
    ("endothelial Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MULAN" . SPARSER::PROTEIN) ("Akt1 and Erk" . SPARSER::COLLECTION)
    ("a strong negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("BRAFV" . SPARSER::PROTEIN) ("PI3K/Akt–MAP kinase" . SPARSER::COLLECTION)
    ("constitutively active PIK3CA (myrPIK3CA and PIK3CA E545K) and oncogenic B-Raf mutant (BRAF V600E)"
     . SPARSER::COLLECTION)
    ("the dual MEK1/MEK2 inhibitor U0126" . SPARSER::DRUG)
    ("MEK1/MEK2" . SPARSER::COLLECTION)
    ("endothelial Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("pAkt and pErk" . SPARSER::COLLECTION) ("pErk" . SPARSER::PROTEIN)
    ("PI3K (wortmannin) and MEK1/2 (PD-98059 and U0126)" . SPARSER::COLLECTION)
    ("PD-98059 and U0126" . SPARSER::COLLECTION)
    ("PI3K-Akt and MAP kinase" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN) ("Akt-GFP" . SPARSER::COLLECTION)
    ("cyan-green fluorescent protein" . SPARSER::COLLECTION)
    ("Akt2 and Akt3" . SPARSER::COLLECTION) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("–green fluorescent protein (GFP)" . SPARSER::COLLECTION)
    ("–green fluorescent protein" . SPARSER::COLLECTION)
    ("constitutively active myristolated Akt1 (myrAkt1) and phosphorylation-site alanine-substitution mutants"
     . SPARSER::COLLECTION)
    ("vascular malformations" . SPARSER::PROTEIN)
    ("–Akt" . SPARSER::COLLECTION)
    ("contextual cues" . SPARSER::PROTEIN-FAMILY)
    ("vSMC-associated VEGF" . SPARSER::PROTEIN) ("P31582" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("l -glutamine" . SPARSER::MOLECULE)
    ("Hsc-70" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TTC3" . SPARSER::PROTEIN)
    ("tetratricopeptide repeat domain 3" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("PD-98059" . SPARSER::DRUG)
    ("PI3K-Akt" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ggc" . SPARSER::PROTEIN) ("gga" . SPARSER::MOLECULE)
    ("the latter mutant" . SPARSER::MUTANT)
    ("PCR/sequencing" . SPARSER::PROTEIN) ("CCL" . SPARSER::DRUG)
    ("LNA-PCR/sequencing" . SPARSER::COLLECTION)
    ("DNA or RNA" . SPARSER::COLLECTION)
    ("-oxygen and the 4" . SPARSER::COLLECTION) ("-oxygen" . SPARSER::MOLECULE)
    ("at least a 20 " . SPARSER::PROTEIN) ("poses" . SPARSER::PROTEIN)
    ("gefitinib, erlotinib, or afatinib" . SPARSER::COLLECTION)
    ("-TKIs" . SPARSER::COLLECTION) ("Cysteine" . SPARSER::AMINO-ACID)
    ("Fragment" . SPARSER::FRAGMENT) ("DNA polymerase " . SPARSER::PROTEIN)
    ("tag 1" . SPARSER::PROTEIN)
    ("the TN as well as the ERPR+ patient group" . SPARSER::COLLECTION)
    ("amplifiable DNA" . SPARSER::DNA) ("TN and ERPR+" . SPARSER::COLLECTION)
    ("Estrogen and progesterone" . SPARSER::COLLECTION)
    ("patient TN8" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("the triple negative group" . SPARSER::MOLECULE)
    ("Triple negative group" . SPARSER::MOLECULE)
    ("homozygous allele 2 and heterozygous patients" . SPARSER::COLLECTION)
    ("homozygous allele" . SPARSER::ALLELE) ("FAM" . SPARSER::PROTEIN)
    ("phosphoryl" . SPARSER::MOLECULE) ("ACs" . SPARSER::PROTEIN)
    ("the topological DNA" . SPARSER::DNA) ("no clear AC" . SPARSER::PROTEIN)
    ("AC" . SPARSER::PROTEIN) ("Herceptin" . SPARSER::DRUG)
    ("erbB-2 and neu" . SPARSER::COLLECTION)
    ("the HER2 gene as well as the juxtaposed TOP2A gene"
     . SPARSER::COLLECTION)
    ("Tamoxifen and aromatase" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("HER2/TOP2A" . SPARSER::COLLECTION)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("SNP 2" . SPARSER::PROTEIN) ("SNP 3" . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("SNP 1" . SPARSER::PROTEIN)
    ("CT1" . SPARSER::PROTEIN) ("ER-α and IGF-1R" . SPARSER::COLLECTION)
    ("this mature SREBP-1" . SPARSER::PROTEIN)
    ("the mature form" . SPARSER::FORM)
    ("the mature active N-terminal form" . SPARSER::FORM)
    ("ER/IGF1-R" . SPARSER::COLLECTION) ("ER and IGF1-R" . SPARSER::COLLECTION)
    ("ERα and IGF-1" . SPARSER::COLLECTION)
    ("MAPK and GSK3" . SPARSER::COLLECTION)
    ("mTOR/eIF4E-binding protein 1" . SPARSER::COLLECTION)
    ("exogenous palmitate" . SPARSER::PROTEIN)
    ("FBS or exogenous lipids [ xref – xref , xref ]" . SPARSER::COLLECTION)
    ("exogenous lipids" . SPARSER::LIPID)
    ("endogenously-synthesized MUFA" . SPARSER::MOLECULE)
    ("ample exogenous lipids" . SPARSER::LIPID)
    ("adding exogenous oleic acid" . SPARSER::MOLECULE)
    ("exogenous MUFA" . SPARSER::MOLECULE)
    ("pre-adipocytes" . SPARSER::COLLECTION) ("PUFA" . SPARSER::MOLECULE)
    ("cellular fatty acid" . SPARSER::MOLECULE)
    ("estrogen and SCD-1" . SPARSER::COLLECTION)
    ("response element (SRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("saturated fatty acyl-CoA" . SPARSER::MOLECULE)
    ("-delta" . SPARSER::COLLECTION) ("IGF-1/IGF-1R" . SPARSER::COLLECTION)
    ("the principal signalling molecules" . SPARSER::MOLECULE)
    ("receptors (ER)" . SPARSER::RECEPTOR)
    ("cellular MUFA" . SPARSER::MOLECULE)
    ("the mature active 60 kDa form" . SPARSER::FORM)
    ("tamoxifen or siRNA" . SPARSER::COLLECTION) ("MUFA" . SPARSER::MOLECULE)
    ("ER-α " . SPARSER::PROTEIN) ("IGF1-R" . SPARSER::PROTEIN)
    ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE) ("SREBP-1a" . SPARSER::PROTEIN)
    ("SCD1" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("non-targeting" . SPARSER::PROTEIN) ("– 2" . SPARSER::PROTEIN)
    ("AG 1024" . SPARSER::DRUG)
    ("sterol regulatory element binding protein 1" . SPARSER::PROTEIN)
    ("acyl-CoA" . SPARSER::MOLECULE) ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("palmitic acid" . SPARSER::MOLECULE) ("SCD-1" . SPARSER::PROTEIN)
    ("Stearoyl-CoA" . SPARSER::MOLECULE) ("E–T–CMF" . SPARSER::COLLECTION)
    ("EGFR, HER2 or HER3" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("luminal-HER2 and HER2-enriched" . SPARSER::COLLECTION)
    ("ER and PgR" . SPARSER::COLLECTION)
    ("ER (Mann–Whitney, p < 0.001) and PgR (p = 0.005)" . SPARSER::COLLECTION)
    ("HER2 and HER4" . SPARSER::COLLECTION)
    ("the EGFR (Chi square test, p < 0.001) and the HER2 (Chi square test, p < 0.001) receptors"
     . SPARSER::COLLECTION)
    ("DCT" . SPARSER::PROTEIN)
    ("dose-dense sequential or concurrent epirubicin and paclitaxel"
     . SPARSER::COLLECTION)
    ("epirubicin and paclitaxel" . SPARSER::COLLECTION)
    ("ErbB-3 (HER3) and ErbB-4 (HER4)" . SPARSER::COLLECTION)
    ("ErbB-1 (epidermal growth factor receptor [EGFR] or HER1), ErbB-2 (HER2), ErbB-3 (HER3) and ErbB-4 (HER4)"
     . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("HER3 and HER4" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION) ("MIB-1" . SPARSER::PROTEIN)
    ("E–T" . SPARSER::PROTEIN) ("ErbB-1" . SPARSER::PROTEIN)
    ("LSL-KRasG12D" . SPARSER::COLLECTION) ("RasG" . SPARSER::PROTEIN)
    ("KRasG" . SPARSER::PROTEIN) ("LSL" . SPARSER::PROTEIN)
    ("H 2 O 2 and catalase" . SPARSER::COLLECTION)
    ("two major antioxidants" . SPARSER::DRUG) ("miR155" . SPARSER::PROTEIN)
    ("another major antioxidant" . SPARSER::PROTEIN)
    ("Catalase" . SPARSER::PROTEIN) ("a major antioxidant" . SPARSER::PROTEIN)
    ("both superoxide (O 2  − ) and hydrogen (H 2 O 2 ) levels (Figure xref )"
     . SPARSER::COLLECTION)
    ("c-myc and Ras" . SPARSER::COLLECTION) ("MAPK-AP1" . SPARSER::COLLECTION)
    ("K-Ras, Erk and NF-κB" . SPARSER::COLLECTION)
    ("K-Ras and the downs stream effectors" . SPARSER::COLLECTION)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("AP1" . SPARSER::PROTEIN) ("Erk and NF-κB" . SPARSER::COLLECTION)
    ("T-Rex/K-ras" . SPARSER::COLLECTION) ("T-Rex/K-Ras" . SPARSER::COLLECTION)
    ("miRNA and redox" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("-kinase, and RalGDS" . SPARSER::COLLECTION)
    ("major antioxidants" . SPARSER::DRUG)
    ("SOD2 and catalase" . SPARSER::COLLECTION) ("CM-H" . SPARSER::MOLECULE)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("RasG12V" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("IGF2 and IGFBP2" . SPARSER::COLLECTION)
    ("biological networks experimentally shed light" . SPARSER::PROTEIN)
    ("NFKBIA" . SPARSER::PROTEIN) ("NFKBIZ" . SPARSER::PROTEIN)
    ("Pregnancy-Associated Plasma Protein A (PAPPA)" . SPARSER::PROTEIN)
    ("IGF-receptors" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("the receptor tyrosine kinases IGF1R (ENSG00000140443) and IGF2R (ENSG00000197081)"
     . SPARSER::COLLECTION)
    ("-kinase" . SPARSER::KINASE)
    ("phosphatidylinositide-3" . SPARSER::COLLECTION)
    ("IGF2, IGF-binding proteins (IGFBPs), and membrane-associated receptors"
     . SPARSER::COLLECTION)
    ("membrane-associated receptors" . SPARSER::PROTEIN)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("mannose-6-phosphate receptor/IGF-II" . SPARSER::COLLECTION)
    ("placental growth factor (PGF)" . SPARSER::GROWTH-FACTOR)
    ("the most influential HSC regulators" . SPARSER::REGULATOR)
    ("CTSB" . SPARSER::PROTEIN)
    ("hepatocellular growth factor (HGF)" . SPARSER::GROWTH-FACTOR)
    ("algorithm and MGSA" . SPARSER::COLLECTION)
    ("HSC genes instead of HCC genes" . SPARSER::COLLECTION)
    ("was run" . SPARSER::PROTEIN-FAMILY)
    ("IGF1 (ENSG00000017427) and IGF2 (ENSG00000167244)" . SPARSER::COLLECTION)
    ("‘receptor’" . SPARSER::RECEPTOR)
    ("the respective HCC gene" . SPARSER::GENE)
    ("the HSC gene and the HCC gene" . SPARSER::COLLECTION)
    ("x and y" . SPARSER::COLLECTION)
    ("NPC2 (ENSG119655) and FGF5 (ENSG00000138675)" . SPARSER::COLLECTION)
    ("CSF1 (ENSG00000184371), NPC2 (ENSG119655) and FGF5 (ENSG00000138675)"
     . SPARSER::COLLECTION)
    ("NFκB, JAK1 and MAP kinase" . SPARSER::COLLECTION)
    ("TGF-beta/SMAD3" . SPARSER::COLLECTION) ("algorithm" . SPARSER::PROTEIN)
    ("x" . SPARSER::PROTEIN) ("algorithms" . SPARSER::PROTEIN)
    ("PC-algorithm" . SPARSER::PROTEIN-PAIR) ("IDA" . SPARSER::PROTEIN)
    ("cirrhosis" . SPARSER::PROTEIN) ("MGSA" . SPARSER::PROTEIN)
    ("Placental Growth Factor (PGF) and Periostin (POSTN)"
     . SPARSER::COLLECTION)
    ("Placental Growth Factor (PGF)" . SPARSER::GROWTH-FACTOR)
    ("PAPPA" . SPARSER::PROTEIN) ("POSTN" . SPARSER::PROTEIN)
    ("Periostin" . SPARSER::PROTEIN) ("IGF-IRs" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("MAP3K8" . SPARSER::PROTEIN)
    ("IGF2R" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("mannose-6-phosphate receptor" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("macrophage colony-stimulating factor 1" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("x11" . SPARSER::PROTEIN)
    ("FGF5" . SPARSER::PROTEIN) ("NPC2" . SPARSER::PROTEIN)
    ("CSF1" . SPARSER::PROTEIN) ("RND1" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("TGF-beta" . SPARSER::PROTEIN)
    ("Pregnancy-Associated Plasma Protein A" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("homozygous variants" . SPARSER::VARIANT) ("Platinum" . SPARSER::MOLECULE)
    ("GATA-2 transcription factor and the variant" . SPARSER::COLLECTION)
    ("histologic type" . TYPE) ("navelbine" . SPARSER::DRUG)
    ("TERT variants and cancer progression" . SPARSER::COLLECTION)
    ("GATA-2" . SPARSER::PROTEIN) ("ST" . SPARSER::PROTEIN)
    ("ALK and EGFR" . SPARSER::COLLECTION)
    ("protein, mRNA, and gene" . SPARSER::COLLECTION)
    ("protein and FGFR1" . SPARSER::COLLECTION)
    ("at least 4 FGFR1" . SPARSER::PROTEIN)
    ("FGFR1 and FGF2" . SPARSER::COLLECTION)
    ("FGFR1 and FGF9" . SPARSER::COLLECTION)
    ("FGFR1, FGF2, or FGF9" . SPARSER::COLLECTION)
    ("FGF9–FGFR1" . SPARSER::COLLECTION)
    ("FGFR1, FGF2, and FGF9" . SPARSER::COLLECTION)
    ("protein and messenger RNA" . SPARSER::COLLECTION)
    ("Ponatinib" . SPARSER::DRUG)
    ("a mitogen and a survival factor" . SPARSER::COLLECTION)
    ("p12" . SPARSER::PROTEIN) ("FGF2 and FGF9" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase and Ras" . SPARSER::COLLECTION)
    ("FGFR1–FGFR4" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("FGFs" . SPARSER::PROTEIN)
    ("/fibroblast growth factor receptor" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and anaplastic lymphoma kinase (ALK) inhibitors"
     . SPARSER::COLLECTION)
    ("FGFR1 and ligand" . SPARSER::COLLECTION)
    ("FGF2, FGF9, and FGFR1" . SPARSER::COLLECTION)
    ("FGFR1 and ligands" . SPARSER::COLLECTION)
    ("FGFR1, FGF2 and FGF9" . SPARSER::COLLECTION)
    ("fibroblast growth factors (FGF2, FGF9) and their high-affinity receptor"
     . SPARSER::COLLECTION)
    ("P30" . SPARSER::PROTEIN) ("P50" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("D-8" . SPARSER::PROTEIN) ("MTA-1" . SPARSER::PROTEIN)
    ("PD173074" . SPARSER::DRUG) ("LY2874455" . SPARSER::DRUG)
    ("AZD 4547" . SPARSER::DRUG) ("FGFR4" . SPARSER::PROTEIN)
    ("FGF9" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("TAs and KRAS" . SPARSER::COLLECTION) ("SSA" . SPARSER::PROTEIN)
    ("Serrated" . SPARSER::PROTEIN)
    ("64 TAs and 32 SSAs" . SPARSER::COLLECTION)
    ("TAs and SSAs" . SPARSER::COLLECTION) ("SSAs" . SPARSER::PROTEIN)
    ("serrated" . SPARSER::PROTEIN) ("TAs" . SPARSER::PROTEIN)
    ("class 1A" . SPARSER::PROTEIN) ("p110 alpha" . SPARSER::PROTEIN)
    ("alpha polypeptide" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antivirals" . SPARSER::DRUG) ("NF- κ B/p65" . SPARSER::COLLECTION)
    ("both an NF- κ B signaling inhibitor and a NOTCH2 luciferase promoter reporter construct lacking"
     . SPARSER::COLLECTION)
    ("β -catenin and NF- κ B" . SPARSER::COLLECTION)
    ("the cellular transcription factor Zeb2" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("NOTCH2 and NF- κ B" . SPARSER::COLLECTION)
    ("EBNA2 and NOTCH2" . SPARSER::COLLECTION)
    ("AP-1/ATF" . SPARSER::COLLECTION) ("RBPJ" . SPARSER::PROTEIN)
    ("ATF" . SPARSER::PROTEIN)
    ("NOTCH2 and its target genes" . SPARSER::COLLECTION)
    ("antibodies and TGF- β" . SPARSER::COLLECTION)
    ("butyrate" . SPARSER::PROTEIN)
    ("GSI and ganciclovir (GCV)" . SPARSER::COLLECTION)
    ("viral lytic protein kinase" . SPARSER::KINASE)
    ("antiviral drugs" . SPARSER::DRUG)
    ("GSI and ganciclovir" . SPARSER::COLLECTION)
    ("ganciclovir" . SPARSER::DRUG)
    ("late lytic gp350 viral protein" . SPARSER::PROTEIN)
    ("DNase" . SPARSER::PROTEIN) ("DBZ" . SPARSER::DRUG)
    ("GSI" . SPARSER::PROTEIN) ("HES1 and BATF" . SPARSER::COLLECTION)
    ("dibenzazepine" . SPARSER::DRUG) ("GSIs" . SPARSER::PROTEIN)
    ("the viral latent membrane protein 1" . SPARSER::PROTEIN)
    ("pEGFP" . SPARSER::PROTEIN) ("AI" . SPARSER::PROTEIN)
    ("Wnt and NF- κ B" . SPARSER::COLLECTION) ("–TERT" . SPARSER::COLLECTION)
    ("pEGFP–hTERT" . SPARSER::COLLECTION)
    ("JAG1 and NOTCH2" . SPARSER::COLLECTION)
    ("JAG1 and HES1" . SPARSER::COLLECTION)
    ("NOTCH2 and JAG1" . SPARSER::COLLECTION)
    ("TERT, BATF and NOTCH2" . SPARSER::COLLECTION)
    ("TERT and TA" . SPARSER::COLLECTION)
    ("BATF and NOTCH2" . SPARSER::COLLECTION)
    ("EBV early antigen diffuse (EA-D) and glycoprotein 350 (gp350) EBV lytic proteins"
     . SPARSER::COLLECTION)
    ("specific siRNA or short-hairpin (sh) RNA" . SPARSER::COLLECTION)
    ("functional NOTCH2" . SPARSER::PROTEIN)
    ("NOTCH2 and BATF" . SPARSER::COLLECTION) ("BATF" . SPARSER::PROTEIN)
    ("reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("latent viral proteins" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("s 5 A" . SPARSER::PROTEIN) ("β catenin" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("LMP 2A" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("EBNA2" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("LEF-1" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("pMT2" . SPARSER::PROTEIN)
    ("v-myc avian myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("HES1" . SPARSER::PROTEIN)
    ("hes family bHLH transcription factor 1" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("jagged 1" . SPARSER::PROTEIN)
    ("gamma-secretase" . SPARSER::PROTEIN) ("EA-D" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("TAp73/AP-1" . SPARSER::COLLECTION)
    ("FosB and JunB" . SPARSER::COLLECTION) ("CREs" . SPARSER::PROTEIN)
    ("p300 and its homologue CRE-binding protein" . SPARSER::COLLECTION)
    ("p73 and c-Jun" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("JunB, JunD, and FosB" . SPARSER::COLLECTION)
    ("the AP-1 target cyclin D1 promoter and not the canonical p53 target mdm2 promoter"
     . SPARSER::COLLECTION)
    ("c-Jun, FosB, or Fra2" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, Fra1, and Fra2" . SPARSER::COLLECTION)
    ("TAp73 and AP-1" . SPARSER::COLLECTION)
    ("TAp73 and TAp73" . SPARSER::COLLECTION)
    ("collagenase or cyclin D1" . SPARSER::COLLECTION)
    ("TAp73 and c-Jun" . SPARSER::COLLECTION) ("TAp73" . SPARSER::PROTEIN)
    ("the soluble cellular fractions" . SPARSER::COMPONENT)
    ("cyclin D1 and cyclin A1" . SPARSER::COLLECTION)
    ("a DNA-binding domain-defective mutant" . SPARSER::MUTANT)
    ("the exact short canonical TRE" . SPARSER::PROTEIN)
    ("neither STAT3 nor p65" . SPARSER::COLLECTION)
    ("the full-length or minimal collagenase promoter ( xref  F )"
     . SPARSER::COLLECTION)
    ("minimal collagenase promoter" . SPARSER::PROMOTER)
    ("NFκB/p65" . SPARSER::COLLECTION)
    ("the minimal promoter" . SPARSER::PROMOTER)
    ("NFκB and STAT3" . SPARSER::COLLECTION) ("c-Jun-" . SPARSER::PROTEIN)
    ("c-Jun and TAp73" . SPARSER::COLLECTION)
    ("c-Jun and p73" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("TRE/AP-1" . SPARSER::COLLECTION) ("Promoters" . SPARSER::PROMOTER)
    ("collagenase and cyclin D1" . SPARSER::COLLECTION)
    ("c-Fos/Fra1" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, and Fra1" . SPARSER::COLLECTION)
    ("c-Fos, Fra1, and FosB" . SPARSER::COLLECTION)
    ("JunB and FosB" . SPARSER::COLLECTION)
    ("JunB/c-Jun" . SPARSER::COLLECTION) ("JunB/JunB" . SPARSER::COLLECTION)
    ("c-Jun/FosB" . SPARSER::COLLECTION) ("c-Jun/ATF2" . SPARSER::COLLECTION)
    ("c-Jun/Fra2" . SPARSER::COLLECTION) ("c-Jun/Fra1" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("Fra2 and JunD" . SPARSER::COLLECTION)
    ("c-Fos, Fra1, FosB, and JunB" . SPARSER::COLLECTION)
    ("both the human collagenase and the cyclin D1 promoter-luciferase"
     . SPARSER::COLLECTION)
    ("TAM" . SPARSER::PROTEIN) ("delta" . SPARSER::PROTEIN)
    ("cyclin D1 and collagenase" . SPARSER::COLLECTION)
    ("collagenase/MMP-1" . SPARSER::COLLECTION) ("phorbol" . SPARSER::DRUG)
    ("NGF" . SPARSER::PROTEIN)
    ("repressing tumor suppressor genes or cell cycle regulatory genes ( xref , xref )"
     . SPARSER::COLLECTION)
    ("c-Jun, JunB, and JunD" . SPARSER::COLLECTION)
    ("c-Fos, FosB, Fra1, and Fra2" . SPARSER::COLLECTION)
    ("ATF-2, ATF-3, and B-ATF" . SPARSER::COLLECTION)
    ("FosB" . SPARSER::PROTEIN) ("JunD" . SPARSER::PROTEIN)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AP" . SPARSER::PROTEIN)
    ("the second internal promoter" . SPARSER::PROMOTER)
    ("relevant target genes" . SPARSER::GENE)
    ("c-Fos or Fra1" . SPARSER::COLLECTION)
    ("c-Fos and Fra1" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the canonical AP-1" . SPARSER::PROTEIN)
    ("the chromatin around TRE" . SPARSER::PROTEIN) ("B–D" . SPARSER::PROTEIN)
    ("FOXK2" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("cyclin A1" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("MMP-1" . SPARSER::PROTEIN) ("B-ATF" . SPARSER::PROTEIN)
    ("ATF-3" . SPARSER::PROTEIN) ("ATF-2" . SPARSER::PROTEIN)
    ("Fra2" . SPARSER::PROTEIN) ("caspase 2" . SPARSER::PROTEIN)
    ("Fra1" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN)
    ("proto-oncogene c-Jun" . SPARSER::PROTEIN)
    ("RAC2 and mitochondrial transport proteins" . SPARSER::COLLECTION)
    ("normal HSCs" . SPARSER::PROTEIN)
    ("SAM50 and another mitochondrial membrane protein" . SPARSER::COLLECTION)
    ("mitofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAC2-SAM50" . SPARSER::COLLECTION)
    ("RAC2-associated complexes several mitochondrial proteins"
     . SPARSER::PROTEIN)
    ("homology, RAC1 and RAC2" . SPARSER::COLLECTION)
    ("MRC" . SPARSER::PROTEIN) ("RAC2-" . SPARSER::PROTEIN)
    ("human leukemic HSPCs" . SPARSER::PROTEIN)
    ("proteins and RAC2" . SPARSER::COLLECTION)
    ("Streptavidin" . SPARSER::PROTEIN)
    ("proteins, SAM50 and Metaxin 1" . SPARSER::COLLECTION)
    ("SAM" . SPARSER::MOLECULE) ("TF-1" . SPARSER::PROTEIN)
    ("RAC1- or RAC2-associated protein" . SPARSER::COLLECTION)
    ("RAC1 or RAC2 associated proteins" . SPARSER::PROTEIN)
    ("RAC2-associated protein" . SPARSER::PROTEIN)
    ("the Polycomb Repressive Complex" . SPARSER::BIO-COMPLEX)
    ("the control cells contained such abnormal mitochondria"
     . SPARSER::PROTEIN)
    ("BCR-ABL and shRAC2" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("NSC23766 (NSC)" . SPARSER::DRUG)
    ("RAC1 or RAC2" . SPARSER::COLLECTION)
    ("SAM50 and Metaxin1" . SPARSER::COLLECTION) ("RAC1-" . SPARSER::PROTEIN)
    ("BCR-ABL and MLL-AF9-driven" . SPARSER::COLLECTION)
    ("RAC1 and RAC2" . SPARSER::COLLECTION)
    ("RAC1, RAC2 and RAC3" . SPARSER::COLLECTION)
    ("receptors, and cell-to-cell" . SPARSER::COLLECTION)
    ("an inactive GDP-bound state and an active state" . SPARSER::COLLECTION)
    ("SAM50 and Metaxin 1" . SPARSER::COLLECTION)
    ("severe mitochondrial ultrastructural malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("HSPCs" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("RPL27" . SPARSER::PROTEIN) ("MitoTracker Red" . SPARSER::MOLECULE)
    ("c-kit ligand" . SPARSER::PROTEIN)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("Flt3L" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony stimulating factor" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN)
    ("granulocyte-colony stimulating factor" . SPARSER::PROTEIN)
    ("Metaxin1" . SPARSER::PROTEIN) ("AF9" . SPARSER::PROTEIN)
    ("RAC3" . SPARSER::PROTEIN) ("G protein-coupled" . SPARSER::PROTEIN)
    ("Metaxin 1" . SPARSER::PROTEIN) ("SAM50" . SPARSER::PROTEIN)
    ("RAC2" . SPARSER::PROTEIN) ("soluble ligands" . SPARSER::LIGAND)
    ("sHB-EGF-stimulated retrograde EGFR" . SPARSER::PROTEIN)
    ("receptor-associated ligand" . SPARSER::LIGAND)
    ("western-blot" . SPARSER::PROTEIN) ("ProHB-EGF" . SPARSER::COLLECTION)
    ("its soluble form" . SPARSER::FORM)
    ("EGFR or ErbB4" . SPARSER::COLLECTION)
    ("AG1478 or PAO" . SPARSER::COLLECTION)
    ("EGFR/GST-sHB-EGF" . SPARSER::COLLECTION) ("PAO" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE) ("GST-sHB-EGF" . SPARSER::COLLECTION)
    ("cisplatinum" . SPARSER::DRUG) ("EGFR/sHB-EGF" . SPARSER::COLLECTION)
    ("CGN-ER" . SPARSER::COLLECTION) ("CGN" . SPARSER::PROTEIN)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mCherry-sHB-EGF" . SPARSER::COLLECTION)
    ("sHB-EGF/EGFR" . SPARSER::COLLECTION)
    ("STAT3 or STAT5" . SPARSER::COLLECTION)
    ("ErbB2 [ xref ] and ErbB3 [ xref ]" . SPARSER::COLLECTION)
    ("ErbB1 (EGFR) [ xref ], ErbB2 [ xref ] and ErbB3 [ xref ]"
     . SPARSER::COLLECTION)
    ("the soluble form" . SPARSER::FORM) ("soluble HB-EGF" . SPARSER::PROTEIN)
    ("proHB-EGF" . SPARSER::COLLECTION)
    ("the EGFR family receptors ErbB1 (EGFR) and ErbB4" . SPARSER::COLLECTION)
    ("ErbB1 (EGFR)" . SPARSER::PROTEIN) ("soluble form" . SPARSER::FORM)
    ("extracellular proteases" . SPARSER::PROTEIN)
    ("heparin and heparan sulfate" . SPARSER::COLLECTION)
    ("sHB-EGF–EGFR" . SPARSER::COLLECTION) ("Soluble form" . SPARSER::FORM)
    ("sHB-EGF" . SPARSER::COLLECTION) ("α-actin" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("ml -1" . SPARSER::PROTEIN) ("CL-6" . SPARSER::PROTEIN)
    ("H2O2" . SPARSER::DRUG) ("ml-1" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("pro-HB-EGF" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE) ("HB-EGF" . SPARSER::PROTEIN)
    ("AG-1478" . SPARSER::DRUG) ("CAV1 or CAV2" . SPARSER::COLLECTION)
    ("the risk-associated minor alleles" . SPARSER::ALLELE)
    ("eQTL" . SPARSER::PROTEIN) ("cis-eQTL" . SPARSER::PROTEIN-PAIR)
    ("the HTG risk-associated allele" . SPARSER::ALLELE)
    ("the HTG risk-associated alleles" . SPARSER::ALLELE)
    ("CAV1-CAV2" . SPARSER::COLLECTION)
    ("the POAG risk-associated SNP alleles" . SPARSER::ALLELE)
    ("Afro" . SPARSER::PROTEIN)
    ("CAV2 (gene ID: 858; OMIM; upstream) and CAV1 (gene ID: 857; OMIM; downstream)"
     . SPARSER::COLLECTION)
    ("CAV1 and CAV2" . SPARSER::COLLECTION) ("GENe" . SPARSER::GENE)
    ("Cav1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("open angle" . SPARSER::PROTEIN) ("Formaldehyde" . SPARSER::MOLECULE)
    ("pre- and post-TKI" . SPARSER::COLLECTION) ("pre-" . SPARSER::PROTEIN)
    ("pre" . SPARSER::PROTEIN) ("pre-TKI" . SPARSER::COLLECTION)
    ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("PKCδ and K-Ras" . SPARSER::COLLECTION)
    ("PI3K or ERK" . SPARSER::COLLECTION)
    ("K-Ras, N-Ras, and H-Ras" . SPARSER::COLLECTION)
    ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("PI3 kinase-Akt" . SPARSER::COLLECTION) ("Raf-ERK" . SPARSER::COLLECTION)
    ("GDP and GTP" . SPARSER::COLLECTION)
    ("Ras and PKCδ" . SPARSER::COLLECTION)
    ("pan-Ras and PKCδ" . SPARSER::COLLECTION)
    ("pan-Ras, PKCδ, and p-ERK" . SPARSER::COLLECTION)
    ("both western blot" . SPARSER::PROTEIN)
    ("PKCδ, pan-Ras, p-ERK, and c-Myc" . SPARSER::COLLECTION)
    ("PCNA and c-Myc" . SPARSER::COLLECTION) ("shK-Ras" . SPARSER::COLLECTION)
    ("Rottlerin" . SPARSER::DRUG) ("dominant-negative PKCδ" . SPARSER::PROTEIN)
    ("PKCδ and Ras" . SPARSER::COLLECTION)
    ("pan-Ras and K-Ras" . SPARSER::COLLECTION)
    ("the normal endometrial epithelial cell line EM-E6/E7/hTERT"
     . SPARSER::COLLECTION)
    ("EM-E6/E7/hTERT" . SPARSER::COLLECTION)
    ("PKCα, PKCε, or PKCζ" . SPARSER::COLLECTION)
    ("the membraneous estrogen receptor" . SPARSER::PROTEIN)
    ("membrane-impermeable BSA" . SPARSER::PROTEIN)
    ("-BSA" . SPARSER::COLLECTION) ("ER-α66" . SPARSER::PROTEIN)
    ("ER-α66-mut" . SPARSER::COLLECTION)
    ("K-Ras and PKCδ" . SPARSER::COLLECTION)
    ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("ER-α and ER-β" . SPARSER::COLLECTION)
    ("PTEN , K-Ras , PIK3CA, and β-catenin" . SPARSER::COLLECTION)
    ("HER-2/neu" . SPARSER::COLLECTION) ("rottlerin" . SPARSER::DRUG)
    ("K-Ras or PKCδ" . SPARSER::COLLECTION) ("Estrogens" . SPARSER::MOLECULE)
    ("3-1" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("K - Ras" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("PKCζ" . SPARSER::PROTEIN) ("PKCε" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN) ("AF-2" . SPARSER::PROTEIN)
    ("ER-β" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN) ("miR-29c-" . SPARSER::PROTEIN)
    ("AXL, CCN2, miR-29c, and IGF-1" . SPARSER::COLLECTION)
    ("Tao" . SPARSER::DRUG) ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("Gankyrin/IL-6" . SPARSER::COLLECTION)
    ("gankyrin and p-AKT ( xref )" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION) ("Gankyrin" . SPARSER::PROTEIN)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("the mesenchymal markers N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("Lenti" . SPARSER::PROTEIN) ("Lenti-shRNA" . SPARSER::PROTEIN-PAIR)
    ("Sav1" . SPARSER::PROTEIN) ("Sav" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nYAP and gankyrin" . SPARSER::COLLECTION)
    ("miR-29c, IGF1, AKT and gankyrin" . SPARSER::COLLECTION)
    ("gankyrin" . SPARSER::PROTEIN) ("nYAP" . SPARSER::PROTEIN-FAMILY)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("p28" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("tilt" . SPARSER::DRUG) ("respective proteins" . SPARSER::PROTEIN)
    ("Trp-Asp" . SPARSER::COLLECTION) ("dipeptide" . SPARSER::MOLECULE)
    ("Apaf-1 and cytochrome c" . SPARSER::COLLECTION)
    ("pKa" . SPARSER::PROTEIN)
    ("cytochrome C and Apaf-1" . SPARSER::COLLECTION)
    ("a sophisticated flexible fitting routine complemented"
     . SPARSER::PROTEIN)
    ("fitting routine complemented" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN) ("cytochrome c-" . SPARSER::PROTEIN)
    ("both principal technological components" . SPARSER::COMPONENT)
    ("Prof" . SPARSER::PROTEIN)
    ("all numerous paralogous proteins" . SPARSER::PROTEIN)
    ("rRNA" . SPARSER::PROTEIN) ("eukaryotic proteins" . SPARSER::PROTEIN)
    ("tryptophane and aspartate" . SPARSER::COLLECTION)
    ("tryptophane" . SPARSER::MOLECULE)
    ("cytochrome c (chain W in [PDB:3CXH]) and cytochrome c  1"
     . SPARSER::COLLECTION)
    ("cytochrome c and the duplet" . SPARSER::COLLECTION)
    ("Arg or Lys" . SPARSER::COLLECTION) ("Asp-Asp" . SPARSER::COLLECTION)
    ("the smallest fraction" . SPARSER::COMPONENT)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the two available acceptors" . SPARSER::MOLECULE)
    ("weak (“minor”) components" . SPARSER::COMPONENT)
    ("acceptors" . SPARSER::MOLECULE) ("cryo" . SPARSER::PROTEIN)
    ("6 new salt" . SPARSER::MOLECULE)
    ("functionally relevant lysine" . SPARSER::AMINO-ACID)
    ("cryo-EM" . SPARSER::COLLECTION) ("EM" . SPARSER::PROTEIN)
    ("rigid protein-protein" . SPARSER::COLLECTION)
    ("particular salt" . SPARSER::MOLECULE) ("x-ray" . SPARSER::PROTEIN-PAIR)
    ("cyt" . SPARSER::MOLECULE)
    ("the yeast cytochrome c and the cytochrome bc  1 complex"
     . SPARSER::COLLECTION)
    ("an active apoptosome" . SPARSER::BIO-COMPLEX)
    ("the oxidized bovine cytochrome c" . SPARSER::PROTEIN)
    ("protein and trigger" . SPARSER::COLLECTION)
    ("Arg, Trp, Gly, Leu or Ala" . SPARSER::COLLECTION)
    ("/Apaf-1" . SPARSER::COLLECTION)
    ("oligomerized Apaf-1 monomers form" . SPARSER::FORM)
    ("disc" . SPARSER::BIO-COMPLEX)
    ("the NBD and the neighboring helix domain 1 (HD1)" . SPARSER::COLLECTION)
    ("dATP" . SPARSER::DATP) ("dADP" . SPARSER::DADP)
    ("NBD" . SPARSER::PROTEIN)
    ("an ancient blade-sized fragment" . SPARSER::FRAGMENT)
    ("propellers" . SPARSER::PROTEIN-FAMILY)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("scaffolds" . SPARSER::SCAFFOLD)
    ("tryptophan" . SPARSER::MOLECULE)
    ("ubiquinol:cytochrome c" . SPARSER::BIO-COMPLEX)
    ("cytochrome" . SPARSER::PROTEIN) ("electrons" . SPARSER::MOLECULE)
    ("simple salt" . SPARSER::MOLECULE)
    ("amino acids of Apaf-1" . SPARSER::PROTEIN) ("Salt" . SPARSER::MOLECULE)
    ("cytochrome c and Apaf-1" . SPARSER::COLLECTION)
    ("cytochrome c and Apaf-1 and cryo-electron" . SPARSER::COLLECTION)
    ("Apaf-1 and cryo-electron" . SPARSER::COLLECTION)
    ("Apaf-1/cytochrome c" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("activating factor" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("PDB2" . SPARSER::PROTEIN)
    ("cytochrome c  1" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("procaspase-9" . SPARSER::PROTEIN) ("HD1" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor 1" . SPARSER::PROTEIN)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("MET and p-MET immunohistochemistry" . SPARSER::COLLECTION)
    ("p-PLCγ1" . SPARSER::COLLECTION) ("BRAF and ROS1" . SPARSER::COLLECTION)
    ("Cbl" . SPARSER::PROTEIN) ("p-MET" . SPARSER::COLLECTION)
    ("previously identified melanoma oncogenes" . SPARSER::ONCOGENE)
    ("TPR-MET" . SPARSER::COLLECTION) ("TPR" . SPARSER::PROTEIN)
    ("BRAF, NRAS, KIT, GNAQ or GNA11" . SPARSER::COLLECTION)
    ("The MET inhibitors cabozantinib (FDA-approved for progressive medullary thyroid cancer) and PF-04217903"
     . SPARSER::COLLECTION)
    ("cabozantinib" . SPARSER::DRUG)
    ("the mitogen-activated protein kinase (MAPK), phosphoinositol-3 kinase (PI3K), and phospholipase C gamma 1 (PLCγ1) pathways"
     . SPARSER::COLLECTION)
    ("ZKSCAN1-MET" . SPARSER::COLLECTION) ("TRIM4-MET" . SPARSER::COLLECTION)
    ("interleukin-2" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("HSP60" . SPARSER::PROTEIN) ("PF04217903" . SPARSER::DRUG)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("PPFIBP1" . SPARSER::PROTEIN)
    ("DCTN1" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("PTPRZ1" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("GNA11" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("phospholipase C gamma" . SPARSER::PROTEIN-FAMILY)
    ("ZKSCAN1" . SPARSER::PROTEIN) ("TRIM4" . SPARSER::PROTEIN)
    ("53BP1 and miR-200b/429 and ZEB1" . SPARSER::COLLECTION)
    ("less metastatic foci" . SPARSER::PROTEIN)
    ("epithelial marker E-cadherin and mesenchymal markers ZEB1 and vimentin"
     . SPARSER::COLLECTION)
    ("mesenchymal markers ZEB1 and vimentin" . SPARSER::COLLECTION)
    ("ZEB1 and miR" . SPARSER::COLLECTION)
    ("several specific mRNAs and one mRNA" . SPARSER::COLLECTION)
    ("Snail, Slug, and ZEB1" . SPARSER::COLLECTION)
    ("53BP1 and miR-200b" . SPARSER::COLLECTION)
    ("53BP1 , miR-200b/429, and ZEB1" . SPARSER::COLLECTION)
    ("ZEB1 and vimentin" . SPARSER::COLLECTION)
    ("ZEB1, E-cadherin, vimentin, and fibronectin" . SPARSER::COLLECTION)
    ("ZEB1 and fibronectin" . SPARSER::COLLECTION)
    ("mesenchymal markers ZEB1 , vimentin, and fibronectin"
     . SPARSER::COLLECTION)
    ("ZEB1 , vimentin, and fibronectin" . SPARSER::COLLECTION)
    ("miR-200c" . SPARSER::MOLECULE) ("miR-200a" . SPARSER::MOLECULE)
    ("N-Myc" . SPARSER::PROTEIN) ("vascular SMCs" . SPARSER::PROTEIN)
    ("the available antibodies" . SPARSER::ANTIBODY)
    ("Fyn and Yes" . SPARSER::COLLECTION)
    ("Src, Fyn, and Yes" . SPARSER::COLLECTION)
    ("cultured arterial SMCs" . SPARSER::PROTEIN) ("SMC" . SPARSER::PROTEIN)
    ("the vascular smooth muscle" . SPARSER::PROTEIN)
    ("Human Arterial SMCs" . SPARSER::PROTEIN)
    ("arterial BP" . SPARSER::PROTEIN)
    ("ERK1/2, JNK, and p38" . SPARSER::COLLECTION)
    ("actin-myosin" . SPARSER::COLLECTION) ("kinase (ZIPK)" . SPARSER::KINASE)
    ("kinase (ILK)" . SPARSER::KINASE)
    ("Rho-associated kinase (ROCK)" . SPARSER::KINASE)
    ("ZIPK" . SPARSER::PROTEIN) ("the myosin’s" . SPARSER::PROTEIN-FAMILY)
    ("actin and use ATP" . SPARSER::COLLECTION)
    ("the vascular SMCs" . SPARSER::PROTEIN)
    ("actin and myosin" . SPARSER::COLLECTION)
    ("Ang II and catecholamines" . SPARSER::COLLECTION)
    ("catecholamines" . SPARSER::MOLECULE) ("SMCs" . SPARSER::PROTEIN)
    ("systemic BP" . SPARSER::PROTEIN) ("BP" . SPARSER::PROTEIN)
    ("Ang" . SPARSER::PROTEIN) ("Angiotensin" . SPARSER::PROTEIN)
    ("AT1" . SPARSER::PROTEIN)
    ("Ca2+/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("SU6656" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("locally acting 11ßHSD2 inhibitors" . SPARSER::INHIBITOR)
    ("mineralocorticoid" . SPARSER::MOLECULE)
    ("a nontoxic, inexpensive and powerful 11ßHSD2 inhibitor"
     . SPARSER::INHIBITOR)
    ("licorice" . SPARSER::DRUG) ("analogs" . SPARSER::ANALOG)
    ("Apc" . SPARSER::PROTEIN)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("hpf" . SPARSER::PROTEIN) ("PERK and eIF2α" . SPARSER::COLLECTION)
    ("BIP/GPR78" . SPARSER::COLLECTION) ("BIP" . SPARSER::PROTEIN)
    ("eIF2α and PERK" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("MR" . SPARSER::PROTEIN) ("fix" . SPARSER::PROTEIN)
    ("water (control) or GA" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("mTOR and ERK" . SPARSER::COLLECTION) ("CBX" . SPARSER::PROTEIN)
    ("carbenoxolone" . SPARSER::DRUG) ("even 1μM CS" . SPARSER::PROTEIN)
    ("corticosterone" . SPARSER::MOLECULE)
    ("COX-2 and 11ßHSD2" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN)
    ("11ß–hydroxysteroid dehydrogenase type I (11ßHSD1) and 11ßHSD2 [ xref ]"
     . SPARSER::COLLECTION)
    ("radiosensitizers" . SPARSER::DRUG) ("celecoxib" . SPARSER::DRUG)
    ("synthetase" . SPARSER::PROTEIN) ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("cyclooxygenase/prostaglandin" . SPARSER::COLLECTION)
    ("prostaglandin" . SPARSER::PROTEIN) ("ERK and mTOR" . SPARSER::COLLECTION)
    ("HSD" . SPARSER::PROTEIN) ("Glucocorticoids" . SPARSER::PROTEIN)
    ("GPR78" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("CD206" . SPARSER::PROTEIN) ("mannose receptor" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("mPGES-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospholipase A 2" . SPARSER::PROTEIN)
    ("thromboxane A 2" . SPARSER::MOLECULE) ("PGI 2" . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG) ("COX-1" . SPARSER::PROTEIN)
    ("PGH 2" . SPARSER::MOLECULE) ("prostaglandin H 2" . SPARSER::MOLECULE)
    ("prostaglandin G 2" . SPARSER::MOLECULE) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("PC 1" . SPARSER::PROTEIN)
    ("The principal components" . SPARSER::COMPONENT)
    ("/phi" . SPARSER::COLLECTION) ("ILE" . SPARSER::AMINO-ACID)
    ("phi" . SPARSER::PROTEIN) ("CYS" . SPARSER::AMINO-ACID)
    ("GLN" . SPARSER::AMINO-ACID) ("TYR" . SPARSER::AMINO-ACID)
    ("ARG" . SPARSER::PROTEIN) ("LYS" . SPARSER::PROTEIN)
    ("ASN" . SPARSER::AMINO-ACID) ("THR" . SPARSER::AMINO-ACID)
    ("PHE" . SPARSER::AMINO-ACID) ("DNA and Mg" . SPARSER::COLLECTION)
    ("Enzyme" . SPARSER::ENZYME) ("enzyme and DNA" . SPARSER::COLLECTION)
    ("helical conformation" . SPARSER::BIO-CONFORMATION)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wt and Mu" . SPARSER::COLLECTION) ("nitrogen" . SPARSER::MOLECULE)
    ("amide" . SPARSER::MOLECULE) ("SER" . SPARSER::AMINO-ACID)
    ("wt and mutant" . SPARSER::COLLECTION) ("Ile" . SPARSER::AMINO-ACID)
    ("a unique cohort" . SPARSER::MOLECULE)
    ("a suicidal enzyme" . SPARSER::ENZYME) ("cystine" . SPARSER::MOLECULE)
    ("-Methylguanine" . SPARSER::MOLECULE)
    ("Methylguanine" . SPARSER::MOLECULE) ("NMU" . SPARSER::PROTEIN)
    ("all known physically interacting amino acids" . SPARSER::AMINO-ACID)
    ("Isoleucine" . SPARSER::AMINO-ACID)
    ("the major DNA repair protein" . SPARSER::PROTEIN)
    ("-methylguanine" . SPARSER::MOLECULE)
    ("methylguanine" . SPARSER::MOLECULE) ("MGMT" . SPARSER::PROTEIN)
    ("Mgcl2" . SPARSER::MOLECULE) ("SO4" . SPARSER::PROTEIN)
    ("PC 2" . SPARSER::PROTEIN) ("N-Nitrosodimethylamine" . SPARSER::MOLECULE)
    ("O 6" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("oligonucleotide or shRNA" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("PRD" . SPARSER::PROTEIN) ("MRS" . SPARSER::PROTEIN)
    ("basic amino acids" . SPARSER::AMINO-ACID) ("Heparin" . SPARSER::PROTEIN)
    ("heparin" . SPARSER::PROTEIN) ("FLAG or MZF-1ΔDBD" . SPARSER::COLLECTION)
    ("FLAG- or c-Myc-vector-transfected" . SPARSER::COLLECTION)
    ("a complex and binding to the PKCα promoter" . SPARSER::COLLECTION)
    ("MZF-1∆DBD or Elk-1∆DBD" . SPARSER::COLLECTION)
    ("pcDNA-Myc" . SPARSER::COLLECTION) ("Elk-1∆DBD" . SPARSER::PROTEIN)
    ("MZF-1∆DBD" . SPARSER::PROTEIN) ("FLAG-MZF-1∆DBD" . SPARSER::PROTEIN-PAIR)
    ("c-Myc-Elk-1∆DBD" . SPARSER::PROTEIN-PAIR)
    ("mutative PKCα promoter" . SPARSER::PROMOTER) ("AAG" . SPARSER::PROTEIN)
    ("GGG" . SPARSER::MOLECULE)
    ("either MZF-1 (MZF-1∆DBD) or Elk-1 (Elk-1∆DBD)" . SPARSER::COLLECTION)
    ("DNA-binding-deficient (∆DBD) mutant" . SPARSER::MUTANT)
    ("Elk-1 or MZF-1" . SPARSER::COLLECTION)
    ("PKCα, Elk-1, and MZF-1" . SPARSER::COLLECTION)
    ("MZF-1, Elk-1, and PKCα" . SPARSER::COLLECTION)
    ("Elk-1 and MZF-1" . SPARSER::COLLECTION)
    ("both extracellular signal-regulated kinase (ERK) and JNK MAP kinase"
     . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MZF-1/Elk-1" . SPARSER::COLLECTION)
    ("MZF-1 and MZF-1" . SPARSER::COLLECTION)
    ("MZF-1 and/or Elk-1" . SPARSER::COLLECTION)
    ("MZF-1 and Elk-1" . SPARSER::COLLECTION)
    ("MZF-1 or Elk-1" . SPARSER::COLLECTION)
    ("Ets-like protein-1 (Elk-1) and myeloid zinc finger-1 (MZF-1)"
     . SPARSER::COLLECTION)
    ("T-3" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("P40" . SPARSER::PROTEIN) ("c- fos" . SPARSER::PROTEIN)
    ("MZF-1" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("two rare NFE2L2" . SPARSER::PROTEIN)
    ("the haplotypes TP3 ( P <0.001, 3.307 years/allele) and TP4 ( P = 0.003, -2.431 years/allele)"
     . SPARSER::COLLECTION)
    ("NFE2L2 and KEAP1" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("VO" . SPARSER::MOLECULE)
    ("particularly haplotypes around NFE2L2" . SPARSER::PROTEIN)
    ("these alternate alleles" . SPARSER::ALLELE)
    ("the alternate allele" . SPARSER::ALLELE)
    ("at least one minor allele" . SPARSER::ALLELE)
    ("conversely haplotype P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pesticides" . SPARSER::MOLECULE)
    ("an alternate allele" . SPARSER::ALLELE) ("MAPs" . SPARSER::PROTEIN)
    ("melt" . SPARSER::DRUG) ("common SNPs around NFE2L2" . SPARSER::PROTEIN)
    ("around NFE2L2" . SPARSER::PROTEIN) ("AAO" . SPARSER::PROTEIN)
    ("l-sulforaphane" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::PROTEIN) ("MPTP" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("CUL3-RBX1" . SPARSER::COLLECTION) ("CNC" . SPARSER::PROTEIN)
    ("pesticide" . SPARSER::MOLECULE)
    ("no obvious pathogenic variants" . SPARSER::VARIANT)
    ("TP4" . SPARSER::PROTEIN) ("TP3" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("6-hydroxydopamine" . SPARSER::DRUG)
    ("RBX1" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("HGF/c-MET" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("EF and pCR" . SPARSER::COLLECTION) ("GNAQ" . SPARSER::PROTEIN)
    ("EF or refractoriness" . SPARSER::COLLECTION) ("PgR" . SPARSER::PROTEIN)
    ("cMET" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("PUM1" . SPARSER::PROTEIN) ("2-4" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("Enzymes" . SPARSER::ENZYME)
    ("anaphase-promoting complex/cyclosome " . SPARSER::COLLECTION)
    ("lactate" . SPARSER::LACTATE) ("cyclosome " . SPARSER::PROTEIN)
    ("JARID1A/1B" . SPARSER::COLLECTION) ("global H3K4" . SPARSER::PROTEIN)
    ("Jumonji/ARID domain-containing protein 1A" . SPARSER::COLLECTION)
    ("Jumonji" . SPARSER::PROTEIN)
    ("cofactors or substrates" . SPARSER::COLLECTION)
    ("Senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("Kirsten rat sarcoma viral oncogene homolog)" . SPARSER::PROTEIN)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("some metabolic genes as well as cell cycle genes (Hsieh et al ., xref ; Blanchet et al ., xref ; Reynolds et al ., xref )"
     . SPARSER::COLLECTION)
    ("palmitate" . SPARSER::PROTEIN) ("etomoxir" . SPARSER::DRUG)
    ("highly active tetrameric pyruvate kinase M2" . SPARSER::MOLECULE)
    ("pyruvate" . SPARSER::PROTEIN) ("DHAP" . SPARSER::MOLECULE)
    ("ALDOC-KD" . SPARSER::COLLECTION) ("PFKM-KD" . SPARSER::COLLECTION)
    ("PFKM and ALDOC" . SPARSER::COLLECTION) ("ALDO" . SPARSER::PROTEIN)
    ("ALDOC" . SPARSER::PROTEIN) ("PFKM" . SPARSER::PROTEIN)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("cytokine and cytokine" . SPARSER::COLLECTION)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("dihydroxyacetone" . SPARSER::MOLECULE) ("Ctrl-KD" . SPARSER::COLLECTION)
    ("cellular metabolites" . SPARSER::PROTEIN) ("ethynyl" . SPARSER::MOLECULE)
    ("MCM3 and MCM5" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION) ("RB-KD" . SPARSER::COLLECTION)
    ("FCCP" . SPARSER::MOLECULE) ("mitochondrial IV COX genes" . SPARSER::GENE)
    ("HIRA" . SPARSER::PROTEIN)
    ("retinoblastoma protein (RB)" . SPARSER::PROTEIN)
    ("senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("CPT1" . SPARSER::PROTEIN) ("L-glutamate" . SPARSER::MOLECULE)
    ("GL3" . SPARSER::PROTEIN) ("Cullin1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3"
     . SPARSER::PROTEIN)
    ("JARID1B" . SPARSER::PROTEIN) ("JARID1A" . SPARSER::PROTEIN)
    ("ARID domain-containing protein 1A" . SPARSER::PROTEIN)
    ("PDP2" . SPARSER::PROTEIN) ("SLC1A5" . SPARSER::PROTEIN)
    ("CPT-1" . SPARSER::PROTEIN) ("PKM2" . SPARSER::PROTEIN)
    ("fructose-bisphosphate" . SPARSER::PROTEIN)
    ("aldolase C" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein beta" . SPARSER::PROTEIN)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("d -glucose" . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("IL8" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("H- ras" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("the most optimal and accurate antibody" . SPARSER::PROTEIN)
    ("ACK-2" . SPARSER::COLLECTION) ("ACK" . SPARSER::PROTEIN)
    ("Weak KITL" . SPARSER::PROTEIN)
    ("weak cytoplasmic c-kit" . SPARSER::PROTEIN)
    ("their associated GC" . SPARSER::PROTEIN)
    ("preantral and antral follicle types" . TYPE)
    ("the predominant isoform" . SPARSER::ISOFORM)
    ("approximately 18 kDa" . SPARSER::PROTEIN)
    ("The Western blot" . SPARSER::PROTEIN)
    ("36 kDa and 33 kDa" . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN) ("GNNK-" . SPARSER::AMINO-ACID)
    ("145 kDa and 120 kDa" . SPARSER::COLLECTION)
    ("GNNK−" . SPARSER::AMINO-ACID) ("Haematoxylin" . SPARSER::MOLECULE)
    ("GNNK" . SPARSER::AMINO-ACID) ("KITL/c-kit" . SPARSER::COLLECTION)
    ("KITL or c-kit" . SPARSER::COLLECTION)
    ("amino acids (GNNK)" . SPARSER::AMINO-ACID)
    ("soluble c-kit" . SPARSER::PROTEIN)
    ("soluble c-kit protein" . SPARSER::PROTEIN)
    ("the preantral follicle cohort" . SPARSER::MOLECULE)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("c-kit/KITL" . SPARSER::COLLECTION)
    ("KITL and c-kit" . SPARSER::COLLECTION)
    ("c-kit and KITL" . SPARSER::COLLECTION)
    ("ligand (KITL)" . SPARSER::MOLECULE) ("KITL" . SPARSER::PROTEIN)
    ("C-kit" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("JMP" . SPARSER::PROTEIN) ("kDa and β -actin" . SPARSER::COLLECTION)
    ("20% ( v/v ) glycerol and 0.03 mM bromophenol" . SPARSER::COLLECTION)
    ("PVDF" . SPARSER::DRUG) ("bromophenol" . SPARSER::MOLECULE)
    ("dodecyl (SDS)" . SPARSER::MOLECULE)
    ("proteases and phosphatases" . SPARSER::COLLECTION)
    ("Inhibitor" . SPARSER::INHIBITOR)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tris" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("deoxycholate" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("naphthol" . SPARSER::MOLECULE) ("HRP" . SPARSER::PROTEIN)
    ("TX" . SPARSER::PROTEIN) ("paraformaldehyde" . SPARSER::DRUG)
    ("KRP" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("VA" . SPARSER::MOLECULE) ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monoclonal anti-human CD31 PE-A" . SPARSER::PROTEIN)
    ("streptomycin" . SPARSER::DRUG) ("Aldrich" . SPARSER::PROTEIN)
    ("Sigma-Aldrich" . SPARSER::COLLECTION) ("collagenase" . SPARSER::PROTEIN)
    ("endotoxin" . SPARSER::MOLECULE) ("approximately 16 h" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("IL-8 and MCP-1" . SPARSER::COLLECTION) ("IFN-gamma" . SPARSER::PROTEIN)
    ("IL-6 and MCP-1" . SPARSER::COLLECTION) ("Nam" . SPARSER::PROTEIN-FAMILY)
    ("the pre-atherosclerotic state" . SPARSER::BIO-STATE)
    ("IL-1α, IL-6, and TNFα" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("MAPK and NF-KappaB" . SPARSER::COLLECTION) ("Tgf" . SPARSER::DRUG)
    ("VCAM-1 and intercellular adhesion molecule-1" . SPARSER::COLLECTION)
    ("VCAM-1, and chemokines" . SPARSER::COLLECTION)
    ("MCP-1 and IL-8" . SPARSER::COLLECTION)
    ("other proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("Monocytes" . SPARSER::PROTEIN) ("pg" . SPARSER::MOLECULE)
    ("the secondary antibody" . SPARSER::PROTEIN)
    ("endotoxins" . SPARSER::MOLECULE) ("LAL" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("various chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("MCP-1, VCAM-1, and interleukin-8" . SPARSER::COLLECTION)
    ("the classic isoforms" . SPARSER::ISOFORM)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("nitric oxide (NO)" . SPARSER::MOLECULE)
    ("a uremic toxin" . SPARSER::MOLECULE) ("eNOS" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("elastin" . SPARSER::PROTEIN) ("the uremic state" . SPARSER::BIO-STATE)
    ("peroxidase" . SPARSER::PROTEIN) ("exogenous forms" . SPARSER::FORM)
    ("Hydroimidazolone" . SPARSER::DRUG) ("carboxymethyl" . SPARSER::MOLECULE)
    ("aldehydes and ketones" . SPARSER::COLLECTION)
    ("ketones" . SPARSER::MOLECULE) ("sugars" . SPARSER::MOLECULE)
    ("chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("uremic toxins and negative consequences" . SPARSER::COLLECTION)
    ("RAGE, MCP-1, and VCAM-1" . SPARSER::COLLECTION)
    ("MCP-1 and VCAM-1" . SPARSER::COLLECTION) ("RAGE" . SPARSER::PROTEIN)
    ("uremic toxins" . SPARSER::MOLECULE) ("DP2" . SPARSER::PROTEIN)
    ("PE-A" . SPARSER::PROTEIN) ("D -glucose" . SPARSER::MOLECULE)
    ("N -acetylcysteine" . SPARSER::DRUG) ("angiotensin II" . SPARSER::PROTEIN)
    ("NF-KappaB" . SPARSER::PROTEIN) ("TGF-β 1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN)
    ("protein kinase-C" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("pro-oxidant" . SPARSER::MOLECULE) ("VCAM-1" . SPARSER::PROTEIN)
    ("p53, p21 and WIP1" . SPARSER::COLLECTION)
    ("p53–p21" . SPARSER::COLLECTION)
    ("Protein, γ-H2AX, and BrdUrd" . SPARSER::COLLECTION)
    ("Phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("p21, WIP1, and β-actin" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY) ("DMEM/F12" . SPARSER::COLLECTION)
    ("monolayers" . SPARSER::PROTEIN)
    ("a p21 homozygous knockout derivative" . SPARSER::DERIVATIVE)
    ("p53-p21" . SPARSER::COLLECTION) ("WIP1 and p53" . SPARSER::COLLECTION)
    ("siRNA and UC2288" . SPARSER::COLLECTION)
    ("iodide and Hoechst" . SPARSER::COLLECTION) ("h" . SPARSER::PROTEIN)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("A 2-h" . SPARSER::PROTEIN-PAIR)
    ("a WIP1 siRNA or a control siRNA [ xref ]" . SPARSER::COLLECTION)
    ("spontaneous γH2AX" . SPARSER::PROTEIN)
    ("foci and DSBs" . SPARSER::COLLECTION)
    ("both p21 [ xref ] and p16 [ xref ]" . SPARSER::COLLECTION)
    ("the PI3K-like protein kinase inhibitors wortmannin (10 μM) and LY294002 (20 μM)"
     . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("caffeine" . SPARSER::MOLECULE)
    ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("WIP1 or p21" . SPARSER::COLLECTION)
    ("p21 and WIP1" . SPARSER::COLLECTION)
    ("γH2AX and other DNA damage response proteins (e.g., ATM, p53, BAX)"
     . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION) ("CIP/KIP" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN)
    ("p21 WAF1 (p21) and/or WIP1" . SPARSER::COLLECTION)
    ("ATM-p53" . SPARSER::COLLECTION) ("WIP1, or PPM1D" . SPARSER::COLLECTION)
    ("A–C" . SPARSER::PROTEIN) ("INK4A" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN) ("type 2C" . SPARSER::PROTEIN)
    ("AXL" . SPARSER::PROTEIN) ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("the Met protein and its activating ligand" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN) ("EMD1214063 and rhHGF" . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("sh-non-targeting" . SPARSER::PROTEIN-PAIR)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("an attractive anti-DDLPS therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("autocrine HGF" . SPARSER::PROTEIN)
    ("Met monoclonal antibodies" . SPARSER::ANTIBODY)
    ("resultant STAT3" . SPARSER::PROTEIN) ("IPT3/IPT4" . SPARSER::COLLECTION)
    ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY) ("neo" . SPARSER::PROTEIN)
    ("the most common histological subtypes" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN)
    ("β-2-microglobulin" . SPARSER::PROTEIN)
    ("chemo-attractants" . SPARSER::PROTEIN) ("B12" . SPARSER::PROTEIN)
    ("G15" . SPARSER::PROTEIN) ("SU11274" . SPARSER::DRUG)
    ("IPT4" . SPARSER::PROTEIN) ("IPT3" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EMD1214063" . SPARSER::DRUG)
    ("Hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("cell-cycle-related genes" . SPARSER::GENE)
    ("previously uncharacterized genes" . SPARSER::GENE)
    ("OCT4, SOX2, and KLF4" . SPARSER::COLLECTION)
    ("retroviral GFP" . SPARSER::PROTEIN)
    ("CD13, SSEA4, and TRA160" . SPARSER::COLLECTION)
    ("MYC and KLF4" . SPARSER::COLLECTION)
    ("NANOG, PRDM14, and LIN28A" . SPARSER::COLLECTION)
    ("Oct4 , Sox2 , and Klf4" . SPARSER::COLLECTION)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("type III and ESC/iPSCs" . SPARSER::COLLECTION)
    ("ESC/iPSC" . SPARSER::PROTEIN) ("LIN28A and PRDM14" . SPARSER::COLLECTION)
    ("around 5,000 genes" . SPARSER::GENE)
    ("PRDM14 and LIN28A" . SPARSER::COLLECTION)
    ("NANOG , PRDM14 , and LIN28A" . SPARSER::COLLECTION)
    ("type III/ESC/iPSCs" . SPARSER::COLLECTION) ("seq" . SPARSER::PROTEIN)
    ("ESC/iPSCs" . SPARSER::PROTEIN) ("OGT and PAF1" . SPARSER::COLLECTION)
    ("OGT" . SPARSER::PROTEIN) ("type III-ESC/iPSC" . SPARSER::COLLECTION)
    ("CD13 , COL1A1 , COL1A2 , and S100A4" . SPARSER::COLLECTION)
    ("PC1-3" . SPARSER::COLLECTION) ("PC1" . SPARSER::PROTEIN)
    ("Developmental genes" . SPARSER::GENE)
    ("Type III and ESC/iPSC" . SPARSER::COLLECTION)
    ("p53, neurotrophin, and MAPK" . SPARSER::COLLECTION)
    ("e-3" . SPARSER::COLLECTION) ("alleles, or cells" . SPARSER::COLLECTION)
    ("Allele" . SPARSER::ALLELE)
    ("a newly identified pluripotent spliced form" . SPARSER::FORM)
    ("p " . SPARSER::PROTEIN) ("Foxp1 and Mbd2" . SPARSER::COLLECTION)
    ("Ccne1" . SPARSER::PROTEIN) ("Mbd2" . SPARSER::PROTEIN)
    ("type III and ESC/iPSC" . SPARSER::COLLECTION)
    ("a previously uncharacterized variant" . SPARSER::VARIANT)
    ("FOXP1 and MBD2" . SPARSER::COLLECTION)
    ("multiple isoforms and functional diversity" . SPARSER::COLLECTION)
    ("ECC" . SPARSER::MOLECULE) ("pluripotent genes" . SPARSER::GENE)
    ("ECCs" . SPARSER::MOLECULE)
    ("epithelium developmental genes" . SPARSER::GENE)
    ("naive state" . SPARSER::BIO-STATE)
    ("type I and ESC/iPSC" . SPARSER::COLLECTION)
    ("State" . SPARSER::BIO-STATE) ("Around 900 genes" . SPARSER::GENE)
    ("type II and type III" . SPARSER::COLLECTION)
    ("COL1A1 and COL1A2" . SPARSER::COLLECTION)
    ("OCT4, KLF4, and MYC" . SPARSER::COLLECTION)
    ("activators and repressors" . SPARSER::COLLECTION)
    ("CD13, SSEA4, and TRA160 or GFP" . SPARSER::COLLECTION)
    ("Phi" . SPARSER::PROTEIN)
    ("virus-driven EGFP and TRA160" . SPARSER::COLLECTION)
    ("EGFP and TRA160" . SPARSER::COLLECTION)
    ("Oct4, Sox2, and Klf4" . SPARSER::COLLECTION)
    ("Myc and Klf4" . SPARSER::COLLECTION)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Oct4-GFP" . SPARSER::COLLECTION)
    ("self-renewal genes" . SPARSER::GENE)
    ("WNT ligands and a downstream component" . SPARSER::COLLECTION)
    ("ACTIVIN/NODAL" . SPARSER::COLLECTION) ("NODAL" . SPARSER::PROTEIN)
    ("ACTIVIN" . SPARSER::PROTEIN) ("BMP" . SPARSER::PROTEIN)
    ("a distinct epigenetic state from type III cells and hESCs"
     . SPARSER::COLLECTION)
    ("several pluripotent genes" . SPARSER::GENE)
    ("Type I and type II" . SPARSER::COLLECTION)
    ("DNMT3B and REX1" . SPARSER::COLLECTION)
    ("CD13 (ANPEP)" . SPARSER::PROTEIN) ("TRA" . SPARSER::PROTEIN)
    ("ANPEP" . SPARSER::PROTEIN) ("types " . TYPE)
    ("regenerative medicine" . SPARSER::DRUG)
    ("a fully pluripotent state" . SPARSER::BIO-STATE)
    ("a pluripotency-specific spliced form" . SPARSER::FORM)
    ("OCT4, SOX2, KLF4, and MYC" . SPARSER::COLLECTION)
    ("e-5" . SPARSER::PROTEIN) ("ZFP42" . SPARSER::PROTEIN)
    ("LIN28A" . SPARSER::PROTEIN) ("S100A4" . SPARSER::PROTEIN)
    ("DLL4" . SPARSER::PROTEIN) ("Foxp1" . SPARSER::PROTEIN)
    ("Cyclin C" . SPARSER::PROTEIN) ("MBD2" . SPARSER::PROTEIN)
    ("FOXP1" . SPARSER::PROTEIN) ("COL1A2" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("TAF11" . SPARSER::PROTEIN)
    ("MED12" . SPARSER::PROTEIN) ("EHMT1" . SPARSER::PROTEIN)
    ("SSEA1" . SPARSER::DRUG) ("THY1" . SPARSER::PROTEIN)
    ("WNT3A" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD13" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("MYC and p53" . SPARSER::COLLECTION)
    ("CDKN1A and CDKN2B" . SPARSER::COLLECTION)
    ("CDKN1A (p21) and CDKN2B (p15)" . SPARSER::COLLECTION)
    ("MYC and each MYCLo-4/6" . SPARSER::COLLECTION)
    ("MYC and the MYCLos" . SPARSER::COLLECTION)
    ("17 genes and 52 genes" . SPARSER::COLLECTION)
    ("32 genes, 17 genes and 52 genes" . SPARSER::COLLECTION)
    ("MYC and MYC-repressed MYCLos" . SPARSER::COLLECTION)
    ("MAFK, CTCF, SMC3 and RAD21" . SPARSER::COLLECTION)
    ("MAFK" . SPARSER::PROTEIN) ("MYCL" . SPARSER::PROTEIN)
    ("Northern blot" . SPARSER::PROTEIN) ("LPP-AS2–2" . SPARSER::COLLECTION)
    ("LPP-AS2–1" . SPARSER::COLLECTION) ("RACE" . SPARSER::PROTEIN)
    ("LPP-AS2" . SPARSER::COLLECTION) ("LPP" . SPARSER::PROTEIN)
    ("promyelocytic leukemia zinc finger ( PLZF ) protein and long noncoding RNA PVT1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("MAX" . SPARSER::PROTEIN)
    ("MYC and the MYC-repressed MYCLos" . SPARSER::COLLECTION)
    ("OAZ1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("RAD21" . SPARSER::PROTEIN) ("AS2" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("GADD45A" . SPARSER::PROTEIN)
    ("Ding" . SPARSER::PROTEIN) ("protein or gene" . SPARSER::COLLECTION)
    ("VHL and PBRM1" . SPARSER::COLLECTION)
    ("ADAMTS12, PYHIN1, RSPO4 and RAB3A" . SPARSER::COLLECTION)
    ("the Von Hippel Lindau ( VHL ) and PBRM1 genes" . SPARSER::COLLECTION)
    ("Von Hippel Lindau ( VHL )" . SPARSER::PROTEIN) ("VHL" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("6-carboxyfluorescein" . SPARSER::DRUG) ("RAB3A" . SPARSER::PROTEIN)
    ("RSPO4" . SPARSER::PROTEIN) ("PYHIN1" . SPARSER::PROTEIN)
    ("ADAMTS12" . SPARSER::PROTEIN) ("TP 53" . SPARSER::PROTEIN)
    ("PBRM1" . SPARSER::PROTEIN) ("Von Hippel Lindau" . SPARSER::PROTEIN)
    ("p53- and MDM2-" . SPARSER::COLLECTION) ("MDM2-" . SPARSER::PROTEIN)
    ("ligase and MDM4" . SPARSER::COLLECTION)
    ("MAGE-A proteins and the RING finger-type ubiquitin E3 ligase"
     . SPARSER::COLLECTION)
    ("MAGE-homology" . SPARSER::COLLECTION)
    ("ligases or de-ubiquitylases" . SPARSER::COLLECTION)
    ("ubiquitylases" . SPARSER::UBIQUITYLASE)
    ("p53 or MDM2" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("A ubiquitylation-defective mutant" . SPARSER::MUTANT)
    ("-agarose" . SPARSER::MOLECULE) ("protein—protein" . SPARSER::COLLECTION)
    ("guanidinium" . SPARSER::MOLECULE)
    ("indeed MAGE-A proteins" . SPARSER::PROTEIN)
    ("the competitive inhibitor" . SPARSER::INHIBITOR)
    ("p53 and MAGE-A2" . SPARSER::COLLECTION) ("GFP-MP1" . SPARSER::COLLECTION)
    ("two strongly interacting peptides" . SPARSER::PEPTIDE)
    ("MDM2 and MAGE-A" . SPARSER::COLLECTION)
    ("antibodies, 4B2 and SMP14" . SPARSER::COLLECTION)
    ("SMP" . SPARSER::PROTEIN) ("PML" . SPARSER::PROTEIN)
    ("a defective ubiquitin ligase" . SPARSER::PROTEIN)
    ("MDMX or HDMX" . SPARSER::COLLECTION) ("HDMX" . SPARSER::PROTEIN)
    ("p53/MDM2" . SPARSER::COLLECTION) ("MDM2 and p53" . SPARSER::COLLECTION)
    ("TAP" . SPARSER::PROTEIN) ("the major p53 regulator" . SPARSER::PROTEIN)
    ("p160 and other co-activator proteins [ xref ]" . SPARSER::COLLECTION)
    ("SKIP or p53" . SPARSER::COLLECTION) ("KAP1/TRIM28" . SPARSER::COLLECTION)
    ("SKIP" . SPARSER::PROTEIN) ("metastatic foci" . SPARSER::PROTEIN)
    ("Antigens" . SPARSER::PROTEIN)
    ("Melanoma-associated antigens (MAGE)" . SPARSER::PROTEIN)
    ("a potent p53 inhibitor and MDM2 partner" . SPARSER::COLLECTION)
    ("Nutlin-3a" . SPARSER::DRUG) ("Amino acids" . SPARSER::AMINO-ACID)
    ("UbcH5" . SPARSER::PROTEIN) ("Oligo 2" . SPARSER::PROTEIN)
    ("Streptavidin-agarose" . SPARSER::DRUG) ("CA5" . SPARSER::PROTEIN)
    ("MP2" . SPARSER::PROTEIN) ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("p53 regulator" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("MAGE-C2" . SPARSER::PROTEIN)
    ("NSE1" . SPARSER::PROTEIN) ("MAGE-G1" . SPARSER::PROTEIN)
    ("TRIM28" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN) ("MAGE-A2" . SPARSER::PROTEIN)
    ("ARHGDIB , PRDX2 and MSH2" . SPARSER::COLLECTION)
    ("ARHGDIB and PRDX2" . SPARSER::COLLECTION)
    ("ARHGDIB , MSH2 or PRDX2" . SPARSER::COLLECTION)
    ("ARHGDIB" . SPARSER::DRUG) ("RH and cHL" . SPARSER::COLLECTION)
    ("another cytoskeletal protein" . SPARSER::PROTEIN)
    ("SEPTIN2 and BCR" . SPARSER::COLLECTION)
    ("CD99 and SEPTIN2" . SPARSER::COLLECTION)
    ("F-actin and pseudopodia" . SPARSER::COLLECTION)
    ("filaments and actin" . SPARSER::COLLECTION)
    ("a filament-forming cytoskeletal GTPase" . SPARSER::GTPASE)
    ("actin and tubulin" . SPARSER::COLLECTION) ("CD99-" . SPARSER::PROTEIN)
    ("plasma cell phenotypic markers CD38 and CD138" . SPARSER::COLLECTION)
    ("CD38 and CD138" . SPARSER::COLLECTION) ("PCM" . SPARSER::PROTEIN)
    ("cortical filamentous actin" . SPARSER::BIO-COMPLEX)
    ("thinner cortical filamentous actin" . SPARSER::BIO-COMPLEX)
    ("SEPTIN2 and F-actin" . SPARSER::COLLECTION) ("SiRNA" . SPARSER::PROTEIN)
    ("Strong STATHMIN" . SPARSER::PROTEIN)
    ("strong SEPTIN2" . SPARSER::PROTEIN) ("RH" . SPARSER::MOLECULE)
    ("CD99 and STATHMIN" . SPARSER::COLLECTION)
    ("SEPTIN2 and upregulaton" . SPARSER::COLLECTION)
    ("CD99 and L428-CTR" . SPARSER::COLLECTION)
    ("L428-CD99 and L428-CTR" . SPARSER::COLLECTION)
    ("A20-CTR" . SPARSER::COLLECTION) ("PMF" . SPARSER::PROTEIN)
    ("CTR" . SPARSER::PROTEIN)
    ("proteins, SEPTIN2 and STATHMIN" . SPARSER::COLLECTION)
    ("21 upregulated proteins and 20 downregulated proteins"
     . SPARSER::COLLECTION)
    ("CD79a and CD79b" . SPARSER::COLLECTION)
    ("SEPTIN2 and STATHMIN" . SPARSER::COLLECTION)
    ("STATHMIN" . SPARSER::PROTEIN) ("PRDX2" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("SiRNA-mediated" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::MOLECULE) ("MIC2" . SPARSER::PROTEIN)
    ("CD79b" . SPARSER::PROTEIN) ("CD79a" . SPARSER::PROTEIN)
    ("Oct-2" . SPARSER::PROTEIN) ("MUM-1" . SPARSER::PROTEIN)
    ("CD138" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("SEPTIN2" . SPARSER::PROTEIN) ("CD99" . SPARSER::PROTEIN)
    ("eIF4" . SPARSER::PROTEIN) ("RPPA and inhibitor" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("the cap-dependent mRNA translation complex and mTOR complex"
     . SPARSER::COLLECTION)
    ("TSC1, TSC2, and PDCD4" . SPARSER::COLLECTION)
    ("the previously identified C-terminal fragment" . SPARSER::FRAGMENT)
    ("220kDa" . SPARSER::PROTEIN)
    ("Ibrutinib, Idelalisib, and NVP-BEZ235" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF4G" . SPARSER::COLLECTION)
    ("Ibrutinib and Idelalisib" . SPARSER::COLLECTION)
    ("the recently developed BTK inhibitor Ibrutinib and the PI3Kδ inhibitor Idelalisib"
     . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR kinase inhibitor" . SPARSER::INHIBITOR)
    ("the recently developed BTK inhibitor Ibrutinib" . SPARSER::DRUG)
    ("a translational regulator" . SPARSER::REGULATOR)
    ("SF2/ASF" . SPARSER::COLLECTION) ("ASF" . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("IRS1, RICTOR, and GAB2" . SPARSER::COLLECTION)
    ("RICTOR" . SPARSER::PROTEIN) ("LCK, SYK, and BTK" . SPARSER::COLLECTION)
    ("total AKT and total mTOR" . SPARSER::COLLECTION)
    ("the pro-apoptotic BAD" . SPARSER::PROTEIN)
    ("BIM, BCL2, BAK, and BAX" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN)
    ("its pro-apoptotic binding partner BAX" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins BIM and BAK" . SPARSER::COLLECTION)
    ("BIM and BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("the SYK and LCK kinase proteins and the Notch-1 signaling activator [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("proteins and phosphoproteins" . SPARSER::COLLECTION)
    ("SYK and LCK" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("eIF4G, SYK, RBM15, and GAB2" . SPARSER::COLLECTION)
    ("Annexin" . SPARSER::PROTEIN) ("SYK" . SPARSER::PROTEIN)
    ("Tyrosine Kinase (BTK)" . SPARSER::PROTEIN)
    ("pro-proliferative proteins" . SPARSER::PROTEIN)
    ("SF3B1 , NOTCH1 , and MYD88" . SPARSER::COLLECTION)
    ("ZAP70 , LPL , CRY1 , and LDOC1" . SPARSER::COLLECTION)
    ("eIF4G, and greater" . SPARSER::COLLECTION)
    ("the BTK inhibitor Ibrutinib and the PI3Kδ inhibitor Idelalisib"
     . SPARSER::COLLECTION)
    ("a PI3K/mTOR dual inhibitor" . SPARSER::INHIBITOR)
    ("Idelalisib" . SPARSER::DRUG) ("Ibrutinib" . SPARSER::DRUG)
    ("eIF" . SPARSER::PROTEIN) ("GS-1101" . SPARSER::DRUG)
    ("EG-1" . SPARSER::PROTEIN) ("PPM1G" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("C-FAG" . SPARSER::PROTEIN)
    ("SF2" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DVL3" . SPARSER::PROTEIN)
    ("GAB2" . SPARSER::PROTEIN) ("RBM15" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("factor 4" . SPARSER::PROTEIN) ("PI3K-delta" . SPARSER::PROTEIN)
    ("Tyrosine Kinase" . SPARSER::PROTEIN) ("LDOC1" . SPARSER::PROTEIN)
    ("CRY1" . SPARSER::PROTEIN) ("PI3Kδ" . SPARSER::PROTEIN)
    ("NVP-BEZ235" . SPARSER::DRUG) ("4E-BP1" . SPARSER::PROTEIN)
    ("LSD1/CoREST" . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutants LSD1(S131A) and LSD1(S137A)"
     . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutants LSD1" . SPARSER::PROTEIN)
    ("RNF168 or another unknown E3 ligase" . SPARSER::COLLECTION)
    ("laser-induced DNA" . SPARSER::DNA) ("RNF8/RNF168" . SPARSER::COLLECTION)
    ("presumably bringing 53BP1" . SPARSER::PROTEIN)
    ("bringing 53BP1" . SPARSER::PROTEIN)
    ("SET8 and MMSET" . SPARSER::COLLECTION)
    ("bleomycin or etoposide" . SPARSER::COLLECTION)
    ("LSD1(S137A) or LSD1(2A)" . SPARSER::COLLECTION)
    ("MYC-RNF168" . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutant HA-LSD1" . SPARSER::COLLECTION)
    ("RNF168 and 53BP1" . SPARSER::COLLECTION)
    ("GST-53BP1-KBD" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("MYC-LSD1" . SPARSER::COLLECTION) ("HA-53BP1" . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutants FLAG-LSD1" . SPARSER::COLLECTION)
    ("HA-53BP1-KBD" . SPARSER::COLLECTION) ("FLAG-LSD1" . SPARSER::COLLECTION)
    ("KBD" . SPARSER::PROTEIN) ("53BP1-KBD" . SPARSER::PROTEIN-PAIR)
    ("LSD1 and 53BP1" . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutants" . SPARSER::MUTANT)
    ("FLAG-RNF168" . SPARSER::COLLECTION)
    ("LSD1 and RNF168" . SPARSER::COLLECTION)
    ("GST-LSD1" . SPARSER::COLLECTION) ("AAs" . SPARSER::MOLECULE)
    ("both the phosphorylation-defective mutants GFP-LSD1"
     . SPARSER::COLLECTION)
    ("TBB" . SPARSER::PROTEIN) ("GFP-LSD1" . SPARSER::COLLECTION)
    ("GST-WIP1" . SPARSER::COLLECTION) ("FLAG-WIP1" . SPARSER::COLLECTION)
    ("HDAC1, CoREST and PF21A" . SPARSER::COLLECTION)
    ("BRAF–HDAC" . SPARSER::COLLECTION) ("BHC" . SPARSER::PROTEIN)
    ("CoREST" . SPARSER::PROTEIN) ("HA-LSD1" . SPARSER::COLLECTION)
    ("CIP" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("efficiently phosphorylated wild-type LSD1 and point mutant LSD1(S166A)"
     . SPARSER::COLLECTION)
    ("the point mutants LSD1(S131A) or LSD1(S137A)" . SPARSER::COLLECTION)
    ("LSD1 and CK2" . SPARSER::COLLECTION) ("GST-CK2α" . SPARSER::COLLECTION)
    ("HIS" . SPARSER::AMINO-ACID) ("CK2α and CK2α" . SPARSER::COLLECTION)
    ("RNF168, LSD1 and 53BP1" . SPARSER::COLLECTION)
    ("CHK1 (S345) and CHK2 (T68)" . SPARSER::COLLECTION)
    ("ATM (S367, S1981), γ-H2AX, CHK1 (S345) and CHK2 (T68)"
     . SPARSER::COLLECTION)
    ("PP2A or PP1" . SPARSER::COLLECTION) ("microcystin" . SPARSER::MOLECULE)
    ("two regulatory β subunits and two catalytic subunits (α and α’)"
     . SPARSER::COLLECTION)
    ("Its tetrameric holoenzyme" . SPARSER::PROTEIN)
    ("demethylase-1" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("VCP/p97" . SPARSER::COLLECTION) ("VCP" . SPARSER::PROTEIN)
    ("SET8, SUV420 and MMSET" . SPARSER::COLLECTION)
    ("MMSET" . SPARSER::PROTEIN)
    ("the telomere-associated protein RIF1" . SPARSER::PROTEIN)
    ("homolog) and PTIP" . SPARSER::COLLECTION) ("PTIP" . SPARSER::PROTEIN)
    ("RNF8-RNF168" . SPARSER::COLLECTION)
    ("MDC1 (mediator of DNA damage checkpoint 1) and 53BP1 (p53 binding protein 1)"
     . SPARSER::COLLECTION)
    ("-CHK2" . SPARSER::COLLECTION) ("CK2/WIP1" . SPARSER::COLLECTION)
    ("phosphorylation-defective mutants" . SPARSER::MUTANT)
    ("LSD1, RNF168 and 53BP1" . SPARSER::COLLECTION)
    ("casein kinase 2 (CK2) and wild-type p53-induced phosphatase 1 (WIP1)"
     . SPARSER::COLLECTION)
    ("local H3K4" . SPARSER::PROTEIN) ("H2A/H2AX" . SPARSER::COLLECTION)
    ("demethylase activity" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("PP2C" . SPARSER::PROTEIN)
    ("PPM1D" . SPARSER::PROTEIN) ("CK2α" . SPARSER::PROTEIN)
    ("Casein kinase 2" . SPARSER::PROTEIN) ("amine oxidase" . SPARSER::PROTEIN)
    ("deacetylase 1" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("Lethal(3) malignant brain tumor-like protein 1" . SPARSER::PROTEIN)
    ("L3MBTL1" . SPARSER::PROTEIN)
    ("valosin-containing protein" . SPARSER::PROTEIN)
    ("p97" . SPARSER::PROTEIN) ("KDM4A" . SPARSER::PROTEIN)
    ("SET8" . SPARSER::PROTEIN) ("m2" . SPARSER::MOLECULE)
    ("PAX-interacting protein 1" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rap1" . SPARSER::PROTEIN)
    ("RIF1" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("p53 binding protein 1" . SPARSER::PROTEIN)
    ("mediator of DNA damage checkpoint 1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("WIP1" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("LSD1" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("IRAK1-NF-κB" . SPARSER::PROTEIN-PAIR)
    ("b-TRAF6" . SPARSER::PROTEIN-PAIR)
    ("MMP-9 and forms" . SPARSER::COLLECTION) ("gemcitabine" . SPARSER::DRUG)
    ("a melanocyte lineage-specific small non-coding miRNA" . SPARSER::PROTEIN)
    ("PRAME and KCNMA1" . SPARSER::COLLECTION) ("PRAME" . SPARSER::PROTEIN)
    ("multi drug resistance-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROCK1 and MAPK1" . SPARSER::COLLECTION)
    ("ROCK and MAPK1" . SPARSER::COLLECTION)
    ("Bcl-w and specificity protein 1 ( xref )" . SPARSER::COLLECTION)
    ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("HDAC3 and Tip60" . SPARSER::COLLECTION)
    ("TBL1 and TBLR1" . SPARSER::COLLECTION)
    ("TRAIL and Fas ligand" . SPARSER::COLLECTION)
    ("SIAH2, MDR1, and SNAIL" . SPARSER::COLLECTION)
    ("celastrol and taxol" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE) ("SIAH2 and HDAC3" . SPARSER::COLLECTION)
    ("PARP and Caspase-3" . SPARSER::COLLECTION)
    ("SIAH2 and MDR1" . SPARSER::COLLECTION)
    ("miR-335 directly targets SIAH2" . SPARSER::PROTEIN)
    ("pGL3-3" . SPARSER::COLLECTION) ("HDAC3 and SIAHs" . SPARSER::COLLECTION)
    ("Src ( xref ) and Src" . SPARSER::COLLECTION)
    ("SIAH1 and SIAH2" . SPARSER::COLLECTION) ("conjugase" . SPARSER::PROTEIN)
    ("Celastrol and taxol" . SPARSER::COLLECTION)
    ("Celastrol" . SPARSER::MOLECULE) ("Vinblastine" . SPARSER::DRUG)
    ("taxol" . SPARSER::DRUG) ("Bcl-w and SP1" . SPARSER::COLLECTION)
    ("CREB and ATM-dependent miR-335 targets CtIP" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("MDR1and β-catenin" . SPARSER::COLLECTION)
    ("N-CoR/SMRT" . SPARSER::COLLECTION)
    ("HDAC3 and SIAH2" . SPARSER::COLLECTION) ("miR-16" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("Caspase-9" . SPARSER::PROTEIN)
    ("subunit 2" . SPARSER::PROTEIN) ("KCNMA1" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("rac1" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("TBLR1" . SPARSER::PROTEIN)
    ("TBL1" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("SIAH1" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("UBCH8" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("RUNX2" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("HIF1 alpha" . SPARSER::PROTEIN)
    ("HIF-1alpha" . SPARSER::PROTEIN) ("Siah2" . SPARSER::PROTEIN)
    ("CREB3" . SPARSER::PROTEIN) ("histone deacetylase-3" . SPARSER::PROTEIN)
    ("SIAH2" . SPARSER::PROTEIN) ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("CD31, CD146 and HIF-1α" . SPARSER::COLLECTION)
    ("monoclonal antibodies or small therapeutic molecules"
     . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("ERBB" . SPARSER::PROTEIN)
    ("anoikis" . SPARSER::PROTEIN)
    ("VEGF, basic fibroblast growth factor and matrix metalloproteinase-9"
     . SPARSER::COLLECTION)
    ("HIF-1α and EGFR" . SPARSER::COLLECTION)
    ("EGFR and CD146" . SPARSER::COLLECTION) ("a severe type" . TYPE)
    ("a tumor-associated endothelial biomarker" . SPARSER::MOLECULE)
    ("MAPK/NF-κB" . SPARSER::COLLECTION) ("Akt/p38" . SPARSER::COLLECTION)
    ("HIF-1α, CD146 and CD31" . SPARSER::COLLECTION)
    ("CD31 and CD146" . SPARSER::COLLECTION)
    ("CD31 and HIF-1α" . SPARSER::COLLECTION)
    ("CD31, HIF-1α, CD146 and EGFR" . SPARSER::COLLECTION)
    ("HIF-1α, CD146 and EGFR" . SPARSER::COLLECTION)
    ("the pathological angiogenesis biomarker" . SPARSER::MOLECULE)
    ("HIF-1α and CD146" . SPARSER::COLLECTION)
    ("tubular forms" . SPARSER::FORM) ("PMA and AdCC" . SPARSER::COLLECTION)
    ("NSG and PMA" . SPARSER::COLLECTION) ("EGFRs" . SPARSER::PROTEIN)
    ("NSG, PMA and AdCC" . SPARSER::COLLECTION)
    ("CD146, HIF-1α, CD31 and EGFR" . SPARSER::COLLECTION)
    ("specifically receptor blocking monoclonal antibodies and small molecule tyrosine kinase inhibitors"
     . SPARSER::COLLECTION)
    ("specifically receptor blocking monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("CD146 and HIF-1α" . SPARSER::COLLECTION)
    ("EGFR and CD31" . SPARSER::COLLECTION)
    ("EGFR, CD146 and HIF-1α" . SPARSER::COLLECTION)
    ("PMA and NSG" . SPARSER::COLLECTION)
    ("EGFR, CD31, CD146 and HIF-1α" . SPARSER::COLLECTION)
    ("EGFR, CD31, CD146 and hypoxia-inducible factor-1α" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN) ("S-P" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("mitochondrial Lck" . SPARSER::PROTEIN)
    ("mitochondrial CRIF1" . SPARSER::PROTEIN)
    ("GADD45 and Nur77" . SPARSER::COLLECTION)
    ("kinase-dead Lck ( xref ) and inactive Lck ( xref )"
     . SPARSER::COLLECTION)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PCNA and Cdc2" . SPARSER::COLLECTION)
    ("The exogenous Lck" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2 (CDK2) and Nur77 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("dasatinib" . SPARSER::DRUG) ("pervanadate" . SPARSER::PROTEIN)
    ("the well-defined human T leukemic cell line Jurkat" . SPARSER::PROTEIN)
    ("the aggressive form" . SPARSER::FORM) ("kinase (SFK)" . SPARSER::KINASE)
    ("receptor and non-receptor" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lck and CRIF1" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("CRIF1 and Lck" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("Nur77" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("Eps15" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor substrate 15" . SPARSER::PROTEIN)
    ("LIM domain only 2" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("CRIF1" . SPARSER::PROTEIN)
    ("CR6-interacting factor 1" . SPARSER::PROTEIN)
    ("TRAF1 or LMP1" . SPARSER::COLLECTION)
    ("keratinocytes, and TRAF1" . SPARSER::COLLECTION)
    ("an LMP1-associated protein" . SPARSER::PROTEIN)
    ("our western blot" . SPARSER::PROTEIN)
    ("TNFR1 and LMP1" . SPARSER::COLLECTION) ("cIAP" . SPARSER::PROTEIN)
    ("TRAF1 or TRAF2" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("TAB/TAK1" . SPARSER::COLLECTION)
    ("a viral oncoprotein" . SPARSER::PROTEIN)
    ("TNFR1, CD40, IL1R1, NOD2, and TLR" . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX)
    ("LMP1, TRAF1 and TRAF2" . SPARSER::COLLECTION)
    ("TRAF1, TRAF2, TRAF3 or GFP" . SPARSER::COLLECTION)
    ("the LMP1 TES1 domain 204 AQAAA 208 triple point mutant"
     . SPARSER::MUTANT)
    ("LMP1, or LMP1" . SPARSER::COLLECTION)
    ("A20, ABIN1 and SQSTM1" . SPARSER::COLLECTION)
    ("TRAF2, TRAF3, cIAP1, and cIAP2" . SPARSER::COLLECTION)
    ("TRAF1 and HOIP" . SPARSER::COLLECTION)
    ("E1, E2, HOIP, HOIL-1L and TRAF1" . SPARSER::COLLECTION)
    ("UBE2L3 and LUBAC" . SPARSER::COLLECTION)
    ("fresh 5% beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("a M1-pUb-specific monoclonal antibody" . SPARSER::DRUG)
    ("TRAF2:cIAP" . SPARSER::PROTEIN-PAIR) ("LMP1/TRAF1" . SPARSER::COLLECTION)
    ("a cell-permeable SMAC mimetic peptide" . SPARSER::PEPTIDE)
    ("TRAF2 and cIAP" . SPARSER::COLLECTION)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("TRAF1 and the LUBAC components HOIP and SHARPIN (Figs xref and xref )"
     . SPARSER::COLLECTION)
    ("HOIP, HOIL-1L, or SHARPIN" . SPARSER::COLLECTION)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("subunits, TRAF2, TRAF3 and cIAP1/2" . SPARSER::COLLECTION)
    ("TRAF2 and the LUBAC subunits HOIP, HOIL-1L and SHARPIN"
     . SPARSER::COLLECTION)
    ("HOIP, HOIL-1L and SHARPIN" . SPARSER::COLLECTION)
    ("TRAF3 or cIAP1/2" . SPARSER::COLLECTION)
    ("FLAG-TRAF" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("mutant (DM)" . SPARSER::MUTANT) ("TES1 and TES2" . SPARSER::COLLECTION)
    ("TES1, TES2 or TES1/TES2" . SPARSER::COLLECTION)
    ("HOIP and HOIL-1L" . SPARSER::COLLECTION)
    ("A20 or ABIN1" . SPARSER::COLLECTION) ("HA-GFP" . SPARSER::COLLECTION)
    ("TRAF1 and IKK-gamma" . SPARSER::COLLECTION)
    ("The characteristic 293 cell LMP1 punctate" . SPARSER::PROTEIN)
    ("EMO/IKK-gamma" . SPARSER::COLLECTION)
    ("TRAF1 and ubiquitin" . SPARSER::COLLECTION)
    ("a TRAF1-associated protein" . SPARSER::PROTEIN)
    ("FLAG-TRAF2" . SPARSER::COLLECTION)
    ("GFP, TRAF1 or TRAF2" . SPARSER::COLLECTION)
    ("FLAG-immuno-purified TRAF1" . SPARSER::PROTEIN)
    ("FLAG-LMP1" . SPARSER::COLLECTION) ("HA-SHARPIN" . SPARSER::COLLECTION)
    ("HOIP and SHARPIN" . SPARSER::COLLECTION)
    ("TRAF1 and TRAF3" . SPARSER::COLLECTION)
    ("FLAG-TRAF3" . SPARSER::COLLECTION)
    ("HOIP and SHARIPN" . SPARSER::COLLECTION) ("K63-" . SPARSER::PROTEIN)
    ("SQSTM1/P62" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("HOIP or HOIL-1L" . SPARSER::COLLECTION)
    ("TRAF1 and the LUBAC catalytic subunits HOIP (SAINT score 0 without induction, 0.99 with induction) and HOIL-1L (SAINT score 0 without induction, 0.79 with induction)"
     . SPARSER::COLLECTION)
    ("the LUBAC catalytic subunits HOIP (SAINT score 0 without induction, 0.99 with induction) and HOIL-1L (SAINT score 0 without induction, 0.79 with induction)"
     . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("FLAG-GFP" . SPARSER::COLLECTION) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("LMP1 1-231-mediated MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p100:p52" . SPARSER::BIO-COMPLEX)
    ("LMP1 TES1-mediated canonical NF-kB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN) ("p38 and ERK" . SPARSER::COLLECTION)
    ("FLAG-TRAF1" . SPARSER::COLLECTION) ("GFP or TRAF1" . SPARSER::COLLECTION)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY)
    ("LMP1 1-231-mediated p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("canonical NF-kB" . SPARSER::PROTEIN)
    ("IKK-alpha and IKK-beta" . SPARSER::COLLECTION)
    ("RIP1 and IKK-gamma, and CD40" . SPARSER::COLLECTION)
    ("IKK-gamma, and CD40" . SPARSER::COLLECTION)
    ("the C-terminal glycine of another ubiquitin molecule [ xref ]"
     . SPARSER::MOLECULE)
    ("subunits, HOIP and HOIL-1L" . SPARSER::COLLECTION)
    ("SHARPIN" . SPARSER::PROTEIN)
    ("TRAF2, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN) ("BB" . SPARSER::MOLECULE)
    ("NF-kB and JNK" . SPARSER::COLLECTION)
    ("TRAF1 and TRAF2" . SPARSER::COLLECTION)
    ("JNK/AP-1" . SPARSER::COLLECTION) ("LMP1 and TRAF1" . SPARSER::COLLECTION)
    ("NF-kB, MAP kinase, and IRF7" . SPARSER::COLLECTION)
    ("TES" . SPARSER::PROTEIN) ("Effector" . SPARSER::EFFECTOR)
    ("the principal EBV oncoprotein" . SPARSER::PROTEIN)
    ("TRAF1 or the LUBAC subunit HOIP" . SPARSER::COLLECTION)
    ("K63-ubiquitin" . SPARSER::COLLECTION)
    ("TRAF1 and LMP1" . SPARSER::COLLECTION)
    ("TRAF1 and LUBAC" . SPARSER::COLLECTION)
    ("microbial pathogens use LUBAC" . SPARSER::BIO-COMPLEX)
    ("NF-kB and MAP kinase" . SPARSER::COLLECTION)
    ("K63-Ub" . SPARSER::COLLECTION)
    ("K63-polyubiquitin" . SPARSER::COLLECTION) ("HOIP" . SPARSER::PROTEIN)
    ("cIAP1 or cIAP2" . SPARSER::COLLECTION)
    ("TRAF1:TRAF2" . SPARSER::BIO-COMPLEX) ("LUBAC" . SPARSER::BIO-COMPLEX)
    ("A20 and ABIN1" . SPARSER::COLLECTION)
    ("IKK-gamma/NEMO" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("LMP1 or TRAF1" . SPARSER::COLLECTION)
    ("TRAF1 and the linear ubiquitin chain assembly complex (LUBAC)"
     . SPARSER::COLLECTION)
    ("complex (LUBAC)" . SPARSER::BIO-COMPLEX)
    ("polyubiquitin" . SPARSER::PROTEIN) ("NOD2" . SPARSER::PROTEIN)
    ("IL1R1" . SPARSER::PROTEIN) ("k63" . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::PROTEIN) ("P62" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("MS-MS" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG) ("UBE2L3" . SPARSER::PROTEIN)
    ("BIN1" . SPARSER::PROTEIN) ("guide RNAs" . SPARSER::RNA)
    ("RBCK1" . SPARSER::PROTEIN) ("RNF31" . SPARSER::PROTEIN)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("Calyculin A" . SPARSER::MOLECULE) ("p100" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("BL2" . SPARSER::PROTEIN) ("IKK-epsilon" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("LMP 1" . SPARSER::PROTEIN) ("IKK-beta" . SPARSER::PROTEIN)
    ("IKK-alpha" . SPARSER::PROTEIN) ("HOIL-1" . SPARSER::PROTEIN)
    ("family member 4" . SPARSER::PROTEIN) ("UBC9" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("TNF receptor associated factor 2" . SPARSER::PROTEIN)
    ("costimulatory molecule" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("ABIN1" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("IKK-gamma" . SPARSER::PROTEIN) ("TRAF1" . SPARSER::PROTEIN)
    ("TES1" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("Latent Membrane Protein 1" . SPARSER::PROTEIN)
    ("caspase and p40 Met" . SPARSER::COLLECTION)
    ("p40 Met" . SPARSER::PROTEIN)
    ("caspase , and p40Met" . SPARSER::COLLECTION)
    ("calpastatin" . SPARSER::PROTEIN) ("labile" . SPARSER::PROTEIN)
    ("a pro-apoptotic fragment" . SPARSER::FRAGMENT) ("LT" . SPARSER::PROTEIN)
    ("both calpains and membrane metalloproteases" . SPARSER::COLLECTION)
    ("caspase-" . SPARSER::PROTEIN)
    ("γ -secretase and lysosome inhibitors" . SPARSER::COLLECTION)
    ("caspase and p40Met" . SPARSER::COLLECTION) ("NTFs" . SPARSER::PROTEIN)
    ("calpain and metalloproteases" . SPARSER::COLLECTION)
    ("uncleavable tropomyosine receptor kinase (TRK)-Met"
     . SPARSER::COLLECTION)
    ("an uncleavable chimeric receptor" . SPARSER::RECEPTOR)
    ("-Met" . SPARSER::COLLECTION) ("TRKA" . SPARSER::PROTEIN)
    ("TRK" . SPARSER::PROTEIN)
    ("p40Met caspase and the K1108A mutant" . SPARSER::COLLECTION)
    ("p40Met" . SPARSER::PROTEIN)
    ("xref  only Flag-p40Met caspase" . SPARSER::PROTEIN)
    ("Flag-p40Met" . SPARSER::PROTEIN-PAIR)
    ("the last amino acids of Met" . SPARSER::AMINO-ACID)
    ("the last amino acids" . SPARSER::AMINO-ACID) ("AspN" . SPARSER::PROTEIN)
    ("caspase and cathepsin" . SPARSER::COLLECTION)
    ("calpeptin" . SPARSER::MOLECULE) ("cathepsin" . SPARSER::PROTEIN)
    ("its downstream signaling proteins ERK (extracellular signal-regulated kinase) and AKT ( xref )"
     . SPARSER::COLLECTION)
    ("Met and production of a fragment of ~40 kDa" . SPARSER::COLLECTION)
    ("Ionomycin" . SPARSER::DRUG) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("ionophore" . SPARSER::MOLECULE)
    ("the pro-apoptotic fragment p40Met caspase" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG) ("Calcium" . SPARSER::CALCIUM)
    ("an extracellular fragment and an intracellular fragment"
     . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("calpains and cathepsins" . SPARSER::COLLECTION)
    ("Calpains" . SPARSER::PROTEIN)
    ("here called p40Met caspase" . SPARSER::PROTEIN)
    ("PS-RIP" . SPARSER::COLLECTION) ("CTF" . SPARSER::PROTEIN)
    ("NTF" . SPARSER::PROTEIN) ("presenilin" . SPARSER::PROTEIN)
    ("Met and cancer" . SPARSER::COLLECTION) ("HGF/SF" . SPARSER::COLLECTION)
    ("SF" . SPARSER::PROTEIN)
    ("the last few amino acids of Met" . SPARSER::AMINO-ACID)
    ("the last few amino acids" . SPARSER::AMINO-ACID)
    ("calpains" . SPARSER::PROTEIN) ("metalloprotease" . SPARSER::PROTEIN)
    ("ionophores" . SPARSER::MOLECULE)
    ("hepatocyte growth factor/scatter factor" . SPARSER::COLLECTION)
    ("CH 3" . SPARSER::MOLECULE) ("HCO 3" . SPARSER::MOLECULE)
    ("GRB2" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("calpain 2" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("l -aspartyl" . SPARSER::MOLECULE) ("p55" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("p45" . SPARSER::PROTEIN) ("γ −secretase" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN) ("calpain 1" . SPARSER::PROTEIN)
    ("calpain inhibitor" . SPARSER::PROTEIN) ("p40" . SPARSER::PROTEIN)
    ("γ -secretase" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("IFN" . SPARSER::DRUG)
    ("Pirh2, MdmX, HAUSP, ARF, COP1 and ARF-BP1" . SPARSER::COLLECTION)
    ("ARF" . SPARSER::PROTEIN) ("HAUSP" . SPARSER::PROTEIN)
    ("MdmX" . SPARSER::PROTEIN)
    ("an antiviral host protein" . SPARSER::PROTEIN)
    ("siRNA or RNF43" . SPARSER::COLLECTION)
    ("p21, Bax and Puma" . SPARSER::COLLECTION)
    ("p53 and its downstream effectors Bax and Puma ( xref )"
     . SPARSER::COLLECTION)
    ("p53 and its regulated molecules" . SPARSER::COLLECTION)
    ("NP and pcDNA" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("NP/RNF43" . SPARSER::COLLECTION) ("NTA" . SPARSER::MOLECULE)
    ("MDM2-Flag" . SPARSER::COLLECTION) ("Ub-myc" . SPARSER::COLLECTION)
    ("p53-GFP" . SPARSER::COLLECTION) ("RNF43-HA" . SPARSER::COLLECTION)
    ("RNF43-Flag-HA" . SPARSER::COLLECTION) ("NP-GFP" . SPARSER::COLLECTION)
    ("a strong inhibitor" . SPARSER::INHIBITOR)
    ("either non-targeting siRNA (NT siRNA) or RNF43 siRNA"
     . SPARSER::COLLECTION)
    ("PB2, PB1, PA and NP" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN) ("mRNA and vRNA" . SPARSER::COLLECTION)
    ("an antiviral protein" . SPARSER::PROTEIN)
    ("pEGFP-NP" . SPARSER::COLLECTION) ("NP and RNF43" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN) ("NP–RNF43" . SPARSER::COLLECTION)
    ("Itch" . SPARSER::PROTEIN) ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("enzyme and E3" . SPARSER::COLLECTION)
    ("viral and cellular proteins" . SPARSER::PROTEIN)
    ("UPP" . SPARSER::PROTEIN) ("Ub" . SPARSER::PROTEIN)
    ("Nucleoprotein" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("nucleoprotein" . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE) ("delta–" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("COP1" . SPARSER::PROTEIN)
    ("Pirh2" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("Tumor suppressor protein" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("PB2" . SPARSER::PROTEIN)
    ("H3N2" . SPARSER::MOLECULE) ("β -galactosidase" . SPARSER::PROTEIN)
    ("NEDL1" . SPARSER::PROTEIN) ("HAP95" . SPARSER::PROTEIN)
    ("RIG1" . SPARSER::PROTEIN) ("TRIM 25" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("UAP56" . SPARSER::PROTEIN)
    ("BAT1" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("α-actinin-4" . SPARSER::PROTEIN) ("RNF43" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN)
    ("antineoplastic drugs" . SPARSER::DRUG)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the pro-apoptotic genes" . SPARSER::GENE)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("p53 and consequently several p53 target genes" . SPARSER::COLLECTION)
    ("consequently several p53 target genes" . SPARSER::GENE)
    ("Puma and Noxa" . SPARSER::COLLECTION)
    ("caspase 3 and Puma" . SPARSER::COLLECTION)
    ("Bax and Puma" . SPARSER::COLLECTION) ("ΔChe-1" . SPARSER::PROTEIN)
    ("Myc-ΔChe-1" . SPARSER::PROTEIN-PAIR)
    ("Puma and Bax" . SPARSER::COLLECTION)
    ("p21 and Gadd45" . SPARSER::COLLECTION)
    ("p21 , Gadd45a , Plk2 and Rrbm2b" . SPARSER::COLLECTION)
    ("Puma , Noxa , Bax and TP53Inp1" . SPARSER::COLLECTION)
    ("TP53Inp1" . SPARSER::PROTEIN) ("Noxa" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HOMER" . SPARSER::PROTEIN-FAMILY) ("massive parallel DNA" . SPARSER::DNA)
    ("p53 and Brca1" . SPARSER::COLLECTION)
    ("p53 and S46" . SPARSER::COLLECTION) ("sub-lethal DNA" . SPARSER::DNA)
    ("ATM and Chk2" . SPARSER::COLLECTION) ("antiserum" . SPARSER::PROTEIN)
    ("bacterial recombinant proteins" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug doxorubicin" . SPARSER::PROTEIN)
    ("anti-p53 or anti-Che-1" . SPARSER::COLLECTION)
    ("DDR and p53" . SPARSER::COLLECTION)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("ATM/Chk2" . SPARSER::COLLECTION) ("Tp53" . SPARSER::PROTEIN)
    ("a promising yet attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("its pro-apoptotic target genes" . SPARSER::GENE)
    ("p53 and the oncosuppressor Brca1" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("Che-1/AATF" . SPARSER::COLLECTION) ("AATF" . SPARSER::PROTEIN)
    ("TP53INP1" . SPARSER::PROTEIN) ("RPL19" . SPARSER::PROTEIN)
    ("Glutathione-S-transferase" . SPARSER::PROTEIN)
    ("intestinal alkaline phosphatase" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Plk2" . SPARSER::PROTEIN) ("Gadd45a" . SPARSER::PROTEIN)
    ("S46" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("Coronin and AIP1" . SPARSER::COLLECTION)
    ("Cofilin, Coronin and AIP1 work alongside other actin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cofilin, Coronin and AIP1" . SPARSER::COLLECTION)
    ("Twinfilin" . SPARSER::PROTEIN) ("GMF" . SPARSER::PROTEIN)
    ("AIP1 displacing one of Cofilin's" . SPARSER::PROTEIN)
    ("nucleotide state and mechanical properties" . SPARSER::COLLECTION)
    ("AIP1 and capping protein" . SPARSER::COLLECTION)
    ("green fluorescent protein–AIP1" . SPARSER::COLLECTION)
    ("Cofilin and AIP1" . SPARSER::COLLECTION)
    ("Coronin and Cofilin" . SPARSER::COLLECTION)
    ("actively growing filaments" . SPARSER::PROTEIN-FAMILY)
    ("AIP1, Cof1 and Cor1B" . SPARSER::COLLECTION)
    ("Cy3–Cof1, Cor1B–SNAP649 and AIP1" . SPARSER::COLLECTION)
    ("Daam1" . SPARSER::PROTEIN) ("proteins—Cof1" . SPARSER::COLLECTION)
    ("Cof1, Cor1B and AIP1" . SPARSER::COLLECTION)
    ("Cof1, Cof1 and AIP1, or Cof1 and Cor1B" . SPARSER::COLLECTION)
    ("AIP1, or Cof1 and Cor1B" . SPARSER::COLLECTION)
    ("new (green) polymer" . SPARSER::MOLECULE)
    ("first polymerized and tethered DY647-labelled actin filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("profilin" . SPARSER::PROTEIN) ("DY" . SPARSER::MOLECULE)
    ("Cof1 and Cor1B" . SPARSER::COLLECTION) ("SNAP647" . SPARSER::PROTEIN)
    ("Cy3–Cof1 and OG–actin filaments" . SPARSER::COLLECTION)
    ("AIP1 and Cof1" . SPARSER::COLLECTION)
    ("Cy3–Cof1 and Cor1B–SNAP649" . SPARSER::COLLECTION)
    ("OG–actin" . SPARSER::COLLECTION) ("AIP1–SNAP647" . SPARSER::COLLECTION)
    ("AIP1 and Cor1B" . SPARSER::COLLECTION) ("SNAP" . SPARSER::PROTEIN)
    ("only one exposed cysteine" . SPARSER::MOLECULE)
    ("maleimide" . SPARSER::DRUG) ("Cof1 and AIP1" . SPARSER::COLLECTION)
    ("Filaments" . SPARSER::PROTEIN-FAMILY)
    ("Cof1, AIP1 and Cor1B" . SPARSER::COLLECTION)
    ("surface-tethered Oregon-green (OG) labelled filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("AIP1 and Coronin-1B" . SPARSER::COLLECTION) ("OG" . SPARSER::PROTEIN)
    ("Cofilin and Coronin" . SPARSER::COLLECTION)
    ("Cofilin, AIP1 and Coronin" . SPARSER::COLLECTION)
    ("Coronins" . SPARSER::DRUG) ("AIP1 and Coronin" . SPARSER::COLLECTION)
    ("−1" . SPARSER::PROTEIN) ("ADP-actin" . SPARSER::COLLECTION)
    ("ADF/Cofilin" . SPARSER::COLLECTION) ("ADF" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("Cof1" . SPARSER::PROTEIN)
    ("Cor" . SPARSER::PROTEIN-FAMILY) ("multi" . SPARSER::PROTEIN)
    ("Coronin, Cofilin and AIP1" . SPARSER::COLLECTION)
    ("Cofilin" . SPARSER::PROTEIN) ("Coronin" . SPARSER::DRUG)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("D-1" . SPARSER::PROTEIN)
    ("l −1" . SPARSER::PROTEIN) ("cm −1" . SPARSER::PROTEIN)
    ("M −1  " . SPARSER::PROTEIN) ("capping protein" . SPARSER::PROTEIN)
    ("Coronin-1B" . SPARSER::PROTEIN) ("Cofilin-1" . SPARSER::PROTEIN)
    ("Srv2" . SPARSER::PROTEIN) ("melting (HRM)" . SPARSER::DRUG)
    ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("a very-conserved arginine" . SPARSER::AMINO-ACID) ("edu" . SPARSER::DRUG)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene and population" . SPARSER::COLLECTION)
    ("multi-exon" . SPARSER::PROTEIN-PAIR)
    ("BRCA1 , BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("BARD1/BRCA1" . SPARSER::COLLECTION)
    ("a 777-amino-acid protein" . SPARSER::PROTEIN)
    ("RAD51D (MIM*602954) and the genes" . SPARSER::COLLECTION)
    ("NBN" . SPARSER::PROTEIN) ("MIM " . SPARSER::PROTEIN)
    ("the highly susceptible BRCA1 (MIM*113705) and BRCA2 (MIM*600185) genes"
     . SPARSER::COLLECTION)
    ("the highly susceptible BRCA1" . SPARSER::PROTEIN)
    ("MIM" . SPARSER::PROTEIN) ("POP7" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN)
    ("BRCA1 associated RING domain 1" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("RAD51B" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN)
    ("protein-inhibitor or protein-protein" . SPARSER::COLLECTION)
    ("IGF-1R and c-Met" . SPARSER::COLLECTION)
    ("proteins or complexes" . SPARSER::COLLECTION)
    ("IGF-1R and an inhibitor (gefitinib or erlotinib)" . SPARSER::COLLECTION)
    ("ErbB-3-c-Met" . SPARSER::COLLECTION)
    ("mutations L858R_T790M and delL747_P753insS" . SPARSER::COLLECTION)
    ("L858R_T790M and delL747_P753insS" . SPARSER::COLLECTION)
    ("c-Met and ErbB-3" . SPARSER::COLLECTION)
    ("L858R_T790M, delE746_A750 and delL747_P753insS" . SPARSER::COLLECTION)
    ("ErbB-2 and IGF-1R" . SPARSER::COLLECTION)
    ("ErbB-3—IGF-1R" . SPARSER::COLLECTION)
    ("ErbB-3—ErbB-2" . SPARSER::COLLECTION)
    ("ErbB-3—c-Met" . SPARSER::COLLECTION)
    ("ErbB-3 and its partners EGFR mutants" . SPARSER::COLLECTION)
    ("c-Met, ErbB-3 and IGF-1R" . SPARSER::COLLECTION)
    ("c-Met-ErbB-3" . SPARSER::COLLECTION)
    ("mutant-ErbB-2 or mutant-c-Met" . SPARSER::COLLECTION)
    ("type and inhibitor" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT) ("IGF-1R/c-Met" . SPARSER::COLLECTION)
    ("the inhibitor or a higher drug resistance level" . SPARSER::COLLECTION)
    ("IGF-1R, c-Met or erlotinib" . SPARSER::COLLECTION)
    ("EGFR-c-Met" . SPARSER::COLLECTION) ("EGFR-IGF-1R" . SPARSER::COLLECTION)
    ("mutant L858R_T790M and a TKI" . SPARSER::COLLECTION)
    ("ErbB-2 or IGF-1R" . SPARSER::COLLECTION)
    ("the WT protein, mutant L858R (frequently occurs in NSCLC and responses well to TKIs) and mutant L858R_T790M (a double-point mutation that commonly triggers drug resistance)"
     . SPARSER::COLLECTION)
    ("ErbB-2, IGF-1R, c-Met, gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("the well-known type L858R_T790M" . SPARSER::PROTEIN)
    ("an inhibitor or a dimerization partner" . SPARSER::COLLECTION)
    ("ps" . SPARSER::PROTEIN)
    ("a mutant and a dimerization partner (ErbB-2, IGF-1R or c-Met)"
     . SPARSER::COLLECTION)
    ("ErbB-2, IGF-1R or c-Met" . SPARSER::COLLECTION)
    ("WT EGFR ( xref ) and L858R_T790M ( xref )" . SPARSER::COLLECTION)
    ("_P753insS" . SPARSER::PROTEIN) ("‘ins’" . SPARSER::PROTEIN)
    ("delE" . SPARSER::PROTEIN) ("ins" . SPARSER::PROTEIN)
    ("delL747" . SPARSER::PROTEIN) ("scap" . SPARSER::PROTEIN)
    ("Scap" . SPARSER::PROTEIN) ("‘mutant’" . SPARSER::MUTANT)
    ("an efficient co-receptor" . SPARSER::PROTEIN) ("PP" . SPARSER::PROTEIN)
    ("quinazoline" . SPARSER::MOLECULE) ("Component" . SPARSER::COMPONENT)
    ("IIIB" . SPARSER::DRUG) ("bank (PDB)" . SPARSER::PROTEIN)
    ("bank" . SPARSER::PROTEIN)
    ("EGFR mutants and their potential dimerization partners (e.g. ErbB-2, IGF-1R and c-Met)"
     . SPARSER::COLLECTION)
    ("innovative drugs" . SPARSER::DRUG) ("EGFR/ErbB-3" . SPARSER::COLLECTION)
    ("c-Met, EGFR, ErbB-2 and ErbB-3" . SPARSER::COLLECTION)
    ("a c-Met kinase inhibitor or c-Met/ErbB dual inhibitors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("c-Met/ErbB dual inhibitors" . SPARSER::INHIBITOR)
    ("EGFR, ErbB-2 and ErbB-3" . SPARSER::COLLECTION)
    ("c-Met (MET)" . SPARSER::PROTEIN)
    ("EGFR and IGF-1R" . SPARSER::COLLECTION)
    ("continuous Erlotinib" . SPARSER::DRUG) ("Mek/Erk" . SPARSER::COLLECTION)
    ("EGFR/IGF-1R" . SPARSER::COLLECTION)
    ("EGFR and insulin-like growth factor 1 receptor" . SPARSER::COLLECTION)
    ("‘active’" . SPARSER::ACTIVE) ("ErbB-2 and ErbB-3" . SPARSER::COLLECTION)
    ("ErbB-2, ErbB-3 and ErbB-4" . SPARSER::COLLECTION)
    ("ErbB-4" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("mutant L858R_T790M" . SPARSER::PROTEIN)
    ("Gefitinib or Erlotinib" . SPARSER::COLLECTION)
    ("gefitinib ( IRESSA ) and erlotinib ( TARCEVA )" . SPARSER::COLLECTION)
    ("two reversible TKIs, gefitinib ( IRESSA ) and erlotinib ( TARCEVA )"
     . SPARSER::COLLECTION)
    ("two reversible TKIs" . SPARSER::PROTEIN) ("TARCEVA" . SPARSER::DRUG)
    ("IRESSA" . SPARSER::DRUG) ("Ras/Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Shc, Grb2 and PI3K" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("Shc" . SPARSER::PROTEIN)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("neuregulins" . SPARSER::PROTEIN)
    ("IGF-1R or c-Met" . SPARSER::COLLECTION)
    ("ErbB-3 and c-Met" . SPARSER::COLLECTION) ("_T790M" . SPARSER::PROTEIN)
    ("IGF-1R, ErbB-2 and c-Met" . SPARSER::COLLECTION)
    ("delL747_P753insS" . SPARSER::PROTEIN)
    ("L858R and L858R_T790M" . SPARSER::PROTEIN)
    ("ErbB-2, IGF-1R and c-Met" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("the EGFR tyrosine kinase and its inhibitor" . SPARSER::COLLECTION)
    ("EGFR and ErbB-3" . SPARSER::COLLECTION) ("co-factor" . SPARSER::MOLECULE)
    ("S  4" . SPARSER::PROTEIN-FAMILY) ("S  2" . SPARSER::MOLECULE)
    ("1K" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN) ("AG1024" . SPARSER::DRUG)
    ("Grb2" . SPARSER::PROTEIN) ("TGF- α" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("ErbB-3" . SPARSER::PROTEIN) ("Caspase-3 and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 and caspase-3" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION) ("histological types" . TYPE)
    ("pro-apoptotic effector caspase-3 mRNA" . SPARSER::PROTEIN)
    ("RLIP76 and Ki67" . SPARSER::COLLECTION)
    ("RLIP76 and Ki-67" . SPARSER::COLLECTION) ("HPF" . SPARSER::PROTEIN)
    ("CH157" . SPARSER::PROTEIN) ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CH157-MN" . SPARSER::COLLECTION)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("penicillin G" . SPARSER::MOLECULE) ("RLIP76" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("drug resistance-associated genes" . SPARSER::GENE)
    ("MDR1, MRP2 and MKNK1" . SPARSER::COLLECTION)
    ("cell death-associated Fas-receptor gene" . SPARSER::GENE)
    ("Cyclin D-CDK4/6" . SPARSER::COLLECTION)
    ("a neuroblastoma-associated antigen" . SPARSER::PROTEIN)
    ("YB-1 and Cyclin D1" . SPARSER::COLLECTION)
    ("shCON or PBS" . SPARSER::COLLECTION)
    ("nuclear condensation and cytoplasm lysis" . SPARSER::COLLECTION)
    ("apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("PARP-1 and Bax" . SPARSER::COLLECTION)
    ("the respective SH-SY5Y" . SPARSER::PROTEIN) ("PI-" . SPARSER::PROTEIN)
    ("shCON" . SPARSER::PROTEIN)
    ("SH-SY5Y, SH-shCON and SH-shYB-1" . SPARSER::COLLECTION)
    ("SH-shCON" . SPARSER::COLLECTION) ("pGL" . SPARSER::PROTEIN)
    ("only CCND1p #1-targeted chromatin fragment" . SPARSER::FRAGMENT)
    ("Cyclin A and Cyclin D1" . SPARSER::COLLECTION)
    ("shYB-1" . SPARSER::PROTEIN) ("SH-shYB-1" . SPARSER::COLLECTION)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("SH-EP" . SPARSER::PROTEIN)
    ("Cyclin A, Cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("MKNK1" . SPARSER::PROTEIN)
    ("MRP2" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("Cyclin family" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("YB-1" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("FOXO3 and PA" . SPARSER::COLLECTION)
    ("hyperglycemic clamp" . SPARSER::PROTEIN-FAMILY)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("modest variants" . SPARSER::VARIANT)
    ("PEPCK , PPARG and TCF7L2" . SPARSER::COLLECTION)
    ("PPARG" . SPARSER::PROTEIN) ("the long-lived cohort" . SPARSER::MOLECULE)
    ("multiple sub-clinical traits" . SPARSER::PROTEIN)
    ("sub-clinical traits" . SPARSER::PROTEIN)
    ("lower fasting plasma glucose and better insulin sensitivity"
     . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO3 variants and moderate physical activity on fasting hyperglycemia"
     . SPARSER::COLLECTION)
    ("FPG and BMI" . SPARSER::COLLECTION)
    ("FPG and HBA1c" . SPARSER::COLLECTION)
    ("skeletal muscle-" . SPARSER::PROTEIN)
    ("improved glycemic traits" . SPARSER::PROTEIN)
    ("FOXO3 and moderate PA" . SPARSER::COLLECTION)
    ("allele and haplotype" . SPARSER::COLLECTION)
    ("-PA" . SPARSER::COLLECTION) ("TBA" . SPARSER::PROTEIN)
    ("variant and haplotype" . SPARSER::COLLECTION)
    ("FPG and HbA 1c" . SPARSER::COLLECTION) ("Variants" . SPARSER::VARIANT)
    ("FH-" . SPARSER::PROTEIN)
    ("three variants (rs2802288*A, rs2802290*G and rs2802292*G) and haplotype 2"
     . SPARSER::COLLECTION)
    ("FH and non-FH" . SPARSER::COLLECTION)
    ("the long-lived individuals cohort" . SPARSER::MOLECULE)
    ("TC" . SPARSER::PROTEIN) ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("APOE" . SPARSER::PROTEIN)
    ("hyperglycemia or type 2" . SPARSER::COLLECTION)
    ("G6Pase and PEPCK" . SPARSER::COLLECTION) ("PEPCK" . SPARSER::PROTEIN)
    ("Cis" . SPARSER::PROTEIN) ("daf" . SPARSER::PROTEIN)
    ("Forkhead" . SPARSER::PROTEIN) ("ADA" . SPARSER::PROTEIN)
    ("hyperglycemia and lifespan" . SPARSER::COLLECTION)
    ("HOMA-IR" . SPARSER::COLLECTION) ("FH" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("HBA1" . SPARSER::PROTEIN)
    ("HbA 1" . SPARSER::PROTEIN) ("HDL-cholesterol" . SPARSER::MOLECULE)
    ("HBA 1" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("G6Pase" . SPARSER::PROTEIN) ("class O" . SPARSER::PROTEIN)
    ("EGFRvIII/STAT3/PEDF" . SPARSER::COLLECTION)
    ("infiltrative GSCs" . SPARSER::PROTEIN)
    ("noninfiltrative EGFRvIII" . SPARSER::PROTEIN)
    ("PEDF and NICD" . SPARSER::COLLECTION)
    ("EGFRvIII and STAT3" . SPARSER::COLLECTION) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN)
    ("proteins, and fibroblast growth factor" . SPARSER::COLLECTION)
    ("Wingless" . SPARSER::PROTEIN)
    ("EGFRvIII and stemness" . SPARSER::COLLECTION)
    ("EGFRvIII/PEDF" . SPARSER::COLLECTION)
    ("EGFRvIII and PEDF" . SPARSER::COLLECTION)
    ("PNPLA2, LRP6, and PLXDC1" . SPARSER::COLLECTION)
    ("myelin" . SPARSER::PROTEIN)
    ("Sox2, NICD, and Hes1" . SPARSER::COLLECTION)
    ("GSCs, MD30, 1123NS and 83NS" . SPARSER::COLLECTION)
    ("EGFRvIII, STAT3, and PEDF" . SPARSER::COLLECTION)
    ("/PEDF" . SPARSER::COLLECTION) ("Nestin and GFAP" . SPARSER::COLLECTION)
    ("ester (DAPT)" . SPARSER::MOLECULE) ("phenylglycine" . SPARSER::MOLECULE)
    ("Notch-1 intracellular domain (NICD)" . SPARSER::PROTEIN)
    ("Hes1 and Hey1" . SPARSER::COLLECTION)
    ("EGFRvIII-STAT3" . SPARSER::COLLECTION)
    ("extracellular PEDF" . SPARSER::PROTEIN)
    ("EGF and bFGF" . SPARSER::COLLECTION)
    ("PEDF and Nestin and Sox2" . SPARSER::COLLECTION)
    ("EGF and basic fibroblast growth factor" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("EGFRvIII/STAT3" . SPARSER::COLLECTION)
    ("an astrocytic differentiation marker GFAP" . SPARSER::PROTEIN)
    ("a secretory protein" . SPARSER::PROTEIN)
    ("the only secretory protein" . SPARSER::PROTEIN)
    ("media (CM)" . SPARSER::PROTEIN) ("Sox2 and Nestin" . SPARSER::COLLECTION)
    ("EGFRvIII + infiltrative GSCs" . SPARSER::PROTEIN)
    ("the most well-known therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Nestin, Sox2, and CD133" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND)
    ("Nestin and Sox2" . SPARSER::COLLECTION) ("Nestin" . SPARSER::PROTEIN)
    ("EGFRvIII-STAT3-PEDF" . SPARSER::COLLECTION) ("NICD" . SPARSER::PROTEIN)
    ("GSCs" . SPARSER::PROTEIN) ("PEDF" . SPARSER::PROTEIN)
    ("CO3" . SPARSER::PROTEIN) ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("PLXDC2" . SPARSER::PROTEIN) ("PLXDC1" . SPARSER::PROTEIN)
    ("LRP6" . SPARSER::PROTEIN) ("PNPLA2" . SPARSER::PROTEIN)
    ("CBF1" . SPARSER::PROTEIN) ("t-butyl" . SPARSER::MOLECULE)
    ("Hey1" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Notch-1 intracellular domain" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bone morphogenetic protein 4" . SPARSER::PROTEIN)
    ("pigment epithelium-derived factor" . SPARSER::PROTEIN)
    ("Fas/STAT3/Fascin" . SPARSER::COLLECTION)
    ("An orally bioavailable small-molecule STAT3 inhibitor"
     . SPARSER::INHIBITOR)
    ("Fas-Fascin" . SPARSER::COLLECTION)
    ("cellular FADD-like IL-1β-converting enzyme-inhibitory protein"
     . SPARSER::PROTEIN)
    ("protein and forms" . SPARSER::COLLECTION)
    ("Fascin and Fas" . SPARSER::COLLECTION)
    ("STAT3 and Fascin" . SPARSER::COLLECTION)
    ("anti-Fas or ISO" . SPARSER::COLLECTION)
    ("STAT3/Fascin" . SPARSER::COLLECTION)
    ("Fas and Fascin" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Fascin" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("Caspase-8" . SPARSER::PROTEIN) ("D-10" . SPARSER::PROTEIN)
    ("S3I-201" . SPARSER::MOLECULE)
    ("NDST1, SATB1, and EGR1" . SPARSER::COLLECTION)
    ("CDK9, NOTCH2, and RPKS6KA3" . SPARSER::COLLECTION)
    ("human epidermal keratinocytes, and CCND2, CSDA, and EGR1"
     . SPARSER::COLLECTION)
    ("keratinocytes, and CCND2, CSDA, and EGR1" . SPARSER::COLLECTION)
    ("CCND2, CSDA, and EGR1" . SPARSER::COLLECTION)
    ("CDK6, SATB1, CCND2, CSDA, and EGR1" . SPARSER::COLLECTION)
    ("AGO2 , BCL2 , CDK6 , CDK9 , NOTCH2 , and RPS6KA3" . SPARSER::COLLECTION)
    ("PRMT or SLC7A1" . SPARSER::COLLECTION) ("PRMT" . SPARSER::PROTEIN)
    ("multiple proto-oncogenes and regulators of proliferation"
     . SPARSER::COLLECTION)
    ("RIP-seq" . SPARSER::PROTEIN-PAIR) ("the mature miRNA" . SPARSER::PROTEIN)
    ("Targets" . SPARSER::TARGET-PROTEIN) ("nocodazole" . SPARSER::DRUG)
    ("the mature duplex form" . SPARSER::FORM)
    ("CDK6 and SATB1" . SPARSER::COLLECTION)
    ("oncogenes and/or tumor suppressors" . SPARSER::COLLECTION)
    ("CDK9, NOTCH2, and RPS6KA3" . SPARSER::COLLECTION)
    ("CDS" . SPARSER::PROTEIN) ("ER-alpha" . SPARSER::PROTEIN)
    ("EGR1" . SPARSER::PROTEIN) ("NDST1" . SPARSER::PROTEIN)
    ("MAPK3" . SPARSER::PROTEIN) ("SLC7A1" . SPARSER::PROTEIN)
    ("Proto-Oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Polynucleotide Kinase" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("Argonaute-2" . SPARSER::PROTEIN) ("protein-G" . SPARSER::PROTEIN)
    ("RNA 1" . SPARSER::PROTEIN-FAMILY) ("RPS6KA3" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("PARP-1 and linker" . SPARSER::COLLECTION)
    ("other possible bile acid transporters" . SPARSER::PROTEIN)
    ("its mature glycosylated form" . SPARSER::FORM)
    ("the canalicular bile acid transporter (BSEP) as well as Ntcp and OATP-1"
     . SPARSER::COLLECTION)
    ("the canalicular bile acid transporter (BSEP)" . SPARSER::PROTEIN)
    ("transporter (BSEP)" . SPARSER::PROTEIN)
    ("the peroxisome proliferator-activated receptor α (PPARα) activator"
     . SPARSER::ACTIVATOR)
    ("Ntcp and OATP-1" . SPARSER::COLLECTION) ("BSEP" . SPARSER::PROTEIN)
    ("ciprofibrate" . SPARSER::DRUG)
    ("Ntcp and the sodium-independent bile acid transporter"
     . SPARSER::COLLECTION)
    ("the sodium-independent bile acid transporter" . SPARSER::PROTEIN)
    ("erthropoietic protoporphyria" . SPARSER::PROTEIN)
    ("fch/fch" . SPARSER::COLLECTION) ("OATP" . SPARSER::PROTEIN)
    ("protoporphyria" . SPARSER::PROTEIN) ("fch" . SPARSER::PROTEIN-FAMILY)
    ("mEH and Ntcp" . SPARSER::COLLECTION)
    ("TJP2, BAAT or H1.2" . SPARSER::COLLECTION)
    ("tight junction protein 2 (TJP2) and bile acid coenzyme A:amino acid N-acyltransferase (BAAT) [ xref ]"
     . SPARSER::COLLECTION)
    ("BAAT" . SPARSER::PROTEIN) ("acyltransferase" . SPARSER::PROTEIN)
    ("the octomeric histone" . SPARSER::PROTEIN)
    ("H1.2 and PARP-1" . SPARSER::COLLECTION) ("Part" . SPARSER::COMPONENT)
    ("cMyb" . SPARSER::PROTEIN)
    ("GATA [ xref ] and C/EBPα [ xref ]" . SPARSER::COLLECTION)
    ("mEH and hypercholanemia" . SPARSER::COLLECTION)
    ("H1.2 and ALY" . SPARSER::COLLECTION) ("ALY" . SPARSER::PROTEIN)
    ("H1.2 as well as Aly (lane 3)" . SPARSER::COLLECTION)
    ("the respective antibodies" . SPARSER::ANTIBODY)
    ("anti-H1.2 and anti-Aly" . SPARSER::COLLECTION)
    ("H1.2 and Aly" . SPARSER::COLLECTION) ("H1.2 and b" . SPARSER::COLLECTION)
    ("the shorter 29 bp oligonucleotide" . SPARSER::MOLECULE)
    ("-CTGTGCACA-3" . SPARSER::COLLECTION)
    ("the -80/+25 proximal promoter" . SPARSER::PROMOTER)
    ("CAR/RXR" . SPARSER::COLLECTION) ("GATA" . SPARSER::PROTEIN)
    ("EPHX" . SPARSER::PROTEIN) ("exon-intron" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("PARP-1 and a linker histone H1.2/Aly complex" . SPARSER::COLLECTION)
    ("Linker" . SPARSER::LINKER)
    ("a multifunctional nuclear protein" . SPARSER::PROTEIN)
    ("nucleosomes and b" . SPARSER::COLLECTION)
    ("several candidate genes [ xref ] as well as a heterozygous region that contains"
     . SPARSER::COLLECTION)
    ("a C/EBPα-NF/Y complex [ xref ] and an HNF-4α/CAR/RXR/PSF complex [ xref ]"
     . SPARSER::COLLECTION)
    ("GATA-4 [ xref ], a C/EBPα-NF/Y complex [ xref ] and an HNF-4α/CAR/RXR/PSF complex [ xref ]"
     . SPARSER::COLLECTION)
    ("salt" . SPARSER::MOLECULE) ("dietary lipids" . SPARSER::LIPID)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("FXR" . SPARSER::PROTEIN)
    ("Ntcp" . SPARSER::PROTEIN) ("taurocholate" . SPARSER::MOLECULE)
    ("a 48-kDa bifunctional protein" . SPARSER::PROTEIN)
    ("the EPHX1 proximal promoter" . SPARSER::PROMOTER)
    ("H1.2/Aly" . SPARSER::COLLECTION) ("Aly" . SPARSER::PROTEIN)
    ("a C/EBPα-NF/Y complex and an HNF-4α/CAR/RXR/PSF complex"
     . SPARSER::COLLECTION)
    ("GATA-4, a C/EBPα-NF/Y complex and an HNF-4α/CAR/RXR/PSF complex"
     . SPARSER::COLLECTION)
    ("PSF" . SPARSER::PROTEIN) ("CAR" . SPARSER::PROTEIN)
    ("a bifunctional protein" . SPARSER::PROTEIN) ("mEH" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("pirinixic acid" . SPARSER::MOLECULE)
    ("PPARα" . SPARSER::PROTEIN) ("TJP2" . SPARSER::PROTEIN)
    ("tight junction protein 2" . SPARSER::PROTEIN)
    ("HNF-3" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("GATA-6" . SPARSER::PROTEIN)
    ("NF-Y" . SPARSER::PROTEIN) ("P-40" . SPARSER::PROTEIN)
    ("DNA polymerase I" . SPARSER::PROTEIN) ("H1.2" . SPARSER::PROTEIN)
    ("EPHX1" . SPARSER::PROTEIN) ("HNF-4" . SPARSER::PROTEIN)
    ("GATA-4" . SPARSER::PROTEIN)
    ("Microsomal epoxide hydrolase" . SPARSER::PROTEIN)
    ("EGFR and Cyclin D1" . SPARSER::COLLECTION)
    ("cetuximab and gefitinib" . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies (cetuximab and panitumumab) or EGFR tyrosine kinase inhibitors (erlotinib, gefitinib and AG1478)"
     . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("erlotinib, gefitinib and AG1478" . SPARSER::COLLECTION)
    ("anti-EGFR and anti-lamin B1" . SPARSER::COLLECTION)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("Lamin B1" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("lamin B1" . SPARSER::PROTEIN)
    ("DRA000924, DRA001271 and DRA002539" . SPARSER::COLLECTION)
    ("DRA" . SPARSER::PROTEIN) ("Metazoan" . SPARSER::PROTEIN-FAMILY)
    ("CDC6 and/or Cdt1" . SPARSER::COLLECTION)
    ("Myb, c-myc and E2F" . SPARSER::COLLECTION) ("Myb" . SPARSER::PROTEIN)
    ("rDNA" . SPARSER::PROTEIN) ("GRWD1 and MCM" . SPARSER::COLLECTION)
    ("LMNB2 and MCM4" . SPARSER::COLLECTION)
    ("anti-CDC6, anti-Cdt1, anti-MCM7, anti-MCM3 and anti-GRWD1"
     . SPARSER::COLLECTION)
    ("_HA-GRWD1" . SPARSER::COLLECTION)
    ("lamin B2, MCM4 and c-myc" . SPARSER::COLLECTION)
    ("around MCM7" . SPARSER::PROTEIN) ("SNS" . SPARSER::PROTEIN)
    ("CDC6 and MCM7" . SPARSER::COLLECTION)
    ("histone-chaperone" . SPARSER::COLLECTION)
    ("H2A/H2B" . SPARSER::COLLECTION) ("HA-GRWD1" . SPARSER::COLLECTION)
    ("HA" . SPARSER::PROTEIN) ("GRWD1 and MCM7" . SPARSER::COLLECTION)
    ("insufficient MCM" . SPARSER::PROTEIN) ("hydroxyurea" . SPARSER::DRUG)
    ("the initiation proteins ( xref – xref ) and GRWD1 (Supplementary Figure S1C)"
     . SPARSER::COLLECTION)
    ("Cdt1, CDC6 or MCM5" . SPARSER::COLLECTION)
    ("CDC6, Cdt1 and MCM7" . SPARSER::COLLECTION)
    ("CDC6 or Cdt1" . SPARSER::COLLECTION)
    ("HBO1 and SNF2H" . SPARSER::COLLECTION)
    ("Cdt1 and CDC6" . SPARSER::COLLECTION) ("-GRWD1" . SPARSER::COLLECTION)
    ("-Cdt1" . SPARSER::COLLECTION)
    ("MCM7- or MCM3-specific antibodies" . SPARSER::COLLECTION)
    ("MCM7-" . SPARSER::PROTEIN)
    ("the lamin B2 ( LMNB2 ) and MCM4 genes" . SPARSER::COLLECTION)
    ("lamin B2 and MCM4" . SPARSER::COLLECTION)
    ("GST-CDC6" . SPARSER::COLLECTION)
    ("the ternary complexes" . SPARSER::BIO-COMPLEX)
    ("GRWD1, CDC6 and Cdt1" . SPARSER::COLLECTION)
    ("GST-Cdt1" . SPARSER::COLLECTION) ("Cdt1 and ORC1" . SPARSER::COLLECTION)
    ("Cul4-DDB1" . SPARSER::COLLECTION) ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Origin Recognition Complex (ORC)" . SPARSER::PROTEIN)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("histone chaperones and histone-modifying enzymes" . SPARSER::COLLECTION)
    ("chromatin-remodeling proteins, histone chaperones and histone-modifying enzymes"
     . SPARSER::COLLECTION)
    ("efficient MCM" . SPARSER::PROTEIN)
    ("CDC6, Cdt1 and MCM" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ORC" . SPARSER::BIO-COMPLEX)
    ("a novel histone-binding protein that regulates chromatin dynamics and MCM loading"
     . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("CDC6 and Cdt1" . SPARSER::COLLECTION) ("CDC6-" . SPARSER::PROTEIN)
    ("Pre-RCs" . SPARSER::BIO-COMPLEX) ("8B" . SPARSER::PROTEIN)
    ("LRIG2" . SPARSER::PROTEIN) ("PAF1" . SPARSER::PROTEIN)
    ("CDC45" . SPARSER::PROTEIN) ("pre-RCs" . SPARSER::BIO-COMPLEX)
    ("NAP1" . SPARSER::PROTEIN) ("LMNB2" . SPARSER::PROTEIN)
    ("lamin B2" . SPARSER::PROTEIN) ("matrix-bound" . SPARSER::PROTEIN)
    ("ORC1" . SPARSER::PROTEIN) ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TX-100" . SPARSER::DRUG) ("Cul4" . SPARSER::PROTEIN)
    ("Origin Recognition Complex" . SPARSER::PROTEIN)
    ("Yph1" . SPARSER::PROTEIN) ("Orc6" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN) ("Rrb1" . SPARSER::PROTEIN)
    ("assembly/disassembly" . SPARSER::PROTEIN) ("SNF2H" . SPARSER::PROTEIN)
    ("HBO1" . SPARSER::PROTEIN) ("Rad17" . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("GRWD1" . SPARSER::PROTEIN)
    ("pre-RC" . SPARSER::BIO-COMPLEX) ("/NF-κB" . SPARSER::COLLECTION)
    ("p53 or ERK" . SPARSER::COLLECTION) ("Elf1" . SPARSER::PROTEIN)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Elf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nrf1" . SPARSER::PROTEIN)
    ("CITED2 and PINK1" . SPARSER::COLLECTION)
    ("FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("ERK and PKB/Akt" . SPARSER::COLLECTION)
    ("RasGTP" . SPARSER::PROTEIN-FAMILY)
    ("Ras–Raf–MEK–ERK" . SPARSER::COLLECTION)
    ("Ras–MAPK" . SPARSER::COLLECTION) ("CDK2 and CDK6" . SPARSER::COLLECTION)
    ("CDK4/6 and CDK2" . SPARSER::COLLECTION)
    ("cyclin E–CDK2" . SPARSER::COLLECTION)
    ("cyclin D–CDK4/6" . SPARSER::COLLECTION)
    ("Cyclin D1 and Cyclin D3" . SPARSER::COLLECTION)
    ("E2F1 and cyclin E2" . SPARSER::COLLECTION) ("CTDSP2-" . SPARSER::PROTEIN)
    ("MEFs and MEFs" . SPARSER::COLLECTION)
    ("CTDSP1 and CTDSP2" . SPARSER::COLLECTION)
    ("a previously described phosphatase-dead mutant" . SPARSER::MUTANT)
    ("CTDSP1, CTDSP2 or CTDSPL" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("GFP–FOXO4" . SPARSER::COLLECTION) ("GFP–FOXO3" . SPARSER::COLLECTION)
    ("GFP–FOXO1" . SPARSER::COLLECTION)
    ("PI3K or PKB/Akt ( xref C and Supplementary Figure S1A)"
     . SPARSER::COLLECTION)
    ("A3-ER" . SPARSER::COLLECTION)
    ("exogenous and endogenous FOXO proteins" . SPARSER::PROTEIN)
    ("PI3K or PKB/Akt ( xref ; two rightmost columns)" . SPARSER::COLLECTION)
    ("FOXO3- and FOXO4-regulated genes" . SPARSER::COLLECTION)
    ("FOXO3-" . SPARSER::PROTEIN) ("DL" . SPARSER::MOLECULE)
    ("DLD" . SPARSER::PROTEIN) ("FOXO1, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("PI3K–PKB/Akt–FOXO" . SPARSER::COLLECTION)
    ("FOXO3 or FOXO4" . SPARSER::COLLECTION)
    ("CTDSP1, CTDSP2 and CTDSPL" . SPARSER::COLLECTION)
    ("CTDSPL (CTDSP-like) and CTDSPL2" . SPARSER::COLLECTION)
    ("CTDSPL" . SPARSER::PROTEIN) ("SCP2 or OS4" . SPARSER::COLLECTION)
    ("growth factor–PI3K–PKB/Akt" . SPARSER::COLLECTION)
    ("PKB/Akt" . SPARSER::COLLECTION)
    ("Growth factor–PI3K" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("p53 and MEK" . SPARSER::COLLECTION) ("cyclin–CDK" . SPARSER::COLLECTION)
    ("FOXO proteins and PI3K–PKB/Akt" . SPARSER::COLLECTION)
    ("PI3K–PKB/Akt" . SPARSER::COLLECTION) ("–PKB" . SPARSER::COLLECTION)
    ("growth factor–PI3K" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("Ras and the cyclin-dependent kinase inhibitor p21 Cip1/Waf1"
     . SPARSER::COLLECTION)
    ("p21 Cip1/Waf1" . SPARSER::COLLECTION) ("SMAD7" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("FAM134C" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("ZFYVE1" . SPARSER::PROTEIN) ("cyclin E family" . SPARSER::PROTEIN-FAMILY)
    ("S5B" . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN) ("E2F7" . SPARSER::PROTEIN)
    ("PINK1" . SPARSER::PROTEIN) ("CITED2" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN)
    ("porphobilinogen deaminase" . SPARSER::PROTEIN)
    ("hydroxymethylbilane synthase" . SPARSER::PROTEIN)
    ("B13" . SPARSER::PROTEIN) ("4OHT" . SPARSER::DRUG)
    ("K-23" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase 1" . SPARSER::PROTEIN)
    ("N-ras" . SPARSER::PROTEIN) ("M-2" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("RBP1" . SPARSER::PROTEIN) ("yeast)" . SPARSER::PROTEIN)
    ("FCP1" . SPARSER::PROTEIN) ("CTDP1" . SPARSER::PROTEIN)
    ("CTDSP1" . SPARSER::PROTEIN) ("OS4" . SPARSER::PROTEIN)
    ("SCP2" . SPARSER::PROTEIN) ("DAF-16" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("CTDSP2" . SPARSER::PROTEIN) ("NGM" . SPARSER::DRUG)
    ("both histological types" . TYPE) ("Dy" . SPARSER::MOLECULE)
    ("Network Genomic Medicine (NGM)" . SPARSER::DRUG)
    ("Medicine" . SPARSER::DRUG)
    ("EGFR , KRAS , ALK , and ROS1" . SPARSER::COLLECTION)
    ("c-Kit, EGFR, IGF1R, KDR, or ERBB2" . SPARSER::COLLECTION)
    ("the same histological type" . TYPE) ("major RTKs" . SPARSER::PROTEIN)
    ("all four major histological types" . TYPE)
    ("the LCNEC group and the SCLC group ( P  = 0.53)" . SPARSER::COLLECTION)
    ("the histological types" . TYPE)
    ("more strongly positive RTKs" . SPARSER::PROTEIN)
    ("EGFR and KDR" . SPARSER::COLLECTION)
    ("strongly positive EGFR in 17 tumors, IGF1R in two, and KDR in five"
     . SPARSER::COLLECTION)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("c-Met and ROS1" . SPARSER::COLLECTION)
    ("strongly positive EGFR" . SPARSER::PROTEIN)
    ("a strongly positive RTK" . SPARSER::PROTEIN)
    ("c-Kit and IGF1R" . SPARSER::COLLECTION)
    ("strongly positive RTK" . SPARSER::PROTEIN)
    ("strongly positive c-Kit" . SPARSER::PROTEIN)
    ("the strongly positive RTKs" . SPARSER::PROTEIN)
    ("KDR and ERBB2" . SPARSER::COLLECTION)
    ("at least one strongly or weakly positive RTK" . SPARSER::PROTEIN)
    ("c-Kit, KDR, and RET" . SPARSER::COLLECTION)
    ("EGFR and IGF1R" . SPARSER::COLLECTION)
    ("c-Kit, IGF1R, and KDR" . SPARSER::COLLECTION)
    ("ERBB2, FGFR1, c-Met, and ROS1" . SPARSER::COLLECTION)
    ("each histological type" . TYPE)
    ("various targetable well-known receptor tyrosine kinase (RTK) genes"
     . SPARSER::GENE)
    ("RB1 , SOX2 , and MYC" . SPARSER::COLLECTION)
    ("these two histological types" . TYPE)
    ("TP53 , RB1 , and EP300" . SPARSER::COLLECTION)
    ("coarse chromatin" . SPARSER::PROTEIN)
    ("a distinctive RTK" . SPARSER::PROTEIN)
    ("the major RTKs" . SPARSER::PROTEIN) ("ADC or SQCC" . SPARSER::COLLECTION)
    ("strongly positive RTKs" . SPARSER::PROTEIN)
    ("ADC and SQCC" . SPARSER::COLLECTION)
    ("c-Kit, EGFR, IGF1R, KDR, ERBB2, FGFR1, c-Met, ALK, RET, and ROS1"
     . SPARSER::COLLECTION)
    ("c-kit" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("kinase insert domain receptor" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("PTC and gene" . SPARSER::COLLECTION) ("classical PTC" . SPARSER::PROTEIN)
    ("the follicular variant" . SPARSER::VARIANT)
    ("allelic loss of heterozygosity" . SPARSER::PROTEIN)
    ("Follicular variant" . SPARSER::VARIANT) ("PTCs" . SPARSER::PROTEIN)
    ("follicular variant" . SPARSER::VARIANT) ("PTC" . SPARSER::PROTEIN)
    ("BcR–NF-κB" . SPARSER::COLLECTION) ("ibrutinib" . SPARSER::DRUG)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("IκBs and p65" . SPARSER::COLLECTION)
    ("IκBα, IκBβ and IκBε, and p65" . SPARSER::COLLECTION)
    ("IκBε, and p65" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION)
    ("IκBε and p65" . SPARSER::COLLECTION)
    ("IκBα or IκBβ" . SPARSER::COLLECTION)
    ("p65 and REL" . SPARSER::COLLECTION) ("BcR/TLR" . SPARSER::COLLECTION)
    ("Rel" . SPARSER::PROTEIN)
    ("TP53 , SF3B1 , or NOTCH1" . SPARSER::COLLECTION)
    ("concomitant poor-prognostic TP53" . SPARSER::PROTEIN)
    ("p50/p65" . SPARSER::COLLECTION) ("IκBε–p65" . SPARSER::COLLECTION)
    ("BIRC3 (noncanonical NF-κB pathway) and MYD88 (TLR signaling; xref )"
     . SPARSER::COLLECTION)
    ("receptor–CD40" . SPARSER::COLLECTION) ("BAFF" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("RELB, and c-REL (REL)" . SPARSER::COLLECTION)
    ("RELB, and c-REL" . SPARSER::COLLECTION) ("REL" . SPARSER::PROTEIN)
    ("RELB" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("BcR" . SPARSER::PROTEIN) ("IkBε" . SPARSER::PROTEIN)
    ("IkB" . SPARSER::PROTEIN) ("NFKBIE" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("S12" . SPARSER::PROTEIN)
    ("S11" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("PCI-32765" . SPARSER::DRUG) ("Gene 2" . SPARSER::PROTEIN)
    ("Ssp1" . SPARSER::PROTEIN) ("IκBζ" . SPARSER::PROTEIN)
    ("l -glutamate" . SPARSER::MOLECULE) ("small nuclear RNAs" . SPARSER::RNA)
    ("CD40 ligand" . SPARSER::PROTEIN) ("IκBβ" . SPARSER::PROTEIN)
    ("transcription factor p65" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("MYD88" . SPARSER::PROTEIN)
    ("BIRC3" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("c-REL" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("NFKB1" . SPARSER::PROTEIN)
    ("IκBε" . SPARSER::PROTEIN) ("CEA" . SPARSER::PROTEIN)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRCs" . SPARSER::PROTEIN)
    ("PTEN/PI3K-AKT" . SPARSER::COLLECTION)
    ("pro-tumoural neutrophils" . SPARSER::PROTEIN)
    ("Neutrophil" . SPARSER::PROTEIN) ("nitrotyrosine" . SPARSER::MOLECULE)
    ("N1 and N2" . SPARSER::COLLECTION) ("iNos" . SPARSER::PROTEIN)
    ("N1 or N2" . SPARSER::COLLECTION) ("HGF or TCM" . SPARSER::COLLECTION)
    ("an anti-HGF" . SPARSER::ANTIBODY) ("Macrophage" . SPARSER::PROTEIN)
    ("naive neutrophils" . SPARSER::PROTEIN)
    ("TNF-α-trap" . SPARSER::COLLECTION) ("Enbrel" . SPARSER::DRUG)
    ("trap" . SPARSER::PROTEIN) ("TNF-α and LPS" . SPARSER::COLLECTION)
    ("HGF, or hypoxia" . SPARSER::COLLECTION)
    ("MMTV-PyMT" . SPARSER::PROTEIN-PAIR) ("Mrp8" . SPARSER::PROTEIN)
    ("only Ly6G + tumour-associated neutrophils" . SPARSER::PROTEIN)
    ("Met  wt/wt (WT) or Tie2" . SPARSER::COLLECTION)
    ("wt/wt (WT)" . SPARSER::PROTEIN) ("lox/lox" . SPARSER::COLLECTION)
    ("Tie2:Cre" . SPARSER::BIO-COMPLEX) ("lox" . SPARSER::PROTEIN)
    ("Cre" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("tumour-derived TNF-α" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("Nitric oxide" . SPARSER::MOLECULE)
    ("beta-tubulin" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("inhibitor 1" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD66b" . SPARSER::PROTEIN) ("Siglec-F" . SPARSER::PROTEIN)
    ("CD115" . SPARSER::PROTEIN) ("Ly6C" . SPARSER::PROTEIN)
    ("CD49b" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("F-11" . SPARSER::PROTEIN) ("S100B" . SPARSER::PROTEIN)
    ("F10" . SPARSER::PROTEIN) ("S100A8" . SPARSER::PROTEIN)
    ("FLT-3" . SPARSER::PROTEIN) ("L-NMMA" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("TNFR2" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("INCB28060" . SPARSER::DRUG)
    ("Ly6G" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wt/wt" . SPARSER::PROTEIN) ("Tie2" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("a new SND1" . SPARSER::PROTEIN)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION) ("genes " . SPARSER::GENE)
    ("ALK , ROS1 , and RET" . SPARSER::COLLECTION)
    ("RAF and MEK" . SPARSER::COLLECTION)
    ("Vemurafenib and Trametinib" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("promoter and exons" . SPARSER::COLLECTION) ("Trametinib" . SPARSER::DRUG)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("SND1 and exons" . SPARSER::COLLECTION)
    ("KRAS, BRAF , and ERBB2" . SPARSER::COLLECTION)
    ("BRAF V600E and BRAF" . SPARSER::COLLECTION)
    ("effectors, MEK and ERK" . SPARSER::COLLECTION)
    ("both genes and a third TBXAS1 gene" . SPARSER::COLLECTION)
    ("SND1 and BRAF" . SPARSER::COLLECTION)
    ("both EGFR (S768I) and PIK3CA (E542K) genes" . SPARSER::COLLECTION)
    ("SND1 and the exons 2-3" . SPARSER::COLLECTION)
    ("ROS1, RET and BRAF" . SPARSER::COLLECTION)
    ("KIF5B-RET" . SPARSER::COLLECTION) ("EZR-ROS1" . SPARSER::COLLECTION)
    ("K- ras, BRAF , or ERBB2" . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::ONCOGENE) ("KIT , and JAK2" . SPARSER::COLLECTION)
    ("AKT1/AKT2" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("gefinitib and crizotinib" . SPARSER::COLLECTION)
    ("gefinitib" . SPARSER::DRUG) ("EML4-ALK" . SPARSER::COLLECTION)
    ("SND1-BRAF" . SPARSER::COLLECTION) ("anti-ERK" . SPARSER::PROTEIN)
    ("TBXAS1" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("SND1" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("the final exon’s" . SPARSER::PROTEIN) ("slo-1" . SPARSER::PROTEIN)
    ("The gene’s" . SPARSER::GENE)
    ("RASA2 , KLHL5 , COX7C and STAT3" . SPARSER::COLLECTION)
    ("exon skipping, mutually exclusive exons, and conventional (>18nt apart) alternate acceptor/donor splice sites"
     . SPARSER::COLLECTION)
    ("cis and trans" . SPARSER::COLLECTION)
    ("18 possible STAT3" . SPARSER::PROTEIN)
    ("STAT3/STAT1" . SPARSER::COLLECTION)
    ("kinases or phosphatases" . SPARSER::COLLECTION)
    ("linker" . SPARSER::LINKER) ("“splico-stat" . SPARSER::COLLECTION)
    ("stat" . SPARSER::PROTEIN) ("JAK/STAT" . SPARSER::COLLECTION)
    ("normal neutrophils" . SPARSER::PROTEIN)
    ("promyelocytic" . SPARSER::PROTEIN) ("melting" . SPARSER::DRUG)
    ("RASA2 (also a Ser indel) and KLHL5 (insertion of stop codon)"
     . SPARSER::COLLECTION)
    ("KLHL5 and RASA2" . SPARSER::COLLECTION) ("GTA" . SPARSER::PROTEIN)
    ("An intron’s" . SPARSER::PROTEIN) ("slo" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN)
    ("α splice variants, that is" . SPARSER::VARIANT)
    ("media, IL3, and IL3+TNFα" . SPARSER::COLLECTION)
    ("GUSB" . SPARSER::PROTEIN) ("glucuronidase" . SPARSER::PROTEIN)
    ("the four possible STAT3 splice variants" . SPARSER::VARIANT)
    ("four possible splice variants" . SPARSER::VARIANT)
    ("Dimerized STAT3" . SPARSER::PROTEIN) ("/STAT" . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("which lacks part" . SPARSER::COMPONENT)
    ("β-glucuronidase" . SPARSER::PROTEIN) ("TG -3" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("COX7C" . SPARSER::PROTEIN)
    ("RASA2" . SPARSER::PROTEIN) ("KLHL5" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("IL3" . SPARSER::PROTEIN)
    ("interleukin 5" . SPARSER::PROTEIN) ("IL5" . SPARSER::PROTEIN)
    ("immediate early" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stattic" . SPARSER::DRUG) ("RPPA" . SPARSER::PROTEIN)
    ("CG" . SPARSER::PROTEIN) ("PTPRT, and LOF" . SPARSER::COLLECTION)
    ("PTPRs" . SPARSER::PROTEIN) ("PTPR" . SPARSER::PROTEIN)
    ("The largest class" . CLASS) ("PTP" . SPARSER::PROTEIN)
    ("a transcription factor and potent oncoprotein" . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::PROTEIN) ("MSP" . SPARSER::PROTEIN)
    ("PTPRT" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("LY2784544" . SPARSER::DRUG) ("JSI-124" . SPARSER::DRUG)
    ("either MT1-MMP and/or Dyn2" . SPARSER::COLLECTION)
    ("extracellular MMP-2" . SPARSER::PROTEIN)
    ("excess soluble protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("the kinase Src or the GTPase Cdc42" . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("MMP-2/MMP-9" . SPARSER::COLLECTION)
    ("type 1-matrix metalloproteinase" . SPARSER::COLLECTION)
    ("the invadopodial master regulators Src and Cdc42" . SPARSER::COLLECTION)
    ("Src and Cdc42" . SPARSER::COLLECTION)
    ("the fluorescent gelatin substrate" . SPARSER::SUBSTRATE)
    ("PP2 or DMSO" . SPARSER::COLLECTION) ("DKO" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN)
    ("the parental MEFs (DKO)" . SPARSER::PROTEIN)
    ("Dyn1 and Dyn2" . SPARSER::COLLECTION)
    ("The ubiquitous form" . SPARSER::FORM) ("dynamin" . SPARSER::PROTEIN)
    ("actin or cortactin" . SPARSER::COLLECTION)
    ("the invadopodial markers actin and cortactin" . SPARSER::COLLECTION)
    ("the fluorescent substrate" . SPARSER::SUBSTRATE)
    ("actin and cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("PDAC" . SPARSER::MOLECULE)
    ("Dynamin" . SPARSER::PROTEIN) ("palladin" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("Src kinase, Cdc42, or Dyn2" . SPARSER::COLLECTION)
    ("Myc-tagged" . SPARSER::PROTEIN) ("MMP- 9" . SPARSER::PROTEIN)
    ("Dynamin 1" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("SB-3CT" . SPARSER::DRUG) ("4-hydroxy-tamoxifen" . SPARSER::DRUG)
    ("Dyn1" . SPARSER::PROTEIN) ("BB-94" . SPARSER::DRUG)
    ("Dynamin 2" . SPARSER::PROTEIN) ("Dyn2" . SPARSER::PROTEIN)
    ("pro-apoptotic Bcl-2 proteins" . SPARSER::PROTEIN)
    ("p53 and the pro-apoptotic gene promoters" . SPARSER::COLLECTION)
    ("Bcl-2-p53" . SPARSER::COLLECTION)
    ("mitochondrial Bcl-2" . SPARSER::PROTEIN)
    ("EGFR, SOS1 or Bcl-2" . SPARSER::COLLECTION)
    ("EGF, EGFR and SOS1" . SPARSER::COLLECTION)
    ("HRAS, PI3K or AKT" . SPARSER::COLLECTION) ("Cisplatin" . SPARSER::DRUG)
    ("SOS1/HRAS/PI3K/AKT" . SPARSER::COLLECTION)
    ("cytometry and MTT" . SPARSER::COLLECTION)
    ("ne-EGFR" . SPARSER::COLLECTION) ("EGF and EGFR" . SPARSER::COLLECTION)
    ("EGF or EGFR" . SPARSER::COLLECTION)
    ("SOS1 and Ect2" . SPARSER::COLLECTION)
    ("GAP and GEF" . SPARSER::COLLECTION)
    ("SOS1, RasGRP3, Ect2, and Collybistin" . SPARSER::COLLECTION)
    ("Ect2" . SPARSER::PROTEIN) ("Collybistin" . SPARSER::PROTEIN)
    ("GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs)"
     . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT-ASPP2" . SPARSER::COLLECTION) ("ASPP2-Bcl-2" . SPARSER::COLLECTION)
    ("p53-Bcl-2" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("ASPP2 and Bcl-2" . SPARSER::COLLECTION)
    ("p53 and the PUMA promoter" . SPARSER::COLLECTION)
    ("AKT or Bcl-2" . SPARSER::COLLECTION)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("ASPP2 and p53" . SPARSER::COLLECTION)
    ("HRAS, PI3K, and AKT" . SPARSER::COLLECTION)
    ("p-PI3K" . SPARSER::COLLECTION)
    ("PUMA, BAX and caspase 9" . SPARSER::COLLECTION)
    ("DR5 , APAF1 , BAX , Caspase 9 , El24 , TRAIL , and PUMA"
     . SPARSER::COLLECTION)
    ("PHCs" . SPARSER::PROTEIN)
    ("a haploinsufficient tumor suppressor" . SPARSER::SUPPRESSOR)
    ("Bcl-2 and p53" . SPARSER::COLLECTION) ("ankyrin" . SPARSER::PROTEIN)
    ("completely cure HCC" . SPARSER::PROTEIN)
    ("EGFR and SOS1" . SPARSER::COLLECTION) ("ASPP2-p53" . SPARSER::COLLECTION)
    ("which releases p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRAS/PI3K/AKT" . SPARSER::COLLECTION)
    ("the pro-apoptotic gene promoters" . SPARSER::PROMOTER)
    ("pro-apoptotic gene promoters" . SPARSER::PROMOTER)
    ("mitochondrial)" . SPARSER::PROTEIN) ("RasGRP3" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN) ("Caspase 9" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("Son of Sevenless" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("C/EBP Homologous Protein" . SPARSER::PROTEIN)
    ("Apoptosis-stimulating protein of p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASPP2" . SPARSER::PROTEIN) ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("LGD" . SPARSER::PROTEIN) ("c-Myc and Ccnd1" . SPARSER::COLLECTION)
    ("-KO" . SPARSER::COLLECTION) ("KO" . SPARSER::PROTEIN)
    ("Tff1-KO" . SPARSER::COLLECTION) ("cagA" . SPARSER::PROTEIN)
    ("β-catenin, c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("CCND1 (Figure xref , p < 0.001 for both J166 and 7.13 strains) and c-MYC (Figure xref , p < 0.01 and p < 0.001 for J166 and 7.13 strains, respectively)"
     . SPARSER::COLLECTION)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("cytotoxin" . SPARSER::PROTEIN) ("CagA" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN)
    ("its target genes and suppression of cell proliferation [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("c-MYC and cyclin D1" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN)
    ("a gastric tumor suppressor gene" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("β-catenin and Ki-67" . SPARSER::COLLECTION)
    ("Ccnd1 and c-Myc" . SPARSER::COLLECTION) ("Ccnd1" . SPARSER::PROTEIN)
    ("Tff1" . SPARSER::PROTEIN) ("c-MYC, and CCND1" . SPARSER::COLLECTION)
    ("p-β-catenin" . SPARSER::COLLECTION)
    ("CCND1 and c-MYC" . SPARSER::COLLECTION)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY) ("TFF3" . SPARSER::PROTEIN)
    ("H3K4 or H3K27" . SPARSER::COLLECTION) ("-GGAGGG-3" . SPARSER::COLLECTION)
    ("-CCCTCC-3" . SPARSER::COLLECTION)
    ("possible target genes" . SPARSER::GENE)
    ("a functional SET domain" . SPARSER::PROTEIN)
    ("slightly higher H3K27me3" . SPARSER::PROTEIN)
    ("repressive complexes" . SPARSER::BIO-COMPLEX)
    ("enzymes or histone" . SPARSER::COLLECTION)
    ("more efficient biomarkers" . SPARSER::MOLECULE)
    ("clinically significant and insignificant PCa" . SPARSER::PROTEIN)
    ("c-Met, MMP-9 and Nkx2.8" . SPARSER::COLLECTION)
    ("AR, c-Met, MMP-9 and Nkx2.8" . SPARSER::COLLECTION)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION)
    ("SMYD3 and Cyclin D2" . SPARSER::COLLECTION)
    ("sh-SMYD3" . SPARSER::COLLECTION)
    ("methyltransferase activity, and CCND2" . SPARSER::COLLECTION)
    ("respective histone" . SPARSER::PROTEIN)
    ("Nkx2.8, WNT10B, RIZ1, c-Met, 15-LOX-1, MMP9 and AR"
     . SPARSER::COLLECTION)
    ("HMTs or HDMs" . SPARSER::COLLECTION) ("HDMs" . SPARSER::PROTEIN)
    ("HMTs" . SPARSER::PROTEIN) ("lysine and arginine" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("methyltransferases and histone" . SPARSER::COLLECTION)
    ("clinically significant and indolent PCa" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN) ("15-LOX-1" . SPARSER::PROTEIN)
    ("RIZ1" . SPARSER::PROTEIN) ("WNT10B" . SPARSER::PROTEIN)
    ("Nkx2.8" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 1" . SPARSER::PROTEIN)
    ("SET and MYND domain-containing protein 3" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("SMYD3" . SPARSER::PROTEIN) ("MET and EGFR" . SPARSER::COLLECTION)
    ("EGFR-ERBB3-PI3K" . SPARSER::COLLECTION)
    ("MET and Src" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("RTKs and small molecules" . SPARSER::COLLECTION)
    ("both monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Gefitinib and Erlotinib" . SPARSER::COLLECTION)
    ("using antibodies or inhibitory small molecules (TKI)"
     . SPARSER::COLLECTION)
    ("molecules (TKI)" . SPARSER::MOLECULE) ("p-PTEN" . SPARSER::COLLECTION)
    ("both AKT (p-AKT Ser-473) and mTOR" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION)
    ("male patients (n = 20) only 55% expressed ROR1" . SPARSER::PROTEIN)
    ("XLA" . SPARSER::PROTEIN) ("Erlotinib" . SPARSER::DRUG)
    ("PC-9" . SPARSER::PROTEIN) ("ROR" . SPARSER::PROTEIN-FAMILY)
    ("an embryonic glycoprotein" . SPARSER::PROTEIN)
    ("ROS, c-MET, FGFR, mTOR, IGFR and RET" . SPARSER::COLLECTION)
    ("RET" . SPARSER::PROTEIN) ("IGFR" . SPARSER::PROTEIN)
    ("HER1 or epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("ROR2" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("ROR1" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src/FAK/cdc42" . SPARSER::COLLECTION)
    ("valine and cysteine" . SPARSER::COLLECTION)
    ("sorafenib, sunitinib, and linifanib" . SPARSER::COLLECTION)
    ("linifanib" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("Src, FAK, and cdc42" . SPARSER::COLLECTION)
    ("triterpenoid" . SPARSER::MOLECULE) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("VEGFR2, Src, and FAK" . SPARSER::COLLECTION)
    ("Flt-3" . SPARSER::COLLECTION) ("VEGFR2 and FAK" . SPARSER::COLLECTION)
    ("phospho-FAK (Tyr397) and F-actin" . SPARSER::COLLECTION)
    ("polymer" . SPARSER::MOLECULE) ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("Src/FAK" . SPARSER::COLLECTION)
    ("down three key VEGFRs" . SPARSER::PROTEIN) ("VEGFRs" . SPARSER::PROTEIN)
    ("Src, FAK, and Rho-GTPase" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("VEGF/VEGFR" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("aggressive HCC" . SPARSER::PROTEIN)
    ("VEGFR2/Src/FAK/cdc42" . SPARSER::COLLECTION)
    ("Ursolic acid" . SPARSER::MOLECULE) ("PDGFRβ" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("Kinase activity" . SPARSER::PROTEIN) ("VEGFR1" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("ursolic acid" . SPARSER::MOLECULE) ("VEGFR2" . SPARSER::PROTEIN)
    ("Foretinib" . SPARSER::DRUG) ("foretinib" . SPARSER::DRUG)
    ("ROS1 and Anaplastic Lymphoma Kinase" . SPARSER::COLLECTION)
    ("ALK/MET" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("ALK" . SPARSER::PROTEIN) ("DDR1 and ROS1" . SPARSER::COLLECTION)
    ("p-AKT1" . SPARSER::COLLECTION)
    ("the downstream EGFR effectors mainly AKT1 and p42 MAPK proteins"
     . SPARSER::PROTEIN)
    ("AKT1 and p42 MAPK" . SPARSER::COLLECTION)
    ("the ROS1 inhibitor and ROS1 inhibitor" . SPARSER::COLLECTION)
    ("ROS1 inhibitor or a combination" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("specifically target ROS1 protein" . SPARSER::PROTEIN)
    ("ROS1 and its ligand VAV3 (Figure xref )" . SPARSER::COLLECTION)
    ("ROS1, and TPM3" . SPARSER::COLLECTION) ("EZR" . SPARSER::PROTEIN)
    ("FIG–ROS" . SPARSER::COLLECTION)
    ("Fused in Glioblastoma–ROS1" . SPARSER::COLLECTION)
    ("FIG" . SPARSER::PROTEIN)
    ("AKT1, AKT2, AKT3, PDGFB, LAMTOR1, LAMTOR2, LAMTOR3 and FIGF"
     . SPARSER::COLLECTION)
    ("ROS1, DDR1 and PRGFRA" . SPARSER::COLLECTION) ("FIGF" . SPARSER::PROTEIN)
    ("PDGFB" . SPARSER::PROTEIN) ("genes and pathways" . SPARSER::COLLECTION)
    ("U87-EGFR" . SPARSER::COLLECTION)
    ("discoidin domain receptor tyrosine kinase 1 (DDR1) or the platelet-derived growth factor receptor"
     . SPARSER::COLLECTION)
    ("the orphan RTK c-ros oncogene 1 (ROS1), discoidin domain receptor tyrosine kinase 1 (DDR1) or the platelet-derived growth factor receptor"
     . SPARSER::COLLECTION)
    ("gefitinib and resistant clones" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("Cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("antibody-" . SPARSER::PROTEIN)
    ("the monoclonal antibodies (mAbs) cetuximab (a chimeric mouse-human IgG1 antibody) and panitumumab (a fully humanized IgG2 antibody)"
     . SPARSER::COLLECTION)
    ("the monoclonal antibodies (mAbs) cetuximab" . SPARSER::DRUG)
    ("secondary EGFR point mutations" . SPARSER::PROTEIN)
    ("RTKs" . SPARSER::PROTEIN)
    ("ERBB2, ERBB3, and ERBB4" . SPARSER::COLLECTION)
    ("HER" . SPARSER::PROTEIN) ("ERBB1 or HER1" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG)
    ("gefitinib and ROS1" . SPARSER::COLLECTION)
    ("ROS1 and DDR1" . SPARSER::COLLECTION)
    ("mainly tyrosine kinase receptors" . SPARSER::RECEPTOR)
    ("ROS1, DDR1 and PDGFRA" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("alpha tubulin" . SPARSER::PROTEIN) ("Vav3" . SPARSER::PROTEIN)
    ("per 3" . SPARSER::PROTEIN) ("GSK1363089" . SPARSER::DRUG)
    ("Anaplastic Lymphoma Kinase" . SPARSER::PROTEIN)
    ("ROS 1" . SPARSER::PROTEIN) ("p-p42" . SPARSER::PROTEIN)
    ("p42 MAPK" . SPARSER::PROTEIN) ("Rho GTPase" . SPARSER::PROTEIN)
    ("RC1" . SPARSER::PROTEIN) ("TPM3" . SPARSER::PROTEIN)
    ("SDC4" . SPARSER::PROTEIN) ("LRIG3" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("SLC34A2" . SPARSER::PROTEIN)
    ("Fused in Glioblastoma" . SPARSER::PROTEIN) ("LAMTOR3" . SPARSER::PROTEIN)
    ("LAMTOR2" . SPARSER::PROTEIN) ("LAMTOR1" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN)
    ("discoidin domain receptor tyrosine kinase 1" . SPARSER::PROTEIN)
    ("c-ros oncogene 1" . SPARSER::PROTEIN) ("IgG2" . SPARSER::BIO-COMPLEX)
    ("ERBB4" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("ERBB1" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("DDR1" . SPARSER::PROTEIN) ("ROS1" . SPARSER::PROTEIN)
    ("CASP" . SPARSER::PROTEIN)
    ("prostanoids and eicosanoids" . SPARSER::COLLECTION)
    ("eicosanoids" . SPARSER::MOLECULE) ("prostanoids" . SPARSER::MOLECULE)
    ("COX" . SPARSER::PROTEIN) ("cyclooxygenase" . SPARSER::PROTEIN)
    ("alcohol" . SPARSER::DRUG) ("C-reactive protein" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("COX - 2" . SPARSER::PROTEIN)
    ("CASP10" . SPARSER::PROTEIN) ("Cyclooxygenase 2" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN)
    ("antioxidant, and pro-angiogenic" . SPARSER::COLLECTION)
    ("oxygen and nutrient" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("statins" . SPARSER::DRUG)
    ("NRF2 and its target genes" . SPARSER::COLLECTION)
    ("antioxidant genes and other cytoprotective phase II"
     . SPARSER::COLLECTION)
    ("GPx-1 and heme oxygenase 1" . SPARSER::COLLECTION)
    ("xenobiotics and antioxidants" . SPARSER::COLLECTION)
    ("enoyl" . SPARSER::PROTEIN) ("cellular antioxidants" . SPARSER::DRUG)
    ("thioredoxins" . SPARSER::PROTEIN) ("Thioredoxin" . SPARSER::PROTEIN)
    ("Thioredoxins and Thioredoxin Reductases" . SPARSER::COLLECTION)
    ("Thioredoxins" . SPARSER::PROTEIN)
    ("GPx-1 and superoxide" . SPARSER::COLLECTION)
    ("Antioxidant" . SPARSER::PROTEIN) ("Sulfane" . SPARSER::MOLECULE)
    ("Skeletal Muscle" . SPARSER::PROTEIN)
    ("enzymes, and NRF2" . SPARSER::COLLECTION) ("GPx" . SPARSER::PROTEIN)
    ("peroxynitrite" . SPARSER::MOLECULE) ("oxidant" . SPARSER::PROTEIN)
    ("hemin" . SPARSER::MOLECULE) ("homocysteine" . SPARSER::MOLECULE)
    ("methionine" . SPARSER::AMINO-ACID)
    ("at least 3 endogenous enzymes" . SPARSER::ENZYME)
    ("MST" . SPARSER::PROTEIN) ("ischemia (CLI)" . SPARSER::PROTEIN)
    ("malondialdehyde" . SPARSER::MOLECULE) ("Biomarkers" . SPARSER::MOLECULE)
    ("catalase, and glutathione peroxidase" . SPARSER::COLLECTION)
    ("catalase" . SPARSER::PROTEIN) ("sulfane" . SPARSER::MOLECULE)
    ("CLI" . SPARSER::PROTEIN)
    ("enzymes, and nuclear factor-erythroid 2-related factor 2"
     . SPARSER::COLLECTION)
    ("ion channels and signaling proteins" . SPARSER::COLLECTION)
    ("mercaptopyruvate" . SPARSER::MOLECULE)
    ("cystathionine" . SPARSER::MOLECULE) ("lyase" . SPARSER::PROTEIN)
    ("Cystathionine" . SPARSER::MOLECULE) ("P20" . SPARSER::PROTEIN)
    ("U24" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("thioredoxin reductases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Thioredoxin reductases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thioredoxin 1" . SPARSER::PROTEIN)
    ("Thioredoxin Reductases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOD1" . SPARSER::PROTEIN) ("GPx-1" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("TXN1" . SPARSER::PROTEIN)
    ("thioredoxin reductase 1" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("Hydrogen sulfide" . SPARSER::MOLECULE)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("hydrogen sulfide" . SPARSER::MOLECULE)
    ("a heterotetrameric complex" . SPARSER::BIO-COMPLEX)
    ("the predominant isoforms" . SPARSER::ISOFORM)
    ("strong GABPA" . SPARSER::PROTEIN) ("spiked" . SPARSER::PROTEIN)
    ("ELF1 or ETS1" . SPARSER::COLLECTION) ("leucine" . SPARSER::AMINO-ACID)
    ("GABPB1 or GABPB2" . SPARSER::COLLECTION)
    ("a fully functional transcription factor" . SPARSER::PROTEIN)
    ("heterodimer (GABP)" . SPARSER::HETERODIMER) ("GABPB" . SPARSER::PROTEIN)
    ("micrococcal nuclease-digested H3K4" . SPARSER::PROTEIN)
    ("Nucleosome" . SPARSER::PROTEIN) ("Pol" . SPARSER::PROTEIN)
    ("ETS1 and ETV4" . SPARSER::COLLECTION)
    ("ETS1 or ETV4" . SPARSER::COLLECTION)
    ("ETS1 and 1.8×10" . SPARSER::COLLECTION)
    ("GABPA, ELF1, ETS1, and ETV4" . SPARSER::COLLECTION)
    ("ETS1 and ETV3" . SPARSER::COLLECTION)
    ("ETS1, ETV3, ETV4, or GABPA" . SPARSER::COLLECTION)
    ("ETS1 and ELF1" . SPARSER::COLLECTION)
    ("ETS1, ETV3, and GABPA" . SPARSER::COLLECTION)
    ("GABPA" . SPARSER::PROTEIN) ("thymine" . SPARSER::MOLECULE)
    ("adenine" . SPARSER::NUCLEOBASE) ("ETS" . SPARSER::PROTEIN)
    ("the multimeric GABP transcription factor" . SPARSER::PROTEIN)
    ("GABP" . SPARSER::PROTEIN) ("GABPB2" . SPARSER::PROTEIN)
    ("GABPB1" . SPARSER::PROTEIN) ("ETS family" . SPARSER::PROTEIN)
    ("ETV4" . SPARSER::PROTEIN) ("ETV3" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("ELF1" . SPARSER::PROTEIN)
    ("histological type" . TYPE) ("exogenous Snail" . SPARSER::PROTEIN)
    ("protein and gene" . SPARSER::COLLECTION) ("OSE" . SPARSER::PROTEIN)
    ("lα" . SPARSER::PROTEIN) ("HIF-1α and E-Cadherin" . SPARSER::COLLECTION)
    ("the histological type" . TYPE)
    ("the human clear cell ovarian cancer cell line ES-2 and the undifferentiated human ovarian cancer cell line TYK"
     . SPARSER::COLLECTION)
    ("the human clear cell ovarian cancer cell line ES-2" . SPARSER::PROTEIN)
    ("HIF-lα" . SPARSER::COLLECTION) ("gene and ChIP" . SPARSER::COLLECTION)
    ("HIF-1α, Snail and E-cadherin" . SPARSER::COLLECTION)
    ("HIF-1α and Snail" . SPARSER::COLLECTION) ("AO" . SPARSER::PROTEIN)
    ("ES-2" . SPARSER::PROTEIN) ("Snail and E-cadherin" . SPARSER::COLLECTION)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("HGF and c-Met" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and follicle-stimulating hormone (FSH)"
     . SPARSER::COLLECTION)
    ("hormone (FSH)" . SPARSER::MOLECULE)
    ("CDK5 kinase regulatory subunit-associated protein 3" . SPARSER::PROTEIN)
    ("FSH" . SPARSER::DRUG) ("si-LIMK1" . SPARSER::COLLECTION)
    ("PAK4-LIMK1-cofilin" . SPARSER::COLLECTION)
    ("LIMK1/cofilin" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("c-Src/mitogen-activated protein kinase kinase 1" . SPARSER::COLLECTION)
    ("PAK4 and p-LIMK1 in 20 human NSCLC tissues using western blotting"
     . SPARSER::COLLECTION)
    ("p-LIMK1" . SPARSER::COLLECTION)
    ("PAK4 (WT) or PAK4 (S445N)" . SPARSER::COLLECTION)
    ("kinase-defective PAK4" . SPARSER::PROTEIN)
    ("purified wild-type PAK4 (WT) and LIMK1 protein" . SPARSER::COLLECTION)
    ("PAK4 (WT)" . SPARSER::PROTEIN)
    ("neither PAK4 nor LIMK1" . SPARSER::COLLECTION)
    ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("PAK4 and LIMK1" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("PAK4 (green) and LIMK1 (red)" . SPARSER::COLLECTION)
    ("LIMK1 and cofilin" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LIMK and its downstream cofillin" . SPARSER::COLLECTION)
    ("LIMK" . SPARSER::PROTEIN) ("si-PAK4" . SPARSER::COLLECTION)
    ("significantly higher PAK4" . SPARSER::PROTEIN) ("HBE" . SPARSER::PROTEIN)
    ("group I (PAK1, 2, 3) and group II (PAK4, 5, 6) PAKs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("new predictive prognostic biomarkers" . SPARSER::MOLECULE)
    ("CDK5RAP3" . SPARSER::PROTEIN) ("CDK5" . SPARSER::PROTEIN)
    ("SCG10" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("LIMK1" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("P21-activated kinase 4" . SPARSER::PROTEIN)
    ("TIAM1, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("a pivotal component" . SPARSER::COMPONENT) ("CTTN" . SPARSER::PROTEIN)
    ("tumor-suppressor or oncogene in different human malignancies"
     . SPARSER::COLLECTION)
    ("pediatric acute leukemia" . SPARSER::PROTEIN)
    ("pcDNA-TIAM1" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("PcDNA-TIAM1" . SPARSER::COLLECTION) ("PcDNA" . SPARSER::PROTEIN)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("approximately 450 miRNAs" . SPARSER::PROTEIN)
    ("MiRNA" . SPARSER::PROTEIN) ("programmed cell death 4" . SPARSER::PROTEIN)
    ("RGS17" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("AG490 or stattic" . SPARSER::COLLECTION) ("propofol" . SPARSER::DRUG)
    ("stattic" . SPARSER::DRUG) ("PI3K and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and JAK2" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("STAT3 and its upstream kinases JAK2" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE) ("N-20 or C-20" . SPARSER::COLLECTION)
    ("amino terminal GRP78 antibodies" . SPARSER::ANTIBODY)
    ("N-20 and C-20" . SPARSER::COLLECTION)
    ("STAT3/shRNA" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("anti-GRP78 antibody or normal goat IgG" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("4 μg/ml anti-GRP78 antibody or normal goat IgG (Santa Cruz)"
     . SPARSER::COLLECTION)
    ("goat" . SPARSER::PROTEIN) ("tunicamycin" . SPARSER::MOLECULE)
    ("PERK and IRE1α" . SPARSER::COLLECTION) ("PERK" . SPARSER::PROTEIN)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("hypoxia, glucose or nutrient" . SPARSER::COLLECTION)
    ("a major ER chaperone and a master regulator" . SPARSER::COLLECTION)
    ("a multi-functional protein" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("mTORC2" . SPARSER::PROTEIN) ("α2-macroglobulin" . SPARSER::PROTEIN)
    ("GRP78 protein" . SPARSER::PROTEIN) ("microcystin-LR" . SPARSER::MOLECULE)
    ("Mitomycin C" . SPARSER::DRUG)
    ("terminal deoxyribonucleotidyl transferase" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("NSC74859" . SPARSER::DRUG) ("IRE1α" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("Glucose regulated protein" . SPARSER::PROTEIN)
    ("glucose regulated protein" . SPARSER::PROTEIN)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("Restin and Necdin" . SPARSER::COLLECTION)
    ("EMT-MET" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("other transcriptional co-factors" . SPARSER::MOLECULE)
    ("mir-200c and mir-141 [ xref ]" . SPARSER::COLLECTION)
    ("mediating Restin’s" . SPARSER::PROTEIN)
    ("Restin and p53" . SPARSER::COLLECTION)
    ("p53, p73 and p63" . SPARSER::COLLECTION)
    ("MAGE group II proteins" . SPARSER::PROTEIN)
    ("p53 and Restin" . SPARSER::COLLECTION)
    ("Flag-Restin" . SPARSER::COLLECTION)
    ("p73 and Restin" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION)
    ("P3 and P4" . SPARSER::COLLECTION)
    ("mir-200a and mir-200b expression by 2.71- and 2.07-fold"
     . SPARSER::COLLECTION)
    ("E-cadherin, Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("ZEB1, ZEB2, Slug and Snail" . SPARSER::COLLECTION)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("Fibronectin" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("neurotrophin" . SPARSER::PROTEIN)
    ("HY" . SPARSER::MOLECULE)
    ("Restin, Necdin and Mage-D1" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN)
    ("Necdin and Mage-D1" . SPARSER::COLLECTION) ("Mage" . SPARSER::PROTEIN)
    ("Necdin" . SPARSER::PROTEIN) ("MAGEs" . SPARSER::PROTEIN-FAMILY)
    ("at least 60 closely related proteins" . SPARSER::PROTEIN)
    ("melanoma-associated antigen (MAGE)" . SPARSER::PROTEIN)
    ("CTA" . SPARSER::PROTEIN) ("MAGE Group II proteins" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE) ("retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("ATRA" . SPARSER::DRUG) ("MAGE" . SPARSER::PROTEIN-FAMILY)
    ("Restin" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mir-200c" . SPARSER::MOLECULE)
    ("ZO-1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p75NTR" . SPARSER::PROTEIN) ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("group I" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("MAGE family" . SPARSER::PROTEIN-FAMILY)
    ("melanoma-associated antigen" . SPARSER::PROTEIN)
    ("mir-200a" . SPARSER::MOLECULE)
    ("TGF-β and inflammatory cytokines" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("whose promoter" . SPARSER::PROMOTER) ("p-Smad3" . SPARSER::COLLECTION)
    ("NF-κB/miR-148a/TGF-β/Smad" . SPARSER::COLLECTION)
    ("Smad2/3" . SPARSER::PROTEIN) ("p-Smad2/3" . SPARSER::PROTEIN-PAIR)
    ("SRE" . SPARSER::PROTEIN-FAMILY) ("SREs" . SPARSER::PROTEIN-FAMILY)
    ("QKI or SKP1" . SPARSER::COLLECTION)
    ("QKI and SKP1" . SPARSER::COLLECTION) ("spike" . SPARSER::PROTEIN)
    ("CAM" . SPARSER::PROTEIN) ("LN18 and U138MG" . SPARSER::COLLECTION)
    ("LN18" . SPARSER::PROTEIN) ("MiR-148a" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("miR-148a" . SPARSER::PROTEIN)
    ("miR-148a-mut" . SPARSER::PROTEIN-PAIR) ("mut" . SPARSER::PROTEIN)
    ("SKP1-3" . SPARSER::COLLECTION) ("U87 and U138MG" . SPARSER::COLLECTION)
    ("the theoretical target gene" . SPARSER::GENE)
    ("the key R-Smads" . SPARSER::PROTEIN) ("ROC1-SCF" . SPARSER::COLLECTION)
    ("SCF" . SPARSER::PROTEIN) ("ROC1" . SPARSER::PROTEIN)
    ("GFP–γ-tubulin" . SPARSER::COLLECTION) ("QKI-3" . SPARSER::COLLECTION)
    ("which targets TGF-β receptor" . SPARSER::RECEPTOR)
    ("KH" . SPARSER::MOLECULE) ("hnRNPK" . SPARSER::PROTEIN)
    ("STAR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and TGF-β" . SPARSER::COLLECTION)
    ("NF-κB and TGF-β pathway" . SPARSER::COLLECTION)
    ("a multifunctional polypeptide" . SPARSER::PEPTIDE)
    ("S-phase kinase–associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β/Smad" . SPARSER::COLLECTION) ("QKI" . SPARSER::PROTEIN)
    ("Inflammatory cytokines and transforming growth factor-β"
     . SPARSER::COLLECTION)
    ("cytokines and transforming growth factor-β" . SPARSER::COLLECTION)
    ("anti-VEGF" . SPARSER::DRUG) ("Ago1" . SPARSER::PROTEIN)
    ("as 2 " . SPARSER::PROTEIN) ("single-stranded RNA" . SPARSER::RNA)
    ("NC2" . SPARSER::PROTEIN) ("NC1" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("cullin 1" . SPARSER::PROTEIN) ("Fbw1a" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("R-Smads" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("TGFβR" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("MIG6" . SPARSER::PROTEIN)
    ("mitogen-inducible gene 6" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("exonic and intronic miRNAs" . SPARSER::PROTEIN)
    ("growth-associated genes" . SPARSER::GENE)
    ("sorting nexin 1 (SNX1) and sphingolipid phosphatase (SGPP1)"
     . SPARSER::COLLECTION)
    ("sphingolipid" . SPARSER::MOLECULE) ("nexin" . SPARSER::PROTEIN)
    ("MiR-" . SPARSER::PROTEIN) ("HER2 and Ras" . SPARSER::COLLECTION)
    ("cyclin D1 and a cell cycle inhibitor" . SPARSER::COLLECTION)
    ("cyclin D1-" . SPARSER::PROTEIN) ("TSP1 and ROCKII" . SPARSER::COLLECTION)
    ("thrombospondin 1 (TSP1) and Rho-activated kinase II (ROCKII)"
     . SPARSER::COLLECTION)
    ("ROCKII" . SPARSER::PROTEIN) ("ADCs" . SPARSER::PROTEIN)
    ("CCND1-HA" . SPARSER::PROTEIN-PAIR)
    ("both the mature and primary forms" . SPARSER::FORM)
    ("metastasis-associated genes" . SPARSER::GENE)
    ("Cyclin D1 and miR-95-3p" . SPARSER::COLLECTION)
    ("AmpF/STR" . SPARSER::COLLECTION) ("STR" . SPARSER::PROTEIN)
    ("ADC" . SPARSER::PROTEIN) ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("Sp4" . SPARSER::PROTEIN) ("set 1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("CUGBP2" . SPARSER::PROTEIN)
    ("CUG triplet repeat RNA-binding protein 2" . SPARSER::PROTEIN)
    ("SGPP1" . SPARSER::PROTEIN) ("SNX1" . SPARSER::PROTEIN)
    ("TSP1" . SPARSER::PROTEIN) ("thrombospondin 1" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("Ago2" . SPARSER::PROTEIN)
    ("Argonaute 2" . SPARSER::PROTEIN)
    ("actin binding LIM protein family member 2" . SPARSER::PROTEIN)
    ("ABLIM2" . SPARSER::PROTEIN) ("Flag-TEAD1–3" . SPARSER::COLLECTION)
    ("TEAD4/KLF5" . SPARSER::COLLECTION)
    ("p27 (Figure xref ) and TEAD4" . SPARSER::COLLECTION)
    ("TEAD, TEAD1 and TEAD4" . SPARSER::COLLECTION)
    ("KLF5 and TEAD4" . SPARSER::COLLECTION)
    ("-CATTCCT-3" . SPARSER::COLLECTION) ("Fluor" . SPARSER::MOLECULE)
    ("EdU" . SPARSER::DRUG) ("KLF5 or TEAD4" . SPARSER::COLLECTION)
    ("exogenous KLF5" . SPARSER::PROTEIN)
    ("TEAD2 and TEAD3" . SPARSER::COLLECTION)
    ("TEAD1 and TEAD4" . SPARSER::COLLECTION)
    ("KLF5 and TEADs" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN) ("TEAD/TEF" . SPARSER::COLLECTION)
    ("TEF" . SPARSER::PROTEIN)
    ("CTGF [ xref ] and Cyr61 [ xref ]" . SPARSER::COLLECTION)
    ("KLF5 and FGF-BP1" . SPARSER::COLLECTION)
    ("TAZ, KLF5 and TEADs" . SPARSER::COLLECTION) ("Hpo" . SPARSER::PROTEIN)
    ("HER-2-" . SPARSER::PROTEIN) ("ERα-" . SPARSER::PROTEIN)
    ("target and biomarker" . SPARSER::COLLECTION)
    ("TEAD4 and KLF5" . SPARSER::COLLECTION)
    ("TEAD4 or KLF5" . SPARSER::COLLECTION) ("K4" . SPARSER::PROTEIN)
    ("p27  Kip1" . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("TEAD3" . SPARSER::PROTEIN) ("TEAD2" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("WWP1" . SPARSER::PROTEIN)
    ("mPGES1" . SPARSER::PROTEIN) ("FGF-BP" . SPARSER::PROTEIN)
    ("RunX2" . SPARSER::PROTEIN) ("TEAD1" . SPARSER::PROTEIN)
    ("14–3-3" . SPARSER::PROTEIN) ("Mob1" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("CAFs and new targets" . SPARSER::COLLECTION)
    ("cyclin D, c-Myc, and cyclin E" . SPARSER::COLLECTION)
    ("ERK and PI3K-AKT" . SPARSER::COLLECTION)
    ("PI3K-AKT, and Wnt" . SPARSER::COLLECTION)
    ("ERK-MAPK" . SPARSER::COLLECTION)
    ("NAC and KU60019" . SPARSER::COLLECTION)
    ("p21 Cip1 and p16 INK4a" . SPARSER::COLLECTION)
    ("p-RB, cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM and PI3K-AKT" . SPARSER::COLLECTION)
    ("pRB and c-Myc" . SPARSER::COLLECTION) ("Redox" . SPARSER::PROTEIN)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("ATM and p-ATM" . SPARSER::COLLECTION)
    ("Mitochondria" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("c-Myc and c-Myc-dependent critical cell cycle proteins"
     . SPARSER::COLLECTION)
    ("KU60019, LY294002, U0126, and XAV939" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, and E2F1" . SPARSER::COLLECTION)
    ("LY294002, U0126, and XAV939" . SPARSER::COLLECTION)
    ("GSK3β/β-Catenin" . SPARSER::COLLECTION)
    ("p-GSK3β " . SPARSER::COLLECTION)
    ("nuclear β-Catenin and total β-Catenin" . SPARSER::COLLECTION)
    ("p-β-Catenin" . SPARSER::COLLECTION) ("p-GSK3β" . SPARSER::COLLECTION)
    ("c-Myc, cyclin D1, cyclin E, and CDC25A" . SPARSER::COLLECTION)
    ("LY294002, U0126, or XAV939" . SPARSER::COLLECTION)
    ("p21 Cip1 and p16 Ink4a" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("PI3K-AKT, ERK, and Wnt" . SPARSER::COLLECTION)
    ("p-RB, cyclin D1, and c-Myc" . SPARSER::COLLECTION)
    ("functional ATM" . SPARSER::PROTEIN)
    ("p-RB and c-Myc" . SPARSER::COLLECTION)
    ("PDTC, DPI, and rotenone" . SPARSER::COLLECTION)
    ("oxidase, and cytochrome P450" . SPARSER::COLLECTION)
    ("rotenone" . SPARSER::PROTEIN) ("chloramphenicol" . SPARSER::DRUG)
    ("oxypurinol" . SPARSER::DRUG) ("flavin" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("iodonium" . SPARSER::MOLECULE)
    ("PDTC" . SPARSER::DRUG) ("pyrrolidine" . SPARSER::DRUG)
    ("xanthine" . SPARSER::MOLECULE) ("ATM and γH2AX" . SPARSER::COLLECTION)
    ("antioxidant NAC and total ATM" . SPARSER::COLLECTION)
    ("Blot" . SPARSER::PROTEIN)
    ("p-RB, c-Myc, and cyclin D1" . SPARSER::COLLECTION)
    ("CDK1, E2F1, CCNA2, and CCNB2" . SPARSER::COLLECTION)
    ("E2F1, CCNB1, and CCNA2" . SPARSER::COLLECTION)
    ("CDKN2B and SFN" . SPARSER::COLLECTION) ("SFN" . SPARSER::PROTEIN)
    ("cyclin E, cyclin D1 and E2F1" . SPARSER::COLLECTION)
    ("KU60019 or siRNA" . SPARSER::COLLECTION)
    ("ERK, PI3K-AKT and Wnt" . SPARSER::COLLECTION)
    ("WNT and ERK" . SPARSER::COLLECTION) ("NFs" . SPARSER::PROTEIN)
    ("TM" . SPARSER::PROTEIN)
    ("cyclinD1, cyclinE, and E2F1" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY) ("-cysteine" . SPARSER::COLLECTION)
    ("ERK, PI3K-AKT, and Wnt" . SPARSER::COLLECTION)
    ("histone 3" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("GSK3β " . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("CDC25A" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("p16 Ink4a" . SPARSER::PROTEIN) ("XAV939" . SPARSER::DRUG)
    ("H 2 DCFDA" . SPARSER::DRUG) ("complex I" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("p-RB" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("KU60019" . SPARSER::DRUG) ("caveolin1" . SPARSER::PROTEIN)
    ("cyclin B2" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E2F1" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("the pro-apoptotic ESR2 gene" . SPARSER::GENE)
    ("a pro-proliferative, pro-angiogenic, pro-migratory and anti-apoptotic oncogene"
     . SPARSER::ONCOGENE)
    ("tertiary lymphoid" . SPARSER::PROTEIN)
    ("CD44, CD68, CD163, CD3Z, TNFR, LYN, LCK, NOS, TRAF and FLT4"
     . SPARSER::COLLECTION)
    ("mediators, BCL2 and IL4" . SPARSER::COLLECTION)
    ("b-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("NOS" . SPARSER::PROTEIN)
    ("LCK" . SPARSER::PROTEIN) ("LYN" . SPARSER::PROTEIN)
    ("TNFR" . SPARSER::PROTEIN) ("HOX" . SPARSER::PROTEIN)
    ("relapsed colon cancer" . SPARSER::PROTEIN)
    ("right-sided stage III colon cancer" . SPARSER::PROTEIN)
    ("reliable TCC" . SPARSER::PROTEIN) ("TCC" . SPARSER::PROTEIN)
    ("RQ" . SPARSER::MOLECULE) ("CD3 and CD8" . SPARSER::COLLECTION)
    ("biologic" . SPARSER::DRUG) ("type and stage" . SPARSER::COLLECTION)
    ("CD8 or CD45RO+" . SPARSER::COLLECTION)
    ("the currently used TNM" . SPARSER::MOLECULE) ("CART" . SPARSER::PROTEIN)
    ("CD3Z, CXCL13 and IGHM" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("SNAI2 or ESR1" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("the relevant patient cohort" . SPARSER::MOLECULE)
    ("left-sided stage III CRC" . SPARSER::PROTEIN)
    ("right-sided stage III CRC" . SPARSER::PROTEIN)
    ("stage III Right-sided mIS-high CRC" . SPARSER::PROTEIN)
    ("CD3/CD8" . SPARSER::COLLECTION)
    ("CD3Z, CD8, CXCL9, CXCL13 and IGHM" . SPARSER::COLLECTION)
    ("286 informative CRC" . SPARSER::PROTEIN)
    ("CD4 and FOXP3" . SPARSER::COLLECTION)
    ("CD3Z, CD8, CD4, CXCL9, CXCL13, IGHM and FOXP3" . SPARSER::COLLECTION)
    ("CD3Z, CD8, CXCL13, SNAI2 and ESR1" . SPARSER::COLLECTION)
    ("IGHM, CD4, CXCL9 and FOXP3" . SPARSER::COLLECTION)
    ("Formalin" . SPARSER::MOLECULE)
    ("prognostic significance b" . SPARSER::PROTEIN)
    ("Mismatch" . SPARSER::PROTEIN)
    ("stage III right-sided CRC" . SPARSER::PROTEIN)
    ("stage III right-sided colon cancer" . SPARSER::PROTEIN)
    ("CD3Z and CD8" . SPARSER::COLLECTION)
    ("CD3Z, CD8, CD4, CXCL9, CXCL13, IGHM, FOXP3, SNAI2 and ESR1"
     . SPARSER::COLLECTION)
    ("CD3Z" . SPARSER::PROTEIN) ("IGHM" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("CDX2" . SPARSER::PROTEIN)
    ("PD1" . SPARSER::PROTEIN) ("FLT4" . SPARSER::PROTEIN)
    ("CD163" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("tissue type" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("CD45RO" . SPARSER::PROTEIN) ("PS 1" . SPARSER::PROTEIN)
    ("TIL 1" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN) ("CXCL9" . SPARSER::PROTEIN)
    ("EGFR, PI3K and mTOR" . SPARSER::COLLECTION)
    ("CDK11A , MME and SEPT6" . SPARSER::COLLECTION)
    ("B-cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("CD10/CALLA" . SPARSER::COLLECTION)
    ("metalloendopeptidase" . SPARSER::PROTEIN) ("CALLA" . SPARSER::PROTEIN)
    ("TP53BP2 , CDK11A , MME and SEPT6" . SPARSER::COLLECTION)
    ("MME" . SPARSER::PROTEIN) ("HRAS and PIK3CA" . SPARSER::COLLECTION)
    ("-GS" . SPARSER::COLLECTION) ("GS" . SPARSER::PROTEIN)
    ("EGFR-GS and EGFR-DEL" . SPARSER::COLLECTION)
    ("EGFR-GS" . SPARSER::PROTEIN-PAIR)
    ("afatinib or gefitinib" . SPARSER::COLLECTION)
    ("afatinib and the monoclonal antibody cetuximab" . SPARSER::COLLECTION)
    ("mostly empty luminal" . SPARSER::DRUG) ("acini" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("gefitinib, erlotinib or cetuximab" . SPARSER::COLLECTION)
    ("endocrine or HER2-mediated" . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("The most aggressive forms" . SPARSER::FORM) ("Mutant" . SPARSER::MUTANT)
    ("derivative" . SPARSER::DERIVATIVE)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-Ras" . SPARSER::PROTEIN) ("p53-2" . SPARSER::PROTEIN)
    ("ASPP1" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("SEPT6" . SPARSER::PROTEIN) ("CDK11A" . SPARSER::PROTEIN)
    ("TP53BP2" . SPARSER::PROTEIN) ("ACA1" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("H-Ras" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("different metastable states" . SPARSER::BIO-STATE)
    ("the naive pluripotency state" . SPARSER::BIO-STATE)
    ("mESC" . SPARSER::PROTEIN)
    ("naive pluripotency biomarkers" . SPARSER::MOLECULE)
    ("GP130, LIFR and JAK" . SPARSER::COLLECTION)
    ("bi-allelic XACT" . SPARSER::DRUG) ("RNA-fluorescent" . SPARSER::RNA)
    ("XACT" . SPARSER::DRUG) ("ATRX" . SPARSER::PROTEIN)
    ("XIST" . SPARSER::PROTEIN)
    ("the proximal and distal enhancers" . SPARSER::PROTEIN)
    ("CpGs" . SPARSER::PROTEIN) ("DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("REX1 and GDF3" . SPARSER::COLLECTION)
    ("NANOG , OCT4 , SOX2 and MYC" . SPARSER::COLLECTION)
    ("developmental genes" . SPARSER::GENE)
    ("HOXA9 , GATA6 , HOXA1 and NKX2.5" . SPARSER::COLLECTION)
    ("KLF2 , KLF4 , GBX2 and TBX3" . SPARSER::COLLECTION)
    ("CYP1B1 , SOCS3 , SP5 and TFCP2L1" . SPARSER::COLLECTION)
    ("repressive H3K27me3 chromatin" . SPARSER::BIO-COMPLEX)
    ("repressive histone" . SPARSER::PROTEIN)
    ("the naive markers KLF4 and TFCP2L1" . SPARSER::COLLECTION)
    ("KLF4 and TFCP2L1" . SPARSER::COLLECTION)
    ("KLF4 and GBX2" . SPARSER::COLLECTION)
    ("SOX2 , NANOG , CDH1 and REX1" . SPARSER::COLLECTION)
    ("CDH1 (E-CADHERIN) and REX1" . SPARSER::COLLECTION)
    ("the naive markers PRDM14" . SPARSER::PROTEIN)
    ("SOX2 and NANOG" . SPARSER::COLLECTION) ("only 9 genes" . SPARSER::GENE)
    ("CDH1 , TFCP2L1 , LHX2 , NROB1 , BRA , AIRE , CER1 , TBX3 and FOXA2"
     . SPARSER::COLLECTION)
    ("the previously mentioned genes" . SPARSER::GENE)
    ("KLF2, KLF4 and KLF5" . SPARSER::COLLECTION)
    ("KLF2, KLF4, KLF5, TFE3 and TFCP2L1" . SPARSER::COLLECTION)
    ("naive pluripotency genes" . SPARSER::GENE)
    ("AIRE , GBX2 , GDF3 and NROB1" . SPARSER::COLLECTION)
    ("KLF2 , KLF4 , TFCP2L1 , ESRRB , FGF4 and TBX3" . SPARSER::COLLECTION)
    ("NROB1 , GDF3 , KLF2 , KLF4 , AIRE , GBX2 , TFCP2L1 , ESRRB , FGF4 and TBX3"
     . SPARSER::COLLECTION)
    ("ESRRB" . SPARSER::PROTEIN) ("AIRE" . SPARSER::PROTEIN)
    ("KLF2 , KLF4 , TFCP2L1 and GBX2" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GO" . SPARSER::PROTEIN)
    ("TL and TL2i" . SPARSER::COLLECTION) ("trypsin" . SPARSER::PROTEIN)
    ("ectodermal, mesodermal and endodermal derivatives" . SPARSER::DERIVATIVE)
    ("LIFR, GP130, JAKs and STAT3" . SPARSER::COLLECTION)
    ("LIFR, gp130, JAK kinases and phospho-(Tyr705)-STAT3 in the F-H9S3-2, TL-H9S3-2 and TL2i-H9S3-2 cells"
     . SPARSER::COLLECTION)
    ("OCT4, NANOG and SSEA4" . SPARSER::COLLECTION) ("TL2i" . SPARSER::PROTEIN)
    ("TL2i-OS3" . SPARSER::COLLECTION)
    ("JAK kinase and the activin receptor" . SPARSER::COLLECTION)
    ("SD1029 and SB431542" . SPARSER::COLLECTION)
    ("only one gene" . SPARSER::GENE) ("TL" . SPARSER::PROTEIN)
    ("Only ten STAT3 target genes" . SPARSER::GENE)
    ("CYP1B1 , C-FOS , ICAM1 , IER3 , JUNB , GBX2 , KLF5 , SOCS2 , SOCS3 and SP5"
     . SPARSER::COLLECTION)
    ("TL-OS3" . SPARSER::COLLECTION) ("receptor (LIFR)" . SPARSER::RECEPTOR)
    ("GP130, JAKs and STAT3" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("LIFR" . SPARSER::PROTEIN) ("FGFR" . SPARSER::PROTEIN)
    ("FGF receptor (SU5402) and activin receptor (SB431542)"
     . SPARSER::COLLECTION)
    ("JAK2 (SD1029), FGF receptor (SU5402) and activin receptor (SB431542)"
     . SPARSER::COLLECTION)
    ("DESMIN" . SPARSER::PROTEIN)
    ("alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("stage-specific embryonic antigen (SSEA)" . SPARSER::PROTEIN)
    ("OCT4 and NANOG" . SPARSER::COLLECTION) ("SSEA" . SPARSER::PROTEIN)
    ("neither LIF nor a constitutively active STAT3" . SPARSER::COLLECTION)
    ("LIF and hormone-dependent STAT3" . SPARSER::COLLECTION)
    ("-STAT3" . SPARSER::COLLECTION) ("GAE-STAT3-ER" . SPARSER::COLLECTION)
    ("MEK and GSK3β" . SPARSER::COLLECTION) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("LIF-JAK/STAT3" . SPARSER::COLLECTION)
    ("Klf4 and Tfcp2L1" . SPARSER::COLLECTION)
    ("inhibitors of signalling pathways ( Socs2 and Socs3 ) and adhesion molecules ( Icam1 and Ocln )"
     . SPARSER::COLLECTION)
    ("Endogenous STAT3 and ligand-dependent STAT3" . SPARSER::COLLECTION)
    ("Klf4 , Klf5 , Smad7 , Tfcp2L1 , c-fos , JunB , Zfp36 , Zfp36L1 , Gbx2 , Sp5 , Sall4 and c-myc"
     . SPARSER::COLLECTION)
    ("Pim1 , Pim3 and Sgk" . SPARSER::COLLECTION)
    ("Socs2 and Socs3" . SPARSER::COLLECTION)
    ("Icam1 and Ocln" . SPARSER::COLLECTION) ("Icam1" . SPARSER::PROTEIN)
    ("Socs3" . SPARSER::PROTEIN) ("Socs2" . SPARSER::PROTEIN)
    ("Sall4" . SPARSER::PROTEIN) ("Sp5" . SPARSER::PROTEIN)
    ("Gbx2" . SPARSER::PROTEIN) ("Zfp36" . SPARSER::PROTEIN)
    ("Ocln" . SPARSER::PROTEIN) ("Icam" . SPARSER::PROTEIN-FAMILY)
    ("JunB" . SPARSER::PROTEIN) ("ERK and protein" . SPARSER::COLLECTION)
    ("the human pluripotent state" . SPARSER::BIO-STATE)
    ("NANOG and KLF2" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("LIF/JAK" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("a distinct pluripotent state" . SPARSER::BIO-STATE)
    ("MEK, GSK3β, ROCK, SRC and BRAF" . SPARSER::COLLECTION)
    ("LIF and activin" . SPARSER::COLLECTION)
    ("FGF2, MEK and GSK3β" . SPARSER::COLLECTION)
    ("FGF2, MEK, GSK3β and ROCK" . SPARSER::COLLECTION)
    ("LIF and MEK, GSK3β and BMP4" . SPARSER::COLLECTION)
    ("MEK, GSK3β and BMP4" . SPARSER::COLLECTION)
    ("FGF2 and TGFβ1" . SPARSER::COLLECTION)
    ("the naive state" . SPARSER::BIO-STATE)
    ("Klf2 and Klf4" . SPARSER::COLLECTION)
    ("Oct4 and Klf4" . SPARSER::COLLECTION) ("Klf2" . SPARSER::PROTEIN)
    ("FGF2 and transforming growth factor-β" . SPARSER::COLLECTION)
    ("/activin/nodal" . SPARSER::COLLECTION)
    ("LIF and inhibitors" . SPARSER::COLLECTION)
    ("MEK and glycogen synthase" . SPARSER::COLLECTION)
    ("FGF2-" . SPARSER::PROTEIN) ("STAT3-ER" . SPARSER::COLLECTION)
    ("LIF/STAT3" . SPARSER::COLLECTION) ("activin/nodal" . SPARSER::COLLECTION)
    ("/STAT3" . SPARSER::COLLECTION) ("activin" . SPARSER::PROTEIN)
    ("LIF" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("activin receptor-like kinase" . SPARSER::PROTEIN)
    ("P28" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("DE-" . SPARSER::MOLECULE)
    ("DNMT3L" . SPARSER::PROTEIN) ("DNMT3B" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("methyl-transferases" . SPARSER::PROTEIN)
    ("NKX2.5" . SPARSER::PROTEIN) ("HOXA1" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN) ("REX1" . SPARSER::PROTEIN)
    ("E-CADHERIN" . SPARSER::PROTEIN) ("PRDM14" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("POU5F1" . SPARSER::PROTEIN)
    ("TFE3" . SPARSER::PROTEIN) ("CER1" . SPARSER::PROTEIN)
    ("LHX2" . SPARSER::PROTEIN) ("LEFTY2" . SPARSER::PROTEIN)
    ("LEFTY1" . SPARSER::PROTEIN) ("TBX3" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN) ("GDF3" . SPARSER::PROTEIN)
    ("NROB1" . SPARSER::PROTEIN) ("TFCP2" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("gp130" . SPARSER::PROTEIN)
    ("CHIR99021" . SPARSER::MOLECULE) ("PD325901" . SPARSER::DRUG)
    ("KLF4" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("KLF5" . SPARSER::PROTEIN) ("GBX2" . SPARSER::PROTEIN)
    ("IER3" . SPARSER::PROTEIN) ("ICAM1" . SPARSER::PROTEIN)
    ("C-FOS" . SPARSER::PROTEIN) ("CYP1B1" . SPARSER::PROTEIN)
    ("GP130" . SPARSER::PROTEIN) ("SB431542" . SPARSER::DRUG)
    ("SU5402" . SPARSER::DRUG) ("SD1029" . SPARSER::DRUG)
    ("GATA4" . SPARSER::PROTEIN) ("FOXA2" . SPARSER::PROTEIN)
    ("α-ACTIN" . SPARSER::PROTEIN) ("TRA-1" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("3-2" . SPARSER::PROTEIN) ("F-H" . SPARSER::PROTEIN)
    ("OS3" . SPARSER::PROTEIN) ("TL2" . SPARSER::PROTEIN)
    ("Pim3" . SPARSER::PROTEIN) ("Pim1" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("Zfp36L1" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("Tfcp2L1" . SPARSER::PROTEIN)
    ("Klf5" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("BMP4" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("Leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("Catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("more aggressive PCa" . SPARSER::PROTEIN) ("bGS" . SPARSER::PROTEIN)
    ("pGS" . SPARSER::PROTEIN) ("the largest cohort" . SPARSER::MOLECULE)
    ("transcriptional E-cadherin" . SPARSER::PROTEIN)
    ("membrane-associated glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("novel diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("Clusterin nor MMP9" . SPARSER::COLLECTION)
    ("TIMP1, Galectin, Clusterin nor MMP9" . SPARSER::COLLECTION)
    ("pGS " . SPARSER::PROTEIN)
    ("E-selectin, MMP2, MMP9, TIMP1, TIMP2, Galectin and Clusterin"
     . SPARSER::COLLECTION)
    ("Nearly all PCas" . SPARSER::PROTEIN)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("curatively treatable PCa" . SPARSER::PROTEIN) ("PCas" . SPARSER::PROTEIN)
    ("MMP2 and Clusterin" . SPARSER::COLLECTION)
    ("MMP9 and TIMP1" . SPARSER::COLLECTION)
    ("sE-cadherin" . SPARSER::COLLECTION)
    ("TIMP1, Galectin and Clusterin" . SPARSER::COLLECTION)
    ("sE-Cadherin" . SPARSER::COLLECTION)
    ("sE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble (s)E-cadherin, E-selectin, MMP2, MMP9, TIMP1, TIMP2, Galectin and Clusterin"
     . SPARSER::COLLECTION)
    ("E-cadherin, E-selectin, MMP2, MMP9, TIMP1, TIMP2, Galectin and Clusterin"
     . SPARSER::COLLECTION)
    ("Clusterin" . SPARSER::PROTEIN) ("RPE" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("TIMP2" . SPARSER::PROTEIN) ("TIMP1" . SPARSER::PROTEIN)
    ("E-selectin" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("locally advanced NPC overexpressed MET protein" . SPARSER::PROTEIN)
    ("onartuzumab" . SPARSER::DRUG) ("rilotumumab" . SPARSER::DRUG)
    ("different primary and secondary antibodies" . SPARSER::ANTIBODY)
    ("IIb" . SPARSER::DRUG) ("HGF, and protein" . SPARSER::COLLECTION)
    ("RAS-RAC/RHO" . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAC" . SPARSER::PROTEIN)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("therapeutic biomarkers" . SPARSER::MOLECULE) ("NPC" . SPARSER::MOLECULE)
    ("HspB6 and the N-terminal mutants" . SPARSER::COLLECTION)
    ("small and large oligomers" . SPARSER::PROTEIN)
    ("the largest part" . SPARSER::COMPONENT)
    ("HspB2, HspB7 and HspB8" . SPARSER::COLLECTION)
    ("HspB7" . SPARSER::PROTEIN)
    ("HspB2, HspB4, HspB5, HspB6 and HspB8" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN) ("HspB5 and HspB6" . SPARSER::COLLECTION)
    ("HspB1 and HspB5" . SPARSER::COLLECTION)
    ("HspB1 and HspB6" . SPARSER::COLLECTION)
    ("HspB2 and the two α-crystallins (HspB4 and HspB5)" . SPARSER::COLLECTION)
    ("HspB4 and HspB5" . SPARSER::COLLECTION)
    ("crystallins" . SPARSER::PROTEIN-FAMILY)
    ("arginine or lysine" . SPARSER::COLLECTION) ("ANS" . SPARSER::PROTEIN)
    ("bis-ANS" . SPARSER::COLLECTION)
    ("the wild type HspB1 and the different N-terminal mutants"
     . SPARSER::COLLECTION)
    ("small heat shock proteins and their protein substrates [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("MDH and the wild type HspB1" . SPARSER::COLLECTION)
    ("dehydrogenase (MDH)" . SPARSER::PROTEIN) ("MDH" . SPARSER::PROTEIN)
    ("HspB1 and HpsB6" . SPARSER::COLLECTION)
    ("HspB6 and the wild type HspB1 ( xref )" . SPARSER::COLLECTION)
    ("Disulfide" . SPARSER::MOLECULE)
    ("heterooligomeric complex" . SPARSER::BIO-COMPLEX)
    ("only one type" . TYPE)
    ("heterooligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("the wild type HspB1 and its P39L mutant ( xref and xref )"
     . SPARSER::COLLECTION)
    ("tryptic peptides" . SPARSER::PEPTIDE)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("Partial" . SPARSER::PROTEIN)
    ("large oligomers and accumulation of small oligomers (dimers or tetramers) of the wild type HspB1 [ xref ]"
     . SPARSER::COLLECTION)
    ("dimers or tetramers" . SPARSER::COLLECTION)
    ("The wild type HspB1 and its N-terminal mutants" . SPARSER::COLLECTION)
    ("practically all analyzed mutants" . SPARSER::MUTANT)
    ("dynamic light" . SPARSER::PROTEIN)
    ("the very C-terminal part" . SPARSER::COMPONENT)
    ("Phe" . SPARSER::AMINO-ACID) ("HspB1/chymotrypsin" . SPARSER::COLLECTION)
    ("SDS" . SPARSER::PROTEIN) ("chymotrypsin" . SPARSER::PROTEIN)
    ("HspB1 and its N-terminal mutants" . SPARSER::COLLECTION)
    ("HspB1 and its mutants" . SPARSER::COLLECTION)
    ("The recombinantly expressed WT HspB1 and the three N-terminal mutants"
     . SPARSER::COLLECTION)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("the wild type HspB1 and its N-terminal mutants" . SPARSER::COLLECTION)
    ("the different congenital HspB1 mutants" . SPARSER::MUTANT)
    ("desmin" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("HspB1, HspB5, HspB6 and HspB8" . SPARSER::COLLECTION)
    ("HspB5" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("Monomers" . SPARSER::MONOMER) ("bis" . SPARSER::PROTEIN)
    ("malate" . SPARSER::MOLECULE) ("lysozyme" . SPARSER::PROTEIN)
    ("parts" . SPARSER::COMPONENT) ("Hsp27" . SPARSER::PROTEIN)
    ("HspB4" . SPARSER::PROTEIN) ("HspB2" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("MKK6 protein" . SPARSER::PROTEIN)
    ("HspB8" . SPARSER::PROTEIN) ("HspB6" . SPARSER::PROTEIN)
    ("HspB1" . SPARSER::PROTEIN) ("P39" . SPARSER::PROTEIN)
    ("the heterodimeric DNA damage-binding (DDB) complex"
     . SPARSER::BIO-COMPLEX)
    ("DDB" . SPARSER::DRUG) ("DDB1 and CUL4" . SPARSER::COLLECTION)
    ("MCM2, MCM3, MCM4, and MCM7" . SPARSER::COLLECTION)
    ("MCM-ASF1" . SPARSER::COLLECTION) ("CHD" . SPARSER::PROTEIN)
    ("STY" . SPARSER::PROTEIN)
    ("Paladin (PALD1) and Importin-7" . SPARSER::COLLECTION)
    ("ASF1A, Paladin (PALD1) and Importin-7" . SPARSER::COLLECTION)
    ("MCM2 and MCMBP" . SPARSER::COLLECTION)
    ("previously known proteins" . SPARSER::PROTEIN)
    ("more obvious colocalization foci" . SPARSER::PROTEIN)
    ("the foci, that was present in some of the cells" . SPARSER::PROTEIN)
    ("MCM2 and ASF1" . SPARSER::COLLECTION)
    ("ASF1 and MCM2" . SPARSER::COLLECTION) ("triton" . SPARSER::MOLECULE)
    ("TCL" . SPARSER::PROTEIN) ("GFP and ASF1" . SPARSER::COLLECTION)
    ("Proteins" . SPARSER::PROTEIN) ("diglycine" . SPARSER::MOLECULE)
    ("MCM2, MCM3, and MCM6" . SPARSER::COLLECTION)
    ("ATM, ATR, and DNA-PK" . SPARSER::COLLECTION) ("SQ" . SPARSER::MOLECULE)
    ("CKII" . SPARSER::PROTEIN) ("casein" . SPARSER::PROTEIN)
    ("Cdc7/Dbf4" . SPARSER::COLLECTION) ("SSP" . SPARSER::PROTEIN)
    ("the putative tyrosine phosphatase Paladin (PALD1) and Importin-7 (IMP7)"
     . SPARSER::COLLECTION)
    ("Paladin" . SPARSER::PROTEIN) ("Ubiquitin" . SPARSER::PROTEIN)
    ("nucleophosmin, BAG2, UPP1, and HDAC10" . SPARSER::COLLECTION)
    ("MCM3 and histones" . SPARSER::COLLECTION)
    ("the T-complex 1 or CCT complex ( xref  F ,)" . SPARSER::COLLECTION)
    ("protein (MCMBP)" . SPARSER::PROTEIN)
    ("proteins and protein" . SPARSER::COLLECTION) ("MCMBP" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("GFP-TRAP" . SPARSER::COLLECTION)
    ("the exogenous protein" . SPARSER::PROTEIN)
    ("The exogenous GFP-MCM2 and GFP-MCM5 proteins" . SPARSER::PROTEIN)
    ("GFP-MCM5" . SPARSER::COLLECTION) ("GFP-MCM2" . SPARSER::COLLECTION)
    ("flp" . SPARSER::PROTEIN)
    ("a topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("subcellular fraction" . SPARSER::COMPONENT)
    ("Importin7 and the histone chaperone ASF1" . SPARSER::COLLECTION)
    ("Nucleophosmin, BAG2, UPP1, and HDAC10" . SPARSER::COLLECTION)
    ("Nucleophosmin" . SPARSER::PROTEIN)
    ("MCM2 and MCM5" . SPARSER::COLLECTION)
    ("replicative helicase" . SPARSER::PROTEIN)
    ("other hexameric helicases" . SPARSER::PROTEIN)
    ("six homologous proteins" . SPARSER::PROTEIN)
    ("MCM2-MCM7" . SPARSER::COLLECTION) ("helicases" . SPARSER::PROTEIN)
    ("ATPase" . SPARSER::PROTEIN) ("paralogs" . SPARSER::PROTEIN)
    ("proteins, Cdt6 and Cdt1" . SPARSER::COLLECTION)
    ("Importin7, the histone chaperone ASF1, and the Chromodomain helicase DNA binding protein 3 (CHD3)"
     . SPARSER::COLLECTION)
    ("polymerases" . SPARSER::PROTEIN)
    ("The eukaryotic MCM complex" . SPARSER::BIO-COMPLEX)
    ("helicase" . SPARSER::PROTEIN) ("MCM" . SPARSER::PROTEIN)
    ("cullin 4" . SPARSER::PROTEIN) ("p48" . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("MCM4" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("MCM6" . SPARSER::PROTEIN)
    ("Dbf4" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("IMP7" . SPARSER::PROTEIN) ("Importin-7" . SPARSER::PROTEIN)
    ("PALD1" . SPARSER::PROTEIN) ("MCM3" . SPARSER::PROTEIN)
    ("T-complex 1" . SPARSER::PROTEIN) ("LAP1" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("ASF1A" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("ASF1" . SPARSER::PROTEIN)
    ("HDAC10" . SPARSER::PROTEIN) ("UPP1" . SPARSER::PROTEIN)
    ("BAG2" . SPARSER::PROTEIN) ("MCM5" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN) ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("CHD3" . SPARSER::PROTEIN)
    ("Chromodomain helicase DNA binding protein 3" . SPARSER::PROTEIN)
    ("histone chaperone ASF1" . SPARSER::PROTEIN)
    ("Importin7" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("oligomer" . SPARSER::MOLECULE) ("study tau’s" . SPARSER::PROTEIN)
    ("Axonal microtubules" . SPARSER::PROTEIN)
    ("neighboring astrocytes" . SPARSER::PROTEIN) ("noRD" . SPARSER::PROTEIN)
    ("other disease-relevant signaling molecules" . SPARSER::MOLECULE)
    ("a key regulator of long-term potentiation and depression ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("tau-" . SPARSER::PROTEIN) ("neurotoxins" . SPARSER::PROTEIN)
    ("these relevant kinases" . SPARSER::KINASE)
    ("caspase-3–Akt" . SPARSER::COLLECTION) ("calcineurin" . SPARSER::PROTEIN)
    ("APP/PS1/Tau" . SPARSER::COLLECTION)
    ("APP/presenilin 1" . SPARSER::COLLECTION)
    ("filamentous tau and the 6D isoform" . SPARSER::COLLECTION)
    ("filamentous tau" . SPARSER::PROTEIN)
    ("two relevant kinases, Fyn and GSK3β" . SPARSER::COLLECTION)
    ("kinases, Fyn and GSK3β" . SPARSER::COLLECTION)
    ("synaptic NMDAR" . SPARSER::PROTEIN)
    ("neurotransmitter" . SPARSER::MOLECULE) ("hAPP-J20" . SPARSER::COLLECTION)
    ("SCA" . SPARSER::PROTEIN) ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("two distinct siRNAs" . SPARSER::PROTEIN)
    ("Tau-AxxA7" . SPARSER::PROTEIN-PAIR) ("hAPP/Fyn" . SPARSER::COLLECTION)
    ("tau–Fyn" . SPARSER::COLLECTION) ("KCl" . SPARSER::MOLECULE)
    ("tau–tubulin" . SPARSER::COLLECTION) ("Tau-noRD" . SPARSER::COLLECTION)
    ("squid optic lobes" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("Tau-1" . SPARSER::COLLECTION) ("soma" . SPARSER::DRUG)
    ("EP" . SPARSER::PROTEIN) ("shRNA or anti-Tau" . SPARSER::COLLECTION)
    ("NMDARs" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("axonal mitochondria" . SPARSER::PROTEIN)
    ("tau and Aβ" . SPARSER::COLLECTION) ("hAPP/Tau" . SPARSER::COLLECTION)
    ("tau, and N -methyl- d -aspartate" . SPARSER::COLLECTION)
    ("NMDAR" . SPARSER::PROTEIN)
    ("mitochondria and TrkA" . SPARSER::COLLECTION) ("TrkA" . SPARSER::PROTEIN)
    ("Pathogenic forms" . SPARSER::FORM) ("hAPP" . SPARSER::PROTEIN)
    ("Fyn" . SPARSER::PROTEIN)
    ("amyloid β (Aβ) peptides and pathological forms of the microtubule-associated protein tau"
     . SPARSER::COLLECTION)
    ("pathological forms" . SPARSER::FORM) ("amyloid" . SPARSER::PROTEIN)
    ("tau" . SPARSER::PROTEIN) ("Tau" . SPARSER::PROTEIN)
    ("CT15" . SPARSER::PROTEIN) ("1 A" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("reducing agent" . SPARSER::MOLECULE)
    ("DIV 1" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG)
    ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("PI3K–Akt" . SPARSER::PROTEIN) ("PS1" . SPARSER::PROTEIN)
    ("presenilin 1" . SPARSER::PROTEIN) ("EphB2" . SPARSER::PROTEIN)
    ("J20" . SPARSER::PROTEIN) ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("SB 415286" . SPARSER::DRUG) ("in Chinese hamster" . SPARSER::PROTEIN)
    ("PHF-1" . SPARSER::PROTEIN) ("D-AP5" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN)
    ("N -methyl- d -aspartate" . SPARSER::MOLECULE)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("microtubule-associated protein tau" . SPARSER::PROTEIN)
    ("FMNL2 and Arp2/3" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("LifeAct" . SPARSER::PROTEIN)
    ("PA-Rac1-mCherry" . SPARSER::COLLECTION) ("PA-Rac1" . SPARSER::COLLECTION)
    ("PA" . SPARSER::PROTEIN)
    ("FMNL2 and the AJ complex" . SPARSER::COLLECTION)
    ("E-Cadherin and FMNL2" . SPARSER::COLLECTION)
    ("Doxycycline" . SPARSER::DRUG) ("RhoC and Cdc42" . SPARSER::COLLECTION)
    ("α-catenin–GST" . SPARSER::COLLECTION)
    ("α-catenin–GFP" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("FLAG-FMNL2" . SPARSER::COLLECTION)
    ("a chemically inert 3D" . SPARSER::PROTEIN-FAMILY)
    ("Jasplakinolide" . SPARSER::DRUG)
    ("free monomeric actin and initial nucleation/polymerization"
     . SPARSER::COLLECTION)
    ("free monomeric actin" . SPARSER::PROTEIN)
    ("GFP-actin" . SPARSER::COLLECTION) ("FRAP" . SPARSER::PROTEIN)
    ("No other tested formin exhibited disregulated junctional actin"
     . SPARSER::PROTEIN)
    ("Lifeact-GFP" . SPARSER::COLLECTION) ("Lifeact" . SPARSER::PROTEIN)
    ("stable junctional actin" . SPARSER::PROTEIN)
    ("LifeAct-GFP" . SPARSER::COLLECTION)
    ("junctional actin" . SPARSER::PROTEIN)
    ("junctional F-actin" . SPARSER::BIO-COMPLEX)
    ("FMNL2-GFP" . SPARSER::COLLECTION)
    ("mDia1 or DIAPH1" . SPARSER::COLLECTION)
    ("mDia1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mDia" . SPARSER::PROTEIN)
    ("INF" . SPARSER::PROTEIN) ("formin" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE) ("E-Cadherin–GFP" . SPARSER::COLLECTION)
    ("DAD" . SPARSER::PROTEIN) ("Formins" . SPARSER::PROTEIN)
    ("formins" . SPARSER::PROTEIN) ("Actin" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("FHOD1" . SPARSER::PROTEIN)
    ("DIAPH3" . SPARSER::PROTEIN) ("DIAPH2" . SPARSER::PROTEIN)
    ("bp 2" . SPARSER::PROTEIN) ("FH3" . SPARSER::PROTEIN)
    ("EF-1 α" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("B20" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("anti–β" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("1 K" . SPARSER::PROTEIN) ("DAAM1" . SPARSER::PROTEIN)
    ("FMNL1" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("Latrunculin B" . SPARSER::DRUG) ("1 C" . SPARSER::PROTEIN)
    ("DIAPH1" . SPARSER::PROTEIN) ("FMNL3" . SPARSER::PROTEIN)
    ("formin-1" . SPARSER::PROTEIN) ("Dia1" . SPARSER::PROTEIN)
    ("Formin-1" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("formin-like" . SPARSER::PROTEIN) ("FMNL2" . SPARSER::PROTEIN)
    ("Formin-like" . SPARSER::PROTEIN)
    ("Cyclin B1 and E-cadherin" . SPARSER::COLLECTION)
    ("matrigel and transwell" . SPARSER::COLLECTION)
    ("siRNA or siRNA" . SPARSER::COLLECTION) ("RR" . SPARSER::MOLECULE)
    ("Slug" . SPARSER::PROTEIN)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("a mitotic cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTNNB1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("s 5A" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("FOXC2" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("leukemic Jurkat" . SPARSER::PROTEIN)
    ("kosmotropic salts" . SPARSER::DRUG) ("citrate" . SPARSER::PROTEIN)
    ("salts" . SPARSER::DRUG)
    ("Dimerized uncleavable chimeric caspase 8" . SPARSER::PROTEIN)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("amides" . SPARSER::MOLECULE) ("sulfoxide" . SPARSER::DRUG)
    ("monomer" . SPARSER::MONOMER) ("caspase 8/cFLIP" . SPARSER::COLLECTION)
    ("caspase 8 and three additional components" . SPARSER::COLLECTION)
    ("cFLIP and FADD" . SPARSER::COLLECTION) ("STD" . SPARSER::PROTEIN)
    ("DMSO (control), TRAIL, compounds 1-4 and the combination"
     . SPARSER::COLLECTION)
    ("ID" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("a productive caspase 8 conformation" . SPARSER::BIO-CONFORMATION)
    ("mature caspase 8 homodimers" . SPARSER::HOMODIMER)
    ("mature caspase 8/zymogen caspase 8 homodimers" . SPARSER::HOMODIMER)
    ("mature caspase 8" . SPARSER::PROTEIN) ("disulfide" . SPARSER::MOLECULE)
    ("the mature caspase 8 homodimers" . SPARSER::HOMODIMER)
    ("a productive conformation" . SPARSER::BIO-CONFORMATION)
    ("the favorable heterodimerization complex" . SPARSER::BIO-COMPLEX)
    ("caspase 8-cFLIP" . SPARSER::COLLECTION)
    ("FLIP and caspase 8" . SPARSER::COLLECTION)
    ("Caspase 8-cFLIP" . SPARSER::COLLECTION) ("cFLIP" . SPARSER::PROTEIN)
    ("DISC" . SPARSER::BIO-COMPLEX) ("Apo2L/TRAIL" . SPARSER::COLLECTION)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("the caspase 8 homodimer’s" . SPARSER::HOMODIMER)
    ("Recombinant soluble TRAIL and agonistic antibodies"
     . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("Recombinant soluble TRAIL" . SPARSER::PROTEIN)
    ("DR4 and DR5" . SPARSER::COLLECTION) ("caspases 3" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("Death Receptor 5" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("caspase 9" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("L-Arginine" . SPARSER::MOLECULE) ("H11" . SPARSER::PROTEIN)
    ("caspase 1" . SPARSER::PROTEIN) ("caspase 7" . SPARSER::PROTEIN)
    ("cellular FLICE-like inhibitory protein" . SPARSER::PROTEIN)
    ("Apo2L" . SPARSER::PROTEIN) ("Caspase 8" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("Akt and GSK3β" . SPARSER::COLLECTION)
    ("Akt and Bax" . SPARSER::COLLECTION)
    ("polymorphonuclear leukocytes" . SPARSER::PROTEIN)
    ("HIF-1-BNIP3" . SPARSER::COLLECTION)
    ("p53-sestrin2" . SPARSER::COLLECTION)
    ("HMGB1 and HSPB1" . SPARSER::COLLECTION) ("-HSPB1" . SPARSER::COLLECTION)
    ("CASP3 and caspase 3" . SPARSER::COLLECTION)
    ("rapamycin and bafilomycin A1" . SPARSER::COLLECTION)
    ("bafilomycin A1 (200 nM, 8h) and rapamycin (100 nM, 24h)"
     . SPARSER::COLLECTION)
    ("LC3-II and p62" . SPARSER::COLLECTION)
    ("approximately 40–50 kDa" . SPARSER::PROTEIN)
    ("AQP1 and HSPB1" . SPARSER::COLLECTION)
    ("AQP1 and LC3" . SPARSER::COLLECTION)
    ("HSPB1 and LC3" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("HSP27 and HSP25" . SPARSER::COLLECTION)
    ("HSP27 (in humans and rats) and HSP25 (in mice)" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN)
    ("green fluorescent protein-LC3" . SPARSER::COLLECTION)
    ("nick" . SPARSER::PROTEIN)
    ("messenger RNA and protein" . SPARSER::COLLECTION)
    ("green fluorescent protein and LC3" . SPARSER::COLLECTION)
    ("NRK-LC3" . SPARSER::COLLECTION)
    ("NRK-light chain 3" . SPARSER::COLLECTION) ("NRK" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("second mitochondria-derived activator of caspase" . SPARSER::PROTEIN)
    ("sestrin2" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("delta-" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("AQP1" . SPARSER::PROTEIN)
    ("aquaporin-1" . SPARSER::PROTEIN) ("HSP25" . SPARSER::PROTEIN)
    ("beta-1" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("ATG8" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("HSPB1" . SPARSER::PROTEIN)
    ("Heat shock protein beta-1" . SPARSER::PROTEIN)
    ("mild hypoxia" . SPARSER::PROTEIN) ("key demethylases" . SPARSER::PROTEIN)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("the principal H3K9 methyltransferases" . SPARSER::PROTEIN)
    ("SETDB1, Suv39h2 and G9a" . SPARSER::COLLECTION)
    ("Suv39h2" . SPARSER::PROTEIN)
    ("SETDB1, Suv3h1/2 and G9a" . SPARSER::COLLECTION)
    ("relatively inaccessible chromatin" . SPARSER::PROTEIN)
    ("neither HIF-1α nor HIF-1β" . SPARSER::COLLECTION)
    ("demethylase" . SPARSER::PROTEIN)
    ("RAD51, MLH1 and BRCA1" . SPARSER::COLLECTION)
    ("SETDB1/ESET" . SPARSER::COLLECTION) ("ESET" . SPARSER::PROTEIN)
    ("GLP" . SPARSER::PROTEIN)
    ("heterochromatin and gene" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN) ("Histones" . SPARSER::PROTEIN)
    ("ATM and p53-Associated KZNF Protein/ZNF420" . SPARSER::COLLECTION)
    ("KRAB" . SPARSER::PROTEIN-FAMILY) ("Suv39h1 or G9a" . SPARSER::COLLECTION)
    ("Suv39h1" . SPARSER::PROTEIN) ("severe hypoxia" . SPARSER::PROTEIN)
    ("Suv3" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("JMJD2E" . SPARSER::PROTEIN)
    ("p53AIP1" . SPARSER::PROTEIN) ("KAP-1" . SPARSER::PROTEIN)
    ("ZNF420" . SPARSER::PROTEIN)
    ("ATM and p53-Associated KZNF Protein" . SPARSER::PROTEIN)
    ("JMJD2" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("Suv39h" . SPARSER::PROTEIN) ("SETDB1" . SPARSER::PROTEIN)
    ("Se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Axin" . SPARSER::PROTEIN)
    ("Ser/Thr" . SPARSER::COLLECTION)
    ("LGALS3 and ITGB4" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("subcellular fractions" . SPARSER::COMPONENT)
    ("p53, HIPK2 and LGALS3" . SPARSER::COLLECTION)
    ("ITGB4 , LGALS3 and SOD2" . SPARSER::COLLECTION)
    ("LGALS3 , ITGB4 and SOD2" . SPARSER::COLLECTION)
    ("NOXA and BAX" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN)
    ("LGALS3, ITGB4 and SOD2" . SPARSER::COLLECTION)
    ("integrin-beta4 (ITGB4) and superoxide dismutase-2 (SOD2)"
     . SPARSER::COLLECTION)
    ("these molecules (ITGB4, LGALS3 and SOD2), xref ," . SPARSER::MOLECULE)
    ("p53 and HIPK2" . SPARSER::COLLECTION)
    ("ITGB4, LGALS3 and SOD2" . SPARSER::COLLECTION)
    ("P4HB, KRT5, KRT8 and S100A11" . SPARSER::COLLECTION)
    ("shotgun" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("Preliminary WB" . SPARSER::PROTEIN) ("Si" . SPARSER::PROTEIN)
    ("MDM4 and Adr" . SPARSER::COLLECTION)
    ("MDM4, MDM2 and p53" . SPARSER::COLLECTION)
    ("MDM4 and MDM2" . SPARSER::COLLECTION) ("GST-HIPK2" . SPARSER::COLLECTION)
    ("HIPK2-p53" . SPARSER::COLLECTION) ("Hipk2" . SPARSER::PROTEIN)
    ("Hipk" . SPARSER::PROTEIN-FAMILY) ("HIPK2 and p53" . SPARSER::COLLECTION)
    ("Western blot (WB)" . SPARSER::PROTEIN)
    ("p53 (MDM4BD+RF) or HIPK2 (MDM4ΔBD)" . SPARSER::COLLECTION)
    ("MDM4/HIPK2" . SPARSER::COLLECTION) ("wt-MDM4" . SPARSER::COLLECTION)
    ("aa" . SPARSER::MOLECULE)
    ("MDM4 ( xref ) and proteasome inhibitor MG132" . SPARSER::COLLECTION)
    ("Tet-sh-MDM4" . SPARSER::COLLECTION) ("adeno-MDM4" . SPARSER::COLLECTION)
    ("MDM4 and HIPK2" . SPARSER::COLLECTION)
    ("GFP-HIPK2" . SPARSER::COLLECTION) ("Adr" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG) ("CTL" . SPARSER::PROTEIN)
    ("si" . SPARSER::PROTEIN) ("MDM4 and p53" . SPARSER::COLLECTION)
    ("MDM2/MDM4" . SPARSER::COLLECTION) ("heterodimer" . SPARSER::HETERODIMER)
    ("HIPK2/p53" . SPARSER::COLLECTION) ("/HIPK2" . SPARSER::COLLECTION)
    ("p53/HIPK2" . SPARSER::COLLECTION) ("MDM4/MDM2" . SPARSER::COLLECTION)
    ("severe DNA" . SPARSER::DNA) ("serine–threonine" . SPARSER::COLLECTION)
    ("MDMX" . SPARSER::PROTEIN) ("Gal-3" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase 2" . SPARSER::PROTEIN)
    ("KPNA4" . SPARSER::PROTEIN) ("integrin-beta4" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("S100A11" . SPARSER::PROTEIN)
    ("KRT8" . SPARSER::PROTEIN) ("KRT5" . SPARSER::PROTEIN)
    ("P4HB" . SPARSER::PROTEIN) ("LGALS3" . SPARSER::PROTEIN)
    ("p53S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mdm4" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("oncogene or putative tumor suppressor genes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("pCDNA" . SPARSER::PROTEIN) ("pCDNA-c-Met" . SPARSER::COLLECTION)
    ("si-c-Met" . SPARSER::PROTEIN-PAIR) ("siRNA-c-Met" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors [ xref – xref ]" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("glucose and lipids" . SPARSER::COLLECTION)
    ("mature miRNAs" . SPARSER::PROTEIN) ("iris" . SPARSER::PROTEIN)
    ("C-Met" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("DCAMKL-1" . SPARSER::PROTEIN)
    ("CaM kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MUM-2" . SPARSER::PROTEIN)
    ("the correct cohorts" . SPARSER::MOLECULE)
    ("the appropriate cohorts" . SPARSER::MOLECULE)
    ("the continued DNA damage-prone state" . SPARSER::BIO-STATE)
    ("-variant and non-variant" . SPARSER::COLLECTION)
    ("the homozygous KRAS -variant group" . SPARSER::MOLECULE)
    ("MBPC" . SPARSER::PROTEIN) ("GT or GG" . SPARSER::COLLECTION)
    ("GT" . SPARSER::PROTEIN) ("charcoal stripped media" . SPARSER::PROTEIN)
    ("Tamoxifen" . SPARSER::MOLECULE)
    ("BRCA1, BRCA2 and PTEN" . SPARSER::COLLECTION)
    ("lobular or tubular subtypes" . SPARSER::PROTEIN)
    ("powerful biomarkers" . SPARSER::MOLECULE)
    ("the KRAS -variant ( n = 286) and KRAS -variant" . SPARSER::COLLECTION)
    ("-variant" . SPARSER::VARIANT)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("MT2" . SPARSER::PROTEIN)
    ("MT1" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("CNA and gene" . SPARSER::COLLECTION)
    ("miRNAs and their targets" . SPARSER::COLLECTION)
    ("miRNAs and mRNAs" . SPARSER::COLLECTION)
    ("KIF15, ILF2, and ASPM" . SPARSER::COLLECTION)
    ("SPAG8 and GL8TD1" . SPARSER::COLLECTION)
    ("SPAG8, KIF15, ILF2, GL8TD1, and ASPM" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("miRNA or mRNA" . SPARSER::COLLECTION)
    ("cytokine-cytokine" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::PROTEIN)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("three miRNAs (miR-154, miR-362-3p, and miR-584) and four genes (GLT8D2, GLT8D1, ECM2, and RASA1)"
     . SPARSER::COLLECTION)
    ("GLT8D2, GLT8D1, ECM2, and RASA1" . SPARSER::COLLECTION)
    ("mature miR-125a-5p" . SPARSER::MOLECULE)
    ("two miRNAs (miR-936 and miR-125a-5p) and four genes (ASPM, ILF2, IL10RB, and IL2RG)"
     . SPARSER::COLLECTION)
    ("human breast cancer-associated specific miRNAs" . SPARSER::PROTEIN)
    ("BRCA1 or siBRCA1" . SPARSER::COLLECTION)
    ("mature forms of miR-143 and miR-145 using quantitative RT-PCR (qRT-PCR) after overexpression or knock-down"
     . SPARSER::COLLECTION)
    ("mature forms" . SPARSER::FORM)
    ("BRCA1 and miR-143-miR-145" . SPARSER::COLLECTION)
    ("two miRNAs (miR-143 and miR-145) and 4 genes (CASC3, ITGA2B, BID, and LMNB1)"
     . SPARSER::COLLECTION)
    ("CASC3, ITGA2B, BID, and LMNB1" . SPARSER::COLLECTION)
    ("three miRNAs (miR-379, miR-190b, and miR-31) and two genes (DKK3 and C1orf 123)"
     . SPARSER::COLLECTION)
    ("DKK3 and C1orf" . SPARSER::COLLECTION) ("orf" . SPARSER::PROTEIN)
    ("miRNAs or genes" . SPARSER::COLLECTION)
    ("group and miR-21" . SPARSER::COLLECTION)
    ("state and the expression change of genes" . SPARSER::COLLECTION)
    ("the simultaneous subtype-specific CNAs" . SPARSER::PROTEIN)
    ("smaller subregions" . SPARSER::PROTEIN) ("subregions" . SPARSER::PROTEIN)
    ("SBL" . SPARSER::PROTEIN) ("CGH" . SPARSER::PROTEIN)
    ("mRNAs or miRNAs" . SPARSER::COLLECTION)
    ("miRNAs-mRNA" . SPARSER::COLLECTION)
    ("subtypes, and gene" . SPARSER::COLLECTION)
    ("estrogen receptors (ERs) and/or progesterone receptors (PRs)"
     . SPARSER::COLLECTION)
    ("PRs" . SPARSER::PROTEIN) ("miRNA-mRNA" . SPARSER::COLLECTION)
    ("mRNA or miRNA" . SPARSER::COLLECTION) ("CCNB2" . SPARSER::PROTEIN)
    ("KIF15" . SPARSER::PROTEIN) ("SPAG8" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("GLT8D1" . SPARSER::PROTEIN)
    ("GLT8D2" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("IL10RB" . SPARSER::PROTEIN) ("ILF2" . SPARSER::PROTEIN)
    ("miR-125a-5p" . SPARSER::MOLECULE) ("IL18" . SPARSER::PROTEIN)
    ("ITGA2B" . SPARSER::PROTEIN) ("CASC3" . SPARSER::PROTEIN)
    ("DKK3" . SPARSER::PROTEIN) ("HTRA1" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("Pri-miRNA" . SPARSER::RNA) ("small nuclear RNA" . SPARSER::RNA)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("/BIM" . SPARSER::COLLECTION) ("proapoptotic BIM" . SPARSER::PROTEIN)
    ("BIM" . SPARSER::PROTEIN) ("NOX4/p22 Phox" . SPARSER::COLLECTION)
    ("NOX4 and p22 Phox" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION) ("NOX" . SPARSER::PROTEIN)
    ("DCF" . SPARSER::PROTEIN) ("cellular ROS" . SPARSER::PROTEIN)
    ("intercalator and topoisomerase" . SPARSER::COLLECTION)
    ("intercalator" . SPARSER::MOLECULE) ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("p53 and Bax" . SPARSER::COLLECTION) ("ADR" . SPARSER::PROTEIN)
    ("Bak-" . SPARSER::PROTEIN) ("Bak" . SPARSER::PROTEIN)
    ("NOX4 and SIRT3" . SPARSER::COLLECTION) ("Waf1/Cip" . SPARSER::COLLECTION)
    ("SIRT3/p53/p21" . SPARSER::COLLECTION) ("/SOD2" . SPARSER::COLLECTION)
    ("/p22 phox" . SPARSER::COLLECTION) ("MIAM" . SPARSER::MOLECULE)
    ("-acetic acid methyl ester (MIAM)" . SPARSER::MOLECULE)
    ("ester (MIAM)" . SPARSER::MOLECULE) ("indole" . SPARSER::DRUG)
    ("ester" . SPARSER::MOLECULE) ("p22 Phox" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("JC-1" . SPARSER::MOLECULE)
    ("p-Rb" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("Waf1" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("Sirtuin3" . SPARSER::PROTEIN)
    ("p22 phox" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("NADPH oxidase 4" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("p53 and SP1" . SPARSER::COLLECTION)
    ("Cyclin E/CDK2" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("SP1" . SPARSER::PROTEIN) ("Cyclin/CDK" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("GAS5, GR, YBX1, and p53" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("YBX1 and p21" . SPARSER::COLLECTION)
    ("YBX1 and p21 protein" . SPARSER::COLLECTION)
    ("GAS5-YBX1" . SPARSER::COLLECTION)
    ("siRNAs and lncRNA" . SPARSER::COLLECTION)
    ("GAS5/YBX1" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("GAS5 and YBX1" . SPARSER::COLLECTION)
    ("GAS5, and NC" . SPARSER::COLLECTION)
    ("response element (GRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("GR" . SPARSER::PROTEIN) ("HOTAIR" . SPARSER::PROTEIN)
    ("RNA and proteins" . SPARSER::COLLECTION)
    ("nearly 2/3" . SPARSER::PROTEIN) ("GAS5/YBX1/p21" . SPARSER::COLLECTION)
    ("E2" . SPARSER::MOLECULE) ("RNA Binding Protein" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("CDK2" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("GAS5" . SPARSER::PROTEIN)
    ("CCCTC-binding factor (CTCF)" . SPARSER::PROTEIN)
    ("DMD" . SPARSER::PROTEIN) ("CTCF" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR)
    ("hypermethylation usually causes gene" . SPARSER::GENE)
    ("an epigenetic biomarker" . SPARSER::MOLECULE)
    ("CpG1, CpG2, CpG3, CpG4, CpG5.6.7, CpG8.9, CpG11, CpG12, CpG13.14, CpG15 and CpG17"
     . SPARSER::COLLECTION)
    ("the EGFR promoter and gastric cancer as well as its clinical characteristics"
     . SPARSER::COLLECTION)
    ("HER3/ErbB3" . SPARSER::COLLECTION)
    ("HER1/EGFR/ErbB1" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN)
    ("a potential epigenetic biomarker" . SPARSER::MOLECULE)
    ("CCCTC-binding factor" . SPARSER::PROTEIN) ("Igf2" . SPARSER::PROTEIN)
    ("Tumor Suppressor Gene" . SPARSER::PROTEIN) ("CpG1" . SPARSER::PROTEIN)
    ("CpG8" . SPARSER::PROTEIN) ("CpG6" . SPARSER::PROTEIN)
    ("CpG5" . SPARSER::PROTEIN) ("CpG4" . SPARSER::PROTEIN)
    ("CpG3" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("I-R" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("c-Src and EGFR" . SPARSER::COLLECTION)
    ("Cripto" . SPARSER::PROTEIN) ("Src and FAK" . SPARSER::COLLECTION)
    ("hepatocellular carcinoma cell lines PLC" . SPARSER::PROTEIN)
    ("c-Src and c-Src" . SPARSER::COLLECTION)
    ("Cortactin and F-actin" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("Cortactin (Y486 and 466) and Paxillin (Y118)" . SPARSER::COLLECTION)
    ("FAK (Y397), Cortactin (Y486 and 466) and Paxillin (Y118)"
     . SPARSER::COLLECTION)
    ("p-c-Src" . SPARSER::COLLECTION) ("GRP78 and c-Src" . SPARSER::COLLECTION)
    ("GST-GRP78" . SPARSER::COLLECTION) ("KDa" . SPARSER::PROTEIN)
    ("agglutinin" . SPARSER::PROTEIN) ("TRITC" . SPARSER::MOLECULE)
    ("using western blot" . SPARSER::PROTEIN)
    ("exogenous and endogenous GRP78" . SPARSER::PROTEIN)
    ("GRP78 or isotype" . SPARSER::COLLECTION) ("COOH" . SPARSER::MOLECULE)
    ("Cellular Src" . SPARSER::PROTEIN) ("MAPK and Akt" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN)
    ("namely cell surface glucose-regulated protein 78 (GRP78) and LDL receptor related protein (LRP) [ xref ]"
     . SPARSER::COLLECTION)
    ("protein (LRP)" . SPARSER::PROTEIN)
    ("namely cell surface glucose-regulated protein" . SPARSER::PROTEIN)
    ("LRP" . SPARSER::PROTEIN) ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the increased serological α 2 M" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and Src" . SPARSER::COLLECTION)
    ("EGFR and c-Src" . SPARSER::COLLECTION)
    ("blot, co-immunoprecipitation" . SPARSER::PROTEIN)
    ("blot, co-immunoprecipitation and GST" . SPARSER::COLLECTION)
    ("far-western blot" . SPARSER::PROTEIN)
    ("GRP78 and Src" . SPARSER::COLLECTION)
    ("Paxillin and Cortactin" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN) ("Cortactin" . SPARSER::PROTEIN)
    ("GRP78-EGFP" . SPARSER::COLLECTION)
    ("a multifunctional receptor" . SPARSER::RECEPTOR)
    ("Par-4" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("NH2" . SPARSER::MOLECULE) ("C20" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("NF-kappaB" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN) ("α2M" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("c-Src" . SPARSER::PROTEIN)
    ("α 2 M" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("the CHEK2 ( n  = 18) and the non- CHEK2" . SPARSER::COLLECTION)
    ("CHEK2 and non- CHEK2" . SPARSER::COLLECTION)
    ("platinum and potentially other agents (Bayraktar and Gluck xref ; Kriege et al. xref ; Tutt et al. xref )"
     . SPARSER::COLLECTION)
    ("the CHEK2 and non- CHEK2" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("anthracyclines" . SPARSER::MOLECULE) ("platinum" . SPARSER::MOLECULE)
    ("TP53 and BRCA1" . SPARSER::COLLECTION) ("CMF" . SPARSER::PROTEIN)
    ("taxanes" . SPARSER::DRUG)
    ("various RNA-binding proteins and small non-coding RNAs"
     . SPARSER::COLLECTION)
    ("this stress-activated regulator" . SPARSER::REGULATOR)
    ("translational initiation factor EIF4G1" . SPARSER::PROTEIN)
    ("tRNA Ala and tRNA Cys" . SPARSER::COLLECTION)
    ("YBX1 and tRNA" . SPARSER::COLLECTION)
    ("microRNA, and CeRNA" . SPARSER::COLLECTION)
    ("EIF4G1, ITGB4, AKT1, and ADAM8" . SPARSER::COLLECTION)
    ("mimetics and anti-sense LNAs ( xref ) and the two cohorts"
     . SPARSER::COLLECTION)
    ("hypoxia and the YBX1-dependence" . SPARSER::COLLECTION)
    ("CD97 and TIMP3" . SPARSER::COLLECTION)
    ("tRF Asp , tRF Glu , and tRF Gly" . SPARSER::COLLECTION)
    ("MDA-parental and CN-parental" . SPARSER::COLLECTION)
    ("EIF4G1, EIF4EBP1, and EIF3B" . SPARSER::COLLECTION)
    ("AKT, EIF4G1, ITGB4, and HMGA1" . SPARSER::COLLECTION)
    ("LNA or tRF" . SPARSER::COLLECTION)
    ("HMGA1, TIMP3, and CD97" . SPARSER::COLLECTION)
    ("HMGA1, CD97, and TIMP3" . SPARSER::COLLECTION)
    ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("MDA-parental and MDA-LM2" . SPARSER::COLLECTION)
    ("HMGA1, CD151, CD97, and TIMP3" . SPARSER::COLLECTION)
    ("tRF-YBX1" . SPARSER::COLLECTION)
    ("an exogenous tRF Glu" . SPARSER::AMINO-ACID)
    ("LNAs or tRF" . SPARSER::COLLECTION)
    ("YBX1 and CU-box" . SPARSER::COLLECTION) ("mer" . SPARSER::PROTEIN)
    ("mers" . SPARSER::PROTEIN) ("LNA" . SPARSER::PROTEIN)
    ("reverse-complement" . SPARSER::PROTEIN) ("tRFs" . SPARSER::PROTEIN)
    ("tRF" . SPARSER::PROTEIN) ("YBX1-tRF" . SPARSER::COLLECTION)
    ("fragments—tRNA" . SPARSER::COLLECTION)
    ("stress-induced RNAs (tiRNAs) and likely play roles"
     . SPARSER::COLLECTION)
    ("stress-induced RNAs" . SPARSER::RNA) ("MDA–parental" . SPARSER::DRUG)
    ("fragments and YBX1" . SPARSER::COLLECTION)
    ("Glu and YBX1" . SPARSER::COLLECTION) ("catabolism" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG)
    ("a multifunctional RNA binding protein" . SPARSER::PROTEIN)
    ("Ala" . SPARSER::AMINO-ACID) ("solution" . SPARSER::MOLECULE)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("a sizeable fraction" . SPARSER::COMPONENT)
    ("MDA-parental" . SPARSER::DRUG) ("MDA" . SPARSER::DRUG)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a versatile RNA-binding protein" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("-tRNA" . SPARSER::COLLECTION)
    ("also known as stress-induced fragments" . SPARSER::FRAGMENT)
    ("Angiogenin" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("LNAs" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::PROTEIN) ("tRNAs" . SPARSER::PROTEIN)
    ("EIF4G" . SPARSER::PROTEIN) ("ADAM8" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("e-12" . SPARSER::PROTEIN)
    ("EIF3B" . SPARSER::PROTEIN) ("EIF4EBP1" . SPARSER::PROTEIN)
    ("ITGB4" . SPARSER::PROTEIN) ("EIF4G1" . SPARSER::PROTEIN)
    ("MAPK14" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("CD97" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("α-amanitin" . SPARSER::MOLECULE)
    ("long form" . SPARSER::PROTEIN) ("guide RNA" . SPARSER::RNA)
    ("RNA binding protein" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("CA9" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("YBX1" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("MOCA" . SPARSER::PROTEIN) ("EGFRvIII" . SPARSER::PROTEIN)
    ("cadherin–Rac" . SPARSER::COLLECTION)
    ("DOCK180 and SOS1" . SPARSER::COLLECTION)
    ("EGFR and E-cadherin" . SPARSER::COLLECTION)
    ("alternative Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dominant-negative Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DOCK180-cadherin" . SPARSER::COLLECTION)
    ("GST–E-cadherin" . SPARSER::COLLECTION)
    ("DOCK180-E-cadherin" . SPARSER::COLLECTION) ("ions" . SPARSER::MOLECULE)
    ("DOCK180 and EGFR" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("versa" . SPARSER::PROTEIN)
    ("SOS1 and DOCK180" . SPARSER::COLLECTION)
    ("exchange factors, SOS1 and DOCK180" . SPARSER::COLLECTION)
    ("E-cadherin–EGFR" . SPARSER::COLLECTION)
    ("ErbB3 or scramble oligos" . SPARSER::COLLECTION)
    ("A–B" . SPARSER::PROTEIN) ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("EGFR or ErbB3" . SPARSER::COLLECTION)
    ("GTPases or proteins" . SPARSER::COLLECTION)
    ("monomers or homodimers" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("monomers" . SPARSER::MONOMER)
    ("ErbB2 or ErbB3" . SPARSER::COLLECTION)
    ("EGFR, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("DOCK180 or SOS1" . SPARSER::COLLECTION)
    ("Ras and Rac" . SPARSER::COLLECTION)
    ("EGFR, ErbB2, ErbB3 or ErbB4" . SPARSER::COLLECTION)
    ("ErbB4" . SPARSER::PROTEIN) ("EGFR–E-cadherin" . SPARSER::COLLECTION)
    ("new cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the unconventional GEFs" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN)
    ("activators or guanine nucleotide exchange factors" . SPARSER::COLLECTION)
    ("Tiam1 or Asef" . SPARSER::COLLECTION) ("Asef" . SPARSER::PROTEIN)
    ("GEF" . SPARSER::GEF) ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the classical prototype cell–cell adhesion receptor" . SPARSER::RECEPTOR)
    ("EGFR and DOCK180" . SPARSER::COLLECTION)
    ("EGFR and two Rac1 GEFs, SOS1 and DOCK180" . SPARSER::COLLECTION)
    ("GEFs, SOS1 and DOCK180" . SPARSER::COLLECTION)
    ("GEFs" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("DOCK3" . SPARSER::PROTEIN) ("DOCK7" . SPARSER::PROTEIN)
    ("F–H" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("E–F" . SPARSER::PROTEIN) ("G–H" . SPARSER::PROTEIN)
    ("C–D" . SPARSER::PROTEIN) ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("G–I" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("Tub2" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("mitomycin C" . SPARSER::DRUG)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ELMO2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("DOCK180" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("Fas-associated death domain protein (FADD)" . SPARSER::PROTEIN)
    ("FAS/tumour necrosis factor" . SPARSER::COLLECTION)
    ("viral IL-10" . SPARSER::PROTEIN)
    ("the HCMV-encoded viral IL-10 homologue" . SPARSER::PROTEIN)
    ("anti-β-actin" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("RFP" . SPARSER::PROTEIN)
    ("the latency-associated LUNA gene" . SPARSER::GENE)
    ("Kasumi-3" . SPARSER::COLLECTION)
    ("IL-10 and PEA-15" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN) ("the viral genes" . SPARSER::GENE)
    ("cellular IL-10" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("Fas-associated death domain protein" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN) ("IE2" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE) ("PEA-15" . SPARSER::PROTEIN)
    ("prenylation inhibitors and a PAK1 inhibitor" . SPARSER::COLLECTION)
    ("Tipifarnib (R115777) and Lonafarnib (SCH66336)" . SPARSER::COLLECTION)
    ("Lonafarnib" . SPARSER::DRUG) ("Tipifarnib" . SPARSER::DRUG)
    ("FTIs" . SPARSER::DRUG) ("Ras-converting enzyme-1" . SPARSER::COLLECTION)
    ("ICMT" . SPARSER::PROTEIN) ("RCE1" . SPARSER::PROTEIN)
    ("PAK1 or prenylation inhibitors" . SPARSER::COLLECTION)
    ("PAK1 and prenylation inhibitors" . SPARSER::COLLECTION)
    ("either prenylation inhibitors or PAK1 inhibitor" . SPARSER::COLLECTION)
    ("prenylation inhibitors and PAK1 inhibitor" . SPARSER::COLLECTION)
    ("PAK1 and KRAS" . SPARSER::COLLECTION)
    ("phospholipase C-epsilon" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("epsilon" . SPARSER::PROTEIN)
    ("RalGDS" . SPARSER::PROTEIN)
    ("PAK1 inhibitor and prenylation inhibitors" . SPARSER::COLLECTION)
    ("FTI and GGTI" . SPARSER::COLLECTION)
    ("farnesyltransferase inhibitors (FTI) and geranylgeranyltransferase inhibitors (GGTI)"
     . SPARSER::COLLECTION)
    ("inhibitors (GGTI)" . SPARSER::INHIBITOR)
    ("inhibitors (FTI)" . SPARSER::INHIBITOR) ("Examples" . SPARSER::EXAMPLE)
    ("adaptor protein/proto-oncogene" . SPARSER::COLLECTION)
    ("MEK, Snail and LIMK-1" . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN)
    ("E-cadherin and p120-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, p120-catenin, total PAK1 and p-PAK1(Thr423)"
     . SPARSER::COLLECTION)
    ("Rank" . SPARSER::PROTEIN) ("PAK1 and Crk-II" . SPARSER::COLLECTION)
    ("p120-catenin/E-cadherin" . SPARSER::COLLECTION)
    ("p120-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("PAK1, Crk, p120-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("onco-protein" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("KRAS or NRAS" . SPARSER::COLLECTION) ("Serine" . SPARSER::AMINO-ACID)
    ("E-cadherin/p120-catenin" . SPARSER::COLLECTION)
    ("KRAS/PAK1/Crk" . SPARSER::COLLECTION) ("FTI " . SPARSER::DRUG)
    ("farnesyltransferase inhibitor (FTI) and geranylgeranyltransferase inhibitor (GGTI)"
     . SPARSER::COLLECTION)
    ("inhibitor (GGTI)" . SPARSER::INHIBITOR)
    ("inhibitor (FTI)" . SPARSER::INHIBITOR) ("p-Crk-II" . SPARSER::COLLECTION)
    ("GGTI" . SPARSER::PROTEIN) ("FTI" . SPARSER::DRUG)
    ("p-Crk" . SPARSER::COLLECTION) ("p-PAK1" . SPARSER::COLLECTION)
    ("PAK1/Crk" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("LIMK-1" . SPARSER::PROTEIN)
    ("CTNND1" . SPARSER::PROTEIN) ("p120 Catenin" . SPARSER::PROTEIN)
    ("p120 catenin" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("FRAX597" . SPARSER::DRUG) ("IPA-3" . SPARSER::MOLECULE)
    ("Crk-II" . SPARSER::PROTEIN) ("c-Crk" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CNR" . SPARSER::MOLECULE)
    ("androgen and ER" . SPARSER::COLLECTION)
    ("another known breast cancer-associated gene" . SPARSER::GENE)
    ("disease-associated alleles" . SPARSER::ALLELE) ("p-" . SPARSER::PROTEIN)
    ("our Sardinian cohort" . SPARSER::MOLECULE)
    ("a less restrictive p  " . SPARSER::PROTEIN)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("FGFR2 and TOX3" . SPARSER::COLLECTION)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("at least 72 common lower penetrance alleles" . SPARSER::ALLELE)
    ("BRCA2 and other genes" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and other genes" . SPARSER::COLLECTION)
    ("TOX3 and FGFR2" . SPARSER::COLLECTION)
    ("a well-established breast cancer-associated gene" . SPARSER::GENE)
    ("Mapping" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("BPC3" . SPARSER::PROTEIN) ("mach2" . SPARSER::DRUG)
    ("erbB-2" . SPARSER::PROTEIN) ("VAV3" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("TOX3" . SPARSER::PROTEIN)
    ("SATB1 and HR" . SPARSER::COLLECTION) ("cofactors" . SPARSER::PROTEIN)
    ("HR- and HR+" . SPARSER::COLLECTION) ("HR-" . SPARSER::PROTEIN)
    ("HER2-" . SPARSER::PROTEIN) ("SATB1-" . SPARSER::PROTEIN)
    ("SATB1, HER2 or HR" . SPARSER::COLLECTION)
    ("SATB1, HER2 and HR" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("ER and HER2" . SPARSER::COLLECTION)
    ("HER2 and other receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("EGF-HER2" . SPARSER::COLLECTION)
    ("growth factors and hormone" . SPARSER::COLLECTION)
    ("HER2 and ER" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/MAPK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogen-receptor (ER) and progesterone-receptor (PR)"
     . SPARSER::COLLECTION)
    ("SATB1 or HER2" . SPARSER::COLLECTION)
    ("SATB1/HER2" . SPARSER::COLLECTION) ("HER2 and HR" . SPARSER::COLLECTION)
    ("SATB1 and HER2" . SPARSER::COLLECTION) ("BCL2" . SPARSER::PROTEIN)
    ("Chromosome17" . SPARSER::PROTEIN)
    ("progesterone-receptor" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("SATB1" . SPARSER::PROTEIN)
    ("Special AT-rich sequence binding protein 1" . SPARSER::PROTEIN)
    ("VLA4 and vascular cellular adhesion molecule-1" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("CD82/integrin" . SPARSER::COLLECTION)
    ("MMP9 and MT1-MMP/MMP-14" . SPARSER::COLLECTION)
    ("MT1-MMP/MMP-14" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("H3K27me3 and the amount of EZH2" . SPARSER::COLLECTION)
    ("Hox" . SPARSER::PROTEIN) ("IgG or CD82" . SPARSER::COLLECTION)
    ("PTEN or p16" . SPARSER::COLLECTION)
    ("p-p38 and a 2-fold" . SPARSER::COLLECTION) ("CEL" . SPARSER::PROTEIN)
    ("/CD82" . SPARSER::COLLECTION) ("CD82 and EZH2" . SPARSER::COLLECTION)
    ("EZH2 and CD82" . SPARSER::COLLECTION)
    ("the CDKN2A (p16) and CDKN1B genes" . SPARSER::COLLECTION)
    ("EZH2, DNMT3A, and histone deacetylase 6" . SPARSER::COLLECTION)
    ("PTEN and p16" . SPARSER::COLLECTION) ("azacytidine" . SPARSER::DRUG)
    ("also known as cyclin dependent kinase inhibitor 2 ( CDKN2A ) and cyclin-dependent kinase 4 inhibitor ( CDK4I )"
     . SPARSER::COLLECTION)
    ("Philadelphia positive acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("DNA methyltransferase 3A (DNMT3A) and EZH2" . SPARSER::COLLECTION)
    ("chronic myelomonocytic leukemia" . SPARSER::PROTEIN)
    ("Polycomb" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("cytarabine" . SPARSER::MOLECULE)
    ("Acute myelogenous leukemia (AML)" . SPARSER::PROTEIN)
    ("shRNA and CD34 +" . SPARSER::COLLECTION) ("/CD38" . SPARSER::COLLECTION)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY) ("VLA-4" . SPARSER::PROTEIN)
    ("VLA4" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("B-ALL" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("CDKN1B" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("p-p38" . SPARSER::PROTEIN) ("waf1" . SPARSER::PROTEIN)
    ("EOL-1" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("CDK4I" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD82" . SPARSER::PROTEIN) ("bax" . SPARSER::PROTEIN)
    ("bisulfite" . SPARSER::MOLECULE)
    ("5-aza-2-deoxycytidine" . SPARSER::PROTEIN-PAIR)
    ("p53 and p73" . SPARSER::COLLECTION) ("TSGs" . SPARSER::PROTEIN)
    ("RPRM and p73" . SPARSER::COLLECTION) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("p53/p73" . SPARSER::COLLECTION)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("TSG" . SPARSER::PROTEIN) ("RPRM" . SPARSER::PROTEIN)
    ("Reprimo" . SPARSER::PROTEIN) ("IGFBP3" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("RPL30" . SPARSER::PROTEIN)
    ("X-Gal" . SPARSER::MOLECULE) ("p-Akt" . SPARSER::COLLECTION)
    ("serines" . SPARSER::AMINO-ACID) ("p53 and PUMA" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN) ("p-AKT" . SPARSER::COLLECTION)
    ("p-HDM2" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("p53 and HDM2" . SPARSER::COLLECTION)
    ("p53 and targets p53" . SPARSER::COLLECTION)
    ("Akt and HDM2" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("AKT/HDM2" . SPARSER::COLLECTION)
    ("p53 and target p53" . SPARSER::COLLECTION) ("/Akt" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("nuclear factor-κB kinases ( xref , xref ) and HDM2 ( xref )"
     . SPARSER::COLLECTION)
    ("B-cell lymphoma 2-associated death promoter" . SPARSER::PROMOTER)
    ("phosphorylating downstream substrates" . SPARSER::SUBSTRATE)
    ("protein phosphatase and lipid" . SPARSER::COLLECTION)
    ("HDM2 and p53" . SPARSER::COLLECTION) ("Akt/HDM2" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN)
    ("Tumor suppressor gene" . SPARSER::PROTEIN) ("MK3" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("PIP3" . SPARSER::PIP3)
    ("factor-κB" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("common sporadic AF" . SPARSER::PROTEIN)
    ("PITX2 and ZFHX3" . SPARSER::COLLECTION)
    ("SYNPO2L , SYNE2 , and HCN4" . SPARSER::COLLECTION)
    ("CAV1/CAV2" . SPARSER::COLLECTION)
    ("HCN4 as well as sodium channels Nav1" . SPARSER::COLLECTION)
    ("cardiac potassium channels Kir2.1" . SPARSER::PROTEIN)
    ("AF or lone AF" . SPARSER::COLLECTION)
    ("CAV1 and AF" . SPARSER::COLLECTION)
    ("AF and lone AF" . SPARSER::COLLECTION)
    ("AF and Lone AF" . SPARSER::COLLECTION)
    ("−3 , OR=1.36" . SPARSER::COLLECTION) ("Lone AF" . SPARSER::PROTEIN)
    ("sporadic AF" . SPARSER::PROTEIN) ("−3 , OR=1.35" . SPARSER::COLLECTION)
    ("−3 , OR=1.34" . SPARSER::COLLECTION) ("obs" . SPARSER::PROTEIN)
    ("KCNN3 and AF" . SPARSER::COLLECTION)
    ("SYNE2 , and SNP" . SPARSER::COLLECTION)
    ("PITX2 , rs7193343 and rs2106261" . SPARSER::COLLECTION)
    ("CAV1 , and rs1152591" . SPARSER::COLLECTION)
    ("SCN5A , KCNQ1 , KCNE2 , KCNJ2 , KCNA5 , KCNH2 , NPPA , and NUP155"
     . SPARSER::COLLECTION)
    ("NPPA" . SPARSER::PROTEIN) ("LV" . SPARSER::MOLECULE)
    ("a strong candidate susceptibility gene" . SPARSER::GENE)
    ("Kir2.1, KCNH2, and HCN4" . SPARSER::COLLECTION)
    ("lone AF" . SPARSER::PROTEIN) ("adj" . SPARSER::DRUG)
    ("SYNE2 , and rs7164883/" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("CAV2" . SPARSER::PROTEIN)
    ("Transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("SCN10A" . SPARSER::PROTEIN) ("sodium channel" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("K1" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("WNT8A" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("NUP155" . SPARSER::PROTEIN) ("KCNA5" . SPARSER::PROTEIN)
    ("KCNJ2" . SPARSER::PROTEIN) ("KCNE2" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("SCN5A" . SPARSER::PROTEIN)
    ("Nav1" . SPARSER::PROTEIN) ("KCNH2" . SPARSER::PROTEIN)
    ("Kir2.1" . SPARSER::PROTEIN) ("HCN4" . SPARSER::PROTEIN)
    ("SYNE2" . SPARSER::PROTEIN) ("SYNPO2L" . SPARSER::PROTEIN)
    ("C9orf3" . SPARSER::PROTEIN) ("PRRX1" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("KCNN3" . SPARSER::PROTEIN)
    ("ZFHX3" . SPARSER::PROTEIN) ("PITX2" . SPARSER::PROTEIN)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("a 170-kDa transmembrane glycoprotein and a tyrosine kinase receptor"
     . SPARSER::COLLECTION)
    ("a 170-kDa transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("EGFR-FISH" . SPARSER::COLLECTION)
    ("gene and chromosome" . SPARSER::COLLECTION)
    ("the major FISH" . SPARSER::PROTEIN) ("1b" . SPARSER::PROTEIN)
    ("valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("EGFR or HER2" . SPARSER::COLLECTION) ("ErbB3/HER3" . SPARSER::COLLECTION)
    ("predictive tumour biomarkers" . SPARSER::MOLECULE)
    ("the main histological type" . TYPE)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("EGFR antibody" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER4" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN)
    ("common NOTCH3 variants and ischemic stroke" . SPARSER::COLLECTION)
    ("PCs" . SPARSER::PROTEIN) ("Cohorts" . SPARSER::MOLECULE)
    ("a hereditary form" . SPARSER::FORM) ("IIB" . SPARSER::PROTEIN)
    ("IA and IB" . SPARSER::COLLECTION) ("IB" . SPARSER::DRUG)
    ("IA" . SPARSER::MOLECULE) ("notch 3" . SPARSER::PROTEIN)
    ("dominant and recessive" . SPARSER::PROTEIN) ("PC2" . SPARSER::PROTEIN)
    ("NOTCH3" . SPARSER::PROTEIN)
    ("clinically and histopathologically evident t-MN" . SPARSER::COLLECTION)
    ("the mutational profile t-MDS" . SPARSER::COLLECTION)
    ("dL" . SPARSER::MOLECULE) ("absolute neutrophil" . SPARSER::PROTEIN)
    ("BRAF , DNMT3A , FLT3 , IDH1 , IDH2 , JAK2 , KRAS , and NPM1"
     . SPARSER::COLLECTION)
    ("a previously published cohort" . SPARSER::MOLECULE)
    ("MDS/AML" . SPARSER::PROTEIN)
    ("t-MDS/AML and de novo MDS/AML" . SPARSER::COLLECTION)
    ("t-MDS/AML" . SPARSER::COLLECTION)
    ("PTPN11 , FLT3 , IDH1 , NRAS , KIT , JAK2 , and MPL"
     . SPARSER::COLLECTION)
    ("MPL" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN) ("Classes" . CLASS)
    ("RARS" . SPARSER::PROTEIN) ("genome-wide DNA" . SPARSER::DNA)
    ("morphologic variants" . SPARSER::VARIANT)
    ("A previously published patient cohort" . SPARSER::MOLECULE)
    ("t-MDS" . SPARSER::COLLECTION) ("MDS" . SPARSER::PROTEIN)
    ("t-MN" . SPARSER::COLLECTION) ("MN" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("ezrin-" . SPARSER::PROTEIN)
    ("ezrin and merlin" . SPARSER::COLLECTION)
    ("ezrin, moesin and CD44" . SPARSER::COLLECTION)
    ("merlin" . SPARSER::PROTEIN) ("MAPK and c-Jun" . SPARSER::COLLECTION)
    ("linkers" . SPARSER::LINKER)
    ("its principal component ezrin" . SPARSER::PROTEIN)
    ("PIK3CA, KRAS, BRAF and EGFR" . SPARSER::COLLECTION)
    ("sorafenib (5 mg/kg/die) and everolimus (1 mg/kg/die)"
     . SPARSER::COLLECTION)
    ("toxic chemical" . SPARSER::MOLECULE)
    ("the stress-activated c-Jun and p38 MAPK" . SPARSER::PROTEIN)
    ("c-Jun and p38" . SPARSER::COLLECTION) ("activators" . SPARSER::ACTIVATOR)
    ("BHA" . SPARSER::MOLECULE) ("everolimus-" . SPARSER::DRUG)
    ("MitoSOX" . SPARSER::DRUG) ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("sorafenib-" . SPARSER::DRUG) ("cJun" . SPARSER::PROTEIN)
    ("Annexin V/PI" . SPARSER::COLLECTION) ("Everolimus" . SPARSER::MOLECULE)
    ("everolimus and sorafenib" . SPARSER::COLLECTION)
    ("its principal component" . SPARSER::COMPONENT)
    ("particular ezrin" . SPARSER::PROTEIN) ("MES" . SPARSER::MOLECULE)
    ("everolimus or sorafenib" . SPARSER::COLLECTION)
    ("MAPK/p90RSK" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("RSK" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("everolimus and/or sorafenib" . SPARSER::COLLECTION)
    ("mTOR and ERK1/2" . SPARSER::COLLECTION)
    ("sarcomatous MPM" . SPARSER::MOLECULE)
    ("both sarcomatous and epithelial subtypes" . SPARSER::PROTEIN)
    ("phosphorylated mTOR (P-mTOR) and ERM (P-ERM)" . SPARSER::COLLECTION)
    ("MPM and ezrin" . SPARSER::COLLECTION) ("Ezrin" . SPARSER::PROTEIN)
    ("ezrin-radixin-moesin" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inositol-3-kinase-mammalian target of rapamycin-protein kinase B"
     . SPARSER::COLLECTION)
    ("inositol" . SPARSER::PROTEIN) ("asbestos" . SPARSER::MOLECULE)
    ("ERM and mTOR" . SPARSER::COLLECTION)
    ("sorafenib and everolimus" . SPARSER::COLLECTION)
    ("Sorafenib and everolimus" . SPARSER::COLLECTION)
    ("AMPK-p38" . SPARSER::COLLECTION) ("Sorafenib" . SPARSER::DRUG)
    ("mTOR and ERM" . SPARSER::COLLECTION)
    ("EGFR, KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("thoracoscopic MPM" . SPARSER::MOLECULE)
    ("the multikinase inhibitor sorafenib and the mTOR inhibitor everolimus"
     . SPARSER::COLLECTION)
    ("commercially available molecules" . SPARSER::MOLECULE)
    ("everolimus" . SPARSER::DRUG) ("sorafenib" . SPARSER::DRUG)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION)
    ("PIK3CA-mTOR-AKT" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("moesin" . SPARSER::PROTEIN) ("radixin" . SPARSER::PROTEIN)
    ("ezrin" . SPARSER::PROTEIN) ("Transducers" . SPARSER::PROTEIN)
    ("MPM" . SPARSER::MOLECULE) ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("c-Jun" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("P-ERM" . SPARSER::PROTEIN)
    ("m-TOR" . SPARSER::PROTEIN) ("linker protein" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA" . SPARSER::PROTEIN)
    ("further affecting pro-apoptotic factor caspase-7" . SPARSER::PROTEIN)
    ("pro-apoptotic factor caspase-7" . SPARSER::PROTEIN)
    ("paclitaxel" . SPARSER::DRUG)
    ("Taxol or vinblastine" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("vinblastine" . SPARSER::DRUG)
    ("Taxol and carboplatin" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR) ("RNA and DNA" . SPARSER::COLLECTION)
    ("uracil" . SPARSER::DRUG) ("antimetabolite" . SPARSER::DRUG)
    ("the pro-apoptotic factor caspase-7" . SPARSER::PROTEIN)
    ("caspases-3, caspases-6, caspases-9, PARP and p38" . SPARSER::COLLECTION)
    ("MDR1 and MRP1" . SPARSER::COLLECTION)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("C-myc and C-myc" . SPARSER::COLLECTION)
    ("approximately 22-nucleotide noncoding RNAs" . SPARSER::RNA)
    ("multiple-drug resistance protein (P-glycoprotein) and multiple-drug resistance-associated protein 1 (MRP1)"
     . SPARSER::COLLECTION)
    ("multiple-drug resistance-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Luciferase" . SPARSER::PROTEIN)
    ("Akt2 and caspase-7" . SPARSER::COLLECTION) ("PI3-K" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("IMP-1" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("C-5" . SPARSER::PROTEIN)
    ("fluorine atom" . SPARSER::MOLECULE) ("let- 7" . SPARSER::RNA)
    ("c-5" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("caspases-9" . SPARSER::PROTEIN)
    ("caspases-6" . SPARSER::PROTEIN) ("caspases-3" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("C-myc" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("caspase-7" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("essential genes" . SPARSER::GENE)
    ("aims" . SPARSER::PROTEIN) ("CD95/Fas" . SPARSER::COLLECTION)
    ("glutathione" . SPARSER::DRUG) ("shRNA-Ctrl" . SPARSER::COLLECTION)
    ("shRNA-FLIP" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("Fas and FLIP" . SPARSER::COLLECTION) ("Receptor" . SPARSER::RECEPTOR)
    ("SD" . SPARSER::PROTEIN)
    ("further assessed using Western blot" . SPARSER::PROTEIN)
    ("p42 and p18" . SPARSER::COLLECTION) ("ctrl" . SPARSER::PROTEIN)
    ("IAPs, survivin, and bcl-w" . SPARSER::COLLECTION)
    ("FLIP/casper" . SPARSER::COLLECTION) ("casper" . SPARSER::PROTEIN)
    ("GADD45, mdm-2, and bcl-2" . SPARSER::COLLECTION)
    ("TRAIL, TRAFs, TNFsf, and FADD" . SPARSER::COLLECTION)
    ("TRAFs" . SPARSER::PROTEIN) ("TNFr" . SPARSER::PROTEIN)
    ("Four housekeeping genes and 96 genes" . SPARSER::COLLECTION)
    ("bleomycin- and bleomycin" . SPARSER::COLLECTION)
    ("TRAIL" . SPARSER::PROTEIN)
    ("FasL or agonistic anti-Fas antibodies [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("agonistic anti-Fas antibodies" . SPARSER::ANTIBODY)
    ("CD95/APO-1" . SPARSER::COLLECTION) ("agonists" . SPARSER::AGONIST)
    ("collagen" . SPARSER::PROTEIN)
    ("Western blot and flow cytometry" . SPARSER::PROTEIN)
    ("FLIP or Fas" . SPARSER::COLLECTION) ("Bleomycin" . SPARSER::DRUG)
    ("MLE" . SPARSER::PROTEIN)
    ("specifically FLICE-like inhibitory protein (FLIP)" . SPARSER::PROTEIN)
    ("protein (FLIP)" . SPARSER::PROTEIN) ("FLIP" . SPARSER::PROTEIN)
    ("FLICE" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("Fas-FasL" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("Fas" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("bcl-w" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("mdm-2" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("mL -1" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("l-glutamine" . SPARSER::MOLECULE) ("TMPYP4" . SPARSER::DRUG)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("APO-1" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("Vemurafenib" . SPARSER::DRUG)
    ("perinatal" . SPARSER::PROTEIN) ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("7/23 sporadic SCAP" . SPARSER::PROTEIN)
    ("sporadic SCAP" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("sporadic SCAPs" . SPARSER::PROTEIN) ("SCAPs" . SPARSER::PROTEIN)
    ("PTCH" . SPARSER::PROTEIN) ("HRAS and KRAS" . SPARSER::COLLECTION)
    ("HRAS" . SPARSER::PROTEIN) ("SCAP" . SPARSER::PROTEIN)
    ("keratin-14" . SPARSER::PROTEIN)
    ("enzalutamide and abiraterone" . SPARSER::COLLECTION)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("bipartite" . SPARSER::PROTEIN)
    ("naturally occurring AR splice variants" . SPARSER::VARIANT)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("Src and Etk/BMX kinases" . SPARSER::COLLECTION)
    ("coactivators and the basal transcriptional complex"
     . SPARSER::COLLECTION)
    ("endogenous wild type AR and the exogenous Y267F mutant AR"
     . SPARSER::COLLECTION)
    ("the exogenous Y267F mutant AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("full length AR protein and the truncated AR splice variant protein"
     . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("AR-wt" . SPARSER::PROTEIN-PAIR)
    ("PSA and KLK2" . SPARSER::COLLECTION)
    ("exogenous AR protein" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("DHT-Ack1" . SPARSER::COLLECTION)
    ("exogenous AR proteins" . SPARSER::PROTEIN)
    ("EGF, heregulin, or Gas6" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN)
    ("exogenous AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARR2-PB" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("full length AR and the constitutively active AR" . SPARSER::COLLECTION)
    ("Tnk2" . SPARSER::PROTEIN) ("Etk/BMX" . SPARSER::COLLECTION)
    ("BMX" . SPARSER::PROTEIN) ("Etk" . SPARSER::PROTEIN)
    ("chromatin, and tumor" . SPARSER::COLLECTION) ("Guo" . SPARSER::MOLECULE)
    ("antiandrogens" . SPARSER::DRUG) ("TIF2/SRC2/NCOA2" . SPARSER::COLLECTION)
    ("androgen or Ack1" . SPARSER::COLLECTION)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protein phosphatase 1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("FL-AR" . SPARSER::PROTEIN) ("KLK2" . SPARSER::PROTEIN)
    ("anti-androgen" . SPARSER::DRUG) ("ARR2" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("Gas6" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("cdc42" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("NCOA2" . SPARSER::PROTEIN)
    ("SRC2" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("Tyr-267" . SPARSER::PROTEIN) ("Ack1" . SPARSER::PROTEIN)
    ("aldehydes" . SPARSER::MOLECULE) ("oxidants" . SPARSER::MOLECULE)
    ("p53-associated deacetylase activity" . SPARSER::PROTEIN)
    ("p53-associated acetylated HDAC1" . SPARSER::PROTEIN)
    ("P53-associated HDAC1" . SPARSER::PROTEIN)
    ("HDAC1 and acetyl-HDAC1" . SPARSER::COLLECTION)
    ("HDAC1 or acetyl-mimic HDAC1 (6Q)" . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN) ("CBP or PCAF" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN)
    ("a major acetyltransferase" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("p53 and its downstream targets" . SPARSER::COLLECTION)
    ("HDAC1 or non-acetyl-mimicking" . SPARSER::COLLECTION)
    ("acetyl-mimic HDAC1 6Q or non-acetyl-mimicking HDAC1 6R"
     . SPARSER::COLLECTION)
    ("Flag-tagged HDAC1, acetyl-mimic HDAC1 6Q or non-acetyl-mimicking HDAC1 6R"
     . SPARSER::COLLECTION)
    ("HDAC1 or HDAC1" . SPARSER::COLLECTION)
    ("wild-type HDAC1 or in vitro acetylated HDAC1" . SPARSER::COLLECTION)
    ("p53 and HDAC1" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("polypeptide" . SPARSER::PROTEIN) ("cofactor" . SPARSER::MOLECULE)
    ("coenzyme" . SPARSER::MOLECULE)
    ("HDAC1 (histone deacetylase 1) and SIRT1 (sirtuin 1)"
     . SPARSER::COLLECTION)
    ("an essential transcription factor" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN) ("cell membrane" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN) ("HSPA4L" . SPARSER::PROTEIN)
    ("P300" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("this novel tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("the intronic miRNAs" . SPARSER::PROTEIN)
    ("its intronic miRNAs" . SPARSER::PROTEIN)
    ("intronic miRNA-hosting genes" . SPARSER::GENE)
    ("tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("an intronic miRNA" . SPARSER::PROTEIN)
    ("a clinical prognostic biomarker" . SPARSER::MOLECULE)
    ("ER, PR, and ErbB2" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("miR-4728-3p directly targets MST4" . SPARSER::PROTEIN)
    ("Sterile" . SPARSER::PROTEIN-FAMILY) ("MASK" . SPARSER::PROTEIN)
    ("targets and kinases" . SPARSER::COLLECTION)
    ("a specific anti-miR" . SPARSER::ANTIBODY)
    ("Subsequent western blot" . SPARSER::PROTEIN)
    ("JNK1-3" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("some intronic miRNAs" . SPARSER::PROTEIN) ("Iodide" . SPARSER::PROTEIN)
    ("the predominant form" . SPARSER::FORM)
    ("the predominantly expressed mature miRNA" . SPARSER::PROTEIN)
    ("two mature miRNAs" . SPARSER::PROTEIN)
    ("antagonistic intronic miRNAs" . SPARSER::PROTEIN)
    ("a novel tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("oncogenes or tumor-suppressor genes and the roles of intronic miRNAs in cancer development and progression"
     . SPARSER::COLLECTION)
    ("tumor-suppressor genes and the roles of intronic miRNAs in cancer development and progression"
     . SPARSER::COLLECTION)
    ("intronic miRNAs" . SPARSER::PROTEIN) ("Introns" . SPARSER::PROTEIN)
    ("a tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("this intronic miRNA" . SPARSER::PROTEIN)
    ("17 β -estradiol" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("NP40" . SPARSER::MOLECULE)
    ("Glo 3" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("Phospho-kinase" . SPARSER::PROTEIN)
    ("p-ERK 1" . SPARSER::PROTEIN) ("ERK 1" . SPARSER::PROTEIN)
    ("ERK 2" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-kinase" . SPARSER::PROTEIN) ("MST4" . SPARSER::PROTEIN)
    ("K-ras and EGFR" . SPARSER::COLLECTION) ("Braf" . SPARSER::PROTEIN)
    ("irinotecan, fluorouracil, and leucovorin" . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG) ("Van" . SPARSER::PROTEIN)
    ("cetuximab and irinotecan or oxaliplatin" . SPARSER::COLLECTION)
    ("irinotecan or oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin-" . SPARSER::DRUG)
    ("irinotecan or cetuximab" . SPARSER::COLLECTION)
    ("irinotecan and those receiving oxaliplatin (p>0.05, xref )"
     . SPARSER::COLLECTION)
    ("DCR" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("Cetuximab" . SPARSER::DRUG)
    ("GTP/GDP" . SPARSER::PROTEIN-PAIR) ("GDP" . SPARSER::NUCLEOTIDE)
    ("EGFR and K-ras" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib, or cetuximab" . SPARSER::COLLECTION)
    ("anti-EGFR-TK" . SPARSER::COLLECTION)
    ("wild-type KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue) metastatic CRC"
     . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN)
    ("oxaliplatin and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("metastatic CRC" . SPARSER::PROTEIN) ("mCRC" . SPARSER::PROTEIN)
    ("cetuximab" . SPARSER::DRUG) ("EGFR-TK" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("K- ras" . SPARSER::PROTEIN)
    ("Mg2+" . SPARSER::MOLECULE) ("p21 RAS" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("WB" . SPARSER::PROTEIN) ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("Protein and RNA" . SPARSER::COLLECTION)
    ("previously described reduced HIF1α" . SPARSER::PROTEIN)
    ("p53/p63/p73" . SPARSER::COLLECTION)
    ("HIF1α and its target BNIP3" . SPARSER::COLLECTION)
    ("bad" . SPARSER::PROTEIN) ("HIFs" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN) ("p53 and TAp73" . SPARSER::COLLECTION)
    ("transactivational (TA) domain-containing isoforms" . SPARSER::ISOFORM)
    ("TA" . SPARSER::PROTEIN) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("- 3" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P73" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("Sodium Bicarbonate" . SPARSER::DRUG)
    ("Apoptosis-Inducing" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("HIF-1a" . SPARSER::PROTEIN) ("TP73" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("placental SIRT1" . SPARSER::PROTEIN)
    ("Significantly elevated LPL and other genes" . SPARSER::COLLECTION)
    ("TG/FA" . SPARSER::COLLECTION) ("FASN and SREBP1c" . SPARSER::COLLECTION)
    ("increased placental TGs and fetal fat" . SPARSER::COLLECTION)
    ("increased placental TGs" . SPARSER::PROTEIN)
    ("maternal blood TGs" . SPARSER::PROTEIN)
    ("dietary protein" . SPARSER::PROTEIN)
    ("decreased maternal blood TGs" . SPARSER::PROTEIN)
    ("FAs and glycerol" . SPARSER::COLLECTION) ("glycerol" . SPARSER::PROTEIN)
    ("SIRT1 and LPL" . SPARSER::COLLECTION) ("hepatocytes" . SPARSER::PROTEIN)
    ("LPL and other proteins" . SPARSER::COLLECTION)
    ("CD36 and VLDLr" . SPARSER::COLLECTION)
    ("The remarkably increased fetal blood FFA" . SPARSER::PROTEIN)
    ("fetal body fat" . SPARSER::PROTEIN) ("fetal fat" . SPARSER::PROTEIN)
    ("significantly more body fat" . SPARSER::PROTEIN)
    ("SIRT1 and PPARγ" . SPARSER::COLLECTION)
    ("PPARγ and SIRT1" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("the maternal HF" . SPARSER::PROTEIN) ("EBP" . SPARSER::PROTEIN)
    ("PPARγ, C/EBPα, and SREBP1c" . SPARSER::COLLECTION)
    ("PPARγ and C/EBPα" . SPARSER::COLLECTION)
    ("LPL and other genes" . SPARSER::COLLECTION)
    ("maternal obesity-increased placental TGs and fetal FFAs"
     . SPARSER::COLLECTION)
    ("fetal FFAs" . SPARSER::PROTEIN)
    ("maternal obesity-increased placental TGs" . SPARSER::PROTEIN)
    ("FFAs" . SPARSER::PROTEIN) ("FASN" . SPARSER::PROTEIN)
    ("triacylglycerol synthesis glycerol-3-phosphate acyltransferase 2 (GPAT2) and GPAT3"
     . SPARSER::COLLECTION)
    ("triacylglycerol" . SPARSER::MOLECULE)
    ("LPL and CD36" . SPARSER::COLLECTION)
    ("LPL, CD36, VLDLr, FABP3, and FABPpm" . SPARSER::COLLECTION)
    ("The elevated fetal serum FFA" . SPARSER::PROTEIN)
    ("fetuses and dams" . SPARSER::COLLECTION)
    ("glucose and FFA" . SPARSER::COLLECTION) ("HF-" . SPARSER::PROTEIN)
    ("TG and glucose" . SPARSER::COLLECTION)
    ("gestational period HF" . SPARSER::PROTEIN)
    ("Fetal Serum FFA" . SPARSER::PROTEIN)
    ("Gestation Increases Fetal Body Fat" . SPARSER::PROTEIN)
    ("FFA" . SPARSER::PROTEIN) ("Fat" . SPARSER::PROTEIN)
    ("PPARγ-specific agonist and antagonist" . SPARSER::COLLECTION)
    ("SIRT1-" . SPARSER::PROTEIN) ("maternal HF" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("fetal FA" . SPARSER::PROTEIN)
    ("increased placental LPL" . SPARSER::PROTEIN)
    ("the last trimester of pregnancy" . SPARSER::PROTEIN)
    ("lipoprotein lipase (LPL) and endothelial lipase" . SPARSER::COLLECTION)
    ("lipases" . SPARSER::PROTEIN) ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGs" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("Triglyceride" . SPARSER::MOLECULE) ("fetal lipids" . SPARSER::LIPID)
    ("FA" . SPARSER::PROTEIN) ("maternal high-fat (HF)" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN)
    ("excess gestational weight gain increase infant body fat"
     . SPARSER::PROTEIN)
    ("activator and inhibitor" . SPARSER::COLLECTION)
    ("Maternal HF" . SPARSER::PROTEIN)
    ("CD36, VLDLr, FABP3, FABPpm, and GPAT2 and -3" . SPARSER::COLLECTION)
    ("GPAT2 and -3" . SPARSER::COLLECTION) ("VLDLr" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE) ("LPL" . SPARSER::PROTEIN)
    ("dams" . SPARSER::PROTEIN) ("Fetuses" . SPARSER::PROTEIN)
    ("HF" . SPARSER::PROTEIN) ("Ex-527" . SPARSER::DRUG)
    ("Ad-C" . SPARSER::PROTEIN) ("GPAT3" . SPARSER::PROTEIN)
    ("glycerol-3-phosphate acyltransferase 2" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN) ("F-12" . SPARSER::PROTEIN)
    ("SREBP1c" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("EX-527" . SPARSER::DRUG)
    ("6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide" . SPARSER::DRUG)
    ("GW9662" . SPARSER::DRUG) ("of pregnancy" . SPARSER::PROTEIN)
    ("endothelial lipase" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("GPAT2" . SPARSER::PROTEIN)
    ("FABP3" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN)
    ("artificial variants" . SPARSER::VARIANT)
    ("this polymorphic variant" . SPARSER::VARIANT)
    ("All pathogenic variants" . SPARSER::VARIANT)
    ("The types and number of SNVs" . SPARSER::COLLECTION)
    ("delTA" . SPARSER::PROTEIN) ("Families" . SPARSER::PROTEIN-FAMILY)
    ("a hereditary component" . SPARSER::COMPONENT) ("delG" . SPARSER::PROTEIN)
    ("new pathogenic variants" . SPARSER::VARIANT) ("Kit 2" . SPARSER::PROTEIN)
    ("panitumumab" . SPARSER::DRUG) ("the entire cohort" . SPARSER::MOLECULE)
    ("ARMS" . SPARSER::PROTEIN) ("NCCN" . SPARSER::MOLECULE)
    ("this biological matrix" . SPARSER::PROTEIN-FAMILY)
    ("medicine" . SPARSER::DRUG) ("p/t" . SPARSER::COLLECTION)
    ("KRAS and SEPT9" . SPARSER::COLLECTION) ("PCDH10" . SPARSER::PROTEIN)
    ("SEPT9" . SPARSER::PROTEIN) ("Bruce" . SPARSER::PROTEIN)
    ("ductal elongation" . SPARSER::PROTEIN)
    ("ERα and PR" . SPARSER::COLLECTION) ("EREs" . SPARSER::PROTEIN)
    ("estradiol or ethanol" . SPARSER::COLLECTION) ("DPN" . SPARSER::MOLECULE)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E 2 and doxycycline" . SPARSER::COLLECTION) ("tet" . SPARSER::PROTEIN)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("apex" . SPARSER::PROTEIN)
    ("E 2 or ethanol" . SPARSER::COLLECTION) ("sh-" . SPARSER::PROTEIN-FAMILY)
    ("hepatocyte growth factor or fibroblast growth factor 2"
     . SPARSER::COLLECTION)
    ("the bipotent progenitor-initiated matrigel" . SPARSER::PROTEIN)
    ("PR and pS2" . SPARSER::COLLECTION)
    ("EtOH- and E 2" . SPARSER::COLLECTION) ("EtOH-" . SPARSER::MOLECULE)
    ("CD49f, EpCAM, cytokeratin 18, and cytokeratin" . SPARSER::COLLECTION)
    ("E 2 or EtOH" . SPARSER::COLLECTION)
    ("EtOH, E 2 , or E 2" . SPARSER::COLLECTION)
    ("the residual estradiol" . SPARSER::PROTEIN)
    ("ethanol" . SPARSER::PROTEIN) ("EtOH" . SPARSER::MOLECULE)
    ("E 2 or E 2" . SPARSER::COLLECTION) ("complete media" . SPARSER::PROTEIN)
    ("Luminal and bipotent progenitors" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG) ("EpCAM" . SPARSER::PROTEIN)
    ("ERα and estrogen" . SPARSER::COLLECTION)
    ("luminal and myoepithelial cells" . SPARSER::COLLECTION)
    ("the progesterone receptor (PR, a classical ERα target in breast cancer cells) and ERα"
     . SPARSER::COLLECTION)
    ("an indirect mitogen" . SPARSER::MITOGEN) ("mitogen" . SPARSER::MITOGEN)
    ("Estrogen" . SPARSER::MOLECULE) ("estrogen–" . SPARSER::MOLECULE)
    ("GATA3" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("pS2" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("sh-RNA" . SPARSER::RNA) ("ICI 182,780" . SPARSER::DRUG)
    ("18 h" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("17β-estradiol" . SPARSER::PROTEIN) ("phenol-red" . SPARSER::DRUG)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD49f" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("estrogen-receptor" . SPARSER::PROTEIN)
    ("new preventive or therapeutic drugs" . SPARSER::DRUG)
    ("lysosomal" . SPARSER::PROTEIN) ("calpain" . SPARSER::PROTEIN)
    ("the pro-autophagic protein" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN) ("LC3 and Beclin-1" . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vps" . SPARSER::PROTEIN)
    ("Bcl-2-Beclin-1" . SPARSER::COLLECTION)
    ("ROCK1, Beclin-1 and RhoA" . SPARSER::COLLECTION)
    ("anti-ROCK1 (Figure  xref A) or anti-Beclin-1 (Figure  xref B)"
     . SPARSER::COLLECTION)
    ("siRNA, 3-MA, and Bafilomycin A1" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN) ("Y-27632 or ROCK1" . SPARSER::COLLECTION)
    ("LC3-GFP" . SPARSER::COLLECTION)
    ("inhibitors and siRNA techniques" . SPARSER::COLLECTION)
    ("previously identified molecules" . SPARSER::MOLECULE)
    ("12 hpi and 24 hpi" . SPARSER::COLLECTION)
    ("microtubule-associated protein1 light chain 3 (LC3) and caspase-3"
     . SPARSER::COLLECTION)
    ("hpi" . SPARSER::PROTEIN) ("MDC- and Hoechst" . SPARSER::COLLECTION)
    ("MDC-" . SPARSER::PROTEIN) ("MDC" . SPARSER::PROTEIN)
    ("ARV nonstructural protein p17" . SPARSER::PROTEIN)
    ("Beclin-1 and LC3" . SPARSER::COLLECTION)
    ("chemicals and infection" . SPARSER::COLLECTION)
    ("PI3K/Beclin-1" . SPARSER::COLLECTION)
    ("nonstructural protein p10" . SPARSER::PROTEIN)
    ("GTPase, RhoA, and Rac1" . SPARSER::COLLECTION)
    ("at least 10 structural proteins and 4 nonstructural proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("4 nonstructural proteins" . SPARSER::PROTEIN)
    ("at least 10 structural proteins" . SPARSER::PROTEIN)
    ("toxic cellular components" . SPARSER::COMPONENT)
    ("Asp-Glu" . SPARSER::MOLECULE) ("MYPT1" . SPARSER::PROTEIN)
    ("myosin phosphatase target subunit 1" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN) ("p160ROCK" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("PI-3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Y-27632" . SPARSER::MOLECULE) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("p17" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("p10" . SPARSER::PROTEIN) ("Bafilomycin A1" . SPARSER::DRUG)
    ("ROCK1" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("an associated protein" . SPARSER::PROTEIN)
    ("p65/p50" . SPARSER::COLLECTION)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("cytokines and signalling proteins" . SPARSER::COLLECTION)
    ("mkp-1" . SPARSER::PROTEIN) ("LPS" . SPARSER::PROTEIN)
    ("MEK and MKP-1" . SPARSER::COLLECTION)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("interferon" . SPARSER::PROTEIN)
    ("MAPK components and their subsequent suppression" . SPARSER::COLLECTION)
    ("cytokines, IL-10 and TGF-β" . SPARSER::COLLECTION)
    ("dicysteine" . SPARSER::MOLECULE)
    ("all the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("BRB" . SPARSER::PROTEIN) ("MEK-1 and IRAK1BP1" . SPARSER::COLLECTION)
    ("MKP-1, TAB2, pIκB and TTP" . SPARSER::COLLECTION)
    ("AM-251 and AM-630 in Tat-transfected cells" . SPARSER::COLLECTION)
    ("MIO" . SPARSER::PROTEIN)
    ("receptors and inhibitors" . SPARSER::COLLECTION)
    ("MKP-1 or MEK-1" . SPARSER::COLLECTION)
    ("NF-κB, pIκB, IRAK1BP1, TAB2, and TTP" . SPARSER::COLLECTION)
    ("destabilise more pro-inflammatory cytokine mRNA" . SPARSER::PROTEIN)
    ("Tristetraprolin" . SPARSER::PROTEIN)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("AM-251 and AM-630 ( xref )" . SPARSER::COLLECTION)
    ("N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3 carboxamide"
     . SPARSER::MOLECULE)
    ("carboxamide" . SPARSER::MOLECULE)
    ("microglia and Müller" . SPARSER::COLLECTION)
    ("IL-10, and MCP-1" . SPARSER::COLLECTION)
    ("MEK-1 or MKP-1" . SPARSER::COLLECTION)
    ("MKP-1 and MEK-1" . SPARSER::COLLECTION)
    ("MEK-1 and MKP-1" . SPARSER::COLLECTION)
    ("MEK1/2, MKP-1 and MKP-2" . SPARSER::COLLECTION)
    ("enzymes and pI3-AKT" . SPARSER::COLLECTION) ("pI3" . SPARSER::PROTEIN)
    ("IL-6 and CXCL-10" . SPARSER::COLLECTION)
    ("PI3/AKT" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, IL-12p70, CXCL-10, and IL-8" . SPARSER::COLLECTION)
    ("cytokines ( xref d-k) and STAT1α ( xref )" . SPARSER::COLLECTION)
    ("Cytokine" . SPARSER::PROTEIN) ("Suppressor" . SPARSER::SUPPRESSOR)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("ERK, and JNK" . SPARSER::COLLECTION)
    ("ERK1/2 and JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("CXCL-10 and MCP-1" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines, TNF-α, IL-6, IFN-γ and IL-12"
     . SPARSER::COLLECTION)
    ("cytokines, TNF-α, IL-6, IFN-γ and IL-12" . SPARSER::COLLECTION)
    ("IL-10 and TGF-β" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("different components of the MAPK, STAT and SOCS pathway"
     . SPARSER::COLLECTION)
    ("arachidonoylethanolamide" . SPARSER::DRUG)
    ("blood-retinal barrier" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("barrier (BBB)" . SPARSER::PROTEIN)
    ("Endocannabinoid" . SPARSER::MOLECULE)
    ("immune-modulators" . SPARSER::PROTEIN)
    ("Endocannabinoids" . SPARSER::MOLECULE)
    ("endocannabinoid" . SPARSER::MOLECULE)
    ("the inner blood retinal barrier (BRB)" . SPARSER::PROTEIN)
    ("glial" . SPARSER::PROTEIN)
    ("inducing inflammatory chemokines" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN) ("CB" . SPARSER::PROTEIN)
    ("NF-κB and TAB2" . SPARSER::COLLECTION) ("AEA" . SPARSER::MOLECULE)
    ("anandamide" . SPARSER::MOLECULE)
    ("signalosome, and TTP" . SPARSER::COLLECTION)
    ("signalosome" . SPARSER::PROTEIN)
    ("several neurotoxic cytokines" . SPARSER::PROTEIN)
    ("The HIV-1 transactivator viral protein" . SPARSER::PROTEIN)
    ("NFκ" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("IL-12p40" . SPARSER::PROTEIN) ("p-38" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("L- glutamine" . SPARSER::MOLECULE)
    ("phospho-ERK" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("H-1" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("IkBα" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("JAK-STAT" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("CB2" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-1R-associated kinase 1" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IκBα" . SPARSER::PROTEIN)
    ("AM-251" . SPARSER::DRUG) ("p65" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MKP-2" . SPARSER::PROTEIN)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PI3" . SPARSER::PROTEIN)
    ("IL-12p70" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("SP600125" . SPARSER::PROTEIN) ("FR180204" . SPARSER::DRUG)
    ("SOCS-3" . SPARSER::PROTEIN) ("SOCS-1" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("IFN gamma" . SPARSER::PROTEIN)
    ("STAT-1" . SPARSER::PROTEIN) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCP-1" . SPARSER::PROTEIN) ("CXCL-10" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase phosphatase-1" . SPARSER::PROTEIN)
    ("A-K" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("IRAK1BP1" . SPARSER::PROTEIN)
    ("TAB2" . SPARSER::PROTEIN) ("MEK-1" . SPARSER::PROTEIN)
    ("MKP-1" . SPARSER::PROTEIN)
    ("Bmi-1 and microRNA-128" . SPARSER::COLLECTION) ("Shh" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG) ("Nanog" . SPARSER::PROTEIN)
    ("Notch-1 and ZEB1" . SPARSER::COLLECTION)
    ("EMT and stem-like" . SPARSER::COLLECTION) ("docetaxel" . SPARSER::DRUG)
    ("LY 294002, γ-TT and 5-AZA" . SPARSER::COLLECTION)
    ("bcl-2 and Akt" . SPARSER::COLLECTION) ("tocotrienol" . SPARSER::MOLECULE)
    ("sibcl-2" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("TGF-" . SPARSER::DRUG) ("TGF" . SPARSER::DRUG)
    ("charcoal stripped (CS)-FBS + 1 nM DHT" . SPARSER::PROTEIN)
    ("CS-FBS " . SPARSER::COLLECTION) ("-FBS " . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN) ("FBS " . SPARSER::PROTEIN)
    ("Cadherin, Vimentin and Snailin" . SPARSER::COLLECTION)
    ("Cadherin, Vimentin and Snailproteins" . SPARSER::COLLECTION)
    ("AR, PSA and CK8" . SPARSER::COLLECTION)
    ("CD133, integrin and CK5" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("CD133 and CD44" . SPARSER::COLLECTION) ("androgen" . SPARSER::PROTEIN)
    ("Androgen/androgen receptor" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN)
    ("Androgen receptor (AR)" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("BMP7 and SIRT1" . SPARSER::COLLECTION) ("PC-3" . SPARSER::PROTEIN)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("PCa" . SPARSER::PROTEIN) ("AZA" . SPARSER::DRUG)
    ("Cadherin, Vimentin and Snail" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LNCaP" . SPARSER::PROTEIN)
    ("Bmi-1" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("stat3" . SPARSER::PROTEIN)
    ("AR-S" . SPARSER::PROTEIN) ("Lin28B" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("PDGF-D" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("D-F" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("CD 44" . SPARSER::PROTEIN)
    ("CK 8" . SPARSER::PROTEIN) ("CK 5" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("Mg 2+" . SPARSER::MOLECULE)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("CD44" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("Wnt-1" . SPARSER::PROTEIN) ("P63" . SPARSER::PROTEIN)
    ("Stat 3" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("Androgen receptor" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("BMP7" . SPARSER::PROTEIN) ("LIV1" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE)
    ("nucleosome/chromatin" . SPARSER::COLLECTION)
    ("H2A-H2B" . SPARSER::COLLECTION) ("nucleosome" . SPARSER::PROTEIN)
    ("tetramer" . SPARSER::TETRAMER) ("EZH2 and BBAP" . SPARSER::COLLECTION)
    ("EZH2 and H3K27me3-mediated chemoresistance" . SPARSER::COLLECTION)
    ("BBAP or DTX3L" . SPARSER::COLLECTION)
    ("Deltex" . SPARSER::PROTEIN-FAMILY) ("BBAP" . SPARSER::PROTEIN)
    ("nail" . SPARSER::PROTEIN)
    ("H3K27me3 and chemoresistance" . SPARSER::COLLECTION)
    ("GOF" . SPARSER::PROTEIN) ("polycomb" . SPARSER::PROTEIN)
    ("oncoprotein or HDACs" . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("rituximab" . SPARSER::DRUG) ("SMARCA5 and HDAC1" . SPARSER::COLLECTION)
    ("tri-nucleosomes" . SPARSER::COLLECTION) ("ISWI" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("nucleosomes" . SPARSER::BIO-COMPLEX)
    ("directly target regulators" . SPARSER::REGULATOR)
    ("elongation" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("Hdac8" . SPARSER::PROTEIN) ("Hdac1 or Hdac2" . SPARSER::COLLECTION)
    ("Hdac1 and Hdac2" . SPARSER::COLLECTION) ("Hdac2" . SPARSER::PROTEIN)
    ("Hdac1" . SPARSER::PROTEIN) ("together shed light" . SPARSER::PROTEIN)
    ("conditional single gene" . SPARSER::GENE)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("NCoR and SMRT" . SPARSER::COLLECTION)
    ("NCOR and SMRT" . SPARSER::COLLECTION) ("NCOR" . SPARSER::PROTEIN)
    ("SMRT" . SPARSER::PROTEIN) ("NCoR" . SPARSER::PROTEIN)
    ("centromeres" . SPARSER::PROTEIN) ("Hdac3" . SPARSER::PROTEIN)
    ("HDACs and HDIs" . SPARSER::COLLECTION)
    ("SAHA and Depsipeptide" . SPARSER::COLLECTION)
    ("Currently available HDIs" . SPARSER::MOLECULE)
    ("HDIs, SAHA or Vorinostat" . SPARSER::COLLECTION)
    ("Depsipeptide or Romidepsin" . SPARSER::COLLECTION)
    ("vorinostat" . SPARSER::DRUG) ("HDI" . SPARSER::MOLECULE)
    ("Romidepsin" . SPARSER::DRUG) ("Depsipeptide" . SPARSER::DRUG)
    ("Vorinostat" . SPARSER::DRUG) ("benzamide" . SPARSER::DRUG)
    ("hydroxamate" . SPARSER::MOLECULE) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("Class" . CLASS) ("histone and non-histone" . SPARSER::COLLECTION)
    ("deacetylases or KDACs" . SPARSER::COLLECTION)
    ("HDIs" . SPARSER::MOLECULE) ("Inhibitors" . SPARSER::INHIBITOR)
    ("Deacetylases" . SPARSER::PROTEIN)
    ("better-targeted cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("2-selective inhibitors and Hdac1,2 conditional knockout systems"
     . SPARSER::COLLECTION)
    ("2-selective inhibitors" . SPARSER::INHIBITOR) ("FDA" . SPARSER::PROTEIN)
    ("Mi-2" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("DTX3L" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("GSK126" . SPARSER::DRUG)
    ("SET domain" . SPARSER::PROTEIN) ("PRC2" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("ATP-dependent" . SPARSER::PROTEIN)
    ("SMARCA5" . SPARSER::PROTEIN) ("protein 3" . SPARSER::PROTEIN)
    ("SMC3" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("anti-neoplastic" . SPARSER::DRUG)
    ("Histone deacetylase" . SPARSER::PROTEIN) ("HDAC11" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hda1" . SPARSER::PROTEIN)
    ("Rpd3" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("Histone Deacetylase" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("BRD4 and H3K27Ac" . SPARSER::COLLECTION)
    ("food and water" . SPARSER::COLLECTION) ("water" . SPARSER::MOLECULE)
    ("food" . SPARSER::MOLECULE) ("matrigel and MKL-1" . SPARSER::COLLECTION)
    ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("The recently developed bromodomain BET inhibitors" . SPARSER::INHIBITOR)
    ("protein-protein" . SPARSER::COLLECTION)
    ("BRD4 and further recruiting other transcriptional activators"
     . SPARSER::COLLECTION)
    ("further recruiting other transcriptional activators"
     . SPARSER::PROTEIN-FAMILY)
    ("hg" . SPARSER::MOLECULE) ("NHLF" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("MKL" . SPARSER::PROTEIN)
    ("H3K27Ac and BRD4" . SPARSER::COLLECTION)
    ("BRD2 and BRD3" . SPARSER::COLLECTION)
    ("K16, and H3K27" . SPARSER::COLLECTION) ("Enhancers" . SPARSER::PROTEIN)
    ("NCT01587703, NCT01713582, NCT01949883, NCT01987362, and NCT01943851"
     . SPARSER::COLLECTION)
    ("BRD4-NUT" . SPARSER::COLLECTION) ("NUT" . SPARSER::PROTEIN)
    ("the bromodomain and extra-terminal (BET) domain family"
     . SPARSER::COLLECTION)
    ("bromodomain and extra-terminal domain family" . SPARSER::COLLECTION)
    ("super-enhancers" . SPARSER::PROTEIN) ("BET" . SPARSER::PROTEIN)
    ("Bromodomain" . SPARSER::PROTEIN) ("MCC" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("MRPS2" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("anti-Histone" . SPARSER::PROTEIN)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("LT1" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Chr8" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("BRD2" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("H3K27Ac" . SPARSER::MOLECULE) ("c-Myc" . SPARSER::PROTEIN)
    ("a cell-intrinsic regulator" . SPARSER::REGULATOR)
    ("the major cytokines" . SPARSER::PROTEIN)
    ("IL-23 and IL-21" . SPARSER::COLLECTION)
    ("IL-23R/STAT3" . SPARSER::COLLECTION)
    ("IL-21R/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT4" . SPARSER::COLLECTION)
    ("STAT4, and IL-21" . SPARSER::COLLECTION)
    ("IL-12Rβ1 and IL-21R" . SPARSER::COLLECTION)
    ("IL-21 and IL-23" . SPARSER::COLLECTION)
    ("the essential role STAT3" . SPARSER::PROTEIN)
    ("IL17A and IL17F" . SPARSER::COLLECTION)
    ("IFNγ and IL-17F" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("IFNγ and Granzyme" . SPARSER::COLLECTION)
    ("Granzyme" . SPARSER::PROTEIN-FAMILY)
    ("anti-CD3, anti-CD28, and anti-CD2" . SPARSER::COLLECTION)
    ("IL-6 and IL-23" . SPARSER::COLLECTION)
    ("TGFβ and IL-1β" . SPARSER::COLLECTION)
    ("IFNγ and Granzyme B" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("CD161 and CCR6" . SPARSER::COLLECTION)
    ("PLZF or RORγt" . SPARSER::COLLECTION)
    ("Eomesodermin and Tbet" . SPARSER::COLLECTION)
    ("Eomesodermin" . SPARSER::PROTEIN) ("RORC" . SPARSER::PROTEIN)
    ("significantly more PLZF" . SPARSER::PROTEIN)
    ("RORγt and PLZF" . SPARSER::COLLECTION) ("PLZF" . SPARSER::PROTEIN)
    ("NKT and MAIT" . SPARSER::COLLECTION) ("OP" . SPARSER::MOLECULE)
    ("tetramers" . SPARSER::TETRAMER)
    ("IL-6, IL-10, IL-21, and IL-23" . SPARSER::COLLECTION)
    ("IgE" . SPARSER::PROTEIN)
    ("cytokines, IFNγ, IL-4, IL-17, and IL-21" . SPARSER::COLLECTION)
    ("NKT or MAIT" . SPARSER::COLLECTION) ("CD1 and MHC" . SPARSER::COLLECTION)
    ("CD1" . SPARSER::PROTEIN) ("galactosylceramide" . SPARSER::MOLECULE)
    ("glycolipids" . SPARSER::MOLECULE)
    ("appropriate reagents" . SPARSER::MOLECULE)
    ("classical MHC molecules" . SPARSER::MOLECULE)
    ("IL-23R and IL-21R" . SPARSER::COLLECTION)
    ("IL12RB1 and IL21R" . SPARSER::COLLECTION)
    ("IFNγ and TNF" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("IL-17A and IL-17F" . SPARSER::COLLECTION) ("NKT" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("CCR7" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("IFNGR1" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("IL-12Rβ1" . SPARSER::PROTEIN) ("IL17F" . SPARSER::PROTEIN)
    ("IL17A" . SPARSER::PROTEIN) ("T-bet" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("Granzyme B" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("Granzyme A" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("CD8" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("CD161" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("IL-21" . SPARSER::PROTEIN) ("CD1d" . SPARSER::PROTEIN)
    ("TCR β" . SPARSER::PROTEIN) ("α-chain" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-21R" . SPARSER::PROTEIN)
    ("IL-23R" . SPARSER::PROTEIN) ("IL21" . SPARSER::PROTEIN)
    ("IL12RB1" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("IL-17F" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("RORγt" . SPARSER::PROTEIN) ("Rep" . SPARSER::PROTEIN)
    ("CHOP" . SPARSER::PROTEIN) ("Bortezomib" . SPARSER::DRUG)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the acidotropic dye LysoTracker" . SPARSER::DRUG)
    ("LysoTracker" . SPARSER::DRUG)
    ("the autophagosomal marker LC3" . SPARSER::PROTEIN)
    ("cyclin E/cyclin" . SPARSER::COLLECTION)
    ("MG132 and GSK-3β" . SPARSER::COLLECTION)
    ("in general all the proteins" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("G-1" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("mM 3" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3 beta" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN)
    ("a cancer-associated protein" . SPARSER::PROTEIN)
    ("types or stages" . SPARSER::COLLECTION)
    ("cathepsin H (CTSH)" . SPARSER::PROTEIN) ("ECM" . SPARSER::PROTEIN)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CTSH" . SPARSER::PROTEIN)
    ("suppressor genes-DKK4 [ xref ] or oncogenes-PTTG1 [ xref ]"
     . SPARSER::COLLECTION)
    ("c-Met (Y1349) and FAK (Y397)" . SPARSER::COLLECTION)
    ("HCCs" . SPARSER::PROTEIN) ("/LCN2/Twist1" . SPARSER::COLLECTION)
    ("EGF" . SPARSER::PROTEIN) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("HER2/PI3K/AKT/NF-κB" . SPARSER::COLLECTION)
    ("vimentin, fibronectin and MMPs" . SPARSER::COLLECTION)
    ("fibronectin" . SPARSER::PROTEIN) ("α5β1/c-Met/FAK" . SPARSER::COLLECTION)
    ("slug and MMP9" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("c-Met/FAK" . SPARSER::COLLECTION) ("integrin" . SPARSER::PROTEIN)
    ("LCN2 and TRα" . SPARSER::COLLECTION)
    ("LCN2 and TRβ1" . SPARSER::COLLECTION)
    ("LCN2 and TRα1" . SPARSER::COLLECTION)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("Huh7-LCN2, L#1 and L#2" . SPARSER::COLLECTION)
    ("SK-HEP1-LCN2, L#1 and L#2" . SPARSER::COLLECTION)
    ("p-FAK" . SPARSER::COLLECTION) ("kinase (FAK)" . SPARSER::KINASE)
    ("LCN2-KD" . SPARSER::COLLECTION) ("hematoxylin" . SPARSER::MOLECULE)
    ("LCN2, Huh7-L#1 and L#2" . SPARSER::COLLECTION)
    ("Furin" . SPARSER::PROTEIN) ("Serial deletion mutants" . SPARSER::MUTANT)
    ("Construct p1" . SPARSER::PROTEIN) ("TK" . SPARSER::PROTEIN)
    ("response element (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HepG2-Neo, HepG2-TRα1 and HepG2-TRβ1" . SPARSER::COLLECTION)
    ("Neo" . SPARSER::PROTEIN) ("TRα1 and TRβ1" . SPARSER::COLLECTION)
    ("HepG2-TRα1 and HepG2-TRβ1" . SPARSER::COLLECTION)
    ("LCN2 and tumor invasion/metastasis" . SPARSER::COLLECTION)
    ("enigmatic proteins" . SPARSER::PROTEIN) ("retinoids" . SPARSER::DRUG)
    ("substances" . SPARSER::SUBSTANCE) ("transporter" . SPARSER::PROTEIN)
    ("lipocalin" . SPARSER::PROTEIN) ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a potential tumor inducer" . SPARSER::MOLECULE)
    ("Pal" . SPARSER::PROTEIN) ("TREs" . SPARSER::PROTEIN)
    ("response elements (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("retinoid X receptor (RXR)" . SPARSER::PROTEIN) ("RXR" . SPARSER::PROTEIN)
    ("heterodimers" . SPARSER::HETERODIMER)
    ("TRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FAK" . SPARSER::PROTEIN)
    ("Met" . SPARSER::AMINO-ACID) ("TRE" . SPARSER::PROTEIN)
    ("/TR" . SPARSER::COLLECTION) ("Oligonucleotide" . SPARSER::MOLECULE)
    ("a tumor-associated protein" . SPARSER::PROTEIN)
    ("receptors (TR)" . SPARSER::RECEPTOR)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brain-specific" . SPARSER::PROTEIN) ("cathepsin H" . SPARSER::PROTEIN)
    ("PTTG1" . SPARSER::PROTEIN) ("DKK4" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("twist1" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("proto-oncogene c-Met" . SPARSER::PROTEIN)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thymidine kinase" . SPARSER::PROTEIN) ("Group B" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN) ("R-250" . SPARSER::PROTEIN)
    ("TRβ1" . SPARSER::PROTEIN) ("TRα1" . SPARSER::PROTEIN)
    ("lipocalin 2" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN) ("TRβ" . SPARSER::PROTEIN)
    ("LCN2" . SPARSER::PROTEIN) ("Lipocalin 2" . SPARSER::PROTEIN)
    ("folate" . SPARSER::MOLECULE) ("TGFβ-Smad" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("platelets" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN)
    ("the connective tissue factor CCN (CTGF, Cyr61, Nov) family"
     . SPARSER::PROTEIN-FAMILY)
    ("CCN" . SPARSER::PROTEIN-FAMILY) ("Taxol" . SPARSER::DRUG)
    ("a major TAZ" . SPARSER::PROTEIN) ("peroxisome" . SPARSER::PROTEIN)
    ("MLCK , and PLK2" . SPARSER::COLLECTION) ("MLCK" . SPARSER::PROTEIN)
    ("MYLK" . SPARSER::PROTEIN) ("CTGF and Cyr61" . SPARSER::COLLECTION)
    ("Cyclin D1 and CDK6" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("vector control siRNA (GFPsi) or TAZ siRNA" . SPARSER::COLLECTION)
    ("NOD" . SPARSER::PROTEIN) ("SK" . SPARSER::PROTEIN)
    ("LATS" . SPARSER::PROTEIN)
    ("TEAD, TTF-1, TBX5 and Pax3" . SPARSER::COLLECTION)
    ("TEAD" . SPARSER::PROTEIN) ("p53 , Rb and p21" . SPARSER::COLLECTION)
    ("CTGF and PDGF-β" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("TAZ" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derived growth factor beta" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("tissue factor" . SPARSER::PROTEIN) ("TEAD4" . SPARSER::PROTEIN)
    ("PAX8" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("PLK2" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCN2" . SPARSER::PROTEIN)
    ("Connective tissue growth factor" . SPARSER::PROTEIN)
    ("Pax3" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("c-sis" . SPARSER::PROTEIN)
    ("Palbociclib" . SPARSER::DRUG) ("STATs" . SPARSER::PROTEIN)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("histones" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chromatin and a cyclin D1-DNA" . SPARSER::COLLECTION)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("transgene" . SPARSER::PROTEIN) ("/CCND1" . SPARSER::COLLECTION)
    ("-CCND1" . SPARSER::COLLECTION) ("-Tet" . SPARSER::COLLECTION)
    ("ON" . SPARSER::PROTEIN) ("Tet" . SPARSER::PROTEIN)
    ("Tetracycline" . SPARSER::MOLECULE)
    ("MMTV-cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1-antisense" . SPARSER::COLLECTION)
    ("rtTA/CCND1" . SPARSER::COLLECTION) ("tetracycline" . SPARSER::DRUG)
    ("exogenous cyclin D1" . SPARSER::PROTEIN) ("Cdk4/6" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN) ("pRB" . SPARSER::PROTEIN)
    ("antagonist" . SPARSER::MOLECULE) ("haploid" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN) ("SpL" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN)
    ("exogenous cyclin D1 KE" . SPARSER::MOLECULE)
    ("MSCV-Cyclin D1" . SPARSER::COLLECTION)
    ("KE and cyclin D1" . SPARSER::COLLECTION)
    ("CDK4 or p27 Kip1" . SPARSER::COLLECTION)
    ("CDK4 and p27 Kip1" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("SKY" . SPARSER::PROTEIN)
    ("cyclin D1 and p300" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("heterochromatin" . SPARSER::BIO-COMPLEX) ("SUV" . SPARSER::PROTEIN)
    ("methylase" . SPARSER::PROTEIN) ("CBP" . SPARSER::PROTEIN)
    ("Chromatin" . SPARSER::PROTEIN) ("DNA-damage" . SPARSER::DNA)
    ("ErbB2" . SPARSER::PROTEIN) ("MMTV" . SPARSER::PROTEIN)
    ("PI-MEC" . SPARSER::COLLECTION) ("MEC" . SPARSER::PROTEIN)
    ("Cyclin D1/CDK4/6" . SPARSER::COLLECTION)
    ("the alternate splice form" . SPARSER::FORM)
    ("cyclin E or an activator" . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN) ("holoenzyme" . SPARSER::PROTEIN)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY) ("KE" . SPARSER::MOLECULE)
    ("MEFs" . SPARSER::PROTEIN) ("cyclin D1/CDK" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("cdk4" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("delta)" . SPARSER::PROTEIN) ("Transcription factor" . SPARSER::PROTEIN)
    ("E-5" . SPARSER::PROTEIN) ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MP1" . SPARSER::PROTEIN) ("LY2835219" . SPARSER::DRUG)
    ("LEE011" . SPARSER::DRUG) ("NFκB" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("HP1α" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("NRF-1" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("cyclin D1b" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin D1" . SPARSER::PROTEIN) ("Hsp90 or Nek6" . SPARSER::COLLECTION)
    ("Wild-type Hsp72 and the T66A mutant" . SPARSER::COLLECTION)
    ("CenpA" . SPARSER::PROTEIN)
    ("A phosphospecific antibody" . SPARSER::PROTEIN)
    ("Flag-TACC3" . SPARSER::COLLECTION) ("doxycycline" . SPARSER::DRUG)
    ("the spindle-associated Cep55" . SPARSER::PROTEIN)
    ("clathrin" . SPARSER::PROTEIN) ("tubulin" . SPARSER::PROTEIN)
    ("functional Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Eg5" . SPARSER::PROTEIN) ("monastrol" . SPARSER::DRUG)
    ("the ch-TOG–TACC3 complex and its recruitment" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM)
    ("α-tubulin and CENP-A" . SPARSER::COLLECTION)
    ("H2B-mCherry" . SPARSER::COLLECTION) ("EGFP–lamin" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("mCherry" . SPARSER::PROTEIN)
    ("lamin" . SPARSER::PROTEIN) ("EGFP" . SPARSER::PROTEIN)
    ("what function Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-competitive" . SPARSER::ATP) ("NTE" . SPARSER::PROTEIN)
    ("Nek6 and Nek7" . SPARSER::COLLECTION) ("Nek9" . SPARSER::PROTEIN)
    ("Flag-Nek6" . SPARSER::COLLECTION) ("IPs" . SPARSER::PROTEIN)
    ("Hsp72, β-tubulin, and actin" . SPARSER::COLLECTION)
    ("excellent substrates" . SPARSER::SUBSTRATE)
    ("mitochondria, Hsc70 and Hsp72" . SPARSER::COLLECTION)
    ("Grp75/mortalin" . SPARSER::COLLECTION)
    ("mitochondria" . SPARSER::PROTEIN) ("mortalin" . SPARSER::PROTEIN)
    ("BiP" . SPARSER::PROTEIN) ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsc70 and Hsp72" . SPARSER::COLLECTION) ("Hsp110" . SPARSER::PROTEIN)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("A phosphomimetic Hsp72 mutant" . SPARSER::MUTANT)
    ("MTs" . SPARSER::PROTEIN) ("microtubules" . SPARSER::PROTEIN)
    ("chaperones" . SPARSER::PROTEIN)
    ("a novel mitotic substrate" . SPARSER::SUBSTRATE)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("γ-tubulin" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("PO 3" . SPARSER::PROTEIN) ("or 2 µ" . SPARSER::MOLECULE)
    ("18 h" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("or 2" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("MnCl 2" . SPARSER::DRUG)
    ("HSF1" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("HSF2" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("Cep55" . SPARSER::PROTEIN)
    ("BubR1" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("β-casein" . SPARSER::PROTEIN) ("Nek7" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("Kif11" . SPARSER::PROTEIN)
    ("Grp75" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSPA8" . SPARSER::PROTEIN) ("Hsc70" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("TACC3" . SPARSER::PROTEIN)
    ("Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U0126 and LY294002" . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION) ("ERK and AKT" . SPARSER::COLLECTION)
    ("the players EphA2, MMP-9, or VE-cadherin" . SPARSER::COLLECTION)
    ("EphA2, MMP-9, or VE-cadherin" . SPARSER::COLLECTION)
    ("MMP-9, EphA2, or VE-cadherin" . SPARSER::COLLECTION)
    ("xref EphA2" . SPARSER::PROTEIN-FAMILY)
    ("only one inhibitor" . SPARSER::INHIBITOR)
    ("LY294002 or U0126" . SPARSER::COLLECTION)
    ("AKT, ERK, MMP-14, and LAMC2" . SPARSER::COLLECTION)
    ("MMP-14 and LAMC2" . SPARSER::COLLECTION)
    ("MMP-2, MMP-14, and LAMC2" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN)
    ("HDAC3 and VM-related molecules" . SPARSER::COLLECTION)
    ("SAHA" . SPARSER::DRUG)
    ("the HDAC3-1 group (for number of intersections, 6.57 ± 0.57; for total tube length, 905 ± 29 μm) and HDAC3-2 group (for number of intersections, 29.71 ± 0.61; for total tube length, 4490 ± 59 μm)"
     . SPARSER::COLLECTION)
    ("the HDAC3-1 ( P  < 0.001) group and HDAC3-2 group ( P  < 0.001)"
     . SPARSER::COLLECTION)
    ("HDAC3-siRNAs" . SPARSER::COLLECTION)
    ("acetyltransferases and HDACs" . SPARSER::COLLECTION)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("HDAC3 and VM" . SPARSER::COLLECTION) ("acetyl" . SPARSER::MOLECULE)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY) ("PI3K and ERK" . SPARSER::COLLECTION)
    ("HDACs" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("U0126" . SPARSER::DRUG)
    ("Histone deacetylase 3" . SPARSER::PROTEIN) ("MMP-14" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("LAMC2" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("laminin5" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("ZFP36 and TNF" . SPARSER::COLLECTION)
    ("Etoposide and SMAC-mimetics" . SPARSER::COLLECTION)
    ("cIAP-1, cIAP-2 and XIAP" . SPARSER::COLLECTION)
    ("GNS" . SPARSER::PROTEIN) ("MDa" . SPARSER::DRUG)
    ("ZFP36 and the Δ3" . SPARSER::COLLECTION)
    ("the oligomerized MLKL" . SPARSER::PROTEIN)
    ("the homo-oligomeric form" . SPARSER::FORM)
    ("the monomeric form" . SPARSER::FORM)
    ("homo-oligomers" . SPARSER::PROTEIN) ("oligomers" . SPARSER::MOLECULE)
    ("protein (MLKL)" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("MLKL" . SPARSER::PROTEIN) ("ZFP36 and RIP1" . SPARSER::COLLECTION)
    ("XIAP and cIAP2" . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XIAP, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("RIP1, caspase-8 and FADD" . SPARSER::COLLECTION)
    ("Etoposide or SMAC-mimetics" . SPARSER::COLLECTION)
    ("SMAC" . SPARSER::PROTEIN) ("Etoposide" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("TIS11/TTP" . SPARSER::COLLECTION)
    ("TTP" . SPARSER::PROTEIN) ("IAPs" . SPARSER::PROTEIN)
    ("cIAP2 and XIAP" . SPARSER::COLLECTION)
    ("caspase-8 and FADD" . SPARSER::COLLECTION) ("FADD" . SPARSER::PROTEIN)
    ("XIAP" . SPARSER::PROTEIN) ("ligases" . SPARSER::PROTEIN)
    ("Ripoptosome" . SPARSER::BIO-COMPLEX) ("K63" . SPARSER::PROTEIN)
    ("cIAP-2" . SPARSER::PROTEIN) ("cIAP-1" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("G-H" . SPARSER::PROTEIN) ("Nec-1" . SPARSER::PROTEIN)
    ("ZFP36 " . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("Mixed lineage kinase domain-like" . SPARSER::PROTEIN)
    ("F-2" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("cIAP1" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("TIS11" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("cIAP2" . SPARSER::PROTEIN) ("RIP1" . SPARSER::PROTEIN)
    ("ZFP36" . SPARSER::PROTEIN) ("shorter RFS" . SPARSER::PROTEIN)
    ("RFS" . SPARSER::PROTEIN) ("TMPRSS-ERG" . SPARSER::COLLECTION)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TMPRSS2:ERG" . SPARSER::BIO-COMPLEX) ("ERG" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("phosphatase and tensin homolog ( PTEN )" . SPARSER::PROTEIN)
    ("additional informative biomarkers" . SPARSER::MOLECULE)
    ("gold" . SPARSER::MOLECULE) ("indolent forms" . SPARSER::FORM)
    ("Prognostic biomarkers" . SPARSER::MOLECULE)
    ("Radical" . SPARSER::MOLECULE) ("HER2/neu" . SPARSER::COLLECTION)
    ("preoperative PSA" . SPARSER::PROTEIN)
    ("pre-operative prostate specific antigen (PSA)" . SPARSER::PROTEIN)
    ("antigen (PSA)" . SPARSER::PROTEIN) ("PSA" . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("HER-2" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("multi-arm" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("BTK" . SPARSER::PROTEIN) ("AURA" . SPARSER::PROTEIN)
    ("TKI" . SPARSER::PROTEIN) ("PD-L1" . SPARSER::PROTEIN)
    ("Bruton tyrosine kinase" . SPARSER::PROTEIN) ("WZ4002" . SPARSER::DRUG)
    ("HKI-272" . SPARSER::DRUG) ("a 20" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("oncoprotein" . SPARSER::PROTEIN)
    ("acetylases and histone" . SPARSER::COLLECTION)
    ("acetylases" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("ABT-888 or PARP-1" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("shRNA-Snail" . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("the promoter and the 3" . SPARSER::COLLECTION)
    ("Snail-ILK" . SPARSER::COLLECTION) ("ILK" . SPARSER::PROTEIN)
    ("an attractive anticancer target [ xref , xref ] and PARP inhibitors"
     . SPARSER::COLLECTION)
    ("an attractive anticancer target" . SPARSER::TARGET-PROTEIN)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("NAD + and ATP" . SPARSER::COLLECTION)
    ("PARP-1 and Snail" . SPARSER::COLLECTION)
    ("growth factors and various signaling molecules [ xref ]"
     . SPARSER::COLLECTION)
    ("TP53 , BID , and Caspase-6" . SPARSER::COLLECTION)
    ("PTEN" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("progesterone" . SPARSER::PROTEIN)
    ("chemotherapeutic adjuvants" . SPARSER::DRUG)
    ("adjuvants" . SPARSER::DRUG) ("Snail" . SPARSER::PROTEIN)
    ("2–4" . SPARSER::PROTEIN) ("Histone H2AX" . SPARSER::PROTEIN)
    ("KDM5B" . SPARSER::PROTEIN) ("lysine demethylase 5B" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("ITPR1" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("Caspase-6" . SPARSER::PROTEIN) ("ABT-888" . SPARSER::DRUG)
    ("PARP-1" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("Han" . SPARSER::PROTEIN) ("epoxide" . SPARSER::MOLECULE)
    ("diol" . SPARSER::MOLECULE) ("pyrene" . SPARSER::PROTEIN)
    ("trp" . SPARSER::AMINO-ACID) ("mutagen" . SPARSER::MOLECULE)
    ("Gln/Arg" . SPARSER::COLLECTION)
    ("a highly complex mixture" . SPARSER::MOLECULE)
    ("mixture" . SPARSER::MOLECULE) ("Tobacco" . SPARSER::DRUG)
    ("quit smoking cigarettes" . SPARSER::DRUG)
    ("XRCC1 (Arg194Trp) and XRCC1 (Arg399Gln)" . SPARSER::COLLECTION)
    ("creatinine" . SPARSER::PROTEIN)
    ("XRCC1 (Arg399Gln) and XRCC1 (Arg194Trp) polymorphisms"
     . SPARSER::COLLECTION)
    ("LDs" . SPARSER::PROTEIN) ("Trp/Trp" . SPARSER::COLLECTION)
    ("Arg/Trp" . SPARSER::COLLECTION)
    ("XRCC1 (Arg399Gln) and XRCC1 (Arg194Trp)" . SPARSER::COLLECTION)
    ("The cigarette smoking-related oxidative DNA" . SPARSER::DNA)
    ("-deoxyguanosine" . SPARSER::MOLECULE) ("radical" . SPARSER::MOLECULE)
    ("oxidative DNA" . SPARSER::DNA) ("deoxyguanosine" . SPARSER::MOLECULE)
    ("cigarettes" . SPARSER::DRUG) ("-1-" . SPARSER::PROTEIN)
    ("nitrosamine" . SPARSER::MOLECULE)
    ("60 carcinogenic chemicals" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cigarette" . SPARSER::DRUG) ("Arg/Gln" . SPARSER::COLLECTION)
    ("Gln/Gln" . SPARSER::COLLECTION) ("Arg/Arg" . SPARSER::COLLECTION)
    ("XRCC1 Arg194Trp and XRCC1 Arg399Gln" . SPARSER::COLLECTION)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("A-T" . SPARSER::PROTEIN)
    ("SO 4" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("RRM2 and ATM" . SPARSER::COLLECTION) ("substrates" . SPARSER::SUBSTRATE)
    ("ATM, RRM2, and c-MYC" . SPARSER::COLLECTION)
    ("p53 and c-MYC" . SPARSER::COLLECTION)
    ("p53 and HSP27" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-glucose" . SPARSER::COLLECTION)
    ("PG" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("metabolites" . SPARSER::MOLECULE) ("Lactate" . SPARSER::LACTATE)
    ("Metabolite" . SPARSER::MOLECULE)
    ("a fluorescent glucose analog" . SPARSER::ANALOG)
    ("analog" . SPARSER::ANALOG) ("NBDG" . SPARSER::DRUG)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("RRM2 and RRM2B" . SPARSER::COLLECTION) ("RNR" . SPARSER::PROTEIN)
    ("Ribonucleotide" . SPARSER::MOLECULE) ("substrate" . SPARSER::SUBSTRATE)
    ("BrdU and γH2AX" . SPARSER::COLLECTION)
    ("its associated DDR" . SPARSER::PROTEIN)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM (shATM) or ATR (shATR)" . SPARSER::COLLECTION)
    ("ATM or ATR" . SPARSER::COLLECTION) ("ATM and ATR" . SPARSER::COLLECTION)
    ("ATM and/or ATR" . SPARSER::COLLECTION)
    ("ATR and ATM" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("a robust DDR" . SPARSER::PROTEIN) ("dNTPs" . SPARSER::MOLECULE)
    ("ribonucleotide" . SPARSER::MOLECULE)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("dNTP" . SPARSER::MOLECULE) ("MgCl2" . SPARSER::MOLECULE)
    ("NADP+" . SPARSER::MOLECULE) ("6PGD" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase activity" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("p27" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("G-6-P" . SPARSER::PROTEIN) ("RRM2B" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("β-Gal" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("contextual oncogene" . SPARSER::ONCOGENE)
    ("mitotic chromatin" . SPARSER::PROTEIN) ("LKB/AMPK" . SPARSER::COLLECTION)
    ("LKB" . SPARSER::PROTEIN)
    ("protein and re-introduction" . SPARSER::COLLECTION)
    ("directly targets CAB39" . SPARSER::PROTEIN)
    ("LKB1, and 14-3-3" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("AMPK/OCT1" . SPARSER::COLLECTION)
    ("insufficient glucose" . SPARSER::PROTEIN)
    ("phosphomimetic S335D mutant" . SPARSER::MUTANT)
    ("the purified recombinant active AMPK complex" . SPARSER::BIO-COMPLEX)
    ("GST" . SPARSER::PROTEIN) ("Flag-tagged AMPKβ1" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("fully functional AMPK" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("AMPK α1 and α2 subunits" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::FRAGMENT) ("OCT1 and AMPKα" . SPARSER::COLLECTION)
    ("Soluble chromatin" . SPARSER::PROTEIN)
    ("exogenous OCT1" . SPARSER::PROTEIN)
    ("previously described binding sites GATA-1 and AP-1"
     . SPARSER::COLLECTION)
    ("GATA-1 and AP-1" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("exogenous LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMPKα and OCT1" . SPARSER::COLLECTION) ("ATP" . SPARSER::ATP)
    ("AMP" . SPARSER::AMP) ("Nek6" . SPARSER::PROTEIN)
    ("14-3-3" . SPARSER::PROTEIN) ("LKB-1" . SPARSER::PROTEIN)
    ("Compound C" . SPARSER::MOLECULE) ("AMPK β" . SPARSER::PROTEIN)
    ("AMPK α1" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN) ("GATA-1" . SPARSER::PROTEIN)
    ("18h" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("AMPKα1" . SPARSER::PROTEIN) ("AMPKβ" . SPARSER::PROTEIN)
    ("Oct1" . SPARSER::PROTEIN) ("CAB39" . SPARSER::PROTEIN)
    ("POU2F1" . SPARSER::PROTEIN) ("de-" . SPARSER::MOLECULE)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OCT1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("a poor DSS" . SPARSER::PROTEIN)
    ("phosphorylated ATM protein and its targets" . SPARSER::COLLECTION)
    ("PAM" . SPARSER::PROTEIN) ("IL" . SPARSER::PROTEIN)
    ("interleukin" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("caspases" . SPARSER::PROTEIN)
    ("a larger distinct cohort" . SPARSER::MOLECULE)
    ("this aggressive tumor type" . TYPE)
    ("a more aggressive tumor type" . TYPE)
    ("the most aggressive breast cancer type" . TYPE)
    ("biomarkers and DSS" . SPARSER::COLLECTION) ("DSS" . SPARSER::PROTEIN)
    ("CAFs" . SPARSER::PROTEIN) ("Representative examples" . SPARSER::EXAMPLE)
    ("run" . SPARSER::PROTEIN-FAMILY) ("Antibody" . SPARSER::PROTEIN)
    ("taxane" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("TMA" . SPARSER::MOLECULE) ("p53 and PIK3A" . SPARSER::COLLECTION)
    ("ataxia" . SPARSER::PROTEIN)
    ("the most common sporadic and inheritable mutated genes" . SPARSER::GENE)
    ("phosphatidyl" . SPARSER::MOLECULE) ("cytotoxic" . SPARSER::PROTEIN)
    ("DAPI" . SPARSER::DRUG) ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("AQUA" . SPARSER::MOLECULE) ("TMAs" . SPARSER::MOLECULE)
    ("p53 and BRCA1/2" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("PIK3" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN)
    ("inositol-3 kinase" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("potentially mutated DNA" . SPARSER::DNA)
    ("another stress-induced transcription factor" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN) ("exogenous FOXO3a" . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("ethidium" . SPARSER::MOLECULE) ("FOXO1 and FOXO3a" . SPARSER::COLLECTION)
    ("cell cycle regulators as well as pro-apoptotic proteins"
     . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("forkhead" . SPARSER::PROTEIN)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("PD0332991" . SPARSER::DRUG)
    ("CDK4/6" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("FOXO3a " . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("FOXO3a" . SPARSER::PROTEIN)
    ("metformin and long-term breast cancer survival" . SPARSER::COLLECTION)
    ("the diabetic cohort" . SPARSER::MOLECULE)
    ("ER, HER2, and mTOR" . SPARSER::COLLECTION)
    ("insulin receptor and IGF-I receptor" . SPARSER::COLLECTION)
    ("ER and growth factor" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("HER2, insulin receptor, and IGF-I receptor" . SPARSER::COLLECTION)
    ("PI3K, AKT, and mTOR" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMPK/mTOR" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("diabetic patients not receiving metformin" . SPARSER::DRUG)
    ("the diabetic non-metformin group" . SPARSER::MOLECULE)
    ("Hormone" . SPARSER::MOLECULE) ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::PROTEIN) ("rank" . SPARSER::PROTEIN)
    ("ER and PR" . SPARSER::COLLECTION)
    ("the diabetic patient group" . SPARSER::MOLECULE)
    ("184 diabetic patients not receiving metformin" . SPARSER::DRUG)
    ("subtypes" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("IGF" . SPARSER::PROTEIN) ("HER2-neu" . SPARSER::COLLECTION)
    ("neu" . SPARSER::PROTEIN) ("Metformin" . SPARSER::DRUG)
    ("hbA1" . SPARSER::PROTEIN) ("IGF-I receptor" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("HR 2" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("Rociletinib and other T790M-targeted drugs" . SPARSER::COLLECTION)
    ("prospective cohorts" . SPARSER::MOLECULE)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("cohorts" . SPARSER::MOLECULE)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("The allelic fractions" . SPARSER::COMPONENT)
    ("fractions" . SPARSER::COMPONENT) ("FISH" . SPARSER::PROTEIN)
    ("dacomitinib" . SPARSER::DRUG) ("their original EGFR" . SPARSER::PROTEIN)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("TKIs" . SPARSER::PROTEIN)
    ("rociletinib (CO-1686) and AZD9291" . SPARSER::COLLECTION)
    ("-mutant" . SPARSER::MUTANT) ("afatinib" . SPARSER::DRUG)
    ("erlotinib" . SPARSER::DRUG) ("EGFR-" . SPARSER::PROTEIN)
    ("rociletinib" . SPARSER::DRUG) ("Rociletinib" . SPARSER::DRUG)
    ("pS6" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("AZD9291" . SPARSER::DRUG)
    ("CO-1686" . SPARSER::DRUG)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both Tshr +/+ and Tshr -/- mice" . SPARSER::COLLECTION)
    ("SREBP-1c and SREBP-2" . SPARSER::COLLECTION)
    ("de novo fatty acid and cholesterol synthesis" . SPARSER::COLLECTION)
    ("ACC1 and HMGCR" . SPARSER::COLLECTION) ("nutrient" . SPARSER::MOLECULE)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("HMGCR and SREBP-2" . SPARSER::COLLECTION)
    ("TSH and lipids" . SPARSER::COLLECTION) ("lipids" . SPARSER::LIPID)
    ("LDL" . SPARSER::PROTEIN)
    ("SREBP-2 and its target genes ( xref  )" . SPARSER::COLLECTION)
    ("AMPK and SREBP-2" . SPARSER::COLLECTION)
    ("threonine (p-Thr) and serine (p-Ser) residues" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID) ("SAMS" . SPARSER::PROTEIN)
    ("PBS" . SPARSER::PROTEIN) ("TSH and AMPK" . SPARSER::COLLECTION)
    ("AICAR-treated Tshr  -/-" . SPARSER::PROTEIN) ("Tshr" . SPARSER::PROTEIN)
    ("p-AMPK" . SPARSER::COLLECTION)
    ("enzymes, HMGCR and HMGCS" . SPARSER::COLLECTION)
    ("SREBP-2, HMGCR and HMGCS" . SPARSER::COLLECTION)
    ("SREBP-1 and SREBP-2" . SPARSER::COLLECTION)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("active (CA)" . SPARSER::ACTIVE)
    ("-AMPK-α1" . SPARSER::COLLECTION) ("kinase (AMPK)" . SPARSER::KINASE)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("SREBP-2 and HMGCR" . SPARSER::COLLECTION)
    ("cAMP/PKA/CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HMGCR (75-fold) and LDLR (5.8-fold)" . SPARSER::COLLECTION)
    ("low-density lipoprotein receptor (LDLR)" . SPARSER::PROTEIN)
    ("synthase (HMGCS)" . SPARSER::PROTEIN)
    ("Sterol regulatory element-binding protein-2" . SPARSER::PROTEIN)
    ("LDLR" . SPARSER::PROTEIN) ("synthase" . SPARSER::PROTEIN)
    ("CoA" . SPARSER::MOLECULE) ("Sterol" . SPARSER::PROTEIN)
    ("triglycerides, and low-density lipoprotein cholesterol"
     . SPARSER::COLLECTION)
    ("triglycerides" . SPARSER::MOLECULE)
    ("a tropic hormone" . SPARSER::MOLECULE) ("Thyroid" . SPARSER::PROTEIN)
    ("SCH" . SPARSER::PROTEIN) ("SREBP-2, and TSH" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID)
    ("SREBP-2 and its target genes HMGCR and HMGCS" . SPARSER::COLLECTION)
    ("HMGCR and HMGCS" . SPARSER::COLLECTION) ("HMGCS" . SPARSER::PROTEIN)
    ("HMGCR" . SPARSER::PROTEIN) ("AICAR" . SPARSER::PROTEIN)
    ("ribonucleoside" . SPARSER::MOLECULE)
    ("TSH, AMPK and SREBP-2" . SPARSER::COLLECTION) ("TSH" . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN) ("sterol" . SPARSER::PROTEIN)
    ("thyroid" . SPARSER::PROTEIN) ("SREBP-1c" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("p-ACC" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–2" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("P81" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("ACC1" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("LMNB1" . SPARSER::PROTEIN)
    ("p-Thr" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("AMPK-α1" . SPARSER::PROTEIN) ("CRTC2" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("alpha subunit" . SPARSER::PROTEIN)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("precursor protein" . SPARSER::PROTEIN) ("LDL-c" . SPARSER::PROTEIN)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("AMP-activated" . SPARSER::PROTEIN) ("SREBP-2" . SPARSER::PROTEIN)
    ("protein-2" . SPARSER::PROTEIN) ("mRNA or protein" . SPARSER::COLLECTION)
    ("p-p70s6k" . SPARSER::COLLECTION) ("survivin" . SPARSER::PROTEIN)
    ("VEGF, MMP-9 and ROCK" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("triphosphatase" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE)
    ("RhoC, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("P70S6K and P53" . SPARSER::COLLECTION)
    ("p14ARF-MDM2-p53" . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION) ("effector" . SPARSER::EFFECTOR)
    ("P70S6K and Bcl-xL" . SPARSER::COLLECTION)
    ("diagnostic and prognostic molecular biomarkers" . SPARSER::MOLECULE)
    ("DV" . SPARSER::MOLECULE)
    ("RhoC, P70S6K, Bcl-xL, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE) ("transfectants" . SPARSER::PROTEIN)
    ("Propidium" . SPARSER::MOLECULE) ("DDP" . SPARSER::PROTEIN)
    ("Chemotherapeutic drugs" . SPARSER::DRUG) ("miR106b" . SPARSER::PROTEIN)
    ("106b" . SPARSER::PROTEIN) ("Sal" . SPARSER::PROTEIN)
    ("mRNAs" . SPARSER::PROTEIN)
    ("miR-106b directly targets RhoC" . SPARSER::PROTEIN)
    ("P70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("RhoC" . SPARSER::PROTEIN) ("Por" . SPARSER::PROTEIN)
    ("relevant molecules" . SPARSER::MOLECULE)
    ("miRNA-106b" . SPARSER::PROTEIN-PAIR) ("microRNA" . SPARSER::RNA)
    ("s6k" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("P70S6" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p14ARF" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("serum albumin" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("b-5" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("miR-106a" . SPARSER::MOLECULE) ("TGF-β1" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("single-stranded RNAs" . SPARSER::RNA)
    ("Matrix metallopeptidase 2" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("P70" . SPARSER::PROTEIN) ("member C" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN)
    ("apoptotic neutrophils" . SPARSER::PROTEIN)
    ("MMP-9 and other proteases" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("elastase" . SPARSER::PROTEIN)
    ("Neutrophils" . SPARSER::PROTEIN) ("Chronic CSE" . SPARSER::PROTEIN)
    ("significantly less active caspase-3" . SPARSER::PROTEIN)
    ("p53, PAI-1 and active" . SPARSER::COLLECTION)
    ("mice showed increased parenchymal lung neutrophils and macrophages"
     . SPARSER::COLLECTION)
    ("PAI-1 expressed M2 antigens" . SPARSER::PROTEIN)
    ("MPO and macrophage" . SPARSER::COLLECTION)
    ("antigens and TUNEL" . SPARSER::COLLECTION)
    ("neutrophil and macrophage" . SPARSER::COLLECTION)
    ("protein and EAR" . SPARSER::COLLECTION)
    ("MPO and neutrophil elastase" . SPARSER::COLLECTION)
    ("peptide (CP)" . SPARSER::PEPTIDE) ("scaffold" . SPARSER::SCAFFOLD)
    ("iodide (PI)" . SPARSER::PROTEIN)
    ("annexin and propidium" . SPARSER::COLLECTION)
    ("annexin" . SPARSER::PROTEIN) ("carbonate" . SPARSER::MOLECULE)
    ("PCS and the relatively strong TUNEL-positivity" . SPARSER::COLLECTION)
    ("The PAI-1 -/- and p53 -/-" . SPARSER::COLLECTION)
    ("neutrophils ( xref ) and macrophages ( xref )" . SPARSER::COLLECTION)
    ("neutrophils and macrophages" . SPARSER::COLLECTION)
    ("MPO and macrophages" . SPARSER::COLLECTION)
    ("discernible emphysema" . SPARSER::PROTEIN)
    ("emphysema" . SPARSER::PROTEIN) ("p53- and PAI-1-" . SPARSER::COLLECTION)
    ("PAI-1-" . SPARSER::PROTEIN) ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leukocytes and protein" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("MPO" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN)
    ("Hematoxylin and Eosin (H&E) staining" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("PCSE-induced p53 and downstream PAI-1" . SPARSER::COLLECTION)
    ("cis" . SPARSER::PROTEIN) ("bleomycin- or PCS-" . SPARSER::COLLECTION)
    ("PCS-" . SPARSER::PROTEIN) ("bleomycin-" . SPARSER::DRUG)
    ("bleomycin" . SPARSER::DRUG) ("PCS" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG) ("ALI" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN) ("smoke (CS)" . SPARSER::MOLECULE)
    ("PAI-1 and AEC" . SPARSER::COLLECTION) ("p53-PAI-1" . SPARSER::COLLECTION)
    ("CS" . SPARSER::PROTEIN)
    ("eosinophil-associated RNase1" . SPARSER::PROTEIN)
    ("peptide (CSP)" . SPARSER::PEPTIDE) ("PCSE" . SPARSER::PROTEIN)
    ("CSP" . SPARSER::PROTEIN) ("passive CSE (PCSE)" . SPARSER::PROTEIN)
    ("p53 and PAI-1" . SPARSER::COLLECTION)
    ("p53 or PAI-1" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("COPD" . SPARSER::PROTEIN) ("CSE" . SPARSER::PROTEIN)
    ("smoke" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("matrix metalloproteinase" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("neutrophil elastase" . SPARSER::PROTEIN)
    ("SP-C" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("N1" . SPARSER::PROTEIN)
    ("SP-B" . SPARSER::PROTEIN) ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("EAR1" . SPARSER::PROTEIN) ("RNase1" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("IDH2 , DNMT3A , EZH2 , and CBL" . SPARSER::COLLECTION)
    ("IDH1 , IDH2 , DNMT3A , and EZH2" . SPARSER::COLLECTION)
    ("RAS and c-KIT" . SPARSER::COLLECTION)
    ("one previously reported intronic variant" . SPARSER::VARIANT)
    ("EZH2 and CBL" . SPARSER::COLLECTION)
    ("DNMT3A and IDH1/2" . SPARSER::COLLECTION)
    ("NPM1 and CEBPA" . SPARSER::COLLECTION)
    ("c-KIT , and casitas" . SPARSER::COLLECTION) ("U2AF1" . SPARSER::PROTEIN)
    ("SF3B1" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("isocitrate" . SPARSER::PROTEIN) ("nucleophosmin" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("NPM1 , CEBPA , IDH1/2 , DNMT3A , EZH2 , and CBL" . SPARSER::COLLECTION)
    ("c-KIT and WT1" . SPARSER::COLLECTION)
    ("NPM1 , CEBPA , c-KIT , IDH1/2 , DNMT3A , EZH2 , WT1 , and CBL"
     . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN) ("CEBPA" . SPARSER::PROTEIN)
    ("CBF" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("p31" . SPARSER::PROTEIN) ("class V" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX)
    ("U2 small nuclear RNA auxiliary factor 1" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN)
    ("serine/arginine-rich splicing factor 2" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("splicing factor 3b" . SPARSER::PROTEIN)
    ("subunit 1" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein alpha" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("KARS" . SPARSER::PROTEIN) ("EGFR" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPase" . SPARSER::GTPASE)
    ("GTP" . SPARSER::NUCLEOTIDE)
    ("both BRAF  V600E and KRAS" . SPARSER::COLLECTION)
    ("either BRAF  V600E or KRAS" . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN) ("BRAF- and KRAS-" . SPARSER::COLLECTION)
    ("KRAS-" . SPARSER::PROTEIN) ("BRAF-" . SPARSER::PROTEIN)
    ("MSS" . SPARSER::PROTEIN) ("valine" . SPARSER::AMINO-ACID)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("MAPK" . SPARSER::PROTEIN)
    ("mAb" . SPARSER::DRUG)
    ("anti-EFGR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("mAbs" . SPARSER::DRUG) ("roughly 2/3" . SPARSER::PROTEIN)
    ("MLH1" . SPARSER::PROTEIN) ("sporadic CRC" . SPARSER::PROTEIN)
    ("APC , KRAS and TP53" . SPARSER::COLLECTION) ("APC" . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN)
    ("KRAS (34.8%) and BRAF  V600E (3.1%)" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("CRC" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("ER/PR" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("estradiol and estrogen receptor" . SPARSER::COLLECTION)
    ("HDAC" . SPARSER::PROTEIN) ("TGF-β and hypoxia" . SPARSER::COLLECTION)
    ("MMP2-mRNA" . SPARSER::COLLECTION) ("MMPs" . SPARSER::PROTEIN)
    ("HR" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("estradiol-" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN) ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("matix-metalloproteinases" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN)
    ("E-cadherin and other epithelial molecules" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN)
    ("matrix-metalloproteinases" . SPARSER::COLLECTION)
    ("MMP" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("SNAI2/SLUG" . SPARSER::COLLECTION)
    ("SLUG" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("N-CoR" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("MMP 2" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-RAS" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("OS 4" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("CALM2" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("a potential biomarker" . SPARSER::MOLECULE)
    ("Erk and Akt" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Chen" . SPARSER::PROTEIN)
    ("STAT3 and its downstream genes" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN) ("p-STAT3" . SPARSER::COLLECTION)
    ("Bcl-xL and MMP-9" . SPARSER::COLLECTION)
    ("MiR-124 directly targets STAT3" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("miRNAs and STAT3" . SPARSER::COLLECTION)
    ("MiRNAs" . SPARSER::PROTEIN) ("metformin" . SPARSER::DRUG)
    ("STAT" . SPARSER::PROTEIN) ("TE-1" . SPARSER::PROTEIN)
    ("EC" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("Oct-1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription-3" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("drug-" . SPARSER::DRUG) ("epirubicin- and CoCl 2" . SPARSER::COLLECTION)
    ("epirubicin- or CoCl 2" . SPARSER::COLLECTION)
    ("Roscovitine" . SPARSER::DRUG) ("roscovitine" . SPARSER::DRUG)
    ("seliciclib" . SPARSER::DRUG)
    ("epirubicin and CoCl 2" . SPARSER::COLLECTION) ("CDKs" . SPARSER::PROTEIN)
    ("drug or hypoxia" . SPARSER::COLLECTION)
    ("monomeric ATM" . SPARSER::PROTEIN)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION) ("inactive" . SPARSER::INACTIVE)
    ("NADPH and ribose" . SPARSER::COLLECTION)
    ("epirubicin- and
CoCl 2"
     . SPARSER::COLLECTION)
    ("epirubicin-" . SPARSER::DRUG) ("sugar" . SPARSER::MOLECULE)
    ("epirubicin or Cocl2" . SPARSER::COLLECTION)
    ("more severe DNA" . SPARSER::DNA)
    ("epirubicin or CoCl2" . SPARSER::COLLECTION)
    ("higher intracellular NADPH and lower ROS" . SPARSER::COLLECTION)
    ("ATM and TIGAR" . SPARSER::COLLECTION) ("siRNAs" . SPARSER::PROTEIN)
    ("ATM and DNA" . SPARSER::COLLECTION) ("HeG" . SPARSER::PROTEIN)
    ("TIGAR and p-ATM" . SPARSER::COLLECTION)
    ("TIGAR and ATM" . SPARSER::COLLECTION) ("Cdk5-ATM" . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN) ("redox" . SPARSER::PROTEIN)
    ("NADPH and
ribose"
     . SPARSER::COLLECTION)
    ("applying exogenous NADPH or ribose" . SPARSER::COLLECTION)
    ("NADPH or ribose" . SPARSER::COLLECTION)
    ("2.5 μg/ml epirubicin or
200 μM CoCl 2"
     . SPARSER::COLLECTION)
    ("NADPH (10 μM) or ribose
(10 mM)"
     . SPARSER::COLLECTION)
    ("epirubicin or
CoCl 2"
     . SPARSER::COLLECTION)
    ("Brdu" . SPARSER::DRUG) ("CoCl 2 or epirubicin" . SPARSER::COLLECTION)
    ("epirubicin or CoCl 2" . SPARSER::COLLECTION)
    ("NADPH and ribose-5-phosphate" . SPARSER::COLLECTION)
    ("Fru-2" . SPARSER::COLLECTION) ("fructose-2" . SPARSER::COLLECTION)
    ("Fru" . SPARSER::PROTEIN) ("fructose" . SPARSER::PROTEIN)
    ("IR" . SPARSER::PROTEIN) ("synergistic DNA" . SPARSER::DNA)
    ("topoisomerase" . SPARSER::PROTEIN) ("Epirubicin" . SPARSER::DRUG)
    ("cisplatin" . SPARSER::DRUG) ("ischemia" . SPARSER::PROTEIN)
    ("TACE" . SPARSER::PROTEIN) ("hydroperoxide" . SPARSER::MOLECULE)
    ("acute hypoxia or
genotoxic drugs"
     . SPARSER::COLLECTION)
    ("acute hypoxia" . SPARSER::PROTEIN) ("Cdk5-AMT" . SPARSER::COLLECTION)
    ("AMT" . SPARSER::PROTEIN) ("ATM" . SPARSER::PROTEIN)
    ("NAC" . SPARSER::PROTEIN) ("NADPH" . SPARSER::PROTEIN)
    ("epirubicin or hypoxia" . SPARSER::COLLECTION)
    ("epirubicin" . SPARSER::DRUG) ("genotoxic drugs" . SPARSER::DRUG)
    ("DDR" . SPARSER::PROTEIN) ("pentose" . SPARSER::MOLECULE)
    ("TIGAR" . SPARSER::PROTEIN) ("Cocl 2" . SPARSER::MOLECULE)
    ("Triton
X-100"
     . SPARSER::MOLECULE)
    ("cdk5" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN)
    ("phosphatidylinositol
3-kinase-related kinase"
     . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("Cocl2" . SPARSER::MOLECULE)
    ("CoCl2" . SPARSER::MOLECULE) ("KU55933" . SPARSER::DRUG)
    ("p-ATM" . SPARSER::PROTEIN)
    ("or
2"
     . SPARSER::MOLECULE)
    ("TRX1" . SPARSER::PROTEIN) ("thioredoxin-1" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE)
    ("TP53-induced glycolysis and apoptosis regulator" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN) ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("Cdk5" . SPARSER::PROTEIN)
    ("possibly another functional allele" . SPARSER::ALLELE)
    ("heterozygotes" . SPARSER::PROTEIN) ("A-B" . SPARSER::PROTEIN)
    ("the singular causative variant" . SPARSER::VARIANT)
    ("‘Eurasian’-type" . TYPE) ("-type" . TYPE)
    ("a causative variant" . SPARSER::VARIANT)
    ("high-HbF associated alleles" . SPARSER::ALLELE)
    ("51 polymorphic variants" . SPARSER::VARIANT)
    ("fragment" . SPARSER::FRAGMENT) ("fine-mapping" . SPARSER::PROTEIN)
    ("causative variants" . SPARSER::VARIANT) ("A 3-bp" . SPARSER::COLLECTION)
    ("bp" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("erythroid" . SPARSER::PROTEIN) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("Val" . SPARSER::AMINO-ACID)
    ("no such candidate causative variant" . SPARSER::VARIANT)
    ("a 3-bp" . SPARSER::PROTEIN-PAIR) ("MACH" . SPARSER::PROTEIN)
    ("HbS" . SPARSER::PROTEIN) ("HBS1L-MYB" . SPARSER::COLLECTION)
    ("SCD" . SPARSER::PROTEIN) ("fetal hemoglobin" . SPARSER::MOLECULE)
    ("hemoglobin" . SPARSER::MOLECULE) ("cMYB" . SPARSER::PROTEIN)
    ("A’" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCL11A" . SPARSER::PROTEIN) ("HBG2" . SPARSER::PROTEIN)
    ("HBS1L" . SPARSER::PROTEIN) ("urethane" . SPARSER::MOLECULE)
    ("mesenchymal component" . SPARSER::COMPONENT)
    ("Nrf2 , Keap1 and Ugt1a6" . SPARSER::COLLECTION)
    ("Ugt1a6" . SPARSER::PROTEIN) ("dien" . SPARSER::MOLECULE)
    ("Nrf2-Nqo1" . SPARSER::COLLECTION) ("inducers" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE) ("repressor" . SPARSER::REPRESSOR)
    ("Nqo1 and Keap1" . SPARSER::COLLECTION)
    ("antioxidant and xenobiotic" . SPARSER::COLLECTION)
    ("xenobiotic" . SPARSER::MOLECULE) ("skeletal muscle" . SPARSER::PROTEIN)
    ("anthracene or 12-O-tetradecanoylphorbol-13-acetate"
     . SPARSER::COLLECTION)
    ("anthracene" . SPARSER::DRUG) ("amine" . SPARSER::MOLECULE)
    ("chemical" . SPARSER::MOLECULE) ("toxins" . SPARSER::MOLECULE)
    ("Nfr2-Keap1" . SPARSER::COLLECTION) ("acinus" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::MOLECULE) ("endo-" . SPARSER::PROTEIN)
    ("antioxidants" . SPARSER::DRUG) ("endo" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE) ("oxidase" . SPARSER::PROTEIN)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("cytoprotective genes" . SPARSER::GENE)
    ("xenobiotics" . SPARSER::MOLECULE) ("quinone" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE) ("oxygenase" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("electrophiles or ROS" . SPARSER::COLLECTION)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("oxygen" . SPARSER::MOLECULE) ("ROS" . SPARSER::PROTEIN)
    ("electrophiles" . SPARSER::MOLECULE)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("Nrf2-Keap1" . SPARSER::COLLECTION)
    ("human b-defensin-1 [ xref ] and IGF-1 [ xref ]" . SPARSER::COLLECTION)
    ("b-defensin-1" . SPARSER::PROTEIN-PAIR) ("hsa" . SPARSER::PROTEIN)
    ("respective candidate genes" . SPARSER::GENE)
    ("MXI1, CASP7 and TBRG1" . SPARSER::COLLECTION) ("TNKS" . SPARSER::PROTEIN)
    ("qter" . SPARSER::DRUG) ("pter" . SPARSER::PROTEIN)
    ("β-catenin7, and HMGIC8" . SPARSER::COLLECTION)
    ("oltipraz" . SPARSER::DRUG) ("NFE2L2 and NQO1" . SPARSER::COLLECTION)
    ("KEAP1 (Kelch-like ECH-associated protein 1) and NQO1 (quinone oxidoreductase)"
     . SPARSER::COLLECTION)
    ("antioxidant" . SPARSER::PROTEIN) ("Nfr2" . SPARSER::PROTEIN)
    ("Nqo1" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("(beta" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("NAD(P)H" . SPARSER::MOLECULE) ("metallothionein 1" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("nrf2" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("defensin-1" . SPARSER::PROTEIN)
    ("CHEK1" . SPARSER::PROTEIN) ("TBRG1" . SPARSER::PROTEIN)
    ("CASP7" . SPARSER::PROTEIN) ("MXI1" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("ANGPT2" . SPARSER::PROTEIN)
    ("MCPH1" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("PLAG1" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("Nrf2" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("tip" . SPARSER::PROTEIN) ("bromodomain" . SPARSER::PROTEIN)
    ("ERs" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("DR" . SPARSER::MOLECULE) ("conformations" . SPARSER::BIO-CONFORMATION)
    ("glycine" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("solvent" . SPARSER::MOLECULE) ("Leu" . SPARSER::AMINO-ACID)
    ("Y537S apostructure" . SPARSER::PROTEIN) ("agonist" . SPARSER::AGONIST)
    ("NR" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("alanine, phenylalanine, glutamic acid, lysine and serine"
     . SPARSER::COLLECTION)
    ("serine" . SPARSER::AMINO-ACID) ("lysine" . SPARSER::AMINO-ACID)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("alanine" . SPARSER::AMINO-ACID)
    ("MTT" . SPARSER::MOLECULE)
    ("GREB1, MYC, PGR and TFF1" . SPARSER::COLLECTION)
    ("PGR" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("tamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("mutants" . SPARSER::MUTANT)
    ("estradiol and anti-estrogens" . SPARSER::COLLECTION)
    ("ERE–luciferase" . SPARSER::PROTEIN-PAIR)
    ("ESR1/YAP1" . SPARSER::COLLECTION) ("estradiol" . SPARSER::PROTEIN)
    ("PDX" . SPARSER::PROTEIN) ("Merenbakh-Lamin" . SPARSER::COLLECTION)
    ("Lamin" . SPARSER::PROTEIN) ("14 commonly fused genes" . SPARSER::GENE)
    ("introns" . SPARSER::PROTEIN)
    ("letrozole or anastrozole" . SPARSER::COLLECTION)
    ("anastrozole" . SPARSER::DRUG) ("letrozole" . SPARSER::DRUG)
    ("tamoxifen (which is a known risk factor for endometrial cancer) and estrogen deprivation therapy [ xref ]"
     . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN) ("Tyr" . SPARSER::AMINO-ACID)
    ("insulin-like growth factor 1 receptor and fibroblast growth factor receptor"
     . SPARSER::COLLECTION)
    ("phosphoinositide 3-kinase/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("aromatase" . SPARSER::PROTEIN)
    ("fulvestrant" . SPARSER::DRUG) ("raloxifene" . SPARSER::PROTEIN)
    ("modulators" . SPARSER::PROTEIN) ("estrogens" . SPARSER::MOLECULE)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response elements (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("estrogen" . SPARSER::MOLECULE) ("homodimer" . SPARSER::HOMODIMER)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("hormone" . SPARSER::MOLECULE) ("A mutated isoform" . SPARSER::ISOFORM)
    ("trastuzumab" . SPARSER::DRUG) ("Target" . SPARSER::TARGET-PROTEIN)
    ("gefitinib" . SPARSER::DRUG) ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("A classic example" . SPARSER::EXAMPLE) ("bicalutamide" . SPARSER::DRUG)
    ("antagonists" . SPARSER::MOLECULE) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endocrine" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("Endocrine" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("TIF2" . SPARSER::PROTEIN) ("GRIP1" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("SRC-1" . SPARSER::PROTEIN)
    ("1B1" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("anti-estrogen" . SPARSER::DRUG)
    ("YAP1" . SPARSER::PROTEIN) ("anti-estrogens" . SPARSER::DRUG)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("AF1" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("BCR-ABL" . SPARSER::PROTEIN) ("androgen receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("novel pathogenic variants" . SPARSER::VARIANT)
    ("MYCN" . SPARSER::PROTEIN) ("complete RB1" . SPARSER::PROTEIN)
    ("a pathogenic variant" . SPARSER::VARIANT)
    ("a novel intronic variant" . SPARSER::VARIANT)
    ("known and novel pathogenic variants" . SPARSER::VARIANT)
    ("potential variants" . SPARSER::VARIANT)
    ("synonymous and polymorphic variants" . SPARSER::VARIANT)
    ("the pathogenic variants" . SPARSER::VARIANT)
    ("Ion-Torrent PGM" . SPARSER::PROTEIN) ("ID " . SPARSER::PROTEIN)
    ("one deep intronic variant" . SPARSER::VARIANT)
    ("deep intronic variant" . SPARSER::VARIANT)
    ("No pathogenic variants" . SPARSER::VARIANT)
    ("RB20, RB23, RB28, RB30 and RB33" . SPARSER::COLLECTION)
    ("Mops" . SPARSER::MOLECULE)
    ("The five pathogenic variants" . SPARSER::VARIANT)
    ("RB2, RB4, RB13, RB24 and RB25" . SPARSER::COLLECTION)
    ("Ion" . SPARSER::MOLECULE) ("ion-torrent PGM" . SPARSER::PROTEIN)
    ("PGM" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("Exon" . SPARSER::PROTEIN)
    ("the germline heterozygous nonsense variant" . SPARSER::VARIANT)
    ("Patient RB25" . SPARSER::PROTEIN)
    ("a somatic loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("patient RB31" . SPARSER::PROTEIN)
    ("patient RB10, RB12 and RB29" . SPARSER::COLLECTION)
    ("the homozygous variants" . SPARSER::VARIANT)
    ("RB10, RB12 and RB29" . SPARSER::COLLECTION)
    ("two heterozygous variants" . SPARSER::VARIANT)
    ("Homozygous variants" . SPARSER::VARIANT)
    ("RB8, RB9 and RB31" . SPARSER::COLLECTION)
    ("sporadic unilateral RB" . SPARSER::PROTEIN)
    ("patient RB11" . SPARSER::PROTEIN) ("patient RB18" . SPARSER::PROTEIN)
    ("agarose" . SPARSER::MOLECULE) ("example" . SPARSER::EXAMPLE)
    ("heterozygous intronic variants" . SPARSER::VARIANT)
    ("A intronic variant" . SPARSER::VARIANT) ("cryptic" . SPARSER::PROTEIN)
    ("patients RB4, RB14, RB17 and RB24" . SPARSER::COLLECTION)
    ("RB4, RB14, RB17 and RB24" . SPARSER::COLLECTION)
    ("HSF and MaxEntScan" . SPARSER::COLLECTION) ("HSF" . SPARSER::PROTEIN)
    ("all the reported pathogenic variants" . SPARSER::VARIANT)
    ("Pathogenic variants" . SPARSER::VARIANT)
    ("All the pathogenic variants" . SPARSER::VARIANT)
    ("no pathogenic variants" . SPARSER::VARIANT)
    ("An automatic in-house variant" . SPARSER::VARIANT)
    ("intron and promoter" . SPARSER::COLLECTION) ("intron" . SPARSER::PROTEIN)
    ("RB1-RB23" . SPARSER::COLLECTION)
    ("RB1 pathogenic variants" . SPARSER::VARIANT)
    ("heterogeneous variants" . SPARSER::VARIANT)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("intron-exon" . SPARSER::PROTEIN-PAIR)
    ("unilateral RB" . SPARSER::PROTEIN) ("bilateral RB" . SPARSER::PROTEIN)
    ("heterogeneous RB1 gene variants" . SPARSER::VARIANT)
    ("SVs" . SPARSER::MOLECULE) ("some unilateral RB" . SPARSER::PROTEIN)
    ("biallelic variants" . SPARSER::VARIANT) ("retina" . SPARSER::DRUG)
    ("nine novel pathogenic variants" . SPARSER::VARIANT)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("The pathogenic variants" . SPARSER::VARIANT) ("MOPS" . SPARSER::MOLECULE)
    ("RB" . SPARSER::PROTEIN) ("RB5" . SPARSER::MOLECULE)
    ("RB3" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("RB7" . SPARSER::PROTEIN) ("RB2" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN)
    ("genes as well as many lncRNAs [ xref , xref ]" . SPARSER::COLLECTION)
    ("masks" . SPARSER::PROTEIN)
    ("SAMSN1 (a protein with an SH3 domain and nuclear localization signals) and MS4A4 (from the same family as MS4A3 )"
     . SPARSER::COLLECTION)
    ("CD24 (a sialoglycoprotein expressed on mature granulocytes and B cells), PASD1 (a transcription factor expressed in diffuse large B-cell lymphoma), MS4A3 (a hematopoietic cell-specific membrane protein), SAMSN1 (a protein with an SH3 domain and nuclear localization signals) and MS4A4 (from the same family as MS4A3 )"
     . SPARSER::COLLECTION)
    ("t" . SPARSER::PROTEIN) ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1.0 μM TSA and 1.0 μM AzdC" . SPARSER::COLLECTION)
    ("complex (RITS)" . SPARSER::BIO-COMPLEX)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("the mature mRNA" . SPARSER::PROTEIN)
    ("TET2 , IDH1 , IDH2 , DNMT3A , ASXL1 , EZH-2 , MLL , RUNX , CBFB and TCF3"
     . SPARSER::COLLECTION)
    ("CBFB" . SPARSER::PROTEIN) ("KIT , CD24 and MS4A4" . SPARSER::COLLECTION)
    ("mediators" . SPARSER::PROTEIN)
    ("MS4A3 , SAMSN1 and MS4A4" . SPARSER::COLLECTION)
    ("KIT , CD24 and PASD1" . SPARSER::COLLECTION)
    ("-KD" . SPARSER::COLLECTION) ("map" . SPARSER::PROTEIN)
    ("CCDC26-KD" . SPARSER::COLLECTION)
    ("FBS- or non-FBS-containing" . SPARSER::COLLECTION)
    ("FBS-" . SPARSER::PROTEIN) ("KD and non-KD" . SPARSER::COLLECTION)
    ("FACS" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("trypan" . SPARSER::DRUG) ("FBS" . SPARSER::PROTEIN)
    ("TSA and AzdC" . SPARSER::COLLECTION)
    ("methyltransferase (DNMT)" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("TSA" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("PVT1 and MYC" . SPARSER::COLLECTION) ("GSDMC" . SPARSER::PROTEIN)
    ("CCDC26 and two additional shRNAs (sh-331-359 and sh-279-307)"
     . SPARSER::COLLECTION)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("pGE-1" . SPARSER::COLLECTION)
    ("pGE" . SPARSER::PROTEIN) ("CCDC26 and hAK015428" . SPARSER::COLLECTION)
    ("AK" . SPARSER::PROTEIN) ("ncRNA" . SPARSER::RNA)
    ("THS" . SPARSER::PROTEIN) ("hot" . SPARSER::PROTEIN)
    ("CCDC26 and MYC" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("MYC" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("CMK" . SPARSER::PROTEIN) ("molecule" . SPARSER::MOLECULE)
    ("acute monocytic leukemia" . SPARSER::PROTEIN) ("Meg" . SPARSER::DRUG)
    ("leukemia and non-leukemia" . SPARSER::COLLECTION)
    ("retroviral DNA" . SPARSER::DNA) ("drugs" . SPARSER::DRUG)
    ("CNA" . SPARSER::PROTEIN) ("CNAs" . SPARSER::PROTEIN)
    ("the hypothetical 109 amino acid protein" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN) ("LSCs" . SPARSER::PROTEIN)
    ("BCR/ABL" . SPARSER::COLLECTION) ("imatinib" . SPARSER::DRUG)
    ("HOXA9 or AML1" . SPARSER::COLLECTION)
    ("BCR and ABL" . SPARSER::COLLECTION)
    ("HOXA9 , AML1 , MLL and RAR α" . SPARSER::COLLECTION)
    ("FLT3 , ABL , RAS and KIT" . SPARSER::COLLECTION)
    ("ABL" . SPARSER::PROTEIN) ("MLL" . SPARSER::PROTEIN)
    ("polypeptides" . SPARSER::PROTEIN) ("ncRNAs" . SPARSER::RNA)
    ("forms" . SPARSER::FORM) ("KIT" . SPARSER::PROTEIN)
    ("shRNA" . SPARSER::PROTEIN) ("shRNAs" . SPARSER::RNA)
    ("KD" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("E1" . SPARSER::MOLECULE) ("beta-actin" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("G418" . SPARSER::MOLECULE)
    ("stem cell factor" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("145 kD" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("TCF3" . SPARSER::PROTEIN) ("EZH-2" . SPARSER::PROTEIN)
    ("ASXL1" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("MS4A4" . SPARSER::PROTEIN) ("SAMSN1" . SPARSER::PROTEIN)
    ("MS4A3" . SPARSER::PROTEIN) ("PASD1" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("PVT1" . SPARSER::PROTEIN)
    ("E3" . SPARSER::MOLECULE) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("GDM-1" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("retinoic acid" . SPARSER::MOLECULE) ("FLT3" . SPARSER::PROTEIN)
    ("RAR α" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN) ("ISCK03" . SPARSER::DRUG)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("precursor mRNA" . SPARSER::RNA) ("CCDC26" . SPARSER::PROTEIN)
    ("GAPDH" . SPARSER::PROTEIN) ("oxidative bisulphite" . SPARSER::MOLECULE)
    ("distant enhancers or the many alternate promoters" . SPARSER::COLLECTION)
    ("the many alternate promoters" . SPARSER::PROMOTER)
    ("distant enhancers" . SPARSER::PROTEIN) ("enhancers" . SPARSER::PROTEIN)
    ("ESR1 and ESR1" . SPARSER::COLLECTION) ("enzymes" . SPARSER::ENZYME)
    ("Active" . SPARSER::ACTIVE) ("methyltransferases" . SPARSER::PROTEIN)
    ("our group and others [ xref , xref ]" . SPARSER::COLLECTION)
    ("media" . SPARSER::PROTEIN) ("antisense" . SPARSER::PROTEIN)
    ("Promoter" . SPARSER::PROMOTER) ("pos" . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN) ("neg" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE) ("histone" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN)
    ("a transcriptionally active gene" . SPARSER::GENE)
    ("promoter and intragenic regions" . SPARSER::COLLECTION)
    ("ER-pos and ER-neg" . SPARSER::COLLECTION)
    ("ER-neg" . SPARSER::COLLECTION) ("ER-pos" . SPARSER::COLLECTION)
    ("decitabine" . SPARSER::DRUG) ("regional chromatin" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("states" . SPARSER::BIO-STATE)
    ("cytosine-guanine" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE) ("guanine" . SPARSER::PROTEIN)
    ("cytosine" . SPARSER::NUCLEOBASE)
    ("promoters and lower intragenic methylation levels (median, 38.62%)"
     . SPARSER::COLLECTION)
    ("Bank" . SPARSER::PROTEIN) ("DAC" . SPARSER::PROTEIN)
    ("receptor (ER)" . SPARSER::RECEPTOR) ("ER" . SPARSER::PROTEIN)
    ("bisulphite" . SPARSER::MOLECULE) ("EBM" . SPARSER::PROTEIN)
    ("DNMT3A" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("L-glutamine" . SPARSER::MOLECULE)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("MH" . SPARSER::MOLECULE)
    ("essential downstream effectors" . SPARSER::EFFECTOR)
    ("effectors" . SPARSER::EFFECTOR) ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("uPA" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("u-PA/u-PAR" . SPARSER::COLLECTION) ("VEGF" . SPARSER::PROTEIN)
    ("endothelial u-PA" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("u-PA and its cell surface receptor" . SPARSER::COLLECTION)
    ("cyclin D1 and u-PA" . SPARSER::COLLECTION) ("HRas" . SPARSER::PROTEIN)
    ("junctional complex components" . SPARSER::COMPONENT)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("GTPases, and RAS" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPases" . SPARSER::GTPASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fat" . SPARSER::PROTEIN)
    ("glucose, PMA, or LiCl" . SPARSER::COLLECTION)
    ("Lef-1" . SPARSER::PROTEIN) ("glucose or PMA" . SPARSER::COLLECTION)
    ("LiCl" . SPARSER::DRUG)
    ("glucose (24 h) or PMA (4 h)" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lef-1/TCF" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("proteasomal" . SPARSER::PROTEIN) ("Genes" . SPARSER::GENE)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("cAMP" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("alanines" . SPARSER::AMINO-ACID) ("Thr" . SPARSER::AMINO-ACID)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("PKC-α or PKC-δ" . SPARSER::COLLECTION)
    ("the corresponding dominant-negative protein" . SPARSER::PROTEIN)
    ("PKC-" . SPARSER::PROTEIN) ("−β2" . SPARSER::COLLECTION)
    ("BAPTA" . SPARSER::MOLECULE) ("bisindolylmaleimide" . SPARSER::DRUG)
    ("PMA" . SPARSER::PROTEIN) ("THP-1" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Src and Pyk2" . SPARSER::COLLECTION) ("Glucose" . SPARSER::PROTEIN)
    ("endothelial barrier" . SPARSER::PROTEIN) ("albumin" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("hyperglycemia" . SPARSER::PROTEIN)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p120, β-catenin, and plakoglobin" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("macrophages/monocytes" . SPARSER::COLLECTION)
    ("macrophages" . SPARSER::PROTEIN)
    ("cytochalasin D and 4-" . SPARSER::COLLECTION)
    ("a nonphosphorylatable dominant-negative form" . SPARSER::FORM)
    ("forskolin" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("endothelial PKC" . SPARSER::PROTEIN)
    ("ERK and myosin light chain" . SPARSER::COLLECTION)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mannitol or 3-O-methyl-D-glucose" . SPARSER::COLLECTION)
    ("mannitol" . SPARSER::DRUG) ("PKC" . SPARSER::PROTEIN)
    ("glucose" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("barrier" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("Vascular endothelial" . SPARSER::PROTEIN) ("u-PAR" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("u-PA" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PKC-α" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG) ("MgCl 2" . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("protein A" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("NP-40" . SPARSER::DRUG)
    ("PKC-δ" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Cytochalasin D" . SPARSER::DRUG) ("G10" . SPARSER::PROTEIN)
    ("VE-cadherin" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("Pyk2" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("Myosin light chain" . SPARSER::PROTEIN) ("α -catenin" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN) ("cytochalasin D" . SPARSER::DRUG)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myosin light chain" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("ligand" . SPARSER::MOLECULE)
    ("HGF" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("potential drug target" . SPARSER::TARGET-PROTEIN)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("ADAM" . SPARSER::PROTEIN) ("metalloproteinase" . SPARSER::PROTEIN)
    ("disintegrin" . SPARSER::PROTEIN)
    ("a potential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("miRNA and gene" . SPARSER::COLLECTION)
    ("MET and phosphorylated-AKT" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("siRNA-MET" . SPARSER::COLLECTION)
    ("component" . SPARSER::COMPONENT) ("inhibitor" . SPARSER::INHIBITOR)
    ("miR-NC" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("LUC-MET" . SPARSER::COLLECTION) ("LUC" . SPARSER::PROTEIN)
    ("ADAM12 and VCAN" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN)
    ("ADAM12, VCAN and MET" . SPARSER::COLLECTION) ("VCAN" . SPARSER::PROTEIN)
    ("matrigel" . SPARSER::PROTEIN)
    ("the peritoneal metastatic foci" . SPARSER::PROTEIN)
    ("GC-associated genes" . SPARSER::GENE)
    ("the key miRNAs" . SPARSER::PROTEIN)
    ("TOB1 and IGF1R" . SPARSER::COLLECTION)
    ("paired primary foci" . SPARSER::PROTEIN)
    ("miRNAs and genes" . SPARSER::COLLECTION) ("foci" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA)
    ("well-documented GC cohort" . SPARSER::MOLECULE)
    ("luciferase" . SPARSER::PROTEIN) ("primary GC" . SPARSER::PROTEIN)
    ("fluorouracil" . SPARSER::DRUG) ("ZFX" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE)
    ("a potential noninvasive biomarker" . SPARSER::MOLECULE)
    ("miRNA" . SPARSER::PROTEIN)
    ("approximately 21–23 nucleotides" . SPARSER::NUCLEOTIDE)
    ("miRNAs" . SPARSER::PROTEIN) ("microRNAs" . SPARSER::RNA)
    ("metastatic GC" . SPARSER::PROTEIN) ("hypoxia" . SPARSER::PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proto-oncogene (MET)" . SPARSER::PROTEIN) ("MET" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("MicroRNAs" . SPARSER::RNA)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("ADAMTS5" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("C-3" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("ADAM12" . SPARSER::PROTEIN) ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("anti–" . SPARSER::ANTIBODY) ("U6" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN) ("TOB1" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("HIF1α" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("Arg280His" . SPARSER::PROTEIN)
    ("XRCC1-Arg280His" . SPARSER::PROTEIN-PAIR) ("tobacco" . SPARSER::DRUG)
    ("HCC" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("gene and prostate" . SPARSER::COLLECTION) ("AH" . SPARSER::MOLECULE)
    ("AA (OR = 0.95, 95%CI = 0.83–1.09, P = 0.480) or the dominant model GG + GA"
     . SPARSER::COLLECTION)
    ("AG" . SPARSER::PROTEIN) ("AA" . SPARSER::MOLECULE)
    ("–1" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("met" . SPARSER::AMINO-ACID) ("APE" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN) ("histidine" . SPARSER::AMINO-ACID)
    ("aflatoxin" . SPARSER::MOLECULE) ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("ligase" . SPARSER::LIGASE) ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("glutamine" . SPARSER::AMINO-ACID)
    ("mismatch" . SPARSER::PROTEIN) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("MMR" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("leukemia" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("States" . SPARSER::BIO-STATE)
    ("ADP-ribose" . SPARSER::MOLECULE) ("DNA polymerase" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("clinically definite TSC" . SPARSER::PROTEIN)
    ("examples" . SPARSER::EXAMPLE) ("TSC2 and TBC1D7" . SPARSER::COLLECTION)
    ("ebi" . SPARSER::PROTEIN) ("promoters" . SPARSER::PROMOTER)
    ("pathogenic and benign variants" . SPARSER::VARIANT)
    ("benign variants" . SPARSER::VARIANT) ("indiviual VII" . SPARSER::PROTEIN)
    ("-AAGAGTATTGTCAATGAG-3" . SPARSER::COLLECTION) ("Alu" . SPARSER::PROTEIN)
    ("Nucleotides" . SPARSER::NUCLEOTIDE) ("IV and VII" . SPARSER::COLLECTION)
    ("VII" . SPARSER::PROTEIN) ("MYB" . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN)
    ("heterozygous TSC1 variant and 6" . SPARSER::COLLECTION)
    ("heterozygous variants" . SPARSER::VARIANT)
    ("heterozygous TSC1 variant" . SPARSER::VARIANT) ("IV" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mapping" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("polymerase" . SPARSER::PROTEIN)
    ("insC" . SPARSER::PROTEIN) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("maps" . SPARSER::PROTEIN) ("acceptor" . SPARSER::MOLECULE)
    ("classes" . CLASS) ("NMI" . SPARSER::PROTEIN)
    ("TSC1-TSC2" . SPARSER::COLLECTION) ("derivatives" . SPARSER::DERIVATIVE)
    ("rapamycin" . SPARSER::DRUG)
    ("lipid and pyrimidine synthesis" . SPARSER::COLLECTION)
    ("pyrimidine" . SPARSER::DRUG) ("regulator" . SPARSER::REGULATOR)
    ("mTOR" . SPARSER::PROTEIN)
    ("hamartin (TSC1; 130 kDa) and tuberin (TSC2; 200 kDa)"
     . SPARSER::COLLECTION)
    ("tuberin" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("hamartin" . SPARSER::PROTEIN) ("exon" . SPARSER::PROTEIN)
    ("definite TSC" . SPARSER::PROTEIN) ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("TBC1D7" . SPARSER::PROTEIN) ("c-MYB" . SPARSER::PROTEIN)
    ("For 3" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("PKD1" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("p13" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("biomarker" . SPARSER::MOLECULE)
    ("CDH1 mRNA and/or protein" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("multidrug" . SPARSER::PROTEIN)
    ("doxorubicin" . SPARSER::PROTEIN) ("methyltransferase" . SPARSER::PROTEIN)
    ("inhibitors" . SPARSER::INHIBITOR) ("deoxycytidine" . SPARSER::PROTEIN)
    ("aza" . SPARSER::DRUG) ("two essential components" . SPARSER::COMPONENT)
    ("oncogenes" . SPARSER::ONCOGENE)
    ("280 HP-positive GCs and 193 HP-negative GCs" . SPARSER::COLLECTION)
    ("suppressor" . SPARSER::SUPPRESSOR) ("promoter" . SPARSER::PROMOTER)
    ("CAM 120/80, or uvomorulin" . SPARSER::COLLECTION)
    ("variety" . SPARSER::VARIETY) ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("calcium" . SPARSER::CALCIUM) ("glycoprotein" . SPARSER::PROTEIN)
    ("uvomorulin" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("an interesting potential drug target" . SPARSER::TARGET-PROTEIN)
    ("drug" . SPARSER::DRUG) ("GCs" . SPARSER::PROTEIN)
    ("HP" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("three domains" . SPARSER::PROTEIN) ("CAM 120/80" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("Cadherin-1" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("“NAMPT-SIRT4-hTERT" . SPARSER::COLLECTION)
    ("male" . SPARSER::MOLECULE)
    ("telomerase activity and Tert" . SPARSER::COLLECTION)
    ("a mutated form" . SPARSER::FORM) ("NAMPT or SIRT4" . SPARSER::COLLECTION)
    ("NAMPT, and SIRT4" . SPARSER::COLLECTION)
    ("SIRT4 and SIRT1" . SPARSER::COLLECTION)
    ("activator" . SPARSER::ACTIVATOR)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("ASM and HMVEC-L" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("Nampt and Sirt4" . SPARSER::COLLECTION)
    ("both Western blot" . SPARSER::PROTEIN) ("Male" . SPARSER::MOLECULE)
    ("Nampt" . SPARSER::PROTEIN) ("SIRT1 and SIRT4" . SPARSER::COLLECTION)
    ("protein and SIRT1" . SPARSER::COLLECTION)
    ("target" . SPARSER::TARGET-PROTEIN) ("Protein" . SPARSER::PROTEIN)
    ("SIRT3 and SIRT1" . SPARSER::COLLECTION)
    ("SIRT1, SIRT3, and SIRT4" . SPARSER::COLLECTION)
    ("NAMPT and hTERT" . SPARSER::COLLECTION) ("NAD" . SPARSER::MOLECULE)
    ("an essential and rate-limiting enzyme" . SPARSER::ENZYME)
    ("NADH" . SPARSER::MOLECULE) ("pCAGGS" . SPARSER::PROTEIN)
    ("pCAGGS-NAMPT or pCAGGS-NAMPT-H247E" . SPARSER::COLLECTION)
    ("pCAGGS-NAMPT" . SPARSER::COLLECTION) ("cntl" . SPARSER::PROTEIN)
    ("siRNA-cntl" . SPARSER::COLLECTION)
    ("hTERT, and a 2.1±0.2" . SPARSER::COLLECTION)
    ("NAMPT-siRNA" . SPARSER::COLLECTION) ("group (UNT)" . SPARSER::MOLECULE)
    ("siRNA-NAMPT" . SPARSER::COLLECTION) ("reagents" . SPARSER::MOLECULE)
    ("UNT" . SPARSER::MOLECULE) ("siRNA" . SPARSER::PROTEIN)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRAP" . SPARSER::PROTEIN)
    ("PC" . SPARSER::PROTEIN) ("mRNA" . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("DMSO" . SPARSER::MOLECULE)
    ("ASM" . SPARSER::PROTEIN)
    ("human Aortic Smooth Muscle" . SPARSER::PROTEIN)
    ("hTERT and telomerase activity" . SPARSER::COLLECTION)
    ("Smooth Muscle" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("resveratrol and NAMPT" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT4" . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("NAD+ and nicotinamide" . SPARSER::COLLECTION)
    ("nicotinamide" . SPARSER::PROTEIN) ("Visfatin" . SPARSER::PROTEIN)
    ("PBEF" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("TERT" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("enzyme" . SPARSER::ENZYME)
    ("repetitive nucleotide" . SPARSER::NUCLEOTIDE)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("resveratrol and CR" . SPARSER::COLLECTION) ("CR" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("pro" . SPARSER::AMINO-ACID)
    ("NAMPT-SIRT4-hTERT" . SPARSER::COLLECTION)
    ("NAMPT and SIRT4" . SPARSER::COLLECTION)
    ("nicotinamide phosphoribosyltransferase (NAMPT)" . SPARSER::PROTEIN)
    ("SIRT4 and telomerase reverse transcriptase" . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("NAMPT" . SPARSER::PROTEIN)
    ("resveratrol" . SPARSER::PROTEIN) ("wine" . SPARSER::MOLECULE)
    ("Resveratrol" . SPARSER::PROTEIN)
    ("Telomerase Activity" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("g protein" . SPARSER::PROTEIN) ("Sirt4" . SPARSER::PROTEIN)
    ("SIRT 2" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("SIRT7" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("Telomerase activity" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) (NIL . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("Pre-B" . SPARSER::PROTEIN)
    ("Nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("BLK or other early B-cell activation-related signaling molecules"
     . SPARSER::COLLECTION)
    ("HCK/FGR" . SPARSER::COLLECTION) ("SRC/FYN" . SPARSER::COLLECTION)
    ("FGR" . SPARSER::PROTEIN) ("HCK" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN) ("SRC" . SPARSER::PROTEIN)
    ("several basic amino acids" . SPARSER::AMINO-ACID)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("lipid" . SPARSER::LIPID)
    ("the third amino acid of BLK" . SPARSER::PROTEIN)
    ("cysteine" . SPARSER::AMINO-ACID)
    ("the second amino acid of BLK" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT)
    ("the CVID-associated L3P-BLK variant" . SPARSER::VARIANT)
    ("a CVID-associated variant" . SPARSER::VARIANT)
    ("proteins" . SPARSER::PROTEIN) ("ICOS" . SPARSER::PROTEIN)
    ("UNG" . SPARSER::PROTEIN) ("AID" . SPARSER::PROTEIN)
    ("Molecules" . SPARSER::MOLECULE) ("CD40L-CD40" . SPARSER::COLLECTION)
    ("HLA-DR and co-stimulatory" . SPARSER::COLLECTION)
    ("L3P- or common BLK variant" . SPARSER::COLLECTION)
    ("anti" . SPARSER::PROTEIN) ("CD40-CD40L" . SPARSER::COLLECTION)
    ("both L3P- or common BLK variant" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT) ("streptavidin" . SPARSER::PROTEIN)
    ("T-cell-" . SPARSER::PROTEIN) ("antigen-BCR" . SPARSER::COLLECTION)
    ("antigen/IgG" . SPARSER::COLLECTION) ("active" . SPARSER::ACTIVE)
    ("BSA" . SPARSER::PROTEIN) ("DQ" . SPARSER::MOLECULE)
    ("kinase" . SPARSER::KINASE) ("tracer" . SPARSER::MOLECULE)
    ("Tracer" . SPARSER::MOLECULE) ("IgM and IgD" . SPARSER::COLLECTION)
    ("IgD" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("either L3P- or common BLK protein" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("either L3P- or common BLK variant" . SPARSER::COLLECTION)
    ("LMP2a" . SPARSER::PROTEIN) ("components" . SPARSER::COMPONENT)
    ("L3P- and common BLK variant (Figure xref )" . SPARSER::COLLECTION)
    ("CD19, CD20, CD21, and membrane-bound" . SPARSER::COLLECTION)
    ("L3P-" . SPARSER::PROTEIN) ("receptor" . SPARSER::RECEPTOR)
    ("anti-IgM and IgG-F" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("COS" . SPARSER::MOLECULE) ("Syk and Igα" . SPARSER::COLLECTION)
    ("DCs" . SPARSER::MOLECULE) ("RNA" . SPARSER::RNA)
    ("PolyPhen-2" . SPARSER::COLLECTION)
    ("known CVID-associated genes" . SPARSER::GENE)
    ("Common Variable Immunodeficiency-associated candidate genes"
     . SPARSER::GENE)
    ("IgM-" . SPARSER::PROTEIN) ("monocytes" . SPARSER::PROTEIN)
    ("antibiotic" . SPARSER::DRUG) ("antigens" . SPARSER::PROTEIN)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE) ("Hib" . SPARSER::DRUG)
    ("IgM" . SPARSER::PROTEIN) ("IgG and IgA" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ig" . SPARSER::MOLECULE)
    ("class" . CLASS) ("subunit" . SPARSER::FRAGMENT)
    ("Proline" . SPARSER::AMINO-ACID) ("Leucine" . SPARSER::AMINO-ACID)
    ("putative) PID-associated gene variants" . SPARSER::VARIANT)
    ("CD40L [ xref ] and ICOS-L [ xref ]" . SPARSER::COLLECTION)
    ("cytokines and co-stimulatory" . SPARSER::COLLECTION)
    ("IL-4 and CD40L" . SPARSER::COLLECTION) ("molecules" . SPARSER::MOLECULE)
    ("cytokines" . SPARSER::PROTEIN) ("form" . SPARSER::FORM)
    ("peptide" . SPARSER::PEPTIDE) ("peptides" . SPARSER::PEPTIDE)
    ("Antigen" . SPARSER::PROTEIN) ("proteases" . SPARSER::PROTEIN)
    ("antigen" . SPARSER::PROTEIN) ("tyrosine kinase (BLK)" . SPARSER::PROTEIN)
    ("member B-lymphoid" . SPARSER::COLLECTION)
    ("Igα and Igβ" . SPARSER::COLLECTION)
    ("BCR-antigen" . SPARSER::PROTEIN-PAIR) ("tyrosine" . SPARSER::AMINO-ACID)
    ("Igα/Igβ" . SPARSER::COLLECTION) ("dimer" . SPARSER::DIMER)
    ("PID" . SPARSER::PROTEIN) ("L3P" . SPARSER::PROTEIN)
    ("L3P-BLK" . SPARSER::COLLECTION) ("Syk" . SPARSER::PROTEIN)
    ("kinases" . SPARSER::KINASE) ("Src" . SPARSER::PROTEIN)
    ("BLK" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("receptors (BCR)" . SPARSER::RECEPTOR) ("MHC" . SPARSER::PROTEIN)
    ("complexes" . SPARSER::BIO-COMPLEX) ("BCR" . SPARSER::PROTEIN)
    ("receptors" . SPARSER::RECEPTOR) ("antibodies" . SPARSER::ANTIBODY)
    ("antibody" . SPARSER::ANTIBODY) ("CO 2" . SPARSER::PROTEIN)
    ("6 B" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("CD154" . SPARSER::PROTEIN)
    ("Sulfo-NHS" . SPARSER::DRUG) ("ZAP70" . SPARSER::PROTEIN)
    ("Serum Albumin" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("gag-pol" . SPARSER::PROTEIN) ("Rev1" . SPARSER::PROTEIN)
    ("tyrosine Kinase" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID)
    ("kinase activity" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("ICAM-1" . SPARSER::PROTEIN)
    ("CD54" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD86" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("LMP2" . SPARSER::PROTEIN) ("LMP2A" . SPARSER::PROTEIN)
    ("Membrane Protein" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("anti-IgM" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("heavy chain" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("putative)" . SPARSER::PROTEIN)
    ("ICOS-L" . SPARSER::PROTEIN) ("CD27" . SPARSER::PROTEIN)
    ("CD81" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("Spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("Igβ" . SPARSER::PROTEIN) ("Igα" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("class-II" . SPARSER::PROTEIN)
    ("part" . SPARSER::COMPONENT) ("type" . TYPE)
    ("complex" . SPARSER::BIO-COMPLEX)
    ("PALB2 and CHEK2" . SPARSER::COLLECTION) ("Lys" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID) ("delC" . SPARSER::PROTEIN)
    ("cohort" . SPARSER::MOLECULE)
    ("French Canadian HBC/HBOC cancer families" . SPARSER::PROTEIN-FAMILY)
    ("mutated TP53 alleles" . SPARSER::ALLELE) ("variant" . SPARSER::VARIANT)
    ("partial" . SPARSER::PROTEIN) ("his" . SPARSER::AMINO-ACID)
    ("37 French Canadian HBC/HBOC families" . SPARSER::PROTEIN-FAMILY)
    ("group" . SPARSER::MOLECULE) ("allele" . SPARSER::ALLELE)
    ("isoform" . SPARSER::ISOFORM) ("weaker" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("proline" . SPARSER::AMINO-ACID)
    ("state" . SPARSER::BIO-STATE)
    ("TP53, dbSNP and EVS" . SPARSER::COLLECTION)
    ("variants" . SPARSER::VARIANT)
    ("French Canadian (Quebec) cancer families" . SPARSER::PROTEIN-FAMILY)
    ("seven" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("Asp" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("Ser" . SPARSER::AMINO-ACID) ("Pro" . SPARSER::AMINO-ACID)
    ("ACC" . SPARSER::PROTEIN)
    ("our previously reported HBC families" . SPARSER::PROTEIN-FAMILY)
    ("families (LFL)" . SPARSER::PROTEIN-FAMILY)
    ("hereditary cancer families" . SPARSER::PROTEIN-FAMILY)
    ("a moderately penetrant breast cancer susceptibility gene"
     . SPARSER::GENE)
    ("gene" . SPARSER::GENE) ("His" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID) ("LSF" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("types" . TYPE) ("LFS" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE) ("BRCA1/BRCA2" . SPARSER::COLLECTION)
    ("TP53, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("ovarian cancer susceptibility genes" . SPARSER::GENE)
    ("ovarian cancer (HBOC) syndrome families" . SPARSER::PROTEIN-FAMILY)
    ("Cys" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("DNA" . SPARSER::DNA)
    ("protein" . SPARSER::PROTEIN)
    ("French Canadian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("family" . SPARSER::PROTEIN-FAMILY)
    ("French Canadian HBC families" . SPARSER::PROTEIN-FAMILY)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("the hereditary breast-ovarian cancer susceptibility (HBC/HBOC) genes"
     . SPARSER::GENE)
    ("BRCA1, BRCA2 and PALB2" . SPARSER::COLLECTION) ("genes" . SPARSER::GENE)
    ("MDM2" . SPARSER::PROTEIN) ("amino acid" . SPARSER::AMINO-ACID)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CHEK2" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)))